	Unnamed: 0.12	Unnamed: 0.11	Unnamed: 0.10	Unnamed: 0.9	Unnamed: 0.8	Unnamed: 0.7	Unnamed: 0.6	Unnamed: 0.5	Unnamed: 0.4	Unnamed: 0.3	Unnamed: 0.2	Unnamed: 0.1	Unnamed: 0	NORMALIZED_COLUMN_HEADER	ATTRIBUTE_TYPE	DATATYPE	DESCRIPTIONS	DISPLAY_NAME	PRIORITY	CATEGORY	VOCABULARY	COLOR	FLAG
0	0	0	0	0	0	0	0	0	0	0	0	0	0	AGE_AT_DIAGNOSIS_mel_cell_2016									
1	1	1	1	1	1	1	1	1	1	1	1	1	1	AGE_AT_DIAGNOSIS_mel_cell_2016_priority									
2	2	2	2	2	2	2	2	2	2	2	2	2	2	AGE_CURRENT_mixedpact									
3	3	3	3	3	3	3	3	3	3	3	3	3	3	AGE_CURRENT_mixedpact_priority									
4	4	4	4	4	4	4	4	4	4	4	4	4	4	AGE_CURRENT_msk_solid_heme									
5	5	5	5	5	5	5	5	5	5	5	5	5	5	AGE_CURRENT_msk_solid_heme_priority									
6	6	6	6	6	6	6	6	6	6	6	6	6	6	AGE_CURRENT_mskarcher									
7	7	7	7	7	7	7	7	7	7	7	7	7	7	AGE_CURRENT_mskarcher_priority									
8	8	8	8	8	8	8	8	8	8	8	8	8	8	AGE_CURRENT_mskimpact									
9	9	9	9	9	9	9	9	9	9	9	9	9	9	AGE_CURRENT_mskimpact_heme									
10	10	10	10	10	10	10	10	10	10	10	10	10	10	AGE_CURRENT_mskimpact_heme_priority									
11	11	11	11	11	11	11	11	11	11	11	11	11	11	AGE_CURRENT_mskimpact_priority									
12	12	12	12	12	12	12	12	12	12	12	12	12	12	AGE_CURRENT_mskraindance									
13	13	13	13	13	13	13	13	13	13	13	13	13	13	AGE_CURRENT_mskraindance_priority									
14	14	14	14	14	14	14	14	14	14	14	14	14	14	AGE_CURRENT_sclc_mskimpact_2017									
15	15	15	15	15	15	15	15	15	15	15	15	15	15	AGE_CURRENT_sclc_mskimpact_2017_priority									
16	16	16	16	16	16	16	16	16	16	16	16	16	16	AGE_mixedpact									
17	17	17	17	17	17	17	17	17	17	17	17	17	17	AGE_mixedpact_priority									
18	18	18	18	18	18	18	18	18	18	18	18	18	18	BIOPSY_TIME_mel_cell_2016									
19	19	19	19	19	19	19	19	19	19	19	19	19	19	BIOPSY_TIME_mel_cell_2016_priority									
20	20	20	20	20	20	20	20	20	20	20	20	20	20	AA_DNA_MUTATION_SIGNATURE	SAMPLE	STRING	AA DNA MUTATION SIGNATURE	AA DNA MUTATION SIGNATURE	1				
21	21	21	21	21	21	21	21	21	21	21	21	21	21	AA_SIGNATURE_NON_NORMALIZED	SAMPLE	STRING	AA SIGNATURE NON NORMALIZED	AA SIGNATURE NON NORMALIZED	1				
22	22	22	22	22	22	22	22	22	22	22	22	22	22	AA_SIGNATURE_NORMALIZED	SAMPLE	STRING	AA SIGNATURE NORMALIZED	AA SIGNATURE NORMALIZED	1				
23	23	23	23	23	23	23	23	23	23	23	23	23	23	ABDOMINAL_DISTENSION	PATIENT	NUMBER	Abdominal Distension (Weeks)	Abdominal Distension (Weeks)	1				
24	24	24	24	24	24	24	24	24	24	24	24	24	24	ABDOMINAL_MASS_WEEKS	PATIENT	NUMBER	Abdominal Mass (Weeks)	Abdominal Mass (Weeks)	1				
25	25	25	25	25	25	25	25	25	25	25	25	25	25	ABDOMINAL_PAIN_WEEKS	PATIENT	NUMBER	Abdominal Pain (Weeks)	Abdominal Pain (Weeks)	1				
26	26	26	26	26	26	26	26	26	26	26	26	26	26	ABERRANT_CELL_FRACTION	SAMPLE	STRING	Aberrant Cell Fraction	Aberrant Cell Fraction	1				
27	27	27	27	27	27	27	27	27	27	27	27	27	27	ABI_ENZA_EXPOSURE_STATUS	PATIENT	STRING	Abiraterone (ABI) and Enzalutamide (ENZA) Exposure Status	Abiraterone (ABI) and Enzalutamide (ENZA) Exposure Status	1				
28	28	28	28	28	28	28	28	28	28	28	28	28	28	ABLATION_EMBOLIZATION_TX_ADJUVANT	PATIENT	STRING	Ablation embolization tx adjuvant	Ablation embolization tx adjuvant	1				
29	29	29	29	29	29	29	29	29	29	29	29	29	29	ABNORMAL_LYMPHOCYTE_PERCENT	SAMPLE	NUMBER	Abnormal Lymphocyte Percent	Abnormal Lymphocyte Percent	1				
30	30	30	30	30	30	30	30	30	30	30	30	30	30	ABSOLUTE_CANCER_DNA_FRACTION	SAMPLE	NUMBER	Absolute cancer dna fraction	Absolute cancer dna fraction	1				
31	31	31	31	31	31	31	31	31	31	31	31	31	31	ABSOLUTE_EXTRACT_PLOIDY	SAMPLE	NUMBER	Absolute extract ploidy.	Absolute Extract Ploidy	1				
32	32	32	32	32	32	32	32	32	32	32	32	32	32	ABSOLUTE_EXTRACT_PURITY	SAMPLE	NUMBER	Absolute extract purity.	Absolute Extract Purity	1				
33	33	33	33	33	33	33	33	33	33	33	33	33	33	ABSOLUTE_GENOME_DOUBLINGS	SAMPLE	STRING	Absolute Genome Doublings	Absolute Genome Doublings	1				
34	34	34	34	34	34	34	34	34	34	34	34	34	34	ABS_NEUTROPHIL_VALUE	PATIENT	STRING	Abs Neutrophil Value	Abs Neutrophil Value	1				
35	35	35	35	35	35	35	35	35	35	35	35	35	35	ACCESSION_OUT	SAMPLE	STRING	Accession Out	Accession Out	1				
36	36	36	36	36	36	36	36	36	36	36	36	36	36	ACGH_DATA	SAMPLE	STRING	ACGH Data.	ACGH Data	1				
37	37	37	37	37	37	37	37	37	37	37	37	37	37	ACGH_TUMOR_TYPE	SAMPLE	STRING	aCGH Tumor Type	aCGH Tumor Type	1				
38	38	38	38	38	38	38	38	38	38	38	38	38	38	ACHIEVED_RESECTION	PATIENT	STRING	Achieved Resection	Achieved Resection	1				
39	39	39	39	39	39	39	39	39	39	39	39	39	39	ACTIONABLE_ALTERATIONS	SAMPLE	NUMBER	Number of actionable alterations	Actionable Alterations	1				
40	40	40	40	40	40	40	40	40	40	40	40	40	40	ACTIONABLE_ALT_LEVEL	SAMPLE	STRING	Level of actionable alterations	Level of actionable alterations	1				
41	41	41	41	41	41	41	41	41	41	41	41	41	41	ADDITIONAL_NOTES	SAMPLE	STRING	Additional Notes	Additional Notes	1				
42	42	42	42	42	42	42	42	42	42	42	42	42	42	ADDITIONAL_RX_TX	PATIENT	STRING	Additional radiation therapy Yes/No indicator	Additional Radiation Therapy	1				
43	43	43	43	43	43	43	43	43	43	43	43	43	43	ADDITIONAL_SAMPLE	SAMPLE	STRING	Is there an additional sample?	Is there an additional sample?	1				
44	44	44	44	44	44	44	44	44	44	44	44	44	44	ADDITIONAL_SURGERY_FOR_NEW_TUMOR_EVENT	SAMPLE	STRING	Additional Surgery For New Tumor Event	Additional Surgery For New Tumor Event	1				
45	45	45	45	45	45	45	45	45	45	45	45	45	45	ADDITIONAL_TREATMENT_FOR_NEW_TUMOR_EVENT_PHARMACEUTICAL	PATIENT	STRING	Additional Treatment For New Tumor Event: Pharmaceutical	Additional Treatment For New Tumor Event: Pharmaceutical	1				
46	46	46	46	46	46	46	46	46	46	46	46	46	46	ADDITIONAL_TREATMENT_FOR_NEW_TUMOR_EVENT_RADIATION	PATIENT	STRING	Additional Treatment For New Tumor Event: Radiation	Additional Treatment For New Tumor Event: Radiation	1				
47	47	47	47	47	47	47	47	47	47	47	47	47	47	ADIPOSE_TISSUE_PERCENTAGE	SAMPLE	NUMBER	% Adipose Tissue	% Adipose Tissue	1				
48	48	48	48	48	48	48	48	48	48	48	48	48	48	ADJUVANT_CHEMO	PATIENT	STRING	Adjuvant Chemotherapy	Adjuvant Chemotherapy	1				
49	49	49	49	49	49	49	49	49	49	49	49	49	49	ADJUVANT_CT	PATIENT	STRING	Adjuvant chemotherapy receivec	Adjuvant Chemotherapy	1				
50	50	50	50	50	50	50	50	50	50	50	50	50	50	ADJUVANT_FOLFOX_METACHRONOUS_METS	SAMPLE	STRING	For metachronous mets, did they get adjuvant FOLFOX	Metachronous Mets received adj FOLFOX	1				
51	51	51	51	51	51	51	51	51	51	51	51	51	51	ADJUVANT_HAIP	PATIENT	STRING	Adjuvant HAIP	Adjuvant HAIP	1				
52	52	52	52	52	52	52	52	52	52	52	52	52	52	ADJUVANT_HORMONE_THERAPY	PATIENT	STRING	Adjuvant Hormone Therapy	Adjuvant Hormone Therapy	1				
53	53	53	53	53	53	53	53	53	53	53	53	53	53	ADJUVANT_NEOADJ_IMATINIB	PATIENT	STRING	Adjuvant/Neoadjuvant Imatinib	Adjuvant/Neoadjuvant Imatinib	1				
54	54	54	54	54	54	54	54	54	54	54	54	54	54	ADJUVANT_TX	PATIENT	STRING	Adjuvant treatment.	Adjuvant Treatment	1				
55	55	55	55	55	55	55	55	55	55	55	55	55	55	ADJ_RT_AFTER_FIRST_SURGERY	PATIENT	STRING	Adjuvant RT after first surgery?	Adjuvant RT after first surgery?	1				
56	56	56	56	56	56	56	56	56	56	56	56	56	56	ADJ_TX_AFTER_FIRST_SURGERY	PATIENT	STRING	Adjuvant therapy after first surgery?	Adjuvant therapy after first surgery?	1				
57	57	57	57	57	57	57	57	57	57	57	57	57	57	ADJ_XRT	PATIENT	STRING	Status of adjuvant radiation therapy. Adjuvant therapy is therapy received after surgery.	MedR Adjuvant Radiation	1				
58	58	58	58	58	58	58	58	58	58	58	58	58	58	ADMINISTRATION_OF_DRUG_WEEKS	PATIENT	NUMBER	Administration Of Drug Weeks	Administration Of Drug Weeks	1				
59	59	59	59	59	59	59	59	59	59	59	59	59	59	AE1	SAMPLE	STRING	AE1	AE1	1				
60	60	60	60	60	60	60	60	60	60	60	60	60	60	AE1_AE3_STAIN	SAMPLE	STRING	AE1:AE3 Stain	AE1:AE3 Stain	1				
61	61	61	61	61	61	61	61	61	61	61	61	61	61	AFB1_SIGNATURE_NON_NORMALIZED	SAMPLE	STRING	AFB1 SIGNATURE NON NORMALIZED	AFB1 SIGNATURE NON NORMALIZED	1				
62	62	62	62	62	62	62	62	62	62	62	62	62	62	AFB1_SIGNATURE_NORMALIZED	SAMPLE	STRING	AFB1 SIGNATURE NORMALIZED	AFB1 SIGNATURE NORMALIZED	1				
63	63	63	63	63	63	63	63	63	63	63	63	63	63	AFP_AT_PROCUREMENT	SAMPLE	STRING	Alpha Fetoprotein At Procurement	AFP At Procurement	1				
64	64	64	64	64	64	64	64	64	64	64	64	64	64	AFP_NORM_RANGE_LOWER	SAMPLE	STRING	AFP Normal Range Lower Bound	AFP Normal Range Lower Bound	1				
65	65	65	65	65	65	65	65	65	65	65	65	65	65	AFP_NORM_RANGE_UPPER	SAMPLE	STRING	AFP Normal Range Higher Bound	AFP Normal Range Higher Bound	1				
66	66	66	66	66	66	66	66	66	66	66	66	66	66	AGE	PATIENT	NUMBER	Age at which a condition or disease was first diagnosed.	Diagnosis Age	1				
67	67	67	67	67	67	67	67	67	67	67	67	67	67	AGENT	PATIENT	STRING	AGENT	AGENT	1				
68	68	68	68	68	68	68	68	68	68	68	68	68	68	AGE_AT_BIRTH_OF_FIRST_CHILD	PATIENT	NUMBER	Age at Birth Of First Child	Age at Birth Of First Child	1				
69	69	69	69	69	69	69	69	69	69	69	69	69	69	AGE_AT_BMI_MEASUREMENT	PATIENT	NUMBER	Age at BMI Measurement	Age at BMI Measurement	1				
70	70	70	70	70	70	70	70	70	70	70	70	70	70	AGE_AT_DEATH	PATIENT	STRING	Age at Death	Age at Death	1				
71	71	71	71	71	71	71	71	71	71	71	71	71	72	AGE_AT_DIAGNOSIS_GROUP	PATIENT	STRING	Patient's age at the time of primary diagnosis with cancer grouped into 5 year intervals.	MedR Age at Diagnosis	1				
72	72	72	72	72	72	72	72	72	72	72	72	72	73	AGE_AT_INITIAL_DIAGNOSIS	SAMPLE	NUMBER	Age recorded at initial diagnosis	Age at Initial Diagnosis	1				
73	73	73	73	73	73	73	73	73	73	73	73	73	74	AGE_AT_INITIAL_PATHOLOGIC_DIAGNOSIS	PATIENT	NUMBER	Age At Initial Pathological Diagnosis	Age At Initial Pathological Diagnosis	1				
74	74	74	74	74	74	74	74	74	74	74	74	74	75	AGE_AT_LAST_FOLLOWUP	PATIENT	NUMBER	Age At Last Follow-up	Age At Last Follow-Up	1				
75	75	75	75	75	75	75	75	75	75	75	75	75	76	AGE_AT_PROCEDURE	SAMPLE	NUMBER	Age recorded at procedure	Age at Procedure	1				
76	76	76	76	76	76	76	76	76	76	76	76	76	77	AGE_AT_PROCUREMENT	PATIENT	NUMBER	Age At Procurement Of The Submitted Specimen	Age At Procurement	1				
77	77	77	77	77	77	77	77	77	77	77	77	77	78	AGE_AT_RELAPSE	PATIENT	NUMBER	Age at relapse	Age at relapse	1				
78	78	78	78	78	78	78	78	78	78	78	78	78	79	AGE_AT_SEQ_REPORT	SAMPLE	NUMBER	Age (in days) at which sequencing was reported	Age at Which Sequencing was Reported (Days)	1				
79	79	79	79	79	79	79	79	79	79	79	79	79	80	AGE_AT_SURGERY	PATIENT	NUMBER	Age at surgery.	Age At Surgery	1				
80	80	80	80	80	80	80	80	80	80	80	80	80	81	AGE_CELL_LINE_YEAR	PATIENT	NUMBER	Age of patient when cell line was established	Age of patient when cell line was established	1				
81	81	81	81	81	81	81	81	81	81	81	81	81	82	AGE_CLASS	PATIENT	NUMBER	Age Class	Age Class	1				
82	82	82	82	82	82	82	82	82	82	82	82	82	83	AGE_CURRENT	PATIENT	NUMBER	Patient Current Age	Patient Current Age	1				
83	83	83	83	83	83	83	83	83	83	83	83	83	84	AGE_FUDR_START	PATIENT	NUMBER	Patient age in years at the start of FUDR treatment	Age at start of FUDR treatment	1				
84	84	84	84	84	84	84	84	84	84	84	84	84	85	AGE_GROUP	PATIENT	STRING	Age Group at Diagnosis in Years	Age Group at Diagnosis in Years	1				
85	85	85	85	85	85	85	85	85	85	85	85	85	86	AGE_IN_DAYS	PATIENT	NUMBER	Age at which a condition or disease was first diagnosed.	Diagnosis Age (days)	1				
86	86	86	86	86	86	86	86	86	86	86	86	86	87	AGE_REGISTRATION	PATIENT	NUMBER	Age at registration of the study	Age at registration of the study	1				
87	87	87	87	87	87	87	87	87	87	87	87	87	88	AGE_TESTING_YEARS	PATIENT	NUMBER	Age at Testing (Years)	Age at Testing (Years)	1				
88	88	88	88	88	88	88	88	88	88	88	88	88	89	AJCC_CLINICAL_TUMOR_STAGE	PATIENT	STRING	The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.	Neoplasm Disease Stage American Joint Committee on Cancer Code	1				
89	89	89	89	89	89	89	89	89	89	89	89	89	90	AJCC_INCIDENTAL_PROSTATE_CANCER	SAMPLE	STRING	American Joint Committee on Cancer Code Incidental Prostate Cancer	AJCC Incidental Prostate Cancer	1				
90	90	90	90	90	90	90	90	90	90	90	90	90	91	AJCC_METASTASIS_CLINICAL_CM	PATIENT	STRING	Extent of the distant metastasis for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.	Neoplasm American Joint Committee on Cancer Clinical Distant Metastasis M Stage	1				
91	91	91	91	91	91	91	91	91	91	91	91	91	92	AJCC_METASTASIS_PATHOLOGIC_PM	PATIENT	STRING	Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).	American Joint Committee on Cancer Metastasis Stage Code	1				
92	92	92	92	92	92	92	92	92	92	92	92	92	93	AJCC_NODES_CLINICAL_CN	PATIENT	STRING	The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.	American Joint Committee on Cancer Lymph Node Stage Code	1				
93	93	93	93	93	93	93	93	93	93	93	93	93	94	AJCC_NODES_CLINICAL_CT	PATIENT	STRING	The codes that represent the stage of cancer based on the nodes present (T stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.	American Joint Committee on Cancer Lymph Node Stage Code	1				
94	94	94	94	94	94	94	94	94	94	94	94	94	95	AJCC_NODES_PATHOLOGIC_PN	PATIENT	STRING	The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.	Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code	1				
95	95	95	95	95	95	95	95	95	95	95	95	95	96	AJCC_PATHOLOGIC_TUMOR_STAGE	PATIENT	STRING	The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.	Neoplasm Disease Stage American Joint Committee on Cancer Code	1				
96	96	96	96	96	96	96	96	96	96	96	96	96	97	AJCC_STAGING_EDITION	PATIENT	STRING	The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.	American Joint Committee on Cancer Publication Version Type	1				
97	97	97	97	97	97	97	97	97	97	97	97	97	98	AJCC_TUMOR_CLINICAL_CT	PATIENT	STRING	Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).	American Joint Committee on Cancer Tumor Stage Code	1				
98	98	98	98	98	98	98	98	98	98	98	98	98	99	AJCC_TUMOR_PATHOLOGIC_PT	PATIENT	STRING	Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).	American Joint Committee on Cancer Tumor Stage Code	1				
99	99	99	99	99	99	99	99	99	99	99	99	99	100	AKT1_E17K_MUTATION_STATUS	SAMPLE	STRING	AKT1 E17K Mutation Status	AKT1 E17K Mutation Status	1				
100	100	100	100	100	100	100	100	100	100	100	100	100	101	AKT1_MUTATION	SAMPLE	STRING	AKT1 Mutation	AKT1 Mutation	1				
101	101	101	101	101	101	101	101	101	101	101	101	101	102	ALB_G_DL	SAMPLE	STRING	alb (g/dl)	alb (g/dl)	1				
102	102	102	102	102	102	102	102	102	102	102	102	102	103	ALCOHOL	PATIENT	STRING	Alcohol	Alcohol	1				
103	103	103	103	103	103	103	103	103	103	103	103	103	104	ALCOHOL_CONSUMPTION_FREQUENCY	PATIENT	STRING	Alcohol Consumption Frequency	Alcohol Consumption Frequency	1				
104	104	104	104	104	104	104	104	104	104	104	104	104	105	ALCOHOL_EXPOSURE_INTENSITY	PATIENT	STRING	Alcohol Exposure Intensity	Alcohol Exposure Intensity	1				
105	105	105	105	105	105	105	105	105	105	105	105	105	106	ALCOHOL_HISTORY_DOCUMENTED	PATIENT	STRING	Alcohol History Documented	Alcohol History Documented	1				
106	106	106	106	106	106	106	106	106	106	106	106	106	107	ALC_COUNT	PATIENT	STRING	ALC Count	ALC Count	1				
107	107	107	107	107	107	107	107	107	107	107	107	107	108	ALIAS	SAMPLE	STRING	Other cell line name or ATCC identifier	Alias	1				
108	108	108	108	108	108	108	108	108	108	108	108	108	109	ALK_ANALYSIS_TYPE	SAMPLE	STRING	ALK Analysis Type	ALK Analysis Type	1				
109	109	109	109	109	109	109	109	109	109	109	109	109	110	ALK_TRANSLOCATION_STATUS	SAMPLE	STRING	ALK Translocation Status	ALK Translocation Status	1				
110	110	110	110	110	110	110	110	110	110	110	110	110	111	ALK_TRANSLOCATION_VARIANT	SAMPLE	STRING	ALK Translocation Variant	ALK Translocation Variant	1				
111	111	111	111	111	111	111	111	111	111	111	111	111	112	ALLELE_FREQUENCY_CELLULARITY	SAMPLE	NUMBER	Cllularity based on allele frequency	Cllularity based on allele frequency	1				
112	112	112	112	112	112	112	112	112	112	112	112	112	113	ALLERGIES	PATIENT	STRING	Allergies	Allergies	1				
113	113	113	113	113	113	113	113	113	113	113	113	113	114	ALPHA_FETOPROTIEN_AT_PROCUREMENT	PATIENT	STRING	Alpha Fetoprotein At Procurement	AFP At Procurement	1				
114	114	114	114	114	114	114	114	114	114	114	114	114	115	ALPHA_FETOPROTIEN_NORMAL_RANGE_LOWER	PATIENT	STRING	AFP Normal Range Lower Bound	AFP Normal Range Lower Bound	1				
115	115	115	115	115	115	115	115	115	115	115	115	115	116	ALPHA_FETOPROTIEN_NORMAL_RANGE_UPPER	PATIENT	STRING	AFP Normal Range Higher Bound	AFP Normal Range Higher Bound	1				
116	116	116	116	116	116	116	116	116	116	116	116	116	117	ALP_U_L	SAMPLE	STRING	alp (u/l)	alp (u/l)	1				
117	117	117	117	117	117	117	117	117	117	117	117	117	118	ALTERATIONS	SAMPLE	STRING	Alterations	Alterations	1				
118	118	118	118	118	118	118	118	118	118	118	118	118	119	ALTERNATE_THERAPY	PATIENT	STRING	Alternative Therapy Given	Alternative Therapy Given	1				
119	119	119	119	119	119	119	119	119	119	119	119	119	120	ALTERNATE_THERAPY_OTHER	PATIENT	STRING	Other Alternative Therapy Given	Other Alternative Therapy Given	1				
120	120	120	120	120	120	120	120	120	120	120	120	120	121	ALT_COUNT	SAMPLE	NUMBER	Alt Count	Alt Count	1				
121	121	121	121	121	121	121	121	121	121	121	121	121	122	ALT_FREQUENCY	SAMPLE	NUMBER	Alt Frequency	Alt Frequency	1				
122	122	122	122	122	122	122	122	122	122	122	122	122	123	AML_DIAGNOSIS	PATIENT	STRING	AML Diagnosis	AML Diagnosis	1				
123	123	123	123	123	123	123	123	123	123	123	123	123	124	AML_IN_SKIN_PERCENTAGE	PATIENT	NUMBER	AML in skin, determined by WGS.	AML in Skin Percentage	1				
124	124	124	124	124	124	124	124	124	124	124	124	124	125	AMOUNT	SAMPLE	STRING	Amount	Amount	1				
125	125	125	125	125	125	125	125	125	125	125	125	125	126	AMPLIFICATION_1P	SAMPLE	STRING	1p Amplification	1p Amplification	1				
126	126	126	126	126	126	126	126	126	126	126	126	126	127	AMPLIFICATION_1Q	SAMPLE	STRING	1q Amplification	1q Amplification	1				
127	127	127	127	127	127	127	127	127	127	127	127	127	128	AMPLIFICATION_STATUS	SAMPLE	STRING	Amplification Status	Amplification Status	1				
128	128	128	128	128	128	128	128	128	128	128	128	128	129	AMP_12Q15_CDK4	SAMPLE	STRING	AMP 12q15 CDK4	AMP 12q15 CDK4	1				
129	129	129	129	129	129	129	129	129	129	129	129	129	130	AMP_12Q15_DDIT3	SAMPLE	STRING	AMP 12q15 DDIT3	AMP 12q15 DDIT3	1				
130	130	130	130	130	130	130	130	130	130	130	130	130	131	AMP_12Q15_FRS2	SAMPLE	STRING	AMP 12q15 FRS2	AMP 12q15 FRS2	1				
131	131	131	131	131	131	131	131	131	131	131	131	131	132	AMP_12Q15_HMGA2	SAMPLE	STRING	AMP 12q15 HMGA2	AMP 12q15 HMGA2	1				
132	132	132	132	132	132	132	132	132	132	132	132	132	133	AMP_12Q15_MDM2	SAMPLE	STRING	AMP 12q15 MDM2	AMP 12q15 MDM2	1				
133	133	133	133	133	133	133	133	133	133	133	133	133	134	AMP_FEATURE	SAMPLE	STRING	Amp Feature	Amp Feature	1				
134	134	134	134	134	134	134	134	134	134	134	134	134	135	ANALYSIS_COHORT	SAMPLE	STRING	Analysis Cohort	Analysis Cohort	1				
135	135	135	135	135	135	135	135	135	135	135	135	135	136	ANALYSIS_COHORT_CA	PATIENT	STRING	ICC evaluated by computational analysis	ICC-CA	1				
136	136	136	136	136	136	136	136	136	136	136	136	136	137	ANALYSIS_COHORT_HA	SAMPLE	STRING	Resected ICC evaluated by semi-quantitative histological assessment	ICC-HA	1				
137	137	137	137	137	137	137	137	137	137	137	137	137	138	ANALYSIS_ID	SAMPLE	STRING	analysis id	analysis id	1				
138	138	138	138	138	138	138	138	138	138	138	138	138	139	ANALYSIS_TYPE	SAMPLE	STRING	Type of analysis performed	Analysis Type	1				
139	139	139	139	139	139	139	139	139	139	139	139	139	140	ANAPLASTIC_PERCENTAGE	PATIENT	STRING	Anaplastic Percentage	Anaplastic Percentage	1				
140	140	140	140	140	140	140	140	140	140	140	140	140	141	ANATOMICAL_SUBTYPE	SAMPLE	STRING	Anatomical Subtype	Anatomical Subtype	1				
141	141	141	141	141	141	141	141	141	141	141	141	141	142	ANATOMIC_REGION	PATIENT	STRING	Anatomic Region.	Anatomic Region	1				
142	142	142	142	142	142	142	142	142	142	142	142	142	143	ANC_COUNT	PATIENT	STRING	ANC Count	ANC Count	1				
143	143	143	143	143	143	143	143	143	143	143	143	143	144	ANDROGEN_DEPRIVATION_THERAPY	PATIENT	STRING	Androgen Deprivation Therapy (ADT)	Androgen Deprivation Therapy (ADT)	1				
144	144	144	144	144	144	144	144	144	144	144	144	144	145	ANEUPLOIDY_SCORE	SAMPLE	NUMBER	Aneuploidy Score	Aneuploidy Score	1				
145	145	145	145	145	145	145	145	145	145	145	145	145	146	ANGIOLYMPHATIC_INVASION	PATIENT	STRING	Presence of angiolymphatic invasion.	Angiolymphatic Invasion	1				
146	146	146	146	146	146	146	146	146	146	146	146	146	147	ANIMAL_INSECT_ALLERGY_AGE	PATIENT	NUMBER	Animal Insect Allergy Age	Animal Insect Allergy Age	1				
147	147	147	147	147	147	147	147	147	147	147	147	147	148	ANIMAL_INSECT_ALLERGY_HIST	PATIENT	STRING	Animal insect allergy history.	Animal Insect Allergy History	1				
148	148	148	148	148	148	148	148	148	148	148	148	148	149	ANIMAL_INSECT_ALLERGY_TYPES	PATIENT	STRING	Animal insect allergy types.	Animal Insect Allergy Types	1				
149	149	149	149	149	149	149	149	149	149	149	149	149	150	ANTIREFLUX_TREATMENT	PATIENT	STRING	Anti-reflux treatment.	Anti-reflux Treatment	1				
150	150	150	150	150	150	150	150	150	150	150	150	150	151	ANTIREFLUX_TREATMENT_TYPE	PATIENT	STRING	Anti-reflux treatment type.	Anti-reflux Treatment Type	1				
151	151	151	151	151	151	151	151	151	151	151	151	151	152	ANTIRETROVIRAL_THERAPY_AT_DIAGNOSIS	PATIENT	STRING	Yes/No indicator for antiretroviral therapy at diagnosis	Antiretroviral Therapy Status at Diagnosis	1				
152	152	152	152	152	152	152	152	152	152	152	152	152	153	ANTI_O_VIVERRINI_IGG	SAMPLE	STRING	anti_O_viverrini_IgG	anti_O_viverrini_IgG	1				
153	153	153	153	153	153	153	153	153	153	153	153	153	154	ANY_THERAPY_2YRS	PATIENT	STRING	Patient-reported response to the question: Since your diagnosis with metastatic breast cancer, have you been on any of your cancer therapies for more than 2 years?	PRD Any Therapy More Than 2 Years	1				
154	154	154	154	154	154	154	154	154	154	154	154	154	155	ANY_THERAPY_XRC_RESPONSE	PATIENT	STRING	Patient-reported response to the question: Have any of your therapies worked extraordinarily well - made your cancer disappear completely (resulting in no evidence of disease, NED) or resulted in a dramatic reduction in tumor size - for any period of time?	PRD Extraordinary Reponse to Any Therapy	1				
155	155	155	155	155	155	155	155	155	155	155	155	155	156	APC_INTRON	SAMPLE	STRING	APC Intron	APC Intron	1				
156	156	156	156	156	156	156	156	156	156	156	156	156	157	ARCHER	SAMPLE	STRING	Archer Panel	Archer Panel	1				
157	157	157	157	157	157	157	157	157	157	157	157	157	158	ARHGAP26_ARHGAP6_CLDN18_REARRANGEMENT	SAMPLE	STRING	ARHGAP26-ARHGAP6-CLDN18 Rearrangement.	ARHGAP26-ARHGAP6-CLDN18 Rearrangement	1				
158	158	158	158	158	158	158	158	158	158	158	158	158	159	ARHGAP35_MUTATION_STATUS	SAMPLE	STRING	ARHGAP35 Mutation Status	ARHGAP35 Mutation Status	1				
159	159	159	159	159	159	159	159	159	159	159	159	159	160	ARID1A_MUTATION	SAMPLE	STRING	ARID1A mutation is present.	ARID1A Mutation	1				
160	160	160	160	160	160	160	160	160	160	160	160	160	161	ARID1A_PROTEIN_CODING	SAMPLE	NUMBER	ARID1A Protein Coding	ARID1A Protein Coding	1				
161	161	161	161	161	161	161	161	161	161	161	161	161	162	ARID5B_MUTATION_STATUS	SAMPLE	STRING	ARID5B Mutation Status	ARID5B Mutation Status	1				
162	162	162	162	162	162	162	162	162	162	162	162	162	163	ARMDRIVER_CN	SAMPLE	STRING	ArmDriver CN	ArmDriver CN	1				
163	163	163	163	163	163	163	163	163	163	163	163	163	164	ARM_SCNA_CLUSTER	SAMPLE	STRING	Arm-level SCNA cluster assignment	Arm-level SCNA cluster assignment	1				
164	164	164	164	164	164	164	164	164	164	164	164	164	165	ARNT_SOMATIC	SAMPLE	STRING	ARNT Somatic Mutation	ARNT Somatic Mutation	1				
165	165	165	165	165	165	165	165	165	165	165	165	165	166	AR_EXPRESSION	SAMPLE	NUMBER	AR Expression	AR Expression	1				
166	166	166	166	166	166	166	166	166	166	166	166	166	167	AR_HIGH	SAMPLE	STRING	AR High	AR High	1				
167	167	167	167	167	167	167	167	167	167	167	167	167	168	AR_MRNA	SAMPLE	NUMBER	AR mRNA	AR mRNA	1				
168	168	168	168	168	168	168	168	168	168	168	168	168	169	AR_PROTEIN	SAMPLE	NUMBER	AR Protein	AR Protein	1				
169	169	169	169	169	169	169	169	169	169	169	169	169	170	AR_SCORE	SAMPLE	NUMBER	AR score	AR Score	1				
170	170	170	170	170	170	170	170	170	170	170	170	170	171	AR_STATUS	SAMPLE	STRING	AR Status.	AR Status	1				
171	171	171	171	171	171	171	171	171	171	171	171	171	172	AR_V7_PRESENCE	SAMPLE	NUMBER	AR V7 Presence	AR V7 Presence	1				
172	172	172	172	172	172	172	172	172	172	172	172	172	173	AR_V7_RATIO	SAMPLE	NUMBER	AR V7 Ratio	AR V7 Ratio	1				
173	173	173	173	173	173	173	173	173	173	173	173	173	174	AR_V7_READS	SAMPLE	NUMBER	AR V7 Reads	AR V7 Reads	1				
174	174	174	174	174	174	174	174	174	174	174	174	174	175	AR_VALUE	SAMPLE	STRING	AR Value	AR Value	1				
175	175	175	175	175	175	175	175	175	175	175	175	175	176	ASBESTOS_EXPOSURE_AGE	PATIENT	STRING	Asbestos Exposure Age	Asbestos Exposure Age	1				
176	176	176	176	176	176	176	176	176	176	176	176	176	177	ASBESTOS_EXPOSURE_AGE_LAST	PATIENT	STRING	Asbestos Exposure Age Last	Asbestos Exposure Age Last	1				
177	177	177	177	177	177	177	177	177	177	177	177	177	178	ASBESTOS_EXPOSURE_SOURCE	PATIENT	STRING	Asbestos Exposure Source	Asbestos Exposure Source	1				
178	178	178	178	178	178	178	178	178	178	178	178	178	179	ASBESTOS_EXPOSURE_TYPE	PATIENT	STRING	Asbestos Exposure Type	Asbestos Exposure Type	1				
179	179	179	179	179	179	179	179	179	179	179	179	179	180	ASBESTOS_EXPOSURE_YEARS	PATIENT	STRING	Asbestos Exposure Years	Asbestos Exposure Years	1				
180	180	180	180	180	180	180	180	180	180	180	180	180	181	ASG_5ME	SAMPLE	STRING	ASG 5ME.	ASG_5ME	1				
181	181	181	181	181	181	181	181	181	181	181	181	181	182	ASSOCIATED_ADENOMA	PATIENT	STRING	Associated Adenoma	Associated Adenoma	1				
182	182	182	182	182	182	182	182	182	182	182	182	182	183	ASSOCIATED_BORDERLINE_OVARIAN_TUMOR	PATIENT	STRING	Associated Borderline Ovarian Tumor	Associated Borderline Ovarian Tumor	1				
183	183	183	183	183	183	183	183	183	183	183	183	183	184	ASSOCIATED_GENETIC_METABOLIC_DISEASE	PATIENT	STRING	Associated Genetic Metabolic Diseases	Associated Genetic Metabolic Diseases	1				
184	184	184	184	184	184	184	184	184	184	184	184	184	185	ASTHMA_ECZEMA_ALLERGY_FIRST_DIAGNOSIS	PATIENT	STRING	First Diagnosis of Asthma Eczema Allergy	First Diagnosis of Asthma Eczema Allergy	1				
185	185	185	185	185	185	185	185	185	185	185	185	185	186	ASTHMA_HISTORY	PATIENT	STRING	Asthma history.	Asthma History	1				
186	186	186	186	186	186	186	186	186	186	186	186	186	187	ASYMPTOMATIC_WEEKS	PATIENT	NUMBER	Asymptomatic (weeks)	Asymptomatic (weeks)	1				
187	187	187	187	187	187	187	187	187	187	187	187	187	188	ATM_MUT	SAMPLE	NUMBER	ATM Mutation	ATM Mutation	1				
188	188	188	188	188	188	188	188	188	188	188	188	188	189	ATM_MUTATION_STATUS	SAMPLE	STRING	ATM Mutation Status	ATM Mutation Status	1				
189	189	189	189	189	189	189	189	189	189	189	189	189	190	ATRA_EXPOSURE	SAMPLE	STRING	Atra Exposure	Atra Exposure	1				
190	190	190	190	190	190	190	190	190	190	190	190	190	191	ATRX_DELETION	SAMPLE	STRING	ATRX Deletion	ATRX Deletion	1				
191	191	191	191	191	191	191	191	191	191	191	191	191	192	ATRX_SOMATIC	SAMPLE	STRING	ATRX Somatic Mutation	ATRX Somatic Mutation	1				
192	192	192	192	192	192	192	192	192	192	192	192	192	193	ATRX_STATUS	SAMPLE	STRING	ATRX status	ATRX status	1				
193	193	193	193	193	193	193	193	193	193	193	193	193	194	ATR_MUTATION_STATUS	SAMPLE	STRING	ATR Mutation Status	ATR Mutation Status	1				
194	194	194	194	194	194	194	194	194	194	194	194	194	195	ATYPICAL_MITOTIC_FIGURES	PATIENT	STRING	Atypical Mitotic Figures	Atypical Mitotic Figures	1				
195	195	195	195	195	195	195	195	195	195	195	195	195	196	AT_PROCUREMENT_PROTHROMBIN_TIME_INR	PATIENT	NUMBER	Laboratory procedure prothrombin time result value	Laboratory procedure prothrombin time result value	1				
196	196	196	196	196	196	196	196	196	196	196	196	196	197	AURKA_FISH	SAMPLE	STRING	AURKA FISH	AURKA FISH	1				
197	197	197	197	197	197	197	197	197	197	197	197	197	198	AVERAGE_SAMPLE_ALLELE_FREQUENCY	SAMPLE	STRING	Average Sample Allele Frequency	Average Sample Allele Frequency	1				
198	198	198	198	198	198	198	198	198	198	198	198	198	199	AVE_DNA_PURITY	SAMPLE	NUMBER	Average DNA Purity	Average DNA Purity	1				
199	199	199	199	199	199	199	199	199	199	199	199	199	200	AVE_PLOIDY	SAMPLE	NUMBER	Average ploidy	Average Ploidy	1				
200	200	200	200	200	200	200	200	200	200	200	200	200	201	AVE_RNA_PURITY	SAMPLE	NUMBER	Average RNA Purity	Average RNA Purity	1				
201	201	201	201	201	201	201	201	201	201	201	201	201	202	AVG_CN_12Q13_15	SAMPLE	STRING	avg CN 12q13~15	avg CN 12q13~15	1				
202	202	202	202	202	202	202	202	202	202	202	202	202	203	A_C	SAMPLE	STRING	A>C	A>C	1				
203	203	203	203	203	203	203	203	203	203	203	203	203	204	A_G	SAMPLE	STRING	A>G	A>G	1				
204	204	204	204	204	204	204	204	204	204	204	204	204	205	A_T	SAMPLE	STRING	A>T	A>T	1				
205	205	205	205	205	205	205	205	205	205	205	205	205	206	BAIT_VERSION	SAMPLE	STRING	Bait Version	Bait Version	1				
206	206	206	206	206	206	206	206	206	206	206	206	206	207	BAP1_LOSS	SAMPLE	STRING	BAP1 Loss	BAP1 Loss	1				
207	207	207	207	207	207	207	207	207	207	207	207	207	208	BARRETTS_ESOPHAGUS	PATIENT	STRING	Barretts esophagus.	Barretts Esophagus	1				
208	208	208	208	208	208	208	208	208	208	208	208	208	209	BASELINE_BIOPSY_SITE	SAMPLE	STRING	Baseline Biopsy site	Baseline Biopsy site	1				
209	209	209	209	209	209	209	209	209	209	209	209	209	210	BASELINE_CNS_DISEASE	PATIENT	STRING	Baseline CNS Disease	Baseline CNS Disease	1				
210	210	210	210	210	210	210	210	210	210	210	210	210	211	BASELINE_EXTRAMEDULLARY_DISEASE	PATIENT	STRING	Baseline Extramedullary Disease	Baseline Extramedullary Disease	1				
211	211	211	211	211	211	211	211	211	211	211	211	211	212	BASOPHILS_COUNT	SAMPLE	NUMBER	Basophils Cell Count	Basophils Cell Count	1				
212	212	212	212	212	212	212	212	212	212	212	212	212	213	BATCH_NUMBER	SAMPLE	STRING	Batch number.	Batch Number	1				
213	213	213	213	213	213	213	213	213	213	213	213	213	214	BCFI_MONTHS	PATIENT	STRING	Breast Cancer-Free Interval Months (BCFI Months)	Breast Cancer-Free Interval Months	1				
214	214	214	214	214	214	214	214	214	214	214	214	214	215	BCFI_STATUS	PATIENT	STRING	Breast Cancer-Free Interval Status	Breast Cancer-Free Interval Status	1				
215	215	215	215	215	215	215	215	215	215	215	215	215	216	BCL2_BA	PATIENT	STRING	BCL2 Break Apart	BCL2 Break Apart	1				
216	216	216	216	216	216	216	216	216	216	216	216	216	217	BCL2_REAR	PATIENT	STRING	BCL2 Rearrangements	BCL2 Rearrangements	1				
217	217	217	217	217	217	217	217	217	217	217	217	217	218	BCL6_BA	PATIENT	STRING	BCL6 Break Apart	BCL6 Break Apart	1				
218	218	218	218	218	218	218	218	218	218	218	218	218	219	BCL6_REAR	PATIENT	STRING	BCL6 Rearrangements	BCL6 Rearrangements	1				
219	219	219	219	219	219	219	219	219	219	219	219	219	220	BCL6_STATUS	SAMPLE	STRING	BCL6 Status	BCL6 Status	1				
220	220	220	220	220	220	220	220	220	220	220	220	220	221	BCLC_STAGE	PATIENT	STRING	BCLC Stage	BCLC Stage	1				
221	221	221	221	221	221	221	221	221	221	221	221	221	222	BCR_ABL1_STATUS	SAMPLE	STRING	BCR ABL1 status	BCR ABL1 Status	1				
222	222	222	222	222	222	222	222	222	222	222	222	222	223	BCR_ABL_P190_NEGATIVE	SAMPLE	STRING	Negative for BCR-ABL(p190)	Negative for BCR-ABL(p190)	1				
223	223	223	223	223	223	223	223	223	223	223	223	223	224	BCR_ABL_P190_POSITIVE	SAMPLE	STRING	Positive for BCR-ABL(p190)	Positive for BCR-ABL(p190)	1				
224	224	224	224	224	224	224	224	224	224	224	224	224	225	BCR_ABL_P210_NEGATIVE	SAMPLE	STRING	Negative for BCL-ABL(p210)	Negative for BCL-ABL(p210)	1				
225	225	225	225	225	225	225	225	225	225	225	225	225	226	BCR_ABL_P210_POSITIVE	SAMPLE	STRING	Positive for BCL-ABL(p210)	Positive for BCL-ABL(p210)	1				
226	226	226	226	226	226	226	226	226	226	226	226	226	227	BCR_FOLLOWUP_BARCODE	PATIENT	STRING	BCR Followup Barcode	BCR Followup Barcode	1				
227	227	227	227	227	227	227	227	227	227	227	227	227	228	BCR_FOLLOWUP_UUID	PATIENT	STRING	BCR Followup UUID	BCR Followup UUID	1				
228	228	228	228	228	228	228	228	228	228	228	228	228	229	BCR_FREE_MONTHS	PATIENT	NUMBER	BCR Free Time in months	BCR Free Months	1				
229	229	229	229	229	229	229	229	229	229	229	229	229	230	BCR_PATIENT_BARCODE	PATIENT	STRING	BCR Patient Barcode	BCR Patient Barcode	1				
230	230	230	230	230	230	230	230	230	230	230	230	230	231	BCR_PATIENT_UUID	PATIENT	STRING	BCR patient uuid	BCR patient uuid	1				
231	231	231	231	231	231	231	231	231	231	231	231	231	232	BCR_SAMPLE_UUID	SAMPLE	STRING	BCR sample uuid	BCR sample uuid	1				
232	232	232	232	232	232	232	232	232	232	232	232	232	233	BCR_STATUS	PATIENT	STRING	BCR status.	BCR Status	1				
233	233	233	233	233	233	233	233	233	233	233	233	233	234	BCR_TREATMENT_BARCODE	PATIENT	STRING	BCR Treatment Barcode	BCR Treatment Barcode	1				
234	234	234	234	234	234	234	234	234	234	234	234	234	235	BEST_ORR	PATIENT	STRING	Best objective response rate	Best objective response rate	1				
235	235	235	235	235	235	235	235	235	235	235	235	235	236	BEST_RANO_RESPONSE	PATIENT	STRING	Best Response Assessment in Neuro-Oncology Criteria (RANO) Response	Best RANO Response	1				
236	236	236	236	236	236	236	236	236	236	236	236	236	237	BEST_RESPONSE_TO_ALKYLATING_AGENT	PATIENT	STRING	Best response to alkylating agent (temozolomide or dacarbazine)	Best response to alkylating agent (temozolomide or dacarbazine)	1				
237	237	237	237	237	237	237	237	237	237	237	237	237	238	BEST_RESPONSE_TO_EVEROLIMUS	PATIENT	STRING	Best response to everolimus	Best response to everolimus	1				
238	238	238	238	238	238	238	238	238	238	238	238	238	239	BEST_RESPONSE_TO_PLATINUM	PATIENT	STRING	Best response to platinum	Best response to platinum	1				
239	239	239	239	239	239	239	239	239	239	239	239	239	240	BEST_RESPONSE_TO_SUNITINIB	PATIENT	STRING	Best response to Sunitinib	Best response to Sunitinib	1				
240	240	240	240	240	240	240	240	240	240	240	240	240	241	BEST_RESPONSE_TO_THERAPY	PATIENT	STRING	Best Response to Therapy	Best Response to Therapy	1				
241	241	241	241	241	241	241	241	241	241	241	241	241	242	BETA_HCG_LEVELS	SAMPLE	STRING	Beta HCG Levels	Beta HCG Levels	1				
242	242	242	242	242	242	242	242	242	242	242	242	242	243	BIC_FILE_SAMPLE_ID	SAMPLE	STRING	BIC File Sample ID	BIC File Sample ID	1				
243	243	243	243	243	243	243	243	243	243	243	243	243	244	BIC_PATIENT_ID	PATIENT	STRING	BIC Patient ID	BIC Patient ID	1				
244	244	244	244	244	244	244	244	244	244	244	244	244	245	BILATERAL	PATIENT	STRING	Bilateral	Bilateral	1				
245	245	245	245	245	245	245	245	245	245	245	245	245	246	BILATERAL_DIAGNOSIS_TIMING_TYPE	SAMPLE	STRING	Bilateral Diagnosis Timing Type	Bilateral Diagnosis Timing Type	1				
246	246	246	246	246	246	246	246	246	246	246	246	246	247	BILIRUBIN_TOTAL	SAMPLE	STRING	Bilirubin Total	Bilirubin Total	1				
247	247	247	247	247	247	247	247	247	247	247	247	247	248	BILIRUBIN_TOTAL_NORMAL_RANGE_LOWER	PATIENT	NUMBER	Bilirubin Total Norm Range Lower	Bilirubin Total Norm Range Lower	1				
248	248	248	248	248	248	248	248	248	248	248	248	248	249	BILIRUBIN_TOTAL_NORMAL_RANGE_UPPER	PATIENT	NUMBER	Bilirubin Total Norm Range Upper	Bilirubin Total Norm Range Upper	1				
249	249	249	249	249	249	249	249	249	249	249	249	249	250	BILIRUBIN_TOTAL_NORM_RANGE_LOWER	SAMPLE	NUMBER	Bilirubin Total Norm Range Lower	Bilirubin Total Norm Range Lower	1				
250	250	250	250	250	250	250	250	250	250	250	250	250	251	BILIRUBIN_TOTAL_NORM_RANGE_UPPER	SAMPLE	NUMBER	Bilirubin Total Norm Range Upper	Bilirubin Total Norm Range Upper	1				
251	251	251	251	251	251	251	251	251	251	251	251	251	252	BIND	SAMPLE	STRING	BIND.	BIND	1				
252	252	252	252	252	252	252	252	252	252	252	252	252	253	BIOCHEMICAL_RECURRENCE_INDICATOR	PATIENT	STRING	Biochemical Recurrence Indicator	Biochemical Recurrence Indicator	1				
253	253	253	253	253	253	253	253	253	253	253	253	253	254	BIOCHEMICAL_TESTING	SAMPLE	STRING	Biochemical Testing Performed	Biochemical Testing Performed	1				
254	254	254	254	254	254	254	254	254	254	254	254	254	255	BIOPSY_AT_PROGRESSION	SAMPLE	STRING	Biopsy at Progression	Biopsy at Progression	1				
255	255	255	255	255	255	255	255	255	255	255	255	255	256	BIOPSY_FROM_IRRADIATED_SITE	PATIENT	STRING	Biopsy From Irradiated Site	Biopsy From Irradiated Site	1				
256	256	256	256	256	256	256	256	256	256	256	256	256	257	BIOPSY_GLEASON_SCORE	SAMPLE	STRING	BIOPSY GLEASON SCORE	BIOPSY GLEASON SCORE	1				
257	257	257	257	257	257	257	257	257	257	257	257	257	258	BIOPSY_GLEASON_SCORE_1	SAMPLE	STRING	BIOPSY GLEASON SCORE 1	BIOPSY GLEASON SCORE 1	1				
258	258	258	258	258	258	258	258	258	258	258	258	258	259	BIOPSY_GLEASON_SCORE_2	SAMPLE	STRING	BIOPSY GLEASON SCORE 2	BIOPSY GLEASON SCORE 2	1				
259	259	259	259	259	259	259	259	259	259	259	259	259	260	BIOPSY_OBTAINED	SAMPLE	STRING	Biopsy Obtained at MSK or OSH	Biopsy Obtained at MSK or OSH	1				
260	260	260	260	260	260	260	260	260	260	260	260	260	261	BIOPSY_PRE_OR_POST_IPI	PATIENT	STRING	Biopsy pre or post IPI	Biopsy pre or post IPI	1				
261	261	261	261	261	261	261	261	261	261	261	261	261	262	BIOPSY_PROCEDURE	PATIENT	STRING	Biopsy procedure.	Biopsy Procedure	1				
262	262	262	262	262	262	262	262	262	262	262	262	262	263	BIOPSY_TIME	SAMPLE	STRING	Biopsy Time	Biopsy Time	1				
263	263	263	263	263	263	263	263	263	263	263	263	263	264	BIRTH_COUNTRY	PATIENT	STRING	Birth Country	Birth Country	1				
264	264	264	264	264	264	264	264	264	264	264	264	264	265	BIRTH_YEAR	PATIENT	NUMBER	Year of Birth	Year of Birth	1				
265	265	265	265	265	265	265	265	265	265	265	265	265	266	BKM120_DOSAGE	PATIENT	STRING	BKM120 Dosage (mg)	BKM120 Dosage (mg)	1				
266	266	266	266	266	266	266	266	266	266	266	266	266	267	BLADDER_GROUP_GRADE	SAMPLE	STRING	Bladder Group Grade	Bladder Group Grade	1				
267	267	267	267	267	267	267	267	267	267	267	267	267	268	BLADDER_GROUP_METASTASIS_STAGE	SAMPLE	STRING	Bladder Group Metastasis Stage	Bladder Group Metastasis Stage	1				
268	268	268	268	268	268	268	268	268	268	268	268	268	269	BLADDER_GROUP_NODE_STAGE	SAMPLE	STRING	Bladder Group Node Stage	Bladder Group Node Stage	1				
269	269	269	269	269	269	269	269	269	269	269	269	269	270	BLADDER_GROUP_STAGE	SAMPLE	STRING	Bladder Group Stage	Bladder Group Stage	1				
270	270	270	270	270	270	270	270	270	270	270	270	270	271	BLADDER_MIBC_CHEMO_TYPE	SAMPLE	STRING	Bladder MIBC Chemo Type	Bladder MIBC Chemo Type	1				
271	271	271	271	271	271	271	271	271	271	271	271	271	272	BLADDER_MIBC_NO_CHEMO_PROGRESSIVE	SAMPLE	STRING	Bladder MIBC No Chemo Progressive	Bladder MIBC No Chemo Progressive	1				
272	272	272	272	272	272	272	272	272	272	272	272	272	273	BLADDER_MIBC_NO_CHEMO_PROGRESSIVEPRIOR_BCG	SAMPLE	STRING	Bladder MIBC No Chemo Progressiveprior Bcg	Bladder MIBC No Chemo Progressiveprior Bcg	1				
273	273	273	273	273	273	273	273	273	273	273	273	273	274	BLADDER_MIBC_OR_NON_MIBC	SAMPLE	STRING	Bladder MIBC Or Non-MIBC	Bladder MIBC Or Non-MIBC	1				
274	274	274	274	274	274	274	274	274	274	274	274	274	275	BLADDER_MIBC_PRIOR_INTRAVESICAL_CHEMOTHERAPY	SAMPLE	STRING	Bladder MIBC Prior Intravesical Chemotherapy	Bladder MIBC Prior Intravesical Chemotherapy	1				
275	275	275	275	275	275	275	275	275	275	275	275	275	276	BLADDER_MIBC_PROGRESSIVE	SAMPLE	STRING	Bladder MIBC Progressivemibc	Bladder MIBC Progressivemibc	1				
276	276	276	276	276	276	276	276	276	276	276	276	276	277	BLADDER_MIBC_SPECIMEN_CHEMOTHERAPY_STATUS	SAMPLE	STRING	Bladder MIBC Specimen Chemotherapy Status	Bladder MIBC Specimen Chemotherapy Status	1				
277	277	277	277	277	277	277	277	277	277	277	277	277	278	BLADDER_NECK_INVASION	PATIENT	STRING	Bladder neck invasion	Bladder Neck Invasion	1				
278	278	278	278	278	278	278	278	278	278	278	278	278	279	BLADDER_NMIBC_ADJUVANT_BCG	SAMPLE	STRING	Bladder NMIBC Adjuvant Bcg	Bladder NMIBC Adjuvant Bcg	1				
279	279	279	279	279	279	279	279	279	279	279	279	279	280	BLADDER_NMIBC_ADJUVANT_MITOMYCIN	SAMPLE	STRING	Bladder NMIBC Adjuvant Mitomycin	Bladder NMIBC Adjuvant Mitomycin	1				
280	280	280	280	280	280	280	280	280	280	280	280	280	281	BLADDER_NMIBC_CIS	SAMPLE	STRING	Bladder NMIBC Cis	Bladder NMIBC Cis	1				
281	281	281	281	281	281	281	281	281	281	281	281	281	282	BLADDER_NMIBC_CYSTO_FUPTIME	SAMPLE	NUMBER	Bladder NMIBC Cysto Followup Time	Bladder NMIBC Cysto Followup Time	1				
282	282	282	282	282	282	282	282	282	282	282	282	282	283	BLADDER_NMIBC_ESTIMATED_TUMOR_SIZE	SAMPLE	STRING	Bladder NMIBC Estimated Tumor Size	Bladder NMIBC Estimated Tumor Size	1				
283	283	283	283	283	283	283	283	283	283	283	283	283	284	BLADDER_NMIBC_GROUP	SAMPLE	STRING	Bladder NMIBC Group	Bladder NMIBC Group	1				
284	284	284	284	284	284	284	284	284	284	284	284	284	285	BLADDER_NMIBC_HIGH_GRADE_NED_AT_24_MONTHS	SAMPLE	STRING	Bladder NMIBC High Grade Ned At 24 Months	Bladder NMIBC High Grade Ned At 24 Months	1				
285	285	285	285	285	285	285	285	285	285	285	285	285	286	BLADDER_NMIBC_HIGH_GRADE_RECURRENCE	SAMPLE	STRING	Bladder NMIBC High Grade Recurrence	Bladder NMIBC High Grade Recurrence	1				
286	286	286	286	286	286	286	286	286	286	286	286	286	287	BLADDER_NMIBC_HIGH_GRADE_RECURR_TIME	SAMPLE	NUMBER	Bladder NMIBC High Grade Recurrence Time	Bladder NMIBC High Grade Recurrence Time	1				
287	287	287	287	287	287	287	287	287	287	287	287	287	288	BLADDER_NMIBC_NED_AT_24_MONTHS	SAMPLE	STRING	Bladder NMIBC Ned At 24 Months	Bladder NMIBC Ned At 24 Months	1				
288	288	288	288	288	288	288	288	288	288	288	288	288	289	BLADDER_NMIBC_RECURRENCE	SAMPLE	STRING	Bladder NMIBC Recurrence	Bladder NMIBC Recurrence	1				
289	289	289	289	289	289	289	289	289	289	289	289	289	290	BLADDER_NMIBC_TCGA_SMOKING_CATEGORY	SAMPLE	STRING	Bladder NMIBC Tcga Smoking Category	Bladder NMIBC Tcga Smoking Category	1				
290	290	290	290	290	290	290	290	290	290	290	290	290	291	BLADDER_NMIBC_TIME_TO_RECURRENCE	SAMPLE	NUMBER	Bladder NMIBC Time To Recurrence	Bladder NMIBC Time To Recurrence	1				
291	291	291	291	291	291	291	291	291	291	291	291	291	292	BLADDER_NMIBC_TUMOR_NUMBER	SAMPLE	STRING	Bladder NMIBC Tumor Number	Bladder NMIBC Tumor Number	1				
292	292	292	292	292	292	292	292	292	292	292	292	292	293	BLAST_COUNT	SAMPLE	NUMBER	Blast Count	Blast Count	1				
293	293	293	293	293	293	293	293	293	293	293	293	293	294	BLAST_PERCENT_CBC	PATIENT	STRING	BLAST Percentage (CBC)	BLAST Percentage (CBC)	1				
294	294	294	294	294	294	294	294	294	294	294	294	294	295	BLEEDING_WEEKS	PATIENT	NUMBER	Bleeding (Weeks)	Bleeding (Weeks)	1				
295	295	295	295	295	295	295	295	295	295	295	295	295	296	BLOCK	SAMPLE	NUMBER	Block.	Block	1				
296	296	296	296	296	296	296	296	296	296	296	296	296	297	BLOCK_ACCESSION	PATIENT	STRING	block accession	block accession	1				
297	297	297	297	297	297	297	297	297	297	297	297	297	298	BLOCK_ID	SAMPLE	STRING	BLOCK ID	BLOCK ID	1				
298	298	298	298	298	298	298	298	298	298	298	298	298	299	BLOOD_COLLECTION	PATIENT	STRING	Blood collection	Blood collection	1				
299	299	299	299	299	299	299	299	299	299	299	299	299	300	BMI	PATIENT	NUMBER	Body Mass Index	BMI	1				
300	300	300	300	300	300	300	300	300	300	300	300	300	301	BMI_CATEGORY	PATIENT	STRING	BMI Category	BMI Category	1				
301	301	301	301	301	301	301	301	301	301	301	301	301	302	BM_BLAST_PERCENTAGE	PATIENT	STRING	Bone marrow blast percentage.	Bone Marrow Blast Percentage	1				
302	302	302	302	302	302	302	302	302	302	302	302	302	303	BM_DAY_15	PATIENT	NUMBER	Bone Marrow Blasts Day 15	Bone Marrow Blasts Day 15	1				
303	303	303	303	303	303	303	303	303	303	303	303	303	304	BM_DAY_29	PATIENT	NUMBER	Bone Marrow Blasts Day 29	Bone Marrow Blasts Day 29	1				
304	304	304	304	304	304	304	304	304	304	304	304	304	305	BM_DAY_43	PATIENT	NUMBER	Bone Marrow Blasts Day 43	Bone Marrow Blasts Day 43	1				
305	305	305	305	305	305	305	305	305	305	305	305	305	306	BM_DAY_8	PATIENT	NUMBER	Bone Marrow Blasts Day 8	Bone Marrow Blasts Day 8	1				
306	306	306	306	306	306	306	306	306	306	306	306	306	307	BONE_MARROW_BIOPSY_PERFORMED	SAMPLE	STRING	Bone Marrow Biopsy Performed	Bone Marrow Biopsy Performed	1				
307	307	307	307	307	307	307	307	307	307	307	307	307	308	BONE_MARROW_INVOLVEMENT	SAMPLE	STRING	Bone Marrow Involvement	Bone Marrow Involvement	1				
308	308	308	308	308	308	308	308	308	308	308	308	308	309	BONE_MARROW_LEUKEMIC_BLAST_PERCENTAGE	PATIENT	NUMBER	Bone marrow leukemic percentage.	Bone Marrow Leukemic Blast Percentage	1				
309	309	309	309	309	309	309	309	309	309	309	309	309	310	BONE_MARROW_SAMPLE_HISTOLOGY	SAMPLE	STRING	Bone Marrow Sample Histology	Bone Marrow Sample Histology	1				
310	310	310	310	310	310	310	310	310	310	310	310	310	311	BONE_MARROW_SITE_OF_RELAPSE	SAMPLE	STRING	Bone Marrow Site of Relapse	Bone Marrow Site of Relapse	1				
311	311	311	311	311	311	311	311	311	311	311	311	311	312	BONE_SCAN_RESULT	PATIENT	STRING	Bone scan result.	Bone Scan Result	1				
312	312	312	312	312	312	312	312	312	312	312	312	312	313	BORBORYGMI_WEEKS	PATIENT	NUMBER	Borborygmi (Weeks)	Borborygmi (Weeks)	1				
313	313	313	313	313	313	313	313	313	313	313	313	313	314	BORR	PATIENT	STRING	BORR	BORR	1				
314	314	314	314	314	314	314	314	314	314	314	314	314	315	BORRMANN_CLASSIFICATION	PATIENT	STRING	Borrmann classification	Borrmann classification	1				
315	315	315	315	315	315	315	315	315	315	315	315	315	316	BOWEL_HABITS_CHANGE_WEEKS	PATIENT	NUMBER	Bowel Habits Change (Weeks)	Bowel Habits Change (Weeks)	1				
316	316	316	316	316	316	316	316	316	316	316	316	316	317	BRAC2_GERMLINE	SAMPLE	STRING	BRAC2 GERMLINE	BRAC2 GERMLINE	1				
317	317	317	317	317	317	317	317	317	317	317	317	317	318	BRACHYTHERAPY_TOTAL_DOSE_POINT_A	PATIENT	STRING	Brachytherapy first reference point administered total dose	Brachytherapy first reference point administered total dose	1				
318	318	318	318	318	318	318	318	318	318	318	318	318	319	BRACHYTHERAPY_TYPE	SAMPLE	STRING	Brachytherapy Type	Brachytherapy Type	1				
319	319	319	319	319	319	319	319	319	319	319	319	319	320	BRACHYTHERAPY_TYPE_OTHER	SAMPLE	STRING	Brachytherapy Type Other	Brachytherapy Type Other	1				
320	320	320	320	320	320	320	320	320	320	320	320	320	321	BRAFV600E_RAF_CLASS	SAMPLE	NUMBER	BRAFV600E RAF Class	BRAFV600E RAF Class	1				
321	321	321	321	321	321	321	321	321	321	321	321	321	322	BRAFV600E_RAF_SCORE	SAMPLE	NUMBER	BRAFV600E RAF Score	BRAFV600E RAF Score	1				
322	322	322	322	322	322	322	322	322	322	322	322	322	323	BRAFV600E_RAS	SAMPLE	STRING	BRAF600E mutation vs. RAS mutation sample	BRAF600E mutation vs. RAS mutation sample	1				
323	323	323	323	323	323	323	323	323	323	323	323	323	324	BRAF_FUSION	SAMPLE	STRING	BRAF Fusion	BRAF Fusion	1				
324	324	324	324	324	324	324	324	324	324	324	324	324	325	BRAF_GENE_ANALYSIS_INDICATOR	SAMPLE	STRING	BRAF Gene Analysis Indicator	BRAF Gene Analysis Indicator	1				
325	325	325	325	325	325	325	325	325	325	325	325	325	326	BRAF_GENE_ANALYSIS_RESULT	SAMPLE	STRING	BRAF Gene Analysis Result	BRAF Gene Analysis Result	1				
326	326	326	326	326	326	326	326	326	326	326	326	326	327	BRAF_KIAA1549_FUSION	SAMPLE	STRING	BRAF-KIAA1549 fusion	BRAF-KIAA1549 fusion	1				
327	327	327	327	327	327	327	327	327	327	327	327	327	328	BRAF_MUTATION	SAMPLE	STRING	BRAF mutation	BRAF mutation	1				
328	328	328	328	328	328	328	328	328	328	328	328	328	329	BRAF_SOMATIC	SAMPLE	STRING	BRAF Somatic Mutation	BRAF Somatic Mutation	1				
329	329	329	329	329	329	329	329	329	329	329	329	329	330	BRAF_STATUS	SAMPLE	STRING	Braf Status	Braf Status	1				
330	330	330	330	330	330	330	330	330	330	330	330	330	331	BRAF_V600E_STATUS	SAMPLE	STRING	BRAF V600E status	BRAF V600E status	1				
331	331	331	331	331	331	331	331	331	331	331	331	331	332	BRAF_V600_LEVEL1	SAMPLE	STRING	BRAF V600 Level1	BRAF V600 Level1	1				
332	332	332	332	332	332	332	332	332	332	332	332	332	333	BRAIN_METS	PATIENT	STRING	Brain Metatstasis	BRAIN METS	1				
333	333	333	333	333	333	333	333	333	333	333	333	333	334	BRCA1_CNA	PATIENT	STRING	Brca1 cna	Brca1 cna	1				
334	334	334	334	334	334	334	334	334	334	334	334	334	335	BRCA1_GERMLINE	SAMPLE	STRING	BRCA1 GERMLINE	BRCA1 GERMLINE	1				
335	335	335	335	335	335	335	335	335	335	335	335	335	336	BRCA1_GERMLINE_MUT	SAMPLE	NUMBER	BRCA1 Germline Mutation	BRCA1 Germline Mutation	1				
336	336	336	336	336	336	336	336	336	336	336	336	336	337	BRCA1_HOMDEL	SAMPLE	STRING	BRCA1 HOMDEL	BRCA1 HOMDEL	1				
337	337	337	337	337	337	337	337	337	337	337	337	337	338	BRCA1_MUTATION	SAMPLE	STRING	BRCA1 Mutation is present	BRCA1 Mutation	1				
338	338	338	338	338	338	338	338	338	338	338	338	338	339	BRCA1_RESULT	SAMPLE	STRING	BRCA1 Result	BRCA1 Result	1				
339	339	339	339	339	339	339	339	339	339	339	339	339	340	BRCA2_CNA	SAMPLE	STRING	BRCA2 CNA	BRCA2 CNA	1				
340	340	340	340	340	340	340	340	340	340	340	340	340	341	BRCA2_GERMLINE_MUT	SAMPLE	NUMBER	BRCA2 Germline Mutation	BRCA2 Germline Mutation	1				
341	341	341	341	341	341	341	341	341	341	341	341	341	342	BRCA2_HOMDEL	SAMPLE	STRING	BRCA2 HOMDEL	BRCA2 HOMDEL	1				
342	342	342	342	342	342	342	342	342	342	342	342	342	343	BRCA2_MUTATION	SAMPLE	STRING	BRCA2 Mutation is present	BRCA2 Mutation	1				
343	343	343	343	343	343	343	343	343	343	343	343	343	344	BRCA2_RESULT	SAMPLE	STRING	BRAC2 Result	BRAC2 Result	1				
344	344	344	344	344	344	344	344	344	344	344	344	344	345	BRCA_GERMLINE_MUTATIONS	SAMPLE	STRING	BRCA Germline mutation	BRCA Germline mutation	1				
345	345	345	345	345	345	345	345	345	345	345	345	345	346	BRCA_TYPE	SAMPLE	STRING	BRCA Type	BRCA Type	1				
346	346	346	346	346	346	346	346	346	346	346	346	346	347	BRCA_VARIANT	SAMPLE	STRING	BRCA Variant	BRCA Variant	1				
347	347	347	347	347	347	347	347	347	347	347	347	347	348	BRC_RECEPTOR_SUBTYPE	SAMPLE	STRING	BRCA Receptor Subtype	BRCA Receptor Subtype	1				
348	348	348	348	348	348	348	348	348	348	348	348	348	349	BREAST_CANCER_RECEPTOR_STATUS	SAMPLE	STRING	Breast Cancer Receptor Status	Breast Cancer Receptor Status	1				
349	349	349	349	349	349	349	349	349	349	349	349	349	350	BREAST_CANCER_RECEPTOR_STATUS_DETAILED	SAMPLE	STRING	Breast Cancer Receptor Status Detailed	Breast Cancer Receptor Status Detailed	1				
350	350	350	350	350	350	350	350	350	350	350	350	350	351	BREAST_CANCER_RECEPTOR_STATUS_FINAL	PATIENT	STRING	Breast Cancer Receptor Status Final	Breast Cancer Receptor Status Final	1				
351	351	351	351	351	351	351	351	351	351	351	351	351	352	BREAST_CANCER_RECEPTOR_STATUS_PRIMARY	SAMPLE	STRING	Breast Cancer Receptor Status Primary	Breast Cancer Receptor Status Primary	1				
352	352	352	352	352	352	352	352	352	352	352	352	352	353	BREAST_SURGERY	PATIENT	STRING	Type of Breast Surgery	Type of Breast Surgery	1				
353	353	353	353	353	353	353	353	353	353	353	353	353	354	BRESLOW_DEPTH	SAMPLE	STRING	breslow depth	breslow depth	1				
354	354	354	354	354	354	354	354	354	354	354	354	354	355	BRONCHOSCOPY	PATIENT	STRING	Bronchoscopy	Bronchoscopy	1				
355	355	355	355	355	355	355	355	355	355	355	355	355	356	BUBBLE_GROUP	SAMPLE	STRING	Bubble Group	Bubble Group	1				
356	356	356	356	356	356	356	356	356	356	356	356	356	357	BXCEP17_COPY	SAMPLE	STRING	Copy number of CEP17 in the pathology report. This is the number of copies of the CEP17 gene seen in the sample, which is used to calculate the HER2/CEP17 ratio. Having multiple copies of a gene means that the tumor's DNA has many consecutive repetitions of the region that codes for a given gene. Having multiple extra copies of a gene is also described as an amplification, while losing copies of a gene is described as a deletion.	PATH CEP17 Copy	1				
357	357	357	357	357	357	357	357	357	357	357	357	357	358	BXHER2_COPY	SAMPLE	STRING	Copy number of HER2 in the pathology report. This is the number of copies of the HER2 gene seen in the sample, which is used to calculate the HER2/CEP17 ratio. Having multiple copies of a gene means that the tumor's DNA has many consecutive repetitions of the region that codes for a given gene. Having multiple extra copies of a gene is also described as an amplification, while losing copies of a gene is described as a deletion.	PATH HER2 Copy	1				
358	358	358	358	358	358	358	358	358	358	358	358	358	359	BXHER2_RATIO	SAMPLE	STRING	Ratio of HER2/CEP17 in the pathology report. This is one component of the Flourescence In Situ Hybridization (FISH) test. This ratio is used to determine if the HER2 gene is overexpressed, relative to the CEP17 protein, which acts as a baseline measurement. HER2/CEP17 ratios >2.2 indicate a HER2 Positive tumor.	PATH HER2 CEP17 Ratio	1				
359	359	359	359	359	359	359	359	359	359	359	359	359	360	BX_DCIS	SAMPLE	STRING	Notes if Ductal Carcinoma In Situ was reported in the pathology report	PATH DCIS Reported	1				
360	360	360	360	360	360	360	360	360	360	360	360	360	361	BX_EPITHELIOID	SAMPLE	STRING	Sample has epithelioid characteristics	PATH Epithelioid	1				
361	361	361	361	361	361	361	361	361	361	361	361	361	362	BX_ER	SAMPLE	STRING	Estrogen Receptor (ER) status reported in the pathology report	PATH Estrogen Receptor Status	1				
362	362	362	362	362	362	362	362	362	362	362	362	362	363	BX_GRADE	SAMPLE	STRING	Sample grade reported in the pathology report	PATH Sample Grade	1				
363	363	363	363	363	363	363	363	363	363	363	363	363	364	BX_HER2FISH	SAMPLE	STRING	HER2 Flourescence In Situ Hyrbridization (FISH) results in the pathology report. This is most commonly performed on tumor samples with a HER2 Immunohistochemistry (IHC) score of 2+, or equivocal. This is an additional test that aims to measure whether or not the HER2 gene is overexpressed in a tumor sample.	PATH HER2 FISH	1				
364	364	364	364	364	364	364	364	364	364	364	364	364	365	BX_HER2IHC	SAMPLE	STRING	HER2 Immunohistochemistry (IHC) results in the pathology report. This test involves staining tissue samples and looking at them under a microscope to determine if the HER2 protein is overexpressed in the sample. Results can be reported as 0+, 1+, 2+, or 3+. 0+ and 1+ indicate a HER2 negative tumor, 2+ is considered equivocal and may require further testing, and 3+ indicates a HER2 Positive tumor.	PATH HER2 IHC	1				
365	365	365	365	365	365	365	365	365	365	365	365	365	366	BX_HER2OVERALL	SAMPLE	STRING	HER2 status reported in the pathology report	PATH HER2 Status	1				
366	366	366	366	366	366	366	366	366	366	366	366	366	367	BX_HISTOLOGY	SAMPLE	STRING	The sample's histology reported in the pathology report (IDC = Invasive Ductal Carcinoma, ILC = Invasive Lobular Carcinoma).	PATH Sample Histology	1				
367	367	367	367	367	367	367	367	367	367	367	367	367	368	BX_KI67	SAMPLE	STRING	The percentage of Ki67 reported in the pathology report	PATH Ki67 Percentage	1				
368	368	368	368	368	368	368	368	368	368	368	368	368	369	BX_LCIS	SAMPLE	STRING	Notes if Lobular Carcinoma In Situ was reported in the pathology report	PATH LCIS Reported	1				
369	369	369	369	369	369	369	369	369	369	369	369	369	370	BX_LOCATION	SAMPLE	STRING	The location in the body where the biopsy or surgery was performed	PATH Procedure Location	1				
370	370	370	370	370	370	370	370	370	370	370	370	370	371	BX_NOTES	SAMPLE	STRING	Additional information regarding the sample	PATH Sample notes	1				
371	371	371	371	371	371	371	371	371	371	371	371	371	372	BX_NUCLEAR_GRADE	SAMPLE	STRING	Nuclear grade of the sample	PATH Nuclear Grade	1				
372	372	372	372	372	372	372	372	372	372	372	372	372	373	BX_PERCENT_ER	SAMPLE	STRING	Percentage of Estrogen Receptor (ER) reported in the pathology report. A value of >= 1% indicates an ER Positive tumor.	PATH Estrogen Receptor Percentage	1				
373	373	373	373	373	373	373	373	373	373	373	373	373	374	BX_PERCENT_PR	SAMPLE	STRING	Progesterone Receptor (PR) percentage reported in the pathology report. A value of >=1% indicates a PR Positive tumor.	PATH Progesterone Receptor Percentage	1				
374	374	374	374	374	374	374	374	374	374	374	374	374	375	BX_PR	SAMPLE	STRING	Progesterone Receptor (PR) status as reported in the pathology report	PATH Progesterone Receptor Status	1				
375	375	375	375	375	375	375	375	375	375	375	375	375	376	BX_SIDEDNESS_BREAST	SAMPLE	STRING	Left or right sidedness for breast procedures	PATH Breast Procedure Laterality	1				
376	376	376	376	376	376	376	376	376	376	376	376	376	377	BX_SPINDLE_CELL	SAMPLE	STRING	Sample has spindle cell characteristics	PATH Spindle Cell	1				
377	377	377	377	377	377	377	377	377	377	377	377	377	378	BX_TIME_DAYS	SAMPLE	NUMBER	Sample collection time in days from primary diagnosis	PATH Sample Collection Time	1				
378	378	378	378	378	378	378	378	378	378	378	378	378	379	BX_TYPE	SAMPLE	STRING	The procedure performed to obtain the sample	PATH Procedure Type	1				
379	379	379	379	379	379	379	379	379	379	379	379	379	380	BX_VASOFORMATIVE	SAMPLE	STRING	Sample has vasoformative characteristics	PATH Vasoformative	1				
380	380	380	380	380	380	380	380	380	380	380	380	380	381	B_CELLS_MEMORY	SAMPLE	NUMBER	B cells memory	B cells memory	1				
381	381	381	381	381	381	381	381	381	381	381	381	381	382	B_CELLS_NAIVE	SAMPLE	NUMBER	B cells naive	B cells naive	1				
382	382	382	382	382	382	382	382	382	382	382	382	382	383	B_CELL_GENOTYPE_METHOD	SAMPLE	STRING	B Cell Genotype Method	B Cell Genotype Method	1				
383	383	383	383	383	383	383	383	383	383	383	383	383	384	CABAZI	SAMPLE	STRING	Cabazi.	Cabazi	1				
384	384	384	384	384	384	384	384	384	384	384	384	384	385	CAISIS_AGE	PATIENT	STRING	Age at which a condition or disease was first diagnosed, as supplied by CAISIS.	CAISIS (Diagnosis Age)	1				
385	385	385	385	385	385	385	385	385	385	385	385	385	386	CAISIS_AGENT	PATIENT	STRING	Agent used for the treatment , as provided by CAISIS.	CAISIS (Agent)	1				
386	386	386	386	386	386	386	386	386	386	386	386	386	387	CAISIS_DFS_MONTHS	PATIENT	NUMBER	Disease free (months) since initial treatment, as provided by CAISIS.	CAISIS (Disease Free Months)	1				
387	387	387	387	387	387	387	387	387	387	387	387	387	388	CAISIS_DFS_STATUS	PATIENT	STRING	Disease free status since initial diagnosis, as provided by CAISIS.	CAISIS (Disease Free Status)	1				
388	388	388	388	388	388	388	388	388	388	388	388	388	389	CAISIS_DIAGNOSTIC_DATE	PATIENT	NUMBER	Diagnsotic date , as provided by CAISIS.	CAISIS (Diagnostic Date)	1				
389	389	389	389	389	389	389	389	389	389	389	389	389	390	CAISIS_DIAGNOSTIC_NOTES	PATIENT	STRING	Notes from the diagnostics , as provided by CAISIS.	CAISIS (Diagnostic Notes)	1				
390	390	390	390	390	390	390	390	390	390	390	390	390	391	CAISIS_DIAGNOSTIC_TARGET	PATIENT	STRING	Diagnostic target, as provided by CAISIS.	CAISIS (Diagnostic Target)	1				
391	391	391	391	391	391	391	391	391	391	391	391	391	392	CAISIS_EVENT_TYPE	PATIENT	STRING	Type of event which can be a treatment, imaging, surgery, specimen collection or status , as provided by CAISIS.	CAISIS (Event Type)	1				
392	392	392	392	392	392	392	392	392	392	392	392	392	393	CAISIS_GENDER	PATIENT	STRING	Patient gender, as supplied by CAISIS.	CAISIS (Person Gender)	1				
393	393	393	393	393	393	393	393	393	393	393	393	393	394	CAISIS_MGMT_STATUS	SAMPLE	STRING	MGMT Status, as supplied by CAISIS	CAISIS (MGMT Status)	1				
394	394	394	394	394	394	394	394	394	394	394	394	394	395	CAISIS_NOTE	PATIENT	STRING	Additional Notes , as provided by CAISIS.	CAISIS (Note)	1				
395	395	395	395	395	395	395	395	395	395	395	395	395	396	CAISIS_OS_MONTHS	PATIENT	NUMBER	Overall survival in months since initial diagnosis, as provided by CAISIS.	CAISIS (Overall Survival Months)	1				
396	396	396	396	396	396	396	396	396	396	396	396	396	397	CAISIS_OS_STATUS	PATIENT	STRING	Overall patient survival status, as provided by CAISIS.	CAISIS (Overall Survival Status)	1				
397	397	397	397	397	397	397	397	397	397	397	397	397	398	CAISIS_RESULT	PATIENT	STRING	Results, as provided by CAISIS.	CAISIS (Result)	1				
398	398	398	398	398	398	398	398	398	398	398	398	398	399	CAISIS_SAMPLE_HISTOLOGY	SAMPLE	STRING	Sample Histology, as supplied by CAISIS	CAISIS (Sample Histology)	1				
399	399	399	399	399	399	399	399	399	399	399	399	399	400	CAISIS_START_DATE	PATIENT	NUMBER	Start date of an event, as provided by CAISIS.	CAISIS (Start date)	1				
400	400	400	400	400	400	400	400	400	400	400	400	400	401	CAISIS_STATUS	PATIENT	STRING	Status of the patient, as provided by CAISIS.	CAISIS (Status)	1				
401	401	401	401	401	401	401	401	401	401	401	401	401	402	CAISIS_STOP_DATE	PATIENT	NUMBER	End date of an event , as provided by CAISIS.	CAISIS (End date)	1				
402	402	402	402	402	402	402	402	402	402	402	402	402	403	CAISIS_SUBTYPE	PATIENT	STRING	Subtype of the treatment, as provided by CAISIS.	CAISIS (Subtype)	1				
403	403	403	403	403	403	403	403	403	403	403	403	403	404	CAISIS_TREATMENT_TYPE	PATIENT	STRING	Type of Treatment which can be medical or radiation therapies, as provided by CAISIS.	CAISIS (Treatment type)	1				
404	404	404	404	404	404	404	404	404	404	404	404	404	405	CAISIS_WHO_GRADE	SAMPLE	STRING	WHO Grade, as aupplied by CAISIS	CAISIS (WHO Grade)	1				
405	405	405	405	405	405	405	405	405	405	405	405	405	406	CALC_AGE_DX	PATIENT	NUMBER	Calculated elapsed time, in years, between the patient-reported date of birth and patient-reported month and year of primary diagnosis with breast cancer. If no month was reported, diagnosis date was defaulted to January of the reported year.	Age at Primary Diagnosis (Calculated Years)	1				
406	406	406	406	406	406	406	406	406	406	406	406	406	407	CALC_DIFF_PRIMARY_DX_METS_DX_MONTHS	PATIENT	NUMBER	Calculated elapsed time, in months, between the patient-reported month and year of primary diagnosis with breast cancer and the patient-reported month and year of diagnosis with metastatic breast cancer. If no month was reported, diagnosis date was defaulted to January of the reported year.	Time to Metastatic Diagnosis (Calculated Months)	1				
407	407	407	407	407	407	407	407	407	407	407	407	407	408	CALC_MET_SETTING	SAMPLE	STRING	Calculated variable to classify if samples were taken while the patient had metastatic disease, or prior to metastatic disease. Samples taken less than 4 months prior to the diagnosis of metastatic disease are classified as METASTATIC DISEASE PRESENT	PATH Sample In Metastatic Setting	1				
408	408	408	408	408	408	408	408	408	408	408	408	408	409	CALC_TIME_TO_METS_DX_DAYS	PATIENT	NUMBER	Calculated elapsed time, in days, between the patient's primary diagnosis with breast cancer and diagnosis with metastatic breast cancer as reported in the medical record	MedR Time to Metastatic Diagnosis (Calculated Days)	1				
409	409	409	409	409	409	409	409	409	409	409	409	409	410	CALC_TIME_TO_METS_DX_MONTHS	PATIENT	NUMBER	Calculated elapsed time, in months, between patient's primary diagnosis with breast cancer and diagnosis with metastatic breast cancer as reported in the medical record	MedR Time to Metastatic Diagnosis (Calculated Months)	1				
410	410	410	410	410	410	410	410	410	410	410	410	410	411	CALC_TREATMENT_NAIVE	SAMPLE	STRING	Calculated variable that is set to YES if a sample was taken prior to the start of any medical therapy	PATH Sample Treatment Naive	1				
411	411	411	411	411	411	411	411	411	411	411	411	411	412	CAM_5_2	SAMPLE	STRING	CAM 5.2	CAM 5.2	1				
412	412	412	412	412	412	412	412	412	412	412	412	412	413	CANCER_DNA_FRACTION	SAMPLE	STRING	Cancer DNA Fraction	Cancer DNA Fraction	1				
413	413	413	413	413	413	413	413	413	413	413	413	413	414	CANCER_PROCUREMENT_STATE_PROVINCE	SAMPLE	STRING	Cancer Procurement State Province	Cancer Procurement State Province	1				
414	414	414	414	414	414	414	414	414	414	414	414	414	415	CANCER_TYPE	SAMPLE	STRING	Cancer Type	Cancer Type	1				
415	415	415	415	415	415	415	415	415	415	415	415	415	416	CANCER_TYPE_ACRONYM	PATIENT	STRING	Text field to hold cancer type acronym used by TCGA PanCanAtlas.	TCGA PanCanAtlas Cancer Type Acronym	1				
416	416	416	416	416	416	416	416	416	416	416	416	416	417	CANCER_TYPE_DETAILED	SAMPLE	STRING	Cancer Type Detailed	Cancer Type Detailed	1				
417	417	417	417	417	417	417	417	417	417	417	417	417	418	CAPSULAR_INVASION	SAMPLE	STRING	CAPSULAR INVASION	CAPSULAR INVASION	1				
418	418	418	418	418	418	418	418	418	418	418	418	418	419	CAPTURE_BAIT_SET	SAMPLE	STRING	Bait Set used in capture	Capture Bait Set	1				
419	419	419	419	419	419	419	419	419	419	419	419	419	420	CARBO	SAMPLE	STRING	Carbo.	Carbo	1				
420	420	420	420	420	420	420	420	420	420	420	420	420	421	CARBON_MONOXIDE_DIFFUSION_DLCO	PATIENT	NUMBER	Carbon monoxide diffusion dlco	Carbon monoxide diffusion dlco	1				
421	421	421	421	421	421	421	421	421	421	421	421	421	422	CATEGORY_SAMPLE	SAMPLE	STRING	Category of Sample	Category of Sample	1				
422	422	422	422	422	422	422	422	422	422	422	422	422	423	CAUSE_OF_DEATH_OTHER	PATIENT	STRING	Death cause text	Cause of death other	1				
423	423	423	423	423	423	423	423	423	423	423	423	423	424	CAUSE_OF_DEATH_SOURCE	PATIENT	STRING	Source of patient death reason	Cause of death source	1				
424	424	424	424	424	424	424	424	424	424	424	424	424	425	CA_125	PATIENT	NUMBER	CA-125	CA-125	1				
425	425	425	425	425	425	425	425	425	425	425	425	425	426	CA_19_9	PATIENT	NUMBER	CA 19-9 Value	CA 19-9 Value	1				
426	426	426	426	426	426	426	426	426	426	426	426	426	427	CBEST_B_MEM	SAMPLE	NUMBER	CIBERSORT-ESTIMATE B cells memory	CBSET B cells memory	1				
427	427	427	427	427	427	427	427	427	427	427	427	427	428	CBEST_B_NAIVE	SAMPLE	NUMBER	CIBERSORT-ESTIMATE B cells naive	CBSET B cells naive	1				
428	428	428	428	428	428	428	428	428	428	428	428	428	429	CBEST_DENDRITIC_ACT	SAMPLE	NUMBER	CIBERSORT-ESTIMATE Dendritic cells activated	CBSET Dendritic cells activated	1				
429	429	429	429	429	429	429	429	429	429	429	429	429	430	CBEST_DENDRITIC_REST	SAMPLE	NUMBER	CIBERSORT-ESTIMATE Dendritic cells resting	CBSET Dendritic cells resting	1				
430	430	430	430	430	430	430	430	430	430	430	430	430	431	CBEST_EOSINOPHILS	SAMPLE	NUMBER	CIBERSORT-ESTIMATE Eosinophils	CBSET Eosinophils	1				
431	431	431	431	431	431	431	431	431	431	431	431	431	432	CBEST_MACRO_M0	SAMPLE	NUMBER	CIBERSORT-ESTIMATE Macrophages M0	CBSET Macrophages M0	1				
432	432	432	432	432	432	432	432	432	432	432	432	432	433	CBEST_MACRO_M1	SAMPLE	NUMBER	CIBERSORT-ESTIMATE Macrophages M1	CBSET Macrophages M1	1				
433	433	433	433	433	433	433	433	433	433	433	433	433	434	CBEST_MACRO_M2	SAMPLE	NUMBER	CIBERSORT-ESTIMATE Macrophages M2	CBSET Macrophages M2	1				
434	434	434	434	434	434	434	434	434	434	434	434	434	435	CBEST_MAST_ACT	SAMPLE	NUMBER	CIBERSORT-ESTIMATE Mast cells activated	CBSET Mast cells activated	1				
435	435	435	435	435	435	435	435	435	435	435	435	435	436	CBEST_MAST_REST	SAMPLE	NUMBER	CIBERSORT-ESTIMATE Mast cells resting	CBSET Mast cells resting	1				
436	436	436	436	436	436	436	436	436	436	436	436	436	437	CBEST_MONO	SAMPLE	NUMBER	CIBERSORT-ESTIMATE Monocytes	CBSET Monocytes	1				
437	437	437	437	437	437	437	437	437	437	437	437	437	438	CBEST_NEUTROPHILS	SAMPLE	NUMBER	CIBERSORT-ESTIMATE Neutrophils	CBSET Neutrophils	1				
438	438	438	438	438	438	438	438	438	438	438	438	438	439	CBEST_NK_ACT	SAMPLE	NUMBER	CIBERSORT-ESTIMATE NK cells activated	CBSET NK cells activated	1				
439	439	439	439	439	439	439	439	439	439	439	439	439	440	CBEST_NK_REST	SAMPLE	NUMBER	CIBERSORT-ESTIMATE NK cells resting	CBSET NK cells resting	1				
440	440	440	440	440	440	440	440	440	440	440	440	440	441	CBEST_PLASMA	SAMPLE	NUMBER	CIBERSORT-ESTIMATE Plasma cells	CBSET Plasma cells	1				
441	441	441	441	441	441	441	441	441	441	441	441	441	442	CBEST_T_CD4_MEM_ACT	SAMPLE	NUMBER	CIBERSORT-ESTIMATE T cells CD4 memory activated	CBSET T cells CD4 memory activated	1				
442	442	442	442	442	442	442	442	442	442	442	442	442	443	CBEST_T_CD4_MEM_REST	SAMPLE	NUMBER	CIBERSORT-ESTIMATE T cells CD4 memory resting	CBSET T cells CD4 memory resting	1				
443	443	443	443	443	443	443	443	443	443	443	443	443	444	CBEST_T_CD4_NAIVE	SAMPLE	NUMBER	CIBERSORT-ESTIMATE T cells CD4 naive	CBSET T cells CD4 naive	1				
444	444	444	444	444	444	444	444	444	444	444	444	444	445	CBEST_T_CD8	SAMPLE	NUMBER	CIBERSORT-ESTIMATE T cells CD8	CBSET T cells CD8	1				
445	445	445	445	445	445	445	445	445	445	445	445	445	446	CBEST_T_FOLLI_HEL	SAMPLE	NUMBER	CIBERSORT-ESTIMATE T cells follicular helper	CBSET T cells follicular helper	1				
446	446	446	446	446	446	446	446	446	446	446	446	446	447	CBEST_T_G_D	SAMPLE	NUMBER	CIBERSORT-ESTIMATE T cells gamma delta	CBSET T cells gamma delta	1				
447	447	447	447	447	447	447	447	447	447	447	447	447	448	CBEST_T_REG	SAMPLE	NUMBER	CIBERSORT-ESTIMATE T cells regulatory (Tregs)	CBSET T cells regulatory (Tregs)	1				
448	448	448	448	448	448	448	448	448	448	448	448	448	449	CBFT2A3_GLIS	SAMPLE	STRING	CBFT2A3 GLIS gene fusion	CBFT2A3-GLIS	1				
449	449	449	449	449	449	449	449	449	449	449	449	449	450	CBIOPORTAL_UPLOAD_DATE	SAMPLE	STRING	cBioPortal Upload Date	cBioPortal Upload Date	1				
450	450	450	450	450	450	450	450	450	450	450	450	450	451	CBIO_PROJECT_NAME	SAMPLE	STRING	Cbioportal Project Name	Cbioportal Project Name	1				
451	451	451	451	451	451	451	451	451	451	451	451	451	452	CC_TT	SAMPLE	STRING	CC>TT	CC>TT	1				
452	452	452	452	452	452	452	452	452	452	452	452	452	453	CD10_STATUS	SAMPLE	STRING	CD10 Status	CD10 Status	1				
453	453	453	453	453	453	453	453	453	453	453	453	453	454	CD14_NEG_CD16_NEG_OUTOF_CD45POS	SAMPLE	STRING	CD14-, CD16- (% of CD45+ cells)	CD14-, CD16-	1				
454	454	454	454	454	454	454	454	454	454	454	454	454	455	CD14_POS_CD16_POS_OUTOF_CD45POS	SAMPLE	STRING	CD14+, CD16+ (% of CD45+ cells)	CD14+, CD16+	1				
455	455	455	455	455	455	455	455	455	455	455	455	455	456	CD15_POS_CD16_POS_OUTOF_CD45POS	SAMPLE	STRING	CD15+, CD16+ (% of CD45+ cells)	CD15+ CD16+	1				
456	456	456	456	456	456	456	456	456	456	456	456	456	457	CD19_PERCENTAGE	PATIENT	STRING	CD19 %	CD19 %	1				
457	457	457	457	457	457	457	457	457	457	457	457	457	458	CD19_POS_OUTOF_CD45POS	SAMPLE	STRING	CD19+ (% of CD45+ cells)	CD19+	1				
458	458	458	458	458	458	458	458	458	458	458	458	458	459	CD33_PERCENTAGE	PATIENT	STRING	CD33%	CD33%	1				
459	459	459	459	459	459	459	459	459	459	459	459	459	460	CD38_PERCENTAGE	PATIENT	STRING	CD38 %	CD38 %	1				
460	460	460	460	460	460	460	460	460	460	460	460	460	461	CD3_NEG_CD56_POS_CD16_NEG_OUTOF_CD45POS	SAMPLE	STRING	CD3-, CD56+, CD16- (% of CD45+ cells)	CD3-, CD56+, CD16-	1				
461	461	461	461	461	461	461	461	461	461	461	461	461	462	CD3_NEG_CD56_POS_CD16_POS_OUTOF_CD45POS	SAMPLE	STRING	CD3-, CD56+, CD16+ (% of CD45+ cells)	CD3-, CD56+, CD16+	1				
462	462	462	462	462	462	462	462	462	462	462	462	462	463	CD3_POS_OUTOF_CD45POS	SAMPLE	STRING	CD3+ (% of CD45+ cells)	CD3+	1				
463	463	463	463	463	463	463	463	463	463	463	463	463	464	CD3_POS_WTT	SAMPLE	STRING	CD3+ (% of whole tumor tissue)	CD3+	1				
464	464	464	464	464	464	464	464	464	464	464	464	464	465	CD45_NEGATIVE	PATIENT	STRING	CD45 Negative	CD45 Negative	1				
465	465	465	465	465	465	465	465	465	465	465	465	465	466	CD45_POS_WTT	SAMPLE	STRING	CD45+ (% of whole tumor tissue)	CD45+	1				
466	466	466	466	466	466	466	466	466	466	466	466	466	467	CD4_COUNTS_AT_DIAGNOSIS	SAMPLE	NUMBER	NADIR CD4 Counts at Diagnosis	NADIR CD4 Counts at Diagnosis	1				
467	467	467	467	467	467	467	467	467	467	467	467	467	468	CD56_POSITIVE	PATIENT	STRING	CD56 Positive	CD56 Positive	1				
468	468	468	468	468	468	468	468	468	468	468	468	468	469	CD5_PERCENTAGE	PATIENT	STRING	CD5 %	CD5 %	1				
469	469	469	469	469	469	469	469	469	469	469	469	469	470	CDC_HIV_RISK_GROUP	PATIENT	STRING	CDC HIV Risk Group	CDC HIV Risk Group	1				
470	470	470	470	470	470	470	470	470	470	470	470	470	471	CDH1_STATUS	SAMPLE	STRING	CDH1 Status	CDH1 Status	1				
471	471	471	471	471	471	471	471	471	471	471	471	471	472	CDK12_CNA	SAMPLE	STRING	CDK12 CNA	CDK12 CNA	1				
472	472	472	472	472	472	472	472	472	472	472	472	472	473	CDK12_MUT	SAMPLE	NUMBER	CDK12 Mutation	CDK12 Mutation	1				
473	473	473	473	473	473	473	473	473	473	473	473	473	474	CDKN1B_CNA	SAMPLE	STRING	CDKN1B CNA	CDKN1B CNA	1				
474	474	474	474	474	474	474	474	474	474	474	474	474	475	CDKN1B_MUT	PATIENT	NUMBER	Cdkn1b mut	Cdkn1b mut	1				
475	475	475	475	475	475	475	475	475	475	475	475	475	476	CDKN2A_DEL	SAMPLE	STRING	CDKN2A Deletion	CDKN2A Deletion	1				
476	476	476	476	476	476	476	476	476	476	476	476	476	477	CDKN2A_MET	SAMPLE	STRING	CDKN2A Methylation	CDKN2A Methylation	1				
477	477	477	477	477	477	477	477	477	477	477	477	477	478	CDKN2A_MUTATION	SAMPLE	STRING	CDKN2A Mutation	CDKN2A Mutation	1				
478	478	478	478	478	478	478	478	478	478	478	478	478	479	CDKN2A_SILENCING	SAMPLE	STRING	Epigenetic silencing status of CDKN2A.	CDKN2A Silencing	1				
479	479	479	479	479	479	479	479	479	479	479	479	479	480	CEA	PATIENT	STRING	The value of carcinoembryonic antigen (CEA) test	CEA	1				
480	480	480	480	480	480	480	480	480	480	480	480	480	481	CEA_RESULTS	PATIENT	STRING	CEA Results	CEA Results	1				
481	481	481	481	481	481	481	481	481	481	481	481	481	482	CEBPA_MUTATION	SAMPLE	STRING	CEBPA mutation.	CEBPA Mutation	1				
482	482	482	482	482	482	482	482	482	482	482	482	482	483	CEBPA_NEGATIVE	SAMPLE	STRING	Negative for CEBPA	Negative for CEBPA	1				
483	483	483	483	483	483	483	483	483	483	483	483	483	484	CEBPA_POSITIVE	SAMPLE	STRING	Positive for CEBPA	Positive for CEBPA	1				
484	484	484	484	484	484	484	484	484	484	484	484	484	485	CELLULARITY	SAMPLE	NUMBER	Tumor Content	Cellularity	1				
485	485	485	485	485	485	485	485	485	485	485	485	485	486	CELL_DIFFERENTIATION	SAMPLE	STRING	Cell Differentiation	Cell Differentiation	1				
486	486	486	486	486	486	486	486	486	486	486	486	486	487	CELL_LINE_INFORMATION	PATIENT	STRING	Cell Line Information	Cell Line Information	1				
487	487	487	487	487	487	487	487	487	487	487	487	487	488	CELL_LINE_ORIGIN	SAMPLE	STRING	Cell Line Origin	Cell Line Origin	1				
488	488	488	488	488	488	488	488	488	488	488	488	488	489	CELL_LINE_SOURCE	SAMPLE	STRING	Cell Line Source	Cell Line Source	1				
489	489	489	489	489	489	489	489	489	489	489	489	489	490	CELL_NUM_PER_VIAL	SAMPLE	NUMBER	Cell Number Per Vial	Cell Number Per Vial	1				
490	490	490	490	490	490	490	490	490	490	490	490	490	491	CELL_OF_ORIGIN	SAMPLE	STRING	Cell of tumor origin	Cell of tumor origin	1				
491	491	491	491	491	491	491	491	491	491	491	491	491	492	CELL_TYPE	SAMPLE	STRING	The type of specimen isolated from blood or bone marrow, ex: Plasma, PBMC, Granulocytes.	Cell Type	1				
492	492	492	492	492	492	492	492	492	492	492	492	492	493	CENSORED	SAMPLE	STRING	Survival Time Censored; True or False	Censored	1				
493	493	493	493	493	493	493	493	493	493	493	493	493	494	CENT17_COPY_NUMBER	SAMPLE	NUMBER	Fluorescence in situ hybridization diagnostic procedure chromosome 17 signal result range	Cent17 Copy Number	1				
494	494	494	494	494	494	494	494	494	494	494	494	494	495	CENTER	PATIENT	STRING	Center of sequencing	Center of sequencing	1				
495	495	495	495	495	495	495	495	495	495	495	495	495	496	CENTRAL	SAMPLE	STRING	Central	Central	1				
496	496	496	496	496	496	496	496	496	496	496	496	496	497	CENTRAL_SCAR_FIBROSIS	PATIENT	STRING	Central Scar/Fibrosis	Central Scar/Fibrosis	1				
497	497	497	497	497	497	497	497	497	497	497	497	497	498	CERVIX_SUV_RESULTS	PATIENT	NUMBER	Standardized uptake value cervix uteri assessment measurement	Standardized uptake value cervix uteri assessment measurement	1				
498	498	498	498	498	498	498	498	498	498	498	498	498	499	CFDNA_INPUT_NG	SAMPLE	STRING	cfDNA isolated from plasma analysed for circulating tumor DNA content	cfDNA Input (ng)	1				
499	499	499	499	499	499	499	499	499	499	499	499	499	500	CFDNA_PDX	SAMPLE	STRING	Is the sample a PDX or cfDNA	cfDNA or PDX	1				
500	500	500	500	500	500	500	500	500	500	500	500	500	501	CGA_IHC	SAMPLE	STRING	CGA IHC	CGA IHC	1				
501	501	501	501	501	501	501	501	501	501	501	501	501	502	CGH	SAMPLE	STRING	CGH	CGH	1				
502	502	502	502	502	502	502	502	502	502	502	502	502	503	CGH_ID	SAMPLE	STRING	CGH Id.	CGH Id	1				
503	503	503	503	503	503	503	503	503	503	503	503	503	504	CGH_SAMPLE_ID	SAMPLE	STRING	CGH Sample ID	CGH Sample ID	1				
504	504	504	504	504	504	504	504	504	504	504	504	504	505	CG_1P	SAMPLE	STRING	CG_1P	CG_1P	1				
505	505	505	505	505	505	505	505	505	505	505	505	505	506	CHD1_CNA	SAMPLE	STRING	CHD1 CNA	CHD1 CNA	1				
506	506	506	506	506	506	506	506	506	506	506	506	506	507	CHD1_MUTATION	SAMPLE	STRING	CHD1 Mutation is present	CHD1 Mutation	1				
507	507	507	507	507	507	507	507	507	507	507	507	507	508	CHD4_MUTATION_STATUS	SAMPLE	STRING	CHD4 Mutation Status	CHD4 Mutation Status	1				
508	508	508	508	508	508	508	508	508	508	508	508	508	509	CHEMOTHERAPY	PATIENT	STRING	Chemotherapy.	Chemotherapy	1				
509	509	509	509	509	509	509	509	509	509	509	509	509	510	CHEMOTHERAPY_DETAILS	PATIENT	STRING	Chemotherapy Details	Chemotherapy Details	1				
510	510	510	510	510	510	510	510	510	510	510	510	510	511	CHEMOTHERAPY_FIRST_LINE_PLATINUM_ETOPOSIDE	PATIENT	STRING	Chemotherapy First Line Platinum Etoposide	Chemotherapy First Line Platinum Etoposide	1				
511	511	511	511	511	511	511	511	511	511	511	511	511	512	CHEMOTHERAPY_PRIOR_IMPACT	PATIENT	STRING	Chemotherapy Prior IMPACT	Chemotherapy Prior IMPACT	1				
512	512	512	512	512	512	512	512	512	512	512	512	512	513	CHEMOTHERAPY_RESPONSE	PATIENT	STRING	Chemotherapy response	Chemotherapy Response	1				
513	513	513	513	513	513	513	513	513	513	513	513	513	514	CHEMO_CONCURRENT_COURSE	PATIENT	STRING	The text that represents the planned dosage frequency for a agent.	Dose Frequency Text	1				
514	514	514	514	514	514	514	514	514	514	514	514	514	515	CHEMO_CONCURRENT_DOSE	PATIENT	STRING	Occurring or operating at the same time. The use of synthetic or naturally-occurring chemicals for the treatment of diseases.	Concurrent Chemotherapy Dose	1				
515	515	515	515	515	515	515	515	515	515	515	515	515	516	CHEMO_CONCURRENT_FRACTIONS_TOTAL	PATIENT	NUMBER	A total number of doses of a drug, vaccine or other agent administered to a patient.	Agent Total Dose Count	1				
516	516	516	516	516	516	516	516	516	516	516	516	516	517	CHEMO_CONCURRENT_REASON_NOT_GIVEN	PATIENT	STRING	Text term to capture the explanation for a chemotherapy not being given concurrent to radiation therapy.	Chemo Concurrent Reason Not Given	1				
517	517	517	517	517	517	517	517	517	517	517	517	517	518	CHEMO_CONCURRENT_REASON_NOT_OTHER	PATIENT	STRING	Another reason that is not already specified or mentioned for why concurrent chemotherapy was not given.	Chemo Concurrent Reason Not Other	1				
518	518	518	518	518	518	518	518	518	518	518	518	518	519	CHEMO_CONCURRENT_TYPE	PATIENT	STRING	The chemotherapy regimen or schedule and agent in the therapy of patient	Chemotherapy Regimen Type	1				
519	519	519	519	519	519	519	519	519	519	519	519	519	520	CHEMO_CONCURRENT_TYPE_OTHER	PATIENT	STRING	Specify the other chemotherapy agent administered.	Other Chemotherapy Agent Administration Specify	1				
520	520	520	520	520	520	520	520	520	520	520	520	520	521	CHEMO_CYCLES	PATIENT	STRING	Chemotherapy Cycles	Chemotherapy Cycles	1				
521	521	521	521	521	521	521	521	521	521	521	521	521	522	CHEMO_DETAILS	PATIENT	STRING	Chemotherapy details	Chemotherapy Details	1				
522	522	522	522	522	522	522	522	522	522	522	522	522	523	CHEMO_END_REPORTING_PERIOD	PATIENT	STRING	End of chemo reporting period	Chemo Reporting Period End	1				
523	523	523	523	523	523	523	523	523	523	523	523	523	524	CHEMO_EXPOSURE	PATIENT	STRING	Chemo Exposure	Chemo Exposure	1				
524	524	524	524	524	524	524	524	524	524	524	524	524	525	CHEMO_EXP_SEQ_SPECIMEN	SAMPLE	STRING	Chemo Exposure of sequenced specimen	Chemo Exposure of sequenced specimen	1				
525	525	525	525	525	525	525	525	525	525	525	525	525	526	CHEMO_FIRST_LINE	PATIENT	STRING	Chemo First Line	Chemo First Line	1				
526	526	526	526	526	526	526	526	526	526	526	526	526	527	CHEMO_FOURTH_LINE	PATIENT	STRING	Chemi Fourth Line	Chemi Fourth Line	1				
527	527	527	527	527	527	527	527	527	527	527	527	527	528	CHEMO_PRE_PUMP	PATIENT	STRING	Yes or No indicator for chemo pre pump usage	Any Chemo Pre-Pump	1				
528	528	528	528	528	528	528	528	528	528	528	528	528	529	CHEMO_PRIOR_IMPACT	SAMPLE	STRING	Chemotherapy prior MSK-IMPACT	Chemotherapy prior MSK-IMPACT	1				
529	529	529	529	529	529	529	529	529	529	529	529	529	530	CHEMO_RECOMMENDED	PATIENT	STRING	Chemo Recommended	Chemo Recommended	1				
530	530	530	530	530	530	530	530	530	530	530	530	530	531	CHEMO_REGIMEN_CATEGORY	PATIENT	STRING	Chemo Regimen Category	Chemo Regimen Category	1				
531	531	531	531	531	531	531	531	531	531	531	531	531	532	CHEMO_RESISTANT	PATIENT	STRING	Chemo Resistance	Chemo Resistance	1				
532	532	532	532	532	532	532	532	532	532	532	532	532	533	CHEMO_SECOND_LINE	PATIENT	STRING	Chemo Second Line	Chemo Second Line	1				
533	533	533	533	533	533	533	533	533	533	533	533	533	534	CHEMO_SETTING_METASTATIC	PATIENT	STRING	Chemotherapy For Metastasis	Chemotherapy For Metastasis	1				
534	534	534	534	534	534	534	534	534	534	534	534	534	535	CHEMO_THIRD_LINE	PATIENT	STRING	Chemo Third Line	Chemo Third Line	1				
535	535	535	535	535	535	535	535	535	535	535	535	535	536	CHEST_PAIN_WEEKS	PATIENT	NUMBER	Chest Pain (Weeks)	Chest Pain (Weeks)	1				
536	536	536	536	536	536	536	536	536	536	536	536	536	537	CHEST_XRAY	PATIENT	STRING	Chest X Ray	Chest X Ray	1				
537	537	537	537	537	537	537	537	537	537	537	537	537	538	CHILD_PUGH_CLASSIFICATION	PATIENT	STRING	Child pugh classification grade	Child pugh classification grade	1				
538	538	538	538	538	538	538	538	538	538	538	538	538	539	CHLOROMA	PATIENT	STRING	Chloroma Disease At Diagnosis Present Indicator	Chloroma	1				
539	539	539	539	539	539	539	539	539	539	539	539	539	540	CHLOROMA_RELAPSE_SITE	PATIENT	STRING	Recurrent Disease Chloroma Present Indicator	Chloroma Site of Relapse	1				
540	540	540	540	540	540	540	540	540	540	540	540	540	541	CHR12_WCD	SAMPLE	STRING	Chr12 WCD	Chr12 WCD	1				
541	541	541	541	541	541	541	541	541	541	541	541	541	542	CHR18_WCD	SAMPLE	STRING	Chr18 WCD	Chr18 WCD	1				
542	542	542	542	542	542	542	542	542	542	542	542	542	543	CHR20_WCD	SAMPLE	STRING	Chr20 WCD	Chr20 WCD	1				
543	543	543	543	543	543	543	543	543	543	543	543	543	544	CHR2_FISH	SAMPLE	STRING	FISH Test on Chr2	FISH Test on Chr2	1				
544	544	544	544	544	544	544	544	544	544	544	544	544	545	CHR3_FISH	SAMPLE	STRING	FISH Test on Chr3	FISH Test on Chr3	1				
545	545	545	545	545	545	545	545	545	545	545	545	545	546	CHR7_WCD	SAMPLE	STRING	Chr7 WCD	Chr7 WCD	1				
546	546	546	546	546	546	546	546	546	546	546	546	546	547	CHROMOTRYPSIS_V2	SAMPLE	STRING	CHROMOTRYPSIS V2	CHROMOTRYPSIS V2	1				
547	547	547	547	547	547	547	547	547	547	547	547	547	548	CHRONIC_HEPATITIS_ANY_TYPE	PATIENT	STRING	History of chronic viral hepatitis	Chronic viral hepatitis	1				
548	548	548	548	548	548	548	548	548	548	548	548	548	549	CHRONIC_INFLAMATION	PATIENT	STRING	Chronic inflamation.	Chronic Inflamation	1				
549	549	549	549	549	549	549	549	549	549	549	549	549	550	CHR_19_20_CO_GAIN	SAMPLE	STRING	Chr 19/20 co-gain	Chr 19/20 co-gain	1				
550	550	550	550	550	550	550	550	550	550	550	550	550	551	CHR_7_GAIN_CHR_10_LOSS	SAMPLE	STRING	Chr 7 gain/Chr 10 loss	Chr 7 gain/Chr 10 loss	1				
551	551	551	551	551	551	551	551	551	551	551	551	551	552	CIBERSORT_ABSOLUTE	SAMPLE	NUMBER	CIBERSORT Absolute Immune Score	CIBERSORT Absolute	1				
552	552	552	552	552	552	552	552	552	552	552	552	552	553	CIBERSORT_CORRELATION	SAMPLE	NUMBER	CIBERSORT Correlation	CIBERSORT Correlation	1				
553	553	553	553	553	553	553	553	553	553	553	553	553	554	CIBERSORT_P	SAMPLE	NUMBER	CIBERSORT P-value	CIBERSORT P-value	1				
554	554	554	554	554	554	554	554	554	554	554	554	554	555	CIBERSORT_RMSE	SAMPLE	NUMBER	CIBERSORT RMSE	CIBERSORT RMSE	1				
555	555	555	555	555	555	555	555	555	555	555	555	555	556	CIMP_CATEGORY	SAMPLE	STRING	CIMP category.	CIMP Category	1				
556	556	556	556	556	556	556	556	556	556	556	556	556	557	CIRRHOSIS	PATIENT	STRING	Cirrhosis.	Cirrhosis	1				
557	557	557	557	557	557	557	557	557	557	557	557	557	558	CIS	PATIENT	STRING	CIS.	CIS	1				
558	558	558	558	558	558	558	558	558	558	558	558	558	559	CISPLATIN	PATIENT	STRING	Cisplatin.	Cisplatin	1				
559	559	559	559	559	559	559	559	559	559	559	559	559	560	CIS_PERCENTAGE	SAMPLE	NUMBER	% Carcinoma In Situ	% CIS	1				
560	560	560	560	560	560	560	560	560	560	560	560	560	561	CITY_OF_PROCUREMENT	PATIENT	STRING	City of procurement.	City of Procurement	1				
561	561	561	561	561	561	561	561	561	561	561	561	561	562	CK18_STAIN	SAMPLE	STRING	CK18 stain	CK18 stain	1				
562	562	562	562	562	562	562	562	562	562	562	562	562	563	CK7_STAIN	SAMPLE	STRING	CK7 stain	CK7 stain	1				
563	563	563	563	563	563	563	563	563	563	563	563	563	564	CKD_EPI	SAMPLE	NUMBER	CKD-EPI	CKD-EPI	1				
564	564	564	564	564	564	564	564	564	564	564	564	564	565	CKIT_EXON_17_MUTATION	PATIENT	STRING	Gene Mutation C-KIT Exon 17 Status Indicator	C-Kit Mutation Exon 17	1				
565	565	565	565	565	565	565	565	565	565	565	565	565	566	CKIT_EXON_8_MUTATION	PATIENT	STRING	Gene Mutation C-KIT Exon 8 Status Indicator	C-Kit Mutation Exon 8	1				
566	566	566	566	566	566	566	566	566	566	566	566	566	567	CKIT_EXON_MUTATION	SAMPLE	STRING	CKIT exon mutation.	CKIT Exon Mutation	1				
567	567	567	567	567	567	567	567	567	567	567	567	567	568	CKIT_MUTATION	SAMPLE	STRING	CKIT mutation.	CKIT Mutation	1				
568	568	568	568	568	568	568	568	568	568	568	568	568	569	CLARK_LEVEL_AT_DIAGNOSIS	PATIENT	STRING	Melanoma clark level value	Clark level at diagnosis	1				
569	569	569	569	569	569	569	569	569	569	569	569	569	570	CLAUDIN_SUBTYPE	PATIENT	STRING	Pam50 + Claudin-low subtype	Pam50 + Claudin-low subtype	1				
570	570	570	570	570	570	570	570	570	570	570	570	570	571	CLG_ID	SAMPLE	STRING	Cell Line Growth Conditions ID	Cell Line Growth Conditions ID	1				
571	571	571	571	571	571	571	571	571	571	571	571	571	572	CLINICAL_ASSESSMENT	PATIENT	STRING	Clinical Assessment	Clinical Assessment	1				
572	572	572	572	572	572	572	572	572	572	572	572	572	573	CLINICAL_ASSOCIATION	PATIENT	STRING	Clinical association.	Clinical Assocation	1				
573	573	573	573	573	573	573	573	573	573	573	573	573	574	CLINICAL_BENEFIT_TARGET_THERAPY	PATIENT	STRING	Clinical benefit from Target Therapy	Clinical benefit from Target Therapy	1				
574	574	574	574	574	574	574	574	574	574	574	574	574	575	CLINICAL_DATA	PATIENT	STRING	Clinical data.	Clinical Data	1				
575	575	575	575	575	575	575	575	575	575	575	575	575	576	CLINICAL_DIAGNOSIS_AND_HISTORY	PATIENT	STRING	Clinical Diagnosis And History	Clinical Diagnosis And History	1				
576	576	576	576	576	576	576	576	576	576	576	576	576	577	CLINICAL_GLEASON	SAMPLE	STRING	Clinical Gleason	Clinical Gleason	1				
577	577	577	577	577	577	577	577	577	577	577	577	577	578	CLINICAL_GLEASON_CATEGORY	SAMPLE	STRING	Clinical Gleason category	Clinical Gleason category	1				
578	578	578	578	578	578	578	578	578	578	578	578	578	579	CLINICAL_GLEASON_SUM	SAMPLE	NUMBER	Clinical Gleason Sum	Clinical Gleason Sum	1				
579	579	579	579	579	579	579	579	579	579	579	579	579	580	CLINICAL_SPECIMEN_DEFINITION	PATIENT	STRING	Clinical Specimen Definition	Clinical Specimen Definition	1				
580	580	580	580	580	580	580	580	580	580	580	580	580	582	CLINICAL_STATE	SAMPLE	STRING	Clinical State	Clinical State	1				
581	581	581	581	581	581	581	581	581	581	581	581	581	583	CLINICAL_STATE_AT_IMPACT_ORDER_DATE	PATIENT	STRING	Clinical State at IMPACT Order Date	Clinical State at IMPACT Order Date	1				
582	582	582	582	582	582	582	582	582	582	582	582	582	584	CLINICAL_STATUS_AT_DIAGNOSIS	PATIENT	STRING	Clinical Status at Diagnosis	Clinical Status at Diagnosis	1				
583	583	583	583	583	583	583	583	583	583	583	583	583	585	CLINICAL_STATUS_WITHIN_3_MTHS_SURGERY	SAMPLE	STRING	Clinical Status Within 3 Mths Surgery	Clinical Status Within 3 Mths Surgery	1				
584	584	584	584	584	584	584	584	584	584	584	584	584	586	CLINICAL_TRIAL	PATIENT	STRING	Clinical Trial	Clinical Trial	1				
585	585	585	585	585	585	585	585	585	585	585	585	585	587	CLINICAL_TRIAL_1L	PATIENT	STRING	Clinical Trial 1L	Clinical Trial 1L	1				
586	586	586	586	586	586	586	586	586	586	586	586	586	588	CLINICAL_TRIAL_2L	PATIENT	STRING	Clinical Trial 2L	Clinical Trial 2L	1				
587	587	587	587	587	587	587	587	587	587	587	587	587	589	CLINICAL_TRIAL_3L	PATIENT	STRING	Clinical Trial 3L	Clinical Trial 3L	1				
588	588	588	588	588	588	588	588	588	588	588	588	588	590	CLINICAL_TRIAL_DETAILS	SAMPLE	STRING	Clinical Trial Details	Clinical Trial Details	1				
589	589	589	589	589	589	589	589	589	589	589	589	589	591	CLINICAL_TRIAL_MT_IT	PATIENT	STRING	Clinical Trail MT/IT	Clinical Trail MT/IT	1				
590	590	590	590	590	590	590	590	590	590	590	590	590	592	CLINICAL_VARIANT	SAMPLE	STRING	Clinical variant	Clinical variant	1				
591	591	591	591	591	591	591	591	591	591	591	591	591	593	CLINICAL_VARIANT_DETAILS	SAMPLE	STRING	Clinical Variant details	Clinical Variant details	1				
592	592	592	592	592	592	592	592	592	592	592	592	592	594	CLIN_AI	PATIENT	STRING	History of autoimmune disease	Autoimmune Disease	1				
593	593	593	593	593	593	593	593	593	593	593	593	593	595	CLIN_IBD	PATIENT	STRING	History of inflammatory bowel disease	IBD	1				
594	594	594	594	594	594	594	594	594	594	594	594	594	596	CLIN_M_STAGE	PATIENT	STRING	Extent of the distant metastasis for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.	Neoplasm American Joint Committee on Cancer Clinical Distant Metastasis M Stage	1				
595	595	595	595	595	595	595	595	595	595	595	595	595	597	CLIN_N_STAGE	PATIENT	STRING	Extent of the regional lymph node involvement for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.	Neoplasm American Joint Committee on Cancer Clinical Regional Lymph Node N Stage	1				
596	596	596	596	596	596	596	596	596	596	596	596	596	598	CLIN_N_STAGE_CODE	PATIENT	STRING	Clinical N Stage Code	Clinical N Stage Code	1				
597	597	597	597	597	597	597	597	597	597	597	597	597	599	CLIN_PSC	PATIENT	STRING	History of primary sclerosing cholangitis	PSC	1				
598	598	598	598	598	598	598	598	598	598	598	598	598	600	CLIN_T_STAGE	PATIENT	STRING	Extent of the primary cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.	Neoplasm American Joint Committee on Cancer Clinical Primary Tumor T Stage	1				
599	599	599	599	599	599	599	599	599	599	599	599	599	601	CLIN_T_STAGE_CODE	PATIENT	STRING	Clinical T Stage Code	Clinical T Stage Code	1				
600	600	600	600	600	600	600	600	600	600	600	600	600	602	CLONALITY	SAMPLE	STRING	Clonality	Clonality	1				
601	601	601	601	601	601	601	601	601	601	601	601	601	603	CLONAL_LABEL	SAMPLE	STRING	Clonal Label	Clonal Label	1				
602	602	602	602	602	602	602	602	602	602	602	602	602	604	CLONET_PURITY	SAMPLE	NUMBER	CLONET Purity	CLONET Purity	1				
603	603	603	603	603	603	603	603	603	603	603	603	603	605	CLONET_STATUS	SAMPLE	STRING	CLONET STATUS	CLONET STATUS	1				
604	604	604	604	604	604	604	604	604	604	604	604	604	606	CMO_PATIENT_ID	PATIENT	STRING	CMO Patient ID	CMO Patient ID	1				
605	605	605	605	605	605	605	605	605	605	605	605	605	607	CNA_CLUSTER_K4	SAMPLE	STRING	CNA cluster K4.	CNA Cluster K4	1				
606	606	606	606	606	606	606	606	606	606	606	606	606	608	CNA_DATA	SAMPLE	STRING	CNA data.	CNA Data	1				
607	607	607	607	607	607	607	607	607	607	607	607	607	609	CNE	SAMPLE	NUMBER	Conserved Noncoding Element	Conserved Noncoding Element	1				
608	608	608	608	608	608	608	608	608	608	608	608	608	610	CNS_DISEASE	PATIENT	STRING	CNS disease.	CNS Disease	1				
609	609	609	609	609	609	609	609	609	609	609	609	609	611	CNS_DISEASE_EVER	PATIENT	STRING	CNS Disease Ever	CNS Disease Ever	1				
610	610	610	610	610	610	610	610	610	610	610	610	610	612	CNS_SITE_OF_RELAPSE	SAMPLE	STRING	CNS Site of Relapse	CNS Site of Relapse	1				
611	611	611	611	611	611	611	611	611	611	611	611	611	613	CNS_STATUS	PATIENT	STRING	CNS status.	CNS Status	1				
612	612	612	612	612	612	612	612	612	612	612	612	612	614	CNS_THERAPY_AGENT	PATIENT	STRING	CNS Therapy Agent	CNS Therapy Agent	1				
613	613	613	613	613	613	613	613	613	613	613	613	613	615	CN_CLUSTER	SAMPLE	STRING	CN cluster.	CN Cluster	1				
614	614	614	614	614	614	614	614	614	614	614	614	614	616	CN_DATA	SAMPLE	STRING	CN data.	CN Data	1				
615	615	615	615	615	615	615	615	615	615	615	615	615	617	CN_INVOLVEMENT	PATIENT	STRING	Yes or No indicator for CN involvement	CN Involvement	1				
616	616	616	616	616	616	616	616	616	616	616	616	616	618	COCA_CLUSTER	SAMPLE	STRING	COCA Cluster	COCA Cluster	1				
617	617	617	617	617	617	617	617	617	617	617	617	617	619	COHORT	PATIENT	STRING	Cohort.	Cohort	1				
618	618	618	618	618	618	618	618	618	618	618	618	618	620	COLLAB_ID	SAMPLE	STRING	Collaboration id.	Collaboration Id	1				
619	619	619	619	619	619	619	619	619	619	619	619	619	621	COLLOID	SAMPLE	STRING	Colloid	Colloid	1				
620	620	620	620	620	620	620	620	620	620	620	620	620	622	COLONOSCOPY	PATIENT	STRING	Colonoscopy	Colonoscopy	1				
621	621	621	621	621	621	621	621	621	621	621	621	621	623	COLON_POLYPS_PRESENT	SAMPLE	STRING	Indicator to determine whether colon polyps are present.	Colon Polyps Present	1				
622	622	622	622	622	622	622	622	622	622	622	622	622	624	COLUMNAR_METAPLASIA_GOBLET_CELL_INDICATOR	SAMPLE	STRING	Columnar mucosa goblet cell present	Columnar mucosa goblet cell present	1				
623	623	623	623	623	623	623	623	623	623	623	623	623	625	COMBO_INV_TRIAL	PATIENT	STRING	Did the patient recieve any investigational therapy in combination with main agent	Combintaion therapy with Investigational Agent	1				
624	624	624	624	624	624	624	624	624	624	624	624	624	626	COMMENTS	PATIENT	STRING	Comments.	Comments	1				
625	625	625	625	625	625	625	625	625	625	625	625	625	627	COMMERCIAL_AVAILABILITY	PATIENT	STRING	Commercial Availability	Commercial Availability	1				
626	626	626	626	626	626	626	626	626	626	626	626	626	628	COMPLETE_DATA	SAMPLE	STRING	Complete data.	Complete Data	1				
627	627	627	627	627	627	627	627	627	627	627	627	627	629	COMPLETE_TCGA_ID	SAMPLE	STRING	Complete TCGA ID	Complete TCGA ID	1				
628	628	628	628	628	628	628	628	628	628	628	628	628	630	COMPLETE_TURBT	SAMPLE	STRING	Complete TURBT	Complete TURBT	1				
629	629	629	629	629	629	629	629	629	629	629	629	629	631	COMPLEXITY	PATIENT	STRING	Complexity.	Complexity	1				
630	630	630	630	630	630	630	630	630	630	630	630	630	632	CONCOMITANT_CIS	SAMPLE	STRING	Concomitant Carcinoma in situ	Concomitant Carcinoma in situ	1				
631	631	631	631	631	631	631	631	631	631	631	631	631	633	CONCURRENT_CHEMO	PATIENT	STRING	Concurrent chemo	Concurrent chemo	1				
632	632	632	632	632	632	632	632	632	632	632	632	632	634	CONCURRENT_CHEMO_DETAILS	PATIENT	STRING	Concurrent Chemo Text	Concurrent Chemo Text	1				
633	633	633	633	633	633	633	633	633	633	633	633	633	635	CONCURRENT_TREATMENT	PATIENT	STRING	Concurrent Treatment	Concurrent Treatment	1				
634	634	634	634	634	634	634	634	634	634	634	634	634	636	CONDITIONING_REGIMEN	PATIENT	STRING	Conditioning Regimen	Conditioning Regimen	1				
635	635	635	635	635	635	635	635	635	635	635	635	635	637	CONFIRMED_DRAW	SAMPLE	STRING	Confirmed Draw	Confirmed Draw	1				
636	636	636	636	636	636	636	636	636	636	636	636	636	638	CONGENITAL_ABNORMALITY	PATIENT	STRING	Congentital abnormality.	Congenital Abnormality	1				
637	637	637	637	637	637	637	637	637	637	637	637	637	639	CONSENSUS_CLUSTER	SAMPLE	STRING	Consensus Cluster	Consensus Cluster	1				
638	638	638	638	638	638	638	638	638	638	638	638	638	640	CONSOLIDATION	PATIENT	STRING	Consolidation	Consolidation	1				
639	639	639	639	639	639	639	639	639	639	639	639	639	641	CONSTIPATION_WEEKS	PATIENT	NUMBER	Constipation (Weeks)	Constipation (Weeks)	1				
640	640	640	640	640	640	640	640	640	640	640	640	640	642	CONTEMPORARY_PATIENTS	PATIENT	STRING	Contemporary Patients	Contemporary Patients	1				
641	641	641	641	641	641	641	641	641	641	641	641	641	643	CONTIGUOUS_ORGAN_INVADED	PATIENT	STRING	Contiguous organ invaded	Contiguous organ invaded	1				
642	642	642	642	642	642	642	642	642	642	642	642	642	644	CONTIGUOUS_ORGAN_RESECTION	PATIENT	STRING	Contiguous organ resection site	Contiguous organ resection	1				
643	643	643	643	643	643	643	643	643	643	643	643	643	645	CONTIGUOUS_ORGAN_RESECTION_OTHER	PATIENT	STRING	Other contiguous organ resection site	Contiguous organ resection other	1				
644	644	644	644	644	644	644	644	644	644	644	644	644	646	CONTROL_SITE	SAMPLE	STRING	Control Site	Control Site	1				
645	645	645	645	645	645	645	645	645	645	645	645	645	647	CONVERTED_STAGE	SAMPLE	STRING	Converted Stage	Converted Stage	1				
646	646	646	646	646	646	646	646	646	646	646	646	646	648	COPY_NUMBER	SAMPLE	STRING	Copy Number	Copy Number	1				
647	647	647	647	647	647	647	647	647	647	647	647	647	649	COPY_NUMBER_CLUSTER	PATIENT	STRING	Copy number cluster.	Copy Number Cluster	1				
648	648	648	648	648	648	648	648	648	648	648	648	648	650	COPY_NUMBER_CLUSTER_EC	SAMPLE	STRING	Copy Number Cluster - EC	Copy Number Cluster - EC	1				
649	649	649	649	649	649	649	649	649	649	649	649	649	651	COPY_NUMBER_CLUSTER_GEA	SAMPLE	STRING	Copy Number Cluster - GEA	Copy Number Cluster - GEA	1				
650	650	650	650	650	650	650	650	650	650	650	650	650	652	COPY_NUMBER_CLUSTER_GEA_CIN	SAMPLE	STRING	Copy Number Cluster - GEA-CIN	Copy Number Cluster - GEA-CIN	1				
651	651	651	651	651	651	651	651	651	651	651	651	651	653	COPY_NUMBER_CLUSTER_SCC	SAMPLE	STRING	Copy Number Cluster - SCC	Copy Number Cluster - SCC	1				
652	652	652	652	652	652	652	652	652	652	652	652	652	654	CORPUS_INVOLVEMENT	PATIENT	STRING	Cervical carcinoma corpus uteri involvement indicator	Cervical carcinoma corpus uteri involvement indicator	1				
653	653	653	653	653	653	653	653	653	653	653	653	653	655	CORRELATION	SAMPLE	NUMBER	Correlation	Correlation	1				
654	654	654	654	654	654	654	654	654	654	654	654	654	656	COUGH_WEEKS	PATIENT	NUMBER	Cough (Weeks)	Cough (Weeks)	1				
655	655	655	655	655	655	655	655	655	655	655	655	655	657	COUNTRY	PATIENT	STRING	Country of procurement.	Country	1				
656	656	656	656	656	656	656	656	656	656	656	656	656	658	COUNTRY_OF_PROCUREMENT	PATIENT	STRING	Country of procurement.	Country of Procurement	1				
657	657	657	657	657	657	657	657	657	657	657	657	657	659	COVERAGE	SAMPLE	STRING	Coverage	Coverage	1				
658	658	658	658	658	658	658	658	658	658	658	658	658	660	COVERAGE_GREATER_THAN_100X	SAMPLE	STRING	Coverage greater than 100X.	Coverage Greater than 100X	1				
659	659	659	659	659	659	659	659	659	659	659	659	659	661	COVERAGE_NORMAL	SAMPLE	NUMBER	Normal Sample Coverage(fold)	Normal Sample Coverage(fold)	1				
660	660	660	660	660	660	660	660	660	660	660	660	660	662	COVERAGE_TUMOR	SAMPLE	NUMBER	Tumor Sample Coverage(fold)	Tumor Sample Coverage(fold)	1				
661	661	661	661	661	661	661	661	661	661	661	661	661	663	COVERED_BASES	SAMPLE	STRING	Covered Bases	Covered Bases	1				
662	662	662	662	662	662	662	662	662	662	662	662	662	664	CQCF_COUNTRY	PATIENT	STRING	CQCF country procurement.	CQCF Country of Procurement	1				
663	663	663	663	663	663	663	663	663	663	663	663	663	665	CQCF_DAYS_TO_SAMPLE_PROCUREMENT	PATIENT	STRING	CQCF days to sample procurement.	CQCF Days to Sample Procurement	1				
664	664	664	664	664	664	664	664	664	664	664	664	664	666	CQCF_METHOD_OF_SAMPLE_PROCUREMEN	PATIENT	STRING	CQCF method of sample procurement.	CQCF Method of Sample Procurement	1				
665	665	665	665	665	665	665	665	665	665	665	665	665	667	CRDB_ADJ_TXT	PATIENT	STRING	Has the patient received adjuvant systemic therapy?	CRDB_ADJ_TXT	1				
666	666	666	666	666	666	666	666	666	666	666	666	666	668	CRDB_BASIC_COMMENTS	PATIENT	STRING	The basic comments at enrollment for 12-245.	CRDB_BASIC_COMMENTS	1				
667	667	667	667	667	667	667	667	667	667	667	667	667	669	CRDB_BRAINMET	PATIENT	STRING	Does the patient have brain metastases?	CRDB_BRAINMET	1				
668	668	668	668	668	668	668	668	668	668	668	668	668	670	CRDB_COMMENTS	PATIENT	STRING	Comments.	CRDB_COMMENTS	1				
669	669	669	669	669	669	669	669	669	669	669	669	669	671	CRDB_CONSENT_DATE_DAYS	PATIENT	NUMBER	12-245 consent date.	CRDB_CONSENT_DATE_DAYS	1				
670	670	670	670	670	670	670	670	670	670	670	670	670	672	CRDB_ECOG	PATIENT	STRING	What is the patient's ECOG status?	CRDB_ECOG	1				
671	671	671	671	671	671	671	671	671	671	671	671	671	673	CRDB_ENROLL_DX_GRADE	PATIENT	STRING	The grade of the disease at enrollment for 12-245.	CRDB_ENROLL_DX_GRADE	1				
672	672	672	672	672	672	672	672	672	672	672	672	672	674	CRDB_ENROLL_DX_GRADE_DSCRP	PATIENT	STRING	The grade description of the disease at enrollment for 12-245.	CRDB_ENROLL_DX_GRADE_DSCRP	1				
673	673	673	673	673	673	673	673	673	673	673	673	673	675	CRDB_ENROLL_DX_HIST	PATIENT	STRING	Histology description associated with the disease at enrollment for 12-245.	CRDB_ENROLL_DX_HIST	1				
674	674	674	674	674	674	674	674	674	674	674	674	674	676	CRDB_ENROLL_DX_M_STAGE	PATIENT	STRING	The M Stage of the disease at enrollment for 12-245.	CRDB_ENROLL_DX_M_STAGE	1				
675	675	675	675	675	675	675	675	675	675	675	675	675	677	CRDB_ENROLL_DX_M_STAGE_DSCRP	PATIENT	STRING	The M Stage description of the disease at enrollment for 12-245.	CRDB_ENROLL_DX_M_STAGE_DSCRP	1				
676	676	676	676	676	676	676	676	676	676	676	676	676	678	CRDB_ENROLL_DX_N_STAGE	PATIENT	STRING	The N Stage of the disease at enrollment for 12-245.	CRDB_ENROLL_DX_N_STAGE	1				
677	677	677	677	677	677	677	677	677	677	677	677	677	679	CRDB_ENROLL_DX_N_STAGE_DSCRP	PATIENT	STRING	The N Stage description of the disease at enrollment for 12-245.	CRDB_ENROLL_DX_N_STAGE_DSCRP	1				
678	678	678	678	678	678	678	678	678	678	678	678	678	680	CRDB_ENROLL_DX_SITE	PATIENT	STRING	Site description associated with the disease at enrollment for 12-245.	CRDB_ENROLL_DX_SITE	1				
679	679	679	679	679	679	679	679	679	679	679	679	679	681	CRDB_ENROLL_DX_STAGE	PATIENT	STRING	The stage of the disease at enrollment for 12-245.	CRDB_ENROLL_DX_STAGE	1				
680	680	680	680	680	680	680	680	680	680	680	680	680	682	CRDB_ENROLL_DX_STAGE_DSCRP	PATIENT	STRING	The stage description at enrollment for 12-245.	CRDB_ENROLL_DX_STAGE_DSCRP	1				
681	681	681	681	681	681	681	681	681	681	681	681	681	683	CRDB_ENROLL_DX_STAGING_DSCRP	PATIENT	STRING	The staging system used to determine the stage of the disease at enrollment for 12-245.	CRDB_ENROLL_DX_STAGING_DSCRP	1				
682	682	682	682	682	682	682	682	682	682	682	682	682	684	CRDB_ENROLL_DX_STATUS	PATIENT	STRING	The status associated with the disease at enrollment for 12-245.	CRDB_ENROLL_DX_STATUS	1				
683	683	683	683	683	683	683	683	683	683	683	683	683	685	CRDB_ENROLL_DX_STATUS_DAYS	PATIENT	NUMBER	The status date associated with the disease at enrollment for 12-245..	CRDB_ENROLL_DX_STATUS_DAYS	1				
684	684	684	684	684	684	684	684	684	684	684	684	684	686	CRDB_ENROLL_DX_STATUS_ID	PATIENT	STRING	The ID related to the disease status information at enrollment for 12-245. Used as CRDB reference.	CRDB_ENROLL_DX_STATUS_ID	1				
685	685	685	685	685	685	685	685	685	685	685	685	685	687	CRDB_ENROLL_DX_SUB_HIST	PATIENT	STRING	Histology sub description associated with the disease at enrollment for 12-245.	CRDB_ENROLL_DX_SUB_HIST	1				
686	686	686	686	686	686	686	686	686	686	686	686	686	688	CRDB_ENROLL_DX_SUB_SITE	PATIENT	STRING	Site sub description associated with the disease at enrollment for 12-245.	CRDB_ENROLL_DX_SUB_SITE	1				
687	687	687	687	687	687	687	687	687	687	687	687	687	689	CRDB_ENROLL_DX_SUB_SUB_HIST	PATIENT	STRING	Histology sub sub description associated with the disease at enrollment for 12-245.	CRDB_ENROLL_DX_SUB_SUB_HIST	1				
688	688	688	688	688	688	688	688	688	688	688	688	688	690	CRDB_ENROLL_DX_SUB_SUB_SITE	PATIENT	STRING	Site sub sub description associated with the disease at enrollment for 12-245.	CRDB_ENROLL_DX_SUB_SUB_SITE	1				
689	689	689	689	689	689	689	689	689	689	689	689	689	691	CRDB_ENROLL_DX_SUB_SUB_SUB_HIST	PATIENT	STRING	Histology sub sub sub description associated with the disease at enrollment for 12-245.	CRDB_ENROLL_DX_SUB_SUB_SUB_HIST	1				
690	690	690	690	690	690	690	690	690	690	690	690	690	692	CRDB_ENROLL_DX_T_STAGE	PATIENT	STRING	The T Stage of the disease at enrollment for 12-245.	CRDB_ENROLL_DX_T_STAGE	1				
691	691	691	691	691	691	691	691	691	691	691	691	691	693	CRDB_ENROLL_DX_T_STAGE_DSCRP	PATIENT	STRING	The T Stage description of the disease at enrollment for 12-245.	CRDB_ENROLL_DX_T_STAGE_DSCRP	1				
692	692	692	692	692	692	692	692	692	692	692	692	692	694	CRDB_FIRST_METASTASIS_DAYS	PATIENT	NUMBER	The disease first metastasis date.	CRDB_FIRST_METASTASIS_DAYS	1				
693	693	693	693	693	693	693	693	693	693	693	693	693	695	CRDB_INITIAL_DX_DAYS	PATIENT	NUMBER	The disease initial diagnosis date.	CRDB_INITIAL_DX_DAYS	1				
694	694	694	694	694	694	694	694	694	694	694	694	694	696	CRDB_INITIAL_SX_DAYS	PATIENT	NUMBER	The disease initial symptom date.	CRDB_INITIAL_SX_DAYS	1				
695	695	695	695	695	695	695	695	695	695	695	695	695	697	CRDB_INIT_DX_GRADE	PATIENT	STRING	The grade of the disease at initial diagnosis.	CRDB_INIT_DX_GRADE	1				
696	696	696	696	696	696	696	696	696	696	696	696	696	698	CRDB_INIT_DX_GRADE_DSCRP	PATIENT	STRING	The grade description of the disease at initial diagnosis.	CRDB_INIT_DX_GRADE_DSCRP	1				
697	697	697	697	697	697	697	697	697	697	697	697	697	699	CRDB_INIT_DX_HIST	PATIENT	STRING	Histology description associated with the disease at initial diagnosis.	CRDB_INIT_DX_HIST	1				
698	698	698	698	698	698	698	698	698	698	698	698	698	700	CRDB_INIT_DX_M_STAGE	PATIENT	STRING	The M Stage of the disease at initial diagnosis.	CRDB_INIT_DX_M_STAGE	1				
699	699	699	699	699	699	699	699	699	699	699	699	699	701	CRDB_INIT_DX_M_STAGE_DSCRP	PATIENT	STRING	The M Stage description of the disease at initial diagnosis.	CRDB_INIT_DX_M_STAGE_DSCRP	1				
700	700	700	700	700	700	700	700	700	700	700	700	700	702	CRDB_INIT_DX_N_STAGE	PATIENT	STRING	The N Stage of the disease at initial diagnosis.	CRDB_INIT_DX_N_STAGE	1				
701	701	701	701	701	701	701	701	701	701	701	701	701	703	CRDB_INIT_DX_N_STAGE_DSCRP	PATIENT	STRING	The N Stage description of the disease at initial diagnosis.	CRDB_INIT_DX_N_STAGE_DSCRP	1				
702	702	702	702	702	702	702	702	702	702	702	702	702	704	CRDB_INIT_DX_SITE	PATIENT	STRING	Site description associated with the disease at initial diagnosis.	CRDB_INIT_DX_SITE	1				
703	703	703	703	703	703	703	703	703	703	703	703	703	705	CRDB_INIT_DX_STAGE	PATIENT	STRING	The stage of the disease at the initial diagnosis.	CRDB_INIT_DX_STAGE	1				
704	704	704	704	704	704	704	704	704	704	704	704	704	706	CRDB_INIT_DX_STAGE_DSCRP	PATIENT	STRING	The stage description at the initial diagnosis.	CRDB_INIT_DX_STAGE_DSCRP	1				
705	705	705	705	705	705	705	705	705	705	705	705	705	707	CRDB_INIT_DX_STAGING_DSCRP	PATIENT	STRING	The staging system used to determine the stage of the disease at the initial diagnosis.	CRDB_INIT_DX_STAGING_DSCRP	1				
706	706	706	706	706	706	706	706	706	706	706	706	706	708	CRDB_INIT_DX_STATUS	PATIENT	STRING	The status associated with the disease initial diagnosis.	CRDB_INIT_DX_STATUS	1				
707	707	707	707	707	707	707	707	707	707	707	707	707	709	CRDB_INIT_DX_STATUS_DAYS	PATIENT	STRING	The status date associated with the disease initial diagnosis	CRDB_INIT_DX_STATUS_DAYS	1				
708	708	708	708	708	708	708	708	708	708	708	708	708	710	CRDB_INIT_DX_STATUS_ID	PATIENT	STRING	The ID related to the disease status information at diagnosis. Used as CRDB reference.	CRDB_INIT_DX_STATUS_ID	1				
709	709	709	709	709	709	709	709	709	709	709	709	709	711	CRDB_INIT_DX_SUB_HIST	PATIENT	STRING	Histology sub description associated with the disease at initial diagnosis.	CRDB_INIT_DX_SUB_HIST	1				
710	710	710	710	710	710	710	710	710	710	710	710	710	712	CRDB_INIT_DX_SUB_SITE	PATIENT	STRING	Site sub description associated with the disease at initial diagnosis.	CRDB_INIT_DX_SUB_SITE	1				
711	711	711	711	711	711	711	711	711	711	711	711	711	713	CRDB_INIT_DX_SUB_SUB_HIST	PATIENT	STRING	Histology sub sub description associated with the disease at initial diagnosis.	CRDB_INIT_DX_SUB_SUB_HIST	1				
712	712	712	712	712	712	712	712	712	712	712	712	712	714	CRDB_INIT_DX_SUB_SUB_SITE	PATIENT	STRING	Site sub sub description associated with the disease at initial diagnosis.	CRDB_INIT_DX_SUB_SUB_SITE	1				
713	713	713	713	713	713	713	713	713	713	713	713	713	715	CRDB_INIT_DX_SUB_SUB_SUB_HIST	PATIENT	STRING	Histology sub sub sub description associated with the disease at initial diagnosis.	CRDB_INIT_DX_SUB_SUB_SUB_HIST	1				
714	714	714	714	714	714	714	714	714	714	714	714	714	716	CRDB_INIT_DX_T_STAGE	PATIENT	STRING	The T Stage of the disease at initial diagnosis.	CRDB_INIT_DX_T_STAGE	1				
715	715	715	715	715	715	715	715	715	715	715	715	715	717	CRDB_INIT_DX_T_STAGE_DSCRP	PATIENT	STRING	The T Stage description of the disease at initial diagnosis.	CRDB_INIT_DX_T_STAGE_DSCRP	1				
716	716	716	716	716	716	716	716	716	716	716	716	716	718	CRDB_NOSYSTXT	PATIENT	STRING	What is the number of prior systemic therapies (Inclusion of endocrine, cytotoxic, biologic therapies)?	CRDB_NOSYSTXT	1				
717	717	717	717	717	717	717	717	717	717	717	717	717	719	CRDB_OFF_STUDY_DAYS	PATIENT	STRING	The patient's 12-245 off study date.	CRDB_OFF_STUDY_DAYS	1				
718	718	718	718	718	718	718	718	718	718	718	718	718	720	CRDB_PRIM_DISEASE_12245	PATIENT	STRING	The patient's primary disease entered under 12-245.	CRDB_PRIM_DISEASE_12245	1				
719	719	719	719	719	719	719	719	719	719	719	719	719	721	CRDB_PRIOR_RX	PATIENT	STRING	Has the patient received prior radiotherapy?	CRDB_PRIOR_RX	1				
720	720	720	720	720	720	720	720	720	720	720	720	720	722	CRDB_QS_DATE	PATIENT	STRING	The date the survey was filled out.	CRDB_QS_DATE	1				
721	721	721	721	721	721	721	721	721	721	721	721	721	723	CRDB_SURVEY_COMMENTS	SAMPLE	STRING	The survey comments at enrollment for 12-245.	CRDB_SURVEY_COMMENTS	1				
722	722	722	722	722	722	722	722	722	722	722	722	722	724	CRDB_SURVIVAL_STATUS	PATIENT	STRING	The patient's survival status.	CRDB_SURVIVAL_STATUS	1				
723	723	723	723	723	723	723	723	723	723	723	723	723	725	CRDB_TREATMENT_END_DAYS	PATIENT	NUMBER	The patient's 12-245 treatment end date.	CRDB_TREATMENT_END_DAYS	1				
724	724	724	724	724	724	724	724	724	724	724	724	724	726	CREATININE	PATIENT	NUMBER	Creatinine	Creatinine	1				
725	725	725	725	725	725	725	725	725	725	725	725	725	727	CREATININE_LEVEL_PRERESECTION	SAMPLE	NUMBER	Hematology serum creatinine laboratory result value in mg dl	Hematology serum creatinine laboratory result value in mg dl	1				
726	726	726	726	726	726	726	726	726	726	726	726	726	728	CREATININE_NORMAL_RANGE_LOWER	PATIENT	NUMBER	Laboratory procedure creatinine result lower limit of normal value	Laboratory procedure creatinine result lower limit of normal value	1				
727	727	727	727	727	727	727	727	727	727	727	727	727	729	CREATININE_NORMAL_RANGE_UPPER	PATIENT	NUMBER	Laboratory procedure creatinine result upper limit of normal value	Laboratory procedure creatinine result upper limit of normal value	1				
728	728	728	728	728	728	728	728	728	728	728	728	728	730	CREATININE_NORM_RANGE_LOWER	SAMPLE	NUMBER	Laboratory procedure creatinine result lower limit of normal value	Laboratory procedure creatinine result lower limit of normal value	1				
729	729	729	729	729	729	729	729	729	729	729	729	729	731	CREATININE_NORM_RANGE_UPPER	SAMPLE	NUMBER	Laboratory procedure creatinine result upper limit of normal value	Laboratory procedure creatinine result upper limit of normal value	1				
730	730	730	730	730	730	730	730	730	730	730	730	730	732	CREATININE_PRIOR_TX	SAMPLE	NUMBER	Laboratory procedure creatinine prior treatment	Laboratory procedure creatinine prior treatment	1				
731	731	731	731	731	731	731	731	731	731	731	731	731	733	CRITERIA	SAMPLE	STRING	Criteria	Criteria	1				
732	732	732	732	732	732	732	732	732	732	732	732	732	734	CRX	PATIENT	NUMBER	Crx	Crx	1				
733	733	733	733	733	733	733	733	733	733	733	733	733	735	CR_STATUS_AT_END_OF_COURSE_1	PATIENT	STRING	CR status at end of course 1.	CR Status at End of Course 1	1				
734	734	734	734	734	734	734	734	734	734	734	734	734	736	CR_STATUS_AT_END_OF_COURSE_2	PATIENT	STRING	CR status at end of course 2.	CR Status at End of Course 2	1				
735	735	735	735	735	735	735	735	735	735	735	735	735	737	CSDE1_SOMATIC	SAMPLE	STRING	CSDE1 Somatic Mutation	CSDE1 Somatic Mutation	1				
736	736	736	736	736	736	736	736	736	736	736	736	736	738	CTCF_MUTATION_STATUS	SAMPLE	STRING	CTCF Mutation Status	CTCF Mutation Status	1				
737	737	737	737	737	737	737	737	737	737	737	737	737	739	CTNNB1_DELETION	SAMPLE	STRING	CTNNB1 Deletion	CTNNB1 Deletion	1				
738	738	738	738	738	738	738	738	738	738	738	738	738	740	CTNNB1_MUTATION	SAMPLE	STRING	CTNNB1 Mutation is present	CTNNB1 Mutation	1				
739	739	739	739	739	739	739	739	739	739	739	739	739	741	CT_ABDOMEN	PATIENT	STRING	CT Abdomen	CT Abdomen	1				
740	740	740	740	740	740	740	740	740	740	740	740	740	742	CT_CAP	PATIENT	STRING	CT Cap	CT Cap	1				
741	741	741	741	741	741	741	741	741	741	741	741	741	743	CT_CHEST	PATIENT	STRING	CT Chest	CT Chest	1				
742	742	742	742	742	742	742	742	742	742	742	742	742	744	CT_SCAN_AB_PELVIS_INDICATOR	PATIENT	STRING	Diagnostic ct abd pelvis performed	Ct scan ab pelvis indicator	1				
743	743	743	743	743	743	743	743	743	743	743	743	743	745	CT_SCAN_AB_PELVIS_RESULTS	PATIENT	STRING	Diagnostic ct abd pelvis result	Ct scan ab pelvis results	1				
744	744	744	744	744	744	744	744	744	744	744	744	744	746	CT_SCAN_PERFORMED	PATIENT	STRING	Yes/No indicator to determine whether a CT scan was performed.	CT Scan Performed	1				
745	745	745	745	745	745	745	745	745	745	745	745	745	747	CT_SCAN_PREOP_RESULTS	PATIENT	STRING	Diagnostic ct result outcome	Ct scan preop results	1				
746	746	746	746	746	746	746	746	746	746	746	746	746	748	CT_SLICE_SPACING	PATIENT	STRING	Distance in mm between CT scan images used to assess quality of volumetric analysis	CT Slice Spacing	1				
747	747	747	747	747	747	747	747	747	747	747	747	747	749	CUD_CATEGORY	SAMPLE	STRING	Cancer of Unknown Driver Category	Cancer of Unknown Driver Category	1				
748	748	748	748	748	748	748	748	748	748	748	748	748	750	CULTURE_PROPERTIES	SAMPLE	STRING	The cells are adherent or in suspension	Culture Properties	1				
749	749	749	749	749	749	749	749	749	749	749	749	749	751	CURATIVE	PATIENT	NUMBER	Curative	Curative	1				
750	750	750	750	750	750	750	750	750	750	750	750	750	752	CURRENT_CLINICAL_STATUS	PATIENT	STRING	Current Clinical Status	Current Clinical Status	1				
751	751	751	751	751	751	751	751	751	751	751	751	751	753	CURRENT_PDX_PASSAGE	SAMPLE	STRING	Current PDX Passage	Current PDX Passage	1				
752	752	752	752	752	752	752	752	752	752	752	752	752	754	CYSTECTOMY_N_STAGE	PATIENT	STRING	Cystectomy N stage	Cystectomy N stage	1				
753	753	753	753	753	753	753	753	753	753	753	753	753	755	CYSTECTOMY_PRIMARY_HISTOLOGY	SAMPLE	STRING	Cystectomy primary histology	Cystectomy primary histology	1				
754	754	754	754	754	754	754	754	754	754	754	754	754	756	CYSTECTOMY_T_STAGE	SAMPLE	STRING	Cystectomy T stage	Cystectomy T stage	1				
755	755	755	755	755	755	755	755	755	755	755	755	755	757	CYSTECTOMY_VARIANT_HISTOLOGY	SAMPLE	STRING	Cystectomy variant histology	Cystectomy variant histology	1				
756	756	756	756	756	756	756	756	756	756	756	756	756	758	CYST_SIZE	SAMPLE	NUMBER	Cyst Size (cm)	Cyst Size (cm)	1				
757	757	757	757	757	757	757	757	757	757	757	757	757	759	CYTOGENETICS	PATIENT	NUMBER	Cytogenetics.	Cytogenetics	1				
758	758	758	758	758	758	758	758	758	758	758	758	758	760	CYTOGENETICS_CATEGORY	PATIENT	STRING	Cytogenetics Category	Cytogenetics Category	1				
759	759	759	759	759	759	759	759	759	759	759	759	759	761	CYTOGENETIC_ABNORMALITY_TYPE	PATIENT	STRING	Cytogenetic abnormality type	Cytogenetic abnormality type	1				
760	760	760	760	760	760	760	760	760	760	760	760	760	762	CYTOGENETIC_CODE_OTHER	PATIENT	STRING	Cytogenetic Abnormality Other Code Text	Cytogenetic Code (Other)	1				
761	761	761	761	761	761	761	761	761	761	761	761	761	763	CYTOGENETIC_COMPLEXITY	PATIENT	STRING	Cytogenetic Abnormality Number of abnormalities	Cytogenetic Complexity	1				
762	762	762	762	762	762	762	762	762	762	762	762	762	764	CYTOGENETIC_RELAPSE_SITE	PATIENT	STRING	Recurrent Disease Cytogenetics Present Indicator	Cytogenetic Relapse Site	1				
763	763	763	763	763	763	763	763	763	763	763	763	763	765	CYTOLOGICAL_PHENOTYPE	SAMPLE	STRING	Cytological Phenotype	Cytological Phenotype	1				
764	764	764	764	764	764	764	764	764	764	764	764	764	766	CYTOLOGY	SAMPLE	STRING	Cytology	Cytology	1				
765	765	765	765	765	765	765	765	765	765	765	765	765	767	CYTOLYTIC_SCORE	SAMPLE	NUMBER	RNA-Seq Cytolytic Score	Cytolytic Score	1				
766	766	766	766	766	766	766	766	766	766	766	766	766	768	CYTOPLASM_PRESENCE_LESS_THAN_EQUAL_25_PERCENT	PATIENT	STRING	Cytoplasm Presence Less Than Equal 25 Percent	Cytoplasm Presence Less Than Equal 25 Percent	1				
767	767	767	767	767	767	767	767	767	767	767	767	767	769	CYTOREDUCTIVE_SURGERY	PATIENT	STRING	Cytoreductive Surgery	Cytoreductive Surgery	1				
768	768	768	768	768	768	768	768	768	768	768	768	768	770	CYTOTOXIC_TREATMENT	PATIENT	STRING	Cytotoxic Treatment	Cytotoxic Treatment	1				
769	769	769	769	769	769	769	769	769	769	769	769	769	771	C_A	SAMPLE	STRING	C>A	C>A	1				
770	770	770	770	770	770	770	770	770	770	770	770	770	772	C_G	SAMPLE	STRING	C>G	C>G	1				
771	771	771	771	771	771	771	771	771	771	771	771	771	773	C_N_STAGE	SAMPLE	STRING	cN Stage	cN Stage	1				
772	772	772	772	772	772	772	772	772	772	772	772	772	774	C_SAMP_METH_K3	SAMPLE	STRING	C samp meth K3.	C Samp METH K3	1				
773	773	773	773	773	773	773	773	773	773	773	773	773	775	C_SAMP_MIRNA_K4	SAMPLE	STRING	C samp mirna K4.	C Samp MIRNA K4	1				
774	774	774	774	774	774	774	774	774	774	774	774	774	776	C_SAMP_MIRNA_K6	SAMPLE	STRING	C samp mirna K6.	C Samp MIRNA K6	1				
775	775	775	775	775	775	775	775	775	775	775	775	775	777	C_SAMP_MRNA_K4	SAMPLE	STRING	C samp mrna K4.	C Samp MRNA K4	1				
776	776	776	776	776	776	776	776	776	776	776	776	776	778	C_SAMP_SCNA_CLUSTER	SAMPLE	STRING	C samp scna cluster.	C Samp SCNA Cluster	1				
777	777	777	777	777	777	777	777	777	777	777	777	777	779	C_T	SAMPLE	STRING	C>T	C>T	1				
778	778	778	778	778	778	778	778	778	778	778	778	778	780	DAILY_ALCOHOL	PATIENT	STRING	Daily alcohol	Daily Alcohol	1				
779	779	779	779	779	779	779	779	779	779	779	779	779	781	DARK	PATIENT	STRING	Primary exome sample with no driver found	Primary exome sample with no driver found	1				
780	780	780	780	780	780	780	780	780	780	780	780	780	782	DARK_ZONE_STAT	PATIENT	STRING	Dark zone stat at transplant.	DZ Stat	1				
781	781	781	781	781	781	781	781	781	781	781	781	781	783	DARWIN_AGE_AT_DIAGNOSIS	PATIENT	NUMBER	Patient age at time of diagnosis.	DARWIN_AGE_AT_DIAGNOSIS	1				
782	782	782	782	782	782	782	782	782	782	782	782	782	784	DARWIN_PATIENT_AGE	PATIENT	NUMBER	The patient age.	DARWIN_PATIENT_AGE	9				
783	783	783	783	783	783	783	783	783	783	783	783	783	785	DARWIN_RACE	PATIENT	STRING	Patient race, as supplied by darwin.	DARWIN_RACE	1				
784	784	784	784	784	784	784	784	784	784	784	784	784	786	DARWIN_RELIGION	PATIENT	STRING	Patient religion, as supplied by darwin.	DARWIN_RELIGION	1				
785	785	785	785	785	785	785	785	785	785	785	785	785	787	DARWIN_SEX	PATIENT	STRING	Patient sex, as supplied by darwin.	DARWIN_SEX	1				
786	786	786	786	786	786	786	786	786	786	786	786	786	788	DARWIN_VITAL_STATUS	PATIENT	STRING	Patient vital status, as supplied by darwin.	DARWIN_VITAL_STATUS	9				
787	787	787	787	787	787	787	787	787	787	787	787	787	789	DATA	SAMPLE	STRING	Data	Data	1				
788	788	788	788	788	788	788	788	788	788	788	788	788	790	DATA_CORE_SAMPLE	SAMPLE	STRING	Data core sample.	Data Core Sample	1				
789	789	789	789	789	789	789	789	789	789	789	789	789	791	DATA_FREEZE_STATUS	SAMPLE	STRING	Data Freeze Status	Data Freeze Status	1				
790	790	790	790	790	790	790	790	790	790	790	790	790	792	DATA_SOURCE	PATIENT	STRING	Data Source	Data Source	1				
791	791	791	791	791	791	791	791	791	791	791	791	791	793	DATE_ADDED	SAMPLE	STRING	Date added to cBioPortal	Date added to cBioPortal	1				
792	792	792	792	792	792	792	792	792	792	792	792	792	794	DATE_ADDITIONAL_CLINICAL_DATA_ADDED	SAMPLE	STRING	Date Additional Clinical data added	Date Additional Clinical data added	1				
793	793	793	793	793	793	793	793	793	793	793	793	793	795	DATE_OF_BIOPSY	PATIENT	STRING	Date of diagnostic biopsy	Date of diagnostic boiopsy	1				
794	794	794	794	794	794	794	794	794	794	794	794	794	796	DATE_OF_BIOPSY_RELAPSE	SAMPLE	STRING	Date of relapse biopsy	Date of relapse biopsy	1				
795	795	795	795	795	795	795	795	795	795	795	795	795	797	DATE_OF_DIAGNOSIS	PATIENT	STRING	Date of Diagnosis	Date Of Diagnosis	1				
796	796	796	796	796	796	796	796	796	796	796	796	796	798	DAXX_STATUS	SAMPLE	STRING	DAXX status	DAXX status	1				
797	797	797	797	797	797	797	797	797	797	797	797	797	799	DAYS_FROM_SURGERY_TO_DEATH	PATIENT	STRING	Days from surgery to death	Days from surgery to death	1				
798	798	798	798	798	798	798	798	798	798	798	798	798	800	DAYS_FROM_SURGERY_TO_LAST_FOLLOWUP	PATIENT	NUMBER	Days from surgery to last followup	Days from surgery to last followup	1				
799	799	799	799	799	799	799	799	799	799	799	799	799	801	DAYS_FROM_SURGERY_TO_RECURRENCE	PATIENT	NUMBER	Days from surgery to recurrence	Days from surgery to recurrence	1				
800	800	800	800	800	800	800	800	800	800	800	800	800	802	DAYS_LAST_FOLLOWUP	PATIENT	NUMBER	Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days..	Last Communication Contact from Initial Pathologic Diagnosis Date	1				
801	801	801	801	801	801	801	801	801	801	801	801	801	803	DAYS_METASTATIC	PATIENT	NUMBER	Time interval from the date of metastasis discovery to the date of initial pathologic diagnosis, represented as a calculated number of days.	Metastasis Less Initial Pathologic Diagnosis Date Calculated Day Value	1				
802	802	802	802	802	802	802	802	802	802	802	802	802	804	DAYS_TO_ADDITIONAL_SURGERY_METASTATIC_PROCEDURE	PATIENT	NUMBER	Days to additional surgery metastatic procedure.	Days to additional surgery metastatic procedure	1				
803	803	803	803	803	803	803	803	803	803	803	803	803	805	DAYS_TO_BILATERAL_TUMOR_DX	PATIENT	NUMBER	Days to bilateral tumor dx	Days to bilateral tumor dx	1				
804	804	804	804	804	804	804	804	804	804	804	804	804	806	DAYS_TO_BIOCHEMICAL_RECURRENCE_FIRST	PATIENT	NUMBER	Days to first biochemical recurrence	Days to biochemical recurrence first	1				
805	805	805	805	805	805	805	805	805	805	805	805	805	807	DAYS_TO_BIRTH	PATIENT	NUMBER	Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.	Birth from Initial Pathologic Diagnosis Date	1				
806	806	806	806	806	806	806	806	806	806	806	806	806	808	DAYS_TO_BONE_SCAN_PERFORMED	PATIENT	NUMBER	Days to bone Scan performed	Days to bone Scan performed	1				
807	807	807	807	807	807	807	807	807	807	807	807	807	809	DAYS_TO_CELL_SURFACE_MARKER_TEST	PATIENT	NUMBER	Days To Cell Surface Marker Test	Days To Cell Surface Marker Test	1				
808	808	808	808	808	808	808	808	808	808	808	808	808	810	DAYS_TO_COLLECTION	SAMPLE	NUMBER	Days to sample collection.	Days to Sample Collection.	1				
809	809	809	809	809	809	809	809	809	809	809	809	809	811	DAYS_TO_CT_SCAN_AB_PELVIS	PATIENT	NUMBER	Days to diagnostic computed tomography performed	Days to ct scan ab pelvis	1				
810	810	810	810	810	810	810	810	810	810	810	810	810	812	DAYS_TO_DEATH	PATIENT	NUMBER	Time interval from a person's date of death to the date of initial pathologic diagnosis, represented as a calculated number of days.	Death from Initial Pathologic Diagnosis Date	1				
811	811	811	811	811	811	811	811	811	811	811	811	811	813	DAYS_TO_DEFINITIVE_SURGICAL_PROCEDURE_PERFORMED	PATIENT	NUMBER	Days to definitive surgical procedure performed	Days to definitive surgical procedure performed	1				
812	812	812	812	812	812	812	812	812	812	812	812	812	814	DAYS_TO_DIAGNOSIS	PATIENT	NUMBER	Days to diagnosis.	Days to Diagnosis	1				
813	813	813	813	813	813	813	813	813	813	813	813	813	815	DAYS_TO_DIAGNOSTIC_COMPUTED_TOMOGRAPHY_PERFORMED	PATIENT	NUMBER	Days to diagnostic computed tomography performed	Days to diagnostic computed tomography performed	1				
814	814	814	814	814	814	814	814	814	814	814	814	814	816	DAYS_TO_DIAGNOSTIC_MRI_PERFORMED	PATIENT	NUMBER	Days to diagnostic mri performed	Days to diagnostic mri performed	1				
815	815	815	815	815	815	815	815	815	815	815	815	815	817	DAYS_TO_EVENT	PATIENT	NUMBER	Time To Event (days)	Time To Event (days)	1				
816	816	816	816	816	816	816	816	816	816	816	816	816	818	DAYS_TO_FDG_OR_CT_PET_PERFORMED	PATIENT	NUMBER	Days to fdg or ct pet performed	Days to fdg or ct pet performed	1				
817	817	817	817	817	817	817	817	817	817	817	817	817	819	DAYS_TO_FIRST_BIOCHEMICAL_RECURRENCE	PATIENT	NUMBER	Days to biochemical recurrence.	Days to First Biochemical Recurrence	1				
818	818	818	818	818	818	818	818	818	818	818	818	818	820	DAYS_TO_FIRST_SMN	PATIENT	NUMBER	Time to first SMN (days)	Time to first SMN (days)	1				
819	819	819	819	819	819	819	819	819	819	819	819	819	821	DAYS_TO_HIV_DIAGNOSIS	PATIENT	NUMBER	Days to HIV diagnosis	HIV Diagnosis (Days)	1				
820	820	820	820	820	820	820	820	820	820	820	820	820	822	DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS	PATIENT	NUMBER	Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.	Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value	1				
821	821	821	821	821	821	821	821	821	821	821	821	821	823	DAYS_TO_INITIAL_SCORE_PERFOR	PATIENT	NUMBER	Days to initial score performance.	Days to Initial Score Performance	1				
822	822	822	822	822	822	822	822	822	822	822	822	822	824	DAYS_TO_LABORATORY_PROCEDURE_TUMOR_MARKER_SQUAMOUS_CELL_CARCINOMA_ANTIGEN_RESULT	PATIENT	NUMBER	Days to laboratory procedure tumor marker squamous cell carcinoma antigen result	Days to laboratory procedure tumor marker squamous cell carcinoma antigen result	1				
823	823	823	823	823	823	823	823	823	823	823	823	823	825	DAYS_TO_LAST_FOLLOWUP	PATIENT	NUMBER	Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days.	Days to Last Followup	1				
824	824	824	824	824	824	824	824	824	824	824	824	824	826	DAYS_TO_LAST_KNOWN_ALIVE	PATIENT	NUMBER	Time interval from the date of last known alive status to the date of initial pathologic diagnosis, represented as a calculated number of days.	Last Known Alive Status Less Initial Pathologic Diagnosis Date Calculated Day Value	1				
825	825	825	825	825	825	825	825	825	825	825	825	825	827	DAYS_TO_MRI	PATIENT	NUMBER	Days to diagnostic mri performed	Days to mri	1				
826	826	826	826	826	826	826	826	826	826	826	826	826	828	DAYS_TO_NEW_TUMOR_EVENT	PATIENT	NUMBER	Time interval from the date of new tumor event including progression, recurrence and new primary malignacies to the date of initial pathologic diagnosis, represented as a calculated number of days.	New Tumor Event Less Initial Pathologic Diagnosis Date Calculated Day Value	1				
827	827	827	827	827	827	827	827	827	827	827	827	827	829	DAYS_TO_NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT	PATIENT	NUMBER	days to new tumor event after initial treatment	days to new tumor event after initial treatment	1				
828	828	828	828	828	828	828	828	828	828	828	828	828	830	DAYS_TO_NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT_1	PATIENT	NUMBER	days to new tumor event after initial treatment 1	days to new tumor event after initial treatment 1	1				
829	829	829	829	829	829	829	829	829	829	829	829	829	831	DAYS_TO_PATIENT_PROGRESSION_FREE	PATIENT	STRING	days_to_patient_progression_free	days_to_patient_progression_free	1				
830	830	830	830	830	830	830	830	830	830	830	830	830	832	DAYS_TO_PERFORMANCE_STATUS_ASSESSMENT	PATIENT	NUMBER	Days to performance status assessment	Days to performance status assessment	1				
831	831	831	831	831	831	831	831	831	831	831	831	831	833	DAYS_TO_POST_ORCHI_SERUM_TEST	PATIENT	NUMBER	Days to post orchi serum test	Days to post orchi serum test	1				
832	832	832	832	832	832	832	832	832	832	832	832	832	834	DAYS_TO_PRE_ORCHI_SERUM_TEST	PATIENT	NUMBER	Days to pre orchi serum test	Days to pre orchi serum test	1				
833	833	833	833	833	833	833	833	833	833	833	833	833	835	DAYS_TO_PSA	PATIENT	NUMBER	Days to Prostate-Specific Antigen (PSA) Test	Days to PSA	1				
834	834	834	834	834	834	834	834	834	834	834	834	834	836	DAYS_TO_RESULTS	PATIENT	NUMBER	Days to Results	Days to Results	1				
835	835	835	835	835	835	835	835	835	835	835	835	835	837	DAYS_TO_SPECIMEN_COLLECTION	SAMPLE	STRING	Days to sample procurement.	Days to Sample Procurement	1				
836	836	836	836	836	836	836	836	836	836	836	836	836	838	DAYS_TO_TREATMENT_END	PATIENT	NUMBER	Days to treatment end	Treatment End (Days)	1				
837	837	837	837	837	837	837	837	837	837	837	837	837	839	DAYS_TO_TREATMENT_START	PATIENT	NUMBER	Days to treatment start	Treatment Start (Days)	1				
838	838	838	838	838	838	838	838	838	838	838	838	838	840	DAYS_TO_TUMOR_PROGRESSION	PATIENT	STRING	days_to_tumor_progression	days_to_tumor_progression	1				
839	839	839	839	839	839	839	839	839	839	839	839	839	841	DAY_TO_RELAPSE	PATIENT	NUMBER	Time To Relapse (days)	Time To Relapse (days)	1				
840	840	840	840	840	840	840	840	840	840	840	840	840	842	DCIS_GRADE	PATIENT	NUMBER	DCIS Grade	DCIS Grade	1				
841	841	841	841	841	841	841	841	841	841	841	841	841	843	DDR_MUTATION	SAMPLE	STRING	DDR Gene Mutation	DDR Gene Mutation	1				
842	842	842	842	842	842	842	842	842	842	842	842	842	844	DEATH_FROM_DISEASE	PATIENT	STRING	Death due to disease	Death due to disease	1				
843	843	843	843	843	843	843	843	843	843	843	843	843	845	DECADRON_TREATMENT	PATIENT	STRING	Decadron Treatment	Decadron Treatment	1				
844	844	844	844	844	844	844	844	844	844	844	844	844	846	DEFINITIVE_SURGERY	PATIENT	STRING	Definitive surgery.	Definitive Surgery	1				
845	845	845	845	845	845	845	845	845	845	845	845	845	847	DEFINITIVE_SURGICAL_PROCEDURE	SAMPLE	STRING	Specimen collection method name	Specimen collection method name	1				
846	846	846	846	846	846	846	846	846	846	846	846	846	848	DEFINITIVE_TX_TYPE	PATIENT	STRING	Definitive TX type.	Definitive TX Type	1				
847	847	847	847	847	847	847	847	847	847	847	847	847	849	DEL_11Q	SAMPLE	STRING	del(11q), ATM	del(11q), ATM	1				
848	848	848	848	848	848	848	848	848	848	848	848	848	850	DEL_12P13	SAMPLE	STRING	del(12p13)	del(12p13)	1				
849	849	849	849	849	849	849	849	849	849	849	849	849	851	DEL_13Q	SAMPLE	STRING	del(13q)	del(13q)	1				
850	850	850	850	850	850	850	850	850	850	850	850	850	852	DEL_13Q14	SAMPLE	STRING	del(13q14) = ETV6 gene	del(13q14) = ETV6 gene	1				
851	851	851	851	851	851	851	851	851	851	851	851	851	853	DEL_16Q	SAMPLE	STRING	del(16q)	del(16q)	1				
852	852	852	852	852	852	852	852	852	852	852	852	852	854	DEL_17Q13	SAMPLE	STRING	del(17p13) = loss of p53	del(17p13) = loss of p53	1				
853	853	853	853	853	853	853	853	853	853	853	853	853	855	DEL_1Q	SAMPLE	STRING	del(1q)	del(1q)	1				
854	854	854	854	854	854	854	854	854	854	854	854	854	856	DEL_20Q	SAMPLE	STRING	del(20q)	del(20q)	1				
855	855	855	855	855	855	855	855	855	855	855	855	855	857	DEL_4Q12	SAMPLE	STRING	del(4q12)	del(4q12)	1				
856	856	856	856	856	856	856	856	856	856	856	856	856	858	DEL_5Q	SAMPLE	STRING	5Q deletion.	5Q Deletion	1				
857	857	857	857	857	857	857	857	857	857	857	857	857	859	DEL_6Q	SAMPLE	STRING	del(6q)	del(6q)	1				
858	858	858	858	858	858	858	858	858	858	858	858	858	860	DEL_7	SAMPLE	STRING	del(7)	del(7)	1				
859	859	859	859	859	859	859	859	859	859	859	859	859	861	DEL_7Q	SAMPLE	STRING	7Q deletion.	7Q Deletion	1				
860	860	860	860	860	860	860	860	860	860	860	860	860	862	DEL_9Q	SAMPLE	STRING	9Q deletion.	9Q Deletion	1				
861	861	861	861	861	861	861	861	861	861	861	861	861	863	DEL_FEATURE	SAMPLE	STRING	Del Feature	Del Feature	1				
862	862	862	862	862	862	862	862	862	862	862	862	862	864	DEMIX_PURITY	SAMPLE	NUMBER	DeMix Purity	DeMix Purity	1				
863	863	863	863	863	863	863	863	863	863	863	863	863	865	DENDRITIC_CELLS_ACTIVATED	SAMPLE	NUMBER	Dendritic cells activated	Dendritic cells activated	1				
864	864	864	864	864	864	864	864	864	864	864	864	864	866	DENDRITIC_CELLS_RESTING	SAMPLE	NUMBER	Dendritic cells resting	Dendritic cells resting	1				
865	865	865	865	865	865	865	865	865	865	865	865	865	867	DERMAGRPHX_DES	SAMPLE	STRING	Total body photographs taken by Dermatology (ie. No, Yes, Unknown).	Dermatology Photographs	1				
866	866	866	866	866	866	866	866	866	866	866	866	866	868	DETAILED_METASTATIC_SITE	SAMPLE	STRING	Detailed Metastatic Site	Detailed Metastatic Site	1				
867	867	867	867	867	867	867	867	867	867	867	867	867	869	DETAILED_PRIMARY_SITE	PATIENT	STRING	Detailed Primary Site	Detailed Primary Site	1				
868	868	868	868	868	868	868	868	868	868	868	868	868	870	DETAILED_SAMPLE_HISTOLOGY_CATEGORY	SAMPLE	STRING	Detailed Sample Histology Category	Detailed Sample Histology Category	1				
869	869	869	869	869	869	869	869	869	869	869	869	869	871	DETAILS_FIRST_LINE_COMMENTS	PATIENT	STRING	Details on First Line & Comments	Details on First Line & Comments	1				
870	870	870	870	870	870	870	870	870	870	870	870	870	872	DE_NOVO_START_OUTOFFRAME	SAMPLE	STRING	de novo start outofframe	de novo start outofframe	1				
871	871	871	871	871	871	871	871	871	871	871	871	871	873	DFS_EVENT	PATIENT	STRING	Disease Free Event	Disease Free Event	1				
872	872	872	872	872	872	872	872	872	872	872	872	872	874	DFS_MONTHS	PATIENT	NUMBER	Disease free (months) since initial treatment.	Disease Free (Months)	1				
873	873	873	873	873	873	873	873	873	873	873	873	873	875	DFS_STATUS	PATIENT	STRING	Disease free status since initial treatment.	Disease Free Status	1				
874	874	874	874	874	874	874	874	874	874	874	874	874	876	DIABETES_DIAGNOSIS_DAYS_TO	PATIENT	STRING	The number of days from the date the patient was diagnosed with cancer to the date of the patient's diagnosis of diabetes.	Diabetes Onset Less Initial Pathologic Diagnosis Date Calculated Day Value	1				
875	875	875	875	875	875	875	875	875	875	875	875	875	877	DIABETES_DIAGNOSIS_INDICATOR	PATIENT	STRING	Participant medical history -diabetes mellitus: a metabolic disorder characterized by abnormally high blood sugar levels due to diminished production of insulin or insulin resistance/desensitization._A term that is used to indicate a question with permissible values of yes/no/unknown.	Participant Personal Medical History Diabetes Mellitus Ind-3	1				
876	876	876	876	876	876	876	876	876	876	876	876	876	878	DIABETES_STATUS	PATIENT	STRING	Diabetes Status	Diabetes Status	1				
877	877	877	877	877	877	877	877	877	877	877	877	877	879	DIAGNOSIS	PATIENT	STRING	Diagnosis.	Diagnosis	1				
878	878	878	878	878	878	878	878	878	878	878	878	878	880	DIAGNOSTIC_CT_ABD_PELVIS_RESULT	PATIENT	STRING	Diagonostic CT abdomin-pelvis result.	Diagnostic CT Abdomin-Pelvis Result	1				
879	879	879	879	879	879	879	879	879	879	879	879	879	881	DIAGNOSTIC_MRI_RESULT	PATIENT	STRING	Diagonostic MRI result.	Diagonstic MRI Result	1				
880	880	880	880	880	880	880	880	880	880	880	880	880	882	DIAGNOSTIC_REFRACTORY_RELAPSE	SAMPLE	STRING	DIAGNOSTIC, REFRACTORY or RELAPSE	DIAGNOSTIC, REFRACTORY or RELAPSE	1				
881	881	881	881	881	881	881	881	881	881	881	881	881	883	DIAGNOSTIC_TYPE	PATIENT	STRING	Type of diagnostics used , as provided by CAISIS.	CAISIS (Diagnostic Type)	1				
882	882	882	882	882	882	882	882	882	882	882	882	882	884	DIAGNOSTIC_TYPE_DETAILED	SAMPLE	STRING	Diagnostic Type Detailed	Diagnostic Type Detailed	1				
883	883	883	883	883	883	883	883	883	883	883	883	883	885	DIAGNOSTIC_TYPE_SITE	PATIENT	STRING	Diagnostic Type Site	Diagnostic Type Site	1				
884	884	884	884	884	884	884	884	884	884	884	884	884	886	DIFF	PATIENT	NUMBER	Diff	Diff	1				
885	885	885	885	885	885	885	885	885	885	885	885	885	887	DIFFERENTIATION	SAMPLE	STRING	Differentiation	Differentiation	1				
886	886	886	886	886	886	886	886	886	886	886	886	886	888	DIFFERENTIATION_SCORE	SAMPLE	NUMBER	Differentiation Score	Differentiation Score	1				
887	887	887	887	887	887	887	887	887	887	887	887	887	889	DIFFUSE_ARCHITECTURE	PATIENT	STRING	Diffuse Architecture	Diffuse Architecture	1				
888	888	888	888	888	888	888	888	888	888	888	888	888	890	DISCONTINUOUS_LESIONS_COUNT	PATIENT	NUMBER	Discontiguous lesion count	Discontinuous lesions count	1				
889	889	889	889	889	889	889	889	889	889	889	889	889	891	DISEASE_AT_DIAGNOSIS	PATIENT	STRING	Disease at diagnosis	Disease at Diagnosis	1				
890	890	890	890	890	890	890	890	890	890	890	890	890	892	DISEASE_CLASSIFICATION	SAMPLE	STRING	The broad FMI tissue/disease classification for the specimen (used during analysis in applying base substitution priors)	Disease Classification	1				
891	891	891	891	891	891	891	891	891	891	891	891	891	893	DISEASE_CODE	SAMPLE	STRING	Disease code	Disease code	1				
892	892	892	892	892	892	892	892	892	892	892	892	892	894	DISEASE_DETECTED_ON_SCREENING	PATIENT	STRING	Indicator to signify whether or not the disease was detected by screening.	Screening Diagnosis Disease Detection Indicator	1				
893	893	893	893	893	893	893	893	893	893	893	893	893	895	DISEASE_EXTENT	PATIENT	STRING	Disease Extent At Time IMPACT Was Sent	Disease Extent At Time IMPACT Was Sent	1				
894	894	894	894	894	894	894	894	894	894	894	894	894	896	DISEASE_MULTIFOCAL_INDICATOR	PATIENT	STRING	Disease multifocal indicator	Disease multifocal indicator	1				
895	895	895	895	895	895	895	895	895	895	895	895	895	897	DISEASE_ONTOLOGY	PATIENT	STRING	Disease Ontology	Disease Ontology	1				
896	896	896	896	896	896	896	896	896	896	896	896	896	898	DISEASE_RECURRENCE_OR_PERSISTENCE	PATIENT	STRING	Disease Recurrence or Persistence	Disease Recurrence or Persistence	1				
897	897	897	897	897	897	897	897	897	897	897	897	897	899	DISEASE_SPECIFIC_FU	PATIENT	NUMBER	Disease specific FU	Disease specific FU	1				
898	898	898	898	898	898	898	898	898	898	898	898	898	900	DISEASE_STAGE	SAMPLE	STRING	Disease Stage	Disease Stage	1				
899	899	899	899	899	899	899	899	899	899	899	899	899	901	DISEASE_STATE_TIME_OF_COLLECTION	PATIENT	STRING	Disease State at time of tissue collection	Disease State at time of tissue collection	1				
900	900	900	900	900	900	900	900	900	900	900	900	900	902	DISEASE_STATUS	PATIENT	STRING	Disease Status	Disease Status	1				
901	901	901	901	901	901	901	901	901	901	901	901	901	903	DISTANCE_FROM_ANAL_VERGE	PATIENT	STRING	Distance from Anal Verge	Distance from Anal Verge	1				
902	902	902	902	902	902	902	902	902	902	902	902	902	904	DISTANT_METASTASIS_PATHOLOGIC_SPREAD	SAMPLE	STRING	Distant metastasis pathologic spread.	Distant Metastasis Pathologic Spread	1				
903	903	903	903	903	903	903	903	903	903	903	903	903	905	DISTANT_METS	SAMPLE	STRING	Distant Metastasis	Distant Metastasis	1				
904	904	904	904	904	904	904	904	904	904	904	904	904	906	DISTANT_MET_CHEMO_IMMUNO	PATIENT	STRING	Distant Metastasis Chemo/Immuno	Distant Metastasis Chemo/Immuno	1				
905	905	905	905	905	905	905	905	905	905	905	905	905	907	DISTANT_RECURRENCE	PATIENT	STRING	Distant recurrence.	Distant Recurrence	1				
906	906	906	906	906	906	906	906	906	906	906	906	906	908	DISTANT_RECURRENCE_NUM	PATIENT	NUMBER	Number of Distant Recurrence	Number of Distant Recurrence	1				
907	907	907	907	907	907	907	907	907	907	907	907	907	909	DISTANT_RECURRENCE_SITE	PATIENT	STRING	Distant Recurrence Site	Distant Recurrence Site	1				
908	908	908	908	908	908	908	908	908	908	908	908	908	910	DISTANT_RFS_MONTHS	PATIENT	NUMBER	Distan RFS (Months)	Distan RFS (Months)	1				
909	909	909	909	909	909	909	909	909	909	909	909	909	911	DM_AT_PRESENTATION	SAMPLE	STRING	DM at Presentation	DM at Presentation	1				
910	910	910	910	910	910	910	910	910	910	910	910	910	912	DM_SITE_CODE	SAMPLE	STRING	DM Site	DM Site	1				
911	911	911	911	911	911	911	911	911	911	911	911	911	913	DNA_INDEX	SAMPLE	STRING	DNA index.	DNA Index	1				
912	912	912	912	912	912	912	912	912	912	912	912	912	914	DNA_INPUT	SAMPLE	STRING	DNA Input	DNA Input	1				
913	913	913	913	913	913	913	913	913	913	913	913	913	915	DNA_METHYLATION_CLUSTER_EC	SAMPLE	STRING	DNA Methylation Cluster - EC	DNA Methylation Cluster - EC	1				
914	914	914	914	914	914	914	914	914	914	914	914	914	916	DNA_METHYLATION_CLUSTER_GEA	SAMPLE	STRING	DNA Methylation Cluster - GEA	DNA Methylation Cluster - GEA	1				
915	915	915	915	915	915	915	915	915	915	915	915	915	917	DNA_METHYLATION_CLUSTER_GEA_CIN	SAMPLE	STRING	DNA Methylation Cluster - GEA-CIN	DNA Methylation Cluster - GEA-CIN	1				
916	916	916	916	916	916	916	916	916	916	916	916	916	918	DNA_METHYLATION_CLUSTER_SCC	SAMPLE	STRING	DNA Methylation Cluster - SCC	DNA Methylation Cluster - SCC	1				
917	917	917	917	917	917	917	917	917	917	917	917	917	919	DNA_REPAIR_STATUS	SAMPLE	STRING	DNA Repair Status	DNA Repair Status	1				
918	918	918	918	918	918	918	918	918	918	918	918	918	920	DOCE	SAMPLE	STRING	DOCE.	DOCE	1				
919	919	919	919	919	919	919	919	919	919	919	919	919	921	DOD	PATIENT	STRING	Died Of Disease	Died Of Disease	1				
920	920	920	920	920	920	920	920	920	920	920	920	920	922	DOMAIN	SAMPLE	STRING	Domain	Domain	1				
921	921	921	921	921	921	921	921	921	921	921	921	921	923	DONOR_SOURCE	PATIENT	STRING	Donor Source	Donor Source	1				
922	922	922	922	922	922	922	922	922	922	922	922	922	924	DOPAMINE	SAMPLE	STRING	Dopamine Secreting	Dopamine Secreting	1				
923	923	923	923	923	923	923	923	923	923	923	923	923	925	DOSAGE	PATIENT	STRING	Dosage	Dosage	1				
924	924	924	924	924	924	924	924	924	924	924	924	924	926	DOUBLING_TIME	SAMPLE	NUMBER	Doubling time  (hrs)	Doubling Time (hrs)	1				
925	925	925	925	925	925	925	925	925	925	925	925	925	927	DRFS_MONTHS	PATIENT	STRING	Distant Recurrence-Free Survival (DRFS Months)	Distant Recurrence-Free Survival (DRFS Months)	1				
926	926	926	926	926	926	926	926	926	926	926	926	926	928	DRFS_STATUS	PATIENT	STRING	Distant Recurrence-Free Survival Status	Distant Recurrence-Free Survival Status	1				
927	927	927	927	927	927	927	927	927	927	927	927	927	929	DRINKER	PATIENT	STRING	Drinker.	Drinker	1				
928	928	928	928	928	928	928	928	928	928	928	928	928	930	DRIVER_MUTATIONS	SAMPLE	STRING	Driver Mutations	Driver Mutations	1				
929	929	929	929	929	929	929	929	929	929	929	929	929	931	DRIVER_MUTATIONS_DETAILED	SAMPLE	STRING	Detailed Driver Mutations	Detailed Driver Mutations	1				
930	930	930	930	930	930	930	930	930	930	930	930	930	932	DSS_MONTHS	PATIENT	NUMBER	The time period (months) usually begins at the time of diagnosis or at the start of treatment and ends at the time of death.	Months of disease-specific survival	1				
931	931	931	931	931	931	931	931	931	931	931	931	931	933	DSS_STATUS	PATIENT	STRING	The time period usually begins at the time of diagnosis or at the start of treatment and ends at the time of death.	Disease-specific Survival status	1				
932	932	932	932	932	932	932	932	932	932	932	932	932	934	DUPLICATION_NUM	SAMPLE	NUMBER	Duplication Number	Duplication Number	1				
933	933	933	933	933	933	933	933	933	933	933	933	933	935	DURABLE_CLINICAL_BENEFIT	PATIENT	STRING	Durable Clinical Benefit	Durable Clinical Benefit	1				
934	934	934	934	934	934	934	934	934	934	934	934	934	936	DURATION	PATIENT	NUMBER	Duration	Duration	1				
935	935	935	935	935	935	935	935	935	935	935	935	935	937	DURATION_OF_ADJUVANT_NEOADJUVANT_TX	PATIENT	STRING	Duration of Adjuvant/Neoadjuvant Treatment	Duration of Adjuvant/Neoadjuvant Treatment	1				
936	936	936	936	936	936	936	936	936	936	936	936	936	938	DURATION_OF_IBD_AT_DIAGNOSIS	PATIENT	STRING	Duration of IBD at Diagnosis	Duration of IBD at Diagnosis	1				
937	937	937	937	937	937	937	937	937	937	937	937	937	939	DURATION_OF_THERAPY_DAYS	PATIENT	STRING	duration of therapy days	duration of therapy days	1				
938	938	938	938	938	938	938	938	938	938	938	938	938	940	DURATION_OF_THERAPY_WEEKS	PATIENT	STRING	duration of therapy weeks	duration of therapy weeks	1				
939	939	939	939	939	939	939	939	939	939	939	939	939	941	DURLASTFU	PATIENT	NUMBER	Durlastfu	Durlastfu	1				
940	940	940	940	940	940	940	940	940	940	940	940	940	942	DX_BIOPSY_LOCATION	PATIENT	STRING	Location of first biopsy that showed presence of angiosarcoma	MedR Diagnositc Biopsy Location	1				
941	941	941	941	941	941	941	941	941	941	941	941	941	943	DX_CEP17_COPY	PATIENT	STRING	Copy number of CEP17 in diagnostic sample. This is the number of copies of the CEP17 gene seen in the sample, which is used to calculate the HER2/CEP17 ratio. Having multiple copies of a gene means that the tumor's DNA has many consecutive repetitions of the region that codes for a given gene. Having multiple extra copies of a gene is also described as an amplification, while losing copies of a gene is described as a deletion.	MedR Diagnostic CEP17 Copy	1				
942	942	942	942	942	942	942	942	942	942	942	942	942	944	DX_ER	PATIENT	STRING	Estrogen Receptor (ER) status of diagnostic sample	MedR Diagnostic ER Status	1				
943	943	943	943	943	943	943	943	943	943	943	943	943	945	DX_GRADE	PATIENT	STRING	Grade of diagnostic sample	MedR Diagnostic Grade	1				
944	944	944	944	944	944	944	944	944	944	944	944	944	946	DX_HER2FISH	PATIENT	STRING	HER2 Flourescence In Situ Hyrbridization (FISH) results in diagnostic sample. This is most commonly performed on tumor samples with a HER2 Immunohistochemistry (IHC) score of 2+, or equivocal. This is an additional test that aims to measure whether or not the HER2 gene is overexpressed in a tumor sample.	MedR Diagnostic HER2 FISH	1				
945	945	945	945	945	945	945	945	945	945	945	945	945	947	DX_HER2IHC	PATIENT	STRING	HER2 Immunohistochemistry (IHC) results of diagnostic sample. This test involves staining tissue samples and looking at them under a microscope to determine if the HER2 protein is overexpressed in the sample. Results can be reported as 0+, 1+, 2+, or 3+. 0+ and 1+ indicate a HER2 negative tumor, 2+ is considered equivocal and may require further testing, and 3+ indicates a HER2 Positive tumor.	MedR Diagnostic HER2 IHC	1				
946	946	946	946	946	946	946	946	946	946	946	946	946	948	DX_HER2OVERALL	PATIENT	STRING	HER2 status of diagnostic sample	MedR Diagnostic HER2 Status	1				
947	947	947	947	947	947	947	947	947	947	947	947	947	949	DX_HER2_COPY	PATIENT	STRING	Copy number of HER2 in diagnostic sample. This is the number of copies of the HER2 gene seen in the sample, which is used to calculate the HER2/CEP17 ratio. Having multiple copies of a gene means that the tumor's DNA has many consecutive repetitions of the region that codes for a given gene. Having multiple extra copies of a gene is also described as an amplification, while losing copies of a gene is described as a deletion.	MedR Diagnostic HER2 Copy	1				
948	948	948	948	948	948	948	948	948	948	948	948	948	950	DX_HER2_RATIO	PATIENT	STRING	Ratio of HER2/CEP17 in diagnostic sample. This is one component of the Flourescence In Situ Hybridization (FISH) test. This ratio is used to determine if the HER2 gene is overexpressed, relative to the CEP17 protein, which acts as a baseline measurement. HER2/CEP17 ratios >2.2 indicate a HER2 Positive tumor.	MedR Diagnostic HER2 Ratio	1				
949	949	949	949	949	949	949	949	949	949	949	949	949	951	DX_HISTOLOGY	PATIENT	STRING	Histology of diagnostic sample	MedR Diagnostic Histology	1				
950	950	950	950	950	950	950	950	950	950	950	950	950	952	DX_LOCATION	PATIENT	STRING	Location in the body of initial breast cancer diagnosis	MedR Diagnosis Location	1				
951	951	951	951	951	951	951	951	951	951	951	951	951	953	DX_PERCENT_ER	PATIENT	STRING	Percentage of Estrogen Receptor (ER) reported in diagnostic sample. A value of >= 1% indicates an ER Positive tumor .	MedR Diagnostic ER %	1				
952	952	952	952	952	952	952	952	952	952	952	952	952	954	DX_PERCENT_PR	PATIENT	STRING	Progesterone Receptor (PR) percentage reported in diagnostic sample. A value of >=1% indicates a PR Positive tumor.	MedR Diagnostic PR %	1				
953	953	953	953	953	953	953	953	953	953	953	953	953	955	DX_PR	PATIENT	STRING	Progesterone Receptor (PR) status of diagnostic sample	MedR Diagnostic PR Status	1				
954	954	954	954	954	954	954	954	954	954	954	954	954	956	DX_SIDEDNESS	PATIENT	STRING	Left or right sidedness of diagnostic sample	MedR Diagnosis Laterality	1				
955	955	955	955	955	955	955	955	955	955	955	955	955	957	DX_STAGE	PATIENT	STRING	American Joint Committee on Cancer (AJCC) Summary Stage at Diagnosis. Using the AJCC method, a breast cancer is characterized by the size of the tumor (T), the number of lymph nodes it has spread to (N), and whether or not it has metastatsized (M). Together, the T, N, and M values are used to determine the Summary stage, e.g. Stage I, Stage II, Stage III, Stage IV	MedR Stage at Diagnosis	1				
956	956	956	956	956	956	956	956	956	956	956	956	956	958	DX_TO_IMPACT_EXTENT_MONTHS	PATIENT	NUMBER	Time from Diagnosis to IMPACT in months	Time from Diagnosis to IMPACT in months	1				
957	957	957	957	957	957	957	957	957	957	957	957	957	959	DX_TYPE	PATIENT	STRING	Type of procedure used to obtain diagnostic sample	MedR Diagnostic Procedure	1				
958	958	958	958	958	958	958	958	958	958	958	958	958	960	DYSPLASIA	SAMPLE	STRING	Dysplasia.	Dysplasia	1				
959	959	959	959	959	959	959	959	959	959	959	959	959	961	E2A_STATUS	SAMPLE	STRING	E2A status.	E2A Status	1				
960	960	960	960	960	960	960	960	960	960	960	960	960	962	EASTERN_CANCER_ONCOLOGY_GROUP	PATIENT	STRING	Eastern Cancer Oncology Group.	Eastern Cancer Onocology Group	1				
961	961	961	961	961	961	961	961	961	961	961	961	961	963	EBV_POSITIVE	PATIENT	NUMBER	EBV Positive	EBV Positive	1				
962	962	962	962	962	962	962	962	962	962	962	962	962	964	EBV_POSITIVE_MALIGNANT_CELLS_PERCENT	SAMPLE	NUMBER	EBV Positive Malignant Cells Percent	EBV Positive Malignant Cells Percent	1				
963	963	963	963	963	963	963	963	963	963	963	963	963	965	EBV_PRESENT	PATIENT	STRING	EBV present.	EBV Present	1				
964	964	964	964	964	964	964	964	964	964	964	964	964	966	EBV_STATUS	PATIENT	STRING	Epstein-Barr Virus (EBV) Status	EBV Status	1				
965	965	965	965	965	965	965	965	965	965	965	965	965	967	EBV_STATUS_MALIGNANT_CELLS_METHOD	PATIENT	STRING	EBV Status Malignant Cells Method	EBV Status Malignant Cells Method	1				
966	966	966	966	966	966	966	966	966	966	966	966	966	968	EBV_TESTED	PATIENT	STRING	EBV Tested	EBV Tested	1				
967	967	967	967	967	967	967	967	967	967	967	967	967	969	EC	PATIENT	STRING	EC	EC	1				
968	968	968	968	968	968	968	968	968	968	968	968	968	970	ECE	SAMPLE	STRING	ECE	ECE	1				
969	969	969	969	969	969	969	969	969	969	969	969	969	971	ECE_BINARY	SAMPLE	STRING	ECE Binary	ECE Binary	1				
970	970	970	970	970	970	970	970	970	970	970	970	970	972	ECOG_AT_STAGE_4_DX	PATIENT	NUMBER	ECOG Score Recorded at Stage IV Diagnosis	ECOG At Stage IV Diagnosis	1				
971	971	971	971	971	971	971	971	971	971	971	971	971	973	ECOG_SCORE	PATIENT	NUMBER	The functional level of the patient based on the Zubrod performance scale.	Performance Status	1				
972	972	972	972	972	972	972	972	972	972	972	972	972	974	ECOG_STATUS	PATIENT	STRING	ECOG status	ECOG status	1				
973	973	973	973	973	973	973	973	973	973	973	973	973	975	ECSMG	PATIENT	STRING	EC-SMG	EC-SMG	1				
974	974	974	974	974	974	974	974	974	974	974	974	974	976	ECZEMA_HISTORY	PATIENT	STRING	History of eczema.	Eczema History	1				
975	975	975	975	975	975	975	975	975	975	975	975	975	977	EDMONDSON_GRADE	SAMPLE	STRING	Edmondson tumor grading	Edmondson tumor grading	1				
976	976	976	976	976	976	976	976	976	976	976	976	976	978	EFSCENS	PATIENT	STRING	EFS-CENS.	EFS-CENS	1				
977	977	977	977	977	977	977	977	977	977	977	977	977	979	EFS_EVENT_TYPE_ID	PATIENT	STRING	EFS event type id.	EFS Event Type ID	1				
978	978	978	978	978	978	978	978	978	978	978	978	978	980	EFS_MONTHS	PATIENT	NUMBER	In cancer, the length of time after primary treatment for a cancer ends that the patient remains free of certain complications or events that the treatment was intended to prevent or delay. These events may include the return of the cancer or the onset of certain symptoms, such as bone pain from cancer that has spread to the bone.	Event Free Survival (Months)	1				
979	979	979	979	979	979	979	979	979	979	979	979	979	981	EFS_STATUS	PATIENT	STRING	Event Free Status	Event Free Status	1				
980	980	980	980	980	980	980	980	980	980	980	980	980	982	EFS_TIME	PATIENT	STRING	EFS time.	EFS Time	1				
981	981	981	981	981	981	981	981	981	981	981	981	981	983	EF_DAYS_DISEASE	PATIENT	NUMBER	Event Free Days (Aggressive disease)	Event Free Days (Aggressive disease)	1				
982	982	982	982	982	982	982	982	982	982	982	982	982	984	EF_DAYS_METASTASIS	PATIENT	NUMBER	Event Free Days (Distant Metastasis)	Event Free Days (Distant Metastasis)	1				
983	983	983	983	983	983	983	983	983	983	983	983	983	985	EGD	PATIENT	STRING	Esophagogastroduodenoscopy	Esophagogastroduodenoscopy	1				
984	984	984	984	984	984	984	984	984	984	984	984	984	986	EGF1	PATIENT	NUMBER	Egf1	Egf1	1				
985	985	985	985	985	985	985	985	985	985	985	985	985	987	EGF2	PATIENT	NUMBER	Egf2	Egf2	1				
986	986	986	986	986	986	986	986	986	986	986	986	986	988	EGLN1_GERMLINE	SAMPLE	STRING	EGLN1 Germline Mutation	EGLN1 Germline Mutation	1				
987	987	987	987	987	987	987	987	987	987	987	987	987	989	ELN_GENETIC_RISK	PATIENT	STRING	ELN Genetic Risk	ELN Genetic Risk	1				
988	988	988	988	988	988	988	988	988	988	988	988	988	990	EMBOLIZATION	SAMPLE	STRING	Embolization	Embolization	1				
989	989	989	989	989	989	989	989	989	989	989	989	989	991	EMT_SCORE	SAMPLE	NUMBER	EMT Score	EMT Score	1				
990	990	990	990	990	990	990	990	990	990	990	990	990	992	ENCAPSULATION	SAMPLE	STRING	ENCAPSULATION	ENCAPSULATION	1				
991	991	991	991	991	991	991	991	991	991	991	991	991	993	ENETS_STAGING	SAMPLE	STRING	ENETS Staging	ENETS Staging	1				
992	992	992	992	992	992	992	992	992	992	992	992	992	994	ENETS_T_STAGING	SAMPLE	STRING	ENETS T-Staging	ENETS T-Staging	1				
993	993	993	993	993	993	993	993	993	993	993	993	993	995	ENROLLMENT_ON_CLINICAL_TRIAL_BASED_ON_IMPACT	PATIENT	STRING	Enrollment on clinical trial based on IMPACT	Enrollment on clinical trial based on IMPACT	1				
994	994	994	994	994	994	994	994	994	994	994	994	994	996	EOSINOPHILS	SAMPLE	NUMBER	Eosinophils	Eosinophils	1				
995	995	995	995	995	995	995	995	995	995	995	995	995	997	EPAS1_SOMATIC	SAMPLE	STRING	EPAS1 Somatic Mutation	EPAS1 Somatic Mutation	1				
996	996	996	996	996	996	996	996	996	996	996	996	996	998	EPIGENETIC	PATIENT	STRING	Epigenetic	Epigenetic	1				
997	997	997	997	997	997	997	997	997	997	997	997	997	999	EPINEPHRINE	SAMPLE	STRING	Epinephrine Secreting	Epinephrine Secreting	1				
998	998	998	998	998	998	998	998	998	998	998	998	998	1000	EPITHELIAL	SAMPLE	STRING	Epithelial.	Epithelial	1				
999	999	999	999	999	999	999	999	999	999	999	999	999	1001	EPITHELIOID_PERCENT_OF_TUMOR	SAMPLE	NUMBER	Epithelioid Percent of Tumor	Epithelioid Percent of Tumor	1				
1000	1000	1000	1000	1000	1000	1000	1000	1000	1000	1000	1000	1000	1002	ERBB_PATHWAY_MUTATION	SAMPLE	STRING	ErbB Pathway Mutation	ErbB Pathway Mutation	1				
1001	1001	1001	1001	1001	1001	1001	1001	1001	1001	1001	1001	1001	1003	ERG_EXPRESSION	SAMPLE	NUMBER	ERG Expression	ERG Expression	1				
1002	1002	1002	1002	1002	1002	1002	1002	1002	1002	1002	1002	1002	1004	ERG_FISH_RESULT	SAMPLE	STRING	ERG Fish result.	ERG FISH Result	1				
1003	1003	1003	1003	1003	1003	1003	1003	1003	1003	1003	1003	1003	1005	ERG_FUSION_ACGH	SAMPLE	STRING	ERG fusion acgh.	ERG Fusion ACGH	1				
1004	1004	1004	1004	1004	1004	1004	1004	1004	1004	1004	1004	1004	1006	ERG_FUSION_GEX	SAMPLE	STRING	ERG fusion gex.	ERG Fusion GEX	1				
1005	1005	1005	1005	1005	1005	1005	1005	1005	1005	1005	1005	1005	1007	ERG_FUSION_RNASEQ	SAMPLE	STRING	ERG FUSION RNASEQ	ERG FUSION RNASEQ	1				
1006	1006	1006	1006	1006	1006	1006	1006	1006	1006	1006	1006	1006	1008	ERG_FUSION_STATUS	SAMPLE	STRING	ERG fusion status.	ERG Fusion Status	1				
1007	1007	1007	1007	1007	1007	1007	1007	1007	1007	1007	1007	1007	1009	ERG_IHC	SAMPLE	STRING	ERG IHC	ERG IHC	1				
1008	1008	1008	1008	1008	1008	1008	1008	1008	1008	1008	1008	1008	1010	ERG_NANOSTRING	SAMPLE	STRING	ERG NANOSTRING	ERG NANOSTRING	1				
1009	1009	1009	1009	1009	1009	1009	1009	1009	1009	1009	1009	1009	1011	ERG_STATUS	PATIENT	STRING	Erg status	Erg status	1				
1010	1010	1010	1010	1010	1010	1010	1010	1010	1010	1010	1010	1010	1012	ERK_SCORE	SAMPLE	NUMBER	ERK Score	ERK Score	1				
1011	1011	1011	1011	1011	1011	1011	1011	1011	1011	1011	1011	1011	1013	ERROR_PERCENT	SAMPLE	STRING	Error percent.	Error Percent	1				
1012	1012	1012	1012	1012	1012	1012	1012	1012	1012	1012	1012	1012	1014	ERYTHROCYTE_SEDIMENTATION_RATE	PATIENT	STRING	Erythrocyte sedimentation rate result	Erythrocyte sedimentation rate	1				
1013	1013	1013	1013	1013	1013	1013	1013	1013	1013	1013	1013	1013	1015	ER_EXPR	PATIENT	STRING	ER status measured by expression	ER status measured by expression	1				
1014	1014	1014	1014	1014	1014	1014	1014	1014	1014	1014	1014	1014	1016	ER_IHC	PATIENT	STRING	ER status measured by IHC	ER status measured by IHC	1				
1015	1015	1015	1015	1015	1015	1015	1015	1015	1015	1015	1015	1015	1017	ER_POSITIVITY_METHOD	SAMPLE	STRING	ER detection method text	ER positivity method	1				
1016	1016	1016	1016	1016	1016	1016	1016	1016	1016	1016	1016	1016	1018	ER_POSITIVITY_SCALE_OTHER	SAMPLE	STRING	Positive finding estrogen receptor other measurement scale text	ER positivity scale other	1				
1017	1017	1017	1017	1017	1017	1017	1017	1017	1017	1017	1017	1017	1019	ER_POSITIVITY_SCALE_USED	SAMPLE	STRING	Breast carcinoma immunohistochemistry er pos finding scale	ER positivity scale used	1				
1018	1018	1018	1018	1018	1018	1018	1018	1018	1018	1018	1018	1018	1020	ER_PR_STATUS	SAMPLE	STRING	ER_PR	ER_PR	1				
1019	1019	1019	1019	1019	1019	1019	1019	1019	1019	1019	1019	1019	1021	ER_STATUS	SAMPLE	STRING	ER Status	ER Status	1				
1020	1020	1020	1020	1020	1020	1020	1020	1020	1020	1020	1020	1020	1022	ER_STATUS_BY_IHC	SAMPLE	STRING	breast carcinoma progesterone receptor status	ER Status By IHC	1				
1021	1021	1021	1021	1021	1021	1021	1021	1021	1021	1021	1021	1021	1023	ER_STATUS_IHC_PERCENT_POSITIVE	SAMPLE	STRING	progesterone receptor level cell percent category	ER Status IHC Percent Positive	1				
1022	1022	1022	1022	1022	1022	1022	1022	1022	1022	1022	1022	1022	1024	ER_STATUS_METASTASIS	PATIENT	STRING	ER Metastatic Status	ER Metastatic Status	1				
1023	1023	1023	1023	1023	1023	1023	1023	1023	1023	1023	1023	1023	1025	ER_STATUS_PRIMARY	PATIENT	STRING	ER Primary Status	ER Primary Status	1				
1024	1024	1024	1024	1024	1024	1024	1024	1024	1024	1024	1024	1024	1026	ESOPHAGEAL_TUMOR_LOCATION_CENTERED	SAMPLE	STRING	Esophageal tumor cental location	Esophageal tumor cental location	1				
1025	1025	1025	1025	1025	1025	1025	1025	1025	1025	1025	1025	1025	1027	ESOPHAGEAL_TUMOR_LOCATION_EPC	SAMPLE	STRING	Esophageal tumor location epc	Esophageal tumor location epc	1				
1026	1026	1026	1026	1026	1026	1026	1026	1026	1026	1026	1026	1026	1028	ESOPHAGEAL_TUMOR_LOCATION_INVOLVED	SAMPLE	STRING	Esophageal tumor involvement site	Esophageal tumor involvement site	1				
1027	1027	1027	1027	1027	1027	1027	1027	1027	1027	1027	1027	1027	1029	ESOPH_COLUMNAR_METAPLASIA_INDICATOR	SAMPLE	STRING	Columnar metaplasia present	Columnar metaplasia present	1				
1028	1028	1028	1028	1028	1028	1028	1028	1028	1028	1028	1028	1028	1030	ESOPH_NON_CA_DEGREE_OF_DYSPLASIA	SAMPLE	STRING	Columnar mucosa dysplasia	Columnar mucosa dysplasia	1				
1029	1029	1029	1029	1029	1029	1029	1029	1029	1029	1029	1029	1029	1031	ESTIMATED_LEUKOCYTE_PERCENTAGE	SAMPLE	NUMBER	Estimated leukocyte percentage.	Estimated Leukocyte Percentage	1				
1030	1030	1030	1030	1030	1030	1030	1030	1030	1030	1030	1030	1030	1032	ESTIMATE_COMBINED_SCORE	SAMPLE	NUMBER	ESTIMATE Score by ESTIMATE	ESTIMATE combined score	1				
1031	1031	1031	1031	1031	1031	1031	1031	1031	1031	1031	1031	1031	1033	ESTIMATE_IMMUNE_SCORE	SAMPLE	NUMBER	Immune Score by ESTIMATE	ESTIMATE immune score	1				
1032	1032	1032	1032	1032	1032	1032	1032	1032	1032	1032	1032	1032	1034	ESTIMATE_SCORE	SAMPLE	NUMBER	ESTIMATE Score by ESTIMATE	ESTIMATE Score	1				
1033	1033	1033	1033	1033	1033	1033	1033	1033	1033	1033	1033	1033	1035	ESTIMATE_STROMAL_SCORE	SAMPLE	NUMBER	Stromal Score by ESTIMATE	ESTIMATE stromal score	1				
1034	1034	1034	1034	1034	1034	1034	1034	1034	1034	1034	1034	1034	1036	EST_TUMOR_CELLULARITY	SAMPLE	STRING	Estimated tumor cellularity.	Estimated Tumor Cellularity	1				
1035	1035	1035	1035	1035	1035	1035	1035	1035	1035	1035	1035	1035	1037	ETE	PATIENT	STRING	ETE	ETE	1				
1036	1036	1036	1036	1036	1036	1036	1036	1036	1036	1036	1036	1036	1038	ETE_STATUS	PATIENT	STRING	Yes or No inidcator for extrathyroid extension	ETE Status	1				
1037	1037	1037	1037	1037	1037	1037	1037	1037	1037	1037	1037	1037	1040	ETHNICITY_NAACCR	PATIENT	STRING	Indication of Spanish/Hispanic origin of the patient; this data element maps to the NAACCR v16 #190. For institutions not collecting Spanish/Hispanic origin, submit a null in this category for all patients.	Ethnicity Category (NAACCR)	1				
1038	1038	1038	1038	1038	1038	1038	1038	1038	1038	1038	1038	1038	1041	ETIOLOGY	PATIENT	STRING	Etiology	Etiology	1				
1039	1039	1039	1039	1039	1039	1039	1039	1039	1039	1039	1039	1039	1042	ETOH	PATIENT	STRING	EtOH	EtOH	1				
1040	1040	1040	1040	1040	1040	1040	1040	1040	1040	1040	1040	1040	1043	ETS	SAMPLE	STRING	ETS	ETS	1				
1041	1041	1041	1041	1041	1041	1041	1041	1041	1041	1041	1041	1041	1044	ETS_FUSION_SEQ	SAMPLE	STRING	ETS fusion seq	ETS Fusion SEQ	1				
1042	1042	1042	1042	1042	1042	1042	1042	1042	1042	1042	1042	1042	1045	ETS_RAF_SPINK1_STATUS	SAMPLE	STRING	ETS RAF-SPINK1 status.	ETS RAF-SPINK1 Status	1				
1043	1043	1043	1043	1043	1043	1043	1043	1043	1043	1043	1043	1043	1046	ETV1_EXPRESSION	SAMPLE	NUMBER	ETV1 Expression	ETV1 Expression	1				
1044	1044	1044	1044	1044	1044	1044	1044	1044	1044	1044	1044	1044	1047	ETV1_FUSION	SAMPLE	STRING	ETV1 Fusion	ETV1 Fusion	1				
1045	1045	1045	1045	1045	1045	1045	1045	1045	1045	1045	1045	1045	1048	ETV1_STATUS	SAMPLE	STRING	ETV1 Status	ETV1 Status	1				
1046	1046	1046	1046	1046	1046	1046	1046	1046	1046	1046	1046	1046	1049	ETV4_EXPRESSION	SAMPLE	NUMBER	ETV4 Expression	ETV4 Expression	1				
1047	1047	1047	1047	1047	1047	1047	1047	1047	1047	1047	1047	1047	1050	ETV4_FUSION	SAMPLE	STRING	ETV4 Fusion	ETV4 Fusion	1				
1048	1048	1048	1048	1048	1048	1048	1048	1048	1048	1048	1048	1048	1051	ETV4_STATUS	SAMPLE	STRING	ETV4 Status	ETV4 Status	1				
1049	1049	1049	1049	1049	1049	1049	1049	1049	1049	1049	1049	1049	1052	ETV6_RUNX1_FUSION_STATUS	SAMPLE	STRING	ETV6-RUNX1 Fusion Status	ETV6-RUNX1 Fusion Status	1				
1050	1050	1050	1050	1050	1050	1050	1050	1050	1050	1050	1050	1050	1053	EVENT_DETAILS	PATIENT	STRING	Event Details	Event Details	1				
1051	1051	1051	1051	1051	1051	1051	1051	1051	1051	1051	1051	1051	1054	EVENT_STATUS_FOR_DFS	PATIENT	STRING	Event Status For Disease Free Survival	Event Status For Disease Free Survival	1				
1052	1052	1052	1052	1052	1052	1052	1052	1052	1052	1052	1052	1052	1055	EVENT_TYPE	PATIENT	STRING	Event Type	Event Type	1				
1053	1053	1053	1053	1053	1053	1053	1053	1053	1053	1053	1053	1053	1056	EVENT_TYPE_DETAILED	PATIENT	STRING	Detailed notes on event type	Event Type Detailed	1				
1054	1054	1054	1054	1054	1054	1054	1054	1054	1054	1054	1054	1054	1057	EVER_METS_SITES	PATIENT	STRING	All locations in the body where breast cancer spread at any point in the patient's treatment	MedR Ever Metastatic Sites	1				
1055	1055	1055	1055	1055	1055	1055	1055	1055	1055	1055	1055	1055	1058	EVIDENCE_FOR_LOSS_OF_HER2	SAMPLE	STRING	Evidence for Loss of HER2	Evidence for Loss of HER2	1				
1056	1056	1056	1056	1056	1056	1056	1056	1056	1056	1056	1056	1056	1059	EXCESSIVE_FRAME_SHIFT_DELETIONS	SAMPLE	STRING	EXCESSIVE FRAME-SHIFT DELETIONS	EXCESSIVE FRAME-SHIFT DELETIONS	1				
1057	1057	1057	1057	1057	1057	1057	1057	1057	1057	1057	1057	1057	1060	EXOME	SAMPLE	STRING	Exome	Exome	1				
1058	1058	1058	1058	1058	1058	1058	1058	1058	1058	1058	1058	1058	1061	EXOME_CAPTURE	SAMPLE	STRING	Exome Capture	Exome Capture	1				
1059	1059	1059	1059	1059	1059	1059	1059	1059	1059	1059	1059	1059	1062	EXOME_SAMPLE_ID	SAMPLE	STRING	EXOME Sample ID	EXOME Sample ID	1				
1060	1060	1060	1060	1060	1060	1060	1060	1060	1060	1060	1060	1060	1063	EXOME_SEQ	PATIENT	STRING	Exome seq	Exome seq	1				
1061	1061	1061	1061	1061	1061	1061	1061	1061	1061	1061	1061	1061	1064	EXOME_SEQUENCED_IN_BARBIERI_ET_AL_2012	SAMPLE	STRING	Exome sequenced in Barbieri et al.	Exome Sequenced in Barbieri et al.	1				
1062	1062	1062	1062	1062	1062	1062	1062	1062	1062	1062	1062	1062	1065	EXON_IMBALANCE_SCORE	SAMPLE	NUMBER	Exon Imbalance Score	Exon Imbalance Score	1				
1063	1063	1063	1063	1063	1063	1063	1063	1063	1063	1063	1063	1063	1066	EXP	SAMPLE	STRING	EXP	EXP	1				
1064	1064	1064	1064	1064	1064	1064	1064	1064	1064	1064	1064	1064	1067	EXPOSURE	SAMPLE	STRING	Exposure	Exposure	1				
1065	1065	1065	1065	1065	1065	1065	1065	1065	1065	1065	1065	1065	1068	EXPRESSION_SUBTYPE	SAMPLE	STRING	Gene Expression Subtype	Gene Expression Subtype	1				
1066	1066	1066	1066	1066	1066	1066	1066	1066	1066	1066	1066	1066	1069	EXP_SAMPLE_ID	SAMPLE	STRING	EXP Sample ID	EXP Sample ID	1				
1067	1067	1067	1067	1067	1067	1067	1067	1067	1067	1067	1067	1067	1070	EXTENSION	SAMPLE	STRING	Extension	Extension	1				
1068	1068	1068	1068	1068	1068	1068	1068	1068	1068	1068	1068	1068	1071	EXTENSIVE_LOCAL_INVASION	PATIENT	STRING	Extensive Local Invasion	Extensive Local Invasion	1				
1069	1069	1069	1069	1069	1069	1069	1069	1069	1069	1069	1069	1069	1072	EXTENT_OF_METS	SAMPLE	STRING	Extent of Mets	Extent of Mets	1				
1070	1070	1070	1070	1070	1070	1070	1070	1070	1070	1070	1070	1070	1073	EXTRACAPSULAR_EXTENSION	SAMPLE	STRING	The yes/no/unknown indicator that asks whether or not there is extracapsular extension.	Extracapsular Extension	1				
1071	1071	1071	1071	1071	1071	1071	1071	1071	1071	1071	1071	1071	1074	EXTRACAPSULAR_EXTENSION_PRESENT	SAMPLE	STRING	Text term to describe the extent of extracapsular extension present in a case of bladder carcinoma.	Extracapsular Extension present	1				
1072	1072	1072	1072	1072	1072	1072	1072	1072	1072	1072	1072	1072	1075	EXTRACAPSULAR_SPREAD	SAMPLE	STRING	extracapsular spread (ECS), can be yes or no	extracapsular spread	1				
1073	1073	1073	1073	1073	1073	1073	1073	1073	1073	1073	1073	1073	1076	EXTRACAPSULAR_SPREAD_PATHOLOGIC	PATIENT	STRING	Presence of pathological nodal extracapsular spread	Extracapsular spread pathologic	1				
1074	1074	1074	1074	1074	1074	1074	1074	1074	1074	1074	1074	1074	1077	EXTRAHEPATIC_DISEASE	PATIENT	STRING	Extrahepatic Disease	Extrahepatic Disease	1				
1075	1075	1075	1075	1075	1075	1075	1075	1075	1075	1075	1075	1075	1078	EXTRAHEPATIC_DISEASE_PRE_PUMP	PATIENT	STRING	Yes or No indicator for extrahep disease pre pump usage	Extrahepatic Disease Pre-Pump	1				
1076	1076	1076	1076	1076	1076	1076	1076	1076	1076	1076	1076	1076	1079	EXTRAHEPATIC_DISEASE_SITE	PATIENT	STRING	Extrahepatic Disease Site	Extrahepatic Disease Site	1				
1077	1077	1077	1077	1077	1077	1077	1077	1077	1077	1077	1077	1077	1080	EXTRANOCULAR_NODULE_SIZE	SAMPLE	STRING	Extranocular Nodule Size	Extranocular Nodule Size	1				
1078	1078	1078	1078	1078	1078	1078	1078	1078	1078	1078	1078	1078	1081	EXTRANODAL_INVOLVEMENT	PATIENT	STRING	Indicator that identifies whether a patient with malignant lymphoma has lymphomatous involvement of an extranodal site.	Lymphomatous Extranodal Site Involvement Indicator	1				
1079	1079	1079	1079	1079	1079	1079	1079	1079	1079	1079	1079	1079	1082	EXTRANODAL_INVOLVEMENT_SITE	SAMPLE	STRING	Extranodal disease involvement site	Extranodal disease involvement site	1				
1080	1080	1080	1080	1080	1080	1080	1080	1080	1080	1080	1080	1080	1083	EXTRANODAL_INVOLVMENT_OTHER	SAMPLE	STRING	Extranodal disease involvement site	Extranodal disease involvement site	1				
1081	1081	1081	1081	1081	1081	1081	1081	1081	1081	1081	1081	1081	1084	EXTRANODAL_LYMPHOMATOUS_INVOLVEMENT	SAMPLE	STRING	Extranodal involvement	Extranodal involvement	1				
1082	1082	1082	1082	1082	1082	1082	1082	1082	1082	1082	1082	1082	1085	EXTRAPROSTATIC_EXTENSION	PATIENT	STRING	Extraprostatic extension	Extraprostatic Extension	1				
1083	1083	1083	1083	1083	1083	1083	1083	1083	1083	1083	1083	1083	1086	EXTRASCLERAL_EXTENSION	SAMPLE	STRING	Extrascleral Extension	Extrascleral Extension	1				
1084	1084	1084	1084	1084	1084	1084	1084	1084	1084	1084	1084	1084	1087	EXTRATHYROIDAL_EXTENSION	SAMPLE	STRING	Extrathyroidal Extension	Extrathyroidal Extension	1				
1085	1085	1085	1085	1085	1085	1085	1085	1085	1085	1085	1085	1085	1088	EXTRAVASCULAR_MATRIX_PATTERNS	SAMPLE	STRING	Extravascular Matrix Patterns	Extravascular Matrix Patterns	1				
1086	1086	1086	1086	1086	1086	1086	1086	1086	1086	1086	1086	1086	1089	EXTRA_PANC_SPREAD	SAMPLE	STRING	Extra-Panc Spread	Extra-Panc Spread	1				
1087	1087	1087	1087	1087	1087	1087	1087	1087	1087	1087	1087	1087	1090	EXT_SLIDES_DES	SAMPLE	STRING	Indicates if these external slides were submitted.	External Slides Submitted	1				
1088	1088	1088	1088	1088	1088	1088	1088	1088	1088	1088	1088	1088	1091	EYE_COLOR	SAMPLE	STRING	Eye Color	Eye Color	1				
1089	1089	1089	1089	1089	1089	1089	1089	1089	1089	1089	1089	1089	1092	E_CIMP	SAMPLE	STRING	E-CIMP	E-CIMP	1				
1090	1090	1090	1090	1090	1090	1090	1090	1090	1090	1090	1090	1090	1093	FAB	PATIENT	STRING	FAB.	FAB	1				
1091	1091	1091	1091	1091	1091	1091	1091	1091	1091	1091	1091	1091	1094	FACETS	SAMPLE	STRING	FACETS	FACETS	1				
1092	1092	1092	1092	1092	1092	1092	1092	1092	1092	1092	1092	1092	1095	FACETS_PLOIDY	SAMPLE	NUMBER	Ploidy (Facets)	Ploidy (Facets)	1				
1093	1093	1093	1093	1093	1093	1093	1093	1093	1093	1093	1093	1093	1096	FACETS_PURITY	SAMPLE	NUMBER	Facets Purity	Facets Purity	1				
1094	1094	1094	1094	1094	1094	1094	1094	1094	1094	1094	1094	1094	1097	FAM175A_CNA	SAMPLE	STRING	FAM175A CNA	FAM175A CNA	1				
1095	1095	1095	1095	1095	1095	1095	1095	1095	1095	1095	1095	1095	1098	FAMILIAL_SYNDROME	PATIENT	STRING	Familial Syndrome	Familial Syndrome	1				
1096	1096	1096	1096	1096	1096	1096	1096	1096	1096	1096	1096	1096	1099	FAMILY_HISTORY	PATIENT	STRING	Family History	Family History	1				
1097	1097	1097	1097	1097	1097	1097	1097	1097	1097	1097	1097	1097	1100	FAMILY_HISTORY_CANCER_NUMBER_RELATIVES	PATIENT	STRING	Cancer diagnosis first degree relative number	Cancer diagnosis first degree relative number	1				
1098	1098	1098	1098	1098	1098	1098	1098	1098	1098	1098	1098	1098	1101	FAMILY_HISTORY_CANCER_RELATIONSHIP	PATIENT	STRING	Text indicator to represent a report or record of a cancer diagnosis in any relative with whom one half of an individual's genes is shared (i.e., parent, sibling, offspring).	Family History Cancer Relationship	1				
1099	1099	1099	1099	1099	1099	1099	1099	1099	1099	1099	1099	1099	1102	FAMILY_HISTORY_CANCER_TYPE	PATIENT	STRING	Family history cancer type.	Family History Cancer Type	1				
1100	1100	1100	1100	1100	1100	1100	1100	1100	1100	1100	1100	1100	1103	FAMILY_HISTORY_CANCER_TYPE_OTHER	PATIENT	STRING	Family History Cancer Type Other	Family History Cancer Type Other	1				
1101	1101	1101	1101	1101	1101	1101	1101	1101	1101	1101	1101	1101	1104	FAMILY_HISTORY_ESOPH_GASTIC_CANCER	PATIENT	STRING	History of esophageal cancer	History of esophageal cancer	1				
1102	1102	1102	1102	1102	1102	1102	1102	1102	1102	1102	1102	1102	1105	FAMILY_HISTORY_OF_CANCER	PATIENT	STRING	Family history of cancer.	Family History of Cancer	1				
1103	1103	1103	1103	1103	1103	1103	1103	1103	1103	1103	1103	1103	1106	FAMILY_HISTORY_OF_PRIMARY_BRAIN_TUMOR	PATIENT	STRING	Family history of primary brain tumor.	Family History of Primary Brain Tumor	1				
1104	1104	1104	1104	1104	1104	1104	1104	1104	1104	1104	1104	1104	1107	FAMILY_HISTORY_OF_RENAL_CELL_CARCINOMA	PATIENT	STRING	Family History of Renal cell carcinoma	Family History of Renal cell carcinoma	1				
1105	1105	1105	1105	1105	1105	1105	1105	1105	1105	1105	1105	1105	1108	FAMILY_HISTORY_OF_STOMACH_CANCER	PATIENT	STRING	Family history of stomach cancer.	Family History of Stomach Cancer	1				
1106	1106	1106	1106	1106	1106	1106	1106	1106	1106	1106	1106	1106	1109	FAMILY_HISTORY_OF_THYROID_CANCER	PATIENT	STRING	Family History of Thyroid Cancer	Family History of Thyroid Cancer	1				
1107	1107	1107	1107	1107	1107	1107	1107	1107	1107	1107	1107	1107	1110	FAMILY_HISTORY_OTHER_CANCER	PATIENT	STRING	Family history other cancer	Family history other cancer	1				
1108	1108	1108	1108	1108	1108	1108	1108	1108	1108	1108	1108	1108	1111	FAMILY_HISTORY_PRAD	PATIENT	STRING	Family History of Prostate Adenocarcinoma	Family History of Prostate Adenocarcinoma	1				
1109	1109	1109	1109	1109	1109	1109	1109	1109	1109	1109	1109	1109	1112	FAMILY_HISTORY_TESTICULAR_CANCER	PATIENT	STRING	Family history testicular cancer	Family history testicular cancer	1				
1110	1110	1110	1110	1110	1110	1110	1110	1110	1110	1110	1110	1110	1113	FAMILY_HISTORY_THYROID_CANCER	PATIENT	STRING	First degree relative history thyroid gland carcinoma diagnosis relationship type	Family history thyroid cancer	1				
1111	1111	1111	1111	1111	1111	1111	1111	1111	1111	1111	1111	1111	1114	FANCC_CNA	SAMPLE	STRING	FANCC CNA	FANCC CNA	1				
1112	1112	1112	1112	1112	1112	1112	1112	1112	1112	1112	1112	1112	1115	FANCC_MUT	SAMPLE	NUMBER	FANCC Mutation	FANCC Mutation	1				
1113	1113	1113	1113	1113	1113	1113	1113	1113	1113	1113	1113	1113	1116	FANCD2_CNA	SAMPLE	STRING	FANCD2 CNA	FANCD2 CNA	1				
1114	1114	1114	1114	1114	1114	1114	1114	1114	1114	1114	1114	1114	1117	FANCD2_MUT	SAMPLE	NUMBER	FANCD2 Mutation	FANCD2 Mutation	1				
1115	1115	1115	1115	1115	1115	1115	1115	1115	1115	1115	1115	1115	1118	FBXW7_MUTATION_STATUS	SAMPLE	STRING	FBXW7 Mutation Status	FBXW7 Mutation Status	1				
1116	1116	1116	1116	1116	1116	1116	1116	1116	1116	1116	1116	1116	1119	FEDPET_OR_CT_RESULTS	PATIENT	STRING	Fdg or ct pet performed outcome	Fdg or ct pet performed outcome	1				
1117	1117	1117	1117	1117	1117	1117	1117	1117	1117	1117	1117	1117	1120	FEMALE_BREAST_FEEDING_OR_PREGNANCY_STATUS_INDICATOR	PATIENT	STRING	Yes/No indicator to determine if female is breast feeding or pregnant.	Female Breast Feeding or Pregnancy Status Indicator	1				
1118	1118	1118	1118	1118	1118	1118	1118	1118	1118	1118	1118	1118	1121	FEV1_FVC_RATIO_POSTBRONCHOLIATOR	PATIENT	NUMBER	Fev1 fvc ratio postbroncholiator	Fev1 fvc ratio postbroncholiator	1				
1119	1119	1119	1119	1119	1119	1119	1119	1119	1119	1119	1119	1119	1122	FEV1_FVC_RATIO_PREBRONCHOLIATOR	PATIENT	NUMBER	Fev1 fvc ratio prebroncholiator	Fev1 fvc ratio prebroncholiator	1				
1120	1120	1120	1120	1120	1120	1120	1120	1120	1120	1120	1120	1120	1123	FEV1_PERCENT_REF_POSTBRONCHOLIATOR	PATIENT	NUMBER	Fev1 percent ref postbroncholiator	Fev1 percent ref postbroncholiator	1				
1121	1121	1121	1121	1121	1121	1121	1121	1121	1121	1121	1121	1121	1124	FEV1_PERCENT_REF_PREBRONCHOLIATOR	PATIENT	NUMBER	Fev1 percent ref prebroncholiator	Fev1 percent ref prebroncholiator	1				
1122	1122	1122	1122	1122	1122	1122	1122	1122	1122	1122	1122	1122	1125	FGA	SAMPLE	NUMBER	FGA	FGA	1				
1123	1123	1123	1123	1123	1123	1123	1123	1123	1123	1123	1123	1123	1126	FGF1	PATIENT	NUMBER	Fgf1	Fgf1	1				
1124	1124	1124	1124	1124	1124	1124	1124	1124	1124	1124	1124	1124	1127	FGF2	PATIENT	NUMBER	Fgf2	Fgf2	1				
1125	1125	1125	1125	1125	1125	1125	1125	1125	1125	1125	1125	1125	1128	FGFR1_FISH	PATIENT	STRING	FGFR1 FISH	FGFR1 FISH	1				
1126	1126	1126	1126	1126	1126	1126	1126	1126	1126	1126	1126	1126	1129	FGFR1_MUTATION	SAMPLE	STRING	FGFR1 Mutation	FGFR1 Mutation	1				
1127	1127	1127	1127	1127	1127	1127	1127	1127	1127	1127	1127	1127	1130	FGFR1_SOMATIC	SAMPLE	STRING	FGFR1 Somatic Mutation	FGFR1 Somatic Mutation	1				
1128	1128	1128	1128	1128	1128	1128	1128	1128	1128	1128	1128	1128	1131	FGFR2_MUTATION_STATUS	SAMPLE	STRING	FGFR2 Mutation Status	FGFR2 Mutation Status	1				
1129	1129	1129	1129	1129	1129	1129	1129	1129	1129	1129	1129	1129	1132	FGFR_ABNORMALITY	SAMPLE	STRING	FGFR Abnormality	FGFR Abnormality	1				
1130	1130	1130	1130	1130	1130	1130	1130	1130	1130	1130	1130	1130	1133	FIBER_PER_GM_IN_LUNG	SAMPLE	NUMBER	Fiber/gm Lung	Fiber/gm Lung	1				
1131	1131	1131	1131	1131	1131	1131	1131	1131	1131	1131	1131	1131	1134	FIGURE_1A	SAMPLE	STRING	Figure 1A	Figure 1A	1				
1132	1132	1132	1132	1132	1132	1132	1132	1132	1132	1132	1132	1132	1135	FIGURE_1B	SAMPLE	STRING	Figure 1B	Figure 1B	1				
1133	1133	1133	1133	1133	1133	1133	1133	1133	1133	1133	1133	1133	1136	FIGURE_2	SAMPLE	STRING	Figure 2	Figure 2	1				
1134	1134	1134	1134	1134	1134	1134	1134	1134	1134	1134	1134	1134	1137	FIGURE_3	SAMPLE	STRING	Figure 3	Figure 3	1				
1135	1135	1135	1135	1135	1135	1135	1135	1135	1135	1135	1135	1135	1138	FIGURE_4A	SAMPLE	STRING	Figure 4A	Figure 4A	1				
1136	1136	1136	1136	1136	1136	1136	1136	1136	1136	1136	1136	1136	1139	FIGURE_4B	SAMPLE	STRING	Figure 4B	Figure 4B	1				
1137	1137	1137	1137	1137	1137	1137	1137	1137	1137	1137	1137	1137	1140	FINAL_GRADE	SAMPLE	STRING	Final Grade	Final Grade	1				
1138	1138	1138	1138	1138	1138	1138	1138	1138	1138	1138	1138	1138	1141	FIRST_ADJUVANT_TX_TYPE	PATIENT	STRING	Type of First Systemic Therapy ADJ	Type of First Systemic Therapy ADJ	1				
1139	1139	1139	1139	1139	1139	1139	1139	1139	1139	1139	1139	1139	1142	FIRST_CYCLE_XRT	PATIENT	STRING	First Cycle XRT	First Cycle XRT	1				
1140	1140	1140	1140	1140	1140	1140	1140	1140	1140	1140	1140	1140	1143	FIRST_DIAGNOSIS_AGE_ASTH_ECZ	PATIENT	STRING	Age at first diagnosis of ASTH-ECZ.	Age at First Diagnosis of ASTH-ECZ	1				
1141	1141	1141	1141	1141	1141	1141	1141	1141	1141	1141	1141	1141	1144	FIRST_DIAGNOSIS_AGE_OF_ANIMA	PATIENT	STRING	Age at first diagnosis of Anima.	Age at First Diagnosis of Anima	1				
1142	1142	1142	1142	1142	1142	1142	1142	1142	1142	1142	1142	1142	1145	FIRST_DIAGNOSIS_AGE_OF_FOOD_ALLERGY	PATIENT	STRING	Age at first diagnosis of food allergy.	Age at First Diagnosis of Food Allergy	1				
1143	1143	1143	1143	1143	1143	1143	1143	1143	1143	1143	1143	1143	1146	FIRST_DISTANT_RECURRENCE_SITE	PATIENT	STRING	Site of First Distant Recurrence	Site of First Distant Recurrence	1				
1144	1144	1144	1144	1144	1144	1144	1144	1144	1144	1144	1144	1144	1147	FIRST_EVENT	PATIENT	STRING	First Event	First Event	1				
1145	1145	1145	1145	1145	1145	1145	1145	1145	1145	1145	1145	1145	1148	FIRST_LINE_THERAPY	PATIENT	STRING	First Line Therapy	First Line Therapy	1				
1146	1146	1146	1146	1146	1146	1146	1146	1146	1146	1146	1146	1146	1149	FIRST_MET_TX_TYPE	PATIENT	STRING	Type of First Systemic Therapy MET	Type of First Systemic Therapy MET	1				
1147	1147	1147	1147	1147	1147	1147	1147	1147	1147	1147	1147	1147	1150	FIRST_PRESENTING_SYMPTOM	PATIENT	STRING	First presenting symptom.	First Presenting Symptom	1				
1148	1148	1148	1148	1148	1148	1148	1148	1148	1148	1148	1148	1148	1151	FIRST_PRESENTING_SYMPTOM_LON	PATIENT	STRING	First presenting symptom LON.	First Presenting Symptom LON	1				
1149	1149	1149	1149	1149	1149	1149	1149	1149	1149	1149	1149	1149	1152	FIRST_RECURRENCE_RESECTABLE_FOR_NED	PATIENT	STRING	First Recurrence Resectable for NED	First Recurrence Resectable for NED	1				
1150	1150	1150	1150	1150	1150	1150	1150	1150	1150	1150	1150	1150	1153	FIRST_SITE_OF_METS	SAMPLE	STRING	First Site of Metastasis	First Site of Metastasis	1				
1151	1151	1151	1151	1151	1151	1151	1151	1151	1151	1151	1151	1151	1154	FIRST_SITE_OF_MET_DETAILED	SAMPLE	STRING	First Site of Metastasis (Detailed)	First Site of Metastasis (Detailed)	1				
1152	1152	1152	1152	1152	1152	1152	1152	1152	1152	1152	1152	1152	1155	FIRST_SURGICAL_PROCEDURE_OTHER	SAMPLE	STRING	Surgical procedure purpose other text	First surgical procedure other	1				
1153	1153	1153	1153	1153	1153	1153	1153	1153	1153	1153	1153	1153	1156	FIRST_SYMPTOM_LONGEST_DURATION	PATIENT	STRING	First symptom longest duration	First symptom longest duration	1				
1154	1154	1154	1154	1154	1154	1154	1154	1154	1154	1154	1154	1154	1157	FIRST_SYSTEMIC_GIVEN_WITH_PUMP	PATIENT	STRING	First Systemic Given with Pump	First Systemic Given with Pump	1				
1155	1155	1155	1155	1155	1155	1155	1155	1155	1155	1155	1155	1155	1158	FIRST_TREATMENT_SUCCESS	PATIENT	STRING	First treatment success	First treatment success	1				
1156	1156	1156	1156	1156	1156	1156	1156	1156	1156	1156	1156	1156	1159	FISH_AR	SAMPLE	STRING	FISH AR	FISH AR	1				
1157	1157	1157	1157	1157	1157	1157	1157	1157	1157	1157	1157	1157	1160	FISH_TRANSLOCATION	SAMPLE	STRING	FISH translocation.	FISH Translocation	1				
1158	1158	1158	1158	1158	1158	1158	1158	1158	1158	1158	1158	1158	1161	FLI1_EXPRESSION	SAMPLE	NUMBER	FLI1 Expression	FLI1 Expression	1				
1159	1159	1159	1159	1159	1159	1159	1159	1159	1159	1159	1159	1159	1162	FLI1_STATUS	SAMPLE	STRING	FLI1 Status	FLI1 Status	1				
1160	1160	1160	1160	1160	1160	1160	1160	1160	1160	1160	1160	1160	1163	FLOWCELL_ANALYSIS	SAMPLE	NUMBER	The FMI identifier for the analysis run that generated this variant report	Flowcell Analysis	1				
1161	1161	1161	1161	1161	1161	1161	1161	1161	1161	1161	1161	1161	1164	FLOW_ABNORMAL_BLAST	PATIENT	STRING	Flow Abnormal BLAST	Flow Abnormal BLAST	1				
1162	1162	1162	1162	1162	1162	1162	1162	1162	1162	1162	1162	1162	1165	FLT3_ITD_ALLELIC_RATIO	SAMPLE	STRING	FLT3-ITD allelic ratio.	FLT3-ITD Allelic Ratio.	1				
1163	1163	1163	1163	1163	1163	1163	1163	1163	1163	1163	1163	1163	1166	FLT3_ITD_POSITIVE	SAMPLE	STRING	FLT3-ITD positive.	FLT3-ITD Postive	1				
1164	1164	1164	1164	1164	1164	1164	1164	1164	1164	1164	1164	1164	1167	FLT3_NEGATIVE	SAMPLE	STRING	Negative for FLT3	Negative for FLT3	1				
1165	1165	1165	1165	1165	1165	1165	1165	1165	1165	1165	1165	1165	1168	FLT3_PM	SAMPLE	STRING	FLT3-PM.	FLT3-PM	1				
1166	1166	1166	1166	1166	1166	1166	1166	1166	1166	1166	1166	1166	1169	FLT3_POSITIVE	SAMPLE	STRING	Positive for FLT3	Positive for FLT3	1				
1167	1167	1167	1167	1167	1167	1167	1167	1167	1167	1167	1167	1167	1170	FMI_CASE_ID	SAMPLE	STRING	Foundation medicine case id.	FMI Case Id.	1				
1168	1168	1168	1168	1168	1168	1168	1168	1168	1168	1168	1168	1168	1171	FNCLCC_GRADE	SAMPLE	NUMBER	FNCLCC Grade	FNCLCC Grade	1				
1169	1169	1169	1169	1169	1169	1169	1169	1169	1169	1169	1169	1169	1172	FOCAL_DRIVER_CN	SAMPLE	STRING	Gene with focal SCNA, CN level	Gene with focal SCNA, CN level	1				
1170	1170	1170	1170	1170	1170	1170	1170	1170	1170	1170	1170	1170	1173	FOCAL_LESIONS_AT_RELAPSE	SAMPLE	STRING	Focal Lesions At Relapse	Focal Lesions At Relapse	1				
1171	1171	1171	1171	1171	1171	1171	1171	1171	1171	1171	1171	1171	1174	FOLLICULAR_COMPONENT_PERCENT	SAMPLE	STRING	Percentage of follicular component	Percentage of follicular component	1				
1172	1172	1172	1172	1172	1172	1172	1172	1172	1172	1172	1172	1172	1175	FOLLOWUP_LENGTH	PATIENT	STRING	Follow up length	Follow up length (year)	1				
1173	1173	1173	1173	1173	1173	1173	1173	1173	1173	1173	1173	1173	1176	FOLLOWUP_TIME_FROM_START_OF_CHEMO	PATIENT	NUMBER	Followup time from start of Chemotherapy in months	Followup time from start of Chemo (months)	1				
1174	1174	1174	1174	1174	1174	1174	1174	1174	1174	1174	1174	1174	1177	FOLLOWUP_TREATMENT_SUCCESS	PATIENT	STRING	Followup treatment success	Followup treatment success	1				
1175	1175	1175	1175	1175	1175	1175	1175	1175	1175	1175	1175	1175	1178	FOLLOWUP_YEARS	PATIENT	NUMBER	Followup in years	Followup (years)	1				
1176	1176	1176	1176	1176	1176	1176	1176	1176	1176	1176	1176	1176	1179	FOLLOW_UP_TIME_MONTHS	PATIENT	NUMBER	Follow up time months	Follow up time months	1				
1177	1177	1177	1177	1177	1177	1177	1177	1177	1177	1177	1177	1177	1180	FOOD_ALLERGY_AGE	PATIENT	NUMBER	Age of Food Allergy	Age of Food Allergy	1				
1178	1178	1178	1178	1178	1178	1178	1178	1178	1178	1178	1178	1178	1181	FOOD_ALLERGY_HISTORY	PATIENT	STRING	Food allergy history.	Food Allergy History	1				
1179	1179	1179	1179	1179	1179	1179	1179	1179	1179	1179	1179	1179	1182	FOOD_ALLERGY_TYPES	PATIENT	STRING	Food allergy types.	Food Allergy Types	1				
1180	1180	1180	1180	1180	1180	1180	1180	1180	1180	1180	1180	1180	1183	FORM_COMPLETION_DATE	PATIENT	STRING	Form completion date	Form completion date	1				
1181	1181	1181	1181	1181	1181	1181	1181	1181	1181	1181	1181	1181	1184	FOXA1_MUTATION	SAMPLE	STRING	FOXA1 mutation is present	FOXA1 mutation	1				
1182	1182	1182	1182	1182	1182	1182	1182	1182	1182	1182	1182	1182	1185	FPSA_PSA	PATIENT	NUMBER	FPSA/PSA	FPSA/PSA	1				
1183	1183	1183	1183	1183	1183	1183	1183	1183	1183	1183	1183	1183	1186	FRACTION_CNA	SAMPLE	NUMBER	Fraction CNA	Fraction CNA	1				
1184	1184	1184	1184	1184	1184	1184	1184	1184	1184	1184	1184	1184	1187	FRACTION_GENOME_ALTERED	SAMPLE	NUMBER	Fraction Genome Altered	Fraction Genome Altered	1				
1185	1185	1185	1185	1185	1185	1185	1185	1185	1185	1185	1185	1185	1188	FRAMESHIFT_DELETION	SAMPLE	STRING	Frameshift Deletion	Frameshift Deletion	1				
1186	1186	1186	1186	1186	1186	1186	1186	1186	1186	1186	1186	1186	1189	FRAMESHIFT_INSERTION	SAMPLE	STRING	Frameshift Insertion	Frameshift Insertion	1				
1187	1187	1187	1187	1187	1187	1187	1187	1187	1187	1187	1187	1187	1190	FUHRMAN_GRADE	SAMPLE	STRING	Fuhrman Grade	Fuhrman Grade	1				
1188	1188	1188	1188	1188	1188	1188	1188	1188	1188	1188	1188	1188	1191	FUNCTIONAL	SAMPLE	STRING	Functional	Functional	1				
1189	1189	1189	1189	1189	1189	1189	1189	1189	1189	1189	1189	1189	1192	FUPTIME	PATIENT	NUMBER	Fuptime	Fuptime	1				
1190	1190	1190	1190	1190	1190	1190	1190	1190	1190	1190	1190	1190	1193	FUPTIME_MONTHS	PATIENT	STRING	F-Uptime in months.	F-Uptime (months)	1				
1191	1191	1191	1191	1191	1191	1191	1191	1191	1191	1191	1191	1191	1194	FUSED_EXONS	SAMPLE	STRING	Fused Exons	Fused Exons	1				
1192	1192	1192	1192	1192	1192	1192	1192	1192	1192	1192	1192	1192	1195	FUSION	SAMPLE	STRING	Fusion	Fusion	1				
1193	1193	1193	1193	1193	1193	1193	1193	1193	1193	1193	1193	1193	1196	FUSION_BY_RNA_PCR	SAMPLE	STRING	Fusion By RNA PCR	Fusion By RNA PCR	1				
1194	1194	1194	1194	1194	1194	1194	1194	1194	1194	1194	1194	1194	1197	FUSION_OTHER	PATIENT	STRING	Description of other gene fusions identified by RT-PCR/qPCR/WGS (non-MYB/MYBL1/NFIB).	Other Gene Fusion	1				
1195	1195	1195	1195	1195	1195	1195	1195	1195	1195	1195	1195	1195	1198	FUSION_STATUS	SAMPLE	STRING	Yes/No indicator of fusion status	Fusion Status	1				
1196	1196	1196	1196	1196	1196	1196	1196	1196	1196	1196	1196	1196	1199	GAIN_8Q	SAMPLE	STRING	8Q gain	8q Gain	1				
1197	1197	1197	1197	1197	1197	1197	1197	1197	1197	1197	1197	1197	1200	GALLBLADDER_STONES	SAMPLE	STRING	Gallbladder Stone	Gallbladder Stone	1				
1198	1198	1198	1198	1198	1198	1198	1198	1198	1198	1198	1198	1198	1201	GASTRECTOMY	PATIENT	STRING	Gastrectomy	Gastrectomy	1				
1199	1199	1199	1199	1199	1199	1199	1199	1199	1199	1199	1199	1199	1202	GASTRIC_CLASSIFICATION	SAMPLE	STRING	Gastric Classification	Gastric Classification	1				
1200	1200	1200	1200	1200	1200	1200	1200	1200	1200	1200	1200	1200	1203	GCLID	PATIENT	NUMBER	Gclid	Gclid	1				
1201	1201	1201	1201	1201	1201	1201	1201	1201	1201	1201	1201	1201	1204	GEA	PATIENT	STRING	GEA	GEA	1				
1202	1202	1202	1202	1202	1202	1202	1202	1202	1202	1202	1202	1202	1205	GEACIN	PATIENT	STRING	GEA-CIN	GEA-CIN	1				
1203	1203	1203	1203	1203	1203	1203	1203	1203	1203	1203	1203	1203	1206	GEACINSMG	PATIENT	STRING	GEA-CIN-SMG	GEA-CIN-SMG	1				
1204	1204	1204	1204	1204	1204	1204	1204	1204	1204	1204	1204	1204	1207	GEAGEJ	PATIENT	STRING	GEA-GEJ	GEA-GEJ	1				
1205	1205	1205	1205	1205	1205	1205	1205	1205	1205	1205	1205	1205	1208	GEASMG	PATIENT	STRING	GEA-SMG	GEA-SMG	1				
1206	1206	1206	1206	1206	1206	1206	1206	1206	1206	1206	1206	1206	1209	GEA_CIN_INTEGRATED_CLUSTER_COCA	SAMPLE	STRING	GEA CIN Integrated Cluster COCA	GEA CIN Integrated Cluster COCA	1				
1207	1207	1207	1207	1207	1207	1207	1207	1207	1207	1207	1207	1207	1210	GEA_CIN_INTEGRATED_CLUSTER_CONSENSUS	SAMPLE	STRING	GEA CIN Integrated Cluster Consensus	GEA CIN Integrated Cluster Consensus	1				
1208	1208	1208	1208	1208	1208	1208	1208	1208	1208	1208	1208	1208	1211	GEA_CIN_INTEGRATED_CLUSTER_ICLUSTER	SAMPLE	STRING	GEA CIN Integrated Cluster iCluster	GEA CIN Integrated Cluster iCluster	1				
1209	1209	1209	1209	1209	1209	1209	1209	1209	1209	1209	1209	1209	1212	GEA_CIN_INTEGRATED_CLUSTER_MKL_KNN_4	SAMPLE	STRING	GEA CIN Integrated Cluster MKL KNN 4	GEA CIN Integrated Cluster MKL KNN 4	1				
1210	1210	1210	1210	1210	1210	1210	1210	1210	1210	1210	1210	1210	1213	GEA_CIN_INTEGRATED_CLUSTER_MKL_KNN_7	SAMPLE	STRING	GEA CIN Integrated Cluster MKL KNN 7	GEA CIN Integrated Cluster MKL KNN 7	1				
1211	1211	1211	1211	1211	1211	1211	1211	1211	1211	1211	1211	1211	1214	GEA_CIN_INTEGRATED_CLUSTER_SUPERCLUSTER	SAMPLE	STRING	GEA CIN Integrated Cluster SuperCluster	GEA CIN Integrated Cluster SuperCluster	1				
1212	1212	1212	1212	1212	1212	1212	1212	1212	1212	1212	1212	1212	1215	GEA_CIN_INTEGRATED_CLUSTER_VOTING	SAMPLE	STRING	GEA CIN Integrated Cluster Voting	GEA CIN Integrated Cluster Voting	1				
1213	1213	1213	1213	1213	1213	1213	1213	1213	1213	1213	1213	1213	1216	GEJ_CATEGORY	PATIENT	STRING	GEJ Category	GEJ Category	1				
1214	1214	1214	1214	1214	1214	1214	1214	1214	1214	1214	1214	1214	1217	GEJ_CATEGORY_DICHOTOMIZED	SAMPLE	STRING	GEJ Category Dichotomized	GEJ Category Dichotomized	1				
1215	1215	1215	1215	1215	1215	1215	1215	1215	1215	1215	1215	1215	1218	GEJ_CATEGORY_DICHOTOMIZED_GEA_CIN_SAMPLES	SAMPLE	STRING	GEJ Category Dichotomized GEA-CIN samples	GEJ Category Dichotomized GEA-CIN samples	1				
1216	1216	1216	1216	1216	1216	1216	1216	1216	1216	1216	1216	1216	1220	GENDER_CODE	PATIENT	NUMBER	Gender Code	Gender Code	1				
1217	1217	1217	1217	1217	1217	1217	1217	1217	1217	1217	1217	1217	1221	GENE	SAMPLE	STRING	Gene	Gene	1				
1218	1218	1218	1218	1218	1218	1218	1218	1218	1218	1218	1218	1218	1222	GENETIC_ABNORMALITY_METHOD_OTHER	SAMPLE	STRING	Abnormality tested methodology	Abnormality tested methodology	1				
1219	1219	1219	1219	1219	1219	1219	1219	1219	1219	1219	1219	1219	1223	GENETIC_ABNORMALITY_RESULTS	SAMPLE	STRING	Abnormality tested results	Abnormality tested results	1				
1220	1220	1220	1220	1220	1220	1220	1220	1220	1220	1220	1220	1220	1224	GENETIC_ABNORMALITY_TESTED	SAMPLE	STRING	Genetic abnormality tested	Genetic abnormality tested	1				
1221	1221	1221	1221	1221	1221	1221	1221	1221	1221	1221	1221	1221	1225	GENETIC_ABNORMALITY_TESTED_OTHER	SAMPLE	STRING	Other genetic abnormality tested	Other genetic abnormality tested	1				
1222	1222	1222	1222	1222	1222	1222	1222	1222	1222	1222	1222	1222	1226	GENETIC_MODIFICATION	SAMPLE	STRING	Was your cell line genetically modified in some way?	Genetic Modification	1				
1223	1223	1223	1223	1223	1223	1223	1223	1223	1223	1223	1223	1223	1227	GENE_EXPRESSION_CLUSTER	SAMPLE	STRING	Gene expression cluster.	Gene Expression Cluster	1				
1224	1224	1224	1224	1224	1224	1224	1224	1224	1224	1224	1224	1224	1228	GENE_EXPRESSION_CLUSTER_EC	SAMPLE	STRING	Gene Expression Cluster - EC	Gene Expression Cluster - EC	1				
1225	1225	1225	1225	1225	1225	1225	1225	1225	1225	1225	1225	1225	1229	GENE_EXPRESSION_CLUSTER_GEA	SAMPLE	STRING	Gene Expression Cluster - GEA	Gene Expression Cluster - GEA	1				
1226	1226	1226	1226	1226	1226	1226	1226	1226	1226	1226	1226	1226	1230	GENE_EXPRESSION_CLUSTER_GEA_CIN	SAMPLE	STRING	Gene Expression Cluster - GEA-CIN	Gene Expression Cluster - GEA-CIN	1				
1227	1227	1227	1227	1227	1227	1227	1227	1227	1227	1227	1227	1227	1231	GENE_EXPRESSION_CLUSTER_SCC	SAMPLE	STRING	Gene Expression Cluster - SCC	Gene Expression Cluster - SCC	1				
1228	1228	1228	1228	1228	1228	1228	1228	1228	1228	1228	1228	1228	1232	GENE_EXPRESSION_PROFILE	SAMPLE	STRING	Gene Expression Profile	Gene Expression Profile	1				
1229	1229	1229	1229	1229	1229	1229	1229	1229	1229	1229	1229	1229	1233	GENE_PANEL	SAMPLE	STRING	Gene panel.	Gene Panel	1				
1230	1230	1230	1230	1230	1230	1230	1230	1230	1230	1230	1230	1230	1234	GENIE_BIRTH_YEAR	PATIENT	NUMBER	The four digit year associated with the patient's date of birth. Please note that each institution must keep the actual DOB in order to create the day intervals as DOB is the anchor date. This data should be masked for patients aged 90 years and greater using <=1925 and patients under 18 years using >1988.	Year of Birth	1				
1231	1231	1231	1231	1231	1231	1231	1231	1231	1231	1231	1231	1231	1235	GENOME_DOUBLED	SAMPLE	STRING	Genome Doubled	Genome Doubled	1				
1232	1232	1232	1232	1232	1232	1232	1232	1232	1232	1232	1232	1232	1236	GENOME_DOUBLINGS	SAMPLE	STRING	Genome Doublings	Genome Doublings	1				
1233	1233	1233	1233	1233	1233	1233	1233	1233	1233	1233	1233	1233	1237	GENOMIC_ALTERATIONS	SAMPLE	NUMBER	Number of genomic alterations	Genomic Alterations	1				
1234	1234	1234	1234	1234	1234	1234	1234	1234	1234	1234	1234	1234	1238	GENOMIC_BIOPSY	PATIENT	STRING	Genomic Biopsy	Genomic Biopsy	1				
1235	1235	1235	1235	1235	1235	1235	1235	1235	1235	1235	1235	1235	1239	GENOMIC_BURDEN	SAMPLE	STRING	Genomic Burden	Genomic Burden	1				
1236	1236	1236	1236	1236	1236	1236	1236	1236	1236	1236	1236	1236	1240	GENOTYPIC_ANALYSIS_DETECTED	SAMPLE	STRING	Genotype analysis performed indicator	Genotypic analysis detected	1				
1237	1237	1237	1237	1237	1237	1237	1237	1237	1237	1237	1237	1237	1241	GENOTYPIC_ANALYSIS_RESULTS_OTHER	SAMPLE	STRING	Other genotyping outcome lab results text	Genotypic analysis results other	1				
1238	1238	1238	1238	1238	1238	1238	1238	1238	1238	1238	1238	1238	1242	GENOTYPING_RESULTS_GENE_MUTATION_NOT_REPORTED_REASON	SAMPLE	STRING	Genotyping results gene mutation not reported reason	Genotyping results gene mutation not reported reason	1				
1239	1239	1239	1239	1239	1239	1239	1239	1239	1239	1239	1239	1239	1243	GEOGRAPHIC_DISTRIBUTION	PATIENT	STRING	Geographic Distribution	Geographic Distribution	1				
1240	1240	1240	1240	1240	1240	1240	1240	1240	1240	1240	1240	1240	1244	GERMLINE_CONTROL	SAMPLE	STRING	Germline Control	Germline Control	1				
1241	1241	1241	1241	1241	1241	1241	1241	1241	1241	1241	1241	1241	1245	GERMLINE_MUTKNOWN_BRCA1	PATIENT	STRING	Reported germline BRCA1 mutation	MedR BRCA1 Mutation	1				
1242	1242	1242	1242	1242	1242	1242	1242	1242	1242	1242	1242	1242	1246	GERMLINE_MUTKNOWN_BRCA2	PATIENT	STRING	Reported germline BRCA2 mutation	MedR BRCA2 Mutation	1				
1243	1243	1243	1243	1243	1243	1243	1243	1243	1243	1243	1243	1243	1247	GERMLINE_MUTKNOWN_OTHER	PATIENT	STRING	Other reported germline mutations	MedR Other Mutation	1				
1244	1244	1244	1244	1244	1244	1244	1244	1244	1244	1244	1244	1244	1248	GERMLINE_MUTKNOWN_PALB2	PATIENT	STRING	Reported germline PALB2 mutation	MedR PALB2 Mutation	1				
1245	1245	1245	1245	1245	1245	1245	1245	1245	1245	1245	1245	1245	1249	GERMLINE_MUT_GENES_VARIANT	SAMPLE	STRING	Germline nonsense or indels within a set of genes: variant type	Germline nonsense or indels within a set of genes: variant type	1				
1246	1246	1246	1246	1246	1246	1246	1246	1246	1246	1246	1246	1246	1250	GERMLINE_TESTED	SAMPLE	STRING	Germline Tested	Germline Tested	1				
1247	1247	1247	1247	1247	1247	1247	1247	1247	1247	1247	1247	1247	1251	GERMLINE_TYPE	SAMPLE	STRING	Germline Type	Germline Type	1				
1248	1248	1248	1248	1248	1248	1248	1248	1248	1248	1248	1248	1248	1252	GLEASON_PATTERN_PRIMARY	PATIENT	NUMBER	Gleason pattern primary	Gleason pattern primary	1				
1249	1249	1249	1249	1249	1249	1249	1249	1249	1249	1249	1249	1249	1253	GLEASON_PATTERN_SECONDARY	PATIENT	NUMBER	Gleason pattern secondary	Gleason pattern secondary	1				
1250	1250	1250	1250	1250	1250	1250	1250	1250	1250	1250	1250	1250	1254	GLEASON_PATTERN_TERTIARY	PATIENT	NUMBER	Gleason pattern tertiary	Gleason pattern tertiary	1				
1251	1251	1251	1251	1251	1251	1251	1251	1251	1251	1251	1251	1251	1255	GLEASON_SCORE	SAMPLE	STRING	The score derived from universally embraced prostate cancer grading system developed by Dr. Donald F. Gleason in 1977. The system provides a reproducible description of the glandular architecture of prostate tissue to which a pathologist assigns a score depending primarily on the microscopic patterns of cancerous glands and cell morphology. The system correlates well with behavior at the extremes: Gleason 1+1 tumors are the most well differentiated, slowly growing and rarely spread; Gleason 4+5 tumors are the most poorly differentiated, often widely metastatic at the time of diagnosis. In the commoner intermediate grade tumors, however, behavior is extremely variable.	Radical Prostatectomy Gleason Score for Prostate Cancer	1				
1252	1252	1252	1252	1252	1252	1252	1252	1252	1252	1252	1252	1252	1256	GLEASON_SCORE_1	SAMPLE	STRING	The score derived from universally embraced prostate cancer grading system developed by Dr. Donald F. Gleason in 1977. The system provides a reproducible description of the glandular architecture of prostate tissue to which a pathologist assigns a score depending primarily on the microscopic patterns of cancerous glands and cell morphology. The system correlates well with behavior at the extremes: Gleason 1+1 tumors are the most well differentiated, slowly growing and rarely spread; Gleason 4+5 tumors are the most poorly differentiated, often widely metastatic at the time of diagnosis. In the commoner intermediate grade tumors, however, behavior is extremely variable.	Radical Prostatectomy Gleason Score for Prostate Cancer	1				
1253	1253	1253	1253	1253	1253	1253	1253	1253	1253	1253	1253	1253	1257	GLEASON_SCORE_2	SAMPLE	STRING	The score derived from universally embraced prostate cancer grading system developed by Dr. Donald F. Gleason in 1977. The system provides a reproducible description of the glandular architecture of prostate tissue to which a pathologist assigns a score depending primarily on the microscopic patterns of cancerous glands and cell morphology. The system correlates well with behavior at the extremes: Gleason 1+1 tumors are the most well differentiated, slowly growing and rarely spread; Gleason 4+5 tumors are the most poorly differentiated, often widely metastatic at the time of diagnosis. In the commoner intermediate grade tumors, however, behavior is extremely variable.	Radical Prostatectomy Gleason Score for Prostate Cancer	1				
1254	1254	1254	1254	1254	1254	1254	1254	1254	1254	1254	1254	1254	1258	GLEASON_SCORE_PERCENT_4_AND_5	SAMPLE	NUMBER	Gleason score percent 4 & 5.	Gleason Score Percent 4 & 5	1				
1255	1255	1255	1255	1255	1255	1255	1255	1255	1255	1255	1255	1255	1259	GLI2_AMPLIFICATION	SAMPLE	STRING	GLI2 Amplification	GLI2 Amplification	1				
1256	1256	1256	1256	1256	1256	1256	1256	1256	1256	1256	1256	1256	1260	GMED_OS_MONTHS	PATIENT	NUMBER	GMED Overall Survival Months	GMED Overall Survival Months	1				
1257	1257	1257	1257	1257	1257	1257	1257	1257	1257	1257	1257	1257	1261	GORLIN_SPORADIC	PATIENT	STRING	Gorlin Sporadic	Gorlin Sporadic	1				
1258	1258	1258	1258	1258	1258	1258	1258	1258	1258	1258	1258	1258	1262	GRADE	SAMPLE	STRING	Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.	Neoplasm Histologic Grade	1				
1259	1259	1259	1259	1259	1259	1259	1259	1259	1259	1259	1259	1259	1263	GRADE_TIER_SYSTEM	SAMPLE	STRING	Term to describe the number of levels or 'tiers' in the system used to describe the cellular histologic grade in a tissue specimen.	Histologic Grading System Tier Category	1				
1260	1260	1260	1260	1260	1260	1260	1260	1260	1260	1260	1260	1260	1264	GREATER_THAN_3_SITES	SAMPLE	STRING	Greater than 3 sites	Greater than 3 sites	1				
1261	1261	1261	1261	1261	1261	1261	1261	1261	1261	1261	1261	1261	1265	GROUP	SAMPLE	STRING	Group	Group	1				
1262	1262	1262	1262	1262	1262	1262	1262	1262	1262	1262	1262	1262	1266	GROWTH_PATTERN	SAMPLE	STRING	Growth Pattern	Growth Pattern	1				
1263	1263	1263	1263	1263	1263	1263	1263	1263	1263	1263	1263	1263	1267	GTF2I_MUTATION_STATUS	SAMPLE	STRING	GTF2I Mutation Status	GTF2I Mutation Status	1				
1264	1264	1264	1264	1264	1264	1264	1264	1264	1264	1264	1264	1264	1268	GUAIAC_POSITIVE_STOOL_WEEKS	PATIENT	NUMBER	Guaiac Positive Stool (weeks)	Guaiac Positive Stool (weeks)	1				
1265	1265	1265	1265	1265	1265	1265	1265	1265	1265	1265	1265	1265	1269	G_CIMP_METHYLATION	SAMPLE	STRING	G-CIMP  Methylation	G-CIMP  Methylation	1				
1266	1266	1266	1266	1266	1266	1266	1266	1266	1266	1266	1266	1266	1270	G_LOH	SAMPLE	STRING	gLOH	gLOH	1				
1267	1267	1267	1267	1267	1267	1267	1267	1267	1267	1267	1267	1267	1271	HAE	PATIENT	STRING	HAE	HAE	1				
1268	1268	1268	1268	1268	1268	1268	1268	1268	1268	1268	1268	1268	1272	HARVEST_DATE	SAMPLE	STRING	Harvest Date	Harvest Date	1				
1269	1269	1269	1269	1269	1269	1269	1269	1269	1269	1269	1269	1269	1273	HAS_MATCHED_NORMAL	SAMPLE	STRING	Has matched normal.	Matched Normal	1				
1270	1270	1270	1270	1270	1270	1270	1270	1270	1270	1270	1270	1270	1274	HAS_OTHER_CANCER	PATIENT	STRING	Has other cancer.	Other Cancer	1				
1271	1271	1271	1271	1271	1271	1271	1271	1271	1271	1271	1271	1271	1275	HAS_OTHER_KIDNEY_CONDITION	PATIENT	STRING	Has other kidney condition.	Other Kidney Condition	1				
1272	1272	1272	1272	1272	1272	1272	1272	1272	1272	1272	1272	1272	1276	HAY_FEVER_HISTORY	PATIENT	STRING	Has history of fever.	Fever History	1				
1273	1273	1273	1273	1273	1273	1273	1273	1273	1273	1273	1273	1273	1277	HBV	PATIENT	STRING	HBV	HBV	1				
1274	1274	1274	1274	1274	1274	1274	1274	1274	1274	1274	1274	1274	1278	HBV_CONSENSUS	SAMPLE	STRING	HBV CONSENSUS	HBV CONSENSUS	1				
1275	1275	1275	1275	1275	1275	1275	1275	1275	1275	1275	1275	1275	1279	HCV	PATIENT	STRING	HCV	HCV	1				
1276	1276	1276	1276	1276	1276	1276	1276	1276	1276	1276	1276	1276	1280	HCV_CONSENSUS	SAMPLE	STRING	HCV CONSENSUS	HCV CONSENSUS	1				
1277	1277	1277	1277	1277	1277	1277	1277	1277	1277	1277	1277	1277	1281	HD_CHEMO_AUTO_SCT	PATIENT	STRING	Did the patient receive high-dose chemotherapy and autologous stem cell reinfusion?	High Dose Chemo + Auto Stem Cell Therapy	1				
1278	1278	1278	1278	1278	1278	1278	1278	1278	1278	1278	1278	1278	1282	HEADACHE_HISTORY	PATIENT	STRING	Has history of headaches.	Headache History	1				
1279	1279	1279	1279	1279	1279	1279	1279	1279	1279	1279	1279	1279	1283	HEAD_VS_BODY_TAIL_PRIMARY_PANCREAS	PATIENT	STRING	Head VS Body/Tail Primary Pancreas	Head VS Body/Tail Primary Pancreas	1				
1280	1280	1280	1280	1280	1280	1280	1280	1280	1280	1280	1280	1280	1284	HEAVY_CHAIN	SAMPLE	STRING	HEAVY CHAIN	HEAVY CHAIN	1				
1281	1281	1281	1281	1281	1281	1281	1281	1281	1281	1281	1281	1281	1285	HEIGHT	PATIENT	NUMBER	Height in centimeters.	Patient Height	1				
1282	1282	1282	1282	1282	1282	1282	1282	1282	1282	1282	1282	1282	1286	HEIGHT_M	PATIENT	NUMBER	Height (metres)	Height (metres)	1				
1283	1283	1283	1283	1283	1283	1283	1283	1283	1283	1283	1283	1283	1287	HEMOGLOBIN_LEVEL	PATIENT	STRING	Hemoglobin result	Hemoglobin level	1				
1284	1284	1284	1284	1284	1284	1284	1284	1284	1284	1284	1284	1284	1288	HEMORRHOIDS	PATIENT	STRING	Hemorrhoids	Hemorrhoids	1				
1285	1285	1285	1285	1285	1285	1285	1285	1285	1285	1285	1285	1285	1289	HEPATIC_INFLAMMATION_ADJUVANT_TISSUE	PATIENT	STRING	Adjacent hepatic tissue inflammation extent type	Adjacent hepatic tissue inflammation extent type	1				
1286	1286	1286	1286	1286	1286	1286	1286	1286	1286	1286	1286	1286	1290	HEPATIC_INFLAMMATION_ADJ_TISSUE	SAMPLE	STRING	Adjacent hepatic tissue inflammation extent type	Adjacent hepatic tissue inflammation extent type	1				
1287	1287	1287	1287	1287	1287	1287	1287	1287	1287	1287	1287	1287	1291	HEPATIC_VEIN_INVASION	PATIENT	STRING	Hepatic vein invasion	Hepatic Vein Invasion	1				
1288	1288	1288	1288	1288	1288	1288	1288	1288	1288	1288	1288	1288	1292	HEPATITIS_B_POSITIVE_CUTOFF_RPM_POS_1_2	SAMPLE	STRING	HEPATITIS B POSITIVE CUTOFF RPM +1 > 2	HEPATITIS B POSITIVE CUTOFF RPM +1 > 2	1				
1289	1289	1289	1289	1289	1289	1289	1289	1289	1289	1289	1289	1289	1293	HEPATITIS_C_POSITIVE_CUTOFF_RPM_POS_1_2	SAMPLE	STRING	HEPATITIS C POSITIVE CUTOFF RPM +1 > 2	HEPATITIS C POSITIVE CUTOFF RPM +1 > 2	1				
1290	1290	1290	1290	1290	1290	1290	1290	1290	1290	1290	1290	1290	1294	HER2N	PATIENT	NUMBER	Her2n	Her2n	1				
1291	1291	1291	1291	1291	1291	1291	1291	1291	1291	1291	1291	1291	1295	HER2NEU	PATIENT	STRING	Her2neu	Her2neu	1				
1292	1292	1292	1292	1292	1292	1292	1292	1292	1292	1292	1292	1292	1296	HER2_AMPLIFICATION_STATUS	SAMPLE	STRING	HER2 Amplification Status	HER2 Amplification Status	1				
1293	1293	1293	1293	1293	1293	1293	1293	1293	1293	1293	1293	1293	1297	HER2_AND_CENT17_CELLS_COUNT	SAMPLE	NUMBER	HER2 neu and centromere 17 copy number analysis input total number count	HER2 and cent17 cells count	1				
1294	1294	1294	1294	1294	1294	1294	1294	1294	1294	1294	1294	1294	1298	HER2_AND_CENT17_SCALE_OTHER	SAMPLE	STRING	HER2 and centromere 17 positive finding other measurement scale text	HER2 and cent17 scale other	1				
1295	1295	1295	1295	1295	1295	1295	1295	1295	1295	1295	1295	1295	1299	HER2_CENT17_COUNTED_CELLS_COUNT	SAMPLE	NUMBER	HER2 neu and centromere 17 copy number metastatic breast carcinoma analysis input total number count	HER2 cent17 counted cells count	1				
1296	1296	1296	1296	1296	1296	1296	1296	1296	1296	1296	1296	1296	1300	HER2_CENT17_RATIO	SAMPLE	NUMBER	HER2 neu chromosone 17 signal ratio value	HER2 cent17 ratio	1				
1297	1297	1297	1297	1297	1297	1297	1297	1297	1297	1297	1297	1297	1301	HER2_COPY_NUMBER	SAMPLE	NUMBER	HER2 neu breast carcinoma copy analysis input total number	HER2 copy number	1				
1298	1298	1298	1298	1298	1298	1298	1298	1298	1298	1298	1298	1298	1302	HER2_DETAILS	SAMPLE	STRING	HER2 Details	HER2 Details	1				
1299	1299	1299	1299	1299	1299	1299	1299	1299	1299	1299	1299	1299	1303	HER2_DISCOVERY_BESTSAMPLE	SAMPLE	STRING	HER2 Discovery:Best Sample	HER2 Discovery:Best Sample	1				
1300	1300	1300	1300	1300	1300	1300	1300	1300	1300	1300	1300	1300	1304	HER2_DISCOVERY_PREORPOST	SAMPLE	STRING	HER2 Discovery:Pre or Post	HER2 Discovery:Pre or Post	1				
1301	1301	1301	1301	1301	1301	1301	1301	1301	1301	1301	1301	1301	1305	HER2_DISCOVERY_VALIDATION	SAMPLE	STRING	HER2 Discovery+Validation	HER2 Discovery+Validation	1				
1302	1302	1302	1302	1302	1302	1302	1302	1302	1302	1302	1302	1302	1306	HER2_EXPR	PATIENT	STRING	HER2 status measured by expression	HER2 status measured by expression	1				
1303	1303	1303	1303	1303	1303	1303	1303	1303	1303	1303	1303	1303	1307	HER2_FISH	SAMPLE	STRING	HER2 FISH	HER2 FISH	1				
1304	1304	1304	1304	1304	1304	1304	1304	1304	1304	1304	1304	1304	1308	HER2_FISH_METHOD	SAMPLE	STRING	HER2 erbb pos finding fluorescence in situ hybridization calculation method text	HER2 fish method	1				
1305	1305	1305	1305	1305	1305	1305	1305	1305	1305	1305	1305	1305	1309	HER2_FISH_METS	SAMPLE	STRING	HER2 FISH Mets Status	HER2 FISH Mets Status	1				
1306	1306	1306	1306	1306	1306	1306	1306	1306	1306	1306	1306	1306	1310	HER2_FISH_PRIMARY	SAMPLE	STRING	HER2 FISH Primary Status	HER2 FISH Primary Status	1				
1307	1307	1307	1307	1307	1307	1307	1307	1307	1307	1307	1307	1307	1311	HER2_FISH_RATIO_METS	SAMPLE	STRING	HER2 FISH Ratio Mets	HER2 FISH Ratio Mets	1				
1308	1308	1308	1308	1308	1308	1308	1308	1308	1308	1308	1308	1308	1312	HER2_FISH_RATIO_PRIMARY	SAMPLE	STRING	HER2 FISH Ratio Primary	HER2 FISH Ratio Primary	1				
1309	1309	1309	1309	1309	1309	1309	1309	1309	1309	1309	1309	1309	1313	HER2_FISH_STATUS	SAMPLE	STRING	Lab procedure HER2 neu in situ hybrid outcome type	HER2 fish status	1				
1310	1310	1310	1310	1310	1310	1310	1310	1310	1310	1310	1310	1310	1314	HER2_IHC_METS	SAMPLE	STRING	HER2 IHC Mets Status	HER2 IHC Mets Status	1				
1311	1311	1311	1311	1311	1311	1311	1311	1311	1311	1311	1311	1311	1315	HER2_IHC_OR_FISH	SAMPLE	STRING	HER2 IHC or FISH	HER2 IHC or FISH	1				
1312	1312	1312	1312	1312	1312	1312	1312	1312	1312	1312	1312	1312	1316	HER2_IHC_PERCENT_POSITIVE	SAMPLE	STRING	HER2 erbb pos finding cell percent category	HER2 ihc percent positive	1				
1313	1313	1313	1313	1313	1313	1313	1313	1313	1313	1313	1313	1313	1317	HER2_IHC_PRIMARY	SAMPLE	STRING	HER2 IHC Primary Status	HER2 IHC Primary Status	1				
1314	1314	1314	1314	1314	1314	1314	1314	1314	1314	1314	1314	1314	1318	HER2_IHC_SCORE	SAMPLE	NUMBER	HER2 immunohistochemistry level result	HER2 ihc score	1				
1315	1315	1315	1315	1315	1315	1315	1315	1315	1315	1315	1315	1315	1319	HER2_IHC_VALUE_METS	SAMPLE	STRING	HER2 IHC Mets Value	HER2 IHC Mets Value	1				
1316	1316	1316	1316	1316	1316	1316	1316	1316	1316	1316	1316	1316	1320	HER2_IHC_VALUE_PRIMARY	SAMPLE	STRING	HER2 IHC Primary Value	HER2 IHC Primary Value	1				
1317	1317	1317	1317	1317	1317	1317	1317	1317	1317	1317	1317	1317	1321	HER2_IMPACT	SAMPLE	STRING	HER2 IMPACT	HER2 IMPACT	1				
1318	1318	1318	1318	1318	1318	1318	1318	1318	1318	1318	1318	1318	1322	HER2_IMPACT_LR	SAMPLE	NUMBER	HER2 IMPACT LR	HER2 IMPACT LR	1				
1319	1319	1319	1319	1319	1319	1319	1319	1319	1319	1319	1319	1319	1323	HER2_NOTES	SAMPLE	STRING	HER2 Notes	HER2 Notes	1				
1320	1320	1320	1320	1320	1320	1320	1320	1320	1320	1320	1320	1320	1324	HER2_POSITIVITY_METHOD_TEXT	SAMPLE	STRING	HER2 erbb method calculation method text	HER2 positivity method text	1				
1321	1321	1321	1321	1321	1321	1321	1321	1321	1321	1321	1321	1321	1325	HER2_POSITIVITY_SCALE_OTHER	SAMPLE	STRING	Pos finding HER2 erbb2 other measurement scale text	HER2 positivity scale other	1				
1322	1322	1322	1322	1322	1322	1322	1322	1322	1322	1322	1322	1322	1326	HER2_RATIO	SAMPLE	STRING	HER2 Ratio	HER2 Ratio	1				
1323	1323	1323	1323	1323	1323	1323	1323	1323	1323	1323	1323	1323	1327	HER2_RESPONSE	SAMPLE	STRING	HER2 Response	HER2 Response	1				
1324	1324	1324	1324	1324	1324	1324	1324	1324	1324	1324	1324	1324	1328	HER2_SNP6	PATIENT	STRING	HER2 status measured by SNP6	HER2 status measured by SNP6	1				
1325	1325	1325	1325	1325	1325	1325	1325	1325	1325	1325	1325	1325	1329	HER2_STATUS	SAMPLE	STRING	HER2 Status	HER2 Status	1				
1326	1326	1326	1326	1326	1326	1326	1326	1326	1326	1326	1326	1326	1330	HER2_STATUS_METASTASIS	PATIENT	STRING	HER2 Metastatic Status	HER2 Metastatic Status	1				
1327	1327	1327	1327	1327	1327	1327	1327	1327	1327	1327	1327	1327	1331	HER2_STATUS_PRIMARY	PATIENT	STRING	HER2 Primary Status	HER2 Primary Status	1				
1328	1328	1328	1328	1328	1328	1328	1328	1328	1328	1328	1328	1328	1332	HER2_STATUS_REPORTED	PATIENT	STRING	Patient-reported response to the question: At any time, was your breast cancer found to be HER2 positive (HER2+)?	PRD Ever HER2 Positive	1				
1329	1329	1329	1329	1329	1329	1329	1329	1329	1329	1329	1329	1329	1333	HER2_TTP_ON_1ST_LINE_MONTHS	SAMPLE	NUMBER	HER2 Total Time Period on First Line (Months)	HER2 Total Time Period on First Line (Months)	1				
1330	1330	1330	1330	1330	1330	1330	1330	1330	1330	1330	1330	1330	1334	HER2_TX_STATUS	SAMPLE	STRING	HER2 Treatment Status	HER2 Treatment Status	1				
1331	1331	1331	1331	1331	1331	1331	1331	1331	1331	1331	1331	1331	1335	HER2_VITAL_STATUS	SAMPLE	STRING	HER2 Vital Status	HER2 Vital Status	1				
1332	1332	1332	1332	1332	1332	1332	1332	1332	1332	1332	1332	1332	1336	HGB_G_DL	SAMPLE	STRING	hgb (g/dl)	hgb (g/dl)	1				
1333	1333	1333	1333	1333	1333	1333	1333	1333	1333	1333	1333	1333	1337	HGF1	PATIENT	NUMBER	Hgf1	Hgf1	1				
1334	1334	1334	1334	1334	1334	1334	1334	1334	1334	1334	1334	1334	1338	HGF2	PATIENT	NUMBER	Hgf2	Hgf2	1				
1335	1335	1335	1335	1335	1335	1335	1335	1335	1335	1335	1335	1335	1339	HHV_8_STATUS	PATIENT	STRING	HHV 8 Status	HHV 8 Status	1				
1336	1336	1336	1336	1336	1336	1336	1336	1336	1336	1336	1336	1336	1340	HIGHEST_ACTIONABLE_LEVEL	SAMPLE	STRING	Highest actionable level	Highest actionable level	1				
1337	1337	1337	1337	1337	1337	1337	1337	1337	1337	1337	1337	1337	1341	HISPANIC	PATIENT	STRING	Patient-reported response to the question: Do you consider yourself Hispanic, Latino/a or Spanish?	PRD Hispanic	1				
1338	1338	1338	1338	1338	1338	1338	1338	1338	1338	1338	1338	1338	1342	HISTOLOGICAL_COMPONENT_SEQUENCED	SAMPLE	STRING	Histological Component Sequenced	Histological Component Sequenced	1				
1339	1339	1339	1339	1339	1339	1339	1339	1339	1339	1339	1339	1339	1343	HISTOLOGICAL_DIAGNOSIS	PATIENT	STRING	Text term for the structural pattern of cancer cells used to define a microscopic diagnosis.	Neoplasm Histologic Type Name	1				
1340	1340	1340	1340	1340	1340	1340	1340	1340	1340	1340	1340	1340	1344	HISTOLOGICAL_SUBTYPE	PATIENT	STRING	Text to describe a tumor's histologic subtype or mixed diagnosis that is different from previously specified options.	Tumor Other Histologic Subtype	1				
1341	1341	1341	1341	1341	1341	1341	1341	1341	1341	1341	1341	1341	1345	HISTOLOGICAL_TYPE	PATIENT	STRING	Histological Type	Histological Type	1				
1342	1342	1342	1342	1342	1342	1342	1342	1342	1342	1342	1342	1342	1346	HISTOLOGICAL_TYPE_ESOPHAGUS	SAMPLE	STRING	Histological Type - Esophagus	Histological Type - Esophagus	1				
1343	1343	1343	1343	1343	1343	1343	1343	1343	1343	1343	1343	1343	1347	HISTOLOGICAL_TYPE_OTHER	SAMPLE	STRING	Text field to describe the tumor histological type (cancer type).	Histological Type Details	1				
1344	1344	1344	1344	1344	1344	1344	1344	1344	1344	1344	1344	1344	1348	HISTOLOGIC_DIAGNOSIS_PERCENT	PATIENT	STRING	Histological percentage	Histologic diagnosis percent	1				
1345	1345	1345	1345	1345	1345	1345	1345	1345	1345	1345	1345	1345	1349	HISTOLOGIC_RESPONSE	PATIENT	STRING	Histologic Response Post Neoadjuvant Therapy Necrosis Percent Category. Stage 1/2 (0-90 % necrosis), Stage 3/4 (91-100 % necrosis)	Histologic Response	1				
1346	1346	1346	1346	1346	1346	1346	1346	1346	1346	1346	1346	1346	1350	HISTOLOGY	PATIENT	STRING	Histology	Histology	1				
1347	1347	1347	1347	1347	1347	1347	1347	1347	1347	1347	1347	1347	1351	HISTOLOGY_CLASSIFICATION_IN_PRIMARY_TUMOR	SAMPLE	STRING	Histology classification in primary tumor	Histology Classification in Primary Tumor	1				
1348	1348	1348	1348	1348	1348	1348	1348	1348	1348	1348	1348	1348	1352	HISTOLOGY_EPC_2CLASS	SAMPLE	STRING	Histology EPC_2class	Histology EPC_2class	1				
1349	1349	1349	1349	1349	1349	1349	1349	1349	1349	1349	1349	1349	1353	HISTOLOGY_EPC_EMBRYONAL_CARCINOMA_NON_SEMINOMA	SAMPLE	STRING	Histology_EPC - Embryonal carcinoma,Non-Seminoma	Histology_EPC - Embryonal carcinoma,Non-Seminoma	1				
1350	1350	1350	1350	1350	1350	1350	1350	1350	1350	1350	1350	1350	1354	HISTOLOGY_EPC_MULTICLASS	SAMPLE	STRING	Histology EPC multiclass	Histology EPC multiclass	1				
1351	1351	1351	1351	1351	1351	1351	1351	1351	1351	1351	1351	1351	1355	HISTOLOGY_EPC_NON_SEMINOMA	SAMPLE	STRING	Histology EPC - Non-Seminoma	Histology EPC - Non-Seminoma	1				
1352	1352	1352	1352	1352	1352	1352	1352	1352	1352	1352	1352	1352	1356	HISTOLOGY_EPC_NON_SEMINOMA_CHORIOCARCINOMA	SAMPLE	STRING	Histology_EPC - Non-Seminoma; Choriocarcinoma	Histology_EPC - Non-Seminoma; Choriocarcinoma	1				
1353	1353	1353	1353	1353	1353	1353	1353	1353	1353	1353	1353	1353	1357	HISTOLOGY_EPC_NON_SEMINOMA_TERATOMA_IMMATURE	SAMPLE	STRING	Histology_EPC - Non-Seminoma; Teratoma (Immature)	Histology_EPC - Non-Seminoma; Teratoma (Immature)	1				
1354	1354	1354	1354	1354	1354	1354	1354	1354	1354	1354	1354	1354	1358	HISTOLOGY_EPC_NON_SEMINOMA_TERATOMA_MATURE	SAMPLE	STRING	Histology_EPC - Non-Seminoma; Teratoma (Mature)	Histology_EPC - Non-Seminoma; Teratoma (Mature)	1				
1355	1355	1355	1355	1355	1355	1355	1355	1355	1355	1355	1355	1355	1359	HISTOLOGY_EPC_NON_SEMINOMA_YOLK_SAC_TUMOR	SAMPLE	STRING	Histology EPC - Non-Seminoma; Yolk Sac Tumor	Histology EPC - Non-Seminoma; Yolk Sac Tumor	1				
1356	1356	1356	1356	1356	1356	1356	1356	1356	1356	1356	1356	1356	1360	HISTOLOGY_EPC_SEMINOMA	SAMPLE	STRING	Histology EPC - Seminoma	Histology EPC - Seminoma	1				
1357	1357	1357	1357	1357	1357	1357	1357	1357	1357	1357	1357	1357	1361	HISTOLOGY_FOR_CALC	PATIENT	STRING	Histology for Calc	Histology for Calc	1				
1358	1358	1358	1358	1358	1358	1358	1358	1358	1358	1358	1358	1358	1362	HISTOLOGY_MULTIVARIATE_ANALYSIS	SAMPLE	STRING	Histology multivariate analysis	Histology multivariate analysis	1				
1359	1359	1359	1359	1359	1359	1359	1359	1359	1359	1359	1359	1359	1363	HISTOLOGY_OF_NEW_TUMOR_EVENT	SAMPLE	STRING	Histology Of New Tumor Event	Histology Of New Tumor Event	1				
1360	1360	1360	1360	1360	1360	1360	1360	1360	1360	1360	1360	1360	1364	HISTOLOGY_OF_PRIMARY_MSKCC	PATIENT	STRING	Histology of Primary (MSKCC)	Histology of Primary (MSKCC)	1				
1361	1361	1361	1361	1361	1361	1361	1361	1361	1361	1361	1361	1361	1365	HISTOLOGY_OF_PRIMARY_TURIN	PATIENT	STRING	Histology of Primary (Turin)	Histology of Primary (Turin)	1				
1362	1362	1362	1362	1362	1362	1362	1362	1362	1362	1362	1362	1362	1366	HISTONE_RELATED_GENES	SAMPLE	STRING	Histone Related Genes	Histone Related Genes	1				
1363	1363	1363	1363	1363	1363	1363	1363	1363	1363	1363	1363	1363	1367	HISTOPATHOLOGY	PATIENT	STRING	Histopathology	Histopathology	1				
1364	1364	1364	1364	1364	1364	1364	1364	1364	1364	1364	1364	1364	1368	HISTORICAL_PATIENTS	PATIENT	STRING	Historical Patients	Historical Patients	1				
1365	1365	1365	1365	1365	1365	1365	1365	1365	1365	1365	1365	1365	1369	HISTORY_ADRENAL_HORMONE_EXCESS	PATIENT	STRING	Excess Adrenal Hormone History Type	Excess Adrenal Hormone History Type	1				
1366	1366	1366	1366	1366	1366	1366	1366	1366	1366	1366	1366	1366	1370	HISTORY_ASBESTOS_EXPOSURE	PATIENT	STRING	History Asbestos Exposure	History Asbestos Exposure	1				
1367	1367	1367	1367	1367	1367	1367	1367	1367	1367	1367	1367	1367	1371	HISTORY_BARRETTS_ESOPHAGEAL_INDICATOR	PATIENT	STRING	Barretts esophagus	Barretts esophagus	1				
1368	1368	1368	1368	1368	1368	1368	1368	1368	1368	1368	1368	1368	1372	HISTORY_BASIS_ADRENAL_HORMONE_DX	PATIENT	STRING	Excess Adrenal Hormone Diagnosis Method Type	Excess Adrenal Hormone Diagnosis Method Type	1				
1369	1369	1369	1369	1369	1369	1369	1369	1369	1369	1369	1369	1369	1373	HISTORY_CHRONIC_PANCREATITIS	PATIENT	STRING	Indicator to signify whether or not the patient has a history of clinical chronic pancreatitis.	Chronic Pancreatitis Personal Medical History Indicator	1				
1370	1370	1370	1370	1370	1370	1370	1370	1370	1370	1370	1370	1370	1374	HISTORY_CHRONIC_PANCREATITIS_DAYS_TO	PATIENT	NUMBER	The number of days from the date the patient was diagnosed with cancer to the date of the patient's diagnosis of clinical chronic pancreatitis.	Chronic Pancreatitis Diagnosis Less Initial Pathologic Diagnosis Date Calculated Day Value	1				
1371	1371	1371	1371	1371	1371	1371	1371	1371	1371	1371	1371	1371	1375	HISTORY_COLORECTAL_CANCER	PATIENT	STRING	History colorectal cancer	History colorectal cancer	1				
1372	1372	1372	1372	1372	1372	1372	1372	1372	1372	1372	1372	1372	1376	HISTORY_FERTILITY	PATIENT	STRING	History fertility	History fertility	1				
1373	1373	1373	1373	1373	1373	1373	1373	1373	1373	1373	1373	1373	1377	HISTORY_HEPATO_CARCINOMA_RISK_FACTORS	PATIENT	STRING	History hepato carcinoma risk factor	History hepato carcinoma risk factor	1				
1374	1374	1374	1374	1374	1374	1374	1374	1374	1374	1374	1374	1374	1378	HISTORY_HORMONAL_CONTRACEPTIVES_USE	PATIENT	STRING	History hormonal contraceptives use	History hormonal contraceptives use	1				
1375	1375	1375	1375	1375	1375	1375	1375	1375	1375	1375	1375	1375	1379	HISTORY_HYPOSPADIAS	PATIENT	STRING	History hypospadias	History hypospadias	1				
1376	1376	1376	1376	1376	1376	1376	1376	1376	1376	1376	1376	1376	1380	HISTORY_IF_BARRETTS_GOBLET_CELL_INDICATOR	SAMPLE	STRING	Goblet cells present	Goblet cells present	1				
1377	1377	1377	1377	1377	1377	1377	1377	1377	1377	1377	1377	1377	1381	HISTORY_IMMUNOLOGICAL_DISEASE	SAMPLE	STRING	Prior immunologic disease type	Prior immunologic disease type	1				
1378	1378	1378	1378	1378	1378	1378	1378	1378	1378	1378	1378	1378	1382	HISTORY_IMMUNOLOGICAL_DISEASE_OTHER	SAMPLE	STRING	Prior immunologic disease other	Prior immunologic disease other	1				
1379	1379	1379	1379	1379	1379	1379	1379	1379	1379	1379	1379	1379	1383	HISTORY_IMMUNOSUPPRESIVE_DX	SAMPLE	STRING	Prior immunosuppressive therapy type	Prior immunosuppressive therapy type	1				
1380	1380	1380	1380	1380	1380	1380	1380	1380	1380	1380	1380	1380	1384	HISTORY_IMMUNOSUPPRESIVE_DX_OTHER	SAMPLE	STRING	Prior immunosuppressive therapy other	Prior immunosuppressive therapy other	1				
1381	1381	1381	1381	1381	1381	1381	1381	1381	1381	1381	1381	1381	1385	HISTORY_IMMUNOSUPPRESSIVE_DISEASE	PATIENT	STRING	Patient history immune system and related disorders name	Patient history immune system and related disorders name	1				
1382	1382	1382	1382	1382	1382	1382	1382	1382	1382	1382	1382	1382	1386	HISTORY_IMMUNOSUPPRESSIVE_TX_OTHER	SAMPLE	STRING	Prior infectious disease other	Prior infectious disease other	1				
1383	1383	1383	1383	1383	1383	1383	1383	1383	1383	1383	1383	1383	1387	HISTORY_IONIZING_RT_TO_HEAD	PATIENT	STRING	History ionizing rt to head	History ionizing rt to head	1				
1384	1384	1384	1384	1384	1384	1384	1384	1384	1384	1384	1384	1384	1388	HISTORY_LGG_DX_OF_BRAIN_TISSUE	PATIENT	STRING	History lgg dx of brain tissue	History lgg dx of brain tissue	1				
1385	1385	1385	1385	1385	1385	1385	1385	1385	1385	1385	1385	1385	1389	HISTORY_MENOPAUSAL_HORMONE_THERAPY	PATIENT	STRING	History menopausal hormone therapy	History menopausal hormone therapy	1				
1386	1386	1386	1386	1386	1386	1386	1386	1386	1386	1386	1386	1386	1390	HISTORY_NEOADJUVANT_MEDICATION	PATIENT	STRING	Text term to describe the patient's history of neoadjuvant treatment and the kind of treatment given prior to resection of the tumor.	Neoadjuvant Therapy Type Administered Prior To Resection Text	1				
1387	1387	1387	1387	1387	1387	1387	1387	1387	1387	1387	1387	1387	1391	HISTORY_NEOADJUVANT_STEROID_TX	PATIENT	STRING	Preoperative corticosteroids	Preoperative corticosteroids	1				
1388	1388	1388	1388	1388	1388	1388	1388	1388	1388	1388	1388	1388	1392	HISTORY_NEOADJUVANT_TRTYN	PATIENT	STRING	Text term to describe the patient's history of neoadjuvant treatment and the kind of treatment given prior to resection of the tumor.	Neoadjuvant Therapy Type Administered Prior To Resection Text	1				
1389	1389	1389	1389	1389	1389	1389	1389	1389	1389	1389	1389	1389	1393	HISTORY_NEOADJUVANT_TX_TYPE	PATIENT	STRING	Prior systemic therapy type	History neoadjuvant tx type	1				
1390	1390	1390	1390	1390	1390	1390	1390	1390	1390	1390	1390	1390	1394	HISTORY_OF_CROHNS_DISEASE	PATIENT	STRING	History of Crohn Disease	History of Crohn Disease	1				
1391	1391	1391	1391	1391	1391	1391	1391	1391	1391	1391	1391	1391	1395	HISTORY_OF_ULCERATIVE_COLITIS	PATIENT	STRING	Prior History of Ulcerative Colitis	Prior History of Ulcerative Colitis	1				
1392	1392	1392	1392	1392	1392	1392	1392	1392	1392	1392	1392	1392	1396	HISTORY_OF_UNDESCENDED_TESTIS	PATIENT	STRING	History of undescended testis	History of undescended testis	1				
1393	1393	1393	1393	1393	1393	1393	1393	1393	1393	1393	1393	1393	1397	HISTORY_OTHER	PATIENT	STRING	Other History	Other History	1				
1394	1394	1394	1394	1394	1394	1394	1394	1394	1394	1394	1394	1394	1398	HISTORY_OTHER_MALIGNANCY	PATIENT	STRING	Text term to describe the patient's history of prior cancer diagnosis and the spatial location of any previous cancer occurrence.	Prior Cancer Diagnosis Occurence	1				
1395	1395	1395	1395	1395	1395	1395	1395	1395	1395	1395	1395	1395	1399	HISTORY_PHEO_OR_PARA_ANATOMIC_SITE	PATIENT	STRING	Text field to describe the anatomic site of the prior pheochromocytoma or paraganglioma.	Prior History Pheochromocytoma Or Paraganglioma Anatomic Site Text	1				
1396	1396	1396	1396	1396	1396	1396	1396	1396	1396	1396	1396	1396	1400	HISTORY_PHEO_OR_PARA_INCLUDE_BENIGN	PATIENT	STRING	Indicator to signify whether or not a patient has a history of pheochromocytoma or paraganglioma.	Patient History Pheochromocytoma Or Paraganglioma Indicator	1				
1397	1397	1397	1397	1397	1397	1397	1397	1397	1397	1397	1397	1397	1401	HISTORY_RADIATION_EXPOSURE	PATIENT	STRING	Person lifetime risk radiation exposure indicator	History radiation exposure	1				
1398	1398	1398	1398	1398	1398	1398	1398	1398	1398	1398	1398	1398	1402	HISTORY_REFLUX_DISEASE_TREATMENT	SAMPLE	STRING	Antireflux treatment type	Antireflux treatment type	1				
1399	1399	1399	1399	1399	1399	1399	1399	1399	1399	1399	1399	1399	1403	HISTORY_RELEVANT_INFECTIOUS_DX	PATIENT	STRING	Prior infectious disease	Prior infectious disease	1				
1400	1400	1400	1400	1400	1400	1400	1400	1400	1400	1400	1400	1400	1404	HISTORY_TAMOXIFEN_USE	PATIENT	STRING	History tamoxifen use	History tamoxifen use	1				
1401	1401	1401	1401	1401	1401	1401	1401	1401	1401	1401	1401	1401	1405	HISTORY_THYROID_DISEASE	PATIENT	STRING	Patient personal medical history thyroid gland disorder name	History thyroid disease	1				
1402	1402	1402	1402	1402	1402	1402	1402	1402	1402	1402	1402	1402	1406	HISTORY_THYROID_DISEASE_OTHER	PATIENT	STRING	Patient personal medical history thyroid other specify text	History thyroid disease other	1				
1403	1403	1403	1403	1403	1403	1403	1403	1403	1403	1403	1403	1403	1407	HISTORY_UROTHELIAL_CARCINOMA	PATIENT	STRING	Prior history of Urothelial Carcinoma	Prior history of Urothelial Carcinoma	1				
1404	1404	1404	1404	1404	1404	1404	1404	1404	1404	1404	1404	1404	1408	HISTO_ANY_DPM	SAMPLE	STRING	DPM pattern, HG or LG	DPM pattern, HG or LG	1				
1405	1405	1405	1405	1405	1405	1405	1405	1405	1405	1405	1405	1405	1409	HISTO_CC	SAMPLE	STRING	Clear cell component >20%	Clear cell	1				
1406	1406	1406	1406	1406	1406	1406	1406	1406	1406	1406	1406	1406	1410	HISTO_CLC	SAMPLE	STRING	>10% cholangiocellular pattern	CLC	1				
1407	1407	1407	1407	1407	1407	1407	1407	1407	1407	1407	1407	1407	1411	HISTO_DUCT	SAMPLE	NUMBER	Duct type (1)	Duct type (1)	1				
1408	1408	1408	1408	1408	1408	1408	1408	1408	1408	1408	1408	1408	1412	HISTO_DUCTULAR	SAMPLE	NUMBER	Ductular type (2)	Ductular type (2)	1				
1409	1409	1409	1409	1409	1409	1409	1409	1409	1409	1409	1409	1409	1413	HISTO_GEO_NECROSIS	SAMPLE	STRING	Geographic necrosis	Necrosis	1				
1410	1410	1410	1410	1410	1410	1410	1410	1410	1410	1410	1410	1410	1414	HISTO_GT	SAMPLE	STRING	Gaping tubule pattern	GT pattern	1				
1411	1411	1411	1411	1411	1411	1411	1411	1411	1411	1411	1411	1411	1415	HISTO_HEPATOID_CYTO	SAMPLE	STRING	Hepatoid	Hepatoid	1				
1412	1412	1412	1412	1412	1412	1412	1412	1412	1412	1412	1412	1412	1416	HISTO_HG_HG_DPM	SAMPLE	NUMBER	DPM pattern, HG	DPM pattern, HG	1				
1413	1413	1413	1413	1413	1413	1413	1413	1413	1413	1413	1413	1413	1417	HISTO_HG_SOLID	SAMPLE	NUMBER	Solid pattern	Solid pattern	1				
1414	1414	1414	1414	1414	1414	1414	1414	1414	1414	1414	1414	1414	1418	HISTO_IG_COMPACT_TUBULAR	SAMPLE	NUMBER	Compact tubular pattern	Compact tubular pattern	1				
1415	1415	1415	1415	1415	1415	1415	1415	1415	1415	1415	1415	1415	1419	HISTO_IG_COMPLEX	SAMPLE	NUMBER	Intermediate complexity pattern	Intermediate complexity pattern	1				
1416	1416	1416	1416	1416	1416	1416	1416	1416	1416	1416	1416	1416	1420	HISTO_INTERFACE	SAMPLE	STRING	Tumor infiltrates hepatocytes at periphery	Interface	1				
1417	1417	1417	1417	1417	1417	1417	1417	1417	1417	1417	1417	1417	1421	HISTO_INTERFACE_FIBROSIS	SAMPLE	STRING	zone of fibrosis at tumor periphery	Interface fibrosis	1				
1418	1418	1418	1418	1418	1418	1418	1418	1418	1418	1418	1418	1418	1422	HISTO_INTRADUCTAL	SAMPLE	STRING	Intraductal growth	Intraductal growth	1				
1419	1419	1419	1419	1419	1419	1419	1419	1419	1419	1419	1419	1419	1423	HISTO_INTRADUCTAL_NEOPLASM	SAMPLE	STRING	Intraductal neoplasm	Intraductal neoplasm	1				
1420	1420	1420	1420	1420	1420	1420	1420	1420	1420	1420	1420	1420	1424	HISTO_LG_DPM	SAMPLE	NUMBER	DPM pattern, LG	DPM pattern, LG	1				
1421	1421	1421	1421	1421	1421	1421	1421	1421	1421	1421	1421	1421	1425	HISTO_LG_LARGE_DUCTS	SAMPLE	NUMBER	Large duct histology	Large duct pattern	1				
1422	1422	1422	1422	1422	1422	1422	1422	1422	1422	1422	1422	1422	1426	HISTO_LG_TRABECULAR	SAMPLE	NUMBER	Trabecular pattern	Trabecular pattern	1				
1423	1423	1423	1423	1423	1423	1423	1423	1423	1423	1423	1423	1423	1427	HISTO_LG_TUBULAR	SAMPLE	NUMBER	Tubular pattern	Tubular pattern	1				
1424	1424	1424	1424	1424	1424	1424	1424	1424	1424	1424	1424	1424	1428	HISTO_LPN	SAMPLE	STRING	Low power nodularity	Nodularity	1				
1425	1425	1425	1425	1425	1425	1425	1425	1425	1425	1425	1425	1425	1429	HISTO_LYC	SAMPLE	STRING	Peritumoral lymphocytes	LYC	1				
1426	1426	1426	1426	1426	1426	1426	1426	1426	1426	1426	1426	1426	1430	HISTO_MUCIN_EC	SAMPLE	STRING	Extracellular mucin	EC Mucin	1				
1427	1427	1427	1427	1427	1427	1427	1427	1427	1427	1427	1427	1427	1431	HISTO_MUCIN_IC	SAMPLE	STRING	Intracellular mucin	IC Mucin	1				
1428	1428	1428	1428	1428	1428	1428	1428	1428	1428	1428	1428	1428	1432	HISTO_PMNS	SAMPLE	STRING	Intratumoral neutrophils	PMN	1				
1429	1429	1429	1429	1429	1429	1429	1429	1429	1429	1429	1429	1429	1433	HISTO_SCAR	SAMPLE	STRING	Ghosting, fibrous scar	Scar	1				
1430	1430	1430	1430	1430	1430	1430	1430	1430	1430	1430	1430	1430	1434	HISTO_SOLID_NESTED	SAMPLE	NUMBER	Nested pattern	Nested pattern	1				
1431	1431	1431	1431	1431	1431	1431	1431	1431	1431	1431	1431	1431	1435	HISTO_SR_DESMOPLASTIC	SAMPLE	STRING	Desmoplastic stroma	Desmoplastic stroma	1				
1432	1432	1432	1432	1432	1432	1432	1432	1432	1432	1432	1432	1432	1436	HISTO_SR_HYALIN	SAMPLE	STRING	Hyalinized stroma	Hyalinized stroma	1				
1433	1433	1433	1433	1433	1433	1433	1433	1433	1433	1433	1433	1433	1437	HISTO_STROMAPOOR	SAMPLE	STRING	Stroma poor tumor	Stroma poor	1				
1434	1434	1434	1434	1434	1434	1434	1434	1434	1434	1434	1434	1434	1438	HISTO_TC	SAMPLE	STRING	Tiny cuboidal pattern	TC pattern	1				
1435	1435	1435	1435	1435	1435	1435	1435	1435	1435	1435	1435	1435	1439	HISTO_TOTAL	SAMPLE	NUMBER	Adding up the prior columns	Total	1				
1436	1436	1436	1436	1436	1436	1436	1436	1436	1436	1436	1436	1436	1440	HISTO_WORST_GRADE	SAMPLE	STRING	Histology grade	Grade	1				
1437	1437	1437	1437	1437	1437	1437	1437	1437	1437	1437	1437	1437	1441	HISTO_ZONES	SAMPLE	STRING	Zones of tumor grade	Zonal pattern	1				
1438	1438	1438	1438	1438	1438	1438	1438	1438	1438	1438	1438	1438	1442	HIV_RNA_LOAD_AT_DIAGNOSIS	SAMPLE	NUMBER	HIV RNA Load at Diagnosis	HIV RNA Load at Diagnosis	1				
1439	1439	1439	1439	1439	1439	1439	1439	1439	1439	1439	1439	1439	1443	HIV_STATUS	PATIENT	STRING	HIV Status	HIV Status	1				
1440	1440	1440	1440	1440	1440	1440	1440	1440	1440	1440	1440	1440	1444	HLA_A	SAMPLE	STRING	Polysolver HLA-A	HLA-A	1				
1441	1441	1441	1441	1441	1441	1441	1441	1441	1441	1441	1441	1441	1445	HLA_B	SAMPLE	STRING	Polysolver HLA-B	HLA-B	1				
1442	1442	1442	1442	1442	1442	1442	1442	1442	1442	1442	1442	1442	1446	HLA_C	SAMPLE	STRING	Polysolver HLA-C	HLA-C	1				
1443	1443	1443	1443	1443	1443	1443	1443	1443	1443	1443	1443	1443	1447	HLA_DPA1	SAMPLE	STRING	SOAP HLA-DPA1	HLA-DPA1	1				
1444	1444	1444	1444	1444	1444	1444	1444	1444	1444	1444	1444	1444	1448	HLA_DPB1	SAMPLE	STRING	SOAP HLA-DPB1	HLA-DPB1	1				
1445	1445	1445	1445	1445	1445	1445	1445	1445	1445	1445	1445	1445	1449	HLA_DQA1	SAMPLE	STRING	SOAP HLA-DQA1	HLA-DQA1	1				
1446	1446	1446	1446	1446	1446	1446	1446	1446	1446	1446	1446	1446	1450	HLA_DQB1	SAMPLE	STRING	SOAP HLA-DQB1	HLA-DQB1	1				
1447	1447	1447	1447	1447	1447	1447	1447	1447	1447	1447	1447	1447	1451	HLA_DRB1	SAMPLE	STRING	SOAP HLA-DRB1	HLA-DRB1	1				
1448	1448	1448	1448	1448	1448	1448	1448	1448	1448	1448	1448	1448	1452	HLA_I	SAMPLE	STRING	HLA class I typing	HLA-I	1				
1449	1449	1449	1449	1449	1449	1449	1449	1449	1449	1449	1449	1449	1453	HLA_II	SAMPLE	STRING	SOAP-HLA HLA-II Call	HLA-II	1				
1450	1450	1450	1450	1450	1450	1450	1450	1450	1450	1450	1450	1450	1454	HL_STATUS	PATIENT	STRING	Hl Status	HL status	1				
1451	1451	1451	1451	1451	1451	1451	1451	1451	1451	1451	1451	1451	1455	HM27	SAMPLE	STRING	HM27	HM27	1				
1452	1452	1452	1452	1452	1452	1452	1452	1452	1452	1452	1452	1452	1456	HM450	SAMPLE	STRING	HM450	HM450	1				
1453	1453	1453	1453	1453	1453	1453	1453	1453	1453	1453	1453	1453	1457	HORMONE_RECEPTOR_STATUS	PATIENT	STRING	Patient-reported response to the question: At any time, was your breast cancer found to be hormone receptor positive (HR+, ER+ and/or PR+)?	PRD Ever Hormone Receptor Positive	1				
1454	1454	1454	1454	1454	1454	1454	1454	1454	1454	1454	1454	1454	1458	HORMONE_STATUS	PATIENT	STRING	Hormone status.	Hormone Status	1				
1455	1455	1455	1455	1455	1455	1455	1455	1455	1455	1455	1455	1455	1459	HORMONE_THERAPY	PATIENT	STRING	Hormone Therapy	Hormone Therapy	1				
1456	1456	1456	1456	1456	1456	1456	1456	1456	1456	1456	1456	1456	1460	HORMONE_THERAPY_DETAILS	PATIENT	STRING	Homrone Therapy Details	Homrone Therapy Details	1				
1457	1457	1457	1457	1457	1457	1457	1457	1457	1457	1457	1457	1457	1461	HORMONE_THERAPY_YEARS	PATIENT	STRING	Hormone Therapy Years	Hormone Therapy Years	1				
1458	1458	1458	1458	1458	1458	1458	1458	1458	1458	1458	1458	1458	1462	HOSPITAL_SITE	PATIENT	STRING	Hospital Site	Hospital Site	1				
1459	1459	1459	1459	1459	1459	1459	1459	1459	1459	1459	1459	1459	1463	HPV_DETAILS	SAMPLE	STRING	HPV Status Details	HPV Status Details	1				
1460	1460	1460	1460	1460	1460	1460	1460	1460	1460	1460	1460	1460	1464	HPV_ISH	SAMPLE	STRING	Tumor human papilloma virus status by in situ hybridization: Positive/Negative/Not Evaluated	Tumor HPV ISH	1				
1461	1461	1461	1461	1461	1461	1461	1461	1461	1461	1461	1461	1461	1465	HPV_PATHSEQ	SAMPLE	STRING	Tumor human papilloma virus status by PathSeq: Positive/Negative	Tumor HPV PATHSEQ	1				
1462	1462	1462	1462	1462	1462	1462	1462	1462	1462	1462	1462	1462	1466	HPV_PCR	SAMPLE	STRING	Tumor human papilloma virus status by HPV-16 PCR: Positive/Negative/Not Evaluated	Tumor HPV PCR	1				
1463	1463	1463	1463	1463	1463	1463	1463	1463	1463	1463	1463	1463	1467	HPV_STATUS	PATIENT	STRING	HPV status.	HPV Status	1				
1464	1464	1464	1464	1464	1464	1464	1464	1464	1464	1464	1464	1464	1468	HPV_STATUS_ISH	PATIENT	STRING	Hpv status by ish testing	Hpv status ish	1				
1465	1465	1465	1465	1465	1465	1465	1465	1465	1465	1465	1465	1465	1469	HPV_STATUS_P16	PATIENT	STRING	Hpv status by p16 testing	Hpv status p16	1				
1466	1466	1466	1466	1466	1466	1466	1466	1466	1466	1466	1466	1466	1470	HPV_TYPES_OTHER	PATIENT	STRING	Human papillomavirus other type text	Human papillomavirus other type text	1				
1467	1467	1467	1467	1467	1467	1467	1467	1467	1467	1467	1467	1467	1471	HPV_TYPES_POSITIVE	PATIENT	STRING	Human papillomavirus type	Human papillomavirus type	1				
1468	1468	1468	1468	1468	1468	1468	1468	1468	1468	1468	1468	1468	1472	HPV_TYPING_METHOD	PATIENT	STRING	Human papillomavirus laboratory procedure performed name	Human papillomavirus laboratory procedure performed name	1				
1469	1469	1469	1469	1469	1469	1469	1469	1469	1469	1469	1469	1469	1473	HPV_TYPING_METHOD_OTHER	PATIENT	STRING	Human papillomavirus laboratory procedure performed text	Human papillomavirus laboratory procedure performed text	1				
1470	1470	1470	1470	1470	1470	1470	1470	1470	1470	1470	1470	1470	1474	HRAS_EXPRESSION	SAMPLE	STRING	HRAS expression	HRAS expression	1				
1471	1471	1471	1471	1471	1471	1471	1471	1471	1471	1471	1471	1471	1475	HRAS_HIGH	SAMPLE	STRING	HRAS high	HRAS High	1				
1472	1472	1472	1472	1472	1472	1472	1472	1472	1472	1472	1472	1472	1476	HRAS_MUTATION	SAMPLE	STRING	HRAS mutation is present	HRAS mutation	1				
1473	1473	1473	1473	1473	1473	1473	1473	1473	1473	1473	1473	1473	1477	HRAS_SOMATIC	SAMPLE	STRING	HRAS Somatic Mutation	HRAS Somatic Mutation	1				
1474	1474	1474	1474	1474	1474	1474	1474	1474	1474	1474	1474	1474	1478	HRD_LOH	SAMPLE	NUMBER	HRD-LOH	HRD-LOH	1				
1475	1475	1475	1475	1475	1475	1475	1475	1475	1475	1475	1475	1475	1479	HRT_HISTORY_YEARS	PATIENT	NUMBER	Hormone Replacement Therapy History in Years	HRT History Years	1				
1476	1476	1476	1476	1476	1476	1476	1476	1476	1476	1476	1476	1476	1480	HSCT	PATIENT	STRING	Yes/No Indicator for hematopoietic stem cell transplantation	Hematopoietic Sem Cell Transplantation (HSCT)	1				
1477	1477	1477	1477	1477	1477	1477	1477	1477	1477	1477	1477	1477	1481	HSCT_DAYS	PATIENT	NUMBER	Days to hematopoietic stem cell transplantation	Hematopoietic Sem Cell Transplantation (HSCT), days	1				
1478	1478	1478	1478	1478	1478	1478	1478	1478	1478	1478	1478	1478	1482	HTN_STATUS	PATIENT	STRING	HTN Status	HTN Status	1				
1479	1479	1479	1479	1479	1479	1479	1479	1479	1479	1479	1479	1479	1483	HYDRONEPHROSIS	SAMPLE	STRING	Hydronephrosis	Hydronephrosis	1				
1480	1480	1480	1480	1480	1480	1480	1480	1480	1480	1480	1480	1480	1484	HYPERCHOLESTEROLEMIA	PATIENT	STRING	Hypercholesterolemia	Hypercholesterolemia	1				
1481	1481	1481	1481	1481	1481	1481	1481	1481	1481	1481	1481	1481	1485	HYPERDIPLOID	SAMPLE	STRING	Hyper-diploid.	Hyper-diploid	1				
1482	1482	1482	1482	1482	1482	1482	1482	1482	1482	1482	1482	1482	1486	HYPERMETH_CLUSTER	SAMPLE	STRING	Hyper-meth Cluster	Hyper-meth Cluster	1				
1483	1483	1483	1483	1483	1483	1483	1483	1483	1483	1483	1483	1483	1487	HYPERMUTATED	SAMPLE	STRING	Hyper-mutated.	Hyper-mutated	1				
1484	1484	1484	1484	1484	1484	1484	1484	1484	1484	1484	1484	1484	1488	HYPERMUTATED_COMBINED	SAMPLE	NUMBER	Hypermutated Combined	Hypermutated Combined	1				
1485	1485	1485	1485	1485	1485	1485	1485	1485	1485	1485	1485	1485	1489	HYPERTENSION_DIAGNOSIS	PATIENT	STRING	Hypertension diagnosis	Hypertension diagnosis	1				
1486	1486	1486	1486	1486	1486	1486	1486	1486	1486	1486	1486	1486	1490	HYPODIPLOID	SAMPLE	STRING	Hypodiploid	Hypodiploid	1				
1487	1487	1487	1487	1487	1487	1487	1487	1487	1487	1487	1487	1487	1491	HYSTERECTOMY_AT_MSK	PATIENT	STRING	Yes or No value if Hysterectomy was performed at MSK	Hysterectomy at MSK	1				
1488	1488	1488	1488	1488	1488	1488	1488	1488	1488	1488	1488	1488	1492	HYSTERECTOMY_TYPE	PATIENT	STRING	Hysterectomy performed type	Hysterectomy performed type	1				
1489	1489	1489	1489	1489	1489	1489	1489	1489	1489	1489	1489	1489	1493	H_PYLORI	SAMPLE	STRING	H-PYLORI.	H-PYLORI	1				
1490	1490	1490	1490	1490	1490	1490	1490	1490	1490	1490	1490	1490	1494	H_PYLORI_INFECTION	PATIENT	STRING	H-PYLORI infection.	H-PYLORI Infection	1				
1491	1491	1491	1491	1491	1491	1491	1491	1491	1491	1491	1491	1491	1495	IBD	PATIENT	STRING	IBD	IBD	1				
1492	1492	1492	1492	1492	1492	1492	1492	1492	1492	1492	1492	1492	1496	ICDO	PATIENT	STRING	ICDO.	ICDO	1				
1493	1493	1493	1493	1493	1493	1493	1493	1493	1493	1493	1493	1493	1497	ICDO_SNOMED_DESCRIPTION	PATIENT	STRING	ICDO snomed description.	ICDO Snomed Description	1				
1494	1494	1494	1494	1494	1494	1494	1494	1494	1494	1494	1494	1494	1498	ICD_0_3_T	SAMPLE	STRING	ICD-0-3-T	ICD-0-3-T	1				
1495	1495	1495	1495	1495	1495	1495	1495	1495	1495	1495	1495	1495	1499	ICD_10	PATIENT	STRING	10th revision of the International Statistical Classification of Diseases and Related Health Problems.	ICD-10 Classification	1				
1496	1496	1496	1496	1496	1496	1496	1496	1496	1496	1496	1496	1496	1500	ICD_O_3_HISTOLOGY	PATIENT	STRING	The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.	International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code	1				
1497	1497	1497	1497	1497	1497	1497	1497	1497	1497	1497	1497	1497	1501	ICD_O_3_SITE	PATIENT	STRING	The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.	International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code	1				
1498	1498	1498	1498	1498	1498	1498	1498	1498	1498	1498	1498	1498	1502	ICLUSTER	SAMPLE	STRING	ICluster.	iCluster	1				
1499	1499	1499	1499	1499	1499	1499	1499	1499	1499	1499	1499	1499	1503	ICLUSTER_K3	SAMPLE	STRING	iCluster analysis k3	iCluster k3	1				
1500	1500	1500	1500	1500	1500	1500	1500	1500	1500	1500	1500	1500	1504	IDFS_MONTHS	PATIENT	STRING	Invasive Disease-Free Survival (IDFS Months)	Invasive Disease-Free Survival (IDFS Months)	1				
1501	1501	1501	1501	1501	1501	1501	1501	1501	1501	1501	1501	1501	1505	IDFS_STATUS	PATIENT	STRING	Invasive Disease-Free Survival Status	Invasive Disease-Free Survival Status	1				
1502	1502	1502	1502	1502	1502	1502	1502	1502	1502	1502	1502	1502	1506	IDH1_MUTATION	SAMPLE	STRING	IDH1 mutation is present	IDH1 Mutation	1				
1503	1503	1503	1503	1503	1503	1503	1503	1503	1503	1503	1503	1503	1507	IDH1_MUTATION_TESTED	SAMPLE	STRING	Was IDH1 Mutation Tested	Was IDH1 Mutation Tested	1				
1504	1504	1504	1504	1504	1504	1504	1504	1504	1504	1504	1504	1504	1508	IDH1_MUTATION_TEST_INDICATOR	SAMPLE	STRING	IDH1 mutation test was performed.	IDH1 Mutation Test Indicator	1				
1505	1505	1505	1505	1505	1505	1505	1505	1505	1505	1505	1505	1505	1509	IDH1_MUTATION_TEST_METHOD	SAMPLE	STRING	Ldh1 mutation test method	Ldh1 mutation test method	1				
1506	1506	1506	1506	1506	1506	1506	1506	1506	1506	1506	1506	1506	1510	IDH1_RESULT_SURGERY_1	PATIENT	STRING	IDH1 Result Surgery 1	IDH1 Result Surgery 1	1				
1507	1507	1507	1507	1507	1507	1507	1507	1507	1507	1507	1507	1507	1511	IDH1_SOMATIC	SAMPLE	STRING	IDH1 Somatic Mutation	IDH1 Somatic Mutation	1				
1508	1508	1508	1508	1508	1508	1508	1508	1508	1508	1508	1508	1508	1512	IDH_1P19Q_SUBTYPE	SAMPLE	STRING	IDH-1P10Q subtype.	IDH-1P10Q Subtype	1				
1509	1509	1509	1509	1509	1509	1509	1509	1509	1509	1509	1509	1509	1513	IDH_CODEL_SUBTYPE	SAMPLE	STRING	IDH/codel subtype	IDH/codel subtype	1				
1510	1510	1510	1510	1510	1510	1510	1510	1510	1510	1510	1510	1510	1514	IDH_LEVEL	PATIENT	STRING	Idh level	Idh level	1				
1511	1511	1511	1511	1511	1511	1511	1511	1511	1511	1511	1511	1511	1515	IDH_SPECIFIC_DNA_METHYLATION_CLUSTER	SAMPLE	STRING	IDH-specific DNA Methylation Cluster	IDH-specific DNA Methylation Cluster	1				
1512	1512	1512	1512	1512	1512	1512	1512	1512	1512	1512	1512	1512	1516	IDH_SPECIFIC_RNA_EXPRESSION_CLUSTER	SAMPLE	STRING	IDH-specific RNA Expression Cluster	IDH-specific RNA Expression Cluster	1				
1513	1513	1513	1513	1513	1513	1513	1513	1513	1513	1513	1513	1513	1517	IDH_STATUS	SAMPLE	STRING	IDH status	IDH status	1				
1514	1514	1514	1514	1514	1514	1514	1514	1514	1514	1514	1514	1514	1518	ID_SAMPLE_TYPE	SAMPLE	STRING	Sample Type ID	Sample Type ID	1				
1515	1515	1515	1515	1515	1515	1515	1515	1515	1515	1515	1515	1515	1519	IFN_TX_90_DAYS_PRIOR_TO_RESECTION	PATIENT	STRING	Interferon 90 day prior excision admin indicator	Ifn tx 90 days prior to resection	1				
1516	1516	1516	1516	1516	1516	1516	1516	1516	1516	1516	1516	1516	1520	IF_AZA_NUMBER_PRIOR_CYCLES	PATIENT	STRING	If Aza Number of Prior Cycles	If Aza Number of Prior Cycles	1				
1517	1517	1517	1517	1517	1517	1517	1517	1517	1517	1517	1517	1517	1521	IF_DECITABINE_PRIOR_CYCLES	PATIENT	STRING	If Decitabine Number of Prior Cycles	If Decitabine Number of Prior Cycles	1				
1518	1518	1518	1518	1518	1518	1518	1518	1518	1518	1518	1518	1518	1522	IF_EXTRACAPSULAR_SPREAD_PRESENT	SAMPLE	STRING	If Extracapsular Spread Present	If Extracapsular Spread Present	1				
1519	1519	1519	1519	1519	1519	1519	1519	1519	1519	1519	1519	1519	1523	IF_INVESTIGATIONAL_TRIAL_IRB	PATIENT	STRING	If Investigational Trial, IRB#	If Investigational Trial, IRB#	1				
1520	1520	1520	1520	1520	1520	1520	1520	1520	1520	1520	1520	1520	1524	IF_SARCOMA_SPECIFY	SAMPLE	STRING	If Histology defined is Sarcoma, please specify what type of Sarcoma	If Histology is Sarcoma, specify	1				
1521	1521	1521	1521	1521	1521	1521	1521	1521	1521	1521	1521	1521	1525	IGCCCG_STAGE	PATIENT	STRING	Igcccg stage	Igcccg stage	1				
1522	1522	1522	1522	1522	1522	1522	1522	1522	1522	1522	1522	1522	1526	IGHV_GENE	SAMPLE	STRING	IGHV Gene	IGHV Gene	1				
1523	1523	1523	1523	1523	1523	1523	1523	1523	1523	1523	1523	1523	1527	IGHV_IDENTITY	SAMPLE	NUMBER	IGHV Identity (%)	IGHV Identity (%)	1				
1524	1524	1524	1524	1524	1524	1524	1524	1524	1524	1524	1524	1524	1528	IGHV_MUTATED	SAMPLE	STRING	IGHV Mutated	IGHV Mutated	1				
1525	1525	1525	1525	1525	1525	1525	1525	1525	1525	1525	1525	1525	1529	IGHV_UNMUTATED	SAMPLE	STRING	IGHV Unmutated	IGHV Unmutated	1				
1526	1526	1526	1526	1526	1526	1526	1526	1526	1526	1526	1526	1526	1530	IGH_GENE	SAMPLE	STRING	IgH Gene	IgH Gene	1				
1527	1527	1527	1527	1527	1527	1527	1527	1527	1527	1527	1527	1527	1531	IGH_GENOTYPE_RESULT	SAMPLE	STRING	Igh genotype results	Igh genotype results	1				
1528	1528	1528	1528	1528	1528	1528	1528	1528	1528	1528	1528	1528	1532	IGH_TRANSLOCATIONS	SAMPLE	STRING	IgH Translocations	IgH Translocations	1				
1529	1529	1529	1529	1529	1529	1529	1529	1529	1529	1529	1529	1529	1533	IGK_GENOTYPE_RESULT	SAMPLE	STRING	Igk genotype results	Igk genotype results	1				
1530	1530	1530	1530	1530	1530	1530	1530	1530	1530	1530	1530	1530	1534	IHC_AR	SAMPLE	STRING	AR IHC	AR IHC	1				
1531	1531	1531	1531	1531	1531	1531	1531	1531	1531	1531	1531	1531	1535	IHC_ARID1A	SAMPLE	STRING	IHC-ARID1A.	IHC-ARID1A	1				
1532	1532	1532	1532	1532	1532	1532	1532	1532	1532	1532	1532	1532	1536	IHC_BAP1	SAMPLE	STRING	BAP1 IHC Result	BAP1 IHC Result	1				
1533	1533	1533	1533	1533	1533	1533	1533	1533	1533	1533	1533	1533	1537	IHC_BASAL	SAMPLE	STRING	Basal carcinoma by immunohistochemistry for EGFR and CK5/6	IHC_BASAL	1				
1534	1534	1534	1534	1534	1534	1534	1534	1534	1534	1534	1534	1534	1538	IHC_BCL6	SAMPLE	STRING	IHC_BCL6	IHC_BCL6	1				
1535	1535	1535	1535	1535	1535	1535	1535	1535	1535	1535	1535	1535	1539	IHC_B_TUBULIN	SAMPLE	STRING	IHC For B Tubulin	IHC For B Tubulin	1				
1536	1536	1536	1536	1536	1536	1536	1536	1536	1536	1536	1536	1536	1540	IHC_CD10	SAMPLE	STRING	IHC_CD10	IHC_CD10	1				
1537	1537	1537	1537	1537	1537	1537	1537	1537	1537	1537	1537	1537	1541	IHC_CDX2	SAMPLE	STRING	IHC For CDX2	IHC For CDX2	1				
1538	1538	1538	1538	1538	1538	1538	1538	1538	1538	1538	1538	1538	1542	IHC_CK20	SAMPLE	STRING	IHC For CK20	IHC For CK20	1				
1539	1539	1539	1539	1539	1539	1539	1539	1539	1539	1539	1539	1539	1543	IHC_CK5_6	SAMPLE	STRING	IHC_CK5/6	IHC_CK5/6	1				
1540	1540	1540	1540	1540	1540	1540	1540	1540	1540	1540	1540	1540	1544	IHC_CK7	SAMPLE	STRING	IHC For CK7	IHC For CK7	1				
1541	1541	1541	1541	1541	1541	1541	1541	1541	1541	1541	1541	1541	1545	IHC_EGFR	SAMPLE	STRING	IHC_EGFR	IHC_EGFR	1				
1542	1542	1542	1542	1542	1542	1542	1542	1542	1542	1542	1542	1542	1546	IHC_ER	SAMPLE	STRING	IHC For ER	IHC For ER	1				
1543	1543	1543	1543	1543	1543	1543	1543	1543	1543	1543	1543	1543	1547	IHC_HER2	SAMPLE	STRING	IHC-HER2	IHC-HER2	1				
1544	1544	1544	1544	1544	1544	1544	1544	1544	1544	1544	1544	1544	1548	IHC_IDH1	SAMPLE	STRING	IDH1 IHC Result	IDH1 IHC Result	1				
1545	1545	1545	1545	1545	1545	1545	1545	1545	1545	1545	1545	1545	1549	IHC_MSH6	SAMPLE	STRING	IHC For MSH6	IHC For MSH6	1				
1546	1546	1546	1546	1546	1546	1546	1546	1546	1546	1546	1546	1546	1550	IHC_MUM1	SAMPLE	STRING	IHC_MUM1	IHC_MUM1	1				
1547	1547	1547	1547	1547	1547	1547	1547	1547	1547	1547	1547	1547	1551	IHC_P16	SAMPLE	STRING	IHC For P16	IHC For P16	1				
1548	1548	1548	1548	1548	1548	1548	1548	1548	1548	1548	1548	1548	1552	IHC_P4EBP1	SAMPLE	STRING	IHC_P4EBP1	IHC_P4EBP1	1				
1549	1549	1549	1549	1549	1549	1549	1549	1549	1549	1549	1549	1549	1553	IHC_PAX8	SAMPLE	STRING	IHC For PAX8	IHC For PAX8	1				
1550	1550	1550	1550	1550	1550	1550	1550	1550	1550	1550	1550	1550	1554	IHC_PBRM1	SAMPLE	STRING	PBRM1 IHC Result	PBRM1 IHC Result	1				
1551	1551	1551	1551	1551	1551	1551	1551	1551	1551	1551	1551	1551	1555	IHC_PMS2	SAMPLE	STRING	IHC For PMS2	IHC For PMS2	1				
1552	1552	1552	1552	1552	1552	1552	1552	1552	1552	1552	1552	1552	1556	IHC_PR	SAMPLE	STRING	IHC For PR	IHC For PR	1				
1553	1553	1553	1553	1553	1553	1553	1553	1553	1553	1553	1553	1553	1557	IHC_PS6	SAMPLE	STRING	IHC For PS6	IHC For PS6	1				
1554	1554	1554	1554	1554	1554	1554	1554	1554	1554	1554	1554	1554	1558	IHC_PS6_235	SAMPLE	STRING	IHC_pS6_235	IHC_pS6_235	1				
1555	1555	1555	1555	1555	1555	1555	1555	1555	1555	1555	1555	1555	1559	IHC_PTEN	SAMPLE	STRING	IHC PTEN	IHC PTEN	1				
1556	1556	1556	1556	1556	1556	1556	1556	1556	1556	1556	1556	1556	1560	IHC_SCORE	SAMPLE	NUMBER	IHC Score	IHC Score	1				
1557	1557	1557	1557	1557	1557	1557	1557	1557	1557	1557	1557	1557	1561	IHC_SMAD4	SAMPLE	STRING	IHC-SMAD4.	IHC-SMAD4	1				
1558	1558	1558	1558	1558	1558	1558	1558	1558	1558	1558	1558	1558	1562	IHC_SUBTYPE	SAMPLE	STRING	Immunohistochemistry Subtype	Immunohistochemistry Subtype	1				
1559	1559	1559	1559	1559	1559	1559	1559	1559	1559	1559	1559	1559	1563	IHC_TP53	SAMPLE	STRING	IHC For TP53	IHC For TP53	1				
1560	1560	1560	1560	1560	1560	1560	1560	1560	1560	1560	1560	1560	1564	IM	PATIENT	STRING	IM.	IM	1				
1561	1561	1561	1561	1561	1561	1561	1561	1561	1561	1561	1561	1561	1565	IMAGING	PATIENT	STRING	Imaging	Imaging	1				
1562	1562	1562	1562	1562	1562	1562	1562	1562	1562	1562	1562	1562	1566	IMMUNE_SCORE	SAMPLE	NUMBER	Immune Score by ESTIMATE	ESTIMATE Immune Score	1				
1563	1563	1563	1563	1563	1563	1563	1563	1563	1563	1563	1563	1563	1567	IMMUNE_STATUS	SAMPLE	STRING	Immune Status	Immune Status	1				
1564	1564	1564	1564	1564	1564	1564	1564	1564	1564	1564	1564	1564	1568	IMMUNE_TREATMENT	PATIENT	STRING	Immunotherapy	Immunotherapy	1				
1565	1565	1565	1565	1565	1565	1565	1565	1565	1565	1565	1565	1565	1569	IMMUNOHISTOCHEMISTRY	SAMPLE	STRING	Immunohistochemistry	Immunohistochemistry	1				
1566	1566	1566	1566	1566	1566	1566	1566	1566	1566	1566	1566	1566	1570	IMMUNOPHENOTYPE	PATIENT	STRING	Immunophenotype.	Immunophenotype	1				
1567	1567	1567	1567	1567	1567	1567	1567	1567	1567	1567	1567	1567	1571	IMMUNOPHENOTYPIC_ANALYSIS_METHOD	SAMPLE	STRING	Immunophenotypic analysis methodology	Immunophenotypic analysis methodology	1				
1568	1568	1568	1568	1568	1568	1568	1568	1568	1568	1568	1568	1568	1572	IMMUNOPHENOTYPIC_ANALYSIS_RESULTS	SAMPLE	STRING	Result of immunophenotypic analysis	Result of immunophenotypic analysis	1				
1569	1569	1569	1569	1569	1569	1569	1569	1569	1569	1569	1569	1569	1573	IMMUNOPHENOTYPIC_ANALYSIS_TESTED	SAMPLE	STRING	Immunophenotypic analysis test	Immunophenotypic analysis test	1				
1570	1570	1570	1570	1570	1570	1570	1570	1570	1570	1570	1570	1570	1574	IMMUNOSUPPRESSION	PATIENT	STRING	Suppression of the immune system.	Immunosuppression	1				
1571	1571	1571	1571	1571	1571	1571	1571	1571	1571	1571	1571	1571	1575	IMMUNOTHERAPY_DURATION	PATIENT	STRING	Duration of Immunotherapy	Duration of Immunotherapy	1				
1572	1572	1572	1572	1572	1572	1572	1572	1572	1572	1572	1572	1572	1576	IMMUNOTHERAPY_RESPONSE	PATIENT	STRING	Response to Immunotherapy	Response to Immunotherapy	1				
1573	1573	1573	1573	1573	1573	1573	1573	1573	1573	1573	1573	1573	1577	IMPACT	SAMPLE	STRING	IMPACT	IMPACT	1				
1574	1574	1574	1574	1574	1574	1574	1574	1574	1574	1574	1574	1574	1578	IMPACT_1P19Q	SAMPLE	STRING	1p/19q status based on IMPACT	1p/19q status based on IMPACT	1				
1575	1575	1575	1575	1575	1575	1575	1575	1575	1575	1575	1575	1575	1579	IMPACT_DIRECTED_SOC_TX	PATIENT	STRING	IMPACT directed SOC Treatment	IMPACT directed SOC Treatment	1				
1576	1576	1576	1576	1576	1576	1576	1576	1576	1576	1576	1576	1576	1580	IMPACT_GUIDED_MGMT_DETAILS	SAMPLE	STRING	How Impact Guided Management	How Impact Guided Management	1				
1577	1577	1577	1577	1577	1577	1577	1577	1577	1577	1577	1577	1577	1581	IMPACT_NOTES	SAMPLE	STRING	IMPACT Notes	IMPACT Notes	1				
1578	1578	1578	1578	1578	1578	1578	1578	1578	1578	1578	1578	1578	1582	IMPACT_PASSAGE	SAMPLE	STRING	IMPACT Passage	IMPACT Passage	1				
1579	1579	1579	1579	1579	1579	1579	1579	1579	1579	1579	1579	1579	1583	IMPACT_PATH_IN_SETTING_OF_TKI_REFRACTORY_DISEASE	SAMPLE	STRING	Impact Path Taken In Setting Of Imatinib/TKI Refractory Disease	Impact Path Taken In Setting Of Imatinib/TKI Refractory Disease	1				
1580	1580	1580	1580	1580	1580	1580	1580	1580	1580	1580	1580	1580	1584	IMPACT_PRE_KITI	PATIENT	STRING	IMPACT Pre KITi	IMPACT Pre KITi	1				
1581	1581	1581	1581	1581	1581	1581	1581	1581	1581	1581	1581	1581	1585	IMPACT_PRE_POST	SAMPLE	STRING	IMPACT pre/post	IMPACT pre/post	1				
1582	1582	1582	1582	1582	1582	1582	1582	1582	1582	1582	1582	1582	1586	IMPACT_PRE_POST_TKI	SAMPLE	STRING	IMPACT performed Pre or Post TKI	IMPACT performed Pre or Post TKI	1				
1583	1583	1583	1583	1583	1583	1583	1583	1583	1583	1583	1583	1583	1587	IMPACT_PRE_RAFI	PATIENT	STRING	IMPACT Pre RAFi	IMPACT Pre RAFi	1				
1584	1584	1584	1584	1584	1584	1584	1584	1584	1584	1584	1584	1584	1588	IMPACT_PRE_TKI	PATIENT	STRING	Pre-IMPACT TKI	Pre-IMPACT TKI	1				
1585	1585	1585	1585	1585	1585	1585	1585	1585	1585	1585	1585	1585	1589	IMPACT_RESULT_GUIDED_MANAGEMENT	SAMPLE	STRING	Impact Result Guided Management	Impact Result Guided Management	1				
1586	1586	1586	1586	1586	1586	1586	1586	1586	1586	1586	1586	1586	1590	IMPACT_SAMPLE_NUMBER	SAMPLE	STRING	IMPACT Sample Number	IMPACT Sample Number	1				
1587	1587	1587	1587	1587	1587	1587	1587	1587	1587	1587	1587	1587	1591	INCIDENTAL_PROSTATE_CANCER	SAMPLE	STRING	Incidental Prostate Cancer Indicator	Incidental Prostate Cancer Indicator	1				
1588	1588	1588	1588	1588	1588	1588	1588	1588	1588	1588	1588	1588	1592	INCLUDE	SAMPLE	STRING	Include	Include	1				
1589	1589	1589	1589	1589	1589	1589	1589	1589	1589	1589	1589	1589	1593	INDEL	SAMPLE	NUMBER	Insertion And Deletion	Insertion And Deletion	1				
1590	1590	1590	1590	1590	1590	1590	1590	1590	1590	1590	1590	1590	1594	INDEL_SOMATIC_CODING	SAMPLE	NUMBER	Indel Somatic Coding	Indel Somatic Coding	1				
1591	1591	1591	1591	1591	1591	1591	1591	1591	1591	1591	1591	1591	1595	INDEL_SOMATIC_GENOMEWIDE	SAMPLE	NUMBER	Indel Somatic Genomewide	Indel Somatic Genomewide	1				
1592	1592	1592	1592	1592	1592	1592	1592	1592	1592	1592	1592	1592	1596	INDEX_LESION	PATIENT	STRING	Index Lesion	Index Lesion	1				
1593	1593	1593	1593	1593	1593	1593	1593	1593	1593	1593	1593	1593	1597	INDUCTION	PATIENT	STRING	Induction.	Induction	1				
1594	1594	1594	1594	1594	1594	1594	1594	1594	1594	1594	1594	1594	1598	INFERRED_GENOMIC_REARRANGEMENT	SAMPLE	STRING	Inferred genomic rearrangement (from RNA-Seq fusion).	Inferred Genomic Rearrangement	1				
1595	1595	1595	1595	1595	1595	1595	1595	1595	1595	1595	1595	1595	1599	INFERRED_MENOPAUSAL_STATE	PATIENT	STRING	Inferred Menopausal State	Inferred Menopausal State	1				
1596	1596	1596	1596	1596	1596	1596	1596	1596	1596	1596	1596	1596	1600	INFLAMMATORY_STATUS	PATIENT	STRING	Patient-reported response to the question: At any time, were you diagnosed with inflammatory breast cancer?	PRD Ever Inflammatory	1				
1597	1597	1597	1597	1597	1597	1597	1597	1597	1597	1597	1597	1597	1601	INFORMED_CONSENT_VERIFIED	PATIENT	STRING	Informed consent verified	Informed consent verified	1				
1598	1598	1598	1598	1598	1598	1598	1598	1598	1598	1598	1598	1598	1602	INHERITED_GENETIC_SYNDROME_FOUND	PATIENT	STRING	Inherited genetic syndrome found.	Inherited Genetic Syndrome Found	1				
1599	1599	1599	1599	1599	1599	1599	1599	1599	1599	1599	1599	1599	1603	INHERITED_GENETIC_SYNDROME_INDICATOR	PATIENT	STRING	Inherited genetic syndrome found	Inherited genetic syndrome found	1				
1600	1600	1600	1600	1600	1600	1600	1600	1600	1600	1600	1600	1600	1604	INHERITED_GENETIC_SYNDROME_RESULT	PATIENT	STRING	Inherited genetic syndrome result.	Inherited Genetic Syndrome Result	1				
1601	1601	1601	1601	1601	1601	1601	1601	1601	1601	1601	1601	1601	1605	INHERITED_GENETIC_SYNDROME_SPECIFIED	PATIENT	STRING	Inherited genetic syndrome result	Inherited genetic syndrome result	1				
1602	1602	1602	1602	1602	1602	1602	1602	1602	1602	1602	1602	1602	1606	INITIALLY_UNRESECTABLE	PATIENT	STRING	Initially Unresectable	Initially Unresectable	1				
1603	1603	1603	1603	1603	1603	1603	1603	1603	1603	1603	1603	1603	1607	INITIAL_CA_125	PATIENT	STRING	Initial CA-125	Initial CA-125	1				
1604	1604	1604	1604	1604	1604	1604	1604	1604	1604	1604	1604	1604	1608	INITIAL_DEFINITIVE_TREATMENT_DETAILS	PATIENT	STRING	Initial definitive treatment details.	Initial Definitive Treatment Details	1				
1605	1605	1605	1605	1605	1605	1605	1605	1605	1605	1605	1605	1605	1609	INITIAL_DIAGNOSIS_ESOPHAGEAL_CA_TYPE	PATIENT	STRING	Initial diagnosis by	Initial diagnosis by	1				
1606	1606	1606	1606	1606	1606	1606	1606	1606	1606	1606	1606	1606	1610	INITIAL_GRADE	SAMPLE	STRING	Initial Grade	Initial Grade	1				
1607	1607	1607	1607	1607	1607	1607	1607	1607	1607	1607	1607	1607	1611	INITIAL_LN_STATUS	PATIENT	STRING	Initial LN Status	Initial LN Status	1				
1608	1608	1608	1608	1608	1608	1608	1608	1608	1608	1608	1608	1608	1612	INITIAL_MET_DISEASE	SAMPLE	STRING	Indicates whether site(s) of metastatic disease is initial or other.	Indicates whether site(s) of metastatic disease is initial or other.	1				
1609	1609	1609	1609	1609	1609	1609	1609	1609	1609	1609	1609	1609	1613	INITIAL_PATHOLOGIC_DIAGNOSIS_METHOD	PATIENT	STRING	Initial pathologic diagnosis method	Initial pathologic diagnosis method	1				
1610	1610	1610	1610	1610	1610	1610	1610	1610	1610	1610	1610	1610	1614	INITIAL_PATHOLOGIC_DX_YEAR	PATIENT	NUMBER	Numeric value to represent the year of an individual's initial pathologic diagnosis of cancer.	Year Cancer Initial Diagnosis	1				
1611	1611	1611	1611	1611	1611	1611	1611	1611	1611	1611	1611	1611	1615	INITIAL_RX	PATIENT	STRING	Initial Rx	Initial Rx	1				
1612	1612	1612	1612	1612	1612	1612	1612	1612	1612	1612	1612	1612	1616	INITIAL_STAGE	PATIENT	STRING	Initial Stage	Initial Stage	1				
1613	1613	1613	1613	1613	1613	1613	1613	1613	1613	1613	1613	1613	1617	INITIAL_SX_YEAR	PATIENT	NUMBER	The disease initial symptom date.	Initial Symptom (Years)	1				
1614	1614	1614	1614	1614	1614	1614	1614	1614	1614	1614	1614	1614	1618	INITIAL_TNM_STAGE	SAMPLE	STRING	Initial TNM Stage	Initial TNM Stage	1				
1615	1615	1615	1615	1615	1615	1615	1615	1615	1615	1615	1615	1615	1619	INITIAL_TREATMENT	PATIENT	STRING	Initial Treatment	Initial Treatment	1				
1616	1616	1616	1616	1616	1616	1616	1616	1616	1616	1616	1616	1616	1620	INITIAL_TX_RESPONSE	PATIENT	STRING	Initial Treatment Response	Initial Treatment Response	1				
1617	1617	1617	1617	1617	1617	1617	1617	1617	1617	1617	1617	1617	1621	INITIAL_WEIGHT	PATIENT	NUMBER	Weight measured in kilograms.	Initial Patient Weight	1				
1618	1618	1618	1618	1618	1618	1618	1618	1618	1618	1618	1618	1618	1622	INIT_PATHOLOGY_DX_METHOD_OTHER	SAMPLE	STRING	Init Pathology Dx Method Other	Init Pathology Dx Method Other	1				
1619	1619	1619	1619	1619	1619	1619	1619	1619	1619	1619	1619	1619	1623	INSERTION_NUM	SAMPLE	NUMBER	Insertion Number	Insertion Number	1				
1620	1620	1620	1620	1620	1620	1620	1620	1620	1620	1620	1620	1620	1624	INSS_STAGE	PATIENT	STRING	Staging according to the International Neuroblastoma Staging System	INSS Stage	1				
1621	1621	1621	1621	1621	1621	1621	1621	1621	1621	1621	1621	1621	1625	INSTITUTE	SAMPLE	STRING	Institute Source	Institute Source	1				
1622	1622	1622	1622	1622	1622	1622	1622	1622	1622	1622	1622	1622	1626	INSULIN_STATUS	PATIENT	STRING	Insulin Status	Insulin Status	1				
1623	1623	1623	1623	1623	1623	1623	1623	1623	1623	1623	1623	1623	1627	INSULIN_USE	PATIENT	STRING	Insulin use description	Insulin Use	1				
1624	1624	1624	1624	1624	1624	1624	1624	1624	1624	1624	1624	1624	1628	INTCLUST	PATIENT	STRING	Integrative Cluster	Integrative Cluster	1				
1625	1625	1625	1625	1625	1625	1625	1625	1625	1625	1625	1625	1625	1629	INTEGRATED_CLUSTERS_NO_EXP	SAMPLE	STRING	Integrated Clusters (no exp)	Integrated Clusters (no exp)	1				
1626	1626	1626	1626	1626	1626	1626	1626	1626	1626	1626	1626	1626	1630	INTEGRATED_CLUSTERS_UNSUP_EXP	SAMPLE	STRING	Integrated Clusters (unsup exp)	Integrated Clusters (unsup exp)	1				
1627	1627	1627	1627	1627	1627	1627	1627	1627	1627	1627	1627	1627	1631	INTEGRATED_CLUSTERS_WITH_PAM50	SAMPLE	STRING	Integrated Clusters (with PAM50)	Integrated Clusters (with PAM50)	1				
1628	1628	1628	1628	1628	1628	1628	1628	1628	1628	1628	1628	1628	1632	INTERVAL_FROM_INDEX_LESION_TO_PRESENT_LESION	PATIENT	STRING	Interval From Index Lesion to Present Lesion (months)	Interval From Index Lesion to Present Lesion (months)	1				
1629	1629	1629	1629	1629	1629	1629	1629	1629	1629	1629	1629	1629	1633	INTERVAL_FROM_LAST_LESION_TO_STUDY	PATIENT	STRING	Interval From Previous Lesion to Tumor Studied (months)	Interval From Previous Lesion to Tumor Studied (months)	1				
1630	1630	1630	1630	1630	1630	1630	1630	1630	1630	1630	1630	1630	1634	INTERVAL_FROM_PRIMARY_TO_MBC_DX_YEARS	PATIENT	NUMBER	Interval from primary to MBC dx (years)	Interval from primary to MBC dx (years)	1				
1631	1631	1631	1631	1631	1631	1631	1631	1631	1631	1631	1631	1631	1635	INTERVAL_TO_METS	PATIENT	STRING	Interval to Mets	Interval to Mets	1				
1632	1632	1632	1632	1632	1632	1632	1632	1632	1632	1632	1632	1632	1636	INTESTINAL_PERCENTAGE	SAMPLE	NUMBER	% Intestinal	% Intestinal	1				
1633	1633	1633	1633	1633	1633	1633	1633	1633	1633	1633	1633	1633	1637	INTESTINAL_TYPE_SUBCLASS	PATIENT	STRING	Intestinal type subclass.	Intestinal Type Subclass	1				
1634	1634	1634	1634	1634	1634	1634	1634	1634	1634	1634	1634	1634	1638	INTRANSIT_DESC	SAMPLE	STRING	Describes site of first recurrence of patient�۪s primary melanoma.  Indicates if there are regional metastases greater than 2 cm from primary melanoma.	Regional Metastases Greater Than 2 cm From Primary Tumor	1				
1635	1635	1635	1635	1635	1635	1635	1635	1635	1635	1635	1635	1635	1639	INTRATUBULAR_GERM_CELL_NEOPLASM	PATIENT	STRING	Intratubular germ cell neoplasm	Intratubular germ cell neoplasm	1				
1636	1636	1636	1636	1636	1636	1636	1636	1636	1636	1636	1636	1636	1640	INTRA_TUMORAL_HETEROGENEITY	SAMPLE	STRING	Intra-tumoral Heterogeneity Y/N	Intra-tumoral Heterogeneity	1				
1637	1637	1637	1637	1637	1637	1637	1637	1637	1637	1637	1637	1637	1641	INT_ID	PATIENT	STRING	INT-ID.	INT-ID	1				
1638	1638	1638	1638	1638	1638	1638	1638	1638	1638	1638	1638	1638	1642	INVADED_STRUCTURES	SAMPLE	STRING	Invaded Structures	Invaded Structures	1				
1639	1639	1639	1639	1639	1639	1639	1639	1639	1639	1639	1639	1639	1643	INVADE_BONE	PATIENT	STRING	Invade Bone	Invade Bone	1				
1640	1640	1640	1640	1640	1640	1640	1640	1640	1640	1640	1640	1640	1644	INVADE_LARGER_THAN_SUBCUTANEOUS_TISSUE	SAMPLE	STRING	Invade > Subcutaneous Tissue	Invade > Subcutaneous Tissue	1				
1641	1641	1641	1641	1641	1641	1641	1641	1641	1641	1641	1641	1641	1645	INVADE_PAROTID	PATIENT	STRING	Invade Parotid	Invade Parotid	1				
1642	1642	1642	1642	1642	1642	1642	1642	1642	1642	1642	1642	1642	1646	INVADE_SKULL_BASE	PATIENT	STRING	Invade Skull Base	Invade Skull Base	1				
1643	1643	1643	1643	1643	1643	1643	1643	1643	1643	1643	1643	1643	1647	INVASION_DEPTH	SAMPLE	STRING	Invasion depth (mm).	Invasion Depth (mm)	1				
1644	1644	1644	1644	1644	1644	1644	1644	1644	1644	1644	1644	1644	1648	INVASIVE	SAMPLE	STRING	Invasive or not (Y/N)	Invasive	1				
1645	1645	1645	1645	1645	1645	1645	1645	1645	1645	1645	1645	1645	1649	INVASIVE_ADENOCARCINOMA_INDICATOR	SAMPLE	STRING	Text term to indicate a histologic diagnosis of invasive adenocarcinoma in a tissue specimen.	Invasive Adenocarcinoma Histology Diagnosis Indicator	1				
1646	1646	1646	1646	1646	1646	1646	1646	1646	1646	1646	1646	1646	1650	INVASIVE_TUMOR_PERCENTAGE	SAMPLE	NUMBER	% Invasive Tumor	% Invasive Tumor	1				
1647	1647	1647	1647	1647	1647	1647	1647	1647	1647	1647	1647	1647	1651	INVESTIGATOR_PATIENT_ID	PATIENT	STRING	Investigator Patient ID	Investigator Patient ID	1				
1648	1648	1648	1648	1648	1648	1648	1648	1648	1648	1648	1648	1648	1652	INVESTIGATOR_SAMPLE_ID	SAMPLE	STRING	Investigator Sample ID	Investigator Sample ID	1				
1649	1649	1649	1649	1649	1649	1649	1649	1649	1649	1649	1649	1649	1653	INV_16	SAMPLE	STRING	inv(16) gene fusion status	inv(16)	1				
1650	1650	1650	1650	1650	1650	1650	1650	1650	1650	1650	1650	1650	1654	INV_3	SAMPLE	STRING	inv(3)	inv(3)	1				
1651	1651	1651	1651	1651	1651	1651	1651	1651	1651	1651	1651	1651	1655	IN_FRAME_DELETION	SAMPLE	STRING	In frame Deletion	In frame Deletion	1				
1652	1652	1652	1652	1652	1652	1652	1652	1652	1652	1652	1652	1652	1656	IN_FRAME_INSERTION	SAMPLE	STRING	In frame Insertion	In frame Insertion	1				
1653	1653	1653	1653	1653	1653	1653	1653	1653	1653	1653	1653	1653	1657	IN_TRANSIT	PATIENT	STRING	In Transit	In Transit	1				
1654	1654	1654	1654	1654	1654	1654	1654	1654	1654	1654	1654	1654	1658	IO_EBV_TESTED	SAMPLE	STRING	IO EBV Tested	IO EBV Tested	1				
1655	1655	1655	1655	1655	1655	1655	1655	1655	1655	1655	1655	1655	1659	IO_EGC_SURVIVAL_OS_MONTHS_START_OF_IO_TO_DATE_OF_DEATH_LAST_FOLLOW_UP	SAMPLE	STRING	EGC Overall Survival from start of IO to date of death/follow up/POD	EGC Overall Survival from start of IO to date of death/follow up/POD	1				
1656	1656	1656	1656	1656	1656	1656	1656	1656	1656	1656	1656	1656	1660	IO_MUT_GROUPS	SAMPLE	STRING	IO Mutation Group	IO Mutation Group	1				
1657	1657	1657	1657	1657	1657	1657	1657	1657	1657	1657	1657	1657	1661	IO_OS_MONTHS_START_OF_IO	PATIENT	NUMBER	IO OS Months From Start of IO	IO OS Months From Start of IO	1				
1658	1658	1658	1658	1658	1658	1658	1658	1658	1658	1658	1658	1658	1662	IO_PDL1_TESTED	SAMPLE	STRING	IO PDL1 Tested	IO PDL1 Tested	1				
1659	1659	1659	1659	1659	1659	1659	1659	1659	1659	1659	1659	1659	1663	IO_PFS_MONTHS_START_OF_IO_TO_POD	PATIENT	NUMBER	IO PFS from Start of IO to POD	IO PFS from Start of IO to POD	1				
1660	1660	1660	1660	1660	1660	1660	1660	1660	1660	1660	1660	1660	1664	IO_PFS_STATUS	PATIENT	STRING	IO Progression Free Status	IO Progression Free Status	1				
1661	1661	1661	1661	1661	1661	1661	1661	1661	1661	1661	1661	1661	1665	IO_REGIMEN_MONOTHERAPY_VS_COMBINATION	SAMPLE	STRING	IO Regimen Monotherapy Vs Combination	IO Regimen Monotherapy Vs Combination	1				
1662	1662	1662	1662	1662	1662	1662	1662	1662	1662	1662	1662	1662	1666	IO_RESPONSE	SAMPLE	STRING	IO Response	IO Response	1				
1663	1663	1663	1663	1663	1663	1663	1663	1663	1663	1663	1663	1663	1667	IPI	PATIENT	NUMBER	International Prognostic Index (IPI)	IPI	1				
1664	1664	1664	1664	1664	1664	1664	1664	1664	1664	1664	1664	1664	1668	IPILIMUMAB_DOSE_MG_PER_KG	PATIENT	STRING	Ipilimumab dose (mg/kg)	Ipilimumab dose (mg/kg)	1				
1665	1665	1665	1665	1665	1665	1665	1665	1665	1665	1665	1665	1665	1669	IPSS_SCORE	PATIENT	STRING	IPSS (the International Prognostic Scoring System) Score	IPSS Score	1				
1666	1666	1666	1666	1666	1666	1666	1666	1666	1666	1666	1666	1666	1670	IRB	PATIENT	STRING	IRB	IRB	1				
1667	1667	1667	1667	1667	1667	1667	1667	1667	1667	1667	1667	1667	1671	ISCN	PATIENT	STRING	ISCN.	ISCN	1				
1668	1668	1668	1668	1668	1668	1668	1668	1668	1668	1668	1668	1668	1672	ISHAK_FIBROSIS_SCORE	PATIENT	STRING	Liver fibrosis ishak score category	Liver fibrosis ishak score category	1				
1669	1669	1669	1669	1669	1669	1669	1669	1669	1669	1669	1669	1669	1673	ISOPURE_PURITY	SAMPLE	NUMBER	ISOpure Purity	ISOpure Purity	1				
1670	1670	1670	1670	1670	1670	1670	1670	1670	1670	1670	1670	1670	1674	IS_FFPE	SAMPLE	STRING	If the sample is from FFPE	Is FFPE	1				
1671	1671	1671	1671	1671	1671	1671	1671	1671	1671	1671	1671	1671	1675	I_131_RADIATION_FIRST_TX_DOSE	PATIENT	STRING	I 131 first administered dose	I 131 radiation first tx dose	1				
1672	1672	1672	1672	1672	1672	1672	1672	1672	1672	1672	1672	1672	1676	I_131_RADIATION_FIRST_TX_METHOD	PATIENT	STRING	I 131 total administered preparation technique	I 131 radiation first tx method	1				
1673	1673	1673	1673	1673	1673	1673	1673	1673	1673	1673	1673	1673	1677	I_131_RADIATION_SUBSEQUENT_TX	PATIENT	STRING	I 131 subsequent administered dose	I 131 radiation subsequent tx	1				
1674	1674	1674	1674	1674	1674	1674	1674	1674	1674	1674	1674	1674	1678	I_131_RADIATION_TX_CUMULATIVE_DOSE	PATIENT	NUMBER	I 131 total administered dose	I 131 radiation tx cumulative dose	1				
1675	1675	1675	1675	1675	1675	1675	1675	1675	1675	1675	1675	1675	1679	JAK2_NEGATIVE	SAMPLE	STRING	JAK2 Negative	JAK2 Negative	1				
1676	1676	1676	1676	1676	1676	1676	1676	1676	1676	1676	1676	1676	1680	JAK2_POSITIVE	SAMPLE	STRING	JAK2 Positive	JAK2 Positive	1				
1677	1677	1677	1677	1677	1677	1677	1677	1677	1677	1677	1677	1677	1681	JAUNDICE	PATIENT	STRING	Jaundice	Jaundice	1				
1678	1678	1678	1678	1678	1678	1678	1678	1678	1678	1678	1678	1678	1682	JEWISH_RELIGION_HERITAGE_INDICATOR	PATIENT	STRING	Text names for Jewish heritage categories for a patient/participant on a clinical trial.	Patient Jewish Heritage Text Category	1				
1679	1679	1679	1679	1679	1679	1679	1679	1679	1679	1679	1679	1679	1683	KAPPA_OR_LAMBDA	SAMPLE	STRING	Kappa or Lambda	Kappa or Lambda	1				
1680	1680	1680	1680	1680	1680	1680	1680	1680	1680	1680	1680	1680	1684	KARNOFSKY_PERFORMANCE_SCORE	PATIENT	NUMBER	Score from the Karnofsky Performance status scale, representing the functional capabilities of a person.	Karnofsky Performance Score	1				
1681	1681	1681	1681	1681	1681	1681	1681	1681	1681	1681	1681	1681	1685	KARYOTYPE	PATIENT	STRING	Karyotype.	Karyotype	1				
1682	1682	1682	1682	1682	1682	1682	1682	1682	1682	1682	1682	1682	1686	KATABI_PATH	PATIENT	STRING	Katabi path.	Katabi Path	1				
1683	1683	1683	1683	1683	1683	1683	1683	1683	1683	1683	1683	1683	1687	KBASE_ID	PATIENT	STRING	Kbase Identifier	Kbase Identifier	1				
1684	1684	1684	1684	1684	1684	1684	1684	1684	1684	1684	1684	1684	1688	KDM6A_MUTATION	SAMPLE	STRING	KDM6A mutation is present	KDM6A mutation	1				
1685	1685	1685	1685	1685	1685	1685	1685	1685	1685	1685	1685	1685	1689	KERATINIZATION_SQUAMOUS_CELL	PATIENT	STRING	Keratinizing squamous cell carcinoma present indicator	Keratinizing squamous cell carcinoma present indicator	1				
1686	1686	1686	1686	1686	1686	1686	1686	1686	1686	1686	1686	1686	1690	KITI_AGENT	PATIENT	STRING	KIT inhibitor type	KIT inhibitor type	1				
1687	1687	1687	1687	1687	1687	1687	1687	1687	1687	1687	1687	1687	1691	KIT_INHIBITOR	PATIENT	STRING	KIT Inhibitor	KIT Inhibitor	1				
1688	1688	1688	1688	1688	1688	1688	1688	1688	1688	1688	1688	1688	1692	KIT_LEVEL_2A	SAMPLE	STRING	KIT Level 2A	KIT Level 2A	1				
1689	1689	1689	1689	1689	1689	1689	1689	1689	1689	1689	1689	1689	1693	KIT_NEGATIVE	SAMPLE	STRING	Negative for KIT	Negative for KIT	1				
1690	1690	1690	1690	1690	1690	1690	1690	1690	1690	1690	1690	1690	1694	KIT_POSITIVE	SAMPLE	STRING	Positive for KIT	Positive for KIT	1				
1691	1691	1691	1691	1691	1691	1691	1691	1691	1691	1691	1691	1691	1695	KI_67	PATIENT	STRING	KI 67	KI 67	1				
1692	1692	1692	1692	1692	1692	1692	1692	1692	1692	1692	1692	1692	1696	KMT2A_MUTATION	SAMPLE	STRING	KMT2A mutation is present	KMT2A mutation	1				
1693	1693	1693	1693	1693	1693	1693	1693	1693	1693	1693	1693	1693	1697	KMT2B_MUTATION_STATUS	SAMPLE	STRING	KMT2B Mutation Status	KMT2B Mutation Status	1				
1694	1694	1694	1694	1694	1694	1694	1694	1694	1694	1694	1694	1694	1698	KMT2C_MUT	SAMPLE	NUMBER	KMT2C Mutation	KMT2C Mutation	1				
1695	1695	1695	1695	1695	1695	1695	1695	1695	1695	1695	1695	1695	1699	KMT2D_MUTATION	SAMPLE	STRING	KMT2D Mutation	KMT2D Mutation	1				
1696	1696	1696	1696	1696	1696	1696	1696	1696	1696	1696	1696	1696	1700	KNOWN_EXPOSURES	PATIENT	STRING	Known exposures	Known exposures	1				
1697	1697	1697	1697	1697	1697	1697	1697	1697	1697	1697	1697	1697	1701	KNOWN_MOLECULAR_CLASSIFIER	PATIENT	STRING	Known Molecular Classifier	Known Molecular Classifier	1				
1698	1698	1698	1698	1698	1698	1698	1698	1698	1698	1698	1698	1698	1702	KNOWN_MOLECULAR_CLASSIFIER_FINAL	PATIENT	STRING	Known Molecular Classifier Final	Known Molecular Classifier Final	1				
1699	1699	1699	1699	1699	1699	1699	1699	1699	1699	1699	1699	1699	1703	KNOWN_MOLECULAR_CLASSIFIER_PRIMARY	SAMPLE	STRING	Known Molecular Classifier Primary	Known Molecular Classifier Primary	1				
1700	1700	1700	1700	1700	1700	1700	1700	1700	1700	1700	1700	1700	1704	KRAS_CELLULARITY	SAMPLE	NUMBER	KRAS Cellularity	KRAS Cellularity	1				
1701	1701	1701	1701	1701	1701	1701	1701	1701	1701	1701	1701	1701	1705	KRAS_GENE_ANALYSIS_INDICATOR	PATIENT	STRING	Kras gene analysis indicator	Kras gene analysis indicator	1				
1702	1702	1702	1702	1702	1702	1702	1702	1702	1702	1702	1702	1702	1706	KRAS_MUTATION	SAMPLE	STRING	KRAS mutation is present.	KRAS Mutation	1				
1703	1703	1703	1703	1703	1703	1703	1703	1703	1703	1703	1703	1703	1707	KRAS_MUTATION_IDENTIFIED_TYPE	PATIENT	STRING	Kras mutation identified type	Kras mutation identified type	1				
1704	1704	1704	1704	1704	1704	1704	1704	1704	1704	1704	1704	1704	1708	KRAS_PROTEIN_CODING	SAMPLE	NUMBER	KRAS Protein Coding	KRAS Protein Coding	1				
1705	1705	1705	1705	1705	1705	1705	1705	1705	1705	1705	1705	1705	1709	KSHV_HHV8_TEST	PATIENT	STRING	Kaposi Sarcoma - Human Herpesvirus 8 Test	Kaposi Sarcoma - Human Herpesvirus 8 Test	1				
1706	1706	1706	1706	1706	1706	1706	1706	1706	1706	1706	1706	1706	1710	LARGEST_METASTATIC_BURDEN	PATIENT	STRING	Largest Metastatic Burden	Largest Metastatic Burden	1				
1707	1707	1707	1707	1707	1707	1707	1707	1707	1707	1707	1707	1707	1711	LARGEST_SIZE	PATIENT	STRING	Largest Size	Largest Size	1				
1708	1708	1708	1708	1708	1708	1708	1708	1708	1708	1708	1708	1708	1712	LARGE_DELETION_NUM	SAMPLE	NUMBER	Large Deletion Number	Large Deletion Number	1				
1709	1709	1709	1709	1709	1709	1709	1709	1709	1709	1709	1709	1709	1713	LAST_CONTACT_DAYS_TO	PATIENT	NUMBER	Time interval from a person's date of death to the date of initial pathologic diagnosis.	Last Communication Contact	1				
1710	1710	1710	1710	1710	1710	1710	1710	1710	1710	1710	1710	1710	1714	LAST_FOLLOWUP_FUDR_START	PATIENT	NUMBER	Last Follow Up Since Fudr Start (Months)	Last Follow Up Since Fudr Start (Months)	1				
1711	1711	1711	1711	1711	1711	1711	1711	1711	1711	1711	1711	1711	1715	LAST_FOLLOWUP_STATUS	PATIENT	STRING	Last Followup Status	Last Followup Status	1				
1712	1712	1712	1712	1712	1712	1712	1712	1712	1712	1712	1712	1712	1716	LAST_FOLLOWUP_YEAR	PATIENT	STRING	Year of Last Followup	Year of Last Followup	1				
1713	1713	1713	1713	1713	1713	1713	1713	1713	1713	1713	1713	1713	1717	LAST_STATUS	PATIENT	STRING	Last Status.	Last Status	1				
1714	1714	1714	1714	1714	1714	1714	1714	1714	1714	1714	1714	1714	1718	LAST_TREATMENT_REGIMEN	PATIENT	STRING	Last Treatment Regimen	Last Treatment Regimen	1				
1715	1715	1715	1715	1715	1715	1715	1715	1715	1715	1715	1715	1715	1719	LATERALITY	PATIENT	STRING	For tumors in paired organs, designates the side on which the cancer originates.	Primary Tumor Laterality	1				
1716	1716	1716	1716	1716	1716	1716	1716	1716	1716	1716	1716	1716	1720	LATERALITY_OF_SECOND_PRIMARY_TUMOR	SAMPLE	STRING	Laterality of Second Primary Tumor	Laterality of Second Primary Tumor	1				
1717	1717	1717	1717	1717	1717	1717	1717	1717	1717	1717	1717	1717	1721	LATERALITY_OF_UNDESCENT	SAMPLE	STRING	Laterality of undescent	Laterality of undescent	1				
1718	1718	1718	1718	1718	1718	1718	1718	1718	1718	1718	1718	1718	1722	LAUREN_CLASS	PATIENT	STRING	Lauren class.	Lauren Class	1				
1719	1719	1719	1719	1719	1719	1719	1719	1719	1719	1719	1719	1719	1723	LDH_LEVEL	SAMPLE	STRING	Information related to the result of the medical procedure that involves testing a sample of blood for lactic dehydrogenase, a family of homotetrameric cytoplasmic enzymes involved in the conversion of L-lactate and NAD to pyruvate and NADH in the final step of anaerobic glycolysis.	Laboratory Procedure Lactate Dehydrogenase Result	1				
1720	1720	1720	1720	1720	1720	1720	1720	1720	1720	1720	1720	1720	1724	LDH_NORM_RANGE_UPPER	SAMPLE	STRING	Ldh upper limit	Ldh upper limit	1				
1721	1721	1721	1721	1721	1721	1721	1721	1721	1721	1721	1721	1721	1725	LDH_U_L	SAMPLE	STRING	ldh (u/l)	ldh (u/l)	1				
1722	1722	1722	1722	1722	1722	1722	1722	1722	1722	1722	1722	1722	1726	LDH_YEAR	SAMPLE	NUMBER	LDH Year	LDH Year	1				
1723	1723	1723	1723	1723	1723	1723	1723	1723	1723	1723	1723	1723	1727	LEIOMYOSARCOMA_HISTOLOGIC_SUBTYPE	SAMPLE	STRING	Text field to describe the subtype of leiomyosarcoma.	Leiomyosarcoma Histologic Subtype	1				
1724	1724	1724	1724	1724	1724	1724	1724	1724	1724	1724	1724	1724	1728	LEIOMYOSARCOMA_UTERINE_INVOLVEMENT	PATIENT	STRING	Primary tumor lower uterus segment	Leiomyosarcoma uterine involvement	1				
1725	1725	1725	1725	1725	1725	1725	1725	1725	1725	1725	1725	1725	1729	LEIOMYO_MAJOR_VESSEL_INVOLVEMENT	PATIENT	STRING	Leiomyosarcoma major vessel involvement	Leiomyo major vessel involvement	1				
1726	1726	1726	1726	1726	1726	1726	1726	1726	1726	1726	1726	1726	1730	LEUKEMIA_TYPE	SAMPLE	STRING	Leukemia Type	Leukemia Type	1				
1727	1727	1727	1727	1727	1727	1727	1727	1727	1727	1727	1727	1727	1731	LEUKOCYTE_FRACTION	SAMPLE	NUMBER	leukocyte_fraction	Leukocyte Fraction	1				
1728	1728	1728	1728	1728	1728	1728	1728	1728	1728	1728	1728	1728	1732	LEUKOCYTE_INDEX_METHYLATION	SAMPLE	NUMBER	Leukocyte Index Methylation	Leukocyte Index Methylation	1				
1729	1729	1729	1729	1729	1729	1729	1729	1729	1729	1729	1729	1729	1733	LEVEL_OF_NON_DESCENT	PATIENT	STRING	Level of non descent	Level of non descent	1				
1730	1730	1730	1730	1730	1730	1730	1730	1730	1730	1730	1730	1730	1734	LIGHT_CHAIN	SAMPLE	STRING	Light chain.	Light Chain	1				
1731	1731	1731	1731	1731	1731	1731	1731	1731	1731	1731	1731	1731	1735	LINES_OF_TX	PATIENT	STRING	Lines of treatment	Lines of treatment	1				
1732	1732	1732	1732	1732	1732	1732	1732	1732	1732	1732	1732	1732	1736	LINES_OF_TX_PRIOR_IMPACT	SAMPLE	STRING	Number Treatment Lines Prior To Receiving Impact Results	Number Treatment Lines Prior To Receiving Impact Results	1				
1733	1733	1733	1733	1733	1733	1733	1733	1733	1733	1733	1733	1733	1737	LIVER_FIBROSIS	PATIENT	STRING	Fibrosis in non-cacerous liver tissue is determined according to the New Inuyama Classification.	Fibrosis in non-cacerous liver tissue is determined according to the New Inuyama Classification.	1				
1734	1734	1734	1734	1734	1734	1734	1734	1734	1734	1734	1734	1734	1738	LIVER_INVOLVEMENT	PATIENT	STRING	Liver Involvement	Liver Involvement	1				
1735	1735	1735	1735	1735	1735	1735	1735	1735	1735	1735	1735	1735	1739	LIVER_PROGRESSION	PATIENT	STRING	Liver Progression	Liver Progression	1				
1736	1736	1736	1736	1736	1736	1736	1736	1736	1736	1736	1736	1736	1740	LNCLIN_STS_DES	SAMPLE	STRING	Indicates whether nonsentinel (macroscopic) lymph nodes are clinically palpable or absent at MSKCC presentation.  Does not pertain to sentinel lymph nodes because they are never clinically palpable.	Nonsentinel Lymph Nodes are Clinically Palpable or Absent	1				
1737	1737	1737	1737	1737	1737	1737	1737	1737	1737	1737	1737	1737	1741	LNDSCT_CMP_DES	SAMPLE	STRING	Indicates if complete lymph node dissection was performed.	Lymph Node Dissection Performed	1				
1738	1738	1738	1738	1738	1738	1738	1738	1738	1738	1738	1738	1738	1742	LNDSCT_YEAR	SAMPLE	NUMBER	Year when complete lymph node dissection was performed.	Year Lymph Node Dissection Performed	1				
1739	1739	1739	1739	1739	1739	1739	1739	1739	1739	1739	1739	1739	1743	LNEXTNODST_DES	SAMPLE	STRING	Indicates if extranodal soft tissue extension is present or absent (synonymous with matted nodes).	Extranodal Soft Tissue Extension Present	1				
1740	1740	1740	1740	1740	1740	1740	1740	1740	1740	1740	1740	1740	1744	LNI	SAMPLE	STRING	Lymph Node Invovlement	LNI	1				
1741	1741	1741	1741	1741	1741	1741	1741	1741	1741	1741	1741	1741	1745	LNIHC_DESC	SAMPLE	STRING	Indicates whether there is evidence of melanoma using immunohistochemistry.	Evidence Of Melanoma Using Immunohistochemistry	1				
1742	1742	1742	1742	1742	1742	1742	1742	1742	1742	1742	1742	1742	1746	LNIMMHMB45_DES	SAMPLE	STRING	Indicates if HMB45 stain shows melanoma in lymph node.	Hmb45 Stain Shows Melanoma In Lymph Node	1				
1743	1743	1743	1743	1743	1743	1743	1743	1743	1743	1743	1743	1743	1747	LNIMM_MELA_DES	SAMPLE	STRING	Indicates if Melan-A (Mart-1) stain shows melanoma in lymph node.	Melan-A (Mart-1) Stain Shows Melanoma In Lymph Node	1				
1744	1744	1744	1744	1744	1744	1744	1744	1744	1744	1744	1744	1744	1748	LNINTRMETS_DES	SAMPLE	STRING	Indicates if patient has regionally recurrent skin metastases at initial presentation.	Patient has Regionally Recurrent Skin Metastases at Initial Presentation	1				
1745	1745	1745	1745	1745	1745	1745	1745	1745	1745	1745	1745	1745	1749	LNMATTED_DESC	SAMPLE	STRING	Indicates the presence or absence of matted lymph nodes (synonymous with extranodal extension).	Presence or Absence of Matted Lymph Nodes	1				
1746	1746	1746	1746	1746	1746	1746	1746	1746	1746	1746	1746	1746	1750	LNPROLYSCT_DES	SAMPLE	STRING	Indicates if lymphoscintigraphy has been performed.	Lymphoscintigraphy Performed	1				
1747	1747	1747	1747	1747	1747	1747	1747	1747	1747	1747	1747	1747	1751	LNPROSUCC_DESC	SAMPLE	STRING	Indicates if lymphoscintigraphy was successful.	Lymphoscintigraphy Successful	1				
1748	1748	1748	1748	1748	1748	1748	1748	1748	1748	1748	1748	1748	1752	LNSENTINBX_DES	SAMPLE	STRING	Indicates if sentinel node biopsy was performed as part of patient�۪s initial diagnosis.	Sentinel Node Biopsy Performed	1				
1749	1749	1749	1749	1749	1749	1749	1749	1749	1749	1749	1749	1749	1753	LNSENTINBX_YEA	SAMPLE	NUMBER	Year when sentinel node biopsy was performed.	Year Sentinel Node Biopsy Performed	1				
1750	1750	1750	1750	1750	1750	1750	1750	1750	1750	1750	1750	1750	1754	LNSIZE	SAMPLE	STRING	Size of the largest clinically positive lymph node removed (cm)	Size Of The Largest Clinically Positive Lymph Node Removed (cm)	1				
1751	1751	1751	1751	1751	1751	1751	1751	1751	1751	1751	1751	1751	1755	LNSIZE_UNK_DES	SAMPLE	STRING	Indicates if size of lymph node is unknown.	Indicates If Size Of Lymph Node Is Unknown	1				
1752	1752	1752	1752	1752	1752	1752	1752	1752	1752	1752	1752	1752	1756	LNSLNLARG_SIZE	SAMPLE	STRING	Indicates the size of the largest sentinel lymph node.	Size Of The Largest Sentinel Lymph Node	1				
1753	1753	1753	1753	1753	1753	1753	1753	1753	1753	1753	1753	1753	1757	LN_METASTASIS_2CAT	SAMPLE	STRING	LT metastasis 2CAT.	LN Metastasis 2CAT	1				
1754	1754	1754	1754	1754	1754	1754	1754	1754	1754	1754	1754	1754	1758	LN_METS	PATIENT	STRING	LN mets.	LN Mets	1				
1755	1755	1755	1755	1755	1755	1755	1755	1755	1755	1755	1755	1755	1759	LOCALIZED_VS_METS_AT_DX	PATIENT	STRING	Localized or Metastaic at Diagnosis	Localized or Metastaic at Diagnosis	1				
1756	1756	1756	1756	1756	1756	1756	1756	1756	1756	1756	1756	1756	1760	LOCAL_DESC	SAMPLE	STRING	Describes site of first recurrence of patient�۪s primary melanoma.  Indicates whether locally recurrent disease within 2 cm of primary melanoma.	Locally Recurrent Disease Within 2 Cm Of Primary Tumor	1				
1757	1757	1757	1757	1757	1757	1757	1757	1757	1757	1757	1757	1757	1761	LOCAL_RECCURENCE_OR_DISTANT_MET	PATIENT	STRING	Local reccurence or distant met	Local reccurence or distant met	1				
1758	1758	1758	1758	1758	1758	1758	1758	1758	1758	1758	1758	1758	1762	LOCAL_RECURRENCE	PATIENT	STRING	Local recurrence.	Local Recurrence	1				
1759	1759	1759	1759	1759	1759	1759	1759	1759	1759	1759	1759	1759	1763	LOCAL_RECURRENCE_MONTHS	PATIENT	NUMBER	Local recurrence (months).	Local Recurrence (months)	1				
1760	1760	1760	1760	1760	1760	1760	1760	1760	1760	1760	1760	1760	1764	LOCAL_RECURRENCE_NUM	PATIENT	NUMBER	Number of Local Recurrence	Number of Local Recurrence	1				
1761	1761	1761	1761	1761	1761	1761	1761	1761	1761	1761	1761	1761	1765	LOCAL_RECURRENCE_PRIOR_TO_DISTANT	SAMPLE	STRING	Local Recurrence Prior to Distant	Local Recurrence Prior to Distant	1				
1762	1762	1762	1762	1762	1762	1762	1762	1762	1762	1762	1762	1762	1766	LOCAL_RECURRENCE_YEAR	SAMPLE	NUMBER	Local Recurrence Year	Local Recurrence Year	1				
1763	1763	1763	1763	1763	1763	1763	1763	1763	1763	1763	1763	1763	1767	LOCAL_REGIONAL_DISEASE_AT_DIAGNOSIS	PATIENT	STRING	Local Regional Disease at Diagnosis	Local Regional Disease at Diagnosis	1				
1764	1764	1764	1764	1764	1764	1764	1764	1764	1764	1764	1764	1764	1768	LOCAL_REGIONAL_RECURENCE	PATIENT	STRING	Positive or negative for local-regional recurrence	Local-regional Recurrence	1				
1765	1765	1765	1765	1765	1765	1765	1765	1765	1765	1765	1765	1765	1769	LOCAL_REGIONAL_RECURRENCE	PATIENT	STRING	Local Regional Recurrence	Local Regional Recurrence	1				
1766	1766	1766	1766	1766	1766	1766	1766	1766	1766	1766	1766	1766	1770	LOCAL_RFS_MONTHS	PATIENT	NUMBER	local recurrence free survival (months)	local recurrence free survival (months)	1				
1767	1767	1767	1767	1767	1767	1767	1767	1767	1767	1767	1767	1767	1771	LOCAL_TEST	SAMPLE	STRING	Local Test	Local Test	1				
1768	1768	1768	1768	1768	1768	1768	1768	1768	1768	1768	1768	1768	1772	LOCATION	PATIENT	STRING	Location	Location	1				
1769	1769	1769	1769	1769	1769	1769	1769	1769	1769	1769	1769	1769	1773	LOCATION_LUNG_PARENCHYMA	PATIENT	STRING	Location lung parenchyma	Location lung parenchyma	1				
1770	1770	1770	1770	1770	1770	1770	1770	1770	1770	1770	1770	1770	1774	LOCOREGIONAL_RECURRENCE_INDICATOR	PATIENT	STRING	Local disease recurrence	Locoregional recurrence indicator	1				
1771	1771	1771	1771	1771	1771	1771	1771	1771	1771	1771	1771	1771	1775	LOCO_REG_MONTHS	PATIENT	NUMBER	Locolized Reg (Months)	Locolized Reg (Months)	1				
1772	1772	1772	1772	1772	1772	1772	1772	1772	1772	1772	1772	1772	1776	LOCO_REG_STATUS	PATIENT	STRING	Locolized Reg Status	Locolized Reg Status	1				
1773	1773	1773	1773	1773	1773	1773	1773	1773	1773	1773	1773	1773	1777	LONGEST_DIMENSION	SAMPLE	NUMBER	Longest Dimension	Longest Dimension	1				
1774	1774	1774	1774	1774	1774	1774	1774	1774	1774	1774	1774	1774	1778	LOSS_OF_HER2	SAMPLE	STRING	Loss of HER2	Loss of HER2	1				
1775	1775	1775	1775	1775	1775	1775	1775	1775	1775	1775	1775	1775	1779	LOST_TO_FOLLOWUP	PATIENT	STRING	Lost To Followup	Lost To Followup	1				
1776	1776	1776	1776	1776	1776	1776	1776	1776	1776	1776	1776	1776	1780	LOWPASS	SAMPLE	STRING	Lowpass WGS sequenced sample	Lowpass WGS Sequenced Sample	1				
1777	1777	1777	1777	1777	1777	1777	1777	1777	1777	1777	1777	1777	1781	LOW_GRADE_HISTORY	PATIENT	STRING	Low grade history.	Low Grade History	1				
1778	1778	1778	1778	1778	1778	1778	1778	1778	1778	1778	1778	1778	1782	LST	SAMPLE	NUMBER	LST	LST	1				
1779	1779	1779	1779	1779	1779	1779	1779	1779	1779	1779	1779	1779	1783	LVI	PATIENT	STRING	Lvi	Lvi	1				
1780	1780	1780	1780	1780	1780	1780	1780	1780	1780	1780	1780	1780	1784	LYMPHOCYTE_INFILTRATION	SAMPLE	STRING	Lymphocyte Infiltration	Lymphocyte Infiltration	1				
1781	1781	1781	1781	1781	1781	1781	1781	1781	1781	1781	1781	1781	1785	LYMPHOVASCULAR_INVASION_INDICATOR	PATIENT	STRING	Lymphovascular invasion indicator	Lymphovascular invasion indicator	1				
1782	1782	1782	1782	1782	1782	1782	1782	1782	1782	1782	1782	1782	1786	LYMPHOVASCULAR_INVASION_PRESENT	SAMPLE	STRING	Lymphovascular invasion present	Lymphovascular invasion present	1				
1783	1783	1783	1783	1783	1783	1783	1783	1783	1783	1783	1783	1783	1787	LYMPHOVASCULAR_INVOLVEMENT	PATIENT	STRING	Lymphovascular invasion indicator	Lymphovascular involvement	1				
1784	1784	1784	1784	1784	1784	1784	1784	1784	1784	1784	1784	1784	1788	LYMPH_NODES	PATIENT	STRING	Lymph Nodes	Lymph Nodes	1				
1785	1785	1785	1785	1785	1785	1785	1785	1785	1785	1785	1785	1785	1789	LYMPH_NODES_AORTIC_EXAMINED_COUNT	SAMPLE	NUMBER	Lymph nodes aortic examined count	Lymph nodes aortic examined count	1				
1786	1786	1786	1786	1786	1786	1786	1786	1786	1786	1786	1786	1786	1790	LYMPH_NODES_AORTIC_POS_BY_HE	SAMPLE	NUMBER	Lymph nodes aortic pos by he	Lymph nodes aortic pos by he	1				
1787	1787	1787	1787	1787	1787	1787	1787	1787	1787	1787	1787	1787	1791	LYMPH_NODES_AORTIC_POS_BY_IHC	SAMPLE	NUMBER	Lymph nodes aortic pos by ihc	Lymph nodes aortic pos by ihc	1				
1788	1788	1788	1788	1788	1788	1788	1788	1788	1788	1788	1788	1788	1792	LYMPH_NODES_AORTIC_POS_TOTAL	SAMPLE	NUMBER	Lymph nodes aortic pos total	Lymph nodes aortic pos total	1				
1789	1789	1789	1789	1789	1789	1789	1789	1789	1789	1789	1789	1789	1793	LYMPH_NODES_EXAMINED	PATIENT	STRING	the yes/no/unknown indicator whether a lymph node assessment was performed at the primary presentation of disease.	Primary Lymph Node Presentation Assessment Ind-3	1				
1790	1790	1790	1790	1790	1790	1790	1790	1790	1790	1790	1790	1790	1794	LYMPH_NODES_EXAMINED_HE_COUNT	PATIENT	NUMBER	Numeric value to signify the count of positive lymph nodes identified through hematoxylin and eosin (H&E) staining light microscopy.	Positive Finding Lymph Node Hematoxylin and Eosin Staining Microscopy Count	1				
1791	1791	1791	1791	1791	1791	1791	1791	1791	1791	1791	1791	1791	1795	LYMPH_NODES_EXAMINED_IHC_COUNT	PATIENT	NUMBER	Numeric value to signify the count of positive lymph nodes identified through keratin immunohistochemistry (IHC) staining method,	Positive Finding Lymph Node Keratin Immunohistochemistry Staining Method Count	1				
1792	1792	1792	1792	1792	1792	1792	1792	1792	1792	1792	1792	1792	1796	LYMPH_NODES_EXAMINED_NEGATIVE	PATIENT	STRING	Number of lymphnodes negative	Lymph nodes examined negative	1				
1793	1793	1793	1793	1793	1793	1793	1793	1793	1793	1793	1793	1793	1797	LYMPH_NODES_EXAMINED_POSITIVE	PATIENT	STRING	Number of lymphnodes positive	Lymph nodes examined positive	1				
1794	1794	1794	1794	1794	1794	1794	1794	1794	1794	1794	1794	1794	1798	LYMPH_NODES_PELVIC_EXAMINED_COUNT	SAMPLE	NUMBER	Lymph nodes pelvic examined count	Lymph nodes pelvic examined count	1				
1795	1795	1795	1795	1795	1795	1795	1795	1795	1795	1795	1795	1795	1799	LYMPH_NODES_PELVIC_POS_BY_IHC	SAMPLE	NUMBER	Lymph nodes pelvic pos by ihc	Lymph nodes pelvic pos by ihc	1				
1796	1796	1796	1796	1796	1796	1796	1796	1796	1796	1796	1796	1796	1800	LYMPH_NODES_PELVIC_POS_TOTAL	SAMPLE	NUMBER	Lymph nodes pelvic pos total	Lymph nodes pelvic pos total	1				
1797	1797	1797	1797	1797	1797	1797	1797	1797	1797	1797	1797	1797	1801	LYMPH_NODES_PELVIC_POS__BY_HE	SAMPLE	NUMBER	Lymph nodes pelvic pos by he	Lymph nodes pelvic pos by he	1				
1798	1798	1798	1798	1798	1798	1798	1798	1798	1798	1798	1798	1798	1802	LYMPH_NODES_PREOP_IMAGING	PATIENT	STRING	Lymph node preoperative scan indicator	Lymph nodes preop imaging	1				
1799	1799	1799	1799	1799	1799	1799	1799	1799	1799	1799	1799	1799	1803	LYMPH_NODES_PREOP_IMAGING_TYPE	PATIENT	STRING	Lymph node preoperative assessment diagnostic imaging type	Lymph nodes preop imaging type	1				
1800	1800	1800	1800	1800	1800	1800	1800	1800	1800	1800	1800	1800	1804	LYMPH_NODES_SUPRACLAVICULAR	PATIENT	STRING	Diagnostic mri result outcome	Diagnostic mri result outcome	1				
1801	1801	1801	1801	1801	1801	1801	1801	1801	1801	1801	1801	1801	1805	LYMPH_NODE_DISSECTION_METHOD	PATIENT	STRING	Lymphnode dissection method left	Lymph node dissection method	1				
1802	1802	1802	1802	1802	1802	1802	1802	1802	1802	1802	1802	1802	1806	LYMPH_NODE_EXAMINED_COUNT	PATIENT	NUMBER	The total number of lymph nodes removed and pathologically assessed for disease.	Lymph Node(s) Examined Number	1				
1803	1803	1803	1803	1803	1803	1803	1803	1803	1803	1803	1803	1803	1807	LYMPH_NODE_INVOLVEMENT	SAMPLE	STRING	Lymphnode involvement noted on pathological specimen	Lymphnode involvement	1				
1804	1804	1804	1804	1804	1804	1804	1804	1804	1804	1804	1804	1804	1808	LYMPH_NODE_INVOLVEMENT_SITE	SAMPLE	STRING	Nodal anatomic site	Nodal anatomic site	1				
1805	1805	1805	1805	1805	1805	1805	1805	1805	1805	1805	1805	1805	1809	LYMPH_NODE_METASTASIS	SAMPLE	STRING	Lymph nodes metastasis.	Lymph Nodes Metastasis	1				
1806	1806	1806	1806	1806	1806	1806	1806	1806	1806	1806	1806	1806	1810	LYMPH_NODE_NECK_DISSECTION_INDICATOR	PATIENT	STRING	Lymphnode neck dissection	Lymph node neck dissection indicator	1				
1807	1807	1807	1807	1807	1807	1807	1807	1807	1807	1807	1807	1807	1811	LYMPH_NODE_SPRD_RADIOGRAPH_EVIDENCE	SAMPLE	STRING	Lymph node metastasis radiographic evidence	Lymph node metastasis radiographic evidence	1				
1808	1808	1808	1808	1808	1808	1808	1808	1808	1808	1808	1808	1808	1812	LYMPH_NODE_STATUS	SAMPLE	STRING	Lymph Node Status	Lymph Node Status	1				
1809	1809	1809	1809	1809	1809	1809	1809	1809	1809	1809	1809	1809	1813	LYNCH	PATIENT	STRING	Lynch	Lynch	1				
1810	1810	1810	1810	1810	1810	1810	1810	1810	1810	1810	1810	1810	1814	LYNCH_SYNDROME	PATIENT	STRING	Lynch Syndrome	Lynch Syndrome	1				
1811	1811	1811	1811	1811	1811	1811	1811	1811	1811	1811	1811	1811	1815	M1_STATUS	SAMPLE	STRING	M1 Status	M1 Status	1				
1812	1812	1812	1812	1812	1812	1812	1812	1812	1812	1812	1812	1812	1816	MACIS_SCORE	PATIENT	NUMBER	MACIS Score	MACIS Score	1				
1813	1813	1813	1813	1813	1813	1813	1813	1813	1813	1813	1813	1813	1817	MACROPHAGES_M0	SAMPLE	NUMBER	Macrophages M0	Macrophages M0	1				
1814	1814	1814	1814	1814	1814	1814	1814	1814	1814	1814	1814	1814	1818	MACROPHAGES_M1	SAMPLE	NUMBER	Macrophages M1	Macrophages M1	1				
1815	1815	1815	1815	1815	1815	1815	1815	1815	1815	1815	1815	1815	1819	MACROPHAGES_M2	SAMPLE	NUMBER	Macrophages M2	Macrophages M2	1				
1816	1816	1816	1816	1816	1816	1816	1816	1816	1816	1816	1816	1816	1820	MAF_DATA	SAMPLE	STRING	MAF Data.	MAF Data	1				
1817	1817	1817	1817	1817	1817	1817	1817	1817	1817	1817	1817	1817	1821	MAINT_THERAPY_COURSE_COMPLETE	PATIENT	STRING	Text field indicating for which cancer maintenance therapy was completed.	Maintenance Therapy Course Completion	1				
1818	1818	1818	1818	1818	1818	1818	1818	1818	1818	1818	1818	1818	1822	MAIN_VS_BRANCH_DUCT	SAMPLE	STRING	Main vs. Branch Duct	Main vs. Branch Duct	1				
1819	1819	1819	1819	1819	1819	1819	1819	1819	1819	1819	1819	1819	1823	MAJOR_ANATOMIC_SITE	SAMPLE	STRING	Major Anatomic Site	Major Anatomic Site	1				
1820	1820	1820	1820	1820	1820	1820	1820	1820	1820	1820	1820	1820	1824	MAPK_PATHWAY_ALTERATION	SAMPLE	STRING	MAPK  Pathway Alteration	MAPK Pathway Alteration	1				
1821	1821	1821	1821	1821	1821	1821	1821	1821	1821	1821	1821	1821	1825	MARGINS_INVOLVED_HYSTERECTOMY	PATIENT	STRING	Cervical neoplasm pathologic margin involved type	Cervical neoplasm pathologic margin involved type	1				
1822	1822	1822	1822	1822	1822	1822	1822	1822	1822	1822	1822	1822	1826	MARGIN_CODE	PATIENT	STRING	Margin Code	Margin Code	1				
1823	1823	1823	1823	1823	1823	1823	1823	1823	1823	1823	1823	1823	1827	MARGIN_STATUS	SAMPLE	STRING	Margin Status	Margin Status	1				
1824	1824	1824	1824	1824	1824	1824	1824	1824	1824	1824	1824	1824	1828	MARGIN_STATUS_REEXCISION	SAMPLE	STRING	Breast cancer surgery margin status	Margin status reexcision	1				
1825	1825	1825	1825	1825	1825	1825	1825	1825	1825	1825	1825	1825	1829	MAST_CELLS_ACTIVATED	SAMPLE	NUMBER	Mast cells activated	Mast cells activated	1				
1826	1826	1826	1826	1826	1826	1826	1826	1826	1826	1826	1826	1826	1830	MAST_CELLS_RESTING	SAMPLE	NUMBER	Mast cells resting	Mast cells resting	1				
1827	1827	1827	1827	1827	1827	1827	1827	1827	1827	1827	1827	1827	1831	MATCHED_GERMLINE_DNA	SAMPLE	STRING	Matched Germline DNA	Matched Germline DNA	1				
1828	1828	1828	1828	1828	1828	1828	1828	1828	1828	1828	1828	1828	1832	MATCHED_GE_ACGH	SAMPLE	STRING	Matched GE acgh.	Matched GE ACGH	1				
1829	1829	1829	1829	1829	1829	1829	1829	1829	1829	1829	1829	1829	1833	MATCHED_NORMAL_ID	PATIENT	STRING	Matched Normal ID	Matched Normal ID	1				
1830	1830	1830	1830	1830	1830	1830	1830	1830	1830	1830	1830	1830	1834	MATCHED_NORMAL_TISSUE	SAMPLE	STRING	Matched Normal Tissue	Matched Normal Tissue	1				
1831	1831	1831	1831	1831	1831	1831	1831	1831	1831	1831	1831	1831	1835	MATCHED_PRE_POST	SAMPLE	STRING	Matched pre/post (Y/N)	Matched pre/post (Y/N)	1				
1832	1832	1832	1832	1832	1832	1832	1832	1832	1832	1832	1832	1832	1836	MATCHED_STATUS	SAMPLE	STRING	Matched Status	Matched Status	1				
1833	1833	1833	1833	1833	1833	1833	1833	1833	1833	1833	1833	1833	1837	MATCH_STATUS	PATIENT	STRING	Match Status	Match Status	1				
1834	1834	1834	1834	1834	1834	1834	1834	1834	1834	1834	1834	1834	1838	MAXIMUM_TUMOR_BULK_ANATOMIC_SITE	SAMPLE	STRING	Maximum tumor bulk anatomic location	Maximum tumor bulk anatomic location	1				
1835	1835	1835	1835	1835	1835	1835	1835	1835	1835	1835	1835	1835	1839	MAX_GERMLINE	SAMPLE	STRING	MAX Germline Mutation	MAX Germline Mutation	1				
1836	1836	1836	1836	1836	1836	1836	1836	1836	1836	1836	1836	1836	1840	MB_COV	PATIENT	NUMBER	MB Cov	MB Cov	1				
1837	1837	1837	1837	1837	1837	1837	1837	1837	1837	1837	1837	1837	1841	MC2_VARIANT_CALLS	SAMPLE	STRING	MC2 Variant Calls	MC2 Variant Calls	1				
1838	1838	1838	1838	1838	1838	1838	1838	1838	1838	1838	1838	1838	1842	MCRC_MSS_SAMPLES	SAMPLE	STRING	mCRC MSS Samples (Single Patient)	mCRC MSS Samples (Single Patient)	1				
1839	1839	1839	1839	1839	1839	1839	1839	1839	1839	1839	1839	1839	1843	MCRC_MSS_SAMPLES_RVSL	SAMPLE	STRING	mCRC MSS Samples RvsL (Single Patient)	mCRC MSS Samples RvsL (Single Patient)	1				
1840	1840	1840	1840	1840	1840	1840	1840	1840	1840	1840	1840	1840	1844	MCRC_TYPE	SAMPLE	STRING	mCRC Type	mCRC Type	1				
1841	1841	1841	1841	1841	1841	1841	1841	1841	1841	1841	1841	1841	1845	MDR	SAMPLE	NUMBER	MDR.	MDR	1				
1842	1842	1842	1842	1842	1842	1842	1842	1842	1842	1842	1842	1842	1846	MEAN_COVERAGE	SAMPLE	NUMBER	Mean Coverage (x)	Mean Coverage (x)	1				
1843	1843	1843	1843	1843	1843	1843	1843	1843	1843	1843	1843	1843	1847	MEAN_PLODY	SAMPLE	STRING	mean plody	mean plody	1				
1844	1844	1844	1844	1844	1844	1844	1844	1844	1844	1844	1844	1844	1848	MEAN_TARGET_COVERAGE_NORMAL	SAMPLE	STRING	mean target coverage normal	mean target coverage normal	1				
1845	1845	1845	1845	1845	1845	1845	1845	1845	1845	1845	1845	1845	1849	MEAN_TARGET_COVERAGE_TUMOR	SAMPLE	STRING	mean target coverage tumor	mean target coverage tumor	1				
1846	1846	1846	1846	1846	1846	1846	1846	1846	1846	1846	1846	1846	1850	MED12_MUTATION	SAMPLE	STRING	MED12 Mutation is present	MED12 Mutation	1				
1847	1847	1847	1847	1847	1847	1847	1847	1847	1847	1847	1847	1847	1851	MEDIA	SAMPLE	STRING	Media	Media	1				
1848	1848	1848	1848	1848	1848	1848	1848	1848	1848	1848	1848	1848	1852	MEDIAN_COVERAGE	SAMPLE	STRING	Median coverage.	Median Coverage	1				
1849	1849	1849	1849	1849	1849	1849	1849	1849	1849	1849	1849	1849	1853	MEDICATION	PATIENT	STRING	medication	medication	1				
1850	1850	1850	1850	1850	1850	1850	1850	1850	1850	1850	1850	1850	1854	MEDR_PRIMARY_SITE	PATIENT	STRING	Site of origin of disease	MedR Primary Site Location	1				
1851	1851	1851	1851	1851	1851	1851	1851	1851	1851	1851	1851	1851	1855	MEGF	PATIENT	NUMBER	Megf	Megf	1				
1852	1852	1852	1852	1852	1852	1852	1852	1852	1852	1852	1852	1852	1856	MEGF1	PATIENT	NUMBER	Megf1	Megf1	1				
1853	1853	1853	1853	1853	1853	1853	1853	1853	1853	1853	1853	1853	1857	MEGF2	PATIENT	NUMBER	Megf2	Megf2	1				
1854	1854	1854	1854	1854	1854	1854	1854	1854	1854	1854	1854	1854	1858	MELF	SAMPLE	STRING	MELF	MELF	1				
1855	1855	1855	1855	1855	1855	1855	1855	1855	1855	1855	1855	1855	1859	MENOPAUSAL_STATUS_AT_DIAGNOSIS	PATIENT	STRING	Menopausal Status At Diagnosis	Menopausal Status At Diagnosis	1				
1856	1856	1856	1856	1856	1856	1856	1856	1856	1856	1856	1856	1856	1860	MENOPAUSE_STATUS	PATIENT	STRING	Text term to signify the status of a woman's menopause, the permanent cessation of menses, usually defined by 6 to 12 months of amenorrhea.	Menopause Status	1				
1857	1857	1857	1857	1857	1857	1857	1857	1857	1857	1857	1857	1857	1861	MENOPAUSE_STATUS_AT_DIAGNOSIS	PATIENT	STRING	Menopasue status at Diagnosis	Menopasue status at Diagnosis	1				
1858	1858	1858	1858	1858	1858	1858	1858	1858	1858	1858	1858	1858	1862	MENTAL_STATUS_CHANGES	PATIENT	STRING	Mental status changes.	Mental Status Changes	1				
1859	1859	1859	1859	1859	1859	1859	1859	1859	1859	1859	1859	1859	1863	MERKEL_CELL	SAMPLE	STRING	Merkel cells are oval receptor cells found in the skin of vertebrates that have synaptic contacts with somatosensory afferents.	Merkel Cell	1				
1860	1860	1860	1860	1860	1860	1860	1860	1860	1860	1860	1860	1860	1864	MESOTHELIOMA_DETECTION_METHOD	PATIENT	STRING	Mesothelioma Detection Method	Mesothelioma Detection Method	1				
1861	1861	1861	1861	1861	1861	1861	1861	1861	1861	1861	1861	1861	1865	METANEPHRINE	SAMPLE	STRING	Metanephrine Secreting	Metanephrine Secreting	1				
1862	1862	1862	1862	1862	1862	1862	1862	1862	1862	1862	1862	1862	1866	METASTASECTOMY	SAMPLE	STRING	Metastasectomy	Metastasectomy	1				
1863	1863	1863	1863	1863	1863	1863	1863	1863	1863	1863	1863	1863	1867	METASTASECTOMY_SITE	SAMPLE	STRING	Metastasectomy Site	Metastasectomy Site	1				
1864	1864	1864	1864	1864	1864	1864	1864	1864	1864	1864	1864	1864	1868	METASTASES_SITE_FIRST_BONE	SAMPLE	STRING	Metastases Site First: Bone	Metastases Site First: Bone	1				
1865	1865	1865	1865	1865	1865	1865	1865	1865	1865	1865	1865	1865	1869	METASTASES_SITE_FIRST_BRAIN	SAMPLE	STRING	Metastases Site First: Brain	Metastases Site First: Brain	1				
1866	1866	1866	1866	1866	1866	1866	1866	1866	1866	1866	1866	1866	1870	METASTASES_SITE_FIRST_GYN	SAMPLE	STRING	Metastases Site First: Gynecological	Metastases Site First: Gynecological	1				
1867	1867	1867	1867	1867	1867	1867	1867	1867	1867	1867	1867	1867	1871	METASTASES_SITE_FIRST_LIVER	SAMPLE	STRING	Metastases Site First: Liver	Metastases Site First: Liver	1				
1868	1868	1868	1868	1868	1868	1868	1868	1868	1868	1868	1868	1868	1872	METASTASES_SITE_FIRST_LN	SAMPLE	STRING	Metastases Site First: Ln	Metastases Site First: Ln	1				
1869	1869	1869	1869	1869	1869	1869	1869	1869	1869	1869	1869	1869	1873	METASTASES_SITE_FIRST_LUNG	SAMPLE	STRING	Metastases Site First: Lung	Metastases Site First: Lung	1				
1870	1870	1870	1870	1870	1870	1870	1870	1870	1870	1870	1870	1870	1874	METASTASES_SITE_FIRST_PELVIS	SAMPLE	STRING	Metastases Site First: Pelvis	Metastases Site First: Pelvis	1				
1871	1871	1871	1871	1871	1871	1871	1871	1871	1871	1871	1871	1871	1875	METASTASES_SITE_FIRST_PERITONEUM_OMENTUM_ABDOMEN	SAMPLE	STRING	Metastases Site First: Peritoneum, omentum, abdomen	Metastases Site First: Peritoneum, omentum, abdomen	1				
1872	1872	1872	1872	1872	1872	1872	1872	1872	1872	1872	1872	1872	1876	METASTASES_SITE_FIRST_PLEURA	SAMPLE	STRING	Metastases Site First: Pleura	Metastases Site First: Pleura	1				
1873	1873	1873	1873	1873	1873	1873	1873	1873	1873	1873	1873	1873	1877	METASTASIS	PATIENT	STRING	Metastasis.	Metastasis	1				
1874	1874	1874	1874	1874	1874	1874	1874	1874	1874	1874	1874	1874	1878	METASTASIS_BONE	PATIENT	STRING	Metastasis bone	Metastasis bone	1				
1875	1875	1875	1875	1875	1875	1875	1875	1875	1875	1875	1875	1875	1879	METASTASIS_CODED	SAMPLE	STRING	Metastasis-Coded	Metastasis-Coded	1				
1876	1876	1876	1876	1876	1876	1876	1876	1876	1876	1876	1876	1876	1880	METASTASIS_EXAMINED	PATIENT	STRING	Metastasis Examined	Metastasis Examined	1				
1877	1877	1877	1877	1877	1877	1877	1877	1877	1877	1877	1877	1877	1881	METASTASIS_LIVER	PATIENT	STRING	Metastasis liver	Metastasis liver	1				
1878	1878	1878	1878	1878	1878	1878	1878	1878	1878	1878	1878	1878	1882	METASTASIS_LUNG	PATIENT	STRING	Metastasis lung	Metastasis lung	1				
1879	1879	1879	1879	1879	1879	1879	1879	1879	1879	1879	1879	1879	1883	METASTASIS_OVARY	PATIENT	STRING	Ovary Metastasis	Ovary Metastasis	1				
1880	1880	1880	1880	1880	1880	1880	1880	1880	1880	1880	1880	1880	1884	METASTASIS_PERITONEUM	PATIENT	STRING	Metastasis peritoneum	Metastasis peritoneum	1				
1881	1881	1881	1881	1881	1881	1881	1881	1881	1881	1881	1881	1881	1885	METASTASIS_TESTED	PATIENT	STRING	Metastasis Tested	Metastasis Tested	1				
1882	1882	1882	1882	1882	1882	1882	1882	1882	1882	1882	1882	1882	1886	METASTATIC_BIOPSY_SITE	SAMPLE	STRING	Metastatic Biopsy Site	Metastatic Biopsy Site	1				
1883	1883	1883	1883	1883	1883	1883	1883	1883	1883	1883	1883	1883	1887	METASTATIC_BX_MSKCC	PATIENT	STRING	Met Bx at MSKCC	Met Bx at MSKCC	1				
1884	1884	1884	1884	1884	1884	1884	1884	1884	1884	1884	1884	1884	1888	METASTATIC_CRC	SAMPLE	STRING	Metastatic_CRC	Metastatic_CRC	1				
1885	1885	1885	1885	1885	1885	1885	1885	1885	1885	1885	1885	1885	1889	METASTATIC_DISEASE	PATIENT	STRING	Metastatic disease	Metastatic disease	1				
1886	1886	1886	1886	1886	1886	1886	1886	1886	1886	1886	1886	1886	1890	METASTATIC_DISEASE_CONFIRMED	PATIENT	STRING	Metastatic neoplasm confirmed	Metastatic disease confirmed	1				
1887	1887	1887	1887	1887	1887	1887	1887	1887	1887	1887	1887	1887	1891	METASTATIC_DX	PATIENT	STRING	Metastatic at Diagnosis	Metastatic at Diagnosis	1				
1888	1888	1888	1888	1888	1888	1888	1888	1888	1888	1888	1888	1888	1892	METASTATIC_DX_CONFIRMED_BY	SAMPLE	STRING	Metastatic Neoplasm Confirmed Diagnosis Method Name	Metastatic Neoplasm Confirmed Diagnosis Method Name	1				
1889	1889	1889	1889	1889	1889	1889	1889	1889	1889	1889	1889	1889	1893	METASTATIC_DX_CONFIRMED_BY_OTHER	SAMPLE	STRING	Metastatic Neoplasm Confirmed Diagnosis Method Text	Metastatic Neoplasm Confirmed Diagnosis Method Text	1				
1890	1890	1890	1890	1890	1890	1890	1890	1890	1890	1890	1890	1890	1894	METASTATIC_RESECTION	PATIENT	STRING	Resection of Mets	Resection of Mets	1				
1891	1891	1891	1891	1891	1891	1891	1891	1891	1891	1891	1891	1891	1895	METASTATIC_SITE	SAMPLE	STRING	The anatomic location to which the cancer has spread.	Metastatic Site	1				
1892	1892	1892	1892	1892	1892	1892	1892	1892	1892	1892	1892	1892	1896	METASTATIC_SITE_OTHER	SAMPLE	STRING	Metastatic Site Other	Metastatic Site Other	1				
1893	1893	1893	1893	1893	1893	1893	1893	1893	1893	1893	1893	1893	1897	METASTATIC_STAGE	SAMPLE	STRING	MET Stage	MET Stage	1				
1894	1894	1894	1894	1894	1894	1894	1894	1894	1894	1894	1894	1894	1898	METASTATIC_TUMOR_INDICATOR	SAMPLE	STRING	Distant metastasis present ind2	Metastatic tumor indicator	1				
1895	1895	1895	1895	1895	1895	1895	1895	1895	1895	1895	1895	1895	1899	METFORMIN_USE	PATIENT	STRING	Metformin Used	Metformin Used	1				
1896	1896	1896	1896	1896	1896	1896	1896	1896	1896	1896	1896	1896	1900	METHOD_NUCLEIC_ACID_DELIVERY	SAMPLE	STRING	Method Nucleic Acid Delivery	Method Nucleic Acid Delivery	1				
1897	1897	1897	1897	1897	1897	1897	1897	1897	1897	1897	1897	1897	1901	METHOD_OF_DIAGNOSIS	PATIENT	STRING	Method of Diagnosis	Method of Diagnosis	1				
1898	1898	1898	1898	1898	1898	1898	1898	1898	1898	1898	1898	1898	1902	METHOD_OF_INITIAL_PATH_DIAGNOSIS	PATIENT	STRING	Method Of Initial Pathologic Diagnosis	Method Of Initial Pathologic Diagnosis	1				
1899	1899	1899	1899	1899	1899	1899	1899	1899	1899	1899	1899	1899	1903	METHOD_OF_INITIAL_PATH_DIAGNOSIS_OTHER	PATIENT	STRING	Other Method Of Initial Pathological Diagnosis	Other Method Of Initial Pathological Diagnosis	1				
1900	1900	1900	1900	1900	1900	1900	1900	1900	1900	1900	1900	1900	1904	METHOD_OF_INITIAL_SAMPLE_PROCUREMENT	PATIENT	STRING	Text name of the procedure to secure the tissue used for the original pathologic diagnosis.	First Pathologic Diagnosis Biospecimen Acquisition Method Type	1				
1901	1901	1901	1901	1901	1901	1901	1901	1901	1901	1901	1901	1901	1905	METHOD_OF_INITIAL_SAMPLE_PROCUREMENT_OTHER	PATIENT	STRING	Text to describe a method used to secure tissue for an original pathologic diagnosis that is different from other identified methods.	First Pathologic Diagnosis Biospecimen Acquisition Other Method Type	1				
1902	1902	1902	1902	1902	1902	1902	1902	1902	1902	1902	1902	1902	1906	METHOD_OF_SAMPLE_PROCUREMENT	PATIENT	STRING	Text name of the procedure to secure the tissue used for the original pathologic diagnosis.	First Pathologic Diagnosis Biospecimen Acquisition Method Type	1				
1903	1903	1903	1903	1903	1903	1903	1903	1903	1903	1903	1903	1903	1907	METHOD_OF_SAMPLE_PROCUREMENT_OTHER	PATIENT	STRING	Text to describe a method used to secure tissue for an original pathologic diagnosis that is different from other identified methods.	First Pathologic Diagnosis Biospecimen Acquisition Other Method Type	1				
1904	1904	1904	1904	1904	1904	1904	1904	1904	1904	1904	1904	1904	1908	METHOD_PURITY	SAMPLE	STRING	Method for purity (ABSOLUTE SNP AC, or AF for mutation allele fraction only)	Method for purity (ABSOLUTE SNP AC, or AF for mutation allele fraction only)	1				
1905	1905	1905	1905	1905	1905	1905	1905	1905	1905	1905	1905	1905	1909	METHOXYTYRAMINE	SAMPLE	STRING	Methoxytyramine Secreting	Methoxytyramine Secreting	1				
1906	1906	1906	1906	1906	1906	1906	1906	1906	1906	1906	1906	1906	1910	METHYL	PATIENT	NUMBER	Methyl	Methyl	1				
1907	1907	1907	1907	1907	1907	1907	1907	1907	1907	1907	1907	1907	1911	METHYLATION450	SAMPLE	STRING	Methylation450	Methylation450	1				
1908	1908	1908	1908	1908	1908	1908	1908	1908	1908	1908	1908	1908	1912	METHYLATION_CLASS	SAMPLE	STRING	Methylation Class	Methylation Class	1				
1909	1909	1909	1909	1909	1909	1909	1909	1909	1909	1909	1909	1909	1913	METHYLATION_CLUSTER	SAMPLE	STRING	Methylation cluster.	Methylation Cluster	1				
1910	1910	1910	1910	1910	1910	1910	1910	1910	1910	1910	1910	1910	1914	METHYLATION_CLUSTER_K3	SAMPLE	STRING	Methylation cluster K3	Methylation cluster K3	1				
1911	1911	1911	1911	1911	1911	1911	1911	1911	1911	1911	1911	1911	1915	METHYLATION_DATA	SAMPLE	STRING	Methylation data.	Methylation Data	1				
1912	1912	1912	1912	1912	1912	1912	1912	1912	1912	1912	1912	1912	1916	METHYLATION_ID	SAMPLE	STRING	Methylation ID Used	Methylation ID	1				
1913	1913	1913	1913	1913	1913	1913	1913	1913	1913	1913	1913	1913	1917	METHYLATION_STATUS	SAMPLE	STRING	Yes/No indicator for methylation data	Methylation Status	1				
1914	1914	1914	1914	1914	1914	1914	1914	1914	1914	1914	1914	1914	1918	METHYLATION_SUBTYPE	SAMPLE	STRING	Methylation subtype.	Methylation Subtype	1				
1915	1915	1915	1915	1915	1915	1915	1915	1915	1915	1915	1915	1915	1919	METS_DISEASE_DATE_INT	SAMPLE	NUMBER	Distant Metastatic Disease Interval	Distant Metastatic Disease Interval	1				
1916	1916	1916	1916	1916	1916	1916	1916	1916	1916	1916	1916	1916	1920	METS_FREE_TIME_MONTHS	PATIENT	NUMBER	MetsFreeTime_Months	MetsFreeTime_Months	1				
1917	1917	1917	1917	1917	1917	1917	1917	1917	1917	1917	1917	1917	1921	METS_SITES_AT_DX	PATIENT	STRING	All locations in the body where breast cancer spread at the time of diagnosis with metastatic breast cancer.	MedR Metastatic Sites at Metastatic Diagnosis	1				
1918	1918	1918	1918	1918	1918	1918	1918	1918	1918	1918	1918	1918	1922	METS_SITES_AT_IMPACT_SAMPLE_COLLECTION	SAMPLE	STRING	Met Sites at IMPACT Sample Collection	Met Sites at IMPACT Sample Collection	1				
1919	1919	1919	1919	1919	1919	1919	1919	1919	1919	1919	1919	1919	1923	METS_SITES_AT_LAST_FOLLOWUP	SAMPLE	STRING	Met Sites at Last Followup	Met Sites at Last Followup	1				
1920	1920	1920	1920	1920	1920	1920	1920	1920	1920	1920	1920	1920	1924	METS_SITES_AT_METS_ABST_ADRENAL_GLAND	PATIENT	STRING	Metastasis to adrenal gland noted during the patient's course of treatment	MedR Ever Adrenal Gland Mets	1				
1921	1921	1921	1921	1921	1921	1921	1921	1921	1921	1921	1921	1921	1925	METS_SITES_AT_METS_ABST_ASCITES	PATIENT	STRING	Metastasis to ascites noted during the patient's course of treatment. Ascites is the accumulation of fluid in the abdominal cavity.	MedR Ever Ascites Mets	1				
1922	1922	1922	1922	1922	1922	1922	1922	1922	1922	1922	1922	1922	1926	METS_SITES_AT_METS_ABST_BONE	PATIENT	STRING	Metastasis to bone noted during the patient's course of treatment	MedR Ever Bone Mets	1				
1923	1923	1923	1923	1923	1923	1923	1923	1923	1923	1923	1923	1923	1927	METS_SITES_AT_METS_ABST_BRAIN_CNS	PATIENT	STRING	Metastasis to brain or central nervous system noted during the patient's course of treatment	MedR Ever Brain/CNS Mets	1				
1924	1924	1924	1924	1924	1924	1924	1924	1924	1924	1924	1924	1924	1928	METS_SITES_AT_METS_ABST_CHEST_WALL	PATIENT	STRING	Metastasis to chest wall noted during the patient's course of treatment	MedR Ever Chest Wall Mets	1				
1925	1925	1925	1925	1925	1925	1925	1925	1925	1925	1925	1925	1925	1929	METS_SITES_AT_METS_ABST_DIST_LYMPH	PATIENT	STRING	Metastasis to distant lymph nodes noted during the patient's course of treatment	MedR Ever Distant Lymph Node Mets	1				
1926	1926	1926	1926	1926	1926	1926	1926	1926	1926	1926	1926	1926	1930	METS_SITES_AT_METS_ABST_INTRA_ABDOMINAL	PATIENT	STRING	Metastasis to intraabdominal area noted during the patient's course of treatment	MedR Ever Intraabdominal Mets	1				
1927	1927	1927	1927	1927	1927	1927	1927	1927	1927	1927	1927	1927	1931	METS_SITES_AT_METS_ABST_LIVER	PATIENT	STRING	Metastasis to liver noted during the patient's course of treatment	MedR Ever Liver Mets	1				
1928	1928	1928	1928	1928	1928	1928	1928	1928	1928	1928	1928	1928	1932	METS_SITES_AT_METS_ABST_LUNG	PATIENT	STRING	Metastasis to lung noted during the patient's course of treatment	MedR Ever Lung Mets	1				
1929	1929	1929	1929	1929	1929	1929	1929	1929	1929	1929	1929	1929	1933	METS_SITES_AT_METS_ABST_OVARY	PATIENT	STRING	Metastasis to ovary noted during the patient's course of treatment	MedR Ever Ovary Mets	1				
1930	1930	1930	1930	1930	1930	1930	1930	1930	1930	1930	1930	1930	1934	METS_SITES_AT_METS_ABST_PLEURAL_EFFUSION	PATIENT	STRING	Metastasis to pleural effusion noted during the patient's course of treatment	MedR Ever Pleural Effusion Mets	1				
1931	1931	1931	1931	1931	1931	1931	1931	1931	1931	1931	1931	1931	1935	METS_SITES_AT_METS_ABST_REG_LYMPH	PATIENT	STRING	Metastasis to regional lymph nodes noted during the patient's course of treatment	MedR Ever Regional Lymph Node Mets	1				
1932	1932	1932	1932	1932	1932	1932	1932	1932	1932	1932	1932	1932	1936	METS_SITES_AT_METS_ABST_SKIN	PATIENT	STRING	Metastasis to skin noted during the patient's course of treatment	MedR Ever Skin Mets	1				
1933	1933	1933	1933	1933	1933	1933	1933	1933	1933	1933	1933	1933	1937	METS_SITES_AT_METS_ABST_SOFT_TISSUE	PATIENT	STRING	Metastasis to soft tissue noted during the patient's course of treatment	MedR Ever Soft Tissue Mets	1				
1934	1934	1934	1934	1934	1934	1934	1934	1934	1934	1934	1934	1934	1938	METS_SITES_AT_METS_ABST_UNKNOWN	PATIENT	STRING	Metastases unknown or not reported during patient's course of treatment. This is set to YES if metastatic sites could not be determined from available medical records.	MedR Ever Unknown Mets	1				
1935	1935	1935	1935	1935	1935	1935	1935	1935	1935	1935	1935	1935	1939	METS_SITES_AT_METS_DX_ADRENAL_GLAND	PATIENT	STRING	Metastasis to adrenal gland noted at time of diagnosis with metastatic disease	MedR Adrenal Gland Mets at Mets Dx	1				
1936	1936	1936	1936	1936	1936	1936	1936	1936	1936	1936	1936	1936	1940	METS_SITES_AT_METS_DX_ASCITES	PATIENT	STRING	Metastasis to ascites noted at time of diagnosis with metastatic disease. Ascites is the accumulation of fluid in the abdominal cavity.	MedR Ascites Mets at Mets Dx	1				
1937	1937	1937	1937	1937	1937	1937	1937	1937	1937	1937	1937	1937	1941	METS_SITES_AT_METS_DX_BONE	PATIENT	STRING	Metastasis to bone noted at time of diagnosis with metastatic disease	MedR Bone Mets at Mets Dx	1				
1938	1938	1938	1938	1938	1938	1938	1938	1938	1938	1938	1938	1938	1942	METS_SITES_AT_METS_DX_BRAIN_CNS	PATIENT	STRING	Metastasis to Brain or Central Nervous System noted at time of diagnosis with metastatic disease	MedR Brain/CNS Mets at Mets Dx	1				
1939	1939	1939	1939	1939	1939	1939	1939	1939	1939	1939	1939	1939	1943	METS_SITES_AT_METS_DX_CHEST_WALL	PATIENT	STRING	Metastasis to chest wall noted at time of diagnosis with metastatic disease	MedR Chest Wall Mets at Mets Dx	1				
1940	1940	1940	1940	1940	1940	1940	1940	1940	1940	1940	1940	1940	1944	METS_SITES_AT_METS_DX_DIST_LYMPH	PATIENT	STRING	Metastasis to distant lymph nodes noted at time of diagnosis with metastatic disease	MedR Distant Lymph Node Mets at Mets Dx	1				
1941	1941	1941	1941	1941	1941	1941	1941	1941	1941	1941	1941	1941	1945	METS_SITES_AT_METS_DX_INTRA_ABDOMINAL	PATIENT	STRING	Metastasis to intraabdominal area noted at time of diagnosis with metastatic disease	MedR Intraabdominal Mets at Mets Dx	1				
1942	1942	1942	1942	1942	1942	1942	1942	1942	1942	1942	1942	1942	1946	METS_SITES_AT_METS_DX_LIVER	PATIENT	STRING	Metastasis to liver noted at time of diagnosis with metastatic disease	MedR Liver Mets at Mets Dx	1				
1943	1943	1943	1943	1943	1943	1943	1943	1943	1943	1943	1943	1943	1947	METS_SITES_AT_METS_DX_LUNG	PATIENT	STRING	Metastasis to lung noted at time of diagnosis with metastatic disease	MedR Lung Mets at Mets Dx	1				
1944	1944	1944	1944	1944	1944	1944	1944	1944	1944	1944	1944	1944	1948	METS_SITES_AT_METS_DX_OVARY	PATIENT	STRING	Metastasis to ovary noted at time of diagnosis with metastatic disease	MedR Ovary Mets at Mets Dx	1				
1945	1945	1945	1945	1945	1945	1945	1945	1945	1945	1945	1945	1945	1949	METS_SITES_AT_METS_DX_PLEURAL_EFFUSION	PATIENT	STRING	Metastasis to pleural effusion noted at time of diagnosis with metastatic disease	MedR Pleural Effusion Mets at Mets Dx	1				
1946	1946	1946	1946	1946	1946	1946	1946	1946	1946	1946	1946	1946	1950	METS_SITES_AT_METS_DX_REG_LYMPH	PATIENT	STRING	Metastasis to regional lymph nodes noted at time of diagnosis with metastatic disease	MedR Regional Lymph Node Mets at Mets Dx	1				
1947	1947	1947	1947	1947	1947	1947	1947	1947	1947	1947	1947	1947	1951	METS_SITES_AT_METS_DX_SKIN	PATIENT	STRING	Metastasis to skin noted at time of diagnosis with metastatic disease	MedR Skin Mets at Mets Dx	1				
1948	1948	1948	1948	1948	1948	1948	1948	1948	1948	1948	1948	1948	1952	METS_SITES_AT_METS_DX_SOFT_TISSUE	PATIENT	STRING	Metastasis to soft tissue noted at time of diagnosis with metastatic disease	MedR Soft Tissue Mets at Mets Dx	1				
1949	1949	1949	1949	1949	1949	1949	1949	1949	1949	1949	1949	1949	1953	METS_SITES_AT_METS_DX_UNKNOWN	PATIENT	STRING	Metastatic sites unknown or not reported at time of diagnosis with metastatic disease. This is set to YES if metastatic sites could not be determined from available medical records.	MedR Unknown Mets at Mets Dx	1				
1950	1950	1950	1950	1950	1950	1950	1950	1950	1950	1950	1950	1950	1954	MET_BONE	SAMPLE	STRING	Bone Metastasis	Bone Metastasis	1				
1951	1951	1951	1951	1951	1951	1951	1951	1951	1951	1951	1951	1951	1955	MET_BRAIN	SAMPLE	STRING	Brain Metastasis	Brain Metastasis	1				
1952	1952	1952	1952	1952	1952	1952	1952	1952	1952	1952	1952	1952	1956	MET_IMPACT_ADRENAL	SAMPLE	STRING	Met IMPACT ADRENAL	Met IMPACT ADRENAL	1				
1953	1953	1953	1953	1953	1953	1953	1953	1953	1953	1953	1953	1953	1957	MET_IMPACT_BONE	SAMPLE	STRING	Met IMPACT BONE	Met IMPACT BONE	1				
1954	1954	1954	1954	1954	1954	1954	1954	1954	1954	1954	1954	1954	1958	MET_IMPACT_LIVER	SAMPLE	STRING	Met IMPACT LIVER	Met IMPACT LIVER	1				
1955	1955	1955	1955	1955	1955	1955	1955	1955	1955	1955	1955	1955	1959	MET_IMPACT_LN	SAMPLE	STRING	Met IMPACT LN	Met IMPACT LN	1				
1956	1956	1956	1956	1956	1956	1956	1956	1956	1956	1956	1956	1956	1960	MET_IMPACT_LUNG	SAMPLE	STRING	Met IMPACT LUNG	Met IMPACT LUNG	1				
1957	1957	1957	1957	1957	1957	1957	1957	1957	1957	1957	1957	1957	1961	MET_IMPACT_PLEURA	SAMPLE	STRING	Met IMPACT PLEURA	Met IMPACT PLEURA	1				
1958	1958	1958	1958	1958	1958	1958	1958	1958	1958	1958	1958	1958	1962	MET_LAST_FUP_ADRENAL	SAMPLE	STRING	Met Last Follow Up Adrenal	Met Last Follow Up Adrenal	1				
1959	1959	1959	1959	1959	1959	1959	1959	1959	1959	1959	1959	1959	1963	MET_LAST_FUP_BONE	SAMPLE	STRING	Met Last Follow Up Bone	Met Last Follow Up Bone	1				
1960	1960	1960	1960	1960	1960	1960	1960	1960	1960	1960	1960	1960	1964	MET_LAST_FUP_BRAIN	SAMPLE	STRING	Met Last Follow Up Brain	Met Last Follow Up Brain	1				
1961	1961	1961	1961	1961	1961	1961	1961	1961	1961	1961	1961	1961	1965	MET_LAST_FUP_LIVER	SAMPLE	STRING	Met Last Follow Up Liver	Met Last Follow Up Liver	1				
1962	1962	1962	1962	1962	1962	1962	1962	1962	1962	1962	1962	1962	1966	MET_LAST_FUP_LN	SAMPLE	STRING	Met Last Follow Up Ln	Met Last Follow Up Ln	1				
1963	1963	1963	1963	1963	1963	1963	1963	1963	1963	1963	1963	1963	1967	MET_LAST_FUP_LUNG	SAMPLE	STRING	Met Last Follow Up Lung	Met Last Follow Up Lung	1				
1964	1964	1964	1964	1964	1964	1964	1964	1964	1964	1964	1964	1964	1968	MET_LAST_FUP_PLEURA	SAMPLE	STRING	Met Last Follow Up Pleura	Met Last Follow Up Pleura	1				
1965	1965	1965	1965	1965	1965	1965	1965	1965	1965	1965	1965	1965	1969	MET_LAST_LMD	SAMPLE	STRING	Met Last Lmd	Met Last Lmd	1				
1966	1966	1966	1966	1966	1966	1966	1966	1966	1966	1966	1966	1966	1970	MET_LAST_PERITONEUM	SAMPLE	STRING	Met Last Peritoneum	Met Last Peritoneum	1				
1967	1967	1967	1967	1967	1967	1967	1967	1967	1967	1967	1967	1967	1971	MET_LAST_SUBCUTANEOUS	SAMPLE	STRING	Met Last Subcutaneous	Met Last Subcutaneous	1				
1968	1968	1968	1968	1968	1968	1968	1968	1968	1968	1968	1968	1968	1972	MET_LIVER	SAMPLE	STRING	Liver Metastasis	Liver Metastasis	1				
1969	1969	1969	1969	1969	1969	1969	1969	1969	1969	1969	1969	1969	1973	MET_LUNG	SAMPLE	STRING	Lung Metastasis	Lung Metastasis	1				
1970	1970	1970	1970	1970	1970	1970	1970	1970	1970	1970	1970	1970	1974	MET_PERITONEUM	SAMPLE	STRING	Peritoneum Metastasis	Peritoneum Metastasis	1				
1971	1971	1971	1971	1971	1971	1971	1971	1971	1971	1971	1971	1971	1975	MET_SITE_OTHER_DMT	SAMPLE	STRING	Other Metastatic Sites Ever per DMT	Other Metastatic Sites Ever per DMT	1				
1972	1972	1972	1972	1972	1972	1972	1972	1972	1972	1972	1972	1972	1976	MET_SKIPPED_EXONS_18_AND_19	SAMPLE	STRING	MET skipped exons 18 and 19.	MET Skipped Exons 18 & 19	1				
1973	1973	1973	1973	1973	1973	1973	1973	1973	1973	1973	1973	1973	1977	MET_SKIPPED_EXON_2	SAMPLE	STRING	MET skipped exon 2.	MET Skipped Exon 2	1				
1974	1974	1974	1974	1974	1974	1974	1974	1974	1974	1974	1974	1974	1978	MFGF	PATIENT	NUMBER	Mfgf	Mfgf	1				
1975	1975	1975	1975	1975	1975	1975	1975	1975	1975	1975	1975	1975	1979	MFGF1	PATIENT	NUMBER	Mfgf1	Mfgf1	1				
1976	1976	1976	1976	1976	1976	1976	1976	1976	1976	1976	1976	1976	1980	MFGF2	PATIENT	NUMBER	Mfgf2	Mfgf2	1				
1977	1977	1977	1977	1977	1977	1977	1977	1977	1977	1977	1977	1977	1981	MGMT_PROMOTER_STATUS	SAMPLE	STRING	MGMT promoter status	MGMT promoter status	1				
1978	1978	1978	1978	1978	1978	1978	1978	1978	1978	1978	1978	1978	1982	MGMT_RESULT_SURGERY_1	PATIENT	STRING	MGMT Result Surgery 1	MGMT Result Surgery 1	1				
1979	1979	1979	1979	1979	1979	1979	1979	1979	1979	1979	1979	1979	1983	MGMT_STATUS	SAMPLE	STRING	MGMT Status	MGMT Status	1				
1980	1980	1980	1980	1980	1980	1980	1980	1980	1980	1980	1980	1980	1984	MHGF	PATIENT	NUMBER	Mhgf	Mhgf	1				
1981	1981	1981	1981	1981	1981	1981	1981	1981	1981	1981	1981	1981	1985	MHGF2	PATIENT	NUMBER	Mhgf2	Mhgf2	1				
1982	1982	1982	1982	1982	1982	1982	1982	1982	1982	1982	1982	1982	1986	MIBC_OR_NON_MIBC	SAMPLE	STRING	Bladder MIBC Or Non-MIBC	Bladder MIBC Or Non-MIBC	1				
1983	1983	1983	1983	1983	1983	1983	1983	1983	1983	1983	1983	1983	1987	MIBC_PROGRESSIVE	SAMPLE	STRING	Bladder MIBC Progressive	MIBC Progressive	1				
1984	1984	1984	1984	1984	1984	1984	1984	1984	1984	1984	1984	1984	1988	MIBC_RECURRENCE	PATIENT	STRING	MIBC recurrence	MIBC recurrence	1				
1985	1985	1985	1985	1985	1985	1985	1985	1985	1985	1985	1985	1985	1989	MIB_1_POSITIVE_PERCENT_RANGE	SAMPLE	STRING	Mib1 positive percentage range	Mib1 positive percentage range	1				
1986	1986	1986	1986	1986	1986	1986	1986	1986	1986	1986	1986	1986	1990	MICROMET_DETECTION_BY_IHC	SAMPLE	STRING	Cytokeratin immunohistochemistry staining method micrometastasis indicator	Micromet detection by ihc	1				
1987	1987	1987	1987	1987	1987	1987	1987	1987	1987	1987	1987	1987	1991	MICRORNA_EXPRESSION_CLUSTER	SAMPLE	STRING	MicroRNA expression cluster.	MicroRNA Expression Cluster	1				
1988	1988	1988	1988	1988	1988	1988	1988	1988	1988	1988	1988	1988	1992	MICROVASCULAR_DENSITY_MVD	SAMPLE	STRING	Microvascular Density Mvd	Microvascular Density Mvd	1				
1989	1989	1989	1989	1989	1989	1989	1989	1989	1989	1989	1989	1989	1993	MICRO_RNA_CLUSTER	SAMPLE	STRING	MicroRNA cluster.	MicroRNA Cluster	1				
1990	1990	1990	1990	1990	1990	1990	1990	1990	1990	1990	1990	1990	1994	MICRO_RNA_SCORE	SAMPLE	NUMBER	MicroRNA score.	MicroRNA Score	1				
1991	1991	1991	1991	1991	1991	1991	1991	1991	1991	1991	1991	1991	1995	MINUS_X	SAMPLE	STRING	Minus-X.	Minus-X	1				
1992	1992	1992	1992	1992	1992	1992	1992	1992	1992	1992	1992	1992	1996	MINUS_Y	SAMPLE	STRING	Minus-Y.	Minus-Y	1				
1993	1993	1993	1993	1993	1993	1993	1993	1993	1993	1993	1993	1993	1997	MIRNASEQ	SAMPLE	STRING	miRNAseq	miRNAseq	1				
1994	1994	1994	1994	1994	1994	1994	1994	1994	1994	1994	1994	1994	1998	MIRNA_CLUSTER	SAMPLE	STRING	MICRNA cluster	MIRNA Cluster	1				
1995	1995	1995	1995	1995	1995	1995	1995	1995	1995	1995	1995	1995	1999	MIRNA_CLUSTER_K3	SAMPLE	STRING	MIRNA CLUSTER K3	MIRNA CLUSTER K3	1				
1996	1996	1996	1996	1996	1996	1996	1996	1996	1996	1996	1996	1996	2000	MIRNA_CLUSTER_K6	SAMPLE	STRING	MIRNA CLUSTER K6	MIRNA CLUSTER K6	1				
1997	1997	1997	1997	1997	1997	1997	1997	1997	1997	1997	1997	1997	2001	MIRNA_EXPRESSION_CLUSTER_EC	SAMPLE	STRING	miRNA Expression Cluster - EC	miRNA Expression Cluster - EC	1				
1998	1998	1998	1998	1998	1998	1998	1998	1998	1998	1998	1998	1998	2002	MIRNA_EXPRESSION_CLUSTER_GEA	SAMPLE	STRING	miRNA Expression Cluster - GEA	miRNA Expression Cluster - GEA	1				
1999	1999	1999	1999	1999	1999	1999	1999	1999	1999	1999	1999	1999	2003	MIRNA_EXPRESSION_CLUSTER_GEA_CIN	SAMPLE	STRING	miRNA Expression Cluster - GEA-CIN	miRNA Expression Cluster - GEA-CIN	1				
2000	2000	2000	2000	2000	2000	2000	2000	2000	2000	2000	2000	2000	2004	MIRNA_EXPRESSION_CLUSTER_SCC	SAMPLE	STRING	miRNA Expression Cluster - SCC	miRNA Expression Cluster - SCC	1				
2001	2001	2001	2001	2001	2001	2001	2001	2001	2001	2001	2001	2001	2005	MISSENSE_MUTATIONS	SAMPLE	NUMBER	Missense Mutations	Missense Mutations	1				
2002	2002	2002	2002	2002	2002	2002	2002	2002	2002	2002	2002	2002	2006	MITO	SAMPLE	STRING	MITO.	MITO	1				
2003	2003	2003	2003	2003	2003	2003	2003	2003	2003	2003	2003	2003	2007	MITOSES_PER_10_HPF	SAMPLE	NUMBER	Mitoses Per 10 HPF	Mitoses Per 10 HPF	1				
2004	2004	2004	2004	2004	2004	2004	2004	2004	2004	2004	2004	2004	2008	MITOSES_PER_50_HPF	PATIENT	NUMBER	Mitoses Count	Mitoses Count	1				
2005	2005	2005	2005	2005	2005	2005	2005	2005	2005	2005	2005	2005	2009	MITOTIC_ACTIVITY	SAMPLE	STRING	Mitotic Activity	Mitotic Activity	1				
2006	2006	2006	2006	2006	2006	2006	2006	2006	2006	2006	2006	2006	2010	MITOTIC_COUNT	SAMPLE	NUMBER	Mitotic Count	Mitotic Count	1				
2007	2007	2007	2007	2007	2007	2007	2007	2007	2007	2007	2007	2007	2011	MITOTIC_INDEX	SAMPLE	STRING	Mitotic Index	Mitotic Index	1				
2008	2008	2008	2008	2008	2008	2008	2008	2008	2008	2008	2008	2008	2012	MITOTIC_RATE	PATIENT	STRING	Mitotic Rate	Mitotic Rate	1				
2009	2009	2009	2009	2009	2009	2009	2009	2009	2009	2009	2009	2009	2013	MITOTIC_SCORE	SAMPLE	NUMBER	Mitotic Score	Mitotic Score	1				
2010	2010	2010	2010	2010	2010	2010	2010	2010	2010	2010	2010	2010	2014	MKI	SAMPLE	STRING	MKI.	MKI	1				
2011	2011	2011	2011	2011	2011	2011	2011	2011	2011	2011	2011	2011	2015	MLH1_METHYLATION	SAMPLE	STRING	MLH1 methylation.	MLH1 Methylation	1				
2012	2012	2012	2012	2012	2012	2012	2012	2012	2012	2012	2012	2012	2016	MLH1_SILENCING	SAMPLE	STRING	Epigenetic silencing status of MLH1.	MLH1 Silencing	1				
2013	2013	2013	2013	2013	2013	2013	2013	2013	2013	2013	2013	2013	2017	MLH1_STATUS	SAMPLE	STRING	MLH1 Status	MLH1 Status	1				
2014	2014	2014	2014	2014	2014	2014	2014	2014	2014	2014	2014	2014	2018	MLL	SAMPLE	STRING	MLL.	MLL	1				
2015	2015	2015	2015	2015	2015	2015	2015	2015	2015	2015	2015	2015	2019	MLL_FUSION	SAMPLE	STRING	MLL Fusion	MLL Fusion	1				
2016	2016	2016	2016	2016	2016	2016	2016	2016	2016	2016	2016	2016	2020	MLL_MULTIPLE_COPIES	SAMPLE	STRING	MLL Multiple Copies	MLL Multiple Copies	1				
2017	2017	2017	2017	2017	2017	2017	2017	2017	2017	2017	2017	2017	2021	MLL_STATUS	SAMPLE	STRING	MLL status.	MLL Status	1				
2018	2018	2018	2018	2018	2018	2018	2018	2018	2018	2018	2018	2018	2022	MODIFIED_CAPRA_S_SCORE_WITHOUT_INCLUDING_SURGICAL_MARGINS	SAMPLE	NUMBER	Modified Capra S Score Without Including Surgical Margins	Modified Capra S Score Without Including Surgical Margins	1				
2019	2019	2019	2019	2019	2019	2019	2019	2019	2019	2019	2019	2019	2023	MOLD_OR_DUST_ALLERGY_HISTORY	PATIENT	STRING	History of mold or dust allergy.	Mold or Dust Allergy History	1				
2020	2020	2020	2020	2020	2020	2020	2020	2020	2020	2020	2020	2020	2024	MOLECULAR_SMOKING_SIGNATURE	PATIENT	STRING	Molecular Smoking Signature	Molecular Smoking Signature	1				
2021	2021	2021	2021	2021	2021	2021	2021	2021	2021	2021	2021	2021	2025	MOLECULAR_STUDIES_OTHERS_PERFORMED	SAMPLE	STRING	Molecular Analysis Performed Indicator	Molecular Analysis Performed Indicator	1				
2022	2022	2022	2022	2022	2022	2022	2022	2022	2022	2022	2022	2022	2026	MOLECULAR_SUBTYPE	SAMPLE	STRING	Molecular subtype.	Molecular Subtype	1				
2023	2023	2023	2023	2023	2023	2023	2023	2023	2023	2023	2023	2023	2027	MOLECULAR_TEST_RESULT	SAMPLE	STRING	Molecular test result	Molecular test result	1				
2024	2024	2024	2024	2024	2024	2024	2024	2024	2024	2024	2024	2024	2028	MONOCYTES	SAMPLE	NUMBER	Monocytes	Monocytes	1				
2025	2025	2025	2025	2025	2025	2025	2025	2025	2025	2025	2025	2025	2029	MONOSOMY_5	SAMPLE	STRING	Monosomy 5.	Monosomy 5	1				
2026	2026	2026	2026	2026	2026	2026	2026	2026	2026	2026	2026	2026	2030	MONOSOMY_7	SAMPLE	STRING	Monosomy 7.	Monosomy 7	1				
2027	2027	2027	2027	2027	2027	2027	2027	2027	2027	2027	2027	2027	2031	MONTHS_ON_STUDY	PATIENT	NUMBER	months on study	months on study	1				
2028	2028	2028	2028	2028	2028	2028	2028	2028	2028	2028	2028	2028	2032	MONTHS_ON_TREATMENT	PATIENT	NUMBER	Months on Treatment	Months on Treatment	1				
2029	2029	2029	2029	2029	2029	2029	2029	2029	2029	2029	2029	2029	2033	MONTHS_TO_DISTANT_RECURRENCE	PATIENT	STRING	Months to distant recurrence.	Months to Distant Recurrence	1				
2030	2030	2030	2030	2030	2030	2030	2030	2030	2030	2030	2030	2030	2034	MONTHS_TO_LOCAL_RECURRENCE	PATIENT	STRING	Months to local recurrence.	Months to Local Recurrence.	1				
2031	2031	2031	2031	2031	2031	2031	2031	2031	2031	2031	2031	2031	2035	MONTH_ADDED	SAMPLE	STRING	Month added to cBioPortal	Month added to cBioPortal	1				
2032	2032	2032	2032	2032	2032	2032	2032	2032	2032	2032	2032	2032	2036	MORE_2SNV_CFDNA	SAMPLE	STRING	More than 2 SNVs detected in ctDNA pre-operatively, meeting threshold for confident ctDNA detection	More than 2 SNVs detected in cfDNA	1				
2033	2033	2033	2033	2033	2033	2033	2033	2033	2033	2033	2033	2033	2037	MORPHOLOGICAL_ARCHITECTURE	SAMPLE	STRING	Morphological Architecture	Morphological Architecture	1				
2034	2034	2034	2034	2034	2034	2034	2034	2034	2034	2034	2034	2034	2038	MORPHOLOGY	SAMPLE	STRING	Morphology	Morphology	1				
2035	2035	2035	2035	2035	2035	2035	2035	2035	2035	2035	2035	2035	2039	MORPHOLOGY_OTHER_FEATURES	SAMPLE	STRING	Morphology Other Features	Morphology Other Features	1				
2036	2036	2036	2036	2036	2036	2036	2036	2036	2036	2036	2036	2036	2040	MORPHOLOGY_SUBTYPE	SAMPLE	STRING	Morphology Subtype	Morphology Subtype	1				
2037	2037	2037	2037	2037	2037	2037	2037	2037	2037	2037	2037	2037	2041	MOTOR_MOVEMENT_CHANGES	PATIENT	STRING	Motor movement changes.	Motor Movement Changes.	1				
2038	2038	2038	2038	2038	2038	2038	2038	2038	2038	2038	2038	2038	2042	MOUSE_STRAIN	SAMPLE	STRING	Mouse Strain	Mouse Strain	1				
2039	2039	2039	2039	2039	2039	2039	2039	2039	2039	2039	2039	2039	2043	MPL_EVIDENCE	SAMPLE	STRING	Evidence of or Not of MPL(W515 or S505)	Evidence of or Not of MPL(W515 or S505)	1				
2040	2040	2040	2040	2040	2040	2040	2040	2040	2040	2040	2040	2040	2044	MPNST_NF1_GENETIC_TESTING_INDICATOR	PATIENT	STRING	Mpnst nf1 genetic testing	Mpnst nf1 genetic testing indicator	1				
2041	2041	2041	2041	2041	2041	2041	2041	2041	2041	2041	2041	2041	2045	MPNST_NF1_MUTATIONS_IDENTIFIED	SAMPLE	STRING	Mpnst specific mutations	Mpnst nf1 mutations identified	1				
2042	2042	2042	2042	2042	2042	2042	2042	2042	2042	2042	2042	2042	2046	MPNST_NF_FAMILIAL_OR_SPORADIC	PATIENT	STRING	Mpnst neurofibromatosis heredity	Mpnst nf familial or sporadic	1				
2043	2043	2043	2043	2043	2043	2043	2043	2043	2043	2043	2043	2043	2047	MPNST_NF_INDICATOR	PATIENT	STRING	Mpnst neurofibromatosis	Mpnst nf indicator	1				
2044	2044	2044	2044	2044	2044	2044	2044	2044	2044	2044	2044	2044	2048	MPNST_PLEXIFORM_NEUROFIBROMA_SITE	SAMPLE	STRING	Mpnst exisiting plexiform neurofibroma	Mpnst plexiform neurofibroma site	1				
2045	2045	2045	2045	2045	2045	2045	2045	2045	2045	2045	2045	2045	2049	MRD_AT_END_OF_COURSE_1	PATIENT	STRING	MRD at end of course 1.	MRD at end of Course 1	1				
2046	2046	2046	2046	2046	2046	2046	2046	2046	2046	2046	2046	2046	2050	MRD_AT_END_OF_COURSE_2	PATIENT	STRING	MRD at end of course 2.	MRD at end of Course 2	1				
2047	2047	2047	2047	2047	2047	2047	2047	2047	2047	2047	2047	2047	2051	MRD_END_CONSOLIDATION	PATIENT	NUMBER	MRD percentage at end of consolidation	MRD Percentage at end of Consolidation	1				
2048	2048	2048	2048	2048	2048	2048	2048	2048	2048	2048	2048	2048	2052	MRD_END_CONSOLIDATION_SENSITIVITY	PATIENT	NUMBER	MRD percentage at end of consolidation Sensitivity	MRD Percentage at end of Consolidation Sensitivity	1				
2049	2049	2049	2049	2049	2049	2049	2049	2049	2049	2049	2049	2049	2053	MRD_PERCENTAGE_AT_END_OF_COURSE_1	PATIENT	NUMBER	MRD percentage at end of course 1.	MRD Percentage at end of Course 1	1				
2050	2050	2050	2050	2050	2050	2050	2050	2050	2050	2050	2050	2050	2054	MRD_PERCENTAGE_AT_END_OF_COURSE_2	PATIENT	NUMBER	MRD percentage at end of course 2.	MRD Percentage at end of Course 2	1				
2051	2051	2051	2051	2051	2051	2051	2051	2051	2051	2051	2051	2051	2055	MRD_PERCENT_DAY_29	PATIENT	NUMBER	MRD percentage at day 29.	MRD Percentage Day 29	1				
2052	2052	2052	2052	2052	2052	2052	2052	2052	2052	2052	2052	2052	2056	MRD_PERCENT_DAY_29_SENSITIVITY	PATIENT	NUMBER	MRD percentage at day 29 Sensitivity	MRD Percentage Day 29 Sensitivity	1				
2053	2053	2053	2053	2053	2053	2053	2053	2053	2053	2053	2053	2053	2057	MRD_PERCENT_DAY_43	PATIENT	NUMBER	MRD percentage at day 43	MRD Percentage Day 43	1				
2054	2054	2054	2054	2054	2054	2054	2054	2054	2054	2054	2054	2054	2058	MRD_PERCENT_DAY_43_SENSITIVITY	PATIENT	NUMBER	MRD percentage at day 43 Sensitivity	MRD Percentage Day 43 Sensitivity	1				
2055	2055	2055	2055	2055	2055	2055	2055	2055	2055	2055	2055	2055	2059	MRD_PERCENT_DAY_8	PATIENT	NUMBER	MRD percentage at day 8	MRD Percentage Day 8	1				
2056	2056	2056	2056	2056	2056	2056	2056	2056	2056	2056	2056	2056	2060	MRD_PERCENT_DAY_8_SENSITIVITY	PATIENT	NUMBER	MRD percentage at day 8 Sensitivity	MRD Percentage Day 8 Sensitivity	1				
2057	2057	2057	2057	2057	2057	2057	2057	2057	2057	2057	2057	2057	2061	MRI	PATIENT	STRING	MRI	MRI	1				
2058	2058	2058	2058	2058	2058	2058	2058	2058	2058	2058	2058	2058	2062	MRI_RESULTS	PATIENT	STRING	Diagnostic mri result	Mri results	1				
2059	2059	2059	2059	2059	2059	2059	2059	2059	2059	2059	2059	2059	2063	MRNASEQ_DATA	SAMPLE	STRING	miRNAseq data.	miRNAseq Data	1				
2060	2060	2060	2060	2060	2060	2060	2060	2060	2060	2060	2060	2060	2064	MRNA_CLUSTER	SAMPLE	NUMBER	MRNA Cluster	MRNA Cluster	1				
2061	2061	2061	2061	2061	2061	2061	2061	2061	2061	2061	2061	2061	2065	MRNA_CLUSTER_K4	SAMPLE	STRING	MRNA CLUSTER K4	MRNA CLUSTER K4	1				
2062	2062	2062	2062	2062	2062	2062	2062	2062	2062	2062	2062	2062	2066	MRNA_DATA	SAMPLE	STRING	MRNA data.	MRNA Data	1				
2063	2063	2063	2063	2063	2063	2063	2063	2063	2063	2063	2063	2063	2067	MRNA_EXPRESSION_CLUSTER	SAMPLE	STRING	MRNA expression cluster.	MRNA Expression Cluster	1				
2064	2064	2064	2064	2064	2064	2064	2064	2064	2064	2064	2064	2064	2068	MRNA_EXPRESSION_CLUSTER_EC	SAMPLE	STRING	MRNA Expression Cluster EC	MRNA Expression Cluster EC	1				
2065	2065	2065	2065	2065	2065	2065	2065	2065	2065	2065	2065	2065	2069	MRNA_EXPRESSION_CLUSTER_GEA	SAMPLE	STRING	MRNA Expression Cluster GEA	MRNA Expression Cluster GEA	1				
2066	2066	2066	2066	2066	2066	2066	2066	2066	2066	2066	2066	2066	2070	MRNA_EXPRESSION_CLUSTER_SCC	SAMPLE	STRING	MRNA Expression Cluster SCC	MRNA Expression Cluster SCC	1				
2067	2067	2067	2067	2067	2067	2067	2067	2067	2067	2067	2067	2067	2071	MRNA_STATUS	SAMPLE	STRING	Yes/No indicator for mRNA data	mRNA Status	1				
2068	2068	2068	2068	2068	2068	2068	2068	2068	2068	2068	2068	2068	2072	MSH2_STATUS	SAMPLE	STRING	MSH2 Status	MSH2 Status	1				
2069	2069	2069	2069	2069	2069	2069	2069	2069	2069	2069	2069	2069	2073	MSH6_STATUS	SAMPLE	STRING	MSH6 Status	MSH6 Status	1				
2070	2070	2070	2070	2070	2070	2070	2070	2070	2070	2070	2070	2070	2074	MSI_COMMENT	SAMPLE	STRING	MSI Comment	MSI Comment	1				
2071	2071	2071	2071	2071	2071	2071	2071	2071	2071	2071	2071	2071	2075	MSI_MMR	SAMPLE	STRING	MSI MMR	MSI MMR	1				
2072	2072	2072	2072	2072	2072	2072	2072	2072	2072	2072	2072	2072	2076	MSI_PREDICTION_SCORE	SAMPLE	NUMBER	MSI Prediction Score	MSI Prediction Score	1				
2073	2073	2073	2073	2073	2073	2073	2073	2073	2073	2073	2073	2073	2077	MSI_SCORE	SAMPLE	NUMBER	MSI Score	MSI Score	1				
2074	2074	2074	2074	2074	2074	2074	2074	2074	2074	2074	2074	2074	2078	MSI_SENSOR_SCORE	SAMPLE	NUMBER	MSI Sensor Score	MSI Sensor Score	1				
2075	2075	2075	2075	2075	2075	2075	2075	2075	2075	2075	2075	2075	2079	MSI_STATUS	SAMPLE	STRING	MSI status.	MSI Status	1				
2076	2076	2076	2076	2076	2076	2076	2076	2076	2076	2076	2076	2076	2080	MSI_STATUS_5_MARKER_CALL	SAMPLE	STRING	MSI status 5 marker call.	MSI Status 5 Marker Call	1				
2077	2077	2077	2077	2077	2077	2077	2077	2077	2077	2077	2077	2077	2081	MSI_STATUS_7_MARKER_CALL	SAMPLE	STRING	MSI status 7 marker call.	MSI Status 7 Marker Call	1				
2078	2078	2078	2078	2078	2078	2078	2078	2078	2078	2078	2078	2078	2082	MSI_TYPE	SAMPLE	STRING	MSI Type	MSI Type	1				
2079	2079	2079	2079	2079	2079	2079	2079	2079	2079	2079	2079	2079	2083	MSKCC_CATEGORY	PATIENT	STRING	MSKCC Category	MSKCC Category	1				
2080	2080	2080	2080	2080	2080	2080	2080	2080	2080	2080	2080	2080	2084	MSK_DEPT	PATIENT	STRING	MSK Department	MSK Department	1				
2081	2081	2081	2081	2081	2081	2081	2081	2081	2081	2081	2081	2081	2085	MSK_NOMOGRAM	PATIENT	NUMBER	MSK Nomogram	MSK Nomogram	1				
2082	2082	2082	2082	2082	2082	2082	2082	2082	2082	2082	2082	2082	2086	MSK_REVIEW_DES	SAMPLE	STRING	Indicates if case was reviewed at MSKCC.	Reviewed at MSK	1				
2083	2083	2083	2083	2083	2083	2083	2083	2083	2083	2083	2083	2083	2087	MSK_THERAPEUTIC_CLINICAL_TRIAL	SAMPLE	STRING	Msk therapeutic clinical trial	Msk therapeutic clinical trial	1				
2084	2084	2084	2084	2084	2084	2084	2084	2084	2084	2084	2084	2084	2088	MSK_VISITS	PATIENT	STRING	Msk visits	Msk visits	1				
2085	2085	2085	2085	2085	2085	2085	2085	2085	2085	2085	2085	2085	2089	MSS_RL_ALL	SAMPLE	STRING	MSS RL ALL	MSS RL ALL	1				
2086	2086	2086	2086	2086	2086	2086	2086	2086	2086	2086	2086	2086	2090	MSS_RL_EARLY_STAGE	SAMPLE	STRING	MSS RL Early Stage	MSS RL Early Stage	1				
2087	2087	2087	2087	2087	2087	2087	2087	2087	2087	2087	2087	2087	2091	MSS_RL_MCRC	SAMPLE	STRING	MSS RL MCRC	MSS RL MCRC	1				
2088	2088	2088	2088	2088	2088	2088	2088	2088	2088	2088	2088	2088	2092	MSS_SAMPLES	SAMPLE	STRING	MSS Samples (Single Patient)	MSS Samples (Single Patient)	1				
2089	2089	2089	2089	2089	2089	2089	2089	2089	2089	2089	2089	2089	2093	MTOR_MUTATION_STATUS	SAMPLE	STRING	MTOR Mutation Status	MTOR Mutation Status	1				
2090	2090	2090	2090	2090	2090	2090	2090	2090	2090	2090	2090	2090	2094	MUCOID_STOOL_WEEKS	PATIENT	NUMBER	Mucoid Stool (Weeks)	Mucoid Stool (Weeks)	1				
2091	2091	2091	2091	2091	2091	2091	2091	2091	2091	2091	2091	2091	2095	MULTICENTRICITY	SAMPLE	STRING	Multicentricity	Multicentricity	1				
2092	2092	2092	2092	2092	2092	2092	2092	2092	2092	2092	2092	2092	2096	MULTIFOCAL	PATIENT	STRING	Multifocal	Multifocal	1				
2093	2093	2093	2093	2093	2093	2093	2093	2093	2093	2093	2093	2093	2097	MULTIPLE_BREAST_PRIMARIES	PATIENT	STRING	Multiple Breast Primaries	Multiple Breast Primaries	1				
2094	2094	2094	2094	2094	2094	2094	2094	2094	2094	2094	2094	2094	2098	MULTIPLE_BREAST_PRIMARIES_SEQUENCE	PATIENT	STRING	Multiple Breast Primaries Sequenced	Multiple Breast Primaries Sequenced	1				
2095	2095	2095	2095	2095	2095	2095	2095	2095	2095	2095	2095	2095	2099	MULTIPLE_HN_CSCC	PATIENT	STRING	Multiple Head and Neck cSCC	Multiple HN cSCC	1				
2096	2096	2096	2096	2096	2096	2096	2096	2096	2096	2096	2096	2096	2100	MULTIPLE_TUMORS	PATIENT	STRING	Multiple Tumors	Multiple Tumors	1				
2097	2097	2097	2097	2097	2097	2097	2097	2097	2097	2097	2097	2097	2101	MULTI_ERBB2	SAMPLE	STRING	Multi ERBB2	Multi ERBB2	1				
2098	2098	2098	2098	2098	2098	2098	2098	2098	2098	2098	2098	2098	2102	MUM1_STATUS	SAMPLE	STRING	MUM1 Status	MUM1 Status	1				
2099	2099	2099	2099	2099	2099	2099	2099	2099	2099	2099	2099	2099	2103	MUTATIONAL_SIGNATURES	SAMPLE	STRING	Mutational Signatures	Mutational Signatures	1				
2100	2100	2100	2100	2100	2100	2100	2100	2100	2100	2100	2100	2100	2104	MUTATIONAL_SIGNATURES_PVAL	SAMPLE	STRING	Mutational Signatures Pval	Mutational Signatures Pval	1				
2101	2101	2101	2101	2101	2101	2101	2101	2101	2101	2101	2101	2101	2105	MUTATIONA_SIGNATURES_PROPORTIONS	SAMPLE	NUMBER	Mutationa Signatures Proportions	Mutationa Signatures Proportions	1				
2102	2102	2102	2102	2102	2102	2102	2102	2102	2102	2102	2102	2102	2106	MUTATIONS	SAMPLE	NUMBER	Mutations	Mutations	1				
2103	2103	2103	2103	2103	2103	2103	2103	2103	2103	2103	2103	2103	2107	MUTATIONS_PER_MEGABASE	SAMPLE	NUMBER	Mutations per megabase	Mutations per megabase	1				
2104	2104	2104	2104	2104	2104	2104	2104	2104	2104	2104	2104	2104	2108	MUTATION_BURDEN	SAMPLE	STRING	Mutation Burden	Mutation Burden	1				
2105	2105	2105	2105	2105	2105	2105	2105	2105	2105	2105	2105	2105	2109	MUTATION_COUNT	SAMPLE	STRING	Mutation Count	Mutation Count	1				
2106	2106	2106	2106	2106	2106	2106	2106	2106	2106	2106	2106	2106	2110	MUTATION_FEATURE	SAMPLE	STRING	Mutation Feature	Mutation Feature	1				
2107	2107	2107	2107	2107	2107	2107	2107	2107	2107	2107	2107	2107	2111	MUTATION_LOAD	SAMPLE	NUMBER	Number of non-synonymous mutations	Mutation Load	1				
2108	2108	2108	2108	2108	2108	2108	2108	2108	2108	2108	2108	2108	2112	MUTATION_RATE	SAMPLE	NUMBER	Mutation Rate	Mutation Rate	1				
2109	2109	2109	2109	2109	2109	2109	2109	2109	2109	2109	2109	2109	2113	MUTATION_RATE_CLUSTER	SAMPLE	STRING	Mutation rate cluster	Mutation Rate Cluster	1				
2110	2110	2110	2110	2110	2110	2110	2110	2110	2110	2110	2110	2110	2114	MUTATION_STATUS	SAMPLE	STRING	Mutation Status	Mutation Status	1				
2111	2111	2111	2111	2111	2111	2111	2111	2111	2111	2111	2111	2111	2115	MUTATION_TYPE	SAMPLE	STRING	Mutation Type	Mutation Type	1				
2112	2112	2112	2112	2112	2112	2112	2112	2112	2112	2112	2112	2112	2116	MUTIPLE_NODULES	SAMPLE	STRING	Synchronous or metachronous nodules	Multiple Nodules	1				
2113	2113	2113	2113	2113	2113	2113	2113	2113	2113	2113	2113	2113	2117	MUTSIG_RATENON_PERMB	SAMPLE	NUMBER	Mutsig rate non-permb.	Mutsig Rate NON-PERMB	1				
2114	2114	2114	2114	2114	2114	2114	2114	2114	2114	2114	2114	2114	2118	MUTSIG_RATESIL_PERMB	SAMPLE	NUMBER	Mutsig rate sil-perbm.	Mutsig Rate SIL-PERMB	1				
2115	2115	2115	2115	2115	2115	2115	2115	2115	2115	2115	2115	2115	2119	MUTSIG_RATETOT_PERMB	SAMPLE	NUMBER	Mutsig rate tot-perbm	Mutsig Rate TOT-PERMB	1				
2116	2116	2116	2116	2116	2116	2116	2116	2116	2116	2116	2116	2116	2120	MUT_CANCER_GENE_CENSUS_PROTEIN_CHANGE	SAMPLE	STRING	Mutation Cancer Gene Census Protein Change	Mutation Cancer Gene Census Protein Change	1				
2117	2117	2117	2117	2117	2117	2117	2117	2117	2117	2117	2117	2117	2121	MUT_CLINDX_TX_GENE_PROTEIN_CHANGE	SAMPLE	STRING	Clinicaly relevant gene non-silent mutations; protein-change, alt allele counts	Clinicaly relevant gene non-silent mutations; protein-change, alt allele counts	1				
2118	2118	2118	2118	2118	2118	2118	2118	2118	2118	2118	2118	2118	2122	MUT_DNAREPAIR_GENE_PROTEIN_CHANGE	SAMPLE	STRING	DNA repair gene non-silent mutations ; protein-change, alt allele counts	DNA repair gene non-silent mutations ; protein-change, alt allele counts	1				
2119	2119	2119	2119	2119	2119	2119	2119	2119	2119	2119	2119	2119	2123	MUT_DRIVER_PROTEIN_CHANGE	SAMPLE	STRING	Non-silent mutation protein change BRAF, HRAS, NRAS, KRAS, EIF1AX: number of alternate allele counts	Non-silent mutation protein change BRAF, HRAS, NRAS, KRAS, EIF1AX: number of alternate allele counts	1				
2120	2120	2120	2120	2120	2120	2120	2120	2120	2120	2120	2120	2120	2124	MUT_EPIGENETIC_PROTEIN_CHANGE	SAMPLE	STRING	Epigenetic modifier gene with protein change and alt allel counts	Epigenetic modifier gene with protein change and alt allel counts	1				
2121	2121	2121	2121	2121	2121	2121	2121	2121	2121	2121	2121	2121	2125	MUT_OTHER_PROTEIN_CHANGE	SAMPLE	STRING	Interesting gene with protein change and alt allel counts	Interesting gene with protein change and alt allel counts	1				
2122	2122	2122	2122	2122	2122	2122	2122	2122	2122	2122	2122	2122	2126	MUT_RARE_DRIVER_PROTEIN_CHANGE	SAMPLE	STRING	Non-silent mutation protein change PP1MD, CHEK2, TSHR : number of alternate allele counts	Non-silent mutation protein change PP1MD, CHEK2, TSHR : number of alternate allele counts	1				
2123	2123	2123	2123	2123	2123	2123	2123	2123	2123	2123	2123	2123	2127	MUT_TUMORPORTAL_GENE_PROTEIN_CHANGE	SAMPLE	STRING	TumorPortal Gene Lawrence et. al. (2014) cancer genes non-silent mutations; protein-change, alt allele counts	TumorPortal Gene Lawrence et. al. (2014) cancer genes non-silent mutations; protein-change, alt allele counts	1				
2124	2124	2124	2124	2124	2124	2124	2124	2124	2124	2124	2124	2124	2128	MVEGF	PATIENT	NUMBER	Mvegf	Mvegf	1				
2125	2125	2125	2125	2125	2125	2125	2125	2125	2125	2125	2125	2125	2129	MVEGF1	PATIENT	NUMBER	Mvegf1	Mvegf1	1				
2126	2126	2126	2126	2126	2126	2126	2126	2126	2126	2126	2126	2126	2130	MVEGF2	PATIENT	NUMBER	Mvegf2	Mvegf2	1				
2127	2127	2127	2127	2127	2127	2127	2127	2127	2127	2127	2127	2127	2131	MYB_ABNORMALITY	SAMPLE	STRING	MYB Abnormality	MYB Abnormality	1				
2128	2128	2128	2128	2128	2128	2128	2128	2128	2128	2128	2128	2128	2132	MYB_ACTIVATION	PATIENT	STRING	Presence of MYB activation	MYB Activation	1				
2129	2129	2129	2129	2129	2129	2129	2129	2129	2129	2129	2129	2129	2133	MYB_FISH	SAMPLE	STRING	MYB FISH probe	MYB FISH probe	1				
2130	2130	2130	2130	2130	2130	2130	2130	2130	2130	2130	2130	2130	2134	MYB_IHC	SAMPLE	STRING	MYB-IHC	MYB-IHC	1				
2131	2131	2131	2131	2131	2131	2131	2131	2131	2131	2131	2131	2131	2135	MYB_MYBL1_FUSION	PATIENT	STRING	Description of MYB or MYBL1 fusions identified.	MYB or MYBL1 Fusion	1				
2132	2132	2132	2132	2132	2132	2132	2132	2132	2132	2132	2132	2132	2136	MYB_MYBL1_FUSION_METHOD	PATIENT	STRING	Method used to validate MYB or MYBL1 gene fusions.	MYB or MYBL1 Fusion Method	1				
2133	2133	2133	2133	2133	2133	2133	2133	2133	2133	2133	2133	2133	2137	MYB_MYBL1_REARRANGEMENT	PATIENT	STRING	Description of MYB or MYBL1 gene rearrangement(s) identified by RT-PCR/qPCR/WGS.	MYB or MYBL1 Gene Rearrangement	1				
2134	2134	2134	2134	2134	2134	2134	2134	2134	2134	2134	2134	2134	2138	MYB_NFIB_CNA	SAMPLE	STRING	MYB-NFIB Fusion Gene Copy Number Alterations	MYB-NFIB Fusion Gene Copy Number Alterations	1				
2135	2135	2135	2135	2135	2135	2135	2135	2135	2135	2135	2135	2135	2139	MYB_NFIB_FISH	SAMPLE	STRING	MYB-NFIB FISH.	MYB-NFIB FISH	1				
2136	2136	2136	2136	2136	2136	2136	2136	2136	2136	2136	2136	2136	2140	MYB_NFIB_NONSYNONYMOUS_COUNT	SAMPLE	STRING	Count of non-synonymous mutations in MYB-NFIB Fusion Gene	MYB-NFIB Fusion Gene Non-synonymous Mutations	1				
2137	2137	2137	2137	2137	2137	2137	2137	2137	2137	2137	2137	2137	2141	MYB_NFIB_REARRANGEMENT	SAMPLE	STRING	MYB-NFIB Rearrangement Description	MYB-NFIB Rearrangement	1				
2138	2138	2138	2138	2138	2138	2138	2138	2138	2138	2138	2138	2138	2142	MYB_NFIB_TRANSCRIPT	SAMPLE	STRING	MYB-NFIB Transcript description.	MYB-NFIB Transcript	1				
2139	2139	2139	2139	2139	2139	2139	2139	2139	2139	2139	2139	2139	2143	MYB_NFIB_TRANSLOCATION	PATIENT	STRING	Description of translocations resulting in MYB-NFIB gene fusions.	MYB-NFIB Translocation	1				
2140	2140	2140	2140	2140	2140	2140	2140	2140	2140	2140	2140	2140	2144	MYB_VALIDATION	PATIENT	STRING	Method used for validating MYB activation	MYB Validation Method	1				
2141	2141	2141	2141	2141	2141	2141	2141	2141	2141	2141	2141	2141	2145	MYCN	SAMPLE	STRING	MYCN.	MYCN	1				
2142	2142	2142	2142	2142	2142	2142	2142	2142	2142	2142	2142	2142	2146	MYCN_AMP	SAMPLE	STRING	MYCN Amplification	MYCN Amplification	1				
2143	2143	2143	2143	2143	2143	2143	2143	2143	2143	2143	2143	2143	2147	MYCN_FISH	SAMPLE	STRING	MYCN FISH	MYCN FISH	1				
2144	2144	2144	2144	2144	2144	2144	2144	2144	2144	2144	2144	2144	2148	MYCOPLASMA_TESTED	SAMPLE	STRING	Mycoplasma Tested	Mycoplasma Tested	1				
2145	2145	2145	2145	2145	2145	2145	2145	2145	2145	2145	2145	2145	2149	MYC_BA	PATIENT	STRING	Myc ba	Myc ba	1				
2146	2146	2146	2146	2146	2146	2146	2146	2146	2146	2146	2146	2146	2150	MYC_REAR	PATIENT	STRING	Myc Rearrangements	Myc Rearrangements	1				
2147	2147	2147	2147	2147	2147	2147	2147	2147	2147	2147	2147	2147	2151	M_SCORE	PATIENT	NUMBER	M Score	M Score	1				
2148	2148	2148	2148	2148	2148	2148	2148	2148	2148	2148	2148	2148	2152	M_STAGE	PATIENT	STRING	M Stage	M Stage	1				
2149	2149	2149	2149	2149	2149	2149	2149	2149	2149	2149	2149	2149	2153	NAACCR_ETHNICITY	PATIENT	NUMBER	NAACCR Ethnicity	NAACCR Ethnicity	1				
2150	2150	2150	2150	2150	2150	2150	2150	2150	2150	2150	2150	2150	2154	NAACCR_RACE	PATIENT	NUMBER	NAACCR Race	NAACCR Race	1				
2151	2151	2151	2151	2151	2151	2151	2151	2151	2151	2151	2151	2151	2155	NADIR_CD4_COUNTS	SAMPLE	NUMBER	NADIR CD4 Counts	NADIR CD4 Counts	1				
2152	2152	2152	2152	2152	2152	2152	2152	2152	2152	2152	2152	2152	2156	NASH	PATIENT	STRING	NASH	NASH	1				
2153	2153	2153	2153	2153	2153	2153	2153	2153	2153	2153	2153	2153	2157	NCNNCT_OTHMETHONSP	PATIENT	STRING	Ncnnct othmethonsp	Ncnnct othmethonsp	1				
2154	2154	2154	2154	2154	2154	2154	2154	2154	2154	2154	2154	2154	2158	NECK_DISSECTION_TYPE	SAMPLE	STRING	Neck Dissection type	Neck Dissection type	1				
2155	2155	2155	2155	2155	2155	2155	2155	2155	2155	2155	2155	2155	2159	NECK_RECURRENCE	PATIENT	STRING	Neck Recurrence	Neck Recurrence	1				
2156	2156	2156	2156	2156	2156	2156	2156	2156	2156	2156	2156	2156	2160	NECK_RFS_MONTHS	PATIENT	NUMBER	Neck Recurrence Free Survival (months)	Neck Recurrence Free Survival (months)	1				
2157	2157	2157	2157	2157	2157	2157	2157	2157	2157	2157	2157	2157	2161	NECROSIS	SAMPLE	STRING	Necrosis	Necrosis	1				
2158	2158	2158	2158	2158	2158	2158	2158	2158	2158	2158	2158	2158	2162	NEOADJUVANT_CHEMO	PATIENT	STRING	Neoadjuvant Chemotherapy.	Neoadjuvant Chemotherapy	1				
2159	2159	2159	2159	2159	2159	2159	2159	2159	2159	2159	2159	2159	2163	NEOADJUVANT_CHEMOTHERAPY_RESPONDER	PATIENT	STRING	Responder to Neoadjuvant Chemotherapy	Responder to Neoadjuvant Chemotherapy	1				
2160	2160	2160	2160	2160	2160	2160	2160	2160	2160	2160	2160	2160	2164	NEOADJUVANT_OR_ADJUVANT	PATIENT	STRING	Neoadjuvant or Adjuvant	Neoadjuvant or Adjuvant	1				
2161	2161	2161	2161	2161	2161	2161	2161	2161	2161	2161	2161	2161	2165	NEOADJUVANT_SYSTEMIC_CHEMO	PATIENT	STRING	Neoadjuvant   Systemic Chemotherapy	Neoadjuvant   Systemic Chemotherapy	1				
2162	2162	2162	2162	2162	2162	2162	2162	2162	2162	2162	2162	2162	2166	NEOADJUVANT_TX	PATIENT	STRING	Neoadjuvant Treatment	Neoadjuvant Treatment	1				
2163	2163	2163	2163	2163	2163	2163	2163	2163	2163	2163	2163	2163	2167	NEOADJ_CHEMO	PATIENT	STRING	Neoadjuvant Chemotherapy.	Neoadjuvant Chemotherapy	1				
2164	2164	2164	2164	2164	2164	2164	2164	2164	2164	2164	2164	2164	2168	NEOADJ_TX_BEFORE_FIRST_SURGERY	PATIENT	STRING	Neoadj Systemic Treatment Before First Surgery	Neoadj Systemic Treatment Before First Surgery	1				
2165	2165	2165	2165	2165	2165	2165	2165	2165	2165	2165	2165	2165	2169	NEOAGCNT	SAMPLE	NUMBER	Number of neoepitops per sample	Neo-antigen Load	1				
2166	2166	2166	2166	2166	2166	2166	2166	2166	2166	2166	2166	2166	2170	NEOANTIGEN_BURDEN	PATIENT	NUMBER	Neoantigen Burden	Neoantigen Burden	1				
2167	2167	2167	2167	2167	2167	2167	2167	2167	2167	2167	2167	2167	2171	NEOCRX	PATIENT	NUMBER	Neocrx	Neocrx	1				
2168	2168	2168	2168	2168	2168	2168	2168	2168	2168	2168	2168	2168	2172	NEORX	PATIENT	NUMBER	Neorx	Neorx	1				
2169	2169	2169	2169	2169	2169	2169	2169	2169	2169	2169	2169	2169	2173	NEPC_SCORE	SAMPLE	NUMBER	NEPC Score	NEPC Score	1				
2170	2170	2170	2170	2170	2170	2170	2170	2170	2170	2170	2170	2170	2174	NEUROENDOCRINE_CARCINOMA	PATIENT	STRING	Neuroendocrine carcinoma	Neuroendocrine carcinoma	1				
2171	2171	2171	2171	2171	2171	2171	2171	2171	2171	2171	2171	2171	2175	NEUROENDOCRINE_FEATURES	SAMPLE	STRING	Neuroendocrine Features	Neuroendocrine Features	1				
2172	2172	2172	2172	2172	2172	2172	2172	2172	2172	2172	2172	2172	2176	NEUTROPHILS	SAMPLE	NUMBER	Neutrophils	Neutrophils	1				
2173	2173	2173	2173	2173	2173	2173	2173	2173	2173	2173	2173	2173	2177	NEW_NEOPLASM_EVENT_OCCURRENCE_ANATOMIC_SITE	SAMPLE	STRING	New neoplasm event occurence anatomic site	New Neoplasm Event Occurence Anatomic Site	1				
2174	2174	2174	2174	2174	2174	2174	2174	2174	2174	2174	2174	2174	2178	NEW_NEOPLASM_EVENT_TYPE	SAMPLE	STRING	New neoplasm event type.	New Neoplasm Event Type	1				
2175	2175	2175	2175	2175	2175	2175	2175	2175	2175	2175	2175	2175	2179	NEW_NEOPLASM_EVENT_TYPE_1	PATIENT	STRING	New Neoplasm Event Type 1	New Neoplasm Event Type 1	1				
2176	2176	2176	2176	2176	2176	2176	2176	2176	2176	2176	2176	2176	2180	NEW_PRIMARY_TESTIS_TUMOR	PATIENT	STRING	New Primary testis tumor	New Primary testis tumor	1				
2177	2177	2177	2177	2177	2177	2177	2177	2177	2177	2177	2177	2177	2181	NEW_TUMOR	PATIENT	STRING	Emergence of new tumor	Emergence of New Tumor	1				
2178	2178	2178	2178	2178	2178	2178	2178	2178	2178	2178	2178	2178	2182	NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT	PATIENT	STRING	Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.	New Neoplasm Event Post Initial Therapy Indicator	1				
2179	2179	2179	2179	2179	2179	2179	2179	2179	2179	2179	2179	2179	2183	NEW_TUMOR_EVENT_DX_INDICATOR	PATIENT	STRING	New tumor event dx indicator	New tumor event dx indicator	1				
2180	2180	2180	2180	2180	2180	2180	2180	2180	2180	2180	2180	2180	2184	NEW_TUMOR_EVENT_MELANOMA_COUNT	PATIENT	NUMBER	Primary anatomic site count	New tumor event melanoma count	1				
2181	2181	2181	2181	2181	2181	2181	2181	2181	2181	2181	2181	2181	2185	NEW_TUMOR_EVENT_OTHER_SITE	PATIENT	STRING	Other Site of New Tumor Event	Other Site of New Tumor Event	1				
2182	2182	2182	2182	2182	2182	2182	2182	2182	2182	2182	2182	2182	2186	NEW_TUMOR_EVENT_PRIOR_TO_BCR_TUMOR	PATIENT	STRING	New tumor dx prior submitted specimen dx	New tumor event prior to bcr tumor	1				
2183	2183	2183	2183	2183	2183	2183	2183	2183	2183	2183	2183	2183	2187	NEW_TUMOR_EVENT_SITE	SAMPLE	STRING	New Tumor Event Site	New Tumor Event Site	1				
2184	2184	2184	2184	2184	2184	2184	2184	2184	2184	2184	2184	2184	2188	NEW_TUMOR_EVENT_TYPE	SAMPLE	STRING	New Tumor Event Type	New Tumor Event Type	1				
2185	2185	2185	2185	2185	2185	2185	2185	2185	2185	2185	2185	2185	2189	NF1_GERMLINE	SAMPLE	STRING	NF1 Germline Mutation	NF1 Germline Mutation	1				
2186	2186	2186	2186	2186	2186	2186	2186	2186	2186	2186	2186	2186	2190	NF1_MUTATION	SAMPLE	STRING	NF1 Mutation	NF1 Mutation	1				
2187	2187	2187	2187	2187	2187	2187	2187	2187	2187	2187	2187	2187	2191	NF1_SOMATIC	SAMPLE	STRING	NF1 Somatic Mutation	NF1 Somatic Mutation	1				
2188	2188	2188	2188	2188	2188	2188	2188	2188	2188	2188	2188	2188	2192	NF2_FISH	SAMPLE	STRING	FISH Test on NF2	FISH Test on NF2	1				
2189	2189	2189	2189	2189	2189	2189	2189	2189	2189	2189	2189	2189	2193	NF2_FUSION	SAMPLE	STRING	NF2 Fusion	NF2 Fusion	1				
2190	2190	2190	2190	2190	2190	2190	2190	2190	2190	2190	2190	2190	2194	NF2_STATUS_ARRAY	SAMPLE	STRING	NF2 status 2.5M array	NF2 status 2.5M array	1				
2191	2191	2191	2191	2191	2191	2191	2191	2191	2191	2191	2191	2191	2195	NFIB_FISH	SAMPLE	STRING	NFIB FISH.	NFIB FISH	1				
2192	2192	2192	2192	2192	2192	2192	2192	2192	2192	2192	2192	2192	2196	NFIB_FUSION_OTHER	PATIENT	STRING	Description of other NFIB fusions.	Other NFIB Fusion	1				
2193	2193	2193	2193	2193	2193	2193	2193	2193	2193	2193	2193	2193	2197	NGS_TEST	SAMPLE	STRING	Sample was NGS tested	NGS Tested	1				
2194	2194	2194	2194	2194	2194	2194	2194	2194	2194	2194	2194	2194	2198	NI	PATIENT	NUMBER	Ni	Ni	1				
2195	2195	2195	2195	2195	2195	2195	2195	2195	2195	2195	2195	2195	2199	NK_CELLS_ACTIVATED	SAMPLE	NUMBER	NK cells activated	NK cells activated	1				
2196	2196	2196	2196	2196	2196	2196	2196	2196	2196	2196	2196	2196	2200	NK_CELLS_RESTING	SAMPLE	NUMBER	NK cells resting	NK cells resting	1				
2197	2197	2197	2197	2197	2197	2197	2197	2197	2197	2197	2197	2197	2201	NODAL_DESC	SAMPLE	STRING	Describes Site of first recurrence of patient�۪s primary melanoma. Describes if there are/is metastases to the regional nodal basin.	If There Are/Is Metastases To The Regional Nodal Basin	1				
2198	2198	2198	2198	2198	2198	2198	2198	2198	2198	2198	2198	2198	2202	NODAL_STAGE	PATIENT	STRING	Nodal stage	Nodal stage	1				
2199	2199	2199	2199	2199	2199	2199	2199	2199	2199	2199	2199	2199	2203	NODAL_STATUS	SAMPLE	STRING	Nodal Status	Nodal Status	1				
2200	2200	2200	2200	2200	2200	2200	2200	2200	2200	2200	2200	2200	2204	NODES	SAMPLE	STRING	NODES	NODES	1				
2201	2201	2201	2201	2201	2201	2201	2201	2201	2201	2201	2201	2201	2205	NODES_DETAILS	PATIENT	STRING	Nodes details.	Nodes Details	1				
2202	2202	2202	2202	2202	2202	2202	2202	2202	2202	2202	2202	2202	2206	NODES_EX	SAMPLE	NUMBER	Nodes Ex	Nodes Ex	1				
2203	2203	2203	2203	2203	2203	2203	2203	2203	2203	2203	2203	2203	2207	NODE_CODED	SAMPLE	STRING	Node-Coded	Node-Coded	1				
2204	2204	2204	2204	2204	2204	2204	2204	2204	2204	2204	2204	2204	2208	NODULE_NUMBER	PATIENT	STRING	Number of Nodules	Number of Nodules	1				
2205	2205	2205	2205	2205	2205	2205	2205	2205	2205	2205	2205	2205	2209	NODULE_SIZE	SAMPLE	NUMBER	Nodule Size (mm)	Nodule Size (mm)	1				
2206	2206	2206	2206	2206	2206	2206	2206	2206	2206	2206	2206	2206	2210	NONINVASIVE_BLADDER_CA_TX_TYPE	PATIENT	STRING	Noninvasive Bladder Cancer Treatment Type	Noninvasive Bladder Cancer Treatment Type	1				
2207	2207	2207	2207	2207	2207	2207	2207	2207	2207	2207	2207	2207	2211	NONINVASIVE_BLADDER_HISTORY	PATIENT	STRING	History of Noninvasive Bladder Cancer	History of Noninvasive Bladder Cancer	1				
2208	2208	2208	2208	2208	2208	2208	2208	2208	2208	2208	2208	2208	2212	NONSENSE_MUTATION	SAMPLE	STRING	Nonsense Mutations	Nonsense Mutations	1				
2209	2209	2209	2209	2209	2209	2209	2209	2209	2209	2209	2209	2209	2213	NONSILENT_DENSITY_AGE_FIT	SAMPLE	NUMBER	Nonsilent Mutation Density Residual with Age Fit	Nonsilent Mutation Density Residual with Age Fit	1				
2210	2210	2210	2210	2210	2210	2210	2210	2210	2210	2210	2210	2210	2214	NONSILENT_MUTATION_DENSITY	SAMPLE	NUMBER	Nonsilent Mutation Density	Nonsilent Mutation Density	1				
2211	2211	2211	2211	2211	2211	2211	2211	2211	2211	2211	2211	2211	2215	NONSILENT_PER_MB	SAMPLE	STRING	Non Silent per Mb	Non Silent per Mb	1				
2212	2212	2212	2212	2212	2212	2212	2212	2212	2212	2212	2212	2212	2216	NONSILENT_RATE	SAMPLE	NUMBER	Nonsilent Mutation Rate	Nonsilent Mutation Rate	1				
2213	2213	2213	2213	2213	2213	2213	2213	2213	2213	2213	2213	2213	2217	NONSTOP_MUTATION	SAMPLE	STRING	Nonstop Mutations	Nonstop Mutations	1				
2214	2214	2214	2214	2214	2214	2214	2214	2214	2214	2214	2214	2214	2218	NONSYNONYMOUS_MUTATION_BURDEN	PATIENT	NUMBER	Nonsynonymous Mutation Burden	Nonsynonymous Mutation Burden	1				
2215	2215	2215	2215	2215	2215	2215	2215	2215	2215	2215	2215	2215	2219	NONSYNONYMOUS_MUTATION_RATE	SAMPLE	NUMBER	Non-synonymous Mutation Rate	Non-synonymous Mutation Rate	1				
2216	2216	2216	2216	2216	2216	2216	2216	2216	2216	2216	2216	2216	2220	NON_SILENT_MUTATION	SAMPLE	STRING	Non Silent Mutations	Non Silent Mutations	1				
2217	2217	2217	2217	2217	2217	2217	2217	2217	2217	2217	2217	2217	2221	NON_SILENT_MUT_TP53_ATRX_CIC_FUBP1	SAMPLE	STRING	Non-silent mutations in TP53, ATRX, CIC, FUBP1	Non-silent mutations in TP53, ATRX, CIC, FUBP1	1				
2218	2218	2218	2218	2218	2218	2218	2218	2218	2218	2218	2218	2218	2222	NON_SILENT_SNV	SAMPLE	NUMBER	Non-Slient Single-Nucleotide Variants	Non-Slient SNVs	1				
2219	2219	2219	2219	2219	2219	2219	2219	2219	2219	2219	2219	2219	2223	NON_STANDARD_ADJUVANT	PATIENT	STRING	Non-Standard Adjuvant	Non-Standard Adjuvant	1				
2220	2220	2220	2220	2220	2220	2220	2220	2220	2220	2220	2220	2220	2224	NOREPINEPHRINE	SAMPLE	STRING	Norepinephrine Secreting	Norepinephrine Secreting	1				
2221	2221	2221	2221	2221	2221	2221	2221	2221	2221	2221	2221	2221	2225	NORMAL	SAMPLE	STRING	Normal	Normal	1				
2222	2222	2222	2222	2222	2222	2222	2222	2222	2222	2222	2222	2222	2226	NORMAL_EPITHELIUM_PERCENTAGE	SAMPLE	NUMBER	% Normal Epithelium	% Normal Epithelium	1				
2223	2223	2223	2223	2223	2223	2223	2223	2223	2223	2223	2223	2223	2227	NORMAL_EXOME_DEPTH	SAMPLE	NUMBER	Normal Exome Depth	Normal Exome Depth	1				
2224	2224	2224	2224	2224	2224	2224	2224	2224	2224	2224	2224	2224	2228	NORMAL_GENOME_COVERAGE	SAMPLE	NUMBER	Normal Genome Coverage	Normal Genome Coverage	1				
2225	2225	2225	2225	2225	2225	2225	2225	2225	2225	2225	2225	2225	2229	NORMAL_GENOME_LIBRARY	SAMPLE	STRING	Normal Genome Library	Normal Genome Library	1				
2226	2226	2226	2226	2226	2226	2226	2226	2226	2226	2226	2226	2226	2230	NORMAL_SITE	SAMPLE	STRING	Tissue where normal was derived.	Normal location	1				
2227	2227	2227	2227	2227	2227	2227	2227	2227	2227	2227	2227	2227	2231	NORMETANEPHRINE	SAMPLE	STRING	Normetanephrine secreting	Normetanephrine secreting	1				
2228	2228	2228	2228	2228	2228	2228	2228	2228	2228	2228	2228	2228	2232	NOSYSTXT	PATIENT	STRING	What is the number of prior systemic therapies (Inclusion of endocrine, cytotoxic, biologic therapies)?	What is the number of prior systemic therapies (Inclusion of endocrine, cytotoxic, biologic therapies)?	1				
2229	2229	2229	2229	2229	2229	2229	2229	2229	2229	2229	2229	2229	2233	NOTE	SAMPLE	STRING	Note.	Note	1				
2230	2230	2230	2230	2230	2230	2230	2230	2230	2230	2230	2230	2230	2234	NO_CHEMO_PROGRESSIVE	SAMPLE	STRING	No Chemo Progressive	No Chemo Progressive	1				
2231	2231	2231	2231	2231	2231	2231	2231	2231	2231	2231	2231	2231	2235	NO_CHEMO_PROGRESSIVE_PRIOR_BCG	SAMPLE	STRING	No Chemo Progressive Prior Bcg	No Chemo Progressive Prior Bcg	1				
2232	2232	2232	2232	2232	2232	2232	2232	2232	2232	2232	2232	2232	2236	NPI	PATIENT	NUMBER	Nottingham prognostic index	Nottingham prognostic index	1				
2233	2233	2233	2233	2233	2233	2233	2233	2233	2233	2233	2233	2233	2237	NPM1_NEGATIVE	SAMPLE	STRING	Negative for NPM1	Negative for NPM1	1				
2234	2234	2234	2234	2234	2234	2234	2234	2234	2234	2234	2234	2234	2238	NPM1_POSITIVE	SAMPLE	STRING	Positive for NPM1	Positive for NPM1	1				
2235	2235	2235	2235	2235	2235	2235	2235	2235	2235	2235	2235	2235	2239	NPM_MUTATION	SAMPLE	STRING	NPM mutation.	NPM Mutation	1				
2236	2236	2236	2236	2236	2236	2236	2236	2236	2236	2236	2236	2236	2240	NRAS_MUTATION	SAMPLE	STRING	NRAS Mutation	NRAS Mutation	1				
2237	2237	2237	2237	2237	2237	2237	2237	2237	2237	2237	2237	2237	2241	NRAS_STATUS	SAMPLE	STRING	nras status	nras status	1				
2238	2238	2238	2238	2238	2238	2238	2238	2238	2238	2238	2238	2238	2242	NSAID_USE	PATIENT	STRING	NSAID Used	NSAID Used	1				
2239	2239	2239	2239	2239	2239	2239	2239	2239	2239	2239	2239	2239	2243	NTAI	SAMPLE	NUMBER	NtAI	NtAI	1				
2240	2240	2240	2240	2240	2240	2240	2240	2240	2240	2240	2240	2240	2244	NTE_AFTER_INITIAL_TREATMENT	PATIENT	STRING	New Tumor Event After Initial Treatment	New Tumor Event After Initial Treatment	1				
2241	2241	2241	2241	2241	2241	2241	2241	2241	2241	2241	2241	2241	2245	NTE_CENT17_HER2_OTHER_SCALE	SAMPLE	STRING	Metastatic breast carcinoma pos finding other scale measurement text	Nte cent17 HER2 other scale	1				
2242	2242	2242	2242	2242	2242	2242	2242	2242	2242	2242	2242	2242	2246	NTE_CENT_17_HER2_RATIO	SAMPLE	NUMBER	Metastatic breast carcinoma HER2 neu chromosone 17 signal ratio value	Nte cent 17 HER2 ratio	1				
2243	2243	2243	2243	2243	2243	2243	2243	2243	2243	2243	2243	2243	2247	NTE_CENT_17_SIGNAL_NUMBER	SAMPLE	STRING	Metastatic breast carcinoma fluorescence in situ hybridization diagnostic proc centromere 17 signal result range	Nte cent 17 signal number	1				
2244	2244	2244	2244	2244	2244	2244	2244	2244	2244	2244	2244	2244	2248	NTE_ER_IHC_INTENSITY_SCORE	SAMPLE	STRING	Metastatic breast carcinoma immunohistochemistry er pos cell score	Nte er ihc intensity score	1				
2245	2245	2245	2245	2245	2245	2245	2245	2245	2245	2245	2245	2245	2249	NTE_ER_POSITIVITY_DEFINE_METHOD	SAMPLE	STRING	Metastatic breast carcinoma estrogen receptor detection method text	Nte er positivity define method	1				
2246	2246	2246	2246	2246	2246	2246	2246	2246	2246	2246	2246	2246	2250	NTE_ER_POSITIVITY_OTHER_SCALE	SAMPLE	STRING	Pos finding metastatic breast carcinoma estrogen receptor other measuremenet scale text	Nte er positivity other scale	1				
2247	2247	2247	2247	2247	2247	2247	2247	2247	2247	2247	2247	2247	2251	NTE_ER_STATUS	SAMPLE	STRING	Metastatic breast carcinoma estrogen receptor status	Nte er status	1				
2248	2248	2248	2248	2248	2248	2248	2248	2248	2248	2248	2248	2248	2252	NTE_ER_STATUS_IHC__POSITIVE	SAMPLE	STRING	Metastatic breast carcinoma estrogen receptor level cell percent category	Nte er status ihc positive	1				
2249	2249	2249	2249	2249	2249	2249	2249	2249	2249	2249	2249	2249	2253	NTE_HER2_FISH_DEFINE_METHOD	SAMPLE	STRING	Metastatic breast carcinoma HER2 erbb pos finding fluorescence in situ hybridization calculation method text	Nte HER2 fish define method	1				
2250	2250	2250	2250	2250	2250	2250	2250	2250	2250	2250	2250	2250	2254	NTE_HER2_FISH_STATUS	SAMPLE	STRING	Metastatic breast carcinoma lab proc HER2 neu in situ hybridization outcome type	Nte HER2 fish status	1				
2251	2251	2251	2251	2251	2251	2251	2251	2251	2251	2251	2251	2251	2255	NTE_HER2_POSITIVITY_IHC_SCORE	SAMPLE	STRING	Metastatic breast carcinoma erbb2 immunohistochemistry level result	Nte HER2 positivity ihc score	1				
2252	2252	2252	2252	2252	2252	2252	2252	2252	2252	2252	2252	2252	2256	NTE_HER2_POSITIVITY_METHOD	SAMPLE	STRING	Metastatic breast carcinoma HER2 erbb method calculation method text	Nte HER2 positivity method	1				
2253	2253	2253	2253	2253	2253	2253	2253	2253	2253	2253	2253	2253	2257	NTE_HER2_POSITIVITY_OTHER_SCALE	SAMPLE	STRING	Metastatic breast carcinoma pos finding HER2 erbb2 other measure scale text	Nte HER2 positivity other scale	1				
2254	2254	2254	2254	2254	2254	2254	2254	2254	2254	2254	2254	2254	2258	NTE_HER2_SIGNAL_NUMBER	SAMPLE	STRING	HER2 neu metastatic breast carcinoma copy analysis input total number	Nte HER2 signal number	1				
2255	2255	2255	2255	2255	2255	2255	2255	2255	2255	2255	2255	2255	2259	NTE_HER2_STATUS	SAMPLE	STRING	Metastatic breast carcinoma lab proc HER2 neu immunohistochemistry receptor status	Nte HER2 status	1				
2256	2256	2256	2256	2256	2256	2256	2256	2256	2256	2256	2256	2256	2260	NTE_HER2_STATUS_IHC__POSITIVE	SAMPLE	STRING	Metastatic breast carcinoma HER2 erbb pos finding cell percent category	Nte HER2 status ihc positive	1				
2257	2257	2257	2257	2257	2257	2257	2257	2257	2257	2257	2257	2257	2261	NTE_LESION_PATHOLOGIC_DEPTH	SAMPLE	NUMBER	Nte lesion pathologic depth	Nte lesion pathologic depth	1				
2258	2258	2258	2258	2258	2258	2258	2258	2258	2258	2258	2258	2258	2262	NTE_LESION_PATHOLOGIC_LENGTH	SAMPLE	NUMBER	Nte lesion pathologic length	Nte lesion pathologic length	1				
2259	2259	2259	2259	2259	2259	2259	2259	2259	2259	2259	2259	2259	2263	NTE_LESION_PATHOLOGIC_WIDTH	SAMPLE	NUMBER	Nte lesion pathologic width	Nte lesion pathologic width	1				
2260	2260	2260	2260	2260	2260	2260	2260	2260	2260	2260	2260	2260	2264	NTE_LESION_RADIOLOGIC_DEPTH	SAMPLE	NUMBER	Nte lesion radiologic depth	Nte lesion radiologic depth	1				
2261	2261	2261	2261	2261	2261	2261	2261	2261	2261	2261	2261	2261	2265	NTE_LESION_RADIOLOGIC_LENGTH	SAMPLE	NUMBER	Nte lesion radiologic length	Nte lesion radiologic length	1				
2262	2262	2262	2262	2262	2262	2262	2262	2262	2262	2262	2262	2262	2266	NTE_LESION_RADIOLOGIC_WIDTH	SAMPLE	NUMBER	Nte lesion radiologic width	Nte lesion radiologic width	1				
2263	2263	2263	2263	2263	2263	2263	2263	2263	2263	2263	2263	2263	2267	NTE_PR_IHC_INTENSITY_SCORE	SAMPLE	NUMBER	Metastatic breast carcinoma immunohistochemistry pr pos cell score	Nte pr ihc intensity score	1				
2264	2264	2264	2264	2264	2264	2264	2264	2264	2264	2264	2264	2264	2268	NTE_PR_POSITIVITY_DEFINE_METHOD	SAMPLE	STRING	Metastatic breast carcinoma progesterone receptor detection method text	Nte pr positivity define method	1				
2265	2265	2265	2265	2265	2265	2265	2265	2265	2265	2265	2265	2265	2269	NTE_PR_POSITIVITY_OTHER_SCALE	SAMPLE	STRING	Metastatic breast carcinoma pos finding progesterone receptor other measure scale text	Nte pr positivity other scale	1				
2266	2266	2266	2266	2266	2266	2266	2266	2266	2266	2266	2266	2266	2270	NTE_PR_STATUS_BY_IHC	SAMPLE	STRING	Metastatic breast carcinoma progesterone receptor status	Nte pr status by ihc	1				
2267	2267	2267	2267	2267	2267	2267	2267	2267	2267	2267	2267	2267	2271	NTE_PR_STATUS_IHC__POSITIVE	SAMPLE	STRING	Metastatic breast carcinoma progesterone receptor level cell percent category	Nte pr status ihc positive	1				
2268	2268	2268	2268	2268	2268	2268	2268	2268	2268	2268	2268	2268	2272	NUCLEAR_GRADE	PATIENT	STRING	Nuclear Grade	Nuclear Grade	1				
2269	2269	2269	2269	2269	2269	2269	2269	2269	2269	2269	2269	2269	2273	NUCLEAR_GRADE_III_IV	PATIENT	STRING	Nuclear Grade III IV	Nuclear Grade III IV	1				
2270	2270	2270	2270	2270	2270	2270	2270	2270	2270	2270	2270	2270	2274	NUMBER_DOSES_IT_THERAPY	PATIENT	STRING	Number of Doses IT Therapy	Number of Doses IT Therapy	1				
2271	2271	2271	2271	2271	2271	2271	2271	2271	2271	2271	2271	2271	2275	NUMBER_OF_LINES_OF_TREATMENT_FOR_MET_DISEASE	PATIENT	NUMBER	Number of Lines of Treatment For Met Disease	Number of Lines of Treatment For Met Disease	1				
2272	2272	2272	2272	2272	2272	2272	2272	2272	2272	2272	2272	2272	2276	NUMBER_OF_LINES_POST_IMPACT	PATIENT	STRING	Number of Lines post IMPACT	Number of Lines post IMPACT	1				
2273	2273	2273	2273	2273	2273	2273	2273	2273	2273	2273	2273	2273	2277	NUMBER_OF_LYMPHNODES_POSITIVE	SAMPLE	STRING	Positive Finding Lymph Node	Positive Finding Lymph Node	1				
2274	2274	2274	2274	2274	2274	2274	2274	2274	2274	2274	2274	2274	2278	NUMBER_OF_LYMPHNODES_POSITIVE_BY_HE	PATIENT	NUMBER	Numeric value to signify the count of positive lymph nodes identified through hematoxylin and eosin (H&E) staining light microscopy.	Positive Finding Lymph Node Hematoxylin and Eosin Staining Microscopy Count	1				
2275	2275	2275	2275	2275	2275	2275	2275	2275	2275	2275	2275	2275	2279	NUMBER_OF_LYMPHNODES_POSITIVE_BY_IHC	PATIENT	STRING	Number of lymphnodes positive by ihc	Number of lymphnodes positive by ihc	1				
2276	2276	2276	2276	2276	2276	2276	2276	2276	2276	2276	2276	2276	2280	NUMBER_OF_ONCOGENIC_MUTATIONS	SAMPLE	STRING	Number of Oncogenic Mutations	Number of Oncogenic Mutations	1				
2277	2277	2277	2277	2277	2277	2277	2277	2277	2277	2277	2277	2277	2281	NUMBER_OF_PRIMARY_SITES	PATIENT	STRING	Number of Primary Sites	Number of Primary Sites	1				
2278	2278	2278	2278	2278	2278	2278	2278	2278	2278	2278	2278	2278	2282	NUMBER_OF_RELATIVES_DIAGNOSED	SAMPLE	NUMBER	Number of relatives diagnosed	Number of relatives diagnosed	1				
2279	2279	2279	2279	2279	2279	2279	2279	2279	2279	2279	2279	2279	2283	NUMBER_OF_RELATIVES_WITH_STOMACH_CANCER	PATIENT	STRING	Number of relatives with stomach cancer.	Number of Relatives w/Stomach Cancer	1				
2280	2280	2280	2280	2280	2280	2280	2280	2280	2280	2280	2280	2280	2284	NUMBER_OF_SITES	SAMPLE	NUMBER	Number Of Sites	Number Of Sites	1				
2281	2281	2281	2281	2281	2281	2281	2281	2281	2281	2281	2281	2281	2285	NUMBER_OF_TARGET_THERAPIES_RECEIVED	PATIENT	STRING	Number Of Targeted Therapies Received Relevant To Impact Results	Number Of Targeted Therapies Received Relevant To Impact Results	1				
2282	2282	2282	2282	2282	2282	2282	2282	2282	2282	2282	2282	2282	2286	NUMBER_OF_TUMORS	PATIENT	NUMBER	Number of Tumors	Number of Tumors	1				
2283	2283	2283	2283	2283	2283	2283	2283	2283	2283	2283	2283	2283	2287	NUMBER_OF_VIAL	SAMPLE	STRING	Vial number	Vial number	1				
2284	2284	2284	2284	2284	2284	2284	2284	2284	2284	2284	2284	2284	2288	NUMBER_PRIOR_THEARPY_REGIMENS	PATIENT	STRING	Number Prior Thearpy Regimens	Number Prior Thearpy Regimens	1				
2285	2285	2285	2285	2285	2285	2285	2285	2285	2285	2285	2285	2285	2289	NUMBER_VIAL	SAMPLE	STRING	Vial Number	Vial Number	1				
2286	2286	2286	2286	2286	2286	2286	2286	2286	2286	2286	2286	2286	2290	NUM_EXTRANODAL_SITES	PATIENT	NUMBER	Number of Extranodal Sites of Disease	Number of Extranodal Sites of Disease	1				
2287	2287	2287	2287	2287	2287	2287	2287	2287	2287	2287	2287	2287	2291	NUM_GENOME_WIDE_SOMATIC_MUTATIONS	SAMPLE	NUMBER	Number of Genome-Wide Somatic Mutations	Number of Genome-Wide Somatic Mutations	1				
2288	2288	2288	2288	2288	2288	2288	2288	2288	2288	2288	2288	2288	2292	NUM_MUT_APOBEC	SAMPLE	NUMBER	APOBEC Mutation Number	APOBEC Mutation Number	1				
2289	2289	2289	2289	2289	2289	2289	2289	2289	2289	2289	2289	2289	2293	NUM_MUT_CPGT	SAMPLE	NUMBER	CpGT Mutation Number	CpGT Mutation Number	1				
2290	2290	2290	2290	2290	2290	2290	2290	2290	2290	2290	2290	2290	2294	NUM_MUT_DBSNP	SAMPLE	NUMBER	Number of mutations in dbSNP	Number of mutations in dbSNP	1				
2291	2291	2291	2291	2291	2291	2291	2291	2291	2291	2291	2291	2291	2295	NUM_NONSILENT_MUTATION	SAMPLE	NUMBER	Total Number of Nonsilent Mutation	Total Number of Nonsilent Mutation	1				
2292	2292	2292	2292	2292	2292	2292	2292	2292	2292	2292	2292	2292	2296	NUM_PRIOR_THERAPIES	PATIENT	NUMBER	Number of Prior Therapies	Number of Prior Therapies	1				
2293	2293	2293	2293	2293	2293	2293	2293	2293	2293	2293	2293	2293	2297	NUM_SAMPLES_CAPTURE_MULTIPLEX	SAMPLE	STRING	NUM SAMPLES CAPTURE MULTIPLEX	NUM SAMPLES CAPTURE MULTIPLEX	1				
2294	2294	2294	2294	2294	2294	2294	2294	2294	2294	2294	2294	2294	2298	NUM_SILENT_MUTATION	SAMPLE	NUMBER	Total Number of Silent Mutation	Total Number of Silent Mutation	1				
2295	2295	2295	2295	2295	2295	2295	2295	2295	2295	2295	2295	2295	2299	NUM_SNV_WITHOUT_SNP	SAMPLE	NUMBER	Number of SNVs (Without SNPs)	Number of SNVs (Without SNPs)	1				
2296	2296	2296	2296	2296	2296	2296	2296	2296	2296	2296	2296	2296	2300	NUM_SOMATIC_MUTATION	SAMPLE	NUMBER	Total Number of Somatic Mutations	Total Number of Somatic Mutations	1				
2297	2297	2297	2297	2297	2297	2297	2297	2297	2297	2297	2297	2297	2301	NUP98_NSD1	SAMPLE	STRING	NUP98 NSD1 gene fusion	NUP98-NSD1	1				
2298	2298	2298	2298	2298	2298	2298	2298	2298	2298	2298	2298	2298	2302	N_POS_N_NEG	SAMPLE	STRING	N+, N-	N+,N-	1				
2299	2299	2299	2299	2299	2299	2299	2299	2299	2299	2299	2299	2299	2303	N_SCORE	PATIENT	NUMBER	N Score	N Score	1				
2300	2300	2300	2300	2300	2300	2300	2300	2300	2300	2300	2300	2300	2304	N_STAGE	PATIENT	STRING	N Stage	N Stage	1				
2301	2301	2301	2301	2301	2301	2301	2301	2301	2301	2301	2301	2301	2305	N_STAGE_REPORTED	PATIENT	STRING	American Joint Committee on Cancer (AJCC) Summary Stage at Diagnosis. Using the AJCC method, a breast cancer is characterized by the size of the tumor (T), the number of lymph nodes it has spread to (N), and whether or not it has metastatsized (M). Together, the T, N, and M values are used to determine the Summary stage, e.g. Stage I, Stage II, Stage III, Stage IV	MedR N Stage at Diagnosis	1				
2302	2302	2302	2302	2302	2302	2302	2302	2302	2302	2302	2302	2302	2306	OBSTRUCTION_WEEKS	PATIENT	NUMBER	Obstruction (Weeks)	Obstruction (Weeks)	1				
2303	2303	2303	2303	2303	2303	2303	2303	2303	2303	2303	2303	2303	2307	OCCUPATION_CURRENT	PATIENT	STRING	The text that describes the type of business or industry associated with a person's job.	Occupation Current	1				
2304	2304	2304	2304	2304	2304	2304	2304	2304	2304	2304	2304	2304	2308	OCCUPATION_PRIMARY	PATIENT	STRING	The primary occupation of the participant for most of their adult employment.	Occupation Primary	1				
2305	2305	2305	2305	2305	2305	2305	2305	2305	2305	2305	2305	2305	2309	OCCUPATION_PRIMARY_CHEMICAL_EXPOSURE	PATIENT	STRING	To specify an exposure to a substance with a defined atomic or molecular structure that results from, or takes part in, reactions involving changes in its structure, composition, or properties at work.	Occupation Primary Chemical Exposure	1				
2306	2306	2306	2306	2306	2306	2306	2306	2306	2306	2306	2306	2306	2310	OCCUPATION_PRIMARY_INDUSTRY	PATIENT	STRING	Text to describe the industry in which a person's primary occupation time was spent.	Occupation Primary Industry	1				
2307	2307	2307	2307	2307	2307	2307	2307	2307	2307	2307	2307	2307	2311	OCCUPATION_PRIMARY_OTHER	PATIENT	STRING	Occupation Primary Other	Occupation Primary Other	1				
2308	2308	2308	2308	2308	2308	2308	2308	2308	2308	2308	2308	2308	2312	OCCUPATION_PRIMARY_YEARS_WORKED	PATIENT	NUMBER	The number that describes the duration of time expressed in number of years that a person has worked in a job.	Occupation Primary Years Worked	1				
2309	2309	2309	2309	2309	2309	2309	2309	2309	2309	2309	2309	2309	2313	OCT_EMBEDDED	SAMPLE	STRING	Oct embedded	Oct embedded	1				
2310	2310	2310	2310	2310	2310	2310	2310	2310	2310	2310	2310	2310	2314	OFFICIAL_PATH	PATIENT	STRING	Official pathology.	Official Pathology	1				
2311	2311	2311	2311	2311	2311	2311	2311	2311	2311	2311	2311	2311	2315	OLAPARIB_DOSAGE	PATIENT	STRING	Olaparib Dosage (mg)	Olaparib Dosage (mg)	1				
2312	2312	2312	2312	2312	2312	2312	2312	2312	2312	2312	2312	2312	2316	OLIGOPROGRESSION	SAMPLE	STRING	Oligoprogression	Oligoprogression	1				
2313	2313	2313	2313	2313	2313	2313	2313	2313	2313	2313	2313	2313	2317	ONCOGENIC_ALTERATIONS	SAMPLE	STRING	Oncogenic Alterations	Oncogenic Alterations	1				
2314	2314	2314	2314	2314	2314	2314	2314	2314	2314	2314	2314	2314	2318	ONCOKB_LEVELS	SAMPLE	STRING	OncoKB Levels	OncoKB Levels	1				
2315	2315	2315	2315	2315	2315	2315	2315	2315	2315	2315	2315	2315	2319	ONCOPANEL_STATUS	PATIENT	STRING	Oncopanel status	Oncopanel status	1				
2316	2316	2316	2316	2316	2316	2316	2316	2316	2316	2316	2316	2316	2320	ONCOPANEL_TUMOR_TYPE	SAMPLE	STRING	Oncopanel Tumor Type	Oncopanel Tumor Type	1				
2317	2317	2317	2317	2317	2317	2317	2317	2317	2317	2317	2317	2317	2321	ONCOPRINT	SAMPLE	STRING	Oncoprint	Oncoprint	1				
2318	2318	2318	2318	2318	2318	2318	2318	2318	2318	2318	2318	2318	2322	ONCOSIGN_CLUSTER	SAMPLE	STRING	Oncosign cluster.	Oncosign Cluster	1				
2319	2319	2319	2319	2319	2319	2319	2319	2319	2319	2319	2319	2319	2323	ONCOSIGN_CLUSTER_2	SAMPLE	STRING	Oncosign cluster 2	Oncosign Cluster 2	1				
2320	2320	2320	2320	2320	2320	2320	2320	2320	2320	2320	2320	2320	2324	ONCOTREE_CODE	SAMPLE	STRING	Oncotree Code	Oncotree Code	1				
2321	2321	2321	2321	2321	2321	2321	2321	2321	2321	2321	2321	2321	2325	ONCOTREE_PRIMARY_NODE	SAMPLE	STRING	Oncotree Primary Node added by script	Oncotree Primary Node	1				
2322	2322	2322	2322	2322	2322	2322	2322	2322	2322	2322	2322	2322	2326	ONCOTREE_SECONDARY_NODE	SAMPLE	STRING	Oncotree Secondary Node added by script	Oncotree Secondary Node	1				
2323	2323	2323	2323	2323	2323	2323	2323	2323	2323	2323	2323	2323	2327	ONCOTYPE_OR_MAMAPRINT	SAMPLE	STRING	Oncotype or Mamaprint genomic assay	Oncotype or Mamaprint	1				
2324	2324	2324	2324	2324	2324	2324	2324	2324	2324	2324	2324	2324	2328	ONGOING_TREATMENT	PATIENT	STRING	Ongoing Treatment	Ongoing Treatment	1				
2325	2325	2325	2325	2325	2325	2325	2325	2325	2325	2325	2325	2325	2329	ORAL_CONTRACEPTION	PATIENT	STRING	Oral Contraception	Oral Contraception	1				
2326	2326	2326	2326	2326	2326	2326	2326	2326	2326	2326	2326	2326	2330	ORAL_CONTRACEPTION_YEARS	PATIENT	NUMBER	Oral Contraception Years	Oral Contraception Years	1				
2327	2327	2327	2327	2327	2327	2327	2327	2327	2327	2327	2327	2327	2331	ORIGINAL_SUBTYPE	SAMPLE	STRING	Original Subtype	Original Subtype	1				
2328	2328	2328	2328	2328	2328	2328	2328	2328	2328	2328	2328	2328	2332	OR_PERCENT	SAMPLE	STRING	OR Percent	OR percent	1				
2329	2329	2329	2329	2329	2329	2329	2329	2329	2329	2329	2329	2329	2333	OR_TIME	PATIENT	NUMBER	OR Date from Diagnosis	OR Date	1				
2330	2330	2330	2330	2330	2330	2330	2330	2330	2330	2330	2330	2330	2334	OS_DAYS	PATIENT	NUMBER	Overall patient survival days	Overall Survival Days	1				
2331	2331	2331	2331	2331	2331	2331	2331	2331	2331	2331	2331	2331	2335	OS_EVENT	PATIENT	STRING	Overall Survival Event	Overall Survival Event	1				
2332	2332	2332	2332	2332	2332	2332	2332	2332	2332	2332	2332	2332	2337	OS_MONTHS_ADDITIONAL	PATIENT	NUMBER	OS Months (Additonal Data)	OS Months (Additonal Data)	1				
2333	2333	2333	2333	2333	2333	2333	2333	2333	2333	2333	2333	2333	2338	OS_MONTHS_ADVANCED_DISEASE	PATIENT	NUMBER	Overall Survival from Advanced Disease	Overall Survival from Advanced Disease	1				
2334	2334	2334	2334	2334	2334	2334	2334	2334	2334	2334	2334	2334	2339	OS_MONTHS_DATE_DX	PATIENT	NUMBER	Survival Date of dx to date of death las FU months for early cases	Survival Date of dx to date of death las FU months for early cases	1				
2335	2335	2335	2335	2335	2335	2335	2335	2335	2335	2335	2335	2335	2340	OS_MONTHS_DMT	PATIENT	NUMBER	Overall Survival Months Reported by DMT	Overall Survival Months Reported by DMT	1				
2336	2336	2336	2336	2336	2336	2336	2336	2336	2336	2336	2336	2336	2341	OS_MONTHS_METS	PATIENT	NUMBER	Survival Date of mets to date of death or last FU (months)	Survival Date of mets to date of death or last FU (months)	1				
2337	2337	2337	2337	2337	2337	2337	2337	2337	2337	2337	2337	2337	2342	OS_MONTHS_PRIMARY	PATIENT	NUMBER	Overall survival in months since primary diagonosis.	Overall Survival (Months) from Primary Diagnosis	1				
2338	2338	2338	2338	2338	2338	2338	2338	2338	2338	2338	2338	2338	2343	OS_MONTHS_RECURRENCE	PATIENT	NUMBER	Overall Survival (Months), Recurrence	Overall Survival (Months), Recurrence	1				
2339	2339	2339	2339	2339	2339	2339	2339	2339	2339	2339	2339	2339	2344	OS_MONTHS_SEQUENCED	PATIENT	NUMBER	Overall Survival (Months), Sequenced	Overall Survival (Months), Sequenced	1				
2340	2340	2340	2340	2340	2340	2340	2340	2340	2340	2340	2340	2340	2345	OS_MONTHS_STAGE_IV	PATIENT	NUMBER	Overall survival in months since stage IV diagonosis	Overall Survival Stage IV Diagnosis (Months)	1				
2341	2341	2341	2341	2341	2341	2341	2341	2341	2341	2341	2341	2341	2347	OS_STATUS_DMT	PATIENT	STRING	Overall Status reported by DMT	Overall Status Reported by DMT	1				
2342	2342	2342	2342	2342	2342	2342	2342	2342	2342	2342	2342	2342	2348	OTHER_CANCER_TYPE	PATIENT	STRING	Types of Other Cancers	Types of Other Cancers	1				
2343	2343	2343	2343	2343	2343	2343	2343	2343	2343	2343	2343	2343	2349	OTHER_CHEMO	PATIENT	STRING	Other Chemotherapy.	Other Chemotherapy	1				
2344	2344	2344	2344	2344	2344	2344	2344	2344	2344	2344	2344	2344	2350	OTHER_DISEASES	PATIENT	STRING	Other diagnosed diseases	Other Diseases	1				
2345	2345	2345	2345	2345	2345	2345	2345	2345	2345	2345	2345	2345	2351	OTHER_DNP	SAMPLE	STRING	other DNP	other DNP	1				
2346	2346	2346	2346	2346	2346	2346	2346	2346	2346	2346	2346	2346	2352	OTHER_HEPATO_CARCINOMA_RISK_FACTORS	PATIENT	STRING	History hepato carcinoma risk factor other	History hepato carcinoma risk factor other	1				
2347	2347	2347	2347	2347	2347	2347	2347	2347	2347	2347	2347	2347	2353	OTHER_HYSTERECTOMY_TYPE	PATIENT	STRING	Hysterectomy performed text	Hysterectomy performed text	1				
2348	2348	2348	2348	2348	2348	2348	2348	2348	2348	2348	2348	2348	2354	OTHER_IMMUNOSUPPRESSIVE_DISEASE	PATIENT	STRING	Patient history immune system and related disorders text	Patient history immune system and related disorders text	1				
2349	2349	2349	2349	2349	2349	2349	2349	2349	2349	2349	2349	2349	2355	OTHER_INVOLVED_MARGINS	PATIENT	STRING	Cervical neoplasm pathologic margin involved text	Cervical neoplasm pathologic margin involved text	1				
2350	2350	2350	2350	2350	2350	2350	2350	2350	2350	2350	2350	2350	2356	OTHER_METHOD_OF_SAMPLE_PROCUREMENT	PATIENT	STRING	The type of procedure or method used to collect the specimen.	Specimen Collection Method	1				
2351	2351	2351	2351	2351	2351	2351	2351	2351	2351	2351	2351	2351	2357	OTHER_MLL	PATIENT	STRING	Other MLL.	Other MLL	1				
2352	2352	2352	2352	2352	2352	2352	2352	2352	2352	2352	2352	2352	2358	OTHER_PATIENT_ID	PATIENT	STRING	Legacy DMP patient identifier (DMPnnnn)	Other Patient ID	1				
2353	2353	2353	2353	2353	2353	2353	2353	2353	2353	2353	2353	2353	2359	OTHER_POS_NODE_LOCATION	PATIENT	STRING	Lymph node location positive pathology text	Lymph node location positive pathology text	1				
2354	2354	2354	2354	2354	2354	2354	2354	2354	2354	2354	2354	2354	2360	OTHER_SAMPLE_ID	SAMPLE	STRING	Other sample identifier	Other Sample ID	1				
2355	2355	2355	2355	2355	2355	2355	2355	2355	2355	2355	2355	2355	2361	OTHER_SITES_OF_METS	SAMPLE	STRING	Other Metastasis Sites Description	Other Metastasis Sites	1				
2356	2356	2356	2356	2356	2356	2356	2356	2356	2356	2356	2356	2356	2362	OTHER_SITE_OF_RELAPSE	SAMPLE	STRING	Other Site of Relapse	Other Site of Relapse	1				
2357	2357	2357	2357	2357	2357	2357	2357	2357	2357	2357	2357	2357	2363	OTHER_SKIN_TUMORS	PATIENT	STRING	Other Skin Tumors	Other Skin Tumors	1				
2358	2358	2358	2358	2358	2358	2358	2358	2358	2358	2358	2358	2358	2364	OTHER_SPECIFY_SECTION	PATIENT	STRING	Other Specify Section	Other Specify Section	1				
2359	2359	2359	2359	2359	2359	2359	2359	2359	2359	2359	2359	2359	2365	OTHER_SYMPTOM_DETAILS	PATIENT	STRING	Other Symptom Details	Other Symptom Details	1				
2360	2360	2360	2360	2360	2360	2360	2360	2360	2360	2360	2360	2360	2366	OTHER_SYMPTOM_DURATION	PATIENT	NUMBER	Other Symptom Duration (Weeks)	Other Symptom Duration (Weeks)	1				
2361	2361	2361	2361	2361	2361	2361	2361	2361	2361	2361	2361	2361	2367	OTHER_TREATMENT_RESPONSE	PATIENT	STRING	Other Treatment Responses	Other Treatment Responses	1				
2362	2362	2362	2362	2362	2362	2362	2362	2362	2362	2362	2362	2362	2368	OUTSIDE_INSTITUTE	SAMPLE	STRING	Indicates if the sample is from outside MSK	Sample is from outside MSK	1				
2363	2363	2363	2363	2363	2363	2363	2363	2363	2363	2363	2363	2363	2369	OUTSIDE_SURGICAL_PROCEDURES	PATIENT	STRING	Outside Surgical Procedures	Outside Surgical Procedures	1				
2364	2364	2364	2364	2364	2364	2364	2364	2364	2364	2364	2364	2364	2370	OVERALL_METASTATIC_BURDEN	PATIENT	STRING	Overall Metastatic Burden	Overall Metastatic Burden	1				
2365	2365	2365	2365	2365	2365	2365	2365	2365	2365	2365	2365	2365	2371	OVERALL_PATIENT_HISTOLOGY	PATIENT	STRING	Overall Patient Histology	Overall Patient Histology	1				
2366	2366	2366	2366	2366	2366	2366	2366	2366	2366	2366	2366	2366	2372	OVERALL_RESPONSE	PATIENT	STRING	Overall Response	Overall Response	1				
2367	2367	2367	2367	2367	2367	2367	2367	2367	2367	2367	2367	2367	2373	OVERALL_STAGE	SAMPLE	STRING	Overall Stage	Overall Stage	1				
2368	2368	2368	2368	2368	2368	2368	2368	2368	2368	2368	2368	2368	2374	P4EBP1_STATUS	SAMPLE	STRING	P4EBP1 Status	P4EBP1 Status	1				
2369	2369	2369	2369	2369	2369	2369	2369	2369	2369	2369	2369	2369	2375	P53	SAMPLE	STRING	P53.	P53	1				
2370	2370	2370	2370	2370	2370	2370	2370	2370	2370	2370	2370	2370	2376	P53_GENE_ANALYSIS	SAMPLE	STRING	P53 gene analysis	P53 gene analysis	1				
2371	2371	2371	2371	2371	2371	2371	2371	2371	2371	2371	2371	2371	2377	P53_GERMLINE	SAMPLE	STRING	P53 Germline	P53 Germline	1				
2372	2372	2372	2372	2372	2372	2372	2372	2372	2372	2372	2372	2372	2378	P53_MUTATION	SAMPLE	STRING	P53 Mutation	P53 Mutation	1				
2373	2373	2373	2373	2373	2373	2373	2373	2373	2373	2373	2373	2373	2379	PAM50_SUBTYPE	SAMPLE	STRING	PAM50 subtype	PAM50 subtype	1				
2374	2374	2374	2374	2374	2374	2374	2374	2374	2374	2374	2374	2374	2380	PAN_GLIOMA_DNA_METHYLATION_CLUSTER	SAMPLE	STRING	Pan-Glioma DNA Methylation Cluster	Pan-Glioma DNA Methylation Cluster	1				
2375	2375	2375	2375	2375	2375	2375	2375	2375	2375	2375	2375	2375	2381	PAN_GLIOMA_RNA_EXPRESSION_CLUSTER	SAMPLE	STRING	Pan-Glioma RNA Expression Cluster	Pan-Glioma RNA Expression Cluster	1				
2376	2376	2376	2376	2376	2376	2376	2376	2376	2376	2376	2376	2376	2382	PAPILLARY_FLAT	SAMPLE	STRING	Papillary/Flat	Papillary/Flat	1				
2377	2377	2377	2377	2377	2377	2377	2377	2377	2377	2377	2377	2377	2383	PARADIGM_CLUSTER	SAMPLE	NUMBER	PARADIGM CLUSTER	PARADIGM CLUSTER	1				
2378	2378	2378	2378	2378	2378	2378	2378	2378	2378	2378	2378	2378	2384	PARADIGM_CLUSTER_K4	SAMPLE	STRING	PARADIGM CLUSTER k4	PARADIGM CLUSTER k4	1				
2379	2379	2379	2379	2379	2379	2379	2379	2379	2379	2379	2379	2379	2385	PARANEOPLASTIC_SYNDROME	PATIENT	STRING	Paraneoplastic syndrome	Paraneoplastic syndrome	1				
2380	2380	2380	2380	2380	2380	2380	2380	2380	2380	2380	2380	2380	2386	PARITY	PATIENT	NUMBER	The number of times a female has been carried the pregnancies to a viable gestational age (parity)	Parity	1				
2381	2381	2381	2381	2381	2381	2381	2381	2381	2381	2381	2381	2381	2387	PAROTID_LN	PATIENT	STRING	Parotid Lymph Node	Parotid LN	1				
2382	2382	2382	2382	2382	2382	2382	2382	2382	2382	2382	2382	2382	2388	PARTA_CONSENTED_12_245	PATIENT	STRING	12-245 Part A Consented Status	12-245 Part A Consented	1				
2383	2383	2383	2383	2383	2383	2383	2383	2383	2383	2383	2383	2383	2389	PARTC_CONSENTED_12_245	PATIENT	STRING	12-245 Part C Consented	12-245 Part C Consented	1				
2384	2384	2384	2384	2384	2384	2384	2384	2384	2384	2384	2384	2384	2390	PASSAGE_NUMBER	SAMPLE	STRING	Passage Number	Passage Number	1				
2385	2385	2385	2385	2385	2385	2385	2385	2385	2385	2385	2385	2385	2391	PATHFINDNUMNODESREMD	PATIENT	NUMBER	Pathfindnumnodesremd	Pathfindnumnodesremd	1				
2386	2386	2386	2386	2386	2386	2386	2386	2386	2386	2386	2386	2386	2392	PATHFINDPOSNODES	PATIENT	NUMBER	Pathfindposnodes	Pathfindposnodes	1				
2387	2387	2387	2387	2387	2387	2387	2387	2387	2387	2387	2387	2387	2393	PATHLOCATION	PATIENT	STRING	Pathlocation	Pathlocation	1				
2388	2388	2388	2388	2388	2388	2388	2388	2388	2388	2388	2388	2388	2394	PATHMARGIN	PATIENT	STRING	Pathmargin	Pathmargin	1				
2389	2389	2389	2389	2389	2389	2389	2389	2389	2389	2389	2389	2389	2395	PATHOLOGICAL_DIAGNOSIS	PATIENT	STRING	Pathological Diagnosis	Pathological Diagnosis	1				
2390	2390	2390	2390	2390	2390	2390	2390	2390	2390	2390	2390	2390	2396	PATHOLOGIC_DISTANT_SPREAD	PATIENT	STRING	Pathologic Distant Spread	Pathologic Distant Spread	1				
2391	2391	2391	2391	2391	2391	2391	2391	2391	2391	2391	2391	2391	2397	PATHOLOGIC_PRIMARY_TUMOR_STAGE	SAMPLE	STRING	pathologic primary tumor stage	pathologic primary tumor stage	1				
2392	2392	2392	2392	2392	2392	2392	2392	2392	2392	2392	2392	2392	2398	PATHOLOGIC_RESPONSE	PATIENT	STRING	Pathologic Response	Pathologic Response	1				
2393	2393	2393	2393	2393	2393	2393	2393	2393	2393	2393	2393	2393	2399	PATHOLOGIC_SPREAD_INCIDENTAL_PROSTATE_CANCER	PATIENT	STRING	Pathologic Spread Incidental Prostate Cancer	Pathologic Spread Incidental Prostate Cancer	1				
2394	2394	2394	2394	2394	2394	2394	2394	2394	2394	2394	2394	2394	2400	PATHOLOGIC_VASCULAR_INVASION	PATIENT	STRING	Pathologic Vascular Invasion	Pathologic Vascular Invasion	1				
2395	2395	2395	2395	2395	2395	2395	2395	2395	2395	2395	2395	2395	2401	PATHOLOGY_CLASSIFICATION	SAMPLE	STRING	Pathology Classification	Pathology Classification	1				
2396	2396	2396	2396	2396	2396	2396	2396	2396	2396	2396	2396	2396	2402	PATHOLOGY_COMMENT	SAMPLE	STRING	Pathology Comment	Pathology Comment	1				
2397	2397	2397	2397	2397	2397	2397	2397	2397	2397	2397	2397	2397	2403	PATHOLOGY_LAUREN	PATIENT	STRING	Pathology Lauren.	Pathology Lauren	1				
2398	2398	2398	2398	2398	2398	2398	2398	2398	2398	2398	2398	2398	2404	PATHOLOGY_REPORT_FILE_NAME	SAMPLE	STRING	Pathology Report File Name	Pathology Report File Name	1				
2399	2399	2399	2399	2399	2399	2399	2399	2399	2399	2399	2399	2399	2405	PATHOLOGY_REPORT_UUID	PATIENT	STRING	Pathology report uuid	Pathology report uuid	1				
2400	2400	2400	2400	2400	2400	2400	2400	2400	2400	2400	2400	2400	2406	PATHPERINEURALINV	PATIENT	STRING	Pathperineuralinv	Pathperineuralinv	1				
2401	2401	2401	2401	2401	2401	2401	2401	2401	2401	2401	2401	2401	2407	PATHSTAGEDISEASE	PATIENT	STRING	Pathstagedisease	Pathstagedisease	1				
2402	2402	2402	2402	2402	2402	2402	2402	2402	2402	2402	2402	2402	2408	PATHSTAGEGROUP	PATIENT	STRING	Pathstagegroup	Pathstagegroup	1				
2403	2403	2403	2403	2403	2403	2403	2403	2403	2403	2403	2403	2403	2409	PATHSTAGEM	PATIENT	STRING	Pathstagem	Pathstagem	1				
2404	2404	2404	2404	2404	2404	2404	2404	2404	2404	2404	2404	2404	2410	PATHSTAGEN	PATIENT	STRING	Pathstagen	Pathstagen	1				
2405	2405	2405	2405	2405	2405	2405	2405	2405	2405	2405	2405	2405	2411	PATHSTAGET	PATIENT	STRING	Pathstaget	Pathstaget	1				
2406	2406	2406	2406	2406	2406	2406	2406	2406	2406	2406	2406	2406	2412	PATHTUMORMAXDIM	PATIENT	NUMBER	Pathtumormaxdim	Pathtumormaxdim	1				
2407	2407	2407	2407	2407	2407	2407	2407	2407	2407	2407	2407	2407	2413	PATHVASCULARINV	PATIENT	STRING	Pathvascularinv	Pathvascularinv	1				
2408	2408	2408	2408	2408	2408	2408	2408	2408	2408	2408	2408	2408	2414	PATH_CANCER_MAX_DIM_CM	PATIENT	STRING	Pathology cancer maximum dimension (cm).	Pathology Cancer Maximum Dimension (cm)	1				
2409	2409	2409	2409	2409	2409	2409	2409	2409	2409	2409	2409	2409	2415	PATH_CAPSULE_INV	SAMPLE	STRING	Tumor invades capsule	Capsule inv	1				
2410	2410	2410	2410	2410	2410	2410	2410	2410	2410	2410	2410	2410	2416	PATH_CODE	PATIENT	NUMBER	Path Code	Path Code	1				
2411	2411	2411	2411	2411	2411	2411	2411	2411	2411	2411	2411	2411	2417	PATH_EXTRAHEPATIC_TISSUE_TYPE	SAMPLE	STRING	Extrahepatic tissue type invaded	EH type	1				
2412	2412	2412	2412	2412	2412	2412	2412	2412	2412	2412	2412	2412	2418	PATH_GLEASON_SCORE	SAMPLE	STRING	PATH GLEASON SCORE	PATH GLEASON SCORE	1				
2413	2413	2413	2413	2413	2413	2413	2413	2413	2413	2413	2413	2413	2419	PATH_GLEASON_SCORE_1	SAMPLE	STRING	PATH GLEASON SCORE 1	PATH GLEASON SCORE 1	1				
2414	2414	2414	2414	2414	2414	2414	2414	2414	2414	2414	2414	2414	2420	PATH_GLEASON_SCORE_2	SAMPLE	STRING	PATH GLEASON SCORE 2	PATH GLEASON SCORE 2	1				
2415	2415	2415	2415	2415	2415	2415	2415	2415	2415	2415	2415	2415	2421	PATH_GRADE	SAMPLE	STRING	Path Grade	Path Grade	1				
2416	2416	2416	2416	2416	2416	2416	2416	2416	2416	2416	2416	2416	2422	PATH_INVASION_DEPTH	SAMPLE	STRING	Path Invasion Depth	Path Invasion Depth	1				
2417	2417	2417	2417	2417	2417	2417	2417	2417	2417	2417	2417	2417	2423	PATH_INV_HST	SAMPLE	STRING	Hilar soft tissue invasion	Hilar invasion	1				
2418	2418	2418	2418	2418	2418	2418	2418	2418	2418	2418	2418	2418	2424	PATH_LVI_LV	SAMPLE	STRING	Lymphovascular invasion, large vessel	LVI-LV	1				
2419	2419	2419	2419	2419	2419	2419	2419	2419	2419	2419	2419	2419	2425	PATH_LVI_SV	SAMPLE	STRING	Lymphovascular invasion, small vessel	LVI-SV	1				
2420	2420	2420	2420	2420	2420	2420	2420	2420	2420	2420	2420	2420	2426	PATH_MARGIN	PATIENT	STRING	Text descriptor of the conclusive results following examination of tissue margin(s) for the presence of disease.	Disease Surgical Margin Status	1				
2421	2421	2421	2421	2421	2421	2421	2421	2421	2421	2421	2421	2421	2427	PATH_MASS_FORMING	SAMPLE	STRING	Mass forming type	MF	1				
2422	2422	2422	2422	2422	2422	2422	2422	2422	2422	2422	2422	2422	2428	PATH_MULTIFOCAL	SAMPLE	STRING	Path Multifocal	Path Multifocal	1				
2423	2423	2423	2423	2423	2423	2423	2423	2423	2423	2423	2423	2423	2429	PATH_M_STAGE	PATIENT	STRING	Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).	American Joint Committee on Cancer Metastasis Stage Code	1				
2424	2424	2424	2424	2424	2424	2424	2424	2424	2424	2424	2424	2424	2430	PATH_N_STAGE	PATIENT	STRING	The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.	Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code	1				
2425	2425	2425	2425	2425	2425	2425	2425	2425	2425	2425	2425	2425	2431	PATH_N_STATUS	PATIENT	STRING	Pathological N Status	Pathological N Status	1				
2426	2426	2426	2426	2426	2426	2426	2426	2426	2426	2426	2426	2426	2432	PATH_PERIDUCTAL_INFIL	SAMPLE	STRING	Periductal infiltrating type	PI	1				
2427	2427	2427	2427	2427	2427	2427	2427	2427	2427	2427	2427	2427	2433	PATH_RELAPSE	SAMPLE	STRING	Pathology of relapse biopsy	Pathology of relapse biopsy	1				
2428	2428	2428	2428	2428	2428	2428	2428	2428	2428	2428	2428	2428	2434	PATH_REPORT_UUID	SAMPLE	STRING	Pathology Report UUID	Pathology Report UUID	1				
2429	2429	2429	2429	2429	2429	2429	2429	2429	2429	2429	2429	2429	2435	PATH_SATELLITE_NODULES	SAMPLE	STRING	Satellite nodules	Satellite nodules	1				
2430	2430	2430	2430	2430	2430	2430	2430	2430	2430	2430	2430	2430	2436	PATH_SOLITARY_MASS	SAMPLE	STRING	Solitary mass	Solitary mass	1				
2431	2431	2431	2431	2431	2431	2431	2431	2431	2431	2431	2431	2431	2437	PATH_STEATOSIS	PATIENT	STRING	>50% steatosis	Steatosis	1				
2432	2432	2432	2432	2432	2432	2432	2432	2432	2432	2432	2432	2432	2438	PATH_T_STAGE	PATIENT	STRING	Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).	American Joint Committee on Cancer Tumor Stage Code	1				
2433	2433	2433	2433	2433	2433	2433	2433	2433	2433	2433	2433	2433	2439	PATH_WHO_TYPE	SAMPLE	STRING	Path WHO Type	Path WHO Type	1				
2434	2434	2434	2434	2434	2434	2434	2434	2434	2434	2434	2434	2434	2440	PATH_WHO_TYPE_2	SAMPLE	STRING	Path WHO Type 2	Path WHO Type 2	1				
2435	2435	2435	2435	2435	2435	2435	2435	2435	2435	2435	2435	2435	2441	PATIENTS_WITH_MULTIPLE_SAMPLES	SAMPLE	STRING	Patients with Multiple Samples	Patients with Multiple Samples	1				
2436	2436	2436	2436	2436	2436	2436	2436	2436	2436	2436	2436	2436	2442	PATIENT_DEATH_REASON	PATIENT	STRING	Text term to identify the cause of death for a patient.	Patient Death Reason	1				
2437	2437	2437	2437	2437	2437	2437	2437	2437	2437	2437	2437	2437	2443	PATIENT_DISPLAY_NAME	PATIENT	STRING	Patient Display Name	Patient Display Name	1				
2438	2438	2438	2438	2438	2438	2438	2438	2438	2438	2438	2438	2438	2444	PATIENT_GRADE	PATIENT	STRING	Patient Tumor Grade	Patient Tumor Grade	1				
2439	2439	2439	2439	2439	2439	2439	2439	2439	2439	2439	2439	2439	2445	PATIENT_HARVEST_YEAR	PATIENT	STRING	The year which the sample was collected from the patient	Patient Harvest Year	1				
2440	2440	2440	2440	2440	2440	2440	2440	2440	2440	2440	2440	2440	2446	PATIENT_ID	PATIENT	STRING	Identifier to uniquely specify a patient.	Patient Identifier	1				
2441	2441	2441	2441	2441	2441	2441	2441	2441	2441	2441	2441	2441	2447	PATIENT_ID_LEGACY	PATIENT	STRING	Deprecated patient identifier	Legacy Patient Identifier	1				
2442	2442	2442	2442	2442	2442	2442	2442	2442	2442	2442	2442	2442	2448	PATIENT_NOTE	PATIENT	STRING	Patient Note	Patient Note	1				
2443	2443	2443	2443	2443	2443	2443	2443	2443	2443	2443	2443	2443	2449	PATIENT_NOTES	PATIENT	STRING	Additional notes about patient's clinical history	MedR Patient Notes	1				
2444	2444	2444	2444	2444	2444	2444	2444	2444	2444	2444	2444	2444	2450	PATIENT_STUDY_ID	PATIENT	STRING	patient study id	patient study id	1				
2445	2445	2445	2445	2445	2445	2445	2445	2445	2445	2445	2445	2445	2451	PATIENT_TO_UNDERGO_SURGERY	PATIENT	STRING	Planned surgery status	Planned surgery status	1				
2446	2446	2446	2446	2446	2446	2446	2446	2446	2446	2446	2446	2446	2452	PAX8	PATIENT	STRING	PAX8	PAX8	1				
2447	2447	2447	2447	2447	2447	2447	2447	2447	2447	2447	2447	2447	2453	PAX_FUSION	SAMPLE	STRING	PAX Fusion	PAX Fusion	1				
2448	2448	2448	2448	2448	2448	2448	2448	2448	2448	2448	2448	2448	2454	PBRM1_LOSS	SAMPLE	STRING	PBRM1 Loss	PBRM1 Loss	1				
2449	2449	2449	2449	2449	2449	2449	2449	2449	2449	2449	2449	2449	2455	PB_BLAST_PERCENTAGE	PATIENT	NUMBER	PB blast percentage	PB Blast Percentage	1				
2450	2450	2450	2450	2450	2450	2450	2450	2450	2450	2450	2450	2450	2456	PCLTPS	PATIENT	NUMBER	Pcltps	Pcltps	1				
2451	2451	2451	2451	2451	2451	2451	2451	2451	2451	2451	2451	2451	2457	PCR_PRIMER_PAIRS	PATIENT	STRING	Oligonucleotide primer pair laboratory procedure performed name	Oligonucleotide primer pair laboratory procedure performed name	1				
2452	2452	2452	2452	2452	2452	2452	2452	2452	2452	2452	2452	2452	2458	PCR_PRIMER_PAIRS_OTHER	PATIENT	STRING	Oligonucleotide primer pair laboratory procedure performed text	Oligonucleotide primer pair laboratory procedure performed text	1				
2453	2453	2453	2453	2453	2453	2453	2453	2453	2453	2453	2453	2453	2459	PC_RPLND	SAMPLE	STRING	RPLND	RPLND	1				
2454	2454	2454	2454	2454	2454	2454	2454	2454	2454	2454	2454	2454	2460	PC_RPLND_STATUS	SAMPLE	STRING	PC RPLND Status	PC RPLND Status	1				
2455	2455	2455	2455	2455	2455	2455	2455	2455	2455	2455	2455	2455	2461	PDL1_EXPRESSION	PATIENT	STRING	PDL1 Expression	PDL1 Expression	1				
2456	2456	2456	2456	2456	2456	2456	2456	2456	2456	2456	2456	2456	2462	PDL1_POS_OUTOFTUMORCELLS	SAMPLE	STRING	PDL1+ (% of tumor cells)	PDL1+ tumor cells	1				
2457	2457	2457	2457	2457	2457	2457	2457	2457	2457	2457	2457	2457	2463	PDL1_POS_OUTOF_CD45POS	SAMPLE	STRING	PDL1+ (% of CD45+ cells)	PDL1+ non tumor cells	1				
2458	2458	2458	2458	2458	2458	2458	2458	2458	2458	2458	2458	2458	2464	PDL1_SCORE	SAMPLE	NUMBER	PD-L1 Score in percent	PD-L1 Score (%)	1				
2459	2459	2459	2459	2459	2459	2459	2459	2459	2459	2459	2459	2459	2465	PDTC_DEFINITION	PATIENT	STRING	PDTC Definition	PDTC Definition	1				
2460	2460	2460	2460	2460	2460	2460	2460	2460	2460	2460	2460	2460	2466	PDX_GENERATION_NUMBER	SAMPLE	NUMBER	PDX Generation Number	PDX Generation Number	1				
2461	2461	2461	2461	2461	2461	2461	2461	2461	2461	2461	2461	2461	2467	PDX_MEDIAN_SURVIVAL	SAMPLE	NUMBER	PDX Median Survival (Day)	PDX Median Survival (Day)	1				
2462	2462	2462	2462	2462	2462	2462	2462	2462	2462	2462	2462	2462	2468	PDX_PARENT	SAMPLE	STRING	PDX Parent	PDX Parent	1				
2463	2463	2463	2463	2463	2463	2463	2463	2463	2463	2463	2463	2463	2469	PDX_SURVIVAL_RANGE	SAMPLE	STRING	PDX Survival Range (Day)	PDX Survival Range (Day)	1				
2464	2464	2464	2464	2464	2464	2464	2464	2464	2464	2464	2464	2464	2470	PDX_TREATMENT	SAMPLE	STRING	PDX Treatment	PDX Treatment	1				
2465	2465	2465	2465	2465	2465	2465	2465	2465	2465	2465	2465	2465	2471	PEDIATRIC_SAMPLE	PATIENT	STRING	Pediatric Sample	Pediatric Sample	1				
2466	2466	2466	2466	2466	2466	2466	2466	2466	2466	2466	2466	2466	2472	PEDS_CANCER_TYPE_DETAILED	SAMPLE	STRING	PED Cancer Type Detailed	PED Cancer Type Detailed	1				
2467	2467	2467	2467	2467	2467	2467	2467	2467	2467	2467	2467	2467	2473	PED_AGE	PATIENT	NUMBER	PED Age	PED Age	1				
2468	2468	2468	2468	2468	2468	2468	2468	2468	2468	2468	2468	2468	2474	PED_DISEASE_CATEGORY	SAMPLE	STRING	PED Disease Category	PED Disease Category	1				
2469	2469	2469	2469	2469	2469	2469	2469	2469	2469	2469	2469	2469	2475	PED_DRIVER_MUTATION	SAMPLE	STRING	PED Driver Mutation	PED Driver Mutation	1				
2470	2470	2470	2470	2470	2470	2470	2470	2470	2470	2470	2470	2470	2476	PED_IND	PATIENT	STRING	Indication on whether this case is a pediatric patient or not	Pediatric Case Indicator	1				
2471	2471	2471	2471	2471	2471	2471	2471	2471	2471	2471	2471	2471	2477	PED_NCCN_LEVEL	SAMPLE	STRING	PED NCCN Level	PED NCCN Level	1				
2472	2472	2472	2472	2472	2472	2472	2472	2472	2472	2472	2472	2472	2478	PED_PRIMARY_SITE	SAMPLE	STRING	PED Primary Site	PED Primary Site	1				
2473	2473	2473	2473	2473	2473	2473	2473	2473	2473	2473	2473	2473	2479	PED_SEX	PATIENT	STRING	PED Sex	PED Sex	1				
2474	2474	2474	2474	2474	2474	2474	2474	2474	2474	2474	2474	2474	2480	PED_SPECIMEN_TYPE	SAMPLE	STRING	PED Speciment Type	PED Speciment Type	1				
2475	2475	2475	2475	2475	2475	2475	2475	2475	2475	2475	2475	2475	2481	PED_STAGE	SAMPLE	STRING	PED Stage	PED Stage	1				
2476	2476	2476	2476	2476	2476	2476	2476	2476	2476	2476	2476	2476	2482	PEG10_MUTATION	SAMPLE	STRING	PEG10 Mutation	PEG10 Mutation	1				
2477	2477	2477	2477	2477	2477	2477	2477	2477	2477	2477	2477	2477	2483	PELLET_STOOL_WEEKS	PATIENT	NUMBER	Pellet Stool (Weeks)	Pellet Stool (Weeks)	1				
2478	2478	2478	2478	2478	2478	2478	2478	2478	2478	2478	2478	2478	2484	PELVIC_EXTENSION_COMMENT	PATIENT	STRING	Cervical carcinoma pelvic extension text	Cervical carcinoma pelvic extension text	1				
2479	2479	2479	2479	2479	2479	2479	2479	2479	2479	2479	2479	2479	2485	PERCENTAGE_NECROSIS	PATIENT	NUMBER	Percent necrosis.	Percent Necrosis	1				
2480	2480	2480	2480	2480	2480	2480	2480	2480	2480	2480	2480	2480	2486	PERCENTAGE_OF_TARGET_EXONS_IN_TUMORS_COVERED	SAMPLE	NUMBER	% of Target Exons in Tumors Covered above 100x	% of Target Exons in Tumors Covered above 100x	1				
2481	2481	2481	2481	2481	2481	2481	2481	2481	2481	2481	2481	2481	2487	PERCENTAGE_TUMOR_PURITY	PATIENT	NUMBER	Percent tumor purity.	Percent Tumor Purity	1				
2482	2482	2482	2482	2482	2482	2482	2482	2482	2482	2482	2482	2482	2488	PERCENT_ANEUPLOIDY	SAMPLE	STRING	Percent aneuploidy	Percent aneuploidy	1				
2483	2483	2483	2483	2483	2483	2483	2483	2483	2483	2483	2483	2483	2489	PERCENT_CHANGE	SAMPLE	NUMBER	Percent Change	Percent Change	1				
2484	2484	2484	2484	2484	2484	2484	2484	2484	2484	2484	2484	2484	2490	PERCENT_GLEASON_PATTERN_4_OR_5	PATIENT	NUMBER	Gleason Score Percent 4 & 5.	Gleason Score Percent 4 & 5	1				
2485	2485	2485	2485	2485	2485	2485	2485	2485	2485	2485	2485	2485	2491	PERCENT_LYMPHOCYTE_INFILTRATION	PATIENT	NUMBER	Numeric value to represent the percentage of infiltration by lymphocytes in a tumor sample or specimen.	Percent Lymphocyte Infiltration	1				
2486	2486	2486	2486	2486	2486	2486	2486	2486	2486	2486	2486	2486	2492	PERCENT_TUMOR_CELLS	PATIENT	NUMBER	Numeric value to represent the percentage of malignant cell tumor nuclei content in a tumor sample or specimen.	Percent Tumor Cells	1				
2487	2487	2487	2487	2487	2487	2487	2487	2487	2487	2487	2487	2487	2493	PERCENT_TUMOR_CELLS_RELAPSE	PATIENT	STRING	Numeric value to represent the percentage of malignant cell tumor nuclei content in a tumor sample or specimen obtained at relapse stage	Percent Tumor Cells from patient's relapse biopsy	1				
2488	2488	2488	2488	2488	2488	2488	2488	2488	2488	2488	2488	2488	2494	PERCENT_TUMOR_NUCLEI	PATIENT	NUMBER	Numeric value to represent the percentage of tumor nuclei in a malignant neoplasm sample or specimen.	Percent Tumor Nuclei	1				
2489	2489	2489	2489	2489	2489	2489	2489	2489	2489	2489	2489	2489	2495	PERCENT_TUMOR_VS_STROMA	PATIENT	STRING	Numeric representation of the ratio of tumor to stroma.	Percent Tumor Vs. Stroma	1				
2490	2490	2490	2490	2490	2490	2490	2490	2490	2490	2490	2490	2490	2496	PERFORMANCE_STATUS	PATIENT	STRING	Performance status	Performance status	1				
2491	2491	2491	2491	2491	2491	2491	2491	2491	2491	2491	2491	2491	2497	PERFORMANCE_STATUS_DAYS_TO	PATIENT	NUMBER	Days to initial score performance status scale	Days to initial score performance status scale	1				
2492	2492	2492	2492	2492	2492	2492	2492	2492	2492	2492	2492	2492	2498	PERFORMANCE_STATUS_OTHER_TIMING	PATIENT	STRING	Performance status assessment timepoint category other text	Performance status other timing	1				
2493	2493	2493	2493	2493	2493	2493	2493	2493	2493	2493	2493	2493	2499	PERFORMANCE_STATUS_SCALE_TIMING	PATIENT	STRING	Performance status scale timing.	Performance Status Scale Timing	1				
2494	2494	2494	2494	2494	2494	2494	2494	2494	2494	2494	2494	2494	2500	PERFORMANCE_STATUS_TIMING	PATIENT	STRING	A timepoint in reference to a patient's therapy in which a performance status assessment is conducted.	Performance Status Assessment Timepoint Category	1				
2495	2495	2495	2495	2495	2495	2495	2495	2495	2495	2495	2495	2495	2501	PERINEURAL_INVASION	SAMPLE	STRING	Perineural invasion.	Perineural Invasion	1				
2496	2496	2496	2496	2496	2496	2496	2496	2496	2496	2496	2496	2496	2502	PERIPHERAL_BLASTS_PERCENTAGE	PATIENT	NUMBER	Peripheral blasts percentage.	Peripheral Blasts Percentage	1				
2497	2497	2497	2497	2497	2497	2497	2497	2497	2497	2497	2497	2497	2503	PERITONEAL_WASHING	PATIENT	STRING	Peritoneal washing	Peritoneal washing	1				
2498	2498	2498	2498	2498	2498	2498	2498	2498	2498	2498	2498	2498	2504	PERI_OP_CHEMO	PATIENT	STRING	peri op chemo	peri op chemo	1				
2499	2499	2499	2499	2499	2499	2499	2499	2499	2499	2499	2499	2499	2505	PERSISTANT_DISEASE_TUMOR_STUDIED	PATIENT	STRING	Persistant Disease Tumor Studied	Persistant Disease Tumor Studied	1				
2500	2500	2500	2500	2500	2500	2500	2500	2500	2500	2500	2500	2500	2506	PERSONAL_HISTORY	PATIENT	STRING	Personal History	Personal History	1				
2501	2501	2501	2501	2501	2501	2501	2501	2501	2501	2501	2501	2501	2507	PERSON_NEOPLASM_CANCER_STATUS	PATIENT	STRING	Person neoplasm cancer status.	Person Neoplasm Cancer Status	1				
2502	2502	2502	2502	2502	2502	2502	2502	2502	2502	2502	2502	2502	2508	PET_CT_STANDARDIZED_VALUES	SAMPLE	STRING	Pet Ct Standardized Values	Pet Ct Standardized Values	1				
2503	2503	2503	2503	2503	2503	2503	2503	2503	2503	2503	2503	2503	2509	PET_SCAN	PATIENT	STRING	PET Scan	PET Scan	1				
2504	2504	2504	2504	2504	2504	2504	2504	2504	2504	2504	2504	2504	2510	PET_TBR	PATIENT	STRING	Positron emission tomography, tumor background ratio	Positron emission tomography, tumor background ratio	1				
2505	2505	2505	2505	2505	2505	2505	2505	2505	2505	2505	2505	2505	2511	PFS_DAYS	PATIENT	NUMBER	Progress Free Survival (Days)	Progress Free Survival (Days)	1				
2506	2506	2506	2506	2506	2506	2506	2506	2506	2506	2506	2506	2506	2512	PFS_EVENT	PATIENT	STRING	Progress Free Survival Event	Progress Free Survival Event	1				
2507	2507	2507	2507	2507	2507	2507	2507	2507	2507	2507	2507	2507	2513	PFS_INTERVAL_GROUP	PATIENT	STRING	PFS Interval group	PFS Interval group	1				
2508	2508	2508	2508	2508	2508	2508	2508	2508	2508	2508	2508	2508	2516	PFS_YEARS	PATIENT	NUMBER	Progress Free Survival (Years)	Progress Free Survival (Years)	1				
2509	2509	2509	2509	2509	2509	2509	2509	2509	2509	2509	2509	2509	2517	PF_MONTHS	PATIENT	STRING	Pf months	Pf months	1				
2510	2510	2510	2510	2510	2510	2510	2510	2510	2510	2510	2510	2510	2518	PF_STATUS	PATIENT	STRING	Pf status	Pf status	1				
2511	2511	2511	2511	2511	2511	2511	2511	2511	2511	2511	2511	2511	2519	PHARMACEUTICAL_TX_ADJUVANT	PATIENT	STRING	Indicator to signify whether or not whether the patient had adjuvant/post-operative pharmaceutical therapy.	Adjuvant Postoperative Pharmaceutical Therapy Administered Indicator	1				
2512	2512	2512	2512	2512	2512	2512	2512	2512	2512	2512	2512	2512	2520	PHARM_REGIMEN	PATIENT	STRING	Pharmaceutial Regimen	Pharmaceutial Regimen	1				
2513	2513	2513	2513	2513	2513	2513	2513	2513	2513	2513	2513	2513	2521	PHARM_REGIMEN_OTHER	PATIENT	STRING	Pharmaceutial Regimen (Other)	Pharmaceutial Regimen (Other)	1				
2514	2514	2514	2514	2514	2514	2514	2514	2514	2514	2514	2514	2514	2522	PHARM_TX_MITOTANE_ADJUVANT	PATIENT	STRING	Mitotane Therapy Adjuvant Setting	Mitotane Therapy adjuvant setting	1				
2515	2515	2515	2515	2515	2515	2515	2515	2515	2515	2515	2515	2515	2523	PHARM_TX_MITOTANE_FOR_MACRO_DISEASE	PATIENT	STRING	Mitotane Therapy For Macroscopic Residual Disease	Mitotane Therapy for macroscopic residual disease	1				
2516	2516	2516	2516	2516	2516	2516	2516	2516	2516	2516	2516	2516	2524	PHARM_TX_MITOTANE_INDICATOR	PATIENT	STRING	Mitotane Therapy	Mitotane Therapy	1				
2517	2517	2517	2517	2517	2517	2517	2517	2517	2517	2517	2517	2517	2525	PHARM_TX_MITOTANE_THERAPUTIC_AT_PROG	PATIENT	STRING	Therapeutic Mitotane Lvl Progression	Therapeutic Mitotane lvl progression	1				
2518	2518	2518	2518	2518	2518	2518	2518	2518	2518	2518	2518	2518	2526	PHARM_TX_MITOTANE_THERAPUTIC_AT_REC	PATIENT	STRING	Therapeutic Mitotane Lvl Recurrence	Therapeutic Mitotane lvl recurrence	1				
2519	2519	2519	2519	2519	2519	2519	2519	2519	2519	2519	2519	2519	2527	PHARM_TX_MITOTANE_THERAPUTIC_LEVELS	PATIENT	STRING	Therapeutic Mitotane Levels Achieved	Therapeutic Mitotane levels achieved	1				
2520	2520	2520	2520	2520	2520	2520	2520	2520	2520	2520	2520	2520	2528	PHARM_TX_MITOTANE_THERAPUTIC_MACRO	PATIENT	STRING	Therapeutic Mitotane Lvl Macroscopic Residual	Therapeutic Mitotane lvl macroscopic residual	1				
2521	2521	2521	2521	2521	2521	2521	2521	2521	2521	2521	2521	2521	2529	PHENOTYPE	SAMPLE	STRING	Phenotype	Phenotype	1				
2522	2522	2522	2522	2522	2522	2522	2522	2522	2522	2522	2522	2522	2530	PHYSICIAN	PATIENT	STRING	Physician.	Physician	1				
2523	2523	2523	2523	2523	2523	2523	2523	2523	2523	2523	2523	2523	2531	PI3K_MTOR_STATUS	SAMPLE	STRING	PI3K_MTOR_STATUS	PI3K_MTOR_STATUS	1				
2524	2524	2524	2524	2524	2524	2524	2524	2524	2524	2524	2524	2524	2532	PI3K_MUTATION	SAMPLE	STRING	PI3K Mutation	PI3K Mutation	1				
2525	2525	2525	2525	2525	2525	2525	2525	2525	2525	2525	2525	2525	2533	PIK3CA_MUTATION	SAMPLE	STRING	PIK3CA mutation is present.	PIK3CA Mutation	1				
2526	2526	2526	2526	2526	2526	2526	2526	2526	2526	2526	2526	2526	2534	PIK3CA_PROTEIN_CODING	SAMPLE	NUMBER	PIK3CA Protein Coding	PIK3CA Protein Coding	1				
2527	2527	2527	2527	2527	2527	2527	2527	2527	2527	2527	2527	2527	2535	PIK3R1_MUTATION_STATUS	SAMPLE	STRING	PIK3R1 Mutation Status	PIK3R1 Mutation Status	1				
2528	2528	2528	2528	2528	2528	2528	2528	2528	2528	2528	2528	2528	2536	PIK3R2_MUTATION_STATUS	SAMPLE	STRING	PIK3R2 Mutation Status	PIK3R2 Mutation Status	1				
2529	2529	2529	2529	2529	2529	2529	2529	2529	2529	2529	2529	2529	2537	PIPELINE_VER	PATIENT	STRING	Pipeline ver	Pipeline ver	1				
2530	2530	2530	2530	2530	2530	2530	2530	2530	2530	2530	2530	2530	2538	PIPELINE_VERSION	SAMPLE	STRING	Analysis pipeline version.	Pipeline Version	1				
2531	2531	2531	2531	2531	2531	2531	2531	2531	2531	2531	2531	2531	2539	PI_REVIEWED	SAMPLE	STRING	PI Reviewed	PI Reviewed	1				
2532	2532	2532	2532	2532	2532	2532	2532	2532	2532	2532	2532	2532	2540	PLASMA_CELLS	SAMPLE	NUMBER	Plasma cells	Plasma cells	1				
2533	2533	2533	2533	2533	2533	2533	2533	2533	2533	2533	2533	2533	2541	PLASMA_SERIES_VALUE	PATIENT	STRING	Plasma Series Value	Plasma Series Value	1				
2534	2534	2534	2534	2534	2534	2534	2534	2534	2534	2534	2534	2534	2542	PLATELET_COUNT	PATIENT	STRING	Platelet qualitative result	Platelet count	1				
2535	2535	2535	2535	2535	2535	2535	2535	2535	2535	2535	2535	2535	2543	PLATELET_COUNT_PRERESECTION	PATIENT	NUMBER	Platelet count preresection	Platelet count preresection	1				
2536	2536	2536	2536	2536	2536	2536	2536	2536	2536	2536	2536	2536	2544	PLATELET_NORMAL_RANGE_LOWER	PATIENT	NUMBER	Laboratory prcoedure platelet result lower limit of normal value	Laboratory prcoedure platelet result lower limit of normal value	1				
2537	2537	2537	2537	2537	2537	2537	2537	2537	2537	2537	2537	2537	2545	PLATELET_NORMAL_RANGE_UPPER	PATIENT	NUMBER	Laboratory prcoedure platelet result upper limit of normal value	Laboratory prcoedure platelet result upper limit of normal value	1				
2538	2538	2538	2538	2538	2538	2538	2538	2538	2538	2538	2538	2538	2546	PLATELET_NORM_RANGE_LOWER	SAMPLE	NUMBER	Laboratory prcoedure platelet result lower limit of normal value	Laboratory prcoedure platelet result lower limit of normal value	1				
2539	2539	2539	2539	2539	2539	2539	2539	2539	2539	2539	2539	2539	2547	PLATELET_NORM_RANGE_UPPER	SAMPLE	NUMBER	Laboratory prcoedure platelet result upper limit of normal value	Laboratory prcoedure platelet result upper limit of normal value	1				
2540	2540	2540	2540	2540	2540	2540	2540	2540	2540	2540	2540	2540	2548	PLATFORM	SAMPLE	STRING	Platform.	Platform	1				
2541	2541	2541	2541	2541	2541	2541	2541	2541	2541	2541	2541	2541	2549	PLATINUM_BEST_RESPONSE	PATIENT	STRING	Platinum Best Response	Platinum Best Response	1				
2542	2542	2542	2542	2542	2542	2542	2542	2542	2542	2542	2542	2542	2550	PLATINUM_DOUBLET	PATIENT	STRING	Platinum Doublet	Platinum Doublet	1				
2543	2543	2543	2543	2543	2543	2543	2543	2543	2543	2543	2543	2543	2551	PLATINUM_GERMLINE_TESTED	PATIENT	STRING	Platinum Germline Tested	Platinum Germline Tested	1				
2544	2544	2544	2544	2544	2544	2544	2544	2544	2544	2544	2544	2544	2552	PLATINUM_HRD_MUTATION	PATIENT	STRING	Platinum HRD Mutation	Platinum HRD Mutation	1				
2545	2545	2545	2545	2545	2545	2545	2545	2545	2545	2545	2545	2545	2553	PLATINUM_LST_SCORE	PATIENT	STRING	Platinum LST Score	Platinum LST Score	1				
2546	2546	2546	2546	2546	2546	2546	2546	2546	2546	2546	2546	2546	2554	PLATINUM_OS_MONTHS	PATIENT	NUMBER	Platinum Overall Survival Months	Platinum Overall Survival Months	1				
2547	2547	2547	2547	2547	2547	2547	2547	2547	2547	2547	2547	2547	2555	PLATINUM_OS_STATUS	PATIENT	STRING	Platinum Overall Survival Status	Platinum Overall Survival Status	1				
2548	2548	2548	2548	2548	2548	2548	2548	2548	2548	2548	2548	2548	2556	PLATINUM_PFS_MONTHS	PATIENT	NUMBER	Platinum Progression Free Months	Platinum Progression Free Months	1				
2549	2549	2549	2549	2549	2549	2549	2549	2549	2549	2549	2549	2549	2557	PLATINUM_PFS_STATUS	PATIENT	STRING	Platinum Progression Free Status	Platinum Progression Free Status	1				
2550	2550	2550	2550	2550	2550	2550	2550	2550	2550	2550	2550	2550	2558	PLATINUM_STATUS	PATIENT	STRING	Platinum status.	Platinum Status	1				
2551	2551	2551	2551	2551	2551	2551	2551	2551	2551	2551	2551	2551	2559	PLEOMORPHISM_SCORE	SAMPLE	STRING	Pleomorphism Score	Pleomorphism Score	1				
2552	2552	2552	2552	2552	2552	2552	2552	2552	2552	2552	2552	2552	2560	PLEURAL_INVASION	SAMPLE	STRING	Pleural Invasion	Pleural Invasion	1				
2553	2553	2553	2553	2553	2553	2553	2553	2553	2553	2553	2553	2553	2561	PLEURA_STATUS	SAMPLE	STRING	Pleura Status	Pleura Status	1				
2554	2554	2554	2554	2554	2554	2554	2554	2554	2554	2554	2554	2554	2562	PLEURODESIS_PERFORMED_90_DAYS	PATIENT	STRING	Pleurodesis Performed in 90 Days	Pleurodesis Performed in 90 Days	1				
2555	2555	2555	2555	2555	2555	2555	2555	2555	2555	2555	2555	2555	2563	PLEURODESIS_PERFORMED_PRIOR	PATIENT	STRING	Prior Pleurodesis Performed	Prior Pleurodesis Performed	1				
2556	2556	2556	2556	2556	2556	2556	2556	2556	2556	2556	2556	2556	2564	PLOCATION	PATIENT	NUMBER	Plocation	Plocation	1				
2557	2557	2557	2557	2557	2557	2557	2557	2557	2557	2557	2557	2557	2565	PLOIDY	SAMPLE	STRING	Ploidy.	Ploidy	1				
2558	2558	2558	2558	2558	2558	2558	2558	2558	2558	2558	2558	2558	2566	PLOIDY_PREDICTION_SCORE	SAMPLE	NUMBER	Ploidy Prediction Score	Ploidy Prediction Score	1				
2559	2559	2559	2559	2559	2559	2559	2559	2559	2559	2559	2559	2559	2567	PLT_COUNT	PATIENT	STRING	PLT Count	PLT Count	1				
2560	2560	2560	2560	2560	2560	2560	2560	2560	2560	2560	2560	2560	2568	PM	PATIENT	NUMBER	Pm	Pm	1				
2561	2561	2561	2561	2561	2561	2561	2561	2561	2561	2561	2561	2561	2569	PMS2_STATUS	SAMPLE	STRING	PMS2 Status	PMS2 Status	1				
2562	2562	2562	2562	2562	2562	2562	2562	2562	2562	2562	2562	2562	2570	PN	PATIENT	NUMBER	Pn	Pn	1				
2563	2563	2563	2563	2563	2563	2563	2563	2563	2563	2563	2563	2563	2571	PNI	PATIENT	STRING	PNI.	PNI	1				
2564	2564	2564	2564	2564	2564	2564	2564	2564	2564	2564	2564	2564	2572	POD_AT_BLOOD_DRAW	SAMPLE	STRING	POD at blood draw	POD at blood draw	1				
2565	2565	2565	2565	2565	2565	2565	2565	2565	2565	2565	2565	2565	2573	POLE_MUTATION_STATUS	SAMPLE	STRING	POLE Mutation Status	POLE Mutation Status	1				
2566	2566	2566	2566	2566	2566	2566	2566	2566	2566	2566	2566	2566	2574	POOL	SAMPLE	STRING	Pool	pool	1				
2567	2567	2567	2567	2567	2567	2567	2567	2567	2567	2567	2567	2567	2575	PORTAL_VEIN_INVASION	PATIENT	STRING	Portal vein invasion	Portal Vein Invasion	1				
2568	2568	2568	2568	2568	2568	2568	2568	2568	2568	2568	2568	2568	2576	POSSIBLE_DNA_CONTANMINATION	SAMPLE	STRING	Possible DNA contanmination	Possible DNA contanmination	1				
2569	2569	2569	2569	2569	2569	2569	2569	2569	2569	2569	2569	2569	2577	POSSIBLE_HPYLORI_INFECTION	PATIENT	NUMBER	Possible hpylori infection	Possible hpylori infection	1				
2570	2570	2570	2570	2570	2570	2570	2570	2570	2570	2570	2570	2570	2578	POSTOPERATIVE_RX_TX	PATIENT	STRING	Postoperative Radiation Treatment	Postoperative Radiation Treatment	1				
2571	2571	2571	2571	2571	2571	2571	2571	2571	2571	2571	2571	2571	2579	POSTOPERATIVE_TX	SAMPLE	STRING	Postoperative tx	Postoperative tx	1				
2572	2572	2572	2572	2572	2572	2572	2572	2572	2572	2572	2572	2572	2580	POSTTREATMENT_STAGE	PATIENT	STRING	Post-treatment stage.	Post-treatment Stage	1				
2573	2573	2573	2573	2573	2573	2573	2573	2573	2573	2573	2573	2573	2581	POST_OP_RADIATION	PATIENT	STRING	Post-operative Radiation Therapy	Post-op Radiation	1				
2574	2574	2574	2574	2574	2574	2574	2574	2574	2574	2574	2574	2574	2582	POST_ORCHI_AFP	SAMPLE	NUMBER	Post orchi afp	Post orchi afp	1				
2575	2575	2575	2575	2575	2575	2575	2575	2575	2575	2575	2575	2575	2583	POST_ORCHI_HCG	SAMPLE	NUMBER	Post orchi hcg	Post orchi hcg	1				
2576	2576	2576	2576	2576	2576	2576	2576	2576	2576	2576	2576	2576	2584	POST_ORCHI_LDH	SAMPLE	NUMBER	Post orchi ldh	Post orchi ldh	1				
2577	2577	2577	2577	2577	2577	2577	2577	2577	2577	2577	2577	2577	2585	POST_ORCHI_LH	SAMPLE	NUMBER	Post orchi lh	Post orchi lh	1				
2578	2578	2578	2578	2578	2578	2578	2578	2578	2578	2578	2578	2578	2586	POST_ORCHI_LYMPH_NODE_DISSECTION	SAMPLE	STRING	Post orchi lymph node dissection	Post orchi lymph node dissection	1				
2579	2579	2579	2579	2579	2579	2579	2579	2579	2579	2579	2579	2579	2587	POST_ORCHI_TESTOSTERONE	SAMPLE	STRING	Post orchi testosterone	Post orchi testosterone	1				
2580	2580	2580	2580	2580	2580	2580	2580	2580	2580	2580	2580	2580	2588	POST_SCT_RELAPSE	PATIENT	STRING	Did the patient relapse after SCT	Patient Relapsed post SCT	1				
2581	2581	2581	2581	2581	2581	2581	2581	2581	2581	2581	2581	2581	2589	POST_SURGERY_PREVENTATIVE_THERAPY	PATIENT	STRING	Post Surgery Preventative Therapy	Post Surgery Preventative Therapy	1				
2582	2582	2582	2582	2582	2582	2582	2582	2582	2582	2582	2582	2582	2590	POST_TX_OVERALL_STAGE	SAMPLE	STRING	PostTx Overall Stage	PostTx Overall Stage	1				
2583	2583	2583	2583	2583	2583	2583	2583	2583	2583	2583	2583	2583	2591	POST_TX_TNM_STAGE	SAMPLE	STRING	PostTx TNM Stage	PostTx TNM Stage	1				
2584	2584	2584	2584	2584	2584	2584	2584	2584	2584	2584	2584	2584	2592	POS_LYMPH_NODE_LOCATION	PATIENT	STRING	Lymph node location positive pathology name	Lymph node location positive pathology name	1				
2585	2585	2585	2585	2585	2585	2585	2585	2585	2585	2585	2585	2585	2593	PPP2R1A_MUTATION	SAMPLE	STRING	PPP2R1A Mutation	PPP2R1A Mutation	1				
2586	2586	2586	2586	2586	2586	2586	2586	2586	2586	2586	2586	2586	2594	PRD_DIAGNOSIS_LOC	PATIENT	STRING	Patient reported response to the question: When you were first diagnosed with angiosarcoma, where in your body was it found (select all that apply)?	PRD_Diagnosis Location	1				
2587	2587	2587	2587	2587	2587	2587	2587	2587	2587	2587	2587	2587	2595	PRD_EVER_LOCATION	PATIENT	STRING	Patient reported response to the question: Please select all of the places in your body that you have ever had angiosarcoma (select all that apply).	PRD_Ever Location	1				
2588	2588	2588	2588	2588	2588	2588	2588	2588	2588	2588	2588	2588	2596	PRD_LOCATION_AT_ENROLLMENT	PATIENT	STRING	Patient reported response to the question: Please select all of the places in your body where you currently have angiosarcoma (select all that apply). If you don���t have evidence of disease, please select ����No Evidence of Disease (NED).	PRD_Location of Disease at Time of Enrollment	1				
2589	2589	2589	2589	2589	2589	2589	2589	2589	2589	2589	2589	2589	2597	PRD_OTHER_CANCER	PATIENT	STRING	Patient reported response to the question: Were you ever diagnosed with any other kind of cancer(s)?	PRD_Other Cancer	1				
2590	2590	2590	2590	2590	2590	2590	2590	2590	2590	2590	2590	2590	2598	PRD_OTHER_CANCER_LIST	PATIENT	STRING	Patient reported response to the question: Please list which cancer(s) and approximate year(s) of diagnosis.	PRD_Other Cancer Type	1				
2591	2591	2591	2591	2591	2591	2591	2591	2591	2591	2591	2591	2591	2599	PRD_OTHER_CANCER_RADIATION	PATIENT	STRING	Patient reported response to the question: Have you had radiation as a treatment for another cancer(s)?	PRD_Radiation for Other Cancers	1				
2592	2592	2592	2592	2592	2592	2592	2592	2592	2592	2592	2592	2592	2600	PRD_RADIATION	PATIENT	STRING	Patient reported response to the question: Have you had radiation as a treatment for angiosarcoma? If you had radiation for other cancers, we will ask you about that later.	PRD_Radiation	1				
2593	2593	2593	2593	2593	2593	2593	2593	2593	2593	2593	2593	2593	2601	PRD_RADIATION_SURGERY	PATIENT	STRING	Patient reported response to the question: Was your radiation before or after surgery?	PRD_ Time of Radiation	1				
2594	2594	2594	2594	2594	2594	2594	2594	2594	2594	2594	2594	2594	2602	PRD_SURGERY	PATIENT	STRING	Patient reported response to the question: Have you had surgery to remove angiosarcoma?	PRD_Surgery	1				
2595	2595	2595	2595	2595	2595	2595	2595	2595	2595	2595	2595	2595	2603	PRD_SURGERY_CLEAN_MARGINS	PATIENT	STRING	Patient reported response to the question: If [surgery], did the surgery remove all known cancer tissue (also known as clean margins)?	PRD_Surgical Margins	1				
2596	2596	2596	2596	2596	2596	2596	2596	2596	2596	2596	2596	2596	2604	PRD_TREATED_AT_ENROLLMENT	PATIENT	STRING	Patient reported response to the question: Are you currently being treated for your angiosarcoma?	PRD_In Treatment At Time of Enrollment	1				
2597	2597	2597	2597	2597	2597	2597	2597	2597	2597	2597	2597	2597	2605	PREGNANCIES_COUNT_ECTOPIC	PATIENT	NUMBER	Ectopic pregnancy count	Ectopic pregnancy count	1				
2598	2598	2598	2598	2598	2598	2598	2598	2598	2598	2598	2598	2598	2606	PREGNANCIES_COUNT_INDUCED_ABORTION	PATIENT	NUMBER	Patient pregnancy therapeutic abortion count	Patient pregnancy therapeutic abortion count	1				
2599	2599	2599	2599	2599	2599	2599	2599	2599	2599	2599	2599	2599	2607	PREGNANCIES_COUNT_LIVE_BIRTH	PATIENT	NUMBER	Number of successful pregnancies which resulted in at least 1 live birth	Number of successful pregnancies which resulted in at least 1 live birth	1				
2600	2600	2600	2600	2600	2600	2600	2600	2600	2600	2600	2600	2600	2608	PREGNANCIES_COUNT_MISCARRIAGE	PATIENT	NUMBER	Patient pregnancy spontaneous abortion count	Patient pregnancy spontaneous abortion count	1				
2601	2601	2601	2601	2601	2601	2601	2601	2601	2601	2601	2601	2601	2609	PREGNANCIES_COUNT_STILLBIRTH	PATIENT	NUMBER	Pregnancy stillbirth count	Pregnancy stillbirth count	1				
2602	2602	2602	2602	2602	2602	2602	2602	2602	2602	2602	2602	2602	2610	PREGNANCIES_COUNT_TOTAL	PATIENT	NUMBER	Total number of pregnancies	Total number of pregnancies	1				
2603	2603	2603	2603	2603	2603	2603	2603	2603	2603	2603	2603	2603	2611	PREGNANCIES_FULL_TERM_COUNT	PATIENT	STRING	Pregnancies full term count	Pregnancies full term count	1				
2604	2604	2604	2604	2604	2604	2604	2604	2604	2604	2604	2604	2604	2612	PREGNANT_AT_DIAGNOSIS	PATIENT	STRING	Pregnant at diagnosis	Pregnant at diagnosis	1				
2605	2605	2605	2605	2605	2605	2605	2605	2605	2605	2605	2605	2605	2613	PRENEOPLASTIC_CHANGE	PATIENT	NUMBER	Preneoplastic change	Preneoplastic change	1				
2606	2606	2606	2606	2606	2606	2606	2606	2606	2606	2606	2606	2606	2614	PREOPERATIVE_ANTISEIZURE_MED	PATIENT	STRING	Pre-operative anti-seizure medication.	Preoperative Anti-Seizure Medication	1				
2607	2607	2607	2607	2607	2607	2607	2607	2607	2607	2607	2607	2607	2615	PREOPERATIVE_CORTICOSTEROIDS	PATIENT	STRING	Pre-operative corticosteriods.	Preoperative Corticosteroids	1				
2608	2608	2608	2608	2608	2608	2608	2608	2608	2608	2608	2608	2608	2616	PREOPERATIVE_PSA	PATIENT	NUMBER	Preop PSA	Preop PSA	1				
2609	2609	2609	2609	2609	2609	2609	2609	2609	2609	2609	2609	2609	2617	PREOPERATIVE_TREATMENT	PATIENT	STRING	Pre-Operative Treatment	Pre-Operative Treatment	1				
2610	2610	2610	2610	2610	2610	2610	2610	2610	2610	2610	2610	2610	2618	PREOP_CT	PATIENT	STRING	Pre-operative Chemotherapy description	Pre-operative Chemotherapy	1				
2611	2611	2611	2611	2611	2611	2611	2611	2611	2611	2611	2611	2611	2619	PREOP_PRETREAT_CEA_LEVEL	PATIENT	NUMBER	The carcinoembryonic antigen (CEA) test measures the level of CEA in the blood. CEA is a protein normally found in the tissue of a developing baby in the womb. The blood level of this protein disappears or becomes very low after birth. In adults, an abnormal level of CEA may be a sign of cancer.	Pre-Operative/Pre-Treatment CEA Level	1				
2612	2612	2612	2612	2612	2612	2612	2612	2612	2612	2612	2612	2612	2620	PREOP_RT_BEFORE_FIRST_SURGERY	PATIENT	STRING	Preop RT before first surgery	Preop RT before first surgery	1				
2613	2613	2613	2613	2613	2613	2613	2613	2613	2613	2613	2613	2613	2621	PRERESECTION_CREATININE_LEVEL	PATIENT	NUMBER	Hematology serum creatinine laboratory result value in mg dl	Hematology serum creatinine laboratory result value in mg dl	1				
2614	2614	2614	2614	2614	2614	2614	2614	2614	2614	2614	2614	2614	2622	PRERESECTION_SERUM_ALBUMIN	PATIENT	NUMBER	Laboratory procedure albumin result specified value	Laboratory procedure albumin result specified value	1				
2615	2615	2615	2615	2615	2615	2615	2615	2615	2615	2615	2615	2615	2623	PRESENTATION	PATIENT	STRING	Presentation	Presentation	1				
2616	2616	2616	2616	2616	2616	2616	2616	2616	2616	2616	2616	2616	2624	PRES_STG_YEAR	PATIENT	NUMBER	Year of Presentation	Year of Presentation	1				
2617	2617	2617	2617	2617	2617	2617	2617	2617	2617	2617	2617	2617	2625	PRETREATED_TISSUE	SAMPLE	STRING	Pretreated Tissue	Pretreated Tissue	1				
2618	2618	2618	2618	2618	2618	2618	2618	2618	2618	2618	2618	2618	2626	PRETREATMENT_HISTORY	PATIENT	STRING	Pre-treatment history.	Pre-treatment History	1				
2619	2619	2619	2619	2619	2619	2619	2619	2619	2619	2619	2619	2619	2627	PRETREATMENT_IMAGING	PATIENT	STRING	Pre-treatment imaging.	Pre-treatment Imaging	1				
2620	2620	2620	2620	2620	2620	2620	2620	2620	2620	2620	2620	2620	2628	PRETREATMENT_STAGE	PATIENT	STRING	Pre-treatment stage.	Pre-treatment Stage	1				
2621	2621	2621	2621	2621	2621	2621	2621	2621	2621	2621	2621	2621	2629	PREVIOUS_MAPKI	PATIENT	STRING	Previous MAPKi treatment	Previous MAPKi	1				
2622	2622	2622	2622	2622	2622	2622	2622	2622	2622	2622	2622	2622	2630	PREVIOUS_MDS_MPN_AML_REGIMEN	PATIENT	STRING	Previous MDS/MPN/AML Regimen	Previous MDS/MPN/AML Regimen	1				
2623	2623	2623	2623	2623	2623	2623	2623	2623	2623	2623	2623	2623	2631	PREVIOUS_TREATMENT	PATIENT	STRING	Previous treatment.	Previous Treatment	1				
2624	2624	2624	2624	2624	2624	2624	2624	2624	2624	2624	2624	2624	2632	PRE_EXISTING_POLYP	PATIENT	STRING	Pre-existing Polyp	Pre-existing Polyp	1				
2625	2625	2625	2625	2625	2625	2625	2625	2625	2625	2625	2625	2625	2633	PRE_ORCHI_AFP	SAMPLE	NUMBER	Pre orchi afp	Pre orchi afp	1				
2626	2626	2626	2626	2626	2626	2626	2626	2626	2626	2626	2626	2626	2634	PRE_ORCHI_HCG	SAMPLE	NUMBER	Pre orchi hcg	Pre orchi hcg	1				
2627	2627	2627	2627	2627	2627	2627	2627	2627	2627	2627	2627	2627	2635	PRE_ORCHI_LDH	SAMPLE	NUMBER	Pre orchi ldh	Pre orchi ldh	1				
2628	2628	2628	2628	2628	2628	2628	2628	2628	2628	2628	2628	2628	2636	PRE_ORCHI_LH	SAMPLE	NUMBER	Pre orchi lh	Pre orchi lh	1				
2629	2629	2629	2629	2629	2629	2629	2629	2629	2629	2629	2629	2629	2637	PRE_ORCHI_TESTOSTERONE	SAMPLE	STRING	Pre orchi testosterone	Pre orchi testosterone	1				
2630	2630	2630	2630	2630	2630	2630	2630	2630	2630	2630	2630	2630	2638	PRE_OR_POST_TX	SAMPLE	STRING	Pre or Post Tx	Pre or Post Tx	1				
2631	2631	2631	2631	2631	2631	2631	2631	2631	2631	2631	2631	2631	2639	PRE_POST_CHEMO	PATIENT	STRING	Pre/Post Chemo	Pre/Post Chemo	1				
2632	2632	2632	2632	2632	2632	2632	2632	2632	2632	2632	2632	2632	2640	PRE_POST_TX	SAMPLE	STRING	Sample retrieved is pre or post treatment	Sample Pre or Post Treatment	1				
2633	2633	2633	2633	2633	2633	2633	2633	2633	2633	2633	2633	2633	2641	PRE_RC_SYSTEMICCHEMO	PATIENT	STRING	Pre RC Systemic Chemotherapy	Pre RC Systemic Chemotherapy	1				
2634	2634	2634	2634	2634	2634	2634	2634	2634	2634	2634	2634	2634	2642	PRIMARY_AT_DX_COUNT	PATIENT	NUMBER	Primary melanoma at diagnosis count	Primary at dx count	1				
2635	2635	2635	2635	2635	2635	2635	2635	2635	2635	2635	2635	2635	2643	PRIMARY_CYTOGENETIC_CODE	PATIENT	STRING	Primary cytogenetic code.	Primary Cytogenetic Code	1				
2636	2636	2636	2636	2636	2636	2636	2636	2636	2636	2636	2636	2636	2644	PRIMARY_DEPTH	SAMPLE	NUMBER	Primary Depth	Primary Depth	1				
2637	2637	2637	2637	2637	2637	2637	2637	2637	2637	2637	2637	2637	2645	PRIMARY_DIAGNOSIS	PATIENT	STRING	Primary Diagnosis	Primary Diagosis	1				
2638	2638	2638	2638	2638	2638	2638	2638	2638	2638	2638	2638	2638	2646	PRIMARY_EXOME	SAMPLE	STRING	Sample has exome passing QC	Sample Has Exome Passing QC	1				
2639	2639	2639	2639	2639	2639	2639	2639	2639	2639	2639	2639	2639	2647	PRIMARY_HISTOLOGY	PATIENT	STRING	Primary Histology	Primary histology	1				
2640	2640	2640	2640	2640	2640	2640	2640	2640	2640	2640	2640	2640	2648	PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT	PATIENT	STRING	Primary lymph node presentation assessment.	Primary Lymph Node Presentation Assessment	1				
2641	2641	2641	2641	2641	2641	2641	2641	2641	2641	2641	2641	2641	2649	PRIMARY_MELANOMA_KNOWN_DX	PATIENT	STRING	Primary neoplasm melanoma dx	Primary melanoma known dx	1				
2642	2642	2642	2642	2642	2642	2642	2642	2642	2642	2642	2642	2642	2650	PRIMARY_MELANOMA_MITOTIC_RATE	PATIENT	NUMBER	Malignant neoplasm mitotic count rate	Primary melanoma mitotic rate	1				
2643	2643	2643	2643	2643	2643	2643	2643	2643	2643	2643	2643	2643	2651	PRIMARY_MELANOMA_SKIN_TYPE	PATIENT	STRING	Melanoma origin skin anatomic site	Primary melanoma skin type	1				
2644	2644	2644	2644	2644	2644	2644	2644	2644	2644	2644	2644	2644	2652	PRIMARY_MELANOMA_TUMOR_ULCERATION	PATIENT	STRING	Melanoma ulceration indicator	Primary melanoma tumor ulceration	1				
2645	2645	2645	2645	2645	2645	2645	2645	2645	2645	2645	2645	2645	2653	PRIMARY_METS_HER2_DISCONCORDANT	SAMPLE	STRING	Primary Mets HER2 Disconcordant	Primary Mets HER2 Disconcordant	1				
2646	2646	2646	2646	2646	2646	2646	2646	2646	2646	2646	2646	2646	2654	PRIMARY_METS_HR_DISCONCORDANT	SAMPLE	STRING	Primary Mets HR Disconcordant	Primary Mets HR Disconcordant	1				
2647	2647	2647	2647	2647	2647	2647	2647	2647	2647	2647	2647	2647	2655	PRIMARY_MITOSES	SAMPLE	STRING	Primary Mitoses	Primary Mitoses	1				
2648	2648	2648	2648	2648	2648	2648	2648	2648	2648	2648	2648	2648	2656	PRIMARY_MITOTIC_RATE_50_HPF	SAMPLE	NUMBER	Primary Mitotic Rate(50 HPF)	Primary Mitotic Rate(50 HPF)	1				
2649	2649	2649	2649	2649	2649	2649	2649	2649	2649	2649	2649	2649	2657	PRIMARY_MULTIPLE_AT_DX	PATIENT	STRING	Primary tumor multiple present ind	Primary multiple at dx	1				
2650	2650	2650	2650	2650	2650	2650	2650	2650	2650	2650	2650	2650	2658	PRIMARY_PHARMA_THERAPY	PATIENT	STRING	Primary pharmacologic therapy.	Primary Pharmacologic Therapy	1				
2651	2651	2651	2651	2651	2651	2651	2651	2651	2651	2651	2651	2651	2659	PRIMARY_RACE	PATIENT	STRING	The primary race recorded for the patient; this data element maps to the NAACCR v16 #160. For institutions collecting more than one race category, this should be the primary race. For institutions not collecting race, submit a null in this category for all patients.	Primary Race	1				
2652	2652	2652	2652	2652	2652	2652	2652	2652	2652	2652	2652	2652	2660	PRIMARY_RADIATION_THERAPY	PATIENT	STRING	Primary radiation therapy.	Primary Radiation Therapy	1				
2653	2653	2653	2653	2653	2653	2653	2653	2653	2653	2653	2653	2653	2661	PRIMARY_RESECTION	PATIENT	STRING	Resection of the primary	Resection of the primary	1				
2654	2654	2654	2654	2654	2654	2654	2654	2654	2654	2654	2654	2654	2662	PRIMARY_RPLND	SAMPLE	STRING	Primary RPLND	Primary RPLND	1				
2655	2655	2655	2655	2655	2655	2655	2655	2655	2655	2655	2655	2655	2663	PRIMARY_SITE	SAMPLE	STRING	Text term to describe the organ sub-division in an individual with cancer.	Primary Tumor Site	1				
2656	2656	2656	2656	2656	2656	2656	2656	2656	2656	2656	2656	2656	2664	PRIMARY_SITE_NOTES	PATIENT	STRING	Notes regarding site of origin of disease	MedR_Primary_Site_Notes	1				
2657	2657	2657	2657	2657	2657	2657	2657	2657	2657	2657	2657	2657	2665	PRIMARY_SITE_OTHER	SAMPLE	STRING	A text description of an 'other' originating or primary anatomic site of the disease/condition under investigation or review.	Primary Other Site of Disease Name	1				
2658	2658	2658	2658	2658	2658	2658	2658	2658	2658	2658	2658	2658	2666	PRIMARY_SITE_PROGRESSION	PATIENT	STRING	Primary site progression.	Primary Site Progression	1				
2659	2659	2659	2659	2659	2659	2659	2659	2659	2659	2659	2659	2659	2667	PRIMARY_SURGICAL_THERAPY	PATIENT	STRING	Primary surgical therapy	Primary surgical therapy	1				
2660	2660	2660	2660	2660	2660	2660	2660	2660	2660	2660	2660	2660	2668	PRIMARY_THERAPY_OUTCOME_SUCCESS	PATIENT	STRING	Primary therapy outhcome success.	Primary Therapy Outcome Success	1				
2661	2661	2661	2661	2661	2661	2661	2661	2661	2661	2661	2661	2661	2669	PRIMARY_THYROID_NEOPLASM_SITE	SAMPLE	STRING	Text field to describe the anatomic site of a primary thyroid neoplasm.	Primary Thyroid Neoplasm Site	1				
2662	2662	2662	2662	2662	2662	2662	2662	2662	2662	2662	2662	2662	2670	PRIMARY_TISSUE	PATIENT	STRING	Primary tissue	Primary tissue	1				
2663	2663	2663	2663	2663	2663	2663	2663	2663	2663	2663	2663	2663	2671	PRIMARY_TUMOR_GRADE	SAMPLE	STRING	Primary Tumor Grade	Primary Tumor Grade	1				
2664	2664	2664	2664	2664	2664	2664	2664	2664	2664	2664	2664	2664	2672	PRIMARY_TUMOR_LOCALIZATION_TYPE	PATIENT	STRING	Primary Tumor Localization Type	Primary Tumor Localization Type	1				
2665	2665	2665	2665	2665	2665	2665	2665	2665	2665	2665	2665	2665	2673	PRIMARY_TUMOR_LOCATION	SAMPLE	STRING	Primary Tumor Location	Primary Tumor Location	1				
2666	2666	2666	2666	2666	2666	2666	2666	2666	2666	2666	2666	2666	2674	PRIMARY_TUMOR_LOCATION_LEFT	SAMPLE	STRING	Primary Tumor Location (with Left)	Primary Tumor Location (with Left)	1				
2667	2667	2667	2667	2667	2667	2667	2667	2667	2667	2667	2667	2667	2675	PRIMARY_TUMOR_LOCATION_RECTUM	SAMPLE	STRING	Primary Tumor Location (with rectum)	Primary Tumor Location (with rectum)	1				
2668	2668	2668	2668	2668	2668	2668	2668	2668	2668	2668	2668	2668	2676	PRIMARY_TUMOR_PATHOLOGIC_SPREAD	PATIENT	STRING	Primary tumor pathologic spread.	Primary Tumor Pathologic Spread	1				
2669	2669	2669	2669	2669	2669	2669	2669	2669	2669	2669	2669	2669	2677	PRIMARY_TUMOR_SIZE	SAMPLE	STRING	Primary Tumor Size	Primary Tumor Size	1				
2670	2670	2670	2670	2670	2670	2670	2670	2670	2670	2670	2670	2670	2678	PRIMARY_TX_MODALITY	PATIENT	STRING	Primary Tx Modalit	Primary Tx Modalit	1				
2671	2671	2671	2671	2671	2671	2671	2671	2671	2671	2671	2671	2671	2679	PRIMARY_VS_SECONDARY	SAMPLE	STRING	Primary Vs Secondary	Primary Vs Secondary	1				
2672	2672	2672	2672	2672	2672	2672	2672	2672	2672	2672	2672	2672	2680	PRIM_SEQ	SAMPLE	STRING	Primary Sequenced	Primary Sequenced	1				
2673	2673	2673	2673	2673	2673	2673	2673	2673	2673	2673	2673	2673	2681	PRINCIPAL_SAMPLE	SAMPLE	STRING	Principal Sample	Principal Sample	1				
2674	2674	2674	2674	2674	2674	2674	2674	2674	2674	2674	2674	2674	2682	PRIORCHEMOFOROTHERCANCER	PATIENT	STRING	Priorchemoforothercancer	Priorchemoforothercancer	1				
2675	2675	2675	2675	2675	2675	2675	2675	2675	2675	2675	2675	2675	2683	PRIORRADIATIONFOROTHERCANCER	PATIENT	STRING	Priorradiationforothercancer	Priorradiationforothercancer	1				
2676	2676	2676	2676	2676	2676	2676	2676	2676	2676	2676	2676	2676	2684	PRIOR_AI	PATIENT	STRING	Prior AI.	Prior AI	1				
2677	2677	2677	2677	2677	2677	2677	2677	2677	2677	2677	2677	2677	2685	PRIOR_AIDS_CONDITIONS	PATIENT	STRING	Prior Aids Conditions	Prior Aids Conditions	1				
2678	2678	2678	2678	2678	2678	2678	2678	2678	2678	2678	2678	2678	2686	PRIOR_ANTIRETROVIRAL_THERAPY	PATIENT	STRING	Yes/No indicator for antiretroviral therapy prior to diagnosis	Antiretroviral Therapy Status Prior to Diagnosis	1				
2679	2679	2679	2679	2679	2679	2679	2679	2679	2679	2679	2679	2679	2687	PRIOR_ANTI_EGFR	PATIENT	STRING	Prior anti-EGFR (before sample collected for sequencing)	Prior anti-EGFR (before sample collected for sequencing)	1				
2680	2680	2680	2680	2680	2680	2680	2680	2680	2680	2680	2680	2680	2688	PRIOR_ANTI_VEGF	PATIENT	STRING	Prior anti-VEGF (before sample collected for sequencing)	Prior anti-VEGF (before sample collected for sequencing)	1				
2681	2681	2681	2681	2681	2681	2681	2681	2681	2681	2681	2681	2681	2689	PRIOR_BCG	PATIENT	STRING	Prior BCG	Prior BCG	1				
2682	2682	2682	2682	2682	2682	2682	2682	2682	2682	2682	2682	2682	2690	PRIOR_CANCER	PATIENT	STRING	Prior Diagnosis of Cancer	Prior Diagnosis of Cancer	1				
2683	2683	2683	2683	2683	2683	2683	2683	2683	2683	2683	2683	2683	2691	PRIOR_CHEMO	SAMPLE	STRING	Prior Chemotherapy	Prior Chemotherapy	1				
2684	2684	2684	2684	2684	2684	2684	2684	2684	2684	2684	2684	2684	2692	PRIOR_DIAGNOSIS	PATIENT	STRING	Prior diagnosis.	Prior Diagnosis	1				
2685	2685	2685	2685	2685	2685	2685	2685	2685	2685	2685	2685	2685	2693	PRIOR_DX	PATIENT	STRING	Prior diagnosis.	Prior Diagnosis	1				
2686	2686	2686	2686	2686	2686	2686	2686	2686	2686	2686	2686	2686	2694	PRIOR_DXYN	PATIENT	STRING	Prior diagnosis.	Prior Diagnosis	1				
2687	2687	2687	2687	2687	2687	2687	2687	2687	2687	2687	2687	2687	2695	PRIOR_FLUOROPYRIMIDINE	PATIENT	STRING	Prior fluoropyrimidine (before sample collected for sequencing)	Prior fluoropyrimidine (before sample collected for sequencing)	1				
2688	2688	2688	2688	2688	2688	2688	2688	2688	2688	2688	2688	2688	2696	PRIOR_FULVESTRANT	PATIENT	STRING	Prior fulvestrant.	Prior Fulvestrant	1				
2689	2689	2689	2689	2689	2689	2689	2689	2689	2689	2689	2689	2689	2697	PRIOR_GLIOMA	PATIENT	STRING	Prior glioma.	Prior Glioma	1				
2690	2690	2690	2690	2690	2690	2690	2690	2690	2690	2690	2690	2690	2698	PRIOR_HAI	PATIENT	STRING	Prior HAI (before sample collected for sequencing)	Prior HAI (before sample collected for sequencing)	1				
2691	2691	2691	2691	2691	2691	2691	2691	2691	2691	2691	2691	2691	2699	PRIOR_HERCEPTIN	PATIENT	STRING	Prior herceptin.	Prior Herceptin	1				
2692	2692	2692	2692	2692	2692	2692	2692	2692	2692	2692	2692	2692	2700	PRIOR_INTRAVESICAL_CHEMO	PATIENT	STRING	Prior Intravesical Chemotherapy	Prior Intravesical Chemotherapy	1				
2693	2693	2693	2693	2693	2693	2693	2693	2693	2693	2693	2693	2693	2701	PRIOR_INTRAVESICAL_CHEMOTHERAPY	SAMPLE	STRING	Prior Intravesical Chemotherapy	Prior Intravesical Chemotherapy	1				
2694	2694	2694	2694	2694	2694	2694	2694	2694	2694	2694	2694	2694	2702	PRIOR_IP	PATIENT	STRING	Prior IP (before sample collected for sequencing)	Prior IP (before sample collected for sequencing)	1				
2695	2695	2695	2695	2695	2695	2695	2695	2695	2695	2695	2695	2695	2703	PRIOR_IRINOTECAN	PATIENT	STRING	Prior irinotecan (before sample collected for sequencing)	Prior irinotecan (before sample collected for sequencing)	1				
2696	2696	2696	2696	2696	2696	2696	2696	2696	2696	2696	2696	2696	2704	PRIOR_LAPATINIB	PATIENT	STRING	Prior lapatinib.	Prior Lapatinib	1				
2697	2697	2697	2697	2697	2697	2697	2697	2697	2697	2697	2697	2697	2705	PRIOR_LOCAL_THERAPY	PATIENT	STRING	Prior Local Therapy	Prior Local Therapy	1				
2698	2698	2698	2698	2698	2698	2698	2698	2698	2698	2698	2698	2698	2706	PRIOR_MDS_AML_TREATMENT	PATIENT	STRING	Prior MDS/AML Treatment?	Prior MDS/AML Treatment?	1				
2699	2699	2699	2699	2699	2699	2699	2699	2699	2699	2699	2699	2699	2707	PRIOR_MGUS	PATIENT	STRING	Prior MGUS.	Prior MGUS	1				
2700	2700	2700	2700	2700	2700	2700	2700	2700	2700	2700	2700	2700	2708	PRIOR_OS_MONTHS	PATIENT	NUMBER	Previous OS status recorded	Previous OS status recorded	1				
2701	2701	2701	2701	2701	2701	2701	2701	2701	2701	2701	2701	2701	2709	PRIOR_OXALIPLATIN	PATIENT	STRING	Prior oxaliplatin (before sample collected for sequencing)	Prior oxaliplatin (before sample collected for sequencing)	1				
2702	2702	2702	2702	2702	2702	2702	2702	2702	2702	2702	2702	2702	2710	PRIOR_PERI_OPERATIVE_CHEMO	PATIENT	STRING	Prior peri-operative chemo	Prior peri-operative chemo	1				
2703	2703	2703	2703	2703	2703	2703	2703	2703	2703	2703	2703	2703	2711	PRIOR_PERTUZUMAB	PATIENT	STRING	Prior pertuzumab.	Prior Pertuzumab	1				
2704	2704	2704	2704	2704	2704	2704	2704	2704	2704	2704	2704	2704	2712	PRIOR_RADIATION_THERAPY	SAMPLE	STRING	Prior Radiation Therapy	Prior Radiation Therapy	1				
2705	2705	2705	2705	2705	2705	2705	2705	2705	2705	2705	2705	2705	2713	PRIOR_RT	PATIENT	STRING	Prior RT.	Prior RT.	1				
2706	2706	2706	2706	2706	2706	2706	2706	2706	2706	2706	2706	2706	2714	PRIOR_RT_OF_SEQUENCED_SITE	PATIENT	STRING	Prior RT (of sequenced site)	Prior RT (of sequenced site)	1				
2707	2707	2707	2707	2707	2707	2707	2707	2707	2707	2707	2707	2707	2715	PRIOR_SURGERY_YEAR	PATIENT	NUMBER	Previous Surgery Year	Previous Surgery Year	1				
2708	2708	2708	2708	2708	2708	2708	2708	2708	2708	2708	2708	2708	2716	PRIOR_SURGICAL_RESECTION	PATIENT	STRING	Prior Surgical Resection	Prior Surgical Resection	1				
2709	2709	2709	2709	2709	2709	2709	2709	2709	2709	2709	2709	2709	2717	PRIOR_SYSTEMIC_CHEMO	PATIENT	STRING	Prior Systemic Chemotherapy	Prior Systemic Chemotherapy	1				
2710	2710	2710	2710	2710	2710	2710	2710	2710	2710	2710	2710	2710	2718	PRIOR_TAMOXIFEN	PATIENT	STRING	Prior tamoxifen.	Prior Tamoxifen	1				
2711	2711	2711	2711	2711	2711	2711	2711	2711	2711	2711	2711	2711	2719	PRIOR_TDM1	PATIENT	STRING	Prior TDM1.	Prior TDM1	1				
2712	2712	2712	2712	2712	2712	2712	2712	2712	2712	2712	2712	2712	2720	PRIOR_THYROID_CANCER	PATIENT	STRING	Prior Thyroid Cancer	Prior Thyroid Cancer	1				
2713	2713	2713	2713	2713	2713	2713	2713	2713	2713	2713	2713	2713	2721	PRIOR_TREATMENT	PATIENT	STRING	Prior treatment.	Prior Treatment	1				
2714	2714	2714	2714	2714	2714	2714	2714	2714	2714	2714	2714	2714	2722	PRIOR_TREATMENT_OF_CYTOTOXIC_CHEMOTHERAPY	PATIENT	NUMBER	Prior Treatment Of Cytotoxic Chemotherapy	Prior Treatment Of Cytotoxic Chemotherapy	1				
2715	2715	2715	2715	2715	2715	2715	2715	2715	2715	2715	2715	2715	2723	PRIOR_TUMOR	SAMPLE	STRING	Prior Tumor	Prior Tumor	1				
2716	2716	2716	2716	2716	2716	2716	2716	2716	2716	2716	2716	2716	2724	PRIOR_TX_TO_IMPACT_SAMPLE	PATIENT	STRING	Prior Treatment to IMPACT Sample	Prior Treatment to IMPACT Sample	1				
2717	2717	2717	2717	2717	2717	2717	2717	2717	2717	2717	2717	2717	2725	PRIOR_VITAL_STATUS	PATIENT	STRING	Previous vital status recorded	Previous vital status recorded	1				
2718	2718	2718	2718	2718	2718	2718	2718	2718	2718	2718	2718	2718	2726	PROCEDURE_COMPLETE_RESECTION	SAMPLE	STRING	Procedure Complete Resection	Procedure Complete Resection	1				
2719	2719	2719	2719	2719	2719	2719	2719	2719	2719	2719	2719	2719	2727	PROCEDURE_DATE	SAMPLE	STRING	Date of Procedure	Procedure Date	1				
2720	2720	2720	2720	2720	2720	2720	2720	2720	2720	2720	2720	2720	2728	PROCEDURE_LOCATION	PATIENT	STRING	Location of Procedure	Procedure Location	1				
2721	2721	2721	2721	2721	2721	2721	2721	2721	2721	2721	2721	2721	2729	PROCEDURE_LOCATION_SPECIFY	PATIENT	STRING	Procedure Location Specified	Procedure Location Specified	1				
2722	2722	2722	2722	2722	2722	2722	2722	2722	2722	2722	2722	2722	2730	PROCEDURE_YEAR	SAMPLE	NUMBER	Procedure date that IMPACT sample was taken.	Procedure Year That Impact Sample Was Taken	1				
2723	2723	2723	2723	2723	2723	2723	2723	2723	2723	2723	2723	2723	2731	PROCINTENT	PATIENT	STRING	Procintent	Procintent	1				
2724	2724	2724	2724	2724	2724	2724	2724	2724	2724	2724	2724	2724	2732	PROCSUBSITE	PATIENT	STRING	Procsubsite	Procsubsite	1				
2725	2725	2725	2725	2725	2725	2725	2725	2725	2725	2725	2725	2725	2733	PROGRESSION_DETERMINED_BY	PATIENT	STRING	Method by which disease progression was determined.	Progression Determined By	1				
2726	2726	2726	2726	2726	2726	2726	2726	2726	2726	2726	2726	2726	2734	PROGRESSION_OF_DISEASE	PATIENT	STRING	Progression of Disease	Progression of Disease	1				
2727	2727	2727	2727	2727	2727	2727	2727	2727	2727	2727	2727	2727	2735	PROJECT_CODE	SAMPLE	STRING	Project code	Project code	1				
2728	2728	2728	2728	2728	2728	2728	2728	2728	2728	2728	2728	2728	2736	PROSPECTIVE_COLLECTION	PATIENT	STRING	Text indicator for the time frame of tissue procurement, indicating that the tissue was procured in parallel to the project.	Tissue Prospective Collection Indicator	1				
2729	2729	2729	2729	2729	2729	2729	2729	2729	2729	2729	2729	2729	2737	PROTEIN_CODING_RHOA	SAMPLE	NUMBER	RHOA Protein Coding	RHOA Protein Coding	1				
2730	2730	2730	2730	2730	2730	2730	2730	2730	2730	2730	2730	2730	2738	PROTEIN_EXPRESSION_CLUSTER	SAMPLE	STRING	Protein Expression Cluster	Protein Expression Cluster	1				
2731	2731	2731	2731	2731	2731	2731	2731	2731	2731	2731	2731	2731	2739	PROTHROMBIN_TIME_INR_AT_PROCUREMENT	SAMPLE	NUMBER	Laboratory procedure prothrombin time result value	Laboratory procedure prothrombin time result value	1				
2732	2732	2732	2732	2732	2732	2732	2732	2732	2732	2732	2732	2732	2740	PROTHROMBIN_TIME_NORMAL_RANGE_UPPER	PATIENT	NUMBER	Laboratory procedure international normalization ratio result upper limit of normal value	Laboratory procedure international normalization ratio result upper limit of normal value	1				
2733	2733	2733	2733	2733	2733	2733	2733	2733	2733	2733	2733	2733	2741	PROTHROMBIN_TIME_NORM_RANGE_UPPER	SAMPLE	NUMBER	Laboratory procedure international normalization ratio result upper limit of normal value	Laboratory procedure international normalization ratio result upper limit of normal value	1				
2734	2734	2734	2734	2734	2734	2734	2734	2734	2734	2734	2734	2734	2742	PROTHROM_TIME_INR_NORMAL_RANGE_LOWER	PATIENT	NUMBER	Laboratory procedure international normalization ratio result lower limit of normal value	Laboratory procedure international normalization ratio result lower limit of normal value	1				
2735	2735	2735	2735	2735	2735	2735	2735	2735	2735	2735	2735	2735	2743	PROTHROM_TIME_INR_NORM_RANGE_LOWER	SAMPLE	NUMBER	Laboratory procedure international normalization ratio result lower limit of normal value	Laboratory procedure international normalization ratio result lower limit of normal value	1				
2736	2736	2736	2736	2736	2736	2736	2736	2736	2736	2736	2736	2736	2744	PROTOCOL	PATIENT	STRING	Protocol.	Protocol	1				
2737	2737	2737	2737	2737	2737	2737	2737	2737	2737	2737	2737	2737	2745	PROTOCOL_NUM	PATIENT	STRING	Protocol Number	Protocol Number	1				
2738	2738	2738	2738	2738	2738	2738	2738	2738	2738	2738	2738	2738	2746	PRRT_THERAPY	PATIENT	STRING	Peptide Receptor Radionuclide Therapy (PRRT)	PRRT Therapy	1				
2739	2739	2739	2739	2739	2739	2739	2739	2739	2739	2739	2739	2739	2747	PR_EXPR	PATIENT	STRING	PR status measured by expression	PR status measured by expression	1				
2740	2740	2740	2740	2740	2740	2740	2740	2740	2740	2740	2740	2740	2748	PR_POSITIVITY_DEFINE_METHOD	SAMPLE	STRING	Pgr detection method text	PR positivity define method	1				
2741	2741	2741	2741	2741	2741	2741	2741	2741	2741	2741	2741	2741	2749	PR_POSITIVITY_IHC_INTENSITY_SCORE	SAMPLE	STRING	Breast carcinoma immunohistochemistry pos cell score	PR positivity ihc intensity score	1				
2742	2742	2742	2742	2742	2742	2742	2742	2742	2742	2742	2742	2742	2750	PR_POSITIVITY_SCALE_OTHER	SAMPLE	STRING	Pos finding progesterone receptor other measurement scale text	PR positivity scale other	1				
2743	2743	2743	2743	2743	2743	2743	2743	2743	2743	2743	2743	2743	2751	PR_POSITIVITY_SCALE_USED	SAMPLE	STRING	Breast carcinoma immunohistochemistry progesterone receptor pos finding scale	PR positivity scale used	1				
2744	2744	2744	2744	2744	2744	2744	2744	2744	2744	2744	2744	2744	2752	PR_STATUS	SAMPLE	STRING	PR Status	PR Status	1				
2745	2745	2745	2745	2745	2745	2745	2745	2745	2745	2745	2745	2745	2753	PR_STATUS_BY_IHC	SAMPLE	STRING	Breast carcinoma progesterone receptor status	PR status by ihc	1				
2746	2746	2746	2746	2746	2746	2746	2746	2746	2746	2746	2746	2746	2754	PR_STATUS_IHC_PERCENT_POSITIVE	SAMPLE	STRING	Progesterone receptor level cell percent category	PR status ihc percent positive	1				
2747	2747	2747	2747	2747	2747	2747	2747	2747	2747	2747	2747	2747	2755	PR_STATUS_METASTASIS	PATIENT	STRING	PR Metastatic Status	PR Metastatic Status	1				
2748	2748	2748	2748	2748	2748	2748	2748	2748	2748	2748	2748	2748	2756	PR_STATUS_PRIMARY	PATIENT	STRING	PR Primary Status	PR Primary Status	1				
2749	2749	2749	2749	2749	2749	2749	2749	2749	2749	2749	2749	2749	2757	PSA	PATIENT	NUMBER	Prostate-specific antigen (ng/ml)	Prostate-specific antigen	1				
2750	2750	2750	2750	2750	2750	2750	2750	2750	2750	2750	2750	2750	2758	PSAT_IMPACT_ORDER	PATIENT	STRING	PSAT IMPACT order	PSAT IMPACT order	1				
2751	2751	2751	2751	2751	2751	2751	2751	2751	2751	2751	2751	2751	2759	PSA_MOST_RECENT_RESULTS	PATIENT	NUMBER	Psa most recent results	Psa most recent results	1				
2752	2752	2752	2752	2752	2752	2752	2752	2752	2752	2752	2752	2752	2760	PSEUDO_ADJ_IMATINIB	SAMPLE	STRING	PSEUDO ADJ IMATINIB/other treatment	PSEUDO ADJ IMATINIB/other treatment	1				
2753	2753	2753	2753	2753	2753	2753	2753	2753	2753	2753	2753	2753	2761	PTCH1_MUTATION	SAMPLE	STRING	PTCH1 Mutation	PTCH1 Mutation	1				
2754	2754	2754	2754	2754	2754	2754	2754	2754	2754	2754	2754	2754	2762	PTEN_CNA	SAMPLE	STRING	PTEN CNA	PTEN CNA	1				
2755	2755	2755	2755	2755	2755	2755	2755	2755	2755	2755	2755	2755	2763	PTEN_DELETION	SAMPLE	STRING	PTEN deletion is present	PTEN Deletion	1				
2756	2756	2756	2756	2756	2756	2756	2756	2756	2756	2756	2756	2756	2764	PTEN_FISH	SAMPLE	STRING	PTEN FISH	PTEN FISH	1				
2757	2757	2757	2757	2757	2757	2757	2757	2757	2757	2757	2757	2757	2765	PTEN_MUTATION	SAMPLE	STRING	PTEN Mutation is present	PTEN Mutation	1				
2758	2758	2758	2758	2758	2758	2758	2758	2758	2758	2758	2758	2758	2766	PTPN11_MUTATION	SAMPLE	STRING	PTPN1 Mutation	PTPN11 Mutation	1				
2759	2759	2759	2759	2759	2759	2759	2759	2759	2759	2759	2759	2759	2767	PT_SIZE_CATEGORY	SAMPLE	STRING	pT Size Category	pT Size Category	1				
2760	2760	2760	2760	2760	2760	2760	2760	2760	2760	2760	2760	2760	2768	PUBMED_ID	PATIENT	STRING	Pubmed ID	Pubmed ID	1				
2761	2761	2761	2761	2761	2761	2761	2761	2761	2761	2761	2761	2761	2769	PULMONARY_FUNCTION_TEST_INDICATOR	PATIENT	STRING	Pulmonary function test indicator	Pulmonary function test indicator	1				
2762	2762	2762	2762	2762	2762	2762	2762	2762	2762	2762	2762	2762	2770	PUMA_COHORT	SAMPLE	STRING	PUMA Cohort	PUMA Cohort	1				
2763	2763	2763	2763	2763	2763	2763	2763	2763	2763	2763	2763	2763	2771	PURITY	SAMPLE	NUMBER	Purity	Purity	1				
2764	2764	2764	2764	2764	2764	2764	2764	2764	2764	2764	2764	2764	2772	PURITY_ABSOLUTE	SAMPLE	NUMBER	Absolute purity.	Absolute Purity	1				
2765	2765	2765	2765	2765	2765	2765	2765	2765	2765	2765	2765	2765	2773	PURITY_ASSESSMENT	PATIENT	STRING	Purity Assessment	Purity Assessment	1				
2766	2766	2766	2766	2766	2766	2766	2766	2766	2766	2766	2766	2766	2774	PURITY_PREDICTION_SCORE	SAMPLE	NUMBER	Purity Prediction Score	Purity Prediction Score	1				
2767	2767	2767	2767	2767	2767	2767	2767	2767	2767	2767	2767	2767	2775	P_VALUE	SAMPLE	NUMBER	P-value	P-value	1				
2768	2768	2768	2768	2768	2768	2768	2768	2768	2768	2768	2768	2768	2776	QS_DATE	PATIENT	STRING	The date the survey was filled out.	QS Date	1				
2769	2769	2769	2769	2769	2769	2769	2769	2769	2769	2769	2769	2769	2777	QUALIFYING_MUT	SAMPLE	STRING	Qualifying Mutation	Qualifying Mutation	1				
2770	2770	2770	2770	2770	2770	2770	2770	2770	2770	2770	2770	2770	2778	R0_SURGERY	PATIENT	NUMBER	R0 Surgery description	R0 Surgery	1				
2771	2771	2771	2771	2771	2771	2771	2771	2771	2771	2771	2771	2771	2780	RACE_AMERICAN_INDIAN_OR_NATIVE_AMERICAN	PATIENT	STRING	Set to 1 if patient selected American Indian or Native American in response to the question: What is your race (select all that apply)? Responses reported by five or fewer patients are redacted (all categories set to 2) to protect confidentiality.	Race- American Indian or Native American	1				
2772	2772	2772	2772	2772	2772	2772	2772	2772	2772	2772	2772	2772	2781	RACE_BLACK_OR_AFRICAN_AMERICAN	PATIENT	STRING	Set to 1 if patient selected Black or African American in response to the question: What is your race (select all that apply)? Responses reported by five or fewer patients are redacted (all categories set to 2) to protect confidentiality.	Race- Black or African American	1				
2773	2773	2773	2773	2773	2773	2773	2773	2773	2773	2773	2773	2773	2782	RACE_CATEGORIZED	PATIENT	STRING	Patient-reported response to the question: What is your race (select all that apply)? Infrequent responses have been categorized as Other for confidentiality.	PRD Race	1				
2774	2774	2774	2774	2774	2774	2774	2774	2774	2774	2774	2774	2774	2783	RACE_CHINESE	PATIENT	STRING	Set to 1 if patient selected Chinese in response to the question: What is your race (select all that apply)? Responses reported by five or fewer patients are redacted (all categories set to 2) to protect confidentiality.	Race- Chinese	1				
2775	2775	2775	2775	2775	2775	2775	2775	2775	2775	2775	2775	2775	2784	RACE_JAPANESE	PATIENT	STRING	Set to 1 if patient selected Japanese in response to the question: What is your race (select all that apply)? Responses reported by five or fewer patients are redacted (all categories set to 2) to protect confidentiality.	Race- Japanese	1				
2776	2776	2776	2776	2776	2776	2776	2776	2776	2776	2776	2776	2776	2785	RACE_NATIVE_HAWAIIAN_OR_OTHER_PACIFIC_ISLANDER	PATIENT	STRING	Set to 1 if patient selected Native Hawaiian or Other Pacific Islander in response to the question: What is your race (select all that apply)? Responses reported by five or fewer patients are redacted (all categories set to 2) to protect confidentiality.	Race- Native Hawaiian or Other Pacific Islander	1				
2777	2777	2777	2777	2777	2777	2777	2777	2777	2777	2777	2777	2777	2786	RACE_OTHER	PATIENT	STRING	Set to 1 if patient selected Other in response to the question: What is your race (select all that apply)? Responses reported by five or fewer patients are redacted (all categories set to 2) to protect confidentiality.	Race- Other	1				
2778	2778	2778	2778	2778	2778	2778	2778	2778	2778	2778	2778	2778	2787	RACE_OTHER_EAST_ASIAN	PATIENT	STRING	Set to 1 if patient selected Other East Asian in response to the question: What is your race (select all that apply)? Responses reported by five or fewer patients are redacted (all categories set to 2) to protect confidentiality.	Race- Other East Asian	1				
2779	2779	2779	2779	2779	2779	2779	2779	2779	2779	2779	2779	2779	2788	RACE_PREFER_NOT_TO_ANSWER	PATIENT	STRING	Set to 1 if patient selected Prefer Not To Answer in response to the question: What is your race (select all that apply)? Responses reported by five or fewer patients are redacted (all categories set to 2) to protect confidentiality.	Race- Prefer Not to Answer	1				
2780	2780	2780	2780	2780	2780	2780	2780	2780	2780	2780	2780	2780	2789	RACE_SOUTH_EAST_ASIAN_OR_INDIAN	PATIENT	STRING	Set to 1 if patient selected South East Asian or Indian in response to the question: What is your race (select all that apply)? Responses reported by five or fewer patients are redacted (all categories set to 2) to protect confidentiality.	Race- South East Asian or Indian	1				
2781	2781	2781	2781	2781	2781	2781	2781	2781	2781	2781	2781	2781	2790	RACE_WHITE	PATIENT	STRING	Set to 1 if patient selected White in response to the question: What is your race (select all that apply)? Responses reported by five or fewer patients are redacted (all categories set to 2) to protect confidentiality.	Race- White	1				
2782	2782	2782	2782	2782	2782	2782	2782	2782	2782	2782	2782	2782	2791	RAD51C_CNA	SAMPLE	STRING	RAD51C CNA	RAD51C CNA	1				
2783	2783	2783	2783	2783	2783	2783	2783	2783	2783	2783	2783	2783	2792	RADADJUVANT	PATIENT	STRING	Radadjuvant	Radadjuvant	1				
2784	2784	2784	2784	2784	2784	2784	2784	2784	2784	2784	2784	2784	2793	RADIATION_HISTORY	PATIENT	STRING	History of radiation	Radiation History	1				
2785	2785	2785	2785	2785	2785	2785	2785	2785	2785	2785	2785	2785	2794	RADIATION_OR_CHEMOTHERAPY	PATIENT	STRING	Patient received Radiation or Chemotherapy	Patient received Radiation or Chemotherapy	1				
2786	2786	2786	2786	2786	2786	2786	2786	2786	2786	2786	2786	2786	2795	RADIATION_THERAPY	PATIENT	STRING	Radiation Therapy.	Radiation Therapy	1				
2787	2787	2787	2787	2787	2787	2787	2787	2787	2787	2787	2787	2787	2796	RADIATION_THERAPY_DOSE_PARAAORTIC_NODES	PATIENT	STRING	External beam radiation therapy administered paraaortic region lymph node dose	External beam radiation therapy administered paraaortic region lymph node dose	1				
2788	2788	2788	2788	2788	2788	2788	2788	2788	2788	2788	2788	2788	2797	RADIATION_THERAPY_XRT_DOSE	PATIENT	NUMBER	Radiation therapy administered dose text	Radiation therapy xrt dose	1				
2789	2789	2789	2789	2789	2789	2789	2789	2789	2789	2789	2789	2789	2798	RADIATION_THERAPY_XRT_METHOD_PREP	PATIENT	STRING	Radiation therapy administered preparation technique text	Radiation therapy xrt method prep	1				
2790	2790	2790	2790	2790	2790	2790	2790	2790	2790	2790	2790	2790	2799	RADIATION_THERAPY_XRT_SENSITIZERS	PATIENT	STRING	Radiosensitizing agent administered indicator	Radiation therapy xrt sensitizers	1				
2791	2791	2791	2791	2791	2791	2791	2791	2791	2791	2791	2791	2791	2800	RADIATION_THERAPY_XRT_TYPE	PATIENT	STRING	Rt administered type	Rt administered type	1				
2792	2792	2792	2792	2792	2792	2792	2792	2792	2792	2792	2792	2792	2801	RADIATION_TREATMENT_ADJUVANT	PATIENT	STRING	A yes/no indicator that asks whether the patient started adjuvant postoperative radiotherapy.	Did patient start adjuvant postoperative radiotherapy?	1				
2793	2793	2793	2793	2793	2793	2793	2793	2793	2793	2793	2793	2793	2802	RADIATION_TREATMENT_NEOADJUVANT	PATIENT	STRING	A yes/no indicator that asks whether the patient startedneoadjuvant preoperative radiotherapy?	Did patient start neoadjuvant preoperative radiotherapy?	1				
2794	2794	2794	2794	2794	2794	2794	2794	2794	2794	2794	2794	2794	2803	RADIATION_TYPE_OTHER	PATIENT	STRING	Radiation type notes	Radiation type notes	1				
2795	2795	2795	2795	2795	2795	2795	2795	2795	2795	2795	2795	2795	2804	RADICALITY	SAMPLE	STRING	Radicality of Surgery: GTR = Gross Total Resection, STR = Sub-Total Resection	Radicality Of Surgery	1				
2796	2796	2796	2796	2796	2796	2796	2796	2796	2796	2796	2796	2796	2805	RADICAL_SURGERY	PATIENT	STRING	Radical surgery	Radical Surgery	1				
2797	2797	2797	2797	2797	2797	2797	2797	2797	2797	2797	2797	2797	2806	RADIO_THERAPY	PATIENT	STRING	Radio Therapy	Radio Therapy	1				
2798	2798	2798	2798	2798	2798	2798	2798	2798	2798	2798	2798	2798	2807	RADNEOADJUVANT	PATIENT	STRING	Radneoadjuvant	Radneoadjuvant	1				
2799	2799	2799	2799	2799	2799	2799	2799	2799	2799	2799	2799	2799	2808	RAF1_FUSION	SAMPLE	STRING	RAF1 Fusion	RAF1 Fusion	1				
2800	2800	2800	2800	2800	2800	2800	2800	2800	2800	2800	2800	2800	2809	RAFI_AGENT	PATIENT	STRING	RAF inhibitor type	RAF inhibitor type	1				
2801	2801	2801	2801	2801	2801	2801	2801	2801	2801	2801	2801	2801	2810	RAF_INHIBITOR	PATIENT	STRING	RAF Inhibitor	RAF Inhibitor	1				
2802	2802	2802	2802	2802	2802	2802	2802	2802	2802	2802	2802	2802	2811	RAF_RAS_STATUS	SAMPLE	STRING	RAF/RAS Status	RAF/RAS Status	1				
2803	2803	2803	2803	2803	2803	2803	2803	2803	2803	2803	2803	2803	2812	RAI	PATIENT	STRING	Radioactive Iodine	Radioactive Iodine	1				
2804	2804	2804	2804	2804	2804	2804	2804	2804	2804	2804	2804	2804	2813	RAI_AVID	PATIENT	STRING	RAI AVID	RAI AVID	1				
2805	2805	2805	2805	2805	2805	2805	2805	2805	2805	2805	2805	2805	2814	RAI_UPTAKE	PATIENT	STRING	RAI Uptake	RAI Uptake	1				
2806	2806	2806	2806	2806	2806	2806	2806	2806	2806	2806	2806	2806	2815	RANDOM_FOREST_STURM_CLUSTER	SAMPLE	STRING	Random Forest Sturm Cluster	Random Forest Sturm Cluster	1				
2807	2807	2807	2807	2807	2807	2807	2807	2807	2807	2807	2807	2807	2816	RAS_MUTATION_RESULT	SAMPLE	STRING	Ras family gene genotyping outcome lab results text	Ras mutation result	1				
2808	2808	2808	2808	2808	2808	2808	2808	2808	2808	2808	2808	2808	2817	RATIO_OF_INDEL_TO_SUBSTITUTIONS	SAMPLE	STRING	Ratio of Indel to Substitutions	Ratio of Indel to Substitutions	1				
2809	2809	2809	2809	2809	2809	2809	2809	2809	2809	2809	2809	2809	2818	RB1_CNA	SAMPLE	STRING	RB1 CNA	RB1 CNA	1				
2810	2810	2810	2810	2810	2810	2810	2810	2810	2810	2810	2810	2810	2819	RB1_MUT	PATIENT	NUMBER	Rb1 mut	Rb1 mut	1				
2811	2811	2811	2811	2811	2811	2811	2811	2811	2811	2811	2811	2811	2820	RC_GRADE	SAMPLE	STRING	RC Grade	RC Grade	1				
2812	2812	2812	2812	2812	2812	2812	2812	2812	2812	2812	2812	2812	2821	RC_YEAR	PATIENT	STRING	RC Year	RC Year	1				
2813	2813	2813	2813	2813	2813	2813	2813	2813	2813	2813	2813	2813	2822	REARRANGEMENT_11Q23	SAMPLE	STRING	11q23 Rearrangement = MLL rearrangement	11q23 Rearrangement = MLL rearrangement	1				
2814	2814	2814	2814	2814	2814	2814	2814	2814	2814	2814	2814	2814	2823	REARRANGEMENT_14Q32	SAMPLE	STRING	14q32 Rearrangement = IGH	14q32 Rearrangement = IGH	1				
2815	2815	2815	2815	2815	2815	2815	2815	2815	2815	2815	2815	2815	2824	REARRANGEMENT_2P23	SAMPLE	STRING	2p23 Rearrangement = ALK	2p23 Rearrangement = ALK	1				
2816	2816	2816	2816	2816	2816	2816	2816	2816	2816	2816	2816	2816	2825	REARRANGEMENT_3P27	SAMPLE	STRING	3p27 Rearrangement = BCL6	3p27 Rearrangement = BCL6	1				
2817	2817	2817	2817	2817	2817	2817	2817	2817	2817	2817	2817	2817	2826	REASON_FOR_TX_DISCONTINUATION	PATIENT	STRING	reason for tx discontinuation	reason for tx discontinuation	1				
2818	2818	2818	2818	2818	2818	2818	2818	2818	2818	2818	2818	2818	2827	REASON_WHY_NOT_RECEIVE_MT	PATIENT	STRING	Reason why not receive MT	Reason why not receive MT	1				
2819	2819	2819	2819	2819	2819	2819	2819	2819	2819	2819	2819	2819	2828	REC	PATIENT	NUMBER	Rec	Rec	1				
2820	2820	2820	2820	2820	2820	2820	2820	2820	2820	2820	2820	2820	2829	RECEIVED_IO_AFTER_1ST_LINE	PATIENT	STRING	Did the patient receive IO after first line therapy	Received IO after First Line	1				
2821	2821	2821	2821	2821	2821	2821	2821	2821	2821	2821	2821	2821	2830	RECIST_BURDEN_OF_DISEASE	PATIENT	STRING	RECIST burden of disease (mm)	RECIST burden of disease (mm)	1				
2822	2822	2822	2822	2822	2822	2822	2822	2822	2822	2822	2822	2822	2831	RECIST_RESPONSE	PATIENT	STRING	RECIST Response	RECIST Response	1				
2823	2823	2823	2823	2823	2823	2823	2823	2823	2823	2823	2823	2823	2832	RECORD_ID	PATIENT	NUMBER	Record ID is an identifier for timeline events	RECORD_ID	1				
2824	2824	2824	2824	2824	2824	2824	2824	2824	2824	2824	2824	2824	2833	RECUR	PATIENT	NUMBER	Recur	Recur	1				
2825	2825	2825	2825	2825	2825	2825	2825	2825	2825	2825	2825	2825	2834	RECUR1	PATIENT	NUMBER	Recur1	Recur1	1				
2826	2826	2826	2826	2826	2826	2826	2826	2826	2826	2826	2826	2826	2835	RECURRED_ON_ADJ_OR_PSEUDO_ADJ_TREATMENT	SAMPLE	STRING	Recurred On Adj Or Pseudo Adj Treatment	Recurred On Adj Or Pseudo Adj Treatment	1				
2827	2827	2827	2827	2827	2827	2827	2827	2827	2827	2827	2827	2827	2836	RECURRENCE	PATIENT	STRING	Recurrence	Recurrence	1				
2828	2828	2828	2828	2828	2828	2828	2828	2828	2828	2828	2828	2828	2837	RECURRENCE_AT_DIAGNOSIS	PATIENT	STRING	Recurrence at Diagnosis	Recurrence at Diagnosis	1				
2829	2829	2829	2829	2829	2829	2829	2829	2829	2829	2829	2829	2829	2838	RECURRENCE_HISTOLOGY	PATIENT	STRING	Recurrence Histology	Recurrence Histology	1				
2830	2830	2830	2830	2830	2830	2830	2830	2830	2830	2830	2830	2830	2839	RECURRENCE_METHOD	PATIENT	STRING	Recurrence Method	Recurrence Method	1				
2831	2831	2831	2831	2831	2831	2831	2831	2831	2831	2831	2831	2831	2840	RECURRENCE_OR_DEATH	PATIENT	STRING	Recorded value if the patient had a recurrence or is deceased	Recurrence or Death	1				
2832	2832	2832	2832	2832	2832	2832	2832	2832	2832	2832	2832	2832	2841	RECURRENCE_STATUS_INTERVAL_YEARS	PATIENT	NUMBER	Recurrence Status Interval Years	Recurrence Status Interval Years	1				
2833	2833	2833	2833	2833	2833	2833	2833	2833	2833	2833	2833	2833	2842	RECURRENT_DISEASE	SAMPLE	STRING	Recurrent Disease	Recurrent Disease	1				
2834	2834	2834	2834	2834	2834	2834	2834	2834	2834	2834	2834	2834	2843	RECURRENT_DISEASE_TUMOR_STUDIED	PATIENT	STRING	Recurrent Disease Tumor Studied	Recurrent Disease Tumor Studies	1				
2835	2835	2835	2835	2835	2835	2835	2835	2835	2835	2835	2835	2835	2844	RECURRENT_FREE_INTERVAL_MONTHS	PATIENT	STRING	Recurrent Free Interval (Months)	Recurrent Free Interval (Months)	1				
2836	2836	2836	2836	2836	2836	2836	2836	2836	2836	2836	2836	2836	2845	RECURRENT_METASTATIC_DISEASE	SAMPLE	STRING	Recurrent/metastatic disease	Recurrent/metastatic disease	1				
2837	2837	2837	2837	2837	2837	2837	2837	2837	2837	2837	2837	2837	2846	RECUR_NDSZ_DES	SAMPLE	STRING	Indicates size of lymph node at first recurrence.	Size of Lymph Node at First Recurrence	1				
2838	2838	2838	2838	2838	2838	2838	2838	2838	2838	2838	2838	2838	2847	RECUR_NODAL_NO	SAMPLE	STRING	Indicates number of lymph nodes at first recurrence.	Number of Lymph Node at First Recurrence	1				
2839	2839	2839	2839	2839	2839	2839	2839	2839	2839	2839	2839	2839	2848	RECUR_TO_IMPACT_EXTENT_MONTHS	SAMPLE	NUMBER	Recurrence to IMPACT (months)	Recurrence to IMPACT (months)	1				
2840	2840	2840	2840	2840	2840	2840	2840	2840	2840	2840	2840	2840	2849	REFLUX_HISTORY	PATIENT	STRING	History of reflux.	Reflux History	1				
2841	2841	2841	2841	2841	2841	2841	2841	2841	2841	2841	2841	2841	2850	REF_COUNT	SAMPLE	NUMBER	Ref Count	Ref Count	1				
2842	2842	2842	2842	2842	2842	2842	2842	2842	2842	2842	2842	2842	2851	REGIONAL_LYMPH_NODE	SAMPLE	STRING	Regional Lymph Node	Regional Lymph Node	1				
2843	2843	2843	2843	2843	2843	2843	2843	2843	2843	2843	2843	2843	2852	REGIONAL_LYMPH_NODES	PATIENT	STRING	Regional lymph nodes	Regional lymph nodes	1				
2844	2844	2844	2844	2844	2844	2844	2844	2844	2844	2844	2844	2844	2853	REGIONAL_NODES_PATHOLOGIC_SPREAD	SAMPLE	STRING	Regional Nodes Pathologic Spread	Regional Nodes Pathologic Spread	1				
2845	2845	2845	2845	2845	2845	2845	2845	2845	2845	2845	2845	2845	2854	REGRESSION_DES	SAMPLE	STRING	One of the histologic features of a primary melanoma where tumor cells are replaced by lymphocytic inflammation with or without dermal melanophages and fibrosis.	Regression Description	1				
2846	2846	2846	2846	2846	2846	2846	2846	2846	2846	2846	2846	2846	2855	RELAPSE	PATIENT	STRING	Relapse.	Relapse	1				
2847	2847	2847	2847	2847	2847	2847	2847	2847	2847	2847	2847	2847	2856	RELAPSE_INTERVAL_IN_DAYS	PATIENT	NUMBER	Relapse Interval In Days	Relapse Interval In Days	1				
2848	2848	2848	2848	2848	2848	2848	2848	2848	2848	2848	2848	2848	2857	RELAPSE_PERCENT_NECROSIS	PATIENT	NUMBER	Numeric value to represent the percentage of cell death in a malignant tumor sample or specimen for the first relapse tissue.	Relapse Percent Necrosis	1				
2849	2849	2849	2849	2849	2849	2849	2849	2849	2849	2849	2849	2849	2858	RELAPSE_PERCENT_STROMA	PATIENT	NUMBER	Numeric representation of the percent of tumor versus stroma for first relapse sample.	Relapse Percent Tumor Vs Stroma	1				
2850	2850	2850	2850	2850	2850	2850	2850	2850	2850	2850	2850	2850	2859	RELAPSE_SEROSA	PATIENT	STRING	Relapse Serosa	Relapse Serosa	1				
2851	2851	2851	2851	2851	2851	2851	2851	2851	2851	2851	2851	2851	2860	RELAPSE_TYPE	PATIENT	STRING	Text term that describes the kind of relapse identified.	Relapse Type	1				
2852	2852	2852	2852	2852	2852	2852	2852	2852	2852	2852	2852	2852	2861	RELAPSE_YEAR	PATIENT	NUMBER	Relapse year.	Relapse Year	1				
2853	2853	2853	2853	2853	2853	2853	2853	2853	2853	2853	2853	2853	2862	RELATED_SYMPTOM_FIRST_PRESENT	PATIENT	STRING	Related symptom first present	Related symptom first present	1				
2854	2854	2854	2854	2854	2854	2854	2854	2854	2854	2854	2854	2854	2863	RELATED_TUMORS_OUTSIDE_ADRENAL_GLANDS	SAMPLE	STRING	Text term to describe any tumor related to the specimen that is outside of the adrenal glands.	Tumor Specimen Outside Adrenal Gland Quantity Description Type	1				
2855	2855	2855	2855	2855	2855	2855	2855	2855	2855	2855	2855	2855	2864	RELATION_TESTICULAR_CANCER	SAMPLE	STRING	Relation testicular cancer	Relation testicular cancer	1				
2856	2856	2856	2856	2856	2856	2856	2856	2856	2856	2856	2856	2856	2865	RELATIVE_FAMILY_CANCER_HX_TEXT	SAMPLE	STRING	Relative family cancer hx text	Relative family cancer hx text	1				
2857	2857	2857	2857	2857	2857	2857	2857	2857	2857	2857	2857	2857	2866	RELEVANT_MEDICAL_HISTORY	PATIENT	STRING	Relevant Medical History	Relevant Medical History	1				
2858	2858	2858	2858	2858	2858	2858	2858	2858	2858	2858	2858	2858	2867	RELIGION	PATIENT	STRING	Religion	Religion	1				
2859	2859	2859	2859	2859	2859	2859	2859	2859	2859	2859	2859	2859	2868	REPORT_YEAR	SAMPLE	NUMBER	Year IMPACT Report was generated	Year Impact Report Was Generated	1				
2860	2860	2860	2860	2860	2860	2860	2860	2860	2860	2860	2860	2860	2869	RESEARCH_NUM	PATIENT	NUMBER	Research Number	Research Number	1				
2861	2861	2861	2861	2861	2861	2861	2861	2861	2861	2861	2861	2861	2870	RESECTION_AT_MSKC	PATIENT	STRING	Resection at MSKCC yes/no indicator	Resection at MSKCC	1				
2862	2862	2862	2862	2862	2862	2862	2862	2862	2862	2862	2862	2862	2871	RESECTION_AT_MSKCC	PATIENT	STRING	Resection At MSKCC	Resection At MSKCC	1				
2863	2863	2863	2863	2863	2863	2863	2863	2863	2863	2863	2863	2863	2872	RESECTION_TIMING	SAMPLE	STRING	Resection timing	Resection timing	1				
2864	2864	2864	2864	2864	2864	2864	2864	2864	2864	2864	2864	2864	2873	RESIDUAL_SIGNATURE_NON_NORMALIZED	SAMPLE	STRING	RESIDUAL SIGNATURE NON NORMALIZED	RESIDUAL SIGNATURE NON NORMALIZED	1				
2865	2865	2865	2865	2865	2865	2865	2865	2865	2865	2865	2865	2865	2874	RESIDUAL_SIGNATURE_NORMALIZED	SAMPLE	STRING	RESIDUAL SIGNATURE NORMALIZED	RESIDUAL SIGNATURE NORMALIZED	1				
2866	2866	2866	2866	2866	2866	2866	2866	2866	2866	2866	2866	2866	2875	RESIDUAL_TUMOR	PATIENT	STRING	Text terms to describe the status of a tissue margin following surgical resection.	Surgical Margin Resection Status	1				
2867	2867	2867	2867	2867	2867	2867	2867	2867	2867	2867	2867	2867	2876	RESOURCE	SAMPLE	STRING	Resource	Resource	1				
2868	2868	2868	2868	2868	2868	2868	2868	2868	2868	2868	2868	2868	2877	RESOURCE_TYPE	SAMPLE	STRING	Resource Type	Resource Type	1				
2869	2869	2869	2869	2869	2869	2869	2869	2869	2869	2869	2869	2869	2878	RESPONSE_DAYS	PATIENT	NUMBER	Days to Response (from date of diagnosis)	Days to Response	1				
2870	2870	2870	2870	2870	2870	2870	2870	2870	2870	2870	2870	2870	2879	RESPONSE_DURATION	PATIENT	NUMBER	Response duration in weeks	Response Duration (Weeks)	1				
2871	2871	2871	2871	2871	2871	2871	2871	2871	2871	2871	2871	2871	2880	RESPONSE_DURATION_MONTHS	PATIENT	NUMBER	Response Duration (Months)	Response Duration (months)	1				
2872	2872	2872	2872	2872	2872	2872	2872	2872	2872	2872	2872	2872	2881	RESPONSE_GRADE	PATIENT	STRING	Response grade	Response grade	1				
2873	2873	2873	2873	2873	2873	2873	2873	2873	2873	2873	2873	2873	2882	RESPONSE_TO_FRONT_LINE_THERAPY	SAMPLE	STRING	response to front line therapy	response to front line therapy	1				
2874	2874	2874	2874	2874	2874	2874	2874	2874	2874	2874	2874	2874	2883	RESPONSE_TO_SMO_INHIBITION	PATIENT	STRING	Response To SMO Inhibition	Response To SMO Inhibition	1				
2875	2875	2875	2875	2875	2875	2875	2875	2875	2875	2875	2875	2875	2884	RESPONSE_TO_TARGET_THERAPY	PATIENT	STRING	Did the patient respond to Target Therapy	Response to Target Therapy	1				
2876	2876	2876	2876	2876	2876	2876	2876	2876	2876	2876	2876	2876	2885	RET	SAMPLE	STRING	RET	RET	1				
2877	2877	2877	2877	2877	2877	2877	2877	2877	2877	2877	2877	2877	2886	RETROSPECTIVE_COLLECTION	PATIENT	STRING	Text indicator for the time frame of tissue procurement, indicating that the tissue was obtained and stored prior to the initiation of the project.	Tissue Retrospective Collection Indicator	1				
2878	2878	2878	2878	2878	2878	2878	2878	2878	2878	2878	2878	2878	2887	RETROSPECTIVE_OR_PROSPECTIVE	SAMPLE	STRING	Is the sample retrospective or prospective	Retrospective or Prospective	1				
2879	2879	2879	2879	2879	2879	2879	2879	2879	2879	2879	2879	2879	2888	RET_GERMLINE	SAMPLE	STRING	RET Germline Mutation	RET Germline Mutation	1				
2880	2880	2880	2880	2880	2880	2880	2880	2880	2880	2880	2880	2880	2889	RET_PTC_REARRANGEMENT_RESULT	SAMPLE	STRING	Ret ptc rearrangement genotyping outcome lab results text	Ret ptc rearrangement result	1				
2881	2881	2881	2881	2881	2881	2881	2881	2881	2881	2881	2881	2881	2890	RET_SOMATIC	SAMPLE	STRING	RET Somatic Mutation	RET Somatic Mutation	1				
2882	2882	2882	2882	2882	2882	2882	2882	2882	2882	2882	2882	2882	2891	REVIEWED_GLEASON	SAMPLE	STRING	Reviewed gleason	Reviewed gleason	1				
2883	2883	2883	2883	2883	2883	2883	2883	2883	2883	2883	2883	2883	2892	REVIEWED_GLEASON_CATEGORY	SAMPLE	STRING	Reviewed Gleason category	Reviewed Gleason Category	1				
2884	2884	2884	2884	2884	2884	2884	2884	2884	2884	2884	2884	2884	2893	REVIEWED_GLEASON_SUM	SAMPLE	NUMBER	Reviewed Gleason Sum	Reviewed Gleason Sum	1				
2885	2885	2885	2885	2885	2885	2885	2885	2885	2885	2885	2885	2885	2894	RFS_MONTHS	PATIENT	NUMBER	Relapse Free Status (Months)	Relapse Free Status (Months)	1				
2886	2886	2886	2886	2886	2886	2886	2886	2886	2886	2886	2886	2886	2895	RFS_STATUS	PATIENT	STRING	Relapse Free Status	Relapse Free Status	1				
2887	2887	2887	2887	2887	2887	2887	2887	2887	2887	2887	2887	2887	2896	RHABDOID	SAMPLE	STRING	Rhabdoid	Rhabdoid	1				
2888	2888	2888	2888	2888	2888	2888	2888	2888	2888	2888	2888	2888	2897	RHOA_MUTATION	SAMPLE	STRING	RHOA mutation is present.	RHOA Mutation	1				
2889	2889	2889	2889	2889	2889	2889	2889	2889	2889	2889	2889	2889	2898	RHOA_PROTEIN_CODING	PATIENT	NUMBER	RHOA Protein Coding	RHOA Protein Coding	1				
2890	2890	2890	2890	2890	2890	2890	2890	2890	2890	2890	2890	2890	2899	RICTOR_MUTATION_STATUS	SAMPLE	STRING	RICTOR Mutation Status	RICTOR Mutation Status	1				
2891	2891	2891	2891	2891	2891	2891	2891	2891	2891	2891	2891	2891	2900	RISK_CYTO	PATIENT	STRING	Risk (Cyto).	Risk (Cyto)	1				
2892	2892	2892	2892	2892	2892	2892	2892	2892	2892	2892	2892	2892	2901	RISK_GROUP	PATIENT	STRING	Risk group.	Risk Group	1				
2893	2893	2893	2893	2893	2893	2893	2893	2893	2893	2893	2893	2893	2902	RISK_MOLECULAR	PATIENT	STRING	Risk (Molecular).	Risk (Molecular)	1				
2894	2894	2894	2894	2894	2894	2894	2894	2894	2894	2894	2894	2894	2903	RISK_STRATIFICATION	PATIENT	STRING	Risk Stratification	Risk Stratification	1				
2895	2895	2895	2895	2895	2895	2895	2895	2895	2895	2895	2895	2895	2904	RMSE	SAMPLE	NUMBER	RMSE	RMSE	1				
2896	2896	2896	2896	2896	2896	2896	2896	2896	2896	2896	2896	2896	2905	RNASEQ_CLUSTER	SAMPLE	STRING	RNA-SEQ cluster.	RNA-SEQ Cluster	1				
2897	2897	2897	2897	2897	2897	2897	2897	2897	2897	2897	2897	2897	2906	RNASEQ_DATA	SAMPLE	STRING	RNA-SEQ data.	RNA-SEQ Data	1				
2898	2898	2898	2898	2898	2898	2898	2898	2898	2898	2898	2898	2898	2907	RNASEQ_PASSAGE	SAMPLE	STRING	RNA Sequence Passage	RNA Sequence Passage	1				
2899	2899	2899	2899	2899	2899	2899	2899	2899	2899	2899	2899	2899	2908	RNASEQ_SAMPLE_NUMBER	SAMPLE	STRING	RNA Sequence Number	RNA Sequence Number	1				
2900	2900	2900	2900	2900	2900	2900	2900	2900	2900	2900	2900	2900	2909	RNA_ID	SAMPLE	STRING	RNA ID Used	RNA ID	1				
2901	2901	2901	2901	2901	2901	2901	2901	2901	2901	2901	2901	2901	2910	RPA	PATIENT	STRING	Recursive Partitioning Analysis	RPA	1				
2902	2902	2902	2902	2902	2902	2902	2902	2902	2902	2902	2902	2902	2911	RPLND_PATH	SAMPLE	STRING	RPLND Path	RPLND Path	1				
2903	2903	2903	2903	2903	2903	2903	2903	2903	2903	2903	2903	2903	2912	RPPA	SAMPLE	STRING	RPPA	RPPA	1				
2904	2904	2904	2904	2904	2904	2904	2904	2904	2904	2904	2904	2904	2913	RPPA_CLUSTER	SAMPLE	STRING	RPPA Cluster.	RPPA Cluster	1				
2905	2905	2905	2905	2905	2905	2905	2905	2905	2905	2905	2905	2905	2914	RPPA_CLUSTERS_K3	SAMPLE	STRING	RPPA CLUSTERS K3	RPPA CLUSTERS K3	1				
2906	2906	2906	2906	2906	2906	2906	2906	2906	2906	2906	2906	2906	2915	RPPA_CLUSTERS_K4	SAMPLE	STRING	RPPA CLUSTERS K4	RPPA CLUSTERS K4	1				
2907	2907	2907	2907	2907	2907	2907	2907	2907	2907	2907	2907	2907	2916	RPPA_CLUSTER_EC	SAMPLE	STRING	RPPA Cluster - EC	RPPA Cluster - EC	1				
2908	2908	2908	2908	2908	2908	2908	2908	2908	2908	2908	2908	2908	2917	RPPA_CLUSTER_GEA	SAMPLE	STRING	RPPA Cluster - GEA	RPPA Cluster - GEA	1				
2909	2909	2909	2909	2909	2909	2909	2909	2909	2909	2909	2909	2909	2918	RPPA_CLUSTER_GEA_CIN	SAMPLE	STRING	RPPA Cluster - GEA-CIN	RPPA Cluster - GEA-CIN	1				
2910	2910	2910	2910	2910	2910	2910	2910	2910	2910	2910	2910	2910	2919	RPPA_CLUSTER_SCC	SAMPLE	STRING	RPPA Cluster - SCC	RPPA Cluster - SCC	1				
2911	2911	2911	2911	2911	2911	2911	2911	2911	2911	2911	2911	2911	2920	RPPA_DATA	SAMPLE	STRING	RPPA data.	RPPA Data	1				
2912	2912	2912	2912	2912	2912	2912	2912	2912	2912	2912	2912	2912	2921	RPS15_MUTATION	SAMPLE	STRING	RPS15 Mutation is Present	RPS15 Mutation	1				
2913	2913	2913	2913	2913	2913	2913	2913	2913	2913	2913	2913	2913	2922	RSITE	PATIENT	NUMBER	Rsite	Rsite	1				
2914	2914	2914	2914	2914	2914	2914	2914	2914	2914	2914	2914	2914	2923	RSITE1	PATIENT	NUMBER	Rsite1	Rsite1	1				
2915	2915	2915	2915	2915	2915	2915	2915	2915	2915	2915	2915	2915	2924	RT_MAX_DOSE_CGY	PATIENT	STRING	RT Max dose cgy	RT Max dose cgy	1				
2916	2916	2916	2916	2916	2916	2916	2916	2916	2916	2916	2916	2916	2925	RT_TX_REASON_NOT_COMPLETED	PATIENT	STRING	Radiation therapy not administered reason	Radiation therapy not administered reason	1				
2917	2917	2917	2917	2917	2917	2917	2917	2917	2917	2917	2917	2917	2926	RT_TX_REASON_NOT_COMPLETED_OTHER	PATIENT	STRING	Radiation therapy not administered specify	Radiation therapy not administered specify	1				
2918	2918	2918	2918	2918	2918	2918	2918	2918	2918	2918	2918	2918	2927	RT_TX_TOTAL_DOSE_TO_PELVIS	PATIENT	STRING	Rt pelvis administered total dose	Rt pelvis administered total dose	1				
2919	2919	2919	2919	2919	2919	2919	2919	2919	2919	2919	2919	2919	2928	RUN	SAMPLE	NUMBER	Run-IMPACT	Run	1				
2920	2920	2920	2920	2920	2920	2920	2920	2920	2920	2920	2920	2920	2929	RX	PATIENT	NUMBER	Rx	Rx	1				
2921	2921	2921	2921	2921	2921	2921	2921	2921	2921	2921	2921	2921	2930	RX_ADJ	PATIENT	STRING	Adjuvant chemotherapy	Adj	1				
2922	2922	2922	2922	2922	2922	2922	2922	2922	2922	2922	2922	2922	2931	RX_NEO_IH_CHEMO	PATIENT	STRING	Neoadjuvant chemotherapy-intrahepatic	Neoadj-IH	1				
2923	2923	2923	2923	2923	2923	2923	2923	2923	2923	2923	2923	2923	2932	RX_NEO_SYS_CHEMO	PATIENT	STRING	Neoadjuvant chemotherapy-systemic	Neoadj-SYS	1				
2924	2924	2924	2924	2924	2924	2924	2924	2924	2924	2924	2924	2924	2933	RX_RADS	PATIENT	STRING	Radiation therapy	Rad	1				
2925	2925	2925	2925	2925	2925	2925	2925	2925	2925	2925	2925	2925	2934	SALVAGE_CHEMO	PATIENT	STRING	Salvage Chemo	Salvage Chemo	1				
2926	2926	2926	2926	2926	2926	2926	2926	2926	2926	2926	2926	2926	2935	SALVAGE_CYSTECTOMY	PATIENT	STRING	Salvage Cystectomy	Salvage Cystectomy	1				
2927	2927	2927	2927	2927	2927	2927	2927	2927	2927	2927	2927	2927	2936	SALVAGE_HAIP	PATIENT	STRING	Salvage HAIP	Salvage HAIP	1				
2928	2928	2928	2928	2928	2928	2928	2928	2928	2928	2928	2928	2928	2937	SAMPLE_ACCESSION_NUMBER	SAMPLE	STRING	Sample Accession Number	Sample Accession Number	1				
2929	2929	2929	2929	2929	2929	2929	2929	2929	2929	2929	2929	2929	2938	SAMPLE_CATEGORY	SAMPLE	STRING	Sample Category	Sample Category	1				
2930	2930	2930	2930	2930	2930	2930	2930	2930	2930	2930	2930	2930	2939	SAMPLE_CLASS	SAMPLE	STRING	The sample classification (i.e., tumor, cellline, xenograph).	Sample Class	1				
2931	2931	2931	2931	2931	2931	2931	2931	2931	2931	2931	2931	2931	2940	SAMPLE_COLLECTION_METHOD	SAMPLE	STRING	Sample Collection Method	Sample Collection Method	1				
2932	2932	2932	2932	2932	2932	2932	2932	2932	2932	2932	2932	2932	2941	SAMPLE_COLLECTION_SOURCE	SAMPLE	STRING	Sample Collection Source	Sample Collection Source	1				
2933	2933	2933	2933	2933	2933	2933	2933	2933	2933	2933	2933	2933	2942	SAMPLE_COVERAGE	SAMPLE	STRING	Sample coverage	Sample coverage	1				
2934	2934	2934	2934	2934	2934	2934	2934	2934	2934	2934	2934	2934	2943	SAMPLE_DETAILED_SUBHISTOLOGIES	SAMPLE	STRING	Sample Detailed Subhistologies	Sample Detailed Subhistologies	1				
2935	2935	2935	2935	2935	2935	2935	2935	2935	2935	2935	2935	2935	2944	SAMPLE_DISPLAY_NAME	SAMPLE	STRING	Sample Display Name	Sample Display Name	1				
2936	2936	2936	2936	2936	2936	2936	2936	2936	2936	2936	2936	2936	2945	SAMPLE_ID	SAMPLE	STRING	A unique sample identifier.	Sample Identifier	1				
2937	2937	2937	2937	2937	2937	2937	2937	2937	2937	2937	2937	2937	2946	SAMPLE_ID_LEGACY	SAMPLE	STRING	Deprecated sample identifier	Former Sample Identifier	1				
2938	2938	2938	2938	2938	2938	2938	2938	2938	2938	2938	2938	2938	2947	SAMPLE_INITIAL_WEIGHT	SAMPLE	NUMBER	Sample Initial Weight	Sample Initial Weight	1				
2939	2939	2939	2939	2939	2939	2939	2939	2939	2939	2939	2939	2939	2948	SAMPLE_MAIN_HISTOLOGY	SAMPLE	STRING	Sample Main Histology	Sample Main Histology	1				
2940	2940	2940	2940	2940	2940	2940	2940	2940	2940	2940	2940	2940	2949	SAMPLE_METH_ID	SAMPLE	STRING	Sample METH ID	Sample METH ID	1				
2941	2941	2941	2941	2941	2941	2941	2941	2941	2941	2941	2941	2941	2950	SAMPLE_NAME	PATIENT	STRING	Sample name	Sample name	1				
2942	2942	2942	2942	2942	2942	2942	2942	2942	2942	2942	2942	2942	2951	SAMPLE_NOTES	SAMPLE	STRING	Notes for the respective Sample	Sample Notes	1				
2943	2943	2943	2943	2943	2943	2943	2943	2943	2943	2943	2943	2943	2952	SAMPLE_ORIGIN	SAMPLE	STRING	Sample origin	Sample origin	1				
2944	2944	2944	2944	2944	2944	2944	2944	2944	2944	2944	2944	2944	2953	SAMPLE_PRE_CHEMO	PATIENT	STRING	Sample procurred pre chemotherapy	Sample procurred pre chemotherapy	1				
2945	2945	2945	2945	2945	2945	2945	2945	2945	2945	2945	2945	2945	2954	SAMPLE_PRE_LUNG_THERAPY	SAMPLE	STRING	Sample pre any Lung Therapy	Sample pre any Lung Therapy	1				
2946	2946	2946	2946	2946	2946	2946	2946	2946	2946	2946	2946	2946	2955	SAMPLE_PRE_POST_IMMUNE	SAMPLE	STRING	Sample procurred pre or post immnunotherapy	Sample procurred pre or post immnunotherapy	1				
2947	2947	2947	2947	2947	2947	2947	2947	2947	2947	2947	2947	2947	2956	SAMPLE_RNA_ID	SAMPLE	STRING	Sample RNA ID	Sample RNA ID	1				
2948	2948	2948	2948	2948	2948	2948	2948	2948	2948	2948	2948	2948	2957	SAMPLE_SITE	SAMPLE	STRING	Sample Site	Site of Sample	1				
2949	2949	2949	2949	2949	2949	2949	2949	2949	2949	2949	2949	2949	2958	SAMPLE_SITE_SOURCE	SAMPLE	STRING	Source of Sample Site	Source of Sample Site	1				
2950	2950	2950	2950	2950	2950	2950	2950	2950	2950	2950	2950	2950	2959	SAMPLE_STATUS	SAMPLE	STRING	Sample Status	Sample Status	1				
2951	2951	2951	2951	2951	2951	2951	2951	2951	2951	2951	2951	2951	2960	SAMPLE_TESTED_CATEGORY	SAMPLE	STRING	Sample Tested Category	Sample Tested Category	1				
2952	2952	2952	2952	2952	2952	2952	2952	2952	2952	2952	2952	2952	2961	SAMPLE_TIMEPOINT	SAMPLE	STRING	Sample sequential timepoint (T1 = timepoint 1, T2 = timepoint 2, etc.)	Sample Timepoint	1				
2953	2953	2953	2953	2953	2953	2953	2953	2953	2953	2953	2953	2953	2963	SAMPLE_TYPE	SAMPLE	STRING	The type of sample (i.e., normal, primary, met, recurrence).	Sample Type	9				
2954	2954	2954	2954	2954	2954	2954	2954	2954	2954	2954	2954	2954	2964	SAMPLE_TYPE_DETAIL	SAMPLE	STRING	Detailed Description of Sample Type	Sample Type Detail	1				
2955	2955	2955	2955	2955	2955	2955	2955	2955	2955	2955	2955	2955	2965	SAMPLE_TYPE_ID	PATIENT	STRING	Sample type id	Sample type id	1				
2956	2956	2956	2956	2956	2956	2956	2956	2956	2956	2956	2956	2956	2966	SAMPLE_TYPE_ID_NUMBER	SAMPLE	STRING	Sample Type ID	Sample Type ID	1				
2957	2957	2957	2957	2957	2957	2957	2957	2957	2957	2957	2957	2957	2967	SARCOMATOID_COMPONENT	SAMPLE	STRING	Sarcomatoid Component	Sarcomatoid Component	1				
2958	2958	2958	2958	2958	2958	2958	2958	2958	2958	2958	2958	2958	2968	SARCOMATOID_FEATURES	PATIENT	STRING	Presence of sarcomatoid features	Sarcomatoid features	1				
2959	2959	2959	2959	2959	2959	2959	2959	2959	2959	2959	2959	2959	2969	SARCOMATOID_PERCENT_OF_TUMOR	PATIENT	STRING	Percent tumor sarcomatoid	Sarcomatoid percent of tumor	1				
2960	2960	2960	2960	2960	2960	2960	2960	2960	2960	2960	2960	2960	2970	SATELLITES_DES	SAMPLE	STRING	Indicates if there are satellite lesions within 2cm of primary tumor	Satellite Lesions	1				
2961	2961	2961	2961	2961	2961	2961	2961	2961	2961	2961	2961	2961	2971	SCA_TYPE	SAMPLE	STRING	Serous Cystadenomas (SCAs)	SCA Type	1				
2962	2962	2962	2962	2962	2962	2962	2962	2962	2962	2962	2962	2962	2972	SCC	PATIENT	STRING	SCC	SCC	1				
2963	2963	2963	2963	2963	2963	2963	2963	2963	2963	2963	2963	2963	2973	SCCA_TUMOR_MARKER	PATIENT	STRING	Laboratory procedure tumor marker squamous cell carcinoma antigen result value	Laboratory procedure tumor marker squamous cell carcinoma antigen result value	1				
2964	2964	2964	2964	2964	2964	2964	2964	2964	2964	2964	2964	2964	2974	SCCSMG	PATIENT	STRING	SCC-SMG	SCC-SMG	1				
2965	2965	2965	2965	2965	2965	2965	2965	2965	2965	2965	2965	2965	2975	SCC_CLUSTER_ICLUSTER_AND_SMARCA4	SAMPLE	STRING	SCC Cluster iCluster and SMARCA4	SCC Cluster iCluster and SMARCA4	1				
2966	2966	2966	2966	2966	2966	2966	2966	2966	2966	2966	2966	2966	2976	SCENS	PATIENT	STRING	SCENS.	SCENS	1				
2967	2967	2967	2967	2967	2967	2967	2967	2967	2967	2967	2967	2967	2977	SCNA_ANALYSIS	SAMPLE	STRING	SCNA Analysis	SCNA Analysis	1				
2968	2968	2968	2968	2968	2968	2968	2968	2968	2968	2968	2968	2968	2978	SCNA_CLUSTER	SAMPLE	STRING	SCNA Cluster	SCNA Cluster	1				
2969	2969	2969	2969	2969	2969	2969	2969	2969	2969	2969	2969	2969	2979	SCNA_CLUSTER_EC	SAMPLE	STRING	SCNA Cluster EC	SCNA Cluster EC	1				
2970	2970	2970	2970	2970	2970	2970	2970	2970	2970	2970	2970	2970	2980	SCNA_CLUSTER_GEA	SAMPLE	STRING	SCNA Cluster GEA	SCNA Cluster GEA	1				
2971	2971	2971	2971	2971	2971	2971	2971	2971	2971	2971	2971	2971	2981	SCNA_CLUSTER_GEA_CIN	SAMPLE	STRING	SCNA Cluster GEA CIN	SCNA Cluster GEA CIN	1				
2972	2972	2972	2972	2972	2972	2972	2972	2972	2972	2972	2972	2972	2982	SCNA_CLUSTER_SCC	SAMPLE	STRING	SCNA Cluster SCC	SCNA Cluster SCC	1				
2973	2973	2973	2973	2973	2973	2973	2973	2973	2973	2973	2973	2973	2983	SCT_IN_FIRST_CR	PATIENT	STRING	SCT in first CR.	SCT in First CR	1				
2974	2974	2974	2974	2974	2974	2974	2974	2974	2974	2974	2974	2974	2984	SDHA	SAMPLE	STRING	SDHA	SDHA	1				
2975	2975	2975	2975	2975	2975	2975	2975	2975	2975	2975	2975	2975	2985	SDHAF2_SDH5	SAMPLE	STRING	SDHAF2 SDH5	SDHAF2 SDH5	1				
2976	2976	2976	2976	2976	2976	2976	2976	2976	2976	2976	2976	2976	2986	SDHB	SAMPLE	STRING	SDHB	SDHB	1				
2977	2977	2977	2977	2977	2977	2977	2977	2977	2977	2977	2977	2977	2987	SDHB_GERMLINE	SAMPLE	STRING	SDHB Germline Mutation	SDHB Germline Mutation	1				
2978	2978	2978	2978	2978	2978	2978	2978	2978	2978	2978	2978	2978	2988	SDHC	SAMPLE	STRING	SDHC	SDHC	1				
2979	2979	2979	2979	2979	2979	2979	2979	2979	2979	2979	2979	2979	2989	SDHD	SAMPLE	STRING	SDHD	SDHD	1				
2980	2980	2980	2980	2980	2980	2980	2980	2980	2980	2980	2980	2980	2990	SDHD_GERMLINE	SAMPLE	STRING	SDHD Germline Mutation	SDHD Germline Mutation	1				
2981	2981	2981	2981	2981	2981	2981	2981	2981	2981	2981	2981	2981	2991	SDH_STATUS	SAMPLE	STRING	SDH Status	SDH Status	1				
2982	2982	2982	2982	2982	2982	2982	2982	2982	2982	2982	2982	2982	2992	SECONDARY_ALTERATIONS	SAMPLE	STRING	Secondary Alterations	Secondary Alterations	1				
2983	2983	2983	2983	2983	2983	2983	2983	2983	2983	2983	2983	2983	2993	SECONDARY_HISTOLOGY	SAMPLE	STRING	Histology Secondary	Histology Secondary	1				
2984	2984	2984	2984	2984	2984	2984	2984	2984	2984	2984	2984	2984	2994	SECONDARY_PLATFORM	SAMPLE	STRING	Secondary Platform	Secondary Platform	1				
2985	2985	2985	2985	2985	2985	2985	2985	2985	2985	2985	2985	2985	2995	SECONDARY_RACE	PATIENT	STRING	The second race recorded for the patient; this data element maps to the NAACCR v16 #161. For institutions not collecting race, submit a null in this category for all patients.	Secondary Race	1				
2986	2986	2986	2986	2986	2986	2986	2986	2986	2986	2986	2986	2986	2996	SECONDARY_THERAPY	PATIENT	STRING	Secondary Line of Therapy	Secondary Line of Therapy	1				
2987	2987	2987	2987	2987	2987	2987	2987	2987	2987	2987	2987	2987	2997	SECOND_PRIMARY_CANCER	SAMPLE	STRING	Refers to a new primary cancer in a person with a history of cancer	Second Primary Cancer	1				
2988	2988	2988	2988	2988	2988	2988	2988	2988	2988	2988	2988	2988	2998	SEIZURE_HISTORY	PATIENT	STRING	Seizure history.	Seizure History	1				
2989	2989	2989	2989	2989	2989	2989	2989	2989	2989	2989	2989	2989	2999	SEMINAL_VESICLE_INVASION	PATIENT	STRING	Seminal vesicle invasion	Seminal Vesicle Invasion	1				
2990	2990	2990	2990	2990	2990	2990	2990	2990	2990	2990	2990	2990	3000	SENSORY_CHANGES	PATIENT	STRING	Sensory changes.	Sensory Changes	1				
2991	2991	2991	2991	2991	2991	2991	2991	2991	2991	2991	2991	2991	3001	SEQCAP_EZ_EXOME_VERSION	SAMPLE	STRING	SEQCAP EZ EXOME VERSION	SEQCAP EZ EXOME VERSION	1				
2992	2992	2992	2992	2992	2992	2992	2992	2992	2992	2992	2992	2992	3002	SEQUENCED	SAMPLE	STRING	Sequenced.	Sequenced	1				
2993	2993	2993	2993	2993	2993	2993	2993	2993	2993	2993	2993	2993	3003	SEQUENCED_SAMPLE	SAMPLE	STRING	Was the sample sequenced?	Was the sample sequenced?	1				
2994	2994	2994	2994	2994	2994	2994	2994	2994	2994	2994	2994	2994	3004	SEQUENCE_REPORT_DATE_INT_STATIC	SAMPLE	NUMBER	Sequence Report Date Interval	Sequence Report Date Interval	1				
2995	2995	2995	2995	2995	2995	2995	2995	2995	2995	2995	2995	2995	3005	SEQUENCING_TYPE	SAMPLE	STRING	Sequencing Type	Sequencing Type	1				
2996	2996	2996	2996	2996	2996	2996	2996	2996	2996	2996	2996	2996	3006	SEQUENOM	SAMPLE	STRING	Sequenom	Sequenom	1				
2997	2997	2997	2997	2997	2997	2997	2997	2997	2997	2997	2997	2997	3007	SEQUENOME_MUTATIONS_FUSIONS	SAMPLE	STRING	Sequenome of mutations of fusions	Sequenome of mutations of fusions	1				
2998	2998	2998	2998	2998	2998	2998	2998	2998	2998	2998	2998	2998	3008	SEQ_ASSAY_ID	SAMPLE	STRING	Sequence Assay ID	Sequence Assay ID	1				
2999	2999	2999	2999	2999	2999	2999	2999	2999	2999	2999	2999	2999	3009	SEQ_DATE	SAMPLE	STRING	Date sample was sequenced	Sequence Date	1				
3000	3000	3000	3000	3000	3000	3000	3000	3000	3000	3000	3000	3000	3010	SERUM_ALBUMIN_NORMAL_RANGE_LOWER	PATIENT	NUMBER	Laboratory procedure albumin result lower limit of normal value	Laboratory procedure albumin result lower limit of normal value	1				
3001	3001	3001	3001	3001	3001	3001	3001	3001	3001	3001	3001	3001	3011	SERUM_ALBUMIN_NORMAL_RANGE_UPPER	PATIENT	NUMBER	Laboratory procedure albumin result upper limit of normal value	Laboratory procedure albumin result upper limit of normal value	1				
3002	3002	3002	3002	3002	3002	3002	3002	3002	3002	3002	3002	3002	3012	SERUM_ALBUMIN_NORM_RANGE_LOWER	SAMPLE	NUMBER	Laboratory procedure albumin result lower limit of normal value	Laboratory procedure albumin result lower limit of normal value	1				
3003	3003	3003	3003	3003	3003	3003	3003	3003	3003	3003	3003	3003	3013	SERUM_ALBUMIN_NORM_RANGE_UPPER	SAMPLE	NUMBER	Laboratory procedure albumin result upper limit of normal value	Laboratory procedure albumin result upper limit of normal value	1				
3004	3004	3004	3004	3004	3004	3004	3004	3004	3004	3004	3004	3004	3014	SERUM_ALBUMIN_PRERESECTION	SAMPLE	NUMBER	Laboratory procedure albumin result specified value	Laboratory procedure albumin result specified value	1				
3005	3005	3005	3005	3005	3005	3005	3005	3005	3005	3005	3005	3005	3015	SERUM_ALPHA_FOETO_PROTEIN	PATIENT	STRING	Serum Alpha Foeto Protein (ng/ml)	Serum Alpha Foeto Protein (ng/ml)	1				
3006	3006	3006	3006	3006	3006	3006	3006	3006	3006	3006	3006	3006	3016	SERUM_CALCIUM_LEVEL	PATIENT	STRING	Serum calcium result	Serum calcium level	1				
3007	3007	3007	3007	3007	3007	3007	3007	3007	3007	3007	3007	3007	3017	SERUM_LACTATE_DEHYDROGENASE	SAMPLE	NUMBER	LDH (normal <246)	Serum Lactate Dehydrogenase	1				
3008	3008	3008	3008	3008	3008	3008	3008	3008	3008	3008	3008	3008	3018	SERUM_MARKERS	PATIENT	STRING	Serum markers	Serum markers	1				
3009	3009	3009	3009	3009	3009	3009	3009	3009	3009	3009	3009	3009	3019	SERUM_MESOTHELIN_LOWER_LIMIT	SAMPLE	NUMBER	Laboratory procedure mesothelin result lower limit of normal value	Laboratory procedure mesothelin result lower limit of normal value	1				
3010	3010	3010	3010	3010	3010	3010	3010	3010	3010	3010	3010	3010	3020	SERUM_MESOTHELIN_PRIOR_TX	SAMPLE	NUMBER	Laboratory procedure mesothelin prior treatment	Laboratory procedure mesothelin prior treatment	1				
3011	3011	3011	3011	3011	3011	3011	3011	3011	3011	3011	3011	3011	3021	SERUM_MESOTHELIN_UPPER_LIMIT	SAMPLE	NUMBER	Laboratory procedure mesothelin result upper limit of normal value	Laboratory procedure mesothelin result upper limit of normal value	1				
3012	3012	3012	3012	3012	3012	3012	3012	3012	3012	3012	3012	3012	3022	SERUM_PSA	PATIENT	NUMBER	Serum PSA.	Serum PSA	1				
3013	3013	3013	3013	3013	3013	3013	3013	3013	3013	3013	3013	3013	3023	SETD2_MUTATION	SAMPLE	STRING	SETD2 Mutation	SETD2 Mutation	1				
3014	3014	3014	3014	3014	3014	3014	3014	3014	3014	3014	3014	3014	3024	SETD2_SOMATIC	SAMPLE	STRING	SETD2 Somatic Mutation	SETD2 Somatic Mutation	1				
3015	3015	3015	3015	3015	3015	3015	3015	3015	3015	3015	3015	3015	3025	SEX	PATIENT	STRING	Sex	Sex	1				
3016	3016	3016	3016	3016	3016	3016	3016	3016	3016	3016	3016	3016	3026	SEX_DMT	PATIENT	STRING	Sex Reported by DMT	Sex Reported by DMT	1				
3017	3017	3017	3017	3017	3017	3017	3017	3017	3017	3017	3017	3017	3027	SEX_NAACCR	PATIENT	STRING	The sex code for the patient; this data element maps to the NAACCR v16 #220.	Sex (NAACCR)	1				
3018	3018	3018	3018	3018	3018	3018	3018	3018	3018	3018	3018	3018	3028	SHH_AMPLIFICATION	SAMPLE	STRING	SHH(Sonic-hedgehog) Amplification	SHH Amplification	1				
3019	3019	3019	3019	3019	3019	3019	3019	3019	3019	3019	3019	3019	3029	SHORTEST_DIMENSION	SAMPLE	NUMBER	Shortest Dimension	Shortest Dimension	1				
3020	3020	3020	3020	3020	3020	3020	3020	3020	3020	3020	3020	3020	3030	SHORT_HISTOLOGY	PATIENT	STRING	Short Histology	Short Histology	1				
3021	3021	3021	3021	3021	3021	3021	3021	3021	3021	3021	3021	3021	3031	SIDE_SURGERY	PATIENT	STRING	Side Surgery	Side Surgery	1				
3022	3022	3022	3022	3022	3022	3022	3022	3022	3022	3022	3022	3022	3032	SIEWERT1	PATIENT	NUMBER	Siewert1	Siewert1	1				
3023	3023	3023	3023	3023	3023	3023	3023	3023	3023	3023	3023	3023	3033	SIGCLUST_INTRINSIC_MRNA	SAMPLE	STRING	SigClust Intrinsic mRNA	SigClust Intrinsic mRNA	1				
3024	3024	3024	3024	3024	3024	3024	3024	3024	3024	3024	3024	3024	3034	SIGCLUST_UNSUPERVISED_MRNA	SAMPLE	STRING	SigClust Unsupervised mRNA	SigClust Unsupervised mRNA	1				
3025	3025	3025	3025	3025	3025	3025	3025	3025	3025	3025	3025	3025	3035	SIGNATUREA	SAMPLE	STRING	SIGNATUREA	SIGNATUREA	1				
3026	3026	3026	3026	3026	3026	3026	3026	3026	3026	3026	3026	3026	3036	SIGNATUREB	SAMPLE	STRING	SIGNATUREB	SIGNATUREB	1				
3027	3027	3027	3027	3027	3027	3027	3027	3027	3027	3027	3027	3027	3037	SIGNATUREC	SAMPLE	STRING	SIGNATUREC	SIGNATUREC	1				
3028	3028	3028	3028	3028	3028	3028	3028	3028	3028	3028	3028	3028	3038	SIGNATURED	SAMPLE	STRING	SIGNATURED	SIGNATURED	1				
3029	3029	3029	3029	3029	3029	3029	3029	3029	3029	3029	3029	3029	3039	SIGNATUREE	SAMPLE	STRING	SIGNATUREE	SIGNATUREE	1				
3030	3030	3030	3030	3030	3030	3030	3030	3030	3030	3030	3030	3030	3040	SIGNATUREF	SAMPLE	STRING	SIGNATUREF	SIGNATUREF	1				
3031	3031	3031	3031	3031	3031	3031	3031	3031	3031	3031	3031	3031	3041	SIGNATURE_A	SAMPLE	STRING	SIGNATURE A	SIGNATURE A	1				
3032	3032	3032	3032	3032	3032	3032	3032	3032	3032	3032	3032	3032	3042	SIGNATURE_B	SAMPLE	STRING	SIGNATURE B	SIGNATURE B	1				
3033	3033	3033	3033	3033	3033	3033	3033	3033	3033	3033	3033	3033	3043	SIGNATURE_C	SAMPLE	STRING	SIGNATURE C	SIGNATURE C	1				
3034	3034	3034	3034	3034	3034	3034	3034	3034	3034	3034	3034	3034	3044	SIGNET_RING	PATIENT	STRING	Signet ring.	Signet Ring	1				
3035	3035	3035	3035	3035	3035	3035	3035	3035	3035	3035	3035	3035	3045	SIGNIFICANT_COMORBIDITIES	PATIENT	STRING	Significant comorbidities	Significant comorbidities	1				
3036	3036	3036	3036	3036	3036	3036	3036	3036	3036	3036	3036	3036	3046	SILENT_MUTATION	SAMPLE	STRING	Silent Mutations	Silent Mutations	1				
3037	3037	3037	3037	3037	3037	3037	3037	3037	3037	3037	3037	3037	3047	SILENT_PER_MB	SAMPLE	STRING	Silent per Mb	Silent per Mb	1				
3038	3038	3038	3038	3038	3038	3038	3038	3038	3038	3038	3038	3038	3048	SILENT_RATE	SAMPLE	NUMBER	Silent Mutation Rate	Silent Mutation Rate	1				
3039	3039	3039	3039	3039	3039	3039	3039	3039	3039	3039	3039	3039	3049	SILENT_SNV	SAMPLE	NUMBER	Silent Single-Nucleotide Variants	Silent Single-Nucleotide Variants	1				
3040	3040	3040	3040	3040	3040	3040	3040	3040	3040	3040	3040	3040	3050	SIMPLIFIED_TUMOR_SITE	SAMPLE	STRING	Location of tumor in study (simplified)	Simplified Tumor Site	1				
3041	3041	3041	3041	3041	3041	3041	3041	3041	3041	3041	3041	3041	3051	SINUSOID_INVASION	SAMPLE	STRING	Sinusoid Invasion	Sinusoid Invasion	1				
3042	3042	3042	3042	3042	3042	3042	3042	3042	3042	3042	3042	3042	3052	SITE	PATIENT	STRING	Site	Site	1				
3043	3043	3043	3043	3043	3043	3043	3043	3043	3043	3043	3043	3043	3053	SITES_IN_COLON	PATIENT	STRING	Sites In Colon	Sites In Colon	1				
3044	3044	3044	3044	3044	3044	3044	3044	3044	3044	3044	3044	3044	3054	SITES_OF_METASTATIC_DISEASE	SAMPLE	STRING	Sites of metastatic disease	Sites of metastatic disease	1				
3045	3045	3045	3045	3045	3045	3045	3045	3045	3045	3045	3045	3045	3055	SITE_FIRST_RECURRENCE	PATIENT	STRING	Site First Recurrence	Site First Recurrence	1				
3046	3046	3046	3046	3046	3046	3046	3046	3046	3046	3046	3046	3046	3056	SITE_ID	SAMPLE	STRING	ID defining the site source	Site ID	1				
3047	3047	3047	3047	3047	3047	3047	3047	3047	3047	3047	3047	3047	3057	SITE_OF_DM	SAMPLE	STRING	Site of DM	Site of DM	1				
3048	3048	3048	3048	3048	3048	3048	3048	3048	3048	3048	3048	3048	3058	SITE_OF_INITIAL_RELAPSE	SAMPLE	STRING	Site of initial relapse.	Site of Initial Relapse	1				
3049	3049	3049	3049	3049	3049	3049	3049	3049	3049	3049	3049	3049	3059	SITE_OF_RADIATION_THERAPY	SAMPLE	STRING	Radiation Therapy Site	Radiation Therapy Site	1				
3050	3050	3050	3050	3050	3050	3050	3050	3050	3050	3050	3050	3050	3060	SITE_OF_RECURRENCE	SAMPLE	STRING	Site of Recurrence	Site of Recurrence	1				
3051	3051	3051	3051	3051	3051	3051	3051	3051	3051	3051	3051	3051	3061	SITE_OF_TISSUE_BIOPSY	SAMPLE	STRING	Site of Tissue Biopsy	Site of Tissue Biopsy	1				
3052	3052	3052	3052	3052	3052	3052	3052	3052	3052	3052	3052	3052	3062	SITE_OF_TISSUE_SOURCE	PATIENT	STRING	Tissue Source Site	Tissue Source Site	1				
3053	3053	3053	3053	3053	3053	3053	3053	3053	3053	3053	3053	3053	3063	SITE_OF_TUMOR_TISSUE	PATIENT	STRING	Tumor Tissue Site	Tumor Tissue Site	1				
3054	3054	3054	3054	3054	3054	3054	3054	3054	3054	3054	3054	3054	3064	SITE_SEQUENCED	SAMPLE	STRING	Site Sequenced	Site Sequenced	1				
3055	3055	3055	3055	3055	3055	3055	3055	3055	3055	3055	3055	3055	3065	SITE_SIMPLIFIED	PATIENT	STRING	Location of tumor in study (simplified)	Simplified Tumor Site	1				
3056	3056	3056	3056	3056	3056	3056	3056	3056	3056	3056	3056	3056	3066	SKMEL_ID	SAMPLE	STRING	SK-MEL Identifier	SK-MEL Identifier	1				
3057	3057	3057	3057	3057	3057	3057	3057	3057	3057	3057	3057	3057	3067	SMAD4_STATUS	SAMPLE	STRING	SMAD4 Status	SMAD4 Status	1				
3058	3058	3058	3058	3058	3058	3058	3058	3058	3058	3058	3058	3058	3068	SMALL_EXONIC_SOMATIC_INDELS	SAMPLE	NUMBER	Small Exonic Somatic Indels	Small Exonic Somatic Indels	1				
3059	3059	3059	3059	3059	3059	3059	3059	3059	3059	3059	3059	3059	3069	SMOKER	PATIENT	STRING	Indicates if person is a smoker.	Smoker	1				
3060	3060	3060	3060	3060	3060	3060	3060	3060	3060	3060	3060	3060	3070	SMOKER_YEARS	PATIENT	NUMBER	Years Smoked	Years Smoked	1				
3061	3061	3061	3061	3061	3061	3061	3061	3061	3061	3061	3061	3061	3071	SMOKING	PATIENT	STRING	Smoking	Smoking	1				
3062	3062	3062	3062	3062	3062	3062	3062	3062	3062	3062	3062	3062	3072	SMOKING_AGE_START_YEARS	PATIENT	NUMBER	Age at which patient began smoking.	Smoking Age Start (Years)	1				
3063	3063	3063	3063	3063	3063	3063	3063	3063	3063	3063	3063	3063	3073	SMOKING_HISTORY	PATIENT	STRING	Smoking History	Smoking History	1				
3064	3064	3064	3064	3064	3064	3064	3064	3064	3064	3064	3064	3064	3074	SMOKING_PACK_PER_DAY	PATIENT	NUMBER	Smoking Pack Per Day	Smoking Pack Per Day	1				
3065	3065	3065	3065	3065	3065	3065	3065	3065	3065	3065	3065	3065	3075	SMOKING_PACK_YEARS	PATIENT	NUMBER	Numeric computed value to represent lifetime tobacco exposure defined as number of cigarettes smoked per day x number of years smoked divided by 20.	Person Cigarette Smoking History Pack Year Value	1				
3066	3066	3066	3066	3066	3066	3066	3066	3066	3066	3066	3066	3066	3076	SMOKING_QUESTIONNAIRE	PATIENT	STRING	smoking questionnaire	smoking questionnaire	1				
3067	3067	3067	3067	3067	3067	3067	3067	3067	3067	3067	3067	3067	3077	SMOKING_YEARS_QUIT	PATIENT	NUMBER	Years since patient quit smoking	Smoking Years Quit	1				
3068	3068	3068	3068	3068	3068	3068	3068	3068	3068	3068	3068	3068	3078	SMOKING_YEAR_STARTED	PATIENT	NUMBER	The year in which the participant began smoking.	Started Smoking Year	1				
3069	3069	3069	3069	3069	3069	3069	3069	3069	3069	3069	3069	3069	3079	SMOKING_YEAR_STOPPED	PATIENT	NUMBER	The year in which the participant quit smoking.	Stopped Smoking Year	1				
3070	3070	3070	3070	3070	3070	3070	3070	3070	3070	3070	3070	3070	3080	SMO_MUTATION	SAMPLE	STRING	SMO Mutation	SMO Mutation	1				
3071	3071	3071	3071	3071	3071	3071	3071	3071	3071	3071	3071	3071	3081	SMS	SAMPLE	STRING	sms	sms	1				
3072	3072	3072	3072	3072	3072	3072	3072	3072	3072	3072	3072	3072	3082	SNAPSHOT_MUTATIONS	SAMPLE	STRING	snapshot mutations	snapshot mutations	1				
3073	3073	3073	3073	3073	3073	3073	3073	3073	3073	3073	3073	3073	3083	SNOMED	PATIENT	STRING	SNOMED	SNOMED	1				
3074	3074	3074	3074	3074	3074	3074	3074	3074	3074	3074	3074	3074	3084	SNP	SAMPLE	STRING	Single Nucleotide Polymorphism	SNP	1				
3075	3075	3075	3075	3075	3075	3075	3075	3075	3075	3075	3075	3075	3085	SNP6	SAMPLE	STRING	SNP6	SNP6	1				
3076	3076	3076	3076	3076	3076	3076	3076	3076	3076	3076	3076	3076	3086	SOCIAL_HISTORY	PATIENT	STRING	Social History	Social History	1				
3077	3077	3077	3077	3077	3077	3077	3077	3077	3077	3077	3077	3077	3087	SOMATIC_BRCA_WT_STATUS	SAMPLE	STRING	Somatic_BRCA_WT_Status	Somatic_BRCA_WT_Status	1				
3078	3078	3078	3078	3078	3078	3078	3078	3078	3078	3078	3078	3078	3088	SOMATIC_STATUS	SAMPLE	STRING	Somatic Status	Somatic Status	1				
3079	3079	3079	3079	3079	3079	3079	3079	3079	3079	3079	3079	3079	3089	SOMATOSTATIN_ANALOG_THERAPY	SAMPLE	STRING	Somatostatin analog therapy	Somatostatin analog therapy	1				
3080	3080	3080	3080	3080	3080	3080	3080	3080	3080	3080	3080	3080	3090	SORT_FILE_NUMBER	SAMPLE	STRING	Sort File Number	Sort File Number	1				
3081	3081	3081	3081	3081	3081	3081	3081	3081	3081	3081	3081	3081	3091	SOURCE	SAMPLE	STRING	Source	Source	1				
3082	3082	3082	3082	3082	3082	3082	3082	3082	3082	3082	3082	3082	3092	SOURCE_LAB	SAMPLE	STRING	Source Lab	Source Lab	1				
3083	3083	3083	3083	3083	3083	3083	3083	3083	3083	3083	3083	3083	3093	SOURCE_OF_RECURRENCE_TISSUE	PATIENT	STRING	Source of Recurrence Tissue	Source of Recurrence Tissue	1				
3084	3084	3084	3084	3084	3084	3084	3084	3084	3084	3084	3084	3084	3094	SOURCE_PATHOLOGY	SAMPLE	STRING	Pathology Source	Pathology Source	1				
3085	3085	3085	3085	3085	3085	3085	3085	3085	3085	3085	3085	3085	3095	SOURCE_TYPE	SAMPLE	STRING	Source type defines where the sample is coming from , ex: Blood, bone marrow . etc.	Source Type	1				
3086	3086	3086	3086	3086	3086	3086	3086	3086	3086	3086	3086	3086	3096	SO_COMMENTS	SAMPLE	STRING	Sign-out comments	SO comments	1				
3087	3087	3087	3087	3087	3087	3087	3087	3087	3087	3087	3087	3087	3097	SPECIAL_HISTOLOGY	PATIENT	STRING	Special Histology	Special Histology	1				
3088	3088	3088	3088	3088	3088	3088	3088	3088	3088	3088	3088	3088	3098	SPECIMEN	SAMPLE	STRING	Specimen	Specimen	1				
3089	3089	3089	3089	3089	3089	3089	3089	3089	3089	3089	3089	3089	3099	SPECIMEN_CHEMOTHERAPY_STATUS	SAMPLE	STRING	Specimen Chemotherapy Status	Specimen Chemotherapy Status	1				
3090	3090	3090	3090	3090	3090	3090	3090	3090	3090	3090	3090	3090	3100	SPECIMEN_CODE	SAMPLE	STRING	Specimen Code	Specimen Code	1				
3091	3091	3091	3091	3091	3091	3091	3091	3091	3091	3091	3091	3091	3101	SPECIMEN_COLLECTION_PRE_OR_POST_CHEMO	SAMPLE	STRING	Specimen Collection Pre or Post Chemo	Specimen Collection Pre or Post Chemo	1				
3092	3092	3092	3092	3092	3092	3092	3092	3092	3092	3092	3092	3092	3102	SPECIMEN_CURRENT_WEIGHT	SAMPLE	STRING	The weight of the specimen.	Specimen Current Weight	1				
3093	3093	3093	3093	3093	3093	3093	3093	3093	3093	3093	3093	3093	3103	SPECIMEN_FREEZING_METHOD	SAMPLE	STRING	The method used to freeze the tissue after removal from the patient.	Specimen Freezing Means	1				
3094	3094	3094	3094	3094	3094	3094	3094	3094	3094	3094	3094	3094	3105	SPECIMEN_REFERENCE_NUMBER	SAMPLE	STRING	Specimen Reference Number	Specimen Reference Number	1				
3095	3095	3095	3095	3095	3095	3095	3095	3095	3095	3095	3095	3095	3106	SPECIMEN_SECOND_LONGEST_DIMENSION	SAMPLE	NUMBER	The second longest dimension of the specimen.	Specimen Second Longest Dimension	1				
3096	3096	3096	3096	3096	3096	3096	3096	3096	3096	3096	3096	3096	3107	SPECIMEN_SITE	SAMPLE	STRING	Specimen Site	Specimen Site	1				
3097	3097	3097	3097	3097	3097	3097	3097	3097	3097	3097	3097	3097	3108	SPECIMEN_TYPE	SAMPLE	STRING	The broad cancer phenotype and site information values for a sample to be processed.	Specimen Type	1				
3098	3098	3098	3098	3098	3098	3098	3098	3098	3098	3098	3098	3098	3109	SPINK1_HIGH	SAMPLE	STRING	SPINK1 High	SPINK1 High	1				
3099	3099	3099	3099	3099	3099	3099	3099	3099	3099	3099	3099	3099	3110	SPLICE_SITE	SAMPLE	STRING	Splice Site	Splice Site	1				
3100	3100	3100	3100	3100	3100	3100	3100	3100	3100	3100	3100	3100	3111	SPLICE_SITE_INSERTION	SAMPLE	STRING	Splice Site Insertion	Splice Site Insertion	1				
3101	3101	3101	3101	3101	3101	3101	3101	3101	3101	3101	3101	3101	3112	SPLICE_SITE_SNP	SAMPLE	STRING	Splice Site SNP	Splice Site SNP	1				
3102	3102	3102	3102	3102	3102	3102	3102	3102	3102	3102	3102	3102	3113	SPOPL_CNA	SAMPLE	STRING	SPOPL CNA	SPOPL CNA	1				
3103	3103	3103	3103	3103	3103	3103	3103	3103	3103	3103	3103	3103	3114	SPOP_MUTATION	SAMPLE	STRING	SPOP Mutation	SPOP Mutation	1				
3104	3104	3104	3104	3104	3104	3104	3104	3104	3104	3104	3104	3104	3115	STAGE	PATIENT	STRING	Stage	Stage	1				
3105	3105	3105	3105	3105	3105	3105	3105	3105	3105	3105	3105	3105	3116	STAGE_AT_DIAGNOSIS	SAMPLE	STRING	Stage At Diagnosis	Stage At Diagnosis	1				
3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3117	STAGE_AT_FIRST_RECURRENCE	SAMPLE	STRING	Stage at first Recurrence	Stage at first Recurrence	1				
3107	3107	3107	3107	3107	3107	3107	3107	3107	3107	3107	3107	3107	3118	STAGE_AT_PRESENTATION	SAMPLE	STRING	Stage at Presentation	Stage at Presentation	1				
3108	3108	3108	3108	3108	3108	3108	3108	3108	3108	3108	3108	3108	3119	STAGE_AT_PRESENTATION_OR_RELAPSE	SAMPLE	STRING	Stage at Presentation or Relapse	Stage at Presentation or Relapse	1				
3109	3109	3109	3109	3109	3109	3109	3109	3109	3109	3109	3109	3109	3120	STAGE_AT_TESTING	PATIENT	STRING	Stage at Testing	Stage at Testing	1				
3110	3110	3110	3110	3110	3110	3110	3110	3110	3110	3110	3110	3110	3121	STAGE_CODE	SAMPLE	STRING	Stage Code	Stage Code	1				
3111	3111	3111	3111	3111	3111	3111	3111	3111	3111	3111	3111	3111	3122	STAGE_M	SAMPLE	STRING	M Stage of tumor	M Stage	1				
3112	3112	3112	3112	3112	3112	3112	3112	3112	3112	3112	3112	3112	3123	STAGE_OTHER	PATIENT	STRING	Stage Other	Stage Other	1				
3113	3113	3113	3113	3113	3113	3113	3113	3113	3113	3113	3113	3113	3124	STAGE_YEAR	SAMPLE	NUMBER	Stage Year	Stage Year	1				
3114	3114	3114	3114	3114	3114	3114	3114	3114	3114	3114	3114	3114	3125	STAGING_SYSTEM	PATIENT	STRING	Staging System.	Staging System	1				
3115	3115	3115	3115	3115	3115	3115	3115	3115	3115	3115	3115	3115	3126	STAGING_SYSTEM_OTHER	SAMPLE	STRING	Staging System Other	Staging System	1				
3116	3116	3116	3116	3116	3116	3116	3116	3116	3116	3116	3116	3116	3127	STAIN_34BE12CK	SAMPLE	STRING	34BE12CK STAIN	34BE12CK STAIN	1				
3117	3117	3117	3117	3117	3117	3117	3117	3117	3117	3117	3117	3117	3128	STANDARDIZED_CELL_NAME	PATIENT	STRING	Standardized Cell Name	Standardized Cell Name	1				
3118	3118	3118	3118	3118	3118	3118	3118	3118	3118	3118	3118	3118	3129	STANDARDIZED_PARENT_CELL_NAME	PATIENT	STRING	Standardized Parent Cell Name	Standardized Parent Cell Name	1				
3119	3119	3119	3119	3119	3119	3119	3119	3119	3119	3119	3119	3119	3130	START_DATE	PATIENT	NUMBER	The start date of a treatment(days)	Start Date	1				
3120	3120	3120	3120	3120	3120	3120	3120	3120	3120	3120	3120	3120	3131	START_DATE_BIRTH_DATE	PATIENT	NUMBER	Start Date Calculated from DOB	Start Date Calculated from DOB	1				
3121	3121	3121	3121	3121	3121	3121	3121	3121	3121	3121	3121	3121	3132	STATE_PROVINCE_COUNTRY_OF_PROCUREMENT	PATIENT	STRING	State, province, or country of procurement.	State-Province-Country of Procurement	1				
3122	3122	3122	3122	3122	3122	3122	3122	3122	3122	3122	3122	3122	3133	STATIN_USE	PATIENT	STRING	Statin Used	Statin Used	1				
3123	3123	3123	3123	3123	3123	3123	3123	3123	3123	3123	3123	3123	3134	STATUS	PATIENT	STRING	Status.	Status	1				
3124	3124	3124	3124	3124	3124	3124	3124	3124	3124	3124	3124	3124	3135	STATUS1	PATIENT	NUMBER	Status1	Status1	1				
3125	3125	3125	3125	3125	3125	3125	3125	3125	3125	3125	3125	3125	3136	STATUSDATE	PATIENT	STRING	Status date.	Status Date	1				
3126	3126	3126	3126	3126	3126	3126	3126	3126	3126	3126	3126	3126	3137	STATUS_10P	SAMPLE	STRING	Chromosome Arm-Calls: 10p	10p Status	1				
3127	3127	3127	3127	3127	3127	3127	3127	3127	3127	3127	3127	3127	3138	STATUS_10Q	SAMPLE	STRING	Chromosome Arm-Calls: 10q	10q Status	1				
3128	3128	3128	3128	3128	3128	3128	3128	3128	3128	3128	3128	3128	3139	STATUS_11P	SAMPLE	STRING	Chromosome Arm-Calls: 11p	11p Status	1				
3129	3129	3129	3129	3129	3129	3129	3129	3129	3129	3129	3129	3129	3140	STATUS_11Q	SAMPLE	STRING	Chromosome Arm-Calls: 11q	11q Status	1				
3130	3130	3130	3130	3130	3130	3130	3130	3130	3130	3130	3130	3130	3141	STATUS_12P	SAMPLE	STRING	Chromosome Arm-Calls: 12p	12p Status	1				
3131	3131	3131	3131	3131	3131	3131	3131	3131	3131	3131	3131	3131	3142	STATUS_12Q	SAMPLE	STRING	Chromosome Arm-Calls: 12q	12q Status	1				
3132	3132	3132	3132	3132	3132	3132	3132	3132	3132	3132	3132	3132	3143	STATUS_13_13Q	SAMPLE	STRING	Chromosome Arm-Calls: 13 (13q)	13 (13q) Status	1				
3133	3133	3133	3133	3133	3133	3133	3133	3133	3133	3133	3133	3133	3144	STATUS_14_14Q	SAMPLE	STRING	Chromosome Arm-Calls: 14 (14q)	14 (14q) Status	1				
3134	3134	3134	3134	3134	3134	3134	3134	3134	3134	3134	3134	3134	3145	STATUS_15_15Q	SAMPLE	STRING	Chromosome Arm-Calls: 15 (15q)	15 (15q) Status	1				
3135	3135	3135	3135	3135	3135	3135	3135	3135	3135	3135	3135	3135	3146	STATUS_16P	SAMPLE	STRING	Chromosome Arm-Calls: 16p	16p Status	1				
3136	3136	3136	3136	3136	3136	3136	3136	3136	3136	3136	3136	3136	3147	STATUS_16Q	SAMPLE	STRING	Chromosome Arm-Calls: 16q	16q Status	1				
3137	3137	3137	3137	3137	3137	3137	3137	3137	3137	3137	3137	3137	3148	STATUS_17P	SAMPLE	STRING	Chromosome Arm-Calls: 17p	17p Status	1				
3138	3138	3138	3138	3138	3138	3138	3138	3138	3138	3138	3138	3138	3149	STATUS_17Q	SAMPLE	STRING	Chromosome Arm-Calls: 17q	17q Status	1				
3139	3139	3139	3139	3139	3139	3139	3139	3139	3139	3139	3139	3139	3150	STATUS_18P	SAMPLE	STRING	Chromosome Arm-Calls: 18p	18p Status	1				
3140	3140	3140	3140	3140	3140	3140	3140	3140	3140	3140	3140	3140	3151	STATUS_18Q	SAMPLE	STRING	Chromosome Arm-Calls: 18q	18q Status	1				
3141	3141	3141	3141	3141	3141	3141	3141	3141	3141	3141	3141	3141	3152	STATUS_19P	SAMPLE	STRING	Chromosome Arm-Calls: 19p	19p Status	1				
3142	3142	3142	3142	3142	3142	3142	3142	3142	3142	3142	3142	3142	3153	STATUS_19Q	SAMPLE	STRING	Chromosome Arm-Calls: 19q	19q Status	1				
3143	3143	3143	3143	3143	3143	3143	3143	3143	3143	3143	3143	3143	3154	STATUS_1P	SAMPLE	STRING	Chromosome Arm-Calls: 1p	1p Status	1				
3144	3144	3144	3144	3144	3144	3144	3144	3144	3144	3144	3144	3144	3155	STATUS_1P_19Q	SAMPLE	STRING	1p/19q Status	1p/19q Status	1				
3145	3145	3145	3145	3145	3145	3145	3145	3145	3145	3145	3145	3145	3156	STATUS_1Q	SAMPLE	STRING	Chromosome Arm-Calls: 1q	1q Status	1				
3146	3146	3146	3146	3146	3146	3146	3146	3146	3146	3146	3146	3146	3157	STATUS_20P	SAMPLE	STRING	Chromosome Arm-Calls: 20p	20p Status	1				
3147	3147	3147	3147	3147	3147	3147	3147	3147	3147	3147	3147	3147	3158	STATUS_20Q	SAMPLE	STRING	Chromosome Arm-Calls: 20q	20q Status	1				
3148	3148	3148	3148	3148	3148	3148	3148	3148	3148	3148	3148	3148	3159	STATUS_21_21Q	SAMPLE	STRING	Chromosome Arm-Calls: 21 (21q)	21 (21q) Status	1				
3149	3149	3149	3149	3149	3149	3149	3149	3149	3149	3149	3149	3149	3160	STATUS_22_22Q	SAMPLE	STRING	Chromosome Arm-Calls: 22 (22q)	22 (22q) Status	1				
3150	3150	3150	3150	3150	3150	3150	3150	3150	3150	3150	3150	3150	3161	STATUS_2P	SAMPLE	STRING	Chromosome Arm-Calls: 2p	2p Status	1				
3151	3151	3151	3151	3151	3151	3151	3151	3151	3151	3151	3151	3151	3162	STATUS_2Q	SAMPLE	STRING	Chromosome Arm-Calls: 2q	2q Status	1				
3152	3152	3152	3152	3152	3152	3152	3152	3152	3152	3152	3152	3152	3163	STATUS_3P	SAMPLE	STRING	Chromosome Arm-Calls: 3p	3p Status	1				
3153	3153	3153	3153	3153	3153	3153	3153	3153	3153	3153	3153	3153	3164	STATUS_3Q	SAMPLE	STRING	Chromosome Arm-Calls: 3q	3q Status	1				
3154	3154	3154	3154	3154	3154	3154	3154	3154	3154	3154	3154	3154	3165	STATUS_4P	SAMPLE	STRING	Chromosome Arm-Calls: 4p	4p Status	1				
3155	3155	3155	3155	3155	3155	3155	3155	3155	3155	3155	3155	3155	3166	STATUS_4Q	SAMPLE	STRING	Chromosome Arm-Calls: 4q	4q Status	1				
3156	3156	3156	3156	3156	3156	3156	3156	3156	3156	3156	3156	3156	3167	STATUS_5P	SAMPLE	STRING	Chromosome Arm-Calls: 5p	5p Status	1				
3157	3157	3157	3157	3157	3157	3157	3157	3157	3157	3157	3157	3157	3168	STATUS_5Q	SAMPLE	STRING	Chromosome Arm-Calls: 5q	5q Status	1				
3158	3158	3158	3158	3158	3158	3158	3158	3158	3158	3158	3158	3158	3169	STATUS_6P	SAMPLE	STRING	Chromosome Arm-Calls: 6p	6p Status	1				
3159	3159	3159	3159	3159	3159	3159	3159	3159	3159	3159	3159	3159	3170	STATUS_6Q	SAMPLE	STRING	Chromosome Arm-Calls: 6q	6q Status	1				
3160	3160	3160	3160	3160	3160	3160	3160	3160	3160	3160	3160	3160	3171	STATUS_7P	SAMPLE	STRING	Chromosome Arm-Calls: 7p	7p Status	1				
3161	3161	3161	3161	3161	3161	3161	3161	3161	3161	3161	3161	3161	3172	STATUS_7Q	SAMPLE	STRING	Chromosome Arm-Calls: 7q	7q Status	1				
3162	3162	3162	3162	3162	3162	3162	3162	3162	3162	3162	3162	3162	3173	STATUS_8P	SAMPLE	STRING	Chromosome Arm-Calls: 8p	8p Status	1				
3163	3163	3163	3163	3163	3163	3163	3163	3163	3163	3163	3163	3163	3174	STATUS_8Q	SAMPLE	STRING	Chromosome Arm-Calls: 8q	8q Status	1				
3164	3164	3164	3164	3164	3164	3164	3164	3164	3164	3164	3164	3164	3175	STATUS_9P	SAMPLE	STRING	Chromosome Arm-Calls: 9p	9p Status	1				
3165	3165	3165	3165	3165	3165	3165	3165	3165	3165	3165	3165	3165	3176	STATUS_9Q	SAMPLE	STRING	Chromosome Arm-Calls: 9q	9q Status	1				
3166	3166	3166	3166	3166	3166	3166	3166	3166	3166	3166	3166	3166	3177	STEAP	SAMPLE	STRING	STEAP.	STEAP	1				
3167	3167	3167	3167	3167	3167	3167	3167	3167	3167	3167	3167	3167	3178	STEPHANSON_5YR_NOMOGRAM	SAMPLE	STRING	stephanson 5yr nomogram	stephanson 5yr nomogram	1				
3168	3168	3168	3168	3168	3168	3168	3168	3168	3168	3168	3168	3168	3179	STES_CIN_GS	SAMPLE	STRING	STES CIN GS	STES CIN GS	1				
3169	3169	3169	3169	3169	3169	3169	3169	3169	3169	3169	3169	3169	3180	STES_UNIQUE_ANATOMIC_SITE	SAMPLE	STRING	STES Unique Anatomic Site	STES Unique Anatomic Site	1				
3170	3170	3170	3170	3170	3170	3170	3170	3170	3170	3170	3170	3170	3181	STES_UNIQUE_ANATOMIC_SITE_GEACIN_SAMPLES_NUMERIC_CODING	SAMPLE	STRING	STES Unique Anatomic Site - GEA-CIN Samples - Numeric coding	STES Unique Anatomic Site - GEA-CIN Samples - Numeric coding	1				
3171	3171	3171	3171	3171	3171	3171	3171	3171	3171	3171	3171	3171	3182	STES_UNIQUE_ANATOMIC_SITE_NUMERIC_CODING	SAMPLE	STRING	STES Unique Anatomic Site - Numeric coding	STES Unique Anatomic Site - Numeric coding	1				
3172	3172	3172	3172	3172	3172	3172	3172	3172	3172	3172	3172	3172	3183	STG_GRP_NAME	SAMPLE	STRING	Stg Group Name	Stg Group Name	1				
3173	3173	3173	3173	3173	3173	3173	3173	3173	3173	3173	3173	3173	3184	STIME	PATIENT	STRING	STIME.	STIME	1				
3174	3174	3174	3174	3174	3174	3174	3174	3174	3174	3174	3174	3174	3185	STOOL_BLOOD_MONTHS	PATIENT	STRING	Stool Blood Months	Stool Blood Months	1				
3175	3175	3175	3175	3175	3175	3175	3175	3175	3175	3175	3175	3175	3186	STOOL_IN_BLOOD	PATIENT	STRING	Stool in Blood	Stool in Blood	1				
3176	3176	3176	3176	3176	3176	3176	3176	3176	3176	3176	3176	3176	3187	STOP_DATE	PATIENT	NUMBER	The last date of the of the treatment(days)	Stop Date	1				
3177	3177	3177	3177	3177	3177	3177	3177	3177	3177	3177	3177	3177	3188	STOP_DATE_BIRTH_DATE	PATIENT	NUMBER	Stop Date Calculated from DOB	Stop Date Calculated from DOB	1				
3178	3178	3178	3178	3178	3178	3178	3178	3178	3178	3178	3178	3178	3189	STRAIN	SAMPLE	STRING	Strain	Strain	1				
3179	3179	3179	3179	3179	3179	3179	3179	3179	3179	3179	3179	3179	3190	STROMAL_SCORE	SAMPLE	NUMBER	Stromal Score by ESTIMATE	ESTIMATE Stromal Score	1				
3180	3180	3180	3180	3180	3180	3180	3180	3180	3180	3180	3180	3180	3191	STROMA_PERCENTAGE	SAMPLE	NUMBER	% Stroma	% Stroma	1				
3181	3181	3181	3181	3181	3181	3181	3181	3181	3181	3181	3181	3181	3192	STRUCTURAL_VARIANTS	SAMPLE	STRING	Structural variants from WGS.	Structural Variants	1				
3182	3182	3182	3182	3182	3182	3182	3182	3182	3182	3182	3182	3182	3193	STR_STATUS	SAMPLE	STRING	Short Tandem Repeat Ratio	STR (affected/tested)	1				
3183	3183	3183	3183	3183	3183	3183	3183	3183	3183	3183	3183	3183	3194	STR_TESTED	SAMPLE	STRING	STR Tested	STR Tested	1				
3184	3184	3184	3184	3184	3184	3184	3184	3184	3184	3184	3184	3184	3195	STS_SRCE_DESC	PATIENT	STRING	Indicates the source of the last known disease status. In EMR check the most recent note indicating the patient̢���s last known disease status and by which source the date and status were updated.	The Source Of The Last Known Disease Status	1				
3185	3185	3185	3185	3185	3185	3185	3185	3185	3185	3185	3185	3185	3196	STUDY	PATIENT	STRING	Study.	Study	1				
3186	3186	3186	3186	3186	3186	3186	3186	3186	3186	3186	3186	3186	3197	STUDY_ARM	PATIENT	STRING	study arm	study arm	1				
3187	3187	3187	3187	3187	3187	3187	3187	3187	3187	3187	3187	3187	3198	STUDY_ID	PATIENT	STRING	Study Identifier	Study ID	1				
3188	3188	3188	3188	3188	3188	3188	3188	3188	3188	3188	3188	3188	3199	SU2C_SAMPLE_ID	SAMPLE	STRING	SU2C sample id.	SU2C Sample Id	1				
3189	3189	3189	3189	3189	3189	3189	3189	3189	3189	3189	3189	3189	3200	SUBCLONAL_GENOMIC_FRACTION	SAMPLE	STRING	Subclone Genomic Fraction	Subclone Genomic Fraction	1				
3190	3190	3190	3190	3190	3190	3190	3190	3190	3190	3190	3190	3190	3201	SUBGROUP	PATIENT	STRING	Subgroup	Subgroup	1				
3191	3191	3191	3191	3191	3191	3191	3191	3191	3191	3191	3191	3191	3202	SUBMITTED_TUMOR_DX_DAYS_TO	PATIENT	NUMBER	Days to submitted specimen dx	Submitted tumor dx days to	1				
3192	3192	3192	3192	3192	3192	3192	3192	3192	3192	3192	3192	3192	3203	SUBSEQUENT_CANCERS	PATIENT	STRING	Subsequent Cancers	Subsequent Cancers	1				
3193	3193	3193	3193	3193	3193	3193	3193	3193	3193	3193	3193	3193	3204	SUBSEQUENT_RX	PATIENT	STRING	Subsequent Rx	Subsequent Rx	1				
3194	3194	3194	3194	3194	3194	3194	3194	3194	3194	3194	3194	3194	3205	SUBSTITUTION	SAMPLE	STRING	Substitution Mutations	Substitution	1				
3195	3195	3195	3195	3195	3195	3195	3195	3195	3195	3195	3195	3195	3206	SUBTYPE	PATIENT	STRING	Subtype	Subtype	1				
3196	3196	3196	3196	3196	3196	3196	3196	3196	3196	3196	3196	3196	3207	SUBTYPE_DETAILS	PATIENT	STRING	Subtype Details	Subtype Details	1				
3197	3197	3197	3197	3197	3197	3197	3197	3197	3197	3197	3197	3197	3208	SUB_CLONES	SAMPLE	STRING	Subclones detected by WGS.	Subclones	1				
3198	3198	3198	3198	3198	3198	3198	3198	3198	3198	3198	3198	3198	3209	SUB_SITE	SAMPLE	STRING	Sub-site.	Sub-site	1				
3199	3199	3199	3199	3199	3199	3199	3199	3199	3199	3199	3199	3199	3210	SUFU_MUTATION	SAMPLE	STRING	SUFU Mutation	SUFU Mutation	1				
3200	3200	3200	3200	3200	3200	3200	3200	3200	3200	3200	3200	3200	3211	SUN_EXPOSURE	PATIENT	STRING	Exposure to Sun	Exposure to Sun	1				
3201	3201	3201	3201	3201	3201	3201	3201	3201	3201	3201	3201	3201	3212	SUPERFICIAL_DX_HISTORY	SAMPLE	STRING	Superficial Dx History	Superficial Dx History	1				
3202	3202	3202	3202	3202	3202	3202	3202	3202	3202	3202	3202	3202	3213	SUPERVISED_DNA_METHYLATION_CLUSTER	SAMPLE	STRING	Supervised DNA Methylation Cluster	Supervised DNA Methylation Cluster	1				
3203	3203	3203	3203	3203	3203	3203	3203	3203	3203	3203	3203	3203	3214	SUPRATENTORIAL_LOCALIZATION	SAMPLE	STRING	Supratentorial localization.	Supratentorial Localization	1				
3204	3204	3204	3204	3204	3204	3204	3204	3204	3204	3204	3204	3204	3215	SURGERY	PATIENT	STRING	Surgery.	Surgery	1				
3205	3205	3205	3205	3205	3205	3205	3205	3205	3205	3205	3205	3205	3216	SURGERY_AT_DX	PATIENT	STRING	Surgery performed within 6 months of diagnosis	MedR Surgery at Diagnosis	1				
3206	3206	3206	3206	3206	3206	3206	3206	3206	3206	3206	3206	3206	3217	SURGERY_AT_MSKCC	PATIENT	STRING	Surgery At MSKCC	Surgery At MSKCC	1				
3207	3207	3207	3207	3207	3207	3207	3207	3207	3207	3207	3207	3207	3218	SURGERY_DETAILS	PATIENT	STRING	Details on type of surgery	Surgery Details	1				
3208	3208	3208	3208	3208	3208	3208	3208	3208	3208	3208	3208	3208	3219	SURGERY_FOR_POSITIVE_MARGINS	SAMPLE	STRING	Breast carcinoma primary surgical procedure name	Surgery for positive margins	1				
3209	3209	3209	3209	3209	3209	3209	3209	3209	3209	3209	3209	3209	3220	SURGERY_FOR_POSITIVE_MARGINS_OTHER	SAMPLE	STRING	Breast neoplasm other surgical procedure descriptive text	Surgery for positive margins other	1				
3210	3210	3210	3210	3210	3210	3210	3210	3210	3210	3210	3210	3210	3221	SURGERY_HISTORY	PATIENT	STRING	surgery history	surgery history	1				
3211	3211	3211	3211	3211	3211	3211	3211	3211	3211	3211	3211	3211	3222	SURGERY_MET	SAMPLE	STRING	Surgery Met	Surgery Met	1				
3212	3212	3212	3212	3212	3212	3212	3212	3212	3212	3212	3212	3212	3223	SURGERY_PROCEDURE	PATIENT	STRING	Surgery Procedure	Surgery Procedure	1				
3213	3213	3213	3213	3213	3213	3213	3213	3213	3213	3213	3213	3213	3224	SURGERY_SITE	SAMPLE	STRING	Site of Surgery	Site of Surgery	1				
3214	3214	3214	3214	3214	3214	3214	3214	3214	3214	3214	3214	3214	3225	SURGICAL_APPROACH_AT_DIAGNOSIS	PATIENT	STRING	Surgical approach at diagnosis	Surgical approach at diagnosis	1				
3215	3215	3215	3215	3215	3215	3215	3215	3215	3215	3215	3215	3215	3226	SURGICAL_MARGIN	PATIENT	STRING	Surgical Margin	Surgical Margin	1				
3216	3216	3216	3216	3216	3216	3216	3216	3216	3216	3216	3216	3216	3227	SURGICAL_PROCEDURE_FIRST	SAMPLE	STRING	Breast carcinoma surgical procedure name	Surgical procedure first	1				
3217	3217	3217	3217	3217	3217	3217	3217	3217	3217	3217	3217	3217	3228	SURGICAL_PROCEDURE_OTHER	PATIENT	STRING	Surgical procedure other	Surgical procedure other	1				
3218	3218	3218	3218	3218	3218	3218	3218	3218	3218	3218	3218	3218	3229	SURVIVAL_AFTER_BIOPSY_MONTHS	SAMPLE	STRING	survival after biopsy months	survival after biopsy months	1				
3219	3219	3219	3219	3219	3219	3219	3219	3219	3219	3219	3219	3219	3230	SURVIVAL_DATA_FORM	SAMPLE	STRING	Survival Data Form	Survival Data Form	1				
3220	3220	3220	3220	3220	3220	3220	3220	3220	3220	3220	3220	3220	3231	SURVIVAL_FROM_FIRST_CHEMOTHERAPY	PATIENT	NUMBER	Survival from first chemotherapy.	Survival from First Chemotherapy	1				
3221	3221	3221	3221	3221	3221	3221	3221	3221	3221	3221	3221	3221	3232	SURVIVAL_FROM_FIRST_HORMONE_THERAPY	PATIENT	NUMBER	Survival from first hormone therapy	Survival from First Hormone Therapy	1				
3222	3222	3222	3222	3222	3222	3222	3222	3222	3222	3222	3222	3222	3233	SUSPECTED_PRIMARY	PATIENT	STRING	Suspected primary	Suspected primary	1				
3223	3223	3223	3223	3223	3223	3223	3223	3223	3223	3223	3223	3223	3234	SUV_OF_PLEURA_MAX	PATIENT	NUMBER	SUV of Pleura Max	SUV of Pleura Max	1				
3224	3224	3224	3224	3224	3224	3224	3224	3224	3224	3224	3224	3224	3235	SVEGF	PATIENT	NUMBER	Svegf	Svegf	1				
3225	3225	3225	3225	3225	3225	3225	3225	3225	3225	3225	3225	3225	3236	SVEGFMED	PATIENT	NUMBER	Svegfmed	Svegfmed	1				
3226	3226	3226	3226	3226	3226	3226	3226	3226	3226	3226	3226	3226	3237	SVI	SAMPLE	STRING	svi	svi	1				
3227	3227	3227	3227	3227	3227	3227	3227	3227	3227	3227	3227	3227	3238	SVMEDBASE	PATIENT	NUMBER	Svmedbase	Svmedbase	1				
3228	3228	3228	3228	3228	3228	3228	3228	3228	3228	3228	3228	3228	3239	SYMP_CHANGES_MENTAL_STATUS	PATIENT	STRING	Symp changes mental status	Symp changes mental status	1				
3229	3229	3229	3229	3229	3229	3229	3229	3229	3229	3229	3229	3229	3240	SYMP_CHANGES_MOTOR_MOVEMENT	PATIENT	STRING	Symp changes motor movement	Symp changes motor movement	1				
3230	3230	3230	3230	3230	3230	3230	3230	3230	3230	3230	3230	3230	3241	SYMP_CHANGES_SENSORY	PATIENT	STRING	Symp changes sensory	Symp changes sensory	1				
3231	3231	3231	3231	3231	3231	3231	3231	3231	3231	3231	3231	3231	3242	SYMP_CHANGES_VISUAL	PATIENT	STRING	Symp changes visual	Symp changes visual	1				
3232	3232	3232	3232	3232	3232	3232	3232	3232	3232	3232	3232	3232	3243	SYNCHRONOUS_COLON_CANCER_PRESENT	SAMPLE	STRING	Yes/No indicator to determine presence or absence of synchronous colon cancer.	Synchronous Colon Cancer Present	1				
3233	3233	3233	3233	3233	3233	3233	3233	3233	3233	3233	3233	3233	3244	SYNCHRONOUS_DISEASE	PATIENT	STRING	Synchronous Disease	Synchronous Disease	1				
3234	3234	3234	3234	3234	3234	3234	3234	3234	3234	3234	3234	3234	3245	SYNCHRONOUS_TUMOR_HISTOLOGY_PCT	SAMPLE	STRING	Synchronous tumor histology pct	Synchronous tumor histology pct	1				
3235	3235	3235	3235	3235	3235	3235	3235	3235	3235	3235	3235	3235	3246	SYNONYMS	PATIENT	STRING	Synonyms.	Synonyms	1				
3236	3236	3236	3236	3236	3236	3236	3236	3236	3236	3236	3236	3236	3247	SYNOVIAL_SS18SSX_FUSION_STATUS	SAMPLE	STRING	Synovial ss18ssx fusion status	Synovial ss18ssx fusion status	1				
3237	3237	3237	3237	3237	3237	3237	3237	3237	3237	3237	3237	3237	3248	SYNOVIAL_SS18SSX_TESTING_METHOD	SAMPLE	STRING	Synovial ss18ssx testing method	Synovial ss18ssx testing method	1				
3238	3238	3238	3238	3238	3238	3238	3238	3238	3238	3238	3238	3238	3249	SYN_IHC	SAMPLE	STRING	SYN IHC	SYN IHC	1				
3239	3239	3239	3239	3239	3239	3239	3239	3239	3239	3239	3239	3239	3250	SYSTEMIC_DISEASE_STATUS	PATIENT	STRING	Systemic disease status	Systemic disease status	1				
3240	3240	3240	3240	3240	3240	3240	3240	3240	3240	3240	3240	3240	3251	SYSTEMIC_THERAPY	PATIENT	STRING	Systemic Therapy	Systemic Therapy	1				
3241	3241	3241	3241	3241	3241	3241	3241	3241	3241	3241	3241	3241	3252	SYSTEMIC_TREATMENT	PATIENT	STRING	Systemic Treatment	Systemic Treatment	1				
3242	3242	3242	3242	3242	3242	3242	3242	3242	3242	3242	3242	3242	3253	SYSTEMIC_TREATMENTS_OTHER	PATIENT	STRING	Systemic Treatments Other	Systemic Treatments Other	1				
3243	3243	3243	3243	3243	3243	3243	3243	3243	3243	3243	3243	3243	3254	SYSTEM_VERSION	PATIENT	STRING	System Version	System Version	1				
3244	3244	3244	3244	3244	3244	3244	3244	3244	3244	3244	3244	3244	3255	SYS_DESC	SAMPLE	STRING	Describes site of first recurrence of patient̢���s primary melanoma.  Indicates if there are/is Metastases to distant skin/soft tissue, nonregional lymph nodes and/or visceral sites.	There Are/Is Metastases To Distant Skin/Soft Tissue, Nonregional Lymph Nodes And/Or Visceral Sites	1				
3245	3245	3245	3245	3245	3245	3245	3245	3245	3245	3245	3245	3245	3256	S_100_STAIN	SAMPLE	STRING	S-100 Stain	S-100 stain	1				
3246	3246	3246	3246	3246	3246	3246	3246	3246	3246	3246	3246	3246	3257	S_STAGE	SAMPLE	STRING	S indicates the serum (blood) levels of tumor markers that are made by some testicular cancers	S Stage	1				
3247	3247	3247	3247	3247	3247	3247	3247	3247	3247	3247	3247	3247	3258	TARGETED_MOLECULAR_THERAPY	PATIENT	STRING	Text term to signify postoperative adjuvant cancer therapies which use drugs to act upon specific molecules, metabolic pathways or processes involved in carcinogenesis, tumor growth, or tumor spread. [Manually-curated]	Adjuvant Postoperative Targeted Therapy Administered Indicator	1				
3248	3248	3248	3248	3248	3248	3248	3248	3248	3248	3248	3248	3248	3259	TARGETED_SEQ	SAMPLE	STRING	Targeted Sequence	Targeted Sequence	1				
3249	3249	3249	3249	3249	3249	3249	3249	3249	3249	3249	3249	3249	3260	TARGET_ID	SAMPLE	STRING	target id	target id	1				
3250	3250	3250	3250	3250	3250	3250	3250	3250	3250	3250	3250	3250	3261	TARGET_THERAPY	PATIENT	STRING	Did the patient recieve target therapy	Target Therapy	1				
3251	3251	3251	3251	3251	3251	3251	3251	3251	3251	3251	3251	3251	3262	TARGET_THERAPY_NAME	SAMPLE	STRING	Target Therapy name	Target Therapy name	1				
3252	3252	3252	3252	3252	3252	3252	3252	3252	3252	3252	3252	3252	3263	TCF3_PBX1_STATUS	SAMPLE	STRING	TCF3-PBX1 Status	TCF3-PBX1 Status	1				
3253	3253	3253	3253	3253	3253	3253	3253	3253	3253	3253	3253	3253	3264	TCGA_SMOKING_CATEGORY	SAMPLE	STRING	TCGA Smoking Category	TCGA Smoking Category	1				
3254	3254	3254	3254	3254	3254	3254	3254	3254	3254	3254	3254	3254	3265	TCR_GAMMA_BETA	SAMPLE	STRING	TCR Gamma or Beta (TCRB or TCRG)	TCR Gamma or Beta (TCRB or TCRG)	1				
3255	3255	3255	3255	3255	3255	3255	3255	3255	3255	3255	3255	3255	3266	TCR_GENE_REARRANGEMENT	SAMPLE	STRING	TCR Gene Rearrangement	TCR Gene Rearrangement	1				
3256	3256	3256	3256	3256	3256	3256	3256	3256	3256	3256	3256	3256	3267	TELOMERE_LENGTH_ESTIMATE_IN_BLOOD_NORMAL_KB	SAMPLE	STRING	Telomere length estimate in blood normal (Kb)	Telomere length estimate in blood normal (Kb)	1				
3257	3257	3257	3257	3257	3257	3257	3257	3257	3257	3257	3257	3257	3268	TELOMERE_LENGTH_ESTIMATE_IN_TUMOR_KB	SAMPLE	STRING	Telomere length estimate in tumor (Kb)	Telomere length estimate in tumor (Kb)	1				
3258	3258	3258	3258	3258	3258	3258	3258	3258	3258	3258	3258	3258	3269	TELOMERE_MAINTENANCE	SAMPLE	STRING	Telomere Maintenance	Telomere Maintenance	1				
3259	3259	3259	3259	3259	3259	3259	3259	3259	3259	3259	3259	3259	3270	TEL_STATUS	PATIENT	STRING	TEL status.	TEL Status	1				
3260	3260	3260	3260	3260	3260	3260	3260	3260	3260	3260	3260	3260	3271	TEMOZOLOMIDE_CONCURRENT_WITH_XRT	PATIENT	STRING	Temozolomide Concurrent with XRT	Temozolomide Concurrent with XRT	1				
3261	3261	3261	3261	3261	3261	3261	3261	3261	3261	3261	3261	3261	3272	TEMOZOLOMIDE_TREATMENT	PATIENT	STRING	Temozolomide Treatment	Temozolomide Treatment	1				
3262	3262	3262	3262	3262	3262	3262	3262	3262	3262	3262	3262	3262	3273	TENESMUS_WEEKS	PATIENT	NUMBER	Tenesmus (Weeks)	Tenesmus (Weeks)	1				
3263	3263	3263	3263	3263	3263	3263	3263	3263	3263	3263	3263	3263	3274	TERTIARY_PATTERN	SAMPLE	STRING	Tertiary pattern.	Tertiary Pattern	1				
3264	3264	3264	3264	3264	3264	3264	3264	3264	3264	3264	3264	3264	3275	TERTIARY_RACE	PATIENT	STRING	The third race code for the patient; this data element maps to the NAACCR v16 #162. For institutions not collecting race, submit a null in this category for all patients.	Tertiary Race	1				
3265	3265	3265	3265	3265	3265	3265	3265	3265	3265	3265	3265	3265	3276	TERT_EXPRESSION_LOG2	SAMPLE	STRING	TERT expression (log2)	TERT expression (log2)	1				
3266	3266	3266	3266	3266	3266	3266	3266	3266	3266	3266	3266	3266	3277	TERT_EXPRESSION_STATUS	SAMPLE	STRING	TERT expression status	TERT expression status	1				
3267	3267	3267	3267	3267	3267	3267	3267	3267	3267	3267	3267	3267	3278	TERT_MUTATION	SAMPLE	STRING	TERT Mutation	TERT Mutation	1				
3268	3268	3268	3268	3268	3268	3268	3268	3268	3268	3268	3268	3268	3279	TERT_PROMOTER_STATUS	SAMPLE	STRING	TERT promoter status	TERT promoter status	1				
3269	3269	3269	3269	3269	3269	3269	3269	3269	3269	3269	3269	3269	3280	TESTES_SITE_OF_RELAPSE	SAMPLE	STRING	Testes Site of Relapse	Testes Site of Relapse	1				
3270	3270	3270	3270	3270	3270	3270	3270	3270	3270	3270	3270	3270	3281	TESTICULAR_INVOLVEMENT	PATIENT	STRING	Yes or No indicator for testicular involvement	Testicular Involvement	1				
3271	3271	3271	3271	3271	3271	3271	3271	3271	3271	3271	3271	3271	3282	TESTIS_TUMOR_MACROEXTENT	SAMPLE	STRING	Testis tumor macroextent	Testis tumor macroextent	1				
3272	3272	3272	3272	3272	3272	3272	3272	3272	3272	3272	3272	3272	3283	TESTIS_TUMOR_MACROEXTENT_OTHER	SAMPLE	STRING	Testis tumor macroextent other	Testis tumor macroextent other	1				
3273	3273	3273	3273	3273	3273	3273	3273	3273	3273	3273	3273	3273	3284	TESTIS_TUMOR_MICROEXTENT	SAMPLE	STRING	Testis tumor microextent	Testis tumor microextent	1				
3274	3274	3274	3274	3274	3274	3274	3274	3274	3274	3274	3274	3274	3285	TEST_ALK_FISH	SAMPLE	STRING	test alk fish	test alk fish	1				
3275	3275	3275	3275	3275	3275	3275	3275	3275	3275	3275	3275	3275	3286	TEST_FGFR1_FISH	SAMPLE	STRING	test fgfr1 fish	test fgfr1 fish	1				
3276	3276	3276	3276	3276	3276	3276	3276	3276	3276	3276	3276	3276	3287	TEST_MET_FISH	SAMPLE	STRING	test met fish	test met fish	1				
3277	3277	3277	3277	3277	3277	3277	3277	3277	3277	3277	3277	3277	3288	TEST_MGMT_IHC	SAMPLE	STRING	test mgmt ihc	test mgmt ihc	1				
3278	3278	3278	3278	3278	3278	3278	3278	3278	3278	3278	3278	3278	3289	TEST_PTEN_IHC	SAMPLE	STRING	test pten ihc	test pten ihc	1				
3279	3279	3279	3279	3279	3279	3279	3279	3279	3279	3279	3279	3279	3290	TG_STAIN	SAMPLE	STRING	Tg Stain	Tg Stain	1				
3280	3280	3280	3280	3280	3280	3280	3280	3280	3280	3280	3280	3280	3291	THERAPIES_2YRS_LIST	PATIENT	STRING	Patient-reported response to the question: If [you have been on any therapies for more than two years], please list the cancer therapies you have been on for more than 2 years, if you know their names.	PRD More Than 2 Years Therapy List	1				
3281	3281	3281	3281	3281	3281	3281	3281	3281	3281	3281	3281	3281	3292	THERAPIES_XRC_LIST	PATIENT	STRING	Patient-reported response to the question: If [you have had an extraordinary response to therapy], please list the cancer therapies that have worked extraordinarily well, if you know their names.	PRD Extraordinary Response Therapy List	1				
3282	3282	3282	3282	3282	3282	3282	3282	3282	3282	3282	3282	3282	3293	THERAPY	PATIENT	STRING	therapy	therapy	1				
3283	3283	3283	3283	3283	3283	3283	3283	3283	3283	3283	3283	3283	3294	THREEGENE	PATIENT	STRING	3-Gene classifier subtype	3-Gene classifier subtype	1				
3284	3284	3284	3284	3284	3284	3284	3284	3284	3284	3284	3284	3284	3295	THYROID_RELATED_DEATH	PATIENT	STRING	Thyroid Related Death	Thyroid Related Death	1				
3285	3285	3285	3285	3285	3285	3285	3285	3285	3285	3285	3285	3285	3296	TIMEPOINT	SAMPLE	STRING	Timepoint	Timepoint	1				
3286	3286	3286	3286	3286	3286	3286	3286	3286	3286	3286	3286	3286	3297	TIMEPOINT_AFATINIB	SAMPLE	STRING	Timepoint Afatinib (Pre/On/Post)	Timepoint Afatinib (Pre/On/Post)	1				
3287	3287	3287	3287	3287	3287	3287	3287	3287	3287	3287	3287	3287	3298	TIMEPOINT_TRASTUZUMAB	SAMPLE	STRING	Timepoint Trastuzumab (Pre/On/Post)	Timepoint Trastuzumab (Pre/On/Post)	1				
3288	3288	3288	3288	3288	3288	3288	3288	3288	3288	3288	3288	3288	3299	TIME_BETWEEN_BLOOD_DRAW_AND_BIOPSY	SAMPLE	NUMBER	Time Between Blood Draw and Biopsy	Time Between Blood Draw and Biopsy	1				
3289	3289	3289	3289	3289	3289	3289	3289	3289	3289	3289	3289	3289	3300	TIME_BETWEEN_CLAMPING_AND_FREEZING	PATIENT	STRING	Time between clamping and freezing	Time between clamping and freezing	1				
3290	3290	3290	3290	3290	3290	3290	3290	3290	3290	3290	3290	3290	3301	TIME_BETWEEN_EXCISION_AND_FREEZING	PATIENT	STRING	Time between excision and freezing	Time between excision and freezing	1				
3291	3291	3291	3291	3291	3291	3291	3291	3291	3291	3291	3291	3291	3302	TIME_BETWEEN_HEALER_AND_PHYSICIAN	PATIENT	NUMBER	Time Between Healer and Physician (Weeks)	Time Between Healer and Physician (Weeks)	1				
3292	3292	3292	3292	3292	3292	3292	3292	3292	3292	3292	3292	3292	3303	TIME_FROM_DX_TO_IMPACT_TESTING_MONTHS	SAMPLE	STRING	Time from Dx to IMPACT testing (in months)	Time from Dx to IMPACT testing (in months)	1				
3293	3293	3293	3293	3293	3293	3293	3293	3293	3293	3293	3293	3293	3304	TIME_FROM_MET_DX_SEQUENCING	SAMPLE	NUMBER	Time from Met Dx to Sequencing	Time from Met Dx to Sequencing	1				
3294	3294	3294	3294	3294	3294	3294	3294	3294	3294	3294	3294	3294	3305	TIME_FROM_OBTAINING_SAMPLE_TO_RUNNING_IMPACT_MONTHS	SAMPLE	STRING	Time from obtaining sample to running IMPACT (in months)	Time from obtaining sample to running IMPACT (in months)	1				
3295	3295	3295	3295	3295	3295	3295	3295	3295	3295	3295	3295	3295	3306	TIME_FROM_SURGERY_TO_CHEMOTHERAPY	PATIENT	NUMBER	Time from Surgery to Chemotherapy calculated in Months	Time from Surgery to Chemotherapy (Months)	1				
3296	3296	3296	3296	3296	3296	3296	3296	3296	3296	3296	3296	3296	3307	TIME_FROM_SURGERY_TO_DEATH	PATIENT	NUMBER	Time from Surgery to Death calculated in months	Time from Surgery to Death (Months)	1				
3297	3297	3297	3297	3297	3297	3297	3297	3297	3297	3297	3297	3297	3308	TIME_FROM_SURGERY_TO_POD	PATIENT	NUMBER	Time from Surgery to Progression to Disease calculated in Months	Time from Surgery to POD (Months)	1				
3298	3298	3298	3298	3298	3298	3298	3298	3298	3298	3298	3298	3298	3309	TIME_POINT	SAMPLE	STRING	Time Point	Time Point	1				
3299	3299	3299	3299	3299	3299	3299	3299	3299	3299	3299	3299	3299	3310	TIME_POST_START_OF_AFATINIB_WEEKS	SAMPLE	NUMBER	Time Post Start of Afatinib (weeks)	Time Post Start of Afatinib (weeks)	1				
3300	3300	3300	3300	3300	3300	3300	3300	3300	3300	3300	3300	3300	3311	TIME_TO_COMPLETE_RESPONSE	PATIENT	NUMBER	Time To Complete Response (months)	Time To Complete Response (months)	1				
3301	3301	3301	3301	3301	3301	3301	3301	3301	3301	3301	3301	3301	3312	TIME_TO_DEATH_MONTHS	PATIENT	NUMBER	Time To Death (Months)	Time To Death (Months)	1				
3302	3302	3302	3302	3302	3302	3302	3302	3302	3302	3302	3302	3302	3313	TIME_TO_DIAGNOSIS_WITH_ADVANCED_DISEASE	PATIENT	STRING	Time to diagnosis with advanced disease	Time to diagnosis with advanced disease	1				
3303	3303	3303	3303	3303	3303	3303	3303	3303	3303	3303	3303	3303	3314	TIME_TO_DISTANT_RECURRENCE	PATIENT	NUMBER	Time to distant recurrence	Time to distant recurrence	1				
3304	3304	3304	3304	3304	3304	3304	3304	3304	3304	3304	3304	3304	3315	TIME_TO_FIRST_EVENT_OR_EVENT_FREE_SURVIAL	PATIENT	NUMBER	Time to first event or event-free survival	Time to First Event/Event Free Survival	1				
3305	3305	3305	3305	3305	3305	3305	3305	3305	3305	3305	3305	3305	3316	TIME_TO_FIRST_RECURRENCE	PATIENT	NUMBER	TIme to first recurrence (months)	TIme to first recurrence (months)	1				
3306	3306	3306	3306	3306	3306	3306	3306	3306	3306	3306	3306	3306	3317	TIME_TO_LAST_FOLLOWUP	PATIENT	NUMBER	Time to last followup.	Time to Last Followup	1				
3307	3307	3307	3307	3307	3307	3307	3307	3307	3307	3307	3307	3307	3318	TIME_TO_LOCAL_RECURRENCE	PATIENT	STRING	Time to local recurrence	Time to local recurrence	1				
3308	3308	3308	3308	3308	3308	3308	3308	3308	3308	3308	3308	3308	3319	TIME_TO_LOCAL_RECURRENCE_STATUS	PATIENT	STRING	Time to local recurrence status	Time to local recurrence status	1				
3309	3309	3309	3309	3309	3309	3309	3309	3309	3309	3309	3309	3309	3320	TIME_TO_METASTASIS_MONTHS	SAMPLE	STRING	TIme to Metastasis Months	TIme to Metastasis Months	1				
3310	3310	3310	3310	3310	3310	3310	3310	3310	3310	3310	3310	3310	3321	TIME_TO_MET_MONTHS	PATIENT	NUMBER	Time to metastasis (months).	Time to Metastasis (months)	1				
3311	3311	3311	3311	3311	3311	3311	3311	3311	3311	3311	3311	3311	3322	TIME_TO_PATH_MONTHS	PATIENT	STRING	Time to Path Months	Time to Path Months	1				
3312	3312	3312	3312	3312	3312	3312	3312	3312	3312	3312	3312	3312	3323	TIME_TO_PROGRESSION_OF_DISEASE	PATIENT	NUMBER	Time to Progression of Disease (Months)	Time to Progression of Disease (Months)	1				
3313	3313	3313	3313	3313	3313	3313	3313	3313	3313	3313	3313	3313	3324	TIME_TO_PROGRESSION_OF_DISEASE_DAYS	PATIENT	NUMBER	Time to Progression of Disease (Days)	Time to Progression of Disease (Days)	1				
3314	3314	3314	3314	3314	3314	3314	3314	3314	3314	3314	3314	3314	3325	TIME_TO_PROGRESSION_ON_FOLFOX_AND_REGORAFENIB	PATIENT	NUMBER	Time to progerssion on FOLFOX+ regorafenib	Time to progerssion on FOLFOX+ regorafenib	1				
3315	3315	3315	3315	3315	3315	3315	3315	3315	3315	3315	3315	3315	3326	TIME_TO_RECURRENCE_AFTER_COMPLERE_RESECTION_OF_METS_MONTHS	SAMPLE	NUMBER	Time to recurrence after complere resection of mets (months)	Time to recurrence after complere resection of mets (months)	1				
3316	3316	3316	3316	3316	3316	3316	3316	3316	3316	3316	3316	3316	3327	TIME_TO_RECURRENCE_MONTHS	PATIENT	STRING	Time to Recurrence (months)	Time to Recurrence (months)	1				
3317	3317	3317	3317	3317	3317	3317	3317	3317	3317	3317	3317	3317	3328	TIME_TO_RECURRENCE_OR_DEATH_MONTHS	PATIENT	NUMBER	Time to recurrence or death (months)	Time to recurrence or death (months)	1				
3318	3318	3318	3318	3318	3318	3318	3318	3318	3318	3318	3318	3318	3329	TIME_TO_RECURRENCE_OR_MET	PATIENT	STRING	Time to Recurrence or Met (months)	Time to Recurrence or Met (months)	1				
3319	3319	3319	3319	3319	3319	3319	3319	3319	3319	3319	3319	3319	3330	TIME_TO_RELAPSE	PATIENT	NUMBER	Time To Relapse (months)	Time To Relapse (months)	1				
3320	3320	3320	3320	3320	3320	3320	3320	3320	3320	3320	3320	3320	3331	TIME_TO_RELAPSE_PROTOCOL_ENROLLMENT	PATIENT	STRING	Time from primary enrollment to enrollment on first secondary protocol measured in days	Time to first enrollment on relapse protocol (days)	1				
3321	3321	3321	3321	3321	3321	3321	3321	3321	3321	3321	3321	3321	3332	TIME_TO_RESECTION	PATIENT	NUMBER	Time to Resection	Time to Resection	1				
3322	3322	3322	3322	3322	3322	3322	3322	3322	3322	3322	3322	3322	3333	TIME_TO_SURGERY	PATIENT	NUMBER	Time till surgery description	Time to Surgery	1				
3323	3323	3323	3323	3323	3323	3323	3323	3323	3323	3323	3323	3323	3334	TIME_TO_TREATMENT	PATIENT	NUMBER	Time to treatment (months)	Time to treatment (months)	1				
3324	3324	3324	3324	3324	3324	3324	3324	3324	3324	3324	3324	3324	3335	TIME_TO_UNRESECTABLE_OR_METASTATIC_DISEASE_MONTHS	PATIENT	NUMBER	Time to unresectable or metastatic disease in months	Time to unresectable or metastatic disease in months	1				
3325	3325	3325	3325	3325	3325	3325	3325	3325	3325	3325	3325	3325	3336	TIMING_OF_IMPACT	SAMPLE	STRING	Timepoint at which IMPACT was done	Timing of IMPACT	1				
3326	3326	3326	3326	3326	3326	3326	3326	3326	3326	3326	3326	3326	3337	TIMING_OF_IMPACT_RELATIVE_TO_DISEASE	SAMPLE	STRING	Timing of IMPACT relative to disease course	Timing of IMPACT relative to disease course	1				
3327	3327	3327	3327	3327	3327	3327	3327	3327	3327	3327	3327	3327	3338	TISSUE_ANALYZED	PATIENT	STRING	Tissue Analyzed	Tissue Analyzed	1				
3328	3328	3328	3328	3328	3328	3328	3328	3328	3328	3328	3328	3328	3339	TISSUE_BANK_AVAIL	SAMPLE	STRING	Tissue Bank Available	Tissue Bank Available	1				
3329	3329	3329	3329	3329	3329	3329	3329	3329	3329	3329	3329	3329	3340	TISSUE_COLLECTION_MONTHS	SAMPLE	NUMBER	Date of Tissue collection calculated in months from Date of Diagnosis	Date of Tissue Collection (months)	1				
3330	3330	3330	3330	3330	3330	3330	3330	3330	3330	3330	3330	3330	3341	TISSUE_DIAGNOSIS	SAMPLE	STRING	Tissue Diagnosis	Tissue Diagnosis	1				
3331	3331	3331	3331	3331	3331	3331	3331	3331	3331	3331	3331	3331	3342	TISSUE_LEVEL_ANATOMIC_SITE	SAMPLE	STRING	Tissue-level Anatomic Site	Tissue-level Anatomic Site	1				
3332	3332	3332	3332	3332	3332	3332	3332	3332	3332	3332	3332	3332	3343	TISSUE_PROSPECTIVE_COLLECTION_INDICATOR	SAMPLE	STRING	Tissue prospective collection indicator.	Tissue Prospective Collection Indicator	1				
3333	3333	3333	3333	3333	3333	3333	3333	3333	3333	3333	3333	3333	3344	TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR	SAMPLE	STRING	Tissue retrospective collection indicator.	Tissue Retrospective Collection Indicator	1				
3334	3334	3334	3334	3334	3334	3334	3334	3334	3334	3334	3334	3334	3345	TISSUE_SEQUENCED	SAMPLE	STRING	Tissue Sequnced	Tissue Sequenced	1				
3335	3335	3335	3335	3335	3335	3335	3335	3335	3335	3335	3335	3335	3346	TISSUE_SITE	SAMPLE	STRING	Tissue Site	Tissue Site	1				
3336	3336	3336	3336	3336	3336	3336	3336	3336	3336	3336	3336	3336	3347	TISSUE_SITE_MET_BURDEN	SAMPLE	STRING	Tissue Site Metastasis Burden	Tissue Site Metastasis Burden	1				
3337	3337	3337	3337	3337	3337	3337	3337	3337	3337	3337	3337	3337	3348	TISSUE_SOURCE_SITE	SAMPLE	STRING	A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.	Tissue Source Site	1				
3338	3338	3338	3338	3338	3338	3338	3338	3338	3338	3338	3338	3338	3349	TISSUE_TYPE	SAMPLE	STRING	Tissue Type	Tissue Type	1				
3339	3339	3339	3339	3339	3339	3339	3339	3339	3339	3339	3339	3339	3350	TMEM127	SAMPLE	STRING	Tmem127	Tmem127	1				
3340	3340	3340	3340	3340	3340	3340	3340	3340	3340	3340	3340	3340	3351	TMEM127_GERMLINE	SAMPLE	STRING	TMEM127 Germline Mutation	TMEM127 Germline Mutation	1				
3341	3341	3341	3341	3341	3341	3341	3341	3341	3341	3341	3341	3341	3352	TMPRSS2_ERG_FUSION_STATUS	SAMPLE	STRING	TMPRESS2-ERG fusion status.	TMPRSS2-ERG Fusion Status	1				
3342	3342	3342	3342	3342	3342	3342	3342	3342	3342	3342	3342	3342	3353	TNM	SAMPLE	STRING	TNM.	TNM	1				
3343	3343	3343	3343	3343	3343	3343	3343	3343	3343	3343	3343	3343	3354	TNMSTAGE	SAMPLE	STRING	TNM stage.	TNM Stage	1				
3344	3344	3344	3344	3344	3344	3344	3344	3344	3344	3344	3344	3344	3355	TOBACCO_SMOKING_HISTORY_INDICATOR	PATIENT	STRING	Category describing current smoking status and smoking history as self-reported by a patient.	Patient Smoking History Category	1				
3345	3345	3345	3345	3345	3345	3345	3345	3345	3345	3345	3345	3345	3356	TOBACCO_TYPE	PATIENT	STRING	Tobacco Type	Tobacco Type	1				
3346	3346	3346	3346	3346	3346	3346	3346	3346	3346	3346	3346	3346	3357	TOTAL	SAMPLE	STRING	TOTAL	TOTAL	1				
3347	3347	3347	3347	3347	3347	3347	3347	3347	3347	3347	3347	3347	3358	TOTAL_BILIRUBIN	PATIENT	STRING	Bilirubin Total	Bilirubin Total	1				
3348	3348	3348	3348	3348	3348	3348	3348	3348	3348	3348	3348	3348	3359	TOTAL_CELL_NUMBERS	SAMPLE	NUMBER	Total Cell Numbers	Total Cell Numbers	1				
3349	3349	3349	3349	3349	3349	3349	3349	3349	3349	3349	3349	3349	3360	TOTAL_CNA	SAMPLE	NUMBER	Total CNA	Total CNA	1				
3350	3350	3350	3350	3350	3350	3350	3350	3350	3350	3350	3350	3350	3361	TOTAL_EXONIC_MUTATION_BURDEN	PATIENT	NUMBER	Total Exonic Mutation Burden	Total Exonic Mutation Burden	1				
3351	3351	3351	3351	3351	3351	3351	3351	3351	3351	3351	3351	3351	3362	TOTAL_MITOSES	SAMPLE	NUMBER	Total Titoses	Total Titoses	1				
3352	3352	3352	3352	3352	3352	3352	3352	3352	3352	3352	3352	3352	3363	TOTAL_MUTATIONS	PATIENT	NUMBER	Total Mutations	Total Mutations	1				
3353	3353	3353	3353	3353	3353	3353	3353	3353	3353	3353	3353	3353	3364	TOTAL_NUMBER_OF_SAMPLES_PER_PATIENT	SAMPLE	STRING	Total # Samples per patient	Total Number of Samples per Patient	1				
3354	3354	3354	3354	3354	3354	3354	3354	3354	3354	3354	3354	3354	3365	TOTAL_PER_MB	SAMPLE	STRING	TOTAL PER Mb	TOTAL PER Mb	1				
3355	3355	3355	3355	3355	3355	3355	3355	3355	3355	3355	3355	3355	3366	TOTAL_POST_INDUCTION_REGIMENS	PATIENT	STRING	Total number of chemo regimens post induction	Total Number of Post Induction Regimens	1				
3356	3356	3356	3356	3356	3356	3356	3356	3356	3356	3356	3356	3356	3367	TOTAL_REARRANGEMENT	SAMPLE	NUMBER	Total Rearrangement	Total Rearrangement	1				
3357	3357	3357	3357	3357	3357	3357	3357	3357	3357	3357	3357	3357	3368	TOTAL_SNV	SAMPLE	NUMBER	Total Single-Nucleotide Variants	Total SNV	1				
3358	3358	3358	3358	3358	3358	3358	3358	3358	3358	3358	3358	3358	3369	TOTAL_TIME_ON_AFATINIB_WEEKS	SAMPLE	NUMBER	Total Time Period on Afatinib (Weeks)	Total Time Period on Afatinib (Weeks)	1				
3359	3359	3359	3359	3359	3359	3359	3359	3359	3359	3359	3359	3359	3370	TOTAL_TIME_PERIOD_MONTHS	PATIENT	NUMBER	Total Time Period in Months	Total Time Period in Months	1				
3360	3360	3360	3360	3360	3360	3360	3360	3360	3360	3360	3360	3360	3371	TP53_CNA	SAMPLE	STRING	TP53 CNA	TP53 CNA	1				
3361	3361	3361	3361	3361	3361	3361	3361	3361	3361	3361	3361	3361	3372	TP53_DELETION	SAMPLE	STRING	TP53 Deletion is present	TP53 Deletion	1				
3362	3362	3362	3362	3362	3362	3362	3362	3362	3362	3362	3362	3362	3373	TP53_MUTATION	SAMPLE	STRING	TP53 mutation is present.	TP53 Mutation	1				
3363	3363	3363	3363	3363	3363	3363	3363	3363	3363	3363	3363	3363	3374	TP53_PROTEIN_CODING	SAMPLE	NUMBER	TP53 Protein Coding	TP53 Protein Coding	1				
3364	3364	3364	3364	3364	3364	3364	3364	3364	3364	3364	3364	3364	3375	TP53_SOMATIC	SAMPLE	STRING	TP53 Somatic Mutation	TP53 Somatic Mutation	1				
3365	3365	3365	3365	3365	3365	3365	3365	3365	3365	3365	3365	3365	3376	TPS	PATIENT	NUMBER	Tps	Tps	1				
3366	3366	3366	3366	3366	3366	3366	3366	3366	3366	3366	3366	3366	3377	TRADITIONAL_HEALER_HISTORY	PATIENT	STRING	History of Traditional Healer	History of Traditional Healer	1				
3367	3367	3367	3367	3367	3367	3367	3367	3367	3367	3367	3367	3367	3378	TRANSCRIPTOME_SUBTYPE	SAMPLE	STRING	Transcriptome Subtype	Transcriptome Subtype	1				
3368	3368	3368	3368	3368	3368	3368	3368	3368	3368	3368	3368	3368	3379	TRANSFORMATION	SAMPLE	STRING	Has your cell line been immortalized or transformed? Please describe method.	Transformation	1				
3369	3369	3369	3369	3369	3369	3369	3369	3369	3369	3369	3369	3369	3380	TRANSFORMED_LYMPHOMA_DAYS	PATIENT	NUMBER	Days to transformed lymphoma diagnosed	Transformed Lymphoma (days)	1				
3370	3370	3370	3370	3370	3370	3370	3370	3370	3370	3370	3370	3370	3381	TRANSLOCATIONS	SAMPLE	STRING	Translocations	Translocations	1				
3371	3371	3371	3371	3371	3371	3371	3371	3371	3371	3371	3371	3371	3382	TRANSLOCATION_16	SAMPLE	STRING	Translocation 16.	Translocation 16	1				
3372	3372	3372	3372	3372	3372	3372	3372	3372	3372	3372	3372	3372	3383	TRANSLOCATION_DEL_CHR_11	SAMPLE	STRING	Any translocation or deletion of chromosome 11	Chr11 Deletion or Translocation	1				
3373	3373	3373	3373	3373	3373	3373	3373	3373	3373	3373	3373	3373	3384	TRANSPLANT_TYPE	PATIENT	STRING	Type of transplant (sib Allo, MUD, Auto, etc).	Transplant Type	1				
3374	3374	3374	3374	3374	3374	3374	3374	3374	3374	3374	3374	3374	3385	TREATED_OR_UNTREATED_AT_TIME_OF_INITIAL_VISIT	PATIENT	STRING	Treated or untreated at time of initial visit	Treated or untreated at time of initial visit	1				
3375	3375	3375	3375	3375	3375	3375	3375	3375	3375	3375	3375	3375	3386	TREATED_OR_UNTREATED_AT_TIME_OF_INITIAL_VISIT_SAMPLE	SAMPLE	STRING	Sample level Treatment data at initial visit	Sample level Treatment data at initial visit	1				
3376	3376	3376	3376	3376	3376	3376	3376	3376	3376	3376	3376	3376	3387	TREATMENT	PATIENT	STRING	Treatment	Treatment	1				
3377	3377	3377	3377	3377	3377	3377	3377	3377	3377	3377	3377	3377	3388	TREATMENT_ARM	PATIENT	STRING	Treatment Arm	Treatment Arm	1				
3378	3378	3378	3378	3378	3378	3378	3378	3378	3378	3378	3378	3378	3389	TREATMENT_AT_MSK	PATIENT	STRING	Treatment at msk	Treatment at msk	1				
3379	3379	3379	3379	3379	3379	3379	3379	3379	3379	3379	3379	3379	3390	TREATMENT_BEFORE_PDX	PATIENT	STRING	Identifies if the patient had cancer treatment prior to establishing PDX 	Treatment Before PDX	1				
3380	3380	3380	3380	3380	3380	3380	3380	3380	3380	3380	3380	3380	3391	TREATMENT_BEST_RESPONSE	PATIENT	STRING	Treatment best response	Treatment best response	1				
3381	3381	3381	3381	3381	3381	3381	3381	3381	3381	3381	3381	3381	3392	TREATMENT_CHEMOTHERAPY	PATIENT	STRING	Chemotherapy.	Chemotherapy	1				
3382	3382	3382	3382	3382	3382	3382	3382	3382	3382	3382	3382	3382	3393	TREATMENT_DETAILS	PATIENT	STRING	Treatment Details	Treatment Details	1				
3383	3383	3383	3383	3383	3383	3383	3383	3383	3383	3383	3383	3383	3394	TREATMENT_EFFECT	PATIENT	STRING	Treatment Effect	Treatment Effect	1				
3384	3384	3384	3384	3384	3384	3384	3384	3384	3384	3384	3384	3384	3395	TREATMENT_EXPOSED_VS_NAIVE	SAMPLE	STRING	Exposed vs. Naive.	Exposed vs. Naive	1				
3385	3385	3385	3385	3385	3385	3385	3385	3385	3385	3385	3385	3385	3396	TREATMENT_FOR_MTS_DISEASE_BEFORE_MTS_SAMPLING	PATIENT	STRING	Treatment for MTS Disease Before MTS Sampling	Treatment for MTS Disease Before MTS Sampling	1				
3386	3386	3386	3386	3386	3386	3386	3386	3386	3386	3386	3386	3386	3397	TREATMENT_HORMONE_THERAPY	PATIENT	STRING	Hormone therapy.	Hormone Therapy	1				
3387	3387	3387	3387	3387	3387	3387	3387	3387	3387	3387	3387	3387	3398	TREATMENT_INTERVENTION	PATIENT	STRING	Treatment Intervention	Treatment Intervention	1				
3388	3388	3388	3388	3388	3388	3388	3388	3388	3388	3388	3388	3388	3399	TREATMENT_OUTCOME_AT_TCGA_FOLLOWUP	PATIENT	STRING	treatment outcome at tcga followup	treatment outcome at tcga followup	1				
3389	3389	3389	3389	3389	3389	3389	3389	3389	3389	3389	3389	3389	3400	TREATMENT_OUTCOME_FIRST_COURSE	PATIENT	STRING	Text term for the measure of success of outcome after primary treatment (surgery and adjuvant therapies).	Primary Therapy Outcome Success Type	1				
3390	3390	3390	3390	3390	3390	3390	3390	3390	3390	3390	3390	3390	3401	TREATMENT_PALLIATIVE_RADIATION	PATIENT	STRING	Palliative radiation.	Palliative Radiation	1				
3391	3391	3391	3391	3391	3391	3391	3391	3391	3391	3391	3391	3391	3402	TREATMENT_PRIOR_TO_RESECTION	SAMPLE	STRING	treatment prior to resection	treatment prior to resection	1				
3392	3392	3392	3392	3392	3392	3392	3392	3392	3392	3392	3392	3392	3403	TREATMENT_PRIOR_TO_SURGERY_INDICATOR	PATIENT	STRING	Treatment prior to surgery	Treatment prior to surgery	1				
3393	3393	3393	3393	3393	3393	3393	3393	3393	3393	3393	3393	3393	3404	TREATMENT_PROSTATECTOMY	PATIENT	STRING	Prostatectomy.	Prostatectomy	1				
3394	3394	3394	3394	3394	3394	3394	3394	3394	3394	3394	3394	3394	3405	TREATMENT_RADIATION	PATIENT	STRING	Radiation.	Radiation	1				
3395	3395	3395	3395	3395	3395	3395	3395	3395	3395	3395	3395	3395	3406	TREATMENT_RESPONSE	PATIENT	STRING	Treatment Response	Treatment Response	1				
3396	3396	3396	3396	3396	3396	3396	3396	3396	3396	3396	3396	3396	3407	TREATMENT_SCHEDULE	PATIENT	NUMBER	Schedule of Administration in Weeks (Pembrolizumab dosed every 2 or 3 weeks)	Treatment Schedule	1				
3397	3397	3397	3397	3397	3397	3397	3397	3397	3397	3397	3397	3397	3408	TREATMENT_STATUS	SAMPLE	STRING	Treatment status (pre or Post treatment sample)	Treatment Status	1				
3398	3398	3398	3398	3398	3398	3398	3398	3398	3398	3398	3398	3398	3409	TREATMENT_TYPE	PATIENT	STRING	Treatment Type	Treatment Type	1				
3399	3399	3399	3399	3399	3399	3399	3399	3399	3399	3399	3399	3399	3410	TRIPLE_NEG_STATUS	PATIENT	STRING	Patient-reported response to the question: At any time, was your breast cancer found to be triple negative (e.g. NOT ER+, PR+, or HER2+)?	PRD Ever Triple Negative	1				
3400	3400	3400	3400	3400	3400	3400	3400	3400	3400	3400	3400	3400	3411	TRISOMY_10_11_P11_2_Q23	SAMPLE	STRING	Trisomy 10-11_P11_2_Q23.	Trisomy 10-11_P11_2_Q23	1				
3401	3401	3401	3401	3401	3401	3401	3401	3401	3401	3401	3401	3401	3412	TRISOMY_11	SAMPLE	STRING	Trisomy 11	Trisomy 11	1				
3402	3402	3402	3402	3402	3402	3402	3402	3402	3402	3402	3402	3402	3413	TRISOMY_11_19_Q23_P13_1	SAMPLE	STRING	Trisomy 11_19_Q23_P13_1.	Trisomy 11_19_Q23_P13_1	1				
3403	3403	3403	3403	3403	3403	3403	3403	3403	3403	3403	3403	3403	3414	TRISOMY_12	SAMPLE	STRING	Trisomy 12	Trisomy 12	1				
3404	3404	3404	3404	3404	3404	3404	3404	3404	3404	3404	3404	3404	3415	TRISOMY_21	SAMPLE	STRING	Trisomy 21.	Trisomy 21	1				
3405	3405	3405	3405	3405	3405	3405	3405	3405	3405	3405	3405	3405	3416	TRISOMY_3	SAMPLE	STRING	Trisomy 3	Trisomy 3	1				
3406	3406	3406	3406	3406	3406	3406	3406	3406	3406	3406	3406	3406	3417	TRISOMY_3_5_Q25_Q34	SAMPLE	STRING	Trisomy 3_5_Q25_Q34.	Trisomy 3_5_Q25_Q34	1				
3407	3407	3407	3407	3407	3407	3407	3407	3407	3407	3407	3407	3407	3418	TRISOMY_4_10	SAMPLE	STRING	Trisomy 4_10.	Trisomy 4_10	1				
3408	3408	3408	3408	3408	3408	3408	3408	3408	3408	3408	3408	3408	3419	TRISOMY_4_10_17	SAMPLE	STRING	Trisomy 4_10_17.	Trisomy 4_10_17	1				
3409	3409	3409	3409	3409	3409	3409	3409	3409	3409	3409	3409	3409	3420	TRISOMY_6_11_Q27_Q23	SAMPLE	STRING	Trisomy 6_11_Q27_Q23.	Trisomy 6_11_Q27_Q23	1				
3410	3410	3410	3410	3410	3410	3410	3410	3410	3410	3410	3410	3410	3421	TRISOMY_6_9	SAMPLE	STRING	Trisomy 6_9.	Trisomy 6_9	1				
3411	3411	3411	3411	3411	3411	3411	3411	3411	3411	3411	3411	3411	3422	TRISOMY_8	SAMPLE	STRING	Trisomy 8.	Trisomy 8	1				
3412	3412	3412	3412	3412	3412	3412	3412	3412	3412	3412	3412	3412	3423	TRISOMY_8_21	SAMPLE	STRING	Trisomy 8_21.	Trisomy 8_21	1				
3413	3413	3413	3413	3413	3413	3413	3413	3413	3413	3413	3413	3413	3424	TRISOMY_9	SAMPLE	STRING	Trisomy 9	Trisomy 9	1				
3414	3414	3414	3414	3414	3414	3414	3414	3414	3414	3414	3414	3414	3425	TRISOMY_9_11_P22_Q23	SAMPLE	STRING	Trisomy 9_11_P22_Q23.	Trisomy 9_11_P22_Q23	1				
3415	3415	3415	3415	3415	3415	3415	3415	3415	3415	3415	3415	3415	3426	TSC1_MUTATION_STATUS	SAMPLE	STRING	TSC1 Mutation Status	TSC1 Mutation Status	1				
3416	3416	3416	3416	3416	3416	3416	3416	3416	3416	3416	3416	3416	3427	TSC2_MUTATION_STATUS	SAMPLE	STRING	TSC2 Mutation Status	TSC2 Mutation Status	1				
3417	3417	3417	3417	3417	3417	3417	3417	3417	3417	3417	3417	3417	3428	TSS_NAME	SAMPLE	STRING	TSS NAME	TSS NAME	1				
3418	3418	3418	3418	3418	3418	3418	3418	3418	3418	3418	3418	3418	3429	TTF1_STAIN	SAMPLE	STRING	TTF1 Stain	TTF1 Stain	1				
3419	3419	3419	3419	3419	3419	3419	3419	3419	3419	3419	3419	3419	3430	TUBE_ID	SAMPLE	STRING	Tube id.	Tube Id	1				
3420	3420	3420	3420	3420	3420	3420	3420	3420	3420	3420	3420	3420	3431	TUBULE_SCORE	SAMPLE	STRING	Tubule Score	Tubule Score	1				
3421	3421	3421	3421	3421	3421	3421	3421	3421	3421	3421	3421	3421	3432	TUMOR	SAMPLE	STRING	Tumor	Tumor	1				
3422	3422	3422	3422	3422	3422	3422	3422	3422	3422	3422	3422	3422	3433	TUMOR_BASAL_DIAMETER	SAMPLE	NUMBER	Tumor Basal Diameter	Tumor Basal Diameter	1				
3423	3423	3423	3423	3423	3423	3423	3423	3423	3423	3423	3423	3423	3434	TUMOR_BASAL_DIAMETER_MX	SAMPLE	STRING	Tumor Basal Diameter Mx	Tumor Basal Diameter Mx	1				
3424	3424	3424	3424	3424	3424	3424	3424	3424	3424	3424	3424	3424	3435	TUMOR_BORDER	SAMPLE	STRING	Tumor Border	Tumor Border	1				
3425	3425	3425	3425	3425	3425	3425	3425	3425	3425	3425	3425	3425	3436	TUMOR_BURDEN_PATHOLOGIC	SAMPLE	STRING	Tumor burden pathologic	Tumor burden pathologic	1				
3426	3426	3426	3426	3426	3426	3426	3426	3426	3426	3426	3426	3426	3437	TUMOR_BURDEN_RADIOLOGIC	SAMPLE	STRING	Tumor burden radiologic	Tumor burden radiologic	1				
3427	3427	3427	3427	3427	3427	3427	3427	3427	3427	3427	3427	3427	3438	TUMOR_CELLULARITY_DOMINANT_CLONE_VAF	SAMPLE	STRING	Tumor cellularity dominant clone vaf	Tumor cellularity dominant clone vaf	1				
3428	3428	3428	3428	3428	3428	3428	3428	3428	3428	3428	3428	3428	3439	TUMOR_CELLULARITY_PATHOLOGY_REVIEW	SAMPLE	STRING	Tumor cellularity dominant pathology review	Tumor cellularity dominant pathology review	1				
3429	3429	3429	3429	3429	3429	3429	3429	3429	3429	3429	3429	3429	3440	TUMOR_CHANGE	SAMPLE	STRING	TumorChange	TumorChange	1				
3430	3430	3430	3430	3430	3430	3430	3430	3430	3430	3430	3430	3430	3441	TUMOR_CONTENT	SAMPLE	NUMBER	tumor content	tumor content	1				
3431	3431	3431	3431	3431	3431	3431	3431	3431	3431	3431	3431	3431	3442	TUMOR_DIFFERENTIATION	SAMPLE	STRING	Tumor Differentiation	Tumor Differentiation	1				
3432	3432	3432	3432	3432	3432	3432	3432	3432	3432	3432	3432	3432	3443	TUMOR_EXOME_DEPTH	SAMPLE	NUMBER	Tumor Exome Depth	Tumor Exome Depth	1				
3433	3433	3433	3433	3433	3433	3433	3433	3433	3433	3433	3433	3433	3444	TUMOR_EXTENT	PATIENT	STRING	Tumor extent	Tumor extent	1				
3434	3434	3434	3434	3434	3434	3434	3434	3434	3434	3434	3434	3434	3445	TUMOR_FOCALITY	PATIENT	STRING	Primary neoplasm focus type	Tumor focality	1				
3435	3435	3435	3435	3435	3435	3435	3435	3435	3435	3435	3435	3435	3446	TUMOR_GENOME_COVERAGE	SAMPLE	NUMBER	Tumor Genome Coverage	Tumor Genome Coverage	1				
3436	3436	3436	3436	3436	3436	3436	3436	3436	3436	3436	3436	3436	3447	TUMOR_GENOME_LIBRARY	SAMPLE	STRING	Tumor Genome Library	Tumor Genome Library	1				
3437	3437	3437	3437	3437	3437	3437	3437	3437	3437	3437	3437	3437	3448	TUMOR_GRADE	PATIENT	STRING	Histologic grading criteria of Tumors	Tumor Grade	1				
3438	3438	3438	3438	3438	3438	3438	3438	3438	3438	3438	3438	3438	3449	TUMOR_INFILTRATING_LYMPHOCYTES	SAMPLE	STRING	Tumor infiltrating lymphocytes (TILs) are a type of white blood cell found in tumors. TILs are implicated in killing tumor cells, and the presence of lymphocytes in tumors is often associated with better clinical outcomes.	Tumor Infiltrating Lymphocytes	1				
3439	3439	3439	3439	3439	3439	3439	3439	3439	3439	3439	3439	3439	3450	TUMOR_INFILTRATING_MACROPHAGES	SAMPLE	STRING	Tumor Infiltrating Macrophages	Tumor Infiltrating Macrophages	1				
3440	3440	3440	3440	3440	3440	3440	3440	3440	3440	3440	3440	3440	3451	TUMOR_INVASION_PERCENT	PATIENT	NUMBER	Tumor invasion percent	Tumor invasion percent	1				
3441	3441	3441	3441	3441	3441	3441	3441	3441	3441	3441	3441	3441	3452	TUMOR_LARGER_THAN_FOUR_CM	SAMPLE	STRING	Tumor Larger Than 4 Cm	Tumor ̢��� 4 cm	1				
3442	3442	3442	3442	3442	3442	3442	3442	3442	3442	3442	3442	3442	3453	TUMOR_LEVEL	SAMPLE	STRING	Tumor level.	Tumor Level	1				
3443	3443	3443	3443	3443	3443	3443	3443	3443	3443	3443	3443	3443	3454	TUMOR_LOCATION	SAMPLE	STRING	Tumor Location	Tumor Location	1				
3444	3444	3444	3444	3444	3444	3444	3444	3444	3444	3444	3444	3444	3455	TUMOR_LOCATION_DETAILED	SAMPLE	STRING	Specific Tumor Location	Tumor Location Detailed	1				
3445	3445	3445	3445	3445	3445	3445	3445	3445	3445	3445	3445	3445	3456	TUMOR_MORPHOLOGY	PATIENT	STRING	Tumor Morphology	Tumor Morphology	1				
3446	3446	3446	3446	3446	3446	3446	3446	3446	3446	3446	3446	3446	3457	TUMOR_MORPHOLOGY_PERCENTAGE	SAMPLE	STRING	Tumor Morphology Percentage	Tumor Morphology Percentage	1				
3447	3447	3447	3447	3447	3447	3447	3447	3447	3447	3447	3447	3447	3458	TUMOR_MSK_IMPACT	SAMPLE	STRING	Tumor MSK-IMPACT	Tumor MSK-IMPACT	1				
3448	3448	3448	3448	3448	3448	3448	3448	3448	3448	3448	3448	3448	3459	TUMOR_PLOIDY	SAMPLE	STRING	Tumor Ploidy	Tumor Ploidy	1				
3449	3449	3449	3449	3449	3449	3449	3449	3449	3449	3449	3449	3449	3460	TUMOR_PURITY	SAMPLE	STRING	Tumor Purity	Tumor Purity	1				
3450	3450	3450	3450	3450	3450	3450	3450	3450	3450	3450	3450	3450	3461	TUMOR_REGION	SAMPLE	STRING	Tumor region.	Tumor Region	1				
3451	3451	3451	3451	3451	3451	3451	3451	3451	3451	3451	3451	3451	3462	TUMOR_RESECTED_MAX_DIMENSION	PATIENT	NUMBER	Tumor resected max dimension	Tumor resected max dimension	1				
3452	3452	3452	3452	3452	3452	3452	3452	3452	3452	3452	3452	3452	3463	TUMOR_RESIDUAL_DISEASE	SAMPLE	STRING	Tumor residual disease.	Tumor Residual Disease	1				
3453	3453	3453	3453	3453	3453	3453	3453	3453	3453	3453	3453	3453	3464	TUMOR_RESPONSE	PATIENT	STRING	Tumor response cdus type	Tumor response cdus type	1				
3454	3454	3454	3454	3454	3454	3454	3454	3454	3454	3454	3454	3454	3465	TUMOR_SAMPLE_HISTOLOGY	SAMPLE	STRING	Tumor Sample Histology	Tumor Sample Histology	1				
3455	3455	3455	3455	3455	3455	3455	3455	3455	3455	3455	3455	3455	3466	TUMOR_SAMPLE_PROCUREMENT_COUNTRY	PATIENT	STRING	Tumor sample procurement country	Tumor sample procurement country	1				
3456	3456	3456	3456	3456	3456	3456	3456	3456	3456	3456	3456	3456	3467	TUMOR_SHAPE_PATHOLOGIC_CLINICAL	SAMPLE	STRING	Tumor Shape Pathologic Clinical	Tumor Shape Pathologic Clinical	1				
3457	3457	3457	3457	3457	3457	3457	3457	3457	3457	3457	3457	3457	3468	TUMOR_SIDE	SAMPLE	STRING	Tumor side.	Tumor Side	1				
3458	3458	3458	3458	3458	3458	3458	3458	3458	3458	3458	3458	3458	3469	TUMOR_SITE	PATIENT	STRING	Tumor Site	Tumor Site	1				
3459	3459	3459	3459	3459	3459	3459	3459	3459	3459	3459	3459	3459	3470	TUMOR_SIZE	SAMPLE	STRING	Tumor size.	Tumor Size	1				
3460	3460	3460	3460	3460	3460	3460	3460	3460	3460	3460	3460	3460	3471	TUMOR_SIZE_WIDTH	SAMPLE	NUMBER	Tumor size width	Tumor size width	1				
3461	3461	3461	3461	3461	3461	3461	3461	3461	3461	3461	3461	3461	3472	TUMOR_STAGE	SAMPLE	STRING	Tumor stage.	Tumor Stage	1				
3462	3462	3462	3462	3462	3462	3462	3462	3462	3462	3462	3462	3462	3473	TUMOR_STAGE_2009	SAMPLE	STRING	Tumor stage 2009.	Tumor Stage 2009	1				
3463	3463	3463	3463	3463	3463	3463	3463	3463	3463	3463	3463	3463	3474	TUMOR_STAGE_MPUC_DX	SAMPLE	STRING	Tumor Stage at MPUC diagnosis	Tumor Stage at MPUC diagnosis	1				
3464	3464	3464	3464	3464	3464	3464	3464	3464	3464	3464	3464	3464	3475	TUMOR_STATUS	PATIENT	STRING	The state or condition of an individual's neoplasm at a particular point in time.	Person Neoplasm Status	1				
3465	3465	3465	3465	3465	3465	3465	3465	3465	3465	3465	3465	3465	3476	TUMOR_SUBTYPE	SAMPLE	STRING	Tumor Subtype	Tumor Subtype	1				
3466	3466	3466	3466	3466	3466	3466	3466	3466	3466	3466	3466	3466	3477	TUMOR_T1_CODED	SAMPLE	STRING	Tumor--T1 Coded	Tumor--T1 Coded	1				
3467	3467	3467	3467	3467	3467	3467	3467	3467	3467	3467	3467	3467	3478	TUMOR_THICKNESS	SAMPLE	NUMBER	Tumor Thickness	Tumor Thickness	1				
3468	3468	3468	3468	3468	3468	3468	3468	3468	3468	3468	3468	3468	3479	TUMOR_THICKNESS_MEASUREMENT	SAMPLE	STRING	Tumor Thickness Measurement	Tumor Thickness Measurement	1				
3469	3469	3469	3469	3469	3469	3469	3469	3469	3469	3469	3469	3469	3480	TUMOR_TISSUE_SITE	SAMPLE	STRING	Text term that describes the anatomic site of the tumor or disease.	Tumor Disease Anatomic Site	1				
3470	3470	3470	3470	3470	3470	3470	3470	3470	3470	3470	3470	3470	3481	TUMOR_TISSUE_SITE_OTHER	SAMPLE	STRING	Tumor tissue site other	Tumor tissue site other	1				
3471	3471	3471	3471	3471	3471	3471	3471	3471	3471	3471	3471	3471	3482	TUMOR_TOTAL_DEPTH	SAMPLE	STRING	Tumor total depth	Tumor total depth	1				
3472	3472	3472	3472	3472	3472	3472	3472	3472	3472	3472	3472	3472	3483	TUMOR_TOTAL_NECROSIS	SAMPLE	STRING	Tumor total necrosis	Tumor total necrosis	1				
3473	3473	3473	3473	3473	3473	3473	3473	3473	3473	3473	3473	3473	3484	TUMOR_TREATED	SAMPLE	STRING	Tumor treated	Tumor treated	1				
3474	3474	3474	3474	3474	3474	3474	3474	3474	3474	3474	3474	3474	3485	TUMOR_TYPE	SAMPLE	STRING	Tumor Type	Tumor Type	1				
3475	3475	3475	3475	3475	3475	3475	3475	3475	3475	3475	3475	3475	3486	TUMOR_VOLUME	SAMPLE	STRING	Tumor volume calculated through computational volumetric analysis of preoperative CT scans	Tumor Volume	1				
3476	3476	3476	3476	3476	3476	3476	3476	3476	3476	3476	3476	3476	3487	TURIN	PATIENT	STRING	Turin	Turin	1				
3477	3477	3477	3477	3477	3477	3477	3477	3477	3477	3477	3477	3477	3488	TX_90DAYS_POST_RESECTION	PATIENT	STRING	Treatment (90 Days Post Resection)	Treatment (90 Days Post Resection)	1				
3478	3478	3478	3478	3478	3478	3478	3478	3478	3478	3478	3478	3478	3489	TX_CLASS	PATIENT	STRING	Treatment Class	Treatment Class	1				
3479	3479	3479	3479	3479	3479	3479	3479	3479	3479	3479	3479	3479	3490	TX_COMPLETE_RESPONSE	PATIENT	STRING	Treatment (Complete Response)	Treatment (Complete Response)	1				
3480	3480	3480	3480	3480	3480	3480	3480	3480	3480	3480	3480	3480	3491	TX_INDUCTION_COURSES_INDICATOR	PATIENT	STRING	Treatment (Induction Courses Indicator)	Treatment (Induction Courses Indicator)	1				
3481	3481	3481	3481	3481	3481	3481	3481	3481	3481	3481	3481	3481	3492	TX_MAINTENANCE_COURSES_INDICATOR	PATIENT	STRING	Treatment (Maintenance Courses Indicator)	Treatment (Maintenance Courses Indicator)	1				
3482	3482	3482	3482	3482	3482	3482	3482	3482	3482	3482	3482	3482	3493	TX_REG	PATIENT	STRING	Tx_Reg	Tx_Reg	1				
3483	3483	3483	3483	3483	3483	3483	3483	3483	3483	3483	3483	3483	3494	TYPE	SAMPLE	STRING	Type	Type	1				
3484	3484	3484	3484	3484	3484	3484	3484	3484	3484	3484	3484	3484	3495	TYPE_OF_CLINICAL_VARIANT	SAMPLE	STRING	Type of clinical variant	Type of clinical variant	1				
3485	3485	3485	3485	3485	3485	3485	3485	3485	3485	3485	3485	3485	3496	TYPE_OF_PRIOR_LOCAL_THERAPY	PATIENT	STRING	Type of Prior Local Therapy	Type of Prior Local Therapy	1				
3486	3486	3486	3486	3486	3486	3486	3486	3486	3486	3486	3486	3486	3497	TYPE_OF_SURGERY	SAMPLE	STRING	Type of Surgery.	Type of Surgery	1				
3487	3487	3487	3487	3487	3487	3487	3487	3487	3487	3487	3487	3487	3498	TYPE_OF_SURGERY_2	SAMPLE	STRING	Type of Surgery 2	Type of Surgery 2	1				
3488	3488	3488	3488	3488	3488	3488	3488	3488	3488	3488	3488	3488	3499	TYPE_OF_TREATMENT_BEFORE_SAMPLING	PATIENT	STRING	Type of Treatment Before Sampling	Type of Treatment Before Sampling	1				
3489	3489	3489	3489	3489	3489	3489	3489	3489	3489	3489	3489	3489	3500	T_10_11_P11_2_Q23	SAMPLE	STRING	t(10;11)(p11.2;q23) gene fusion status	t(10;11)(p11.2;q23)	1				
3490	3490	3490	3490	3490	3490	3490	3490	3490	3490	3490	3490	3490	3501	T_10_19	SAMPLE	STRING	t(10;19)	t(10;19)	1				
3491	3491	3491	3491	3491	3491	3491	3491	3491	3491	3491	3491	3491	3502	T_11Q23	SAMPLE	STRING	t(11q23)	t(11q23)	1				
3492	3492	3492	3492	3492	3492	3492	3492	3492	3492	3492	3492	3492	3503	T_11_14	SAMPLE	STRING	t(11;14)	t(11;14)	1				
3493	3493	3493	3493	3493	3493	3493	3493	3493	3493	3493	3493	3493	3504	T_11_17	SAMPLE	STRING	t(11;17)	t(11;17)	1				
3494	3494	3494	3494	3494	3494	3494	3494	3494	3494	3494	3494	3494	3505	T_11_18	SAMPLE	STRING	t(11;18)	t(11;18)	1				
3495	3495	3495	3495	3495	3495	3495	3495	3495	3495	3495	3495	3495	3506	T_11_19_Q23_P13_1	SAMPLE	STRING	t(11:19)(q23:p13.1) gene fusion status	t(11:19)(q23:p13.1)	1				
3496	3496	3496	3496	3496	3496	3496	3496	3496	3496	3496	3496	3496	3507	T_11_23	SAMPLE	STRING	t(11;23)	t(11;23)	1				
3497	3497	3497	3497	3497	3497	3497	3497	3497	3497	3497	3497	3497	3508	T_12_2	SAMPLE	STRING	t(12;2)	t(12;2)	1				
3498	3498	3498	3498	3498	3498	3498	3498	3498	3498	3498	3498	3498	3509	T_14_16	SAMPLE	STRING	t(14;16)	t(14;16)	1				
3499	3499	3499	3499	3499	3499	3499	3499	3499	3499	3499	3499	3499	3510	T_14_18	SAMPLE	STRING	t(14;18)	t(14;18)	1				
3500	3500	3500	3500	3500	3500	3500	3500	3500	3500	3500	3500	3500	3511	T_15_17	SAMPLE	STRING	t(15;17)	t(15;17)	1				
3501	3501	3501	3501	3501	3501	3501	3501	3501	3501	3501	3501	3501	3512	T_1_19	SAMPLE	STRING	t(1;19)	t(1;19)	1				
3502	3502	3502	3502	3502	3502	3502	3502	3502	3502	3502	3502	3502	3513	T_1_22	SAMPLE	STRING	t(1;22)	t(1;22)	1				
3503	3503	3503	3503	3503	3503	3503	3503	3503	3503	3503	3503	3503	3514	T_3Q27	SAMPLE	STRING	t(3q;27)	t(3q;27)	1				
3504	3504	3504	3504	3504	3504	3504	3504	3504	3504	3504	3504	3504	3515	T_3_5_Q25_Q34	SAMPLE	STRING	t(3;5)(q25;q34) gene fusion status	t(3;5)(q25;q34)	1				
3505	3505	3505	3505	3505	3505	3505	3505	3505	3505	3505	3505	3505	3516	T_4_11	SAMPLE	STRING	t(4;11)	t(4;11)	1				
3506	3506	3506	3506	3506	3506	3506	3506	3506	3506	3506	3506	3506	3517	T_4_14	SAMPLE	STRING	t(4;14)	t(4;14)	1				
3507	3507	3507	3507	3507	3507	3507	3507	3507	3507	3507	3507	3507	3518	T_5_12	SAMPLE	STRING	t(5;12)	t(5;12)	1				
3508	3508	3508	3508	3508	3508	3508	3508	3508	3508	3508	3508	3508	3519	T_5_14	SAMPLE	STRING	t(5;14)	t(5;14)	1				
3509	3509	3509	3509	3509	3509	3509	3509	3509	3509	3509	3509	3509	3520	T_6_11_Q27_Q23	SAMPLE	STRING	t(6;11)(q27;q23) gene fusion status	t(6;11)(q27;q23)	1				
3510	3510	3510	3510	3510	3510	3510	3510	3510	3510	3510	3510	3510	3521	T_6_14	SAMPLE	STRING	t(6;14)	t(6;14)	1				
3511	3511	3511	3511	3511	3511	3511	3511	3511	3511	3511	3511	3511	3522	T_6_9	SAMPLE	STRING	t(6;9) gene fusion status	t(6;9)	1				
3512	3512	3512	3512	3512	3512	3512	3512	3512	3512	3512	3512	3512	3523	T_8_14	SAMPLE	STRING	t(8;14)	t(8;14)	1				
3513	3513	3513	3513	3513	3513	3513	3513	3513	3513	3513	3513	3513	3524	T_8_21	SAMPLE	STRING	t(8;21) gene fusion status	t(8;21)	1				
3514	3514	3514	3514	3514	3514	3514	3514	3514	3514	3514	3514	3514	3525	T_9_11	SAMPLE	STRING	t(9;11)	t(9;11)	1				
3515	3515	3515	3515	3515	3515	3515	3515	3515	3515	3515	3515	3515	3526	T_9_11_P22_Q23	SAMPLE	STRING	t(9;11)(p22;q23) gene fusion status	t(9;11)(p22;q23)	1				
3516	3516	3516	3516	3516	3516	3516	3516	3516	3516	3516	3516	3516	3527	T_9_14	SAMPLE	STRING	t(9;14)	t(9;14)	1				
3517	3517	3517	3517	3517	3517	3517	3517	3517	3517	3517	3517	3517	3528	T_9_22	SAMPLE	STRING	t(9;22) = Ph+	t(9;22) = Ph+	1				
3518	3518	3518	3518	3518	3518	3518	3518	3518	3518	3518	3518	3518	3529	T_CELLS_CD4_MEMORY_ACTIVATED	SAMPLE	NUMBER	T cells CD4 memory activated	T cells CD4 memory activated	1				
3519	3519	3519	3519	3519	3519	3519	3519	3519	3519	3519	3519	3519	3530	T_CELLS_CD4_MEMORY_RESTING	SAMPLE	NUMBER	T cells CD4 memory resting	T cells CD4 memory resting	1				
3520	3520	3520	3520	3520	3520	3520	3520	3520	3520	3520	3520	3520	3531	T_CELLS_CD4_NAIVE	SAMPLE	NUMBER	T cells CD4 naive	T cells CD4 naive	1				
3521	3521	3521	3521	3521	3521	3521	3521	3521	3521	3521	3521	3521	3532	T_CELLS_CD8	SAMPLE	NUMBER	T cells CD8	T cells CD8	1				
3522	3522	3522	3522	3522	3522	3522	3522	3522	3522	3522	3522	3522	3533	T_CELLS_FOLLICULAR_HELPER	SAMPLE	NUMBER	T cells follicular helper	T cells follicular helper	1				
3523	3523	3523	3523	3523	3523	3523	3523	3523	3523	3523	3523	3523	3534	T_CELLS_GAMMA_DELTA	SAMPLE	NUMBER	T cells gamma delta	T cells gamma delta	1				
3524	3524	3524	3524	3524	3524	3524	3524	3524	3524	3524	3524	3524	3535	T_CELLS_REGULATORY_TREGS	SAMPLE	NUMBER	T cells regulatory (Tregs)	T cells regulatory (Tregs)	1				
3525	3525	3525	3525	3525	3525	3525	3525	3525	3525	3525	3525	3525	3536	T_SCORE	PATIENT	NUMBER	T Score	T Score	1				
3526	3526	3526	3526	3526	3526	3526	3526	3526	3526	3526	3526	3526	3537	T_STAGE	SAMPLE	STRING	T Stage	T Stage	1				
3527	3527	3527	3527	3527	3527	3527	3527	3527	3527	3527	3527	3527	3538	T_STAGE_REPORTED	PATIENT	STRING	American Joint Committee on Cancer (AJCC) Summary Stage at Diagnosis. Using the AJCC method, a breast cancer is characterized by the size of the tumor (T), the number of lymph nodes it has spread to (N), and whether or not it has metastatsized (M). Together, the T, N, and M values are used to determine the Summary stage, e.g. Stage I, Stage II, Stage III, Stage IV	MedR T Stage at Diagnosis	1				
3528	3528	3528	3528	3528	3528	3528	3528	3528	3528	3528	3528	3528	3539	U133A	SAMPLE	STRING	U133a	U133a	1				
3529	3529	3529	3529	3529	3529	3529	3529	3529	3529	3529	3529	3529	3540	UBIQUITOUS_ASSAY_PANEL	SAMPLE	STRING	Number of SNVs targed by assay panel that were found in all tumor regions analysed	Ubiquitous Assay Panel	1				
3530	3530	3530	3530	3530	3530	3530	3530	3530	3530	3530	3530	3530	3541	UICC_TUMOR_STAGE	PATIENT	STRING	UICC Tumor Stage	UICC Tumor Stage	1				
3531	3531	3531	3531	3531	3531	3531	3531	3531	3531	3531	3531	3531	3542	ULTRASOUND	PATIENT	STRING	Ultrasound	Ultrasound	1				
3532	3532	3532	3532	3532	3532	3532	3532	3532	3532	3532	3532	3532	3543	UNDESCENDED_TESTIS_CORRECTED	PATIENT	STRING	Undescended testis corrected	Undescended testis corrected	1				
3533	3533	3533	3533	3533	3533	3533	3533	3533	3533	3533	3533	3533	3544	UNDESCENDED_TESTIS_CORRECTED_AGE	PATIENT	STRING	Undescended testis corrected age	Undescended testis corrected age	1				
3534	3534	3534	3534	3534	3534	3534	3534	3534	3534	3534	3534	3534	3545	UNDESCENDED_TESTIS_METHOD_LEFT	PATIENT	STRING	Undescended testis method left	Undescended testis method left	1				
3535	3535	3535	3535	3535	3535	3535	3535	3535	3535	3535	3535	3535	3546	UNDESCENDED_TESTIS_METHOD_RIGHT	PATIENT	STRING	Undescended testis method right	Undescended testis method right	1				
3536	3536	3536	3536	3536	3536	3536	3536	3536	3536	3536	3536	3536	3547	UNIQUE_PAPER_SAMPLES	SAMPLE	STRING	Unique Paper Samples	Unique Paper Samples	1				
3537	3537	3537	3537	3537	3537	3537	3537	3537	3537	3537	3537	3537	3548	UNIT	SAMPLE	STRING	Unit	Unit	1				
3538	3538	3538	3538	3538	3538	3538	3538	3538	3538	3538	3538	3538	3549	UPD	SAMPLE	STRING	UPD	UPD	1				
3539	3539	3539	3539	3539	3539	3539	3539	3539	3539	3539	3539	3539	3550	UROTHELIAL_PRIMARY	PATIENT	STRING	Urothelial primary.	Urothelial Primary	1				
3540	3540	3540	3540	3540	3540	3540	3540	3540	3540	3540	3540	3540	3551	USAGE	SAMPLE	STRING	Usage	Usage	1				
3541	3541	3541	3541	3541	3541	3541	3541	3541	3541	3541	3541	3541	3552	UTERINE_WEIGHT	SAMPLE	NUMBER	Uterine Weight	Uterine Weight	1				
3542	3542	3542	3542	3542	3542	3542	3542	3542	3542	3542	3542	3542	3553	V	PATIENT	NUMBER	V	V	1				
3543	3543	3543	3543	3543	3543	3543	3543	3543	3543	3543	3543	3543	3554	V1	PATIENT	NUMBER	V1	V1	1				
3544	3544	3544	3544	3544	3544	3544	3544	3544	3544	3544	3544	3544	3555	V2	PATIENT	NUMBER	V2	V2	1				
3545	3545	3545	3545	3545	3545	3545	3545	3545	3545	3545	3545	3545	3556	V3	PATIENT	NUMBER	V3	V3	1				
3546	3546	3546	3546	3546	3546	3546	3546	3546	3546	3546	3546	3546	3557	VALIDATION_STATUS	SAMPLE	STRING	Sample validation status (unknown or valid)	Validation status	1				
3547	3547	3547	3547	3547	3547	3547	3547	3547	3547	3547	3547	3547	3558	VARIANT_HISTOLOGY	PATIENT	STRING	Variant Histology	Variant Histology	1				
3548	3548	3548	3548	3548	3548	3548	3548	3548	3548	3548	3548	3548	3559	VARIANT_HISTOLOGY_SUBTYPE	PATIENT	STRING	Variant Histology Subtype	Variant Histology Subtype	1				
3549	3549	3549	3549	3549	3549	3549	3549	3549	3549	3549	3549	3549	3560	VAR_10Q_NEG	SAMPLE	STRING	10q-	10q-	1				
3550	3550	3550	3550	3550	3550	3550	3550	3550	3550	3550	3550	3550	3561	VAR_10_005	PATIENT	STRING	10-005.	10-005	1				
3551	3551	3551	3551	3551	3551	3551	3551	3551	3551	3551	3551	3551	3562	VAR_11Q_NEG	SAMPLE	STRING	11q-	11q-	1				
3552	3552	3552	3552	3552	3552	3552	3552	3552	3552	3552	3552	3552	3563	VAR_11_NEG	SAMPLE	STRING	11-	11-	1				
3553	3553	3553	3553	3553	3553	3553	3553	3553	3553	3553	3553	3553	3564	VAR_11_POS	SAMPLE	STRING	11+	11+	1				
3554	3554	3554	3554	3554	3554	3554	3554	3554	3554	3554	3554	3554	3565	VAR_12P_POS	SAMPLE	STRING	12p+	12p+	1				
3555	3555	3555	3555	3555	3555	3555	3555	3555	3555	3555	3555	3555	3566	VAR_12_245	PATIENT	STRING	12-245	12-245	1				
3556	3556	3556	3556	3556	3556	3556	3556	3556	3556	3556	3556	3556	3567	VAR_13P_NEG	SAMPLE	STRING	13p-	13p-	1				
3557	3557	3557	3557	3557	3557	3557	3557	3557	3557	3557	3557	3557	3568	VAR_13_NEG	SAMPLE	STRING	13-	13-	1				
3558	3558	3558	3558	3558	3558	3558	3558	3558	3558	3558	3558	3558	3569	VAR_14Q_NEG	SAMPLE	STRING	14q-	14q-	1				
3559	3559	3559	3559	3559	3559	3559	3559	3559	3559	3559	3559	3559	3570	VAR_15Q_POS	SAMPLE	STRING	15q+	15q+	1				
3560	3560	3560	3560	3560	3560	3560	3560	3560	3560	3560	3560	3560	3571	VAR_16Q_NEG	SAMPLE	STRING	16q-	16q-	1				
3561	3561	3561	3561	3561	3561	3561	3561	3561	3561	3561	3561	3561	3572	VAR_17P_NEG	SAMPLE	STRING	17p-	17p-	1				
3562	3562	3562	3562	3562	3562	3562	3562	3562	3562	3562	3562	3562	3573	VAR_17Q_POS	SAMPLE	STRING	17q+	17q+	1				
3563	3563	3563	3563	3563	3563	3563	3563	3563	3563	3563	3563	3563	3574	VAR_18_NEG	SAMPLE	STRING	18-	18-	1				
3564	3564	3564	3564	3564	3564	3564	3564	3564	3564	3564	3564	3564	3575	VAR_19P_NEG	SAMPLE	STRING	19p-	19p-	1				
3565	3565	3565	3565	3565	3565	3565	3565	3565	3565	3565	3565	3565	3576	VAR_19Q_POS	SAMPLE	STRING	19q+	19q+	1				
3566	3566	3566	3566	3566	3566	3566	3566	3566	3566	3566	3566	3566	3577	VAR_1P_NEG	SAMPLE	STRING	1p-	1p-	1				
3567	3567	3567	3567	3567	3567	3567	3567	3567	3567	3567	3567	3567	3578	VAR_1Q_POS	SAMPLE	STRING	1q+	1q+	1				
3568	3568	3568	3568	3568	3568	3568	3568	3568	3568	3568	3568	3568	3579	VAR_20Q_POS	SAMPLE	STRING	20q+	20q+	1				
3569	3569	3569	3569	3569	3569	3569	3569	3569	3569	3569	3569	3569	3580	VAR_22_NEG	SAMPLE	STRING	22-	22-	1				
3570	3570	3570	3570	3570	3570	3570	3570	3570	3570	3570	3570	3570	3581	VAR_2P_NEG	SAMPLE	STRING	2p-	2p-	1				
3571	3571	3571	3571	3571	3571	3571	3571	3571	3571	3571	3571	3571	3582	VAR_2P_POS	SAMPLE	STRING	2p+	2p+	1				
3572	3572	3572	3572	3572	3572	3572	3572	3572	3572	3572	3572	3572	3583	VAR_3P_NEG	SAMPLE	STRING	3p-	3p-	1				
3573	3573	3573	3573	3573	3573	3573	3573	3573	3573	3573	3573	3573	3584	VAR_3Q_NEG	SAMPLE	STRING	3q-	3q-	1				
3574	3574	3574	3574	3574	3574	3574	3574	3574	3574	3574	3574	3574	3585	VAR_3Q_POS	SAMPLE	STRING	3q+	3q+	1				
3575	3575	3575	3575	3575	3575	3575	3575	3575	3575	3575	3575	3575	3586	VAR_4P_NEG	SAMPLE	STRING	4p-	4p-	1				
3576	3576	3576	3576	3576	3576	3576	3576	3576	3576	3576	3576	3576	3587	VAR_4_NEG	SAMPLE	STRING	4-	4-	1				
3577	3577	3577	3577	3577	3577	3577	3577	3577	3577	3577	3577	3577	3588	VAR_6P_POS	SAMPLE	STRING	6p+	6p+	1				
3578	3578	3578	3578	3578	3578	3578	3578	3578	3578	3578	3578	3578	3589	VAR_6Q_NEG	SAMPLE	STRING	6q-	6q-	1				
3579	3579	3579	3579	3579	3579	3579	3579	3579	3579	3579	3579	3579	3590	VAR_7Q_POS	SAMPLE	STRING	7q+	7q+	1				
3580	3580	3580	3580	3580	3580	3580	3580	3580	3580	3580	3580	3580	3591	VAR_9P_NEG	SAMPLE	STRING	9p-	9p-	1				
3581	3581	3581	3581	3581	3581	3581	3581	3581	3581	3581	3581	3581	3592	VAR_9_NEG	SAMPLE	STRING	9-	9-	1				
3582	3582	3582	3582	3582	3582	3582	3582	3582	3582	3582	3582	3582	3593	VASCULAR_INVASION	SAMPLE	STRING	Vascular invasion.	Vascular Invasion	1				
3583	3583	3583	3583	3583	3583	3583	3583	3583	3583	3583	3583	3583	3594	VASCULAR_INVASION_INDICATOR	PATIENT	STRING	Vascular invasion indicator	Vascular invasion indicator	1				
3584	3584	3584	3584	3584	3584	3584	3584	3584	3584	3584	3584	3584	3595	VEGF1	PATIENT	NUMBER	Vegf1	Vegf1	1				
3585	3585	3585	3585	3585	3585	3585	3585	3585	3585	3585	3585	3585	3596	VEGF2	PATIENT	NUMBER	Vegf2	Vegf2	1				
3586	3586	3586	3586	3586	3586	3586	3586	3586	3586	3586	3586	3586	3597	VHL	SAMPLE	STRING	Von Hippel-Lindau syndrome (VHL) is a hereditary condition associated with hemangioblastomas, which are blood vessel tumors of the brain, spinal cord, and eye.	Von Hippel-Lindau	1				
3587	3587	3587	3587	3587	3587	3587	3587	3587	3587	3587	3587	3587	3598	VHL_GERMLINE	SAMPLE	STRING	VHL Germline Mutation	VHL Germline Mutation	1				
3588	3588	3588	3588	3588	3588	3588	3588	3588	3588	3588	3588	3588	3599	VHL_MUTATION_AA	SAMPLE	STRING	VHL Mutation (AA)	VHL Mutation (AA)	1				
3589	3589	3589	3589	3589	3589	3589	3589	3589	3589	3589	3589	3589	3600	VHL_MUTATION_CODON	SAMPLE	STRING	VHL Mutation (Codon)	VHL Mutation (Codon)	1				
3590	3590	3590	3590	3590	3590	3590	3590	3590	3590	3590	3590	3590	3601	VHL_SOMATIC	SAMPLE	STRING	VHL Somatic Mutation	VHL Somatic Mutation	1				
3591	3591	3591	3591	3591	3591	3591	3591	3591	3591	3591	3591	3591	3602	VI	PATIENT	NUMBER	Vi	Vi	1				
3592	3592	3592	3592	3592	3592	3592	3592	3592	3592	3592	3592	3592	3603	VIAL_NUMBER	PATIENT	STRING	Vial number	Vial number	1				
3593	3593	3593	3593	3593	3593	3593	3593	3593	3593	3593	3593	3593	3604	VISCERAL_METS	PATIENT	STRING	Visceral Mets	Visceral Mets	1				
3594	3594	3594	3594	3594	3594	3594	3594	3594	3594	3594	3594	3594	3605	VISMO_STATUS	PATIENT	STRING	Vismo Status	Vismo Status	1				
3595	3595	3595	3595	3595	3595	3595	3595	3595	3595	3595	3595	3595	3606	VISUAL_CHANGES	PATIENT	STRING	Visual changes.	Visual Changes	1				
3596	3596	3596	3596	3596	3596	3596	3596	3596	3596	3596	3596	3596	3607	VITAL_STATUS	PATIENT	STRING	The survival state of the person.	Patient's Vital Status	1				
3597	3597	3597	3597	3597	3597	3597	3597	3597	3597	3597	3597	3597	3608	VITAL_STATUS_INTERVAL_YEARS	PATIENT	NUMBER	Vital Status Interval Years	Vital Status Interval Years	1				
3598	3598	3598	3598	3598	3598	3598	3598	3598	3598	3598	3598	3598	3609	WASHING	SAMPLE	STRING	Washing	Washing	1				
3599	3599	3599	3599	3599	3599	3599	3599	3599	3599	3599	3599	3599	3610	WATERFALL_GROUP	SAMPLE	STRING	Waterfall Group	Waterfall Group	1				
3600	3600	3600	3600	3600	3600	3600	3600	3600	3600	3600	3600	3600	3611	WBC	PATIENT	NUMBER	White bloodcell count.	WBC	1				
3601	3601	3601	3601	3601	3601	3601	3601	3601	3601	3601	3601	3601	3612	WBC_X_10_3_PER_MICROLITER	PATIENT	NUMBER	White bloodcell count (10^3 per microliter).	WBC (10^3/microliter)	1				
3602	3602	3602	3602	3602	3602	3602	3602	3602	3602	3602	3602	3602	3613	WEEK_ADDED	SAMPLE	STRING	Week added to cBioPortal	Week added to cBioPortal	1				
3603	3603	3603	3603	3603	3603	3603	3603	3603	3603	3603	3603	3603	3614	WEIGHT	PATIENT	NUMBER	Weight measured in kilograms.	Patient Weight	1				
3604	3604	3604	3604	3604	3604	3604	3604	3604	3604	3604	3604	3604	3615	WEIGHT_LOSS	PATIENT	STRING	Weight Loss (Yes/No)	Weight Loss (Yes/No)	1				
3605	3605	3605	3605	3605	3605	3605	3605	3605	3605	3605	3605	3605	3616	WEIGHT_LOSS_AMOUNT_KG	PATIENT	NUMBER	Weight Loss Amount (Kg)	Weight Loss Amount (Kg)	1				
3606	3606	3606	3606	3606	3606	3606	3606	3606	3606	3606	3606	3606	3617	WEIGHT_LOSS_WEEKS	PATIENT	NUMBER	Weight Loss (weeks)	Weight Loss (weeks)	1				
3607	3607	3607	3607	3607	3607	3607	3607	3607	3607	3607	3607	3607	3618	WEISS_SCORE_OVERALL	SAMPLE	NUMBER	Weiss Score Overall	Weiss Score Overall	1				
3608	3608	3608	3608	3608	3608	3608	3608	3608	3608	3608	3608	3608	3619	WEISS_VENOUS_INVASION	SAMPLE	STRING	Weiss Venous Invasion	Weiss Venous Invasion	1				
3609	3609	3609	3609	3609	3609	3609	3609	3609	3609	3609	3609	3609	3620	WELL_DIFF_LIPOSARC_PRIOR_DX_DAYS_TO	PATIENT	NUMBER	Days to well differentiated liposarcoma primary dx	Well diff liposarc prior dx days to	1				
3610	3610	3610	3610	3610	3610	3610	3610	3610	3610	3610	3610	3610	3621	WELL_DIFF_LIPOSARC_PRIOR_DX_INDICATOR	PATIENT	NUMBER	Well differentiated liposarcoma primary dx	Well diff liposarc prior dx indicator	1				
3611	3611	3611	3611	3611	3611	3611	3611	3611	3611	3611	3611	3611	3622	WELL_DIFF_LIPOSARC_RESECTION_DAYS_TO	PATIENT	NUMBER	Days to well differentiated liposarcoma resection	Well diff liposarc resection days to	1				
3612	3612	3612	3612	3612	3612	3612	3612	3612	3612	3612	3612	3612	3623	WGD	SAMPLE	STRING	WGD	WGD	1				
3613	3613	3613	3613	3613	3613	3613	3613	3613	3613	3613	3613	3613	3624	WGS_BASED_PURITY_ESTIMATION	SAMPLE	NUMBER	WGS based purity estimation	WGS Based Purity Estimation	1				
3614	3614	3614	3614	3614	3614	3614	3614	3614	3614	3614	3614	3614	3625	WGS_STATUS	SAMPLE	STRING	Yes/No indicator for WGS data	WGS Status	1				
3615	3615	3615	3615	3615	3615	3615	3615	3615	3615	3615	3615	3615	3626	WHOLE_EXOME_SEQUENCING	SAMPLE	STRING	Whole Exome Sequencing	Whole Exome Sequencing	1				
3616	3616	3616	3616	3616	3616	3616	3616	3616	3616	3616	3616	3616	3627	WHOLE_GENOME_SEQUENCING	SAMPLE	STRING	Whole Genome Sequencing	Whole Genome Sequencing	1				
3617	3617	3617	3617	3617	3617	3617	3617	3617	3617	3617	3617	3617	3628	WHO_CLASS	PATIENT	STRING	WHO class.	WHO Class	1				
3618	3618	3618	3618	3618	3618	3618	3618	3618	3618	3618	3618	3618	3629	WHO_GRADE	SAMPLE	STRING	WHO Grade	WHO Grade	1				
3619	3619	3619	3619	3619	3619	3619	3619	3619	3619	3619	3619	3619	3630	WITHDRAWAL_OF_CONSENT	SAMPLE	STRING	Withdrawal of Consent	Withdrawal of Consent	1				
3620	3620	3620	3620	3620	3620	3620	3620	3620	3620	3620	3620	3620	3631	WT1_MUTATION	SAMPLE	STRING	WT1 mutation.	WT1 Mutation	1				
3621	3621	3621	3621	3621	3621	3621	3621	3621	3621	3621	3621	3621	3632	XENOGRAFT_INFORMATION	PATIENT	STRING	Xenograft Information	Xenograft Information	1				
3622	3622	3622	3622	3622	3622	3622	3622	3622	3622	3622	3622	3622	3633	XTANDI	SAMPLE	STRING	XTANDI.	XTANDI	1				
3623	3623	3623	3623	3623	3623	3623	3623	3623	3623	3623	3623	3623	3634	XTANDI_EXPOSED_BEFORE_BX	SAMPLE	STRING	XTANDI exposed before BX.	XTANDI Exposed Before BX	1				
3624	3624	3624	3624	3624	3624	3624	3624	3624	3624	3624	3624	3624	3635	X_SOURCEINFO	PATIENT	STRING	X source information.	X Source Infomation	1				
3625	3625	3625	3625	3625	3625	3625	3625	3625	3625	3625	3625	3625	3636	YEAR	PATIENT	NUMBER	Year	Year	1				
3626	3626	3626	3626	3626	3626	3626	3626	3626	3626	3626	3626	3626	3637	YEARS_TO_LAST_KNOWN_ALIVE	PATIENT	NUMBER	Time interval from the year of last known alive status to the year of initial pathologic diagnosis, represented as a calculated number of years.	Last Known Alive Status Less Initial Pathologic Diagnosis Date Calculated Year Value	1				
3627	3627	3627	3627	3627	3627	3627	3627	3627	3627	3627	3627	3627	3638	YEARS_TO_NEW_TUMOR	PATIENT	NUMBER	Years to new tumor	Years to new tumor	1				
3628	3628	3628	3628	3628	3628	3628	3628	3628	3628	3628	3628	3628	3639	YEAR_MET_DISEASE_IDENTIFIED	SAMPLE	NUMBER	Year for Date metastatic disease was identified.	Year for Date metastatic disease was identified.	1				
3629	3629	3629	3629	3629	3629	3629	3629	3629	3629	3629	3629	3629	3640	YEAR_OF_COLLECTION	SAMPLE	NUMBER	Year of Collection	Year of Collection	1				
3630	3630	3630	3630	3630	3630	3630	3630	3630	3630	3630	3630	3630	3641	YEAR_OF_DIAGNOSIS	PATIENT	NUMBER	Year of Diagnosis	Year of Diagnosis	1				
3631	3631	3631	3631	3631	3631	3631	3631	3631	3631	3631	3631	3631	3642	YEAR_OF_INITIAL_PATHOLOGIC_DIAGNOSIS	PATIENT	NUMBER	Year of initial pathologic diagnosis.	Year of initial pathologic diagnosis	1				
3632	3632	3632	3632	3632	3632	3632	3632	3632	3632	3632	3632	3632	3643	YEAR_OF_RC	PATIENT	STRING	Year of rc	Year of rc	1				
3633	3633	3633	3633	3633	3633	3633	3633	3633	3633	3633	3633	3633	3644	YEAR_OF_SPECIMEN	SAMPLE	NUMBER	Year of specimen.	Year of Specimen	1				
3634	3634	3634	3634	3634	3634	3634	3634	3634	3634	3634	3634	3634	3645	YEAR_OF_SURGERY	SAMPLE	NUMBER	Year of surgery.	Year of Surgery	1				
3635	3635	3635	3635	3635	3635	3635	3635	3635	3635	3635	3635	3635	3646	ZAP70_TEST	SAMPLE	STRING	ZAP70	ZAP70	1				
3636	3636	3636	3636	3636	3636	3636	3636	3636	3636	3636	3636	3636	3647	ZMYM3_MUT	PATIENT	NUMBER	Zmym3 mut	Zmym3 mut	1				
3637	3637	3637	3637	3637	3637	3637	3637	3637	3637	3637	3637	3637	3648	ZYTIGA	SAMPLE	STRING	Zytiga.	Zytiga	1				
3638	3638	3638	3638	3638	3638	3638	3638	3638	3638	3638	3638	3638	3649	ZYTIGA_EXPOSED_BEFORE_BX	SAMPLE	STRING	Zytiga exposed before BX.	Zytiga Exposed Before BX	1				
3639	3639	3639	3639	3639	3639	3639	3639	3639	3639	3639	3639	3639	3650	PDX_SAMPLE_STATUS	SAMPLE	STRING	PDX Sample Status	PDX Sample Status	1				
3640	3640	3640	3640	3640	3640	3640	3640	3640	3640	3640	3640	3640	3651	MUTATION_NUMBER	SAMPLE	STRING	Number of Mutations	Number of Mutations	1				
3641	3641	3641	3641	3641	3641	3641	3641	3641	3641	3641	3641	3641	3652	CNA_NUMBER	SAMPLE	STRING	Number of Copy Number Alterations	Number of Copy Number Alterations	1				
3642	3642	3642	3642	3642	3642	3642	3642	3642	3642	3642	3642	3642	3653	RNA_SEQUENCED	SAMPLE	STRING	RNA Sequenced	RNA Sequenced	1				
3643	3643	3643	3643	3643	3643	3643	3643	3643	3643	3643	3643	3643	3654	PDX_NOTES	SAMPLE	STRING	PDX Notes	PDX Notes	1				
3644	3644	3644	3644	3644	3644	3644	3644	3644	3644	3644	3644	3644	3655	IN_PANCANPATHWAYS_FREEZE	PATIENT	STRING	Patient Part of PanCan Pathway Analysis	In PanCan Pathway Analysis	1				
3645	3645	3645	3645	3645	3645	3645	3645	3645	3645	3645	3645	3645	3656	TEXTURE	PATIENT	STRING	Texture	Texture	1				
3646	3646	3646	3646	3646	3646	3646	3646	3646	3646	3646	3646	3646	3657	HGP_SCORE	PATIENT	STRING	HGP Score	HGP Score	1				
3647	3647	3647	3647	3647	3647	3647	3647	3647	3647	3647	3647	3647	3658	STEATOFFIBROSISSCORE	PATIENT	STRING	Steat of Fibrosis Score	Steat of Fibrosis Score	1				
3648	3648	3648	3648	3648	3648	3648	3648	3648	3648	3648	3648	3648	3659	ADJUVANTCREASY_PATIENTS	PATIENT	STRING	Adjuvant Creasy Patients	Adjuvant Creasy Patients	1				
3649	3649	3649	3649	3649	3649	3649	3649	3649	3649	3649	3649	3649	3660	PRESENCE_OF_ADENOMA	SAMPLE	STRING	Presence of Adenoma	Presence of Adenoma	1				
3650	3650	3650	3650	3650	3650	3650	3650	3650	3650	3650	3650	3650	3661	PRESENCE_OF_EXOCRINE_COMPONENT	SAMPLE	STRING	Presence of Exocrine Component	Presence of Exocrine Component	1				
3651	3651	3651	3651	3651	3651	3651	3651	3651	3651	3651	3651	3651	3662	REGIONAL_VS_PRIMARY	SAMPLE	STRING	Regional or Primary	Regional or Primary	1				
3652	3652	3652	3652	3652	3652	3652	3652	3652	3652	3652	3652	3652	3663	UV_SIGNATURE	PATIENT	STRING	UV Signature	UV Signature	1				
3653	3653	3653	3653	3653	3653	3653	3653	3653	3653	3653	3653	3653	3664	UV_RATE	PATIENT	STRING	UV Rate	UV Rate	1				
3654	3654	3654	3654	3654	3654	3654	3654	3654	3654	3654	3654	3654	3665	AGE_AT_TCGA_SPECIMEN	PATIENT	NUMBER	Age at TCGA Specimen	Age at TCGA Specimen	1				
3655	3655	3655	3655	3655	3655	3655	3655	3655	3655	3655	3655	3655	3666	SITE_OF_PRIMARY_TUMOR_KNOWN_PRIMARY_ONLY	SAMPLE	STRING	Site of Primary Tumor Known (Primary Only)	Site of Primary Tumor Known (Primary Only)	1				
3656	3656	3656	3656	3656	3656	3656	3656	3656	3656	3656	3656	3656	3667	SITE_OF_PRIMARY_TUMOR_INCLUDING_UNKNOWN	SAMPLE	STRING	Site of Primary Tumor Including Unknown	Site of Primary Tumor Including Unknown	1				
3657	3657	3657	3657	3657	3657	3657	3657	3657	3657	3657	3657	3657	3668	BRESLOW	PATIENT	NUMBER	Breslow	Breslow	1				
3658	3658	3658	3658	3658	3658	3658	3658	3658	3658	3658	3658	3658	3669	ULCERATION	SAMPLE	STRING	Ulceration	Ulceration	1				
3659	3659	3659	3659	3659	3659	3659	3659	3659	3659	3659	3659	3659	3670	T_STAGE_AT_DIAGNOSIS_COMPLEX	PATIENT	STRING	T-Stage at Diagnosis (Complex)	T-Stage at Diagnosis (Complex)	1				
3660	3660	3660	3660	3660	3660	3660	3660	3660	3660	3660	3660	3660	3671	T_STAGE_AT_DIAGNOSIS_SIMPLE	PATIENT	STRING	T-Stage at Diagnosis (Simple)	T-Stage at Diagnosis (Simple)	1				
3661	3661	3661	3661	3661	3661	3661	3661	3661	3661	3661	3661	3661	3672	N_STAGE_AT_DIAGNOSIS_COMPLEX	PATIENT	STRING	N-Stage at Diagnosis (Complex)	N-Stage at Diagnosis (Complex)	1				
3662	3662	3662	3662	3662	3662	3662	3662	3662	3662	3662	3662	3662	3673	N_STAGE_AT_DIAGNOSIS_SIMPLE	PATIENT	STRING	N-Stage at Diagnosis (Simple)	N-Stage at Diagnosis (Simple)	1				
3663	3663	3663	3663	3663	3663	3663	3663	3663	3663	3663	3663	3663	3674	M_STAGE_AT_DIAGNOSIS_COMPLEX	PATIENT	STRING	M-Stage at Diagnosis (Complex)	M-Stage at Diagnosis (Complex)	1				
3664	3664	3664	3664	3664	3664	3664	3664	3664	3664	3664	3664	3664	3675	M_STAGE_AT_DIAGNOSIS_SIMPLE	PATIENT	STRING	M-Stage at Diagnosis (Simple)	M-Stage at Diagnosis (Simple)	1				
3665	3665	3665	3665	3665	3665	3665	3665	3665	3665	3665	3665	3665	3676	PATHOLOGIC_STAGE_AJCC7_AT_DIAGNOSIS_COMPLEX	PATIENT	STRING	Pathologic AJCC7 Stage at Diagnosis (Complex)	Pathologic AJCC7 Stage at Diagnosis (Complex)	1				
3666	3666	3666	3666	3666	3666	3666	3666	3666	3666	3666	3666	3666	3677	PATHOLOGIC_STAGE_AJCC7_AT_DIAGNOSIS_SIMPLE	PATIENT	STRING	Pathologic AJCC7 Stage at Diagnosis (Simple)	Pathologic AJCC7 Stage at Diagnosis (Simple)	1				
3667	3667	3667	3667	3667	3667	3667	3667	3667	3667	3667	3667	3667	3678	TCGA_SPECIMEN_SITE	SAMPLE	STRING	TCGA Specimen Site	TCGA Specimen Site	1				
3668	3668	3668	3668	3668	3668	3668	3668	3668	3668	3668	3668	3668	3679	DISTANT_ANATOMIC_SITE	PATIENT	STRING	Distant Anatomic Site	Distant Anatomic Site	1				
3669	3669	3669	3669	3669	3669	3669	3669	3669	3669	3669	3669	3669	3680	TCGA_DAYS_TO_DEATH_OR_LAST_FU	PATIENT	NUMBER	TCGA Days to Death or Last Followup	TCGA Days to Death or Last Followup	1				
3670	3670	3670	3670	3670	3670	3670	3670	3670	3670	3670	3670	3670	3681	TCGA_SPECIMEN_DISTANT	SAMPLE	STRING	TCGA Specimen (Distant)	TCGA Specimen (Distant)	1				
3671	3671	3671	3671	3671	3671	3671	3671	3671	3671	3671	3671	3671	3682	STAGE_HCC_SYSTEMIC	PATIENT	STRING	Stage of HCC at Systemic	Stage of HCC at Systemic	1				
3672	3672	3672	3672	3672	3672	3672	3672	3672	3672	3672	3672	3672	3683	INTRAHEPATIC_DISEASE	PATIENT	STRING	Intrahepatic Disease	Intrahepatic Disease	1				
3673	3673	3673	3673	3673	3673	3673	3673	3673	3673	3673	3673	3673	3684	GROSS_VASCULAR_INVOLVEMENT	PATIENT	STRING	Gross Vascular Involvement	Gross Vascular Involvement	1				
3674	3674	3674	3674	3674	3674	3674	3674	3674	3674	3674	3674	3674	3685	PRIOR_TRANSPLANT	PATIENT	STRING	Prior Transplant	Prior Transplant	1				
3675	3675	3675	3675	3675	3675	3675	3675	3675	3675	3675	3675	3675	3686	PRIOR_RESECTION	PATIENT	STRING	Prior Resection	Prior Resection	1				
3676	3676	3676	3676	3676	3676	3676	3676	3676	3676	3676	3676	3676	3687	PRIOR_REGIONAL_TREATMENT	PATIENT	STRING	Prior Regional Treatment	Prior Regional Treatment	1				
3677	3677	3677	3677	3677	3677	3677	3677	3677	3677	3677	3677	3677	3688	SORAFENIB_TREATMENT	PATIENT	STRING	Sorafenib Treatment	Sorafenib Treatment	1				
3678	3678	3678	3678	3678	3678	3678	3678	3678	3678	3678	3678	3678	3689	MUTATION_CLASS	SAMPLE	STRING	Mutation Class	Mutation Class	1				
3679	3679	3679	3679	3679	3679	3679	3679	3679	3679	3679	3679	3679	3690	FIG2_ORDER	SAMPLE	NUMBER	Figure 2 order.	Figure 2 Order	1				
3680	3680	3680	3680	3680	3680	3680	3680	3680	3680	3680	3680	3680	3691	PRIOR_TAXANE	SAMPLE	STRING	Prior to taxane.	Prior Taxane	1				
3681	3681	3681	3681	3681	3681	3681	3681	3681	3681	3681	3681	3681	3692	PRIOR_ABI_OR_ENZ	SAMPLE	STRING	Prior to Abiraterone acetate or Enzalutamid.	Prior Abi/Enz	1				
3682	3682	3682	3682	3682	3682	3682	3682	3682	3682	3682	3682	3682	3693	NON_VIRAL	SAMPLE	STRING	If sample doesn't have HBV/HCV etc.	Non Viral	1				
3683	3683	3683	3683	3683	3683	3683	3683	3683	3683	3683	3683	3683	3694	PDX_CASE_ID	SAMPLE	STRING	PDX Case ID	PDX Case ID	1				
3684	3684	3684	3684	3684	3684	3684	3684	3684	3684	3684	3684	3684	3695	TREATMENT_BEFORE_COLLECTION	SAMPLE	STRING	Treatment before Collection	Treatment before Collection	1				
3685	3685	3685	3685	3685	3685	3685	3685	3685	3685	3685	3685	3685	3696	IMPACT_PDX_PASSAGE	SAMPLE	STRING	IMPACT PDX Passage	IMPACT PDX Passage	1				
3686	3686	3686	3686	3686	3686	3686	3686	3686	3686	3686	3686	3686	3697	IMPACT_NUMBER	SAMPLE	NUMBER	IMPACT Number	IMPACT Number	1				
3687	3687	3687	3687	3687	3687	3687	3687	3687	3687	3687	3687	3687	3698	RNASEQ_NUMBER	SAMPLE	NUMBER	RNASeq Number	RNASeq Number	1				
3688	3688	3688	3688	3688	3688	3688	3688	3688	3688	3688	3688	3688	3699	PDX_LIB_NUMBER	PATIENT	NUMBER	PDX Library Number	PDX Library Number	1				
3689	3689	3689	3689	3689	3689	3689	3689	3689	3689	3689	3689	3689	3700	ANATOMY	PATIENT	STRING	Anatomy	Anatomy	1				
3690	3690	3690	3690	3690	3690	3690	3690	3690	3690	3690	3690	3690	3701	PLANNED_DOSE	PATIENT	STRING	Planned Radiation Dosage	Planned Dose	1				
3691	3691	3691	3691	3691	3691	3691	3691	3691	3691	3691	3691	3691	3702	DELIVERED_DOSE	PATIENT	STRING	Delivered Radiation Dose	Delivered Dose	1				
3692	3692	3692	3692	3692	3692	3692	3692	3692	3692	3692	3692	3692	3703	PLANNED_FRACTIONS	PATIENT	STRING	Planned Radation Fraction	Planned Fractions	1				
3693	3693	3693	3693	3693	3693	3693	3693	3693	3693	3693	3693	3693	3704	DELIVERED_FRACTIONS	PATIENT	STRING	Delivered Radation Fraction	Delivered Fractions	1				
3694	3694	3694	3694	3694	3694	3694	3694	3694	3694	3694	3694	3694	3705	REF_POINT_SITE	PATIENT	STRING	Reference Point Site	Reference Point Site	1				
3695	3695	3695	3695	3695	3695	3695	3695	3695	3695	3695	3695	3695	3706	INDUCTION_CHEMO	PATIENT	STRING	Did patient receive induction chemotherapy?	Induction Chemo	1				
3696	3696	3696	3696	3696	3696	3696	3696	3696	3696	3696	3696	3696	3707	INDUCTION_XRT	PATIENT	STRING	Did patient receive radiation therapy (XRT)?	Induction XRT	1				
3697	3697	3697	3697	3697	3697	3697	3697	3697	3697	3697	3697	3697	3708	PATHOLOGIC_STAGE_AJCC8	PATIENT	STRING	AJCC 8th edition pathologic stage	Path Stage (AJCC 8th Edition)	1				
3698	3698	3698	3698	3698	3698	3698	3698	3698	3698	3698	3698	3698	3709	PATHOLOGIC_STAGE_AJCC8_COLLAPSE	PATIENT	STRING	AJCC 8th edition pathologic stage collapse (e.g. IA1, IA2 etc. to IA)	Path Stage Collapse (AJCC 8th Edition)	1				
3699	3699	3699	3699	3699	3699	3699	3699	3699	3699	3699	3699	3699	3710	PATHOLOGIC_STAGE_AJCC8_CODE	PATIENT	STRING	AJCC 8th edition pathologic stage code (e.g. IA, IB etc. to I)	Path Stage Code (AJCC 8th Edition)	1				
3700	3700	3700	3700	3700	3700	3700	3700	3700	3700	3700	3700	3700	3711	RESECTION	PATIENT	STRING	Resection	Resection	1				
3701	3701	3701	3701	3701	3701	3701	3701	3701	3701	3701	3701	3701	3712	POST_OP_RECUR	PATIENT	STRING	Did patient patient ever have a recurrence after surgery?	Post Op Recur	1				
3702	3702	3702	3702	3702	3702	3702	3702	3702	3702	3702	3702	3702	3713	MONTHS_FROM_SURGERY_TO_RECURRENCE	PATIENT	NUMBER	Months from surgery to first recurrence	Months from surgery to first recurrence	1				
3703	3703	3703	3703	3703	3703	3703	3703	3703	3703	3703	3703	3703	3714	POST_OP_RECUR_FIRST_SITE_TYPE	PATIENT	STRING	First type recurrence post operation (LR locoregional)	Post Op First Site Type Recur	1				
3704	3704	3704	3704	3704	3704	3704	3704	3704	3704	3704	3704	3704	3715	BRAIN_RECUR_STATUS	PATIENT	STRING	Did patient ever have a brain recurrence?	Brain Recur	1				
3705	3705	3705	3705	3705	3705	3705	3705	3705	3705	3705	3705	3705	3716	BRAIN_RECUR_MONTHS	PATIENT	NUMBER	Months to first recurrence in (or death without recurrence) in brain	First Recur in Brain (months)	1				
3706	3706	3706	3706	3706	3706	3706	3706	3706	3706	3706	3706	3706	3717	BONE_RECUR_STATUS	PATIENT	STRING	Did patient ever have a bone recurrence?	Bone Recur	1				
3707	3707	3707	3707	3707	3707	3707	3707	3707	3707	3707	3707	3707	3718	DFS_BONE_RECUR_MONTHS	PATIENT	NUMBER	Months to first recurrence in (or death without recurrence) in bone	First Recur in Bone (months)	1				
3708	3708	3708	3708	3708	3708	3708	3708	3708	3708	3708	3708	3708	3719	INITIAL_SAMPLE_WEIGHT_GRAMS	SAMPLE	NUMBER	Initial Sample Weight Grams	Initial Sample Weight Grams	1				
3709	3709	3709	3709	3709	3709	3709	3709	3709	3709	3709	3709	3709	3720	X2YR_AIS	PATIENT	STRING	Calculated based on patient-reported response to the question: If [you have been on any therapies for more than two years], please list the cancer therapies you have been on for more than 2 years, if you know their names. Listed as TRUE if patients reported being on an aromatase inhibitors for more than 2 years.	PRD More Than 2 Years Aromatase Inhibitors	1				
3710	3710	3710	3710	3710	3710	3710	3710	3710	3710	3710	3710	3710	3721	X2YR_TAMOXIFEN	PATIENT	STRING	Calculated based on patient-reported response to the question:  If [you have been on any therapies for more than two years], please list the cancer therapies you have been on for more than 2 years, if you know their names. Listed as TRUE if patients reported being on tamoxifen for more than 2 years.	PRD More Than 2 Years Tamoxifen	1				
3711	3711	3711	3711	3711	3711	3711	3711	3711	3711	3711	3711	3711	3722	X2YR_ANTIHER2	PATIENT	STRING	Calculated based on patient-reported response to the question:  If [you have been on any therapies for more than two years], please list the cancer therapies you have been on for more than 2 years, if you know their names. Listed as TRUE if patients reported being on anti-HER2 therapy for more than 2 years.	PRD More Than 2 Years Anti-HER2	1				
3712	3712	3712	3712	3712	3712	3712	3712	3712	3712	3712	3712	3712	3723	X2YR_FULVESTRANT	PATIENT	STRING	Calculated based on patient-reported response to the question:  If [you have been on any therapies for more than two years], please list the cancer therapies you have been on for more than 2 years, if you know their names. Listed as TRUE if patients reported being on fulvestrant for more than 2 years.	PRD More Than 2 Years Fulvestrant	1				
3713	3713	3713	3713	3713	3713	3713	3713	3713	3713	3713	3713	3713	3724	X2YR_CAPECITABINE	PATIENT	STRING	Calculated based on patient-reported response to the question:  If [you have been on any therapies for more than two years], please list the cancer therapies you have been on for more than 2 years, if you know their names. Listed as TRUE if patients reported being on capecitabine for more than 2 years.	PRD More Than 2 Years Capecitabine	1				
3714	3714	3714	3714	3714	3714	3714	3714	3714	3714	3714	3714	3714	3725	X2YR_VEGF_INHIBITOR	PATIENT	STRING	Calculated based on patient-reported response to the question:  If [you have been on any therapies for more than two years], please list the cancer therapies you have been on for more than 2 years, if you know their names. Listed as TRUE if patients reported being on a VEGF inhibitor for more than 2 years.	PRD More Than 2 Years VEGF Inhibitor	1				
3715	3715	3715	3715	3715	3715	3715	3715	3715	3715	3715	3715	3715	3726	X2YR_ANTHRACYCLINE	PATIENT	STRING	Calculated based on patient-reported response to the question:  If [you have been on any therapies for more than two years], please list the cancer therapies you have been on for more than 2 years, if you know their names. Listed as TRUE if patients reported being on an anthracycline for more than 2 years.	PRD More Than 2 Years Anthracycline	1				
3716	3716	3716	3716	3716	3716	3716	3716	3716	3716	3716	3716	3716	3727	X2YR_ALKYLATING_AGENT	PATIENT	STRING	Calculated based on patient-reported response to the question:  If [you have been on any therapies for more than two years], please list the cancer therapies you have been on for more than 2 years, if you know their names. Listed as TRUE if patients reported being on an alkylating agent for more than 2 years.	PRD More Than 2 Years Alkylating Agent	1				
3717	3717	3717	3717	3717	3717	3717	3717	3717	3717	3717	3717	3717	3728	X2YR_CDK46	PATIENT	STRING	Calculated based on patient-reported response to the question:  If [you have been on any therapies for more than two years], please list the cancer therapies you have been on for more than 2 years, if you know their names. Listed as TRUE if patients reported being on a CDK4/6 inhibitor for more than 2 years.	PRD More Than 2 Years CDK4/6 Inhibitor	1				
3718	3718	3718	3718	3718	3718	3718	3718	3718	3718	3718	3718	3718	3729	X2YR_TAXANE	PATIENT	STRING	Calculated based on patient-reported response to the question:  If [you have been on any therapies for more than two years], please list the cancer therapies you have been on for more than 2 years, if you know their names. Listed as TRUE if patients reported being on a taxane for more than 2 years.	PRD More Than 2 Years Taxane	1				
3719	3719	3719	3719	3719	3719	3719	3719	3719	3719	3719	3719	3719	3730	PATIENT_TREATMENT_MODE	PATIENT	STRING	Patient Treatment Mode	Patient Treatment Mode	1				
3720	3720	3720	3720	3720	3720	3720	3720	3720	3720	3720	3720	3720	3731	REGIMEN	PATIENT	STRING	Regimen	Regimen Details	1				
3721	3721	3721	3721	3721	3721	3721	3721	3721	3721	3721	3721	3721	3732	RELAPSE_SEQUENCED	SAMPLE	STRING	Relapse/Sequenced	Relapse/Sequenced	1				
3722	3722	3722	3722	3722	3722	3722	3722	3722	3722	3722	3722	3722	3733	ETS_FUSION_DETAILS	SAMPLE	STRING	ETS Fusion Details	ETS Fusion Details	1				
3723	3723	3723	3723	3723	3723	3723	3723	3723	3723	3723	3723	3723	3734	RAF1_BRAF_STATUS	SAMPLE	STRING	RAF1/BRAF Alteration Status	RAF1/BRAF Status	1				
3724	3724	3724	3724	3724	3724	3724	3724	3724	3724	3724	3724	3724	3735	TMB_COHORT	PATIENT	NUMBER	TMB (Tumor Mutation Burden) Score Relative to Cohort	TMB Score (Cohort)	1				
3725	3725	3725	3725	3725	3725	3725	3725	3725	3725	3725	3725	3725	3736	TMB_COHORT_PERCENTILE	PATIENT	NUMBER	TMB (Tumor Mutation Burden) Score Percentile Relative to Cohort	TMB Score (Cohort Percentile)	1				
3726	3726	3726	3726	3726	3726	3726	3726	3726	3726	3726	3726	3726	3737	TMB_TT_COHORT	PATIENT	NUMBER	TMB (Tumor Mutation Burden) Score Relative to Tumor Type Cohort	TMB Score (Tumor Type Cohort)	1				
3727	3727	3727	3727	3727	3727	3727	3727	3727	3727	3727	3727	3727	3738	TMB_TT_COHORT_PERCENTILE	PATIENT	NUMBER	TMB (Tumor Mutation Burden) Score Percentile Relative to Tumor Type Cohort	TMB Score (Tumor Type Cohort Percentile)	1				
3728	3728	3728	3728	3728	3728	3728	3728	3728	3728	3728	3728	3728	3739	TMB_SCORE	PATIENT	NUMBER	TMB (Tumor Mutation Burden) Score	TMB Score	1				
3729	3729	3729	3729	3729	3729	3729	3729	3729	3729	3729	3729	3729	3740	POLYA_ARV7_SRPM	SAMPLE	NUMBER	polyA ARV7 SRPM spliced reads per million	polyA ARV7 SRPM spliced reads per million	1				
3730	3730	3730	3730	3730	3730	3730	3730	3730	3730	3730	3730	3730	3741	CAPTURE_ARV7_SRPM	SAMPLE	NUMBER	Capture ARV7 SRPM spliced reads per million	Capture ARV7 SRPM spliced reads per million	1				
3731	3731	3731	3731	3731	3731	3731	3731	3731	3731	3731	3731	3731	3742	AR_POLYA_SCORE	PATIENT	NUMBER	AR Score (PolyA)	AR Score (PolyA)	1				
3732	3732	3732	3732	3732	3732	3732	3732	3732	3732	3732	3732	3732	3743	AR_CAPTURE_SCORE	PATIENT	NUMBER	AR Score (Capture)	AR Score (Capture)	1				
3733	3733	3733	3733	3733	3733	3733	3733	3733	3733	3733	3733	3733	3744	NEPC_CAPTURE_SCORE	PATIENT	NUMBER	NEPC Score (Capture)	NEPC Score (Capture)	1				
3734	3734	3734	3734	3734	3734	3734	3734	3734	3734	3734	3734	3734	3745	NEPC_POLYA_SCORE	PATIENT	NUMBER	NEPC Score (PolyA)	NEPC Score (PolyA)	1				
3735	3735	3735	3735	3735	3735	3735	3735	3735	3735	3735	3735	3735	3746	CVR_TMB_COHORT	PATIENT	NUMBER	Median TMB for MSK-IMPACT cohort	TMB Score (Cohort)	1				
3736	3736	3736	3736	3736	3736	3736	3736	3736	3736	3736	3736	3736	3747	CVR_TMB_COHORT_PERCENTILE	SAMPLE	NUMBER	Percentile for the TMB within the MSK-IMAPCT cohort	Impact TMB Percentile (Across All Tumor Types)	1				
3737	3737	3737	3737	3737	3737	3737	3737	3737	3737	3737	3737	3737	3748	CVR_TMB_TT_COHORT	PATIENT	NUMBER	Median TMB for tumor type cohort	TMB Score (Tumor Type Cohort)	1				
3738	3738	3738	3738	3738	3738	3738	3738	3738	3738	3738	3738	3738	3749	CVR_TMB_TT_COHORT_PERCENTILE	SAMPLE	NUMBER	Percentile for the TMB within the Tumor type cohort (at least 10 cases are needed in that tumor type to have a result for this)	Impact TMB Percentile (Within Tumor Type)	1				
3739	3739	3739	3739	3739	3739	3739	3739	3739	3739	3739	3739	3739	3750	CVR_TMB_SCORE	SAMPLE	NUMBER	Calculated TMB score	Impact TMB Score	1				
3740	3740	3740	3740	3740	3740	3740	3740	3740	3740	3740	3740	3740	3751	PASSAGE_ID	SAMPLE	STRING	Passage ID	Passage ID	1				
3741	3741	3741	3741	3741	3741	3741	3741	3741	3741	3741	3741	3741	3752	PROCEDURE_TYPE	PATIENT	STRING	Procedure Type	Procedure Type	1				
3742	3742	3742	3742	3742	3742	3742	3742	3742	3742	3742	3742	3742	3753	PRETREATED	PATIENT	STRING	Pretreated	Any Pretreatment	1				
3743	3743	3743	3743	3743	3743	3743	3743	3743	3743	3743	3743	3743	3754	TREATED	PATIENT	STRING	Treated	Any Treatment	1				
3744	3744	3744	3744	3744	3744	3744	3744	3744	3744	3744	3744	3744	3755	STAGE_AT_HCC_DIAGNOSIS	PATIENT	STRING	Stage of HCC at Diagnosis	Stage of HCC at Diagnosis	1				
3745	3745	3745	3745	3745	3745	3745	3745	3745	3745	3745	3745	3745	3756	EARLY_RESISTANCE	PATIENT	STRING	Early Resistance	Early Resistance	1				
3746	3746	3746	3746	3746	3746	3746	3746	3746	3746	3746	3746	3746	3757	AGE_AT_SEQ_REPORTED_YEARS	SAMPLE	NUMBER	Age (in years) at which sequencing was reported	Age at Which Sequencing was Reported (Years)	1				
3747	3747	3747	3747	3747	3747	3747	3747	3747	3747	3747	3747	3747	3758	SEQ_YEAR	SAMPLE	NUMBER	Date sample was sequenced in years	Sequence Year	1				
3748	3748	3748	3748	3748	3748	3748	3748	3748	3748	3748	3748	3748	3759	CANCER_STUDY_ID	SAMPLE	STRING	cBioPortal study identifier	Cancer Study ID	1				
3749	3749	3749	3749	3749	3749	3749	3749	3749	3749	3749	3749	3749	3760	NONSYNONYMOUS_MUTATION_COUNT	SAMPLE	NUMBER	Nonsynonymous Mutation Count	Nonsynonymous Mutation Count	1				
3750	3750	3750	3750	3750	3750	3750	3750	3750	3750	3750	3750	3750	3761	EXOME_COVERAGE	SAMPLE	NUMBER	Exome Coverage	Exome Coverage	1				
3751	3751	3751	3751	3751	3751	3751	3751	3751	3751	3751	3751	3751	3762	EGFR_POSITIVE	SAMPLE	STRING	Is the EGFR Status for sample positive?	EGFR Positive	1				
3752	3752	3752	3752	3752	3752	3752	3752	3752	3752	3752	3752	3752	3763	ALK_NEGATIVE	SAMPLE	STRING	Is the ALK Status negative?	ALK Negative	1				
3753	3753	3753	3753	3753	3753	3753	3753	3753	3753	3753	3753	3753	3764	KRAS_NEGATIVE	SAMPLE	STRING	Is the KRAS Status negative?	KRAS Negative	1				
3754	3754	3754	3754	3754	3754	3754	3754	3754	3754	3754	3754	3754	3765	OTHER_CONCURRENT_THERAPY	PATIENT	STRING	Did the patient receive any other concurrent therapy 	Other Concurrent Therapy	1				
3755	3755	3755	3755	3755	3755	3755	3755	3755	3755	3755	3755	3755	3766	DRUG_TYPE	PATIENT	STRING	What type of drug was administered?	Drug Type	1				
3756	3756	3756	3756	3756	3756	3756	3756	3756	3756	3756	3756	3756	3767	RECIST	PATIENT	STRING	RECIST Status	RECIST	1				
3757	3757	3757	3757	3757	3757	3757	3757	3757	3757	3757	3757	3757	3768	VA_RESPONSE	PATIENT	STRING	VA Response	VA Response	1				
3758	3758	3758	3758	3758	3758	3758	3758	3758	3758	3758	3758	3758	3769	ROH_RESPONSE	PATIENT	STRING	ROH Response	ROH Response	1				
3759	3759	3759	3759	3759	3759	3759	3759	3759	3759	3759	3759	3759	3770	P16_ISH	PATIENT	STRING	p16 ISH	p16 ISH	1				
3760	3760	3760	3760	3760	3760	3760	3760	3760	3760	3760	3760	3760	3771	AGE_START_IO	PATIENT	STRING	Age Start IO	Age Start IO	1				
3761	3761	3761	3761	3761	3761	3761	3761	3761	3761	3761	3761	3761	3772	METASTATIC_SITE_PATIENT	PATIENT	STRING	The anatomic location to which the cancer has spread.	Metastatic Site	1				
3762	3762	3762	3762	3762	3762	3762	3762	3762	3762	3762	3762	3762	3773	PRIMARY_SITE_PATIENT	PATIENT	STRING	Text term to describe the organ sub-division in an individual with cancer.	Primary Tumor Site	1				
3763	3763	3763	3763	3763	3763	3763	3763	3763	3763	3763	3763	3763	3774	TUMOR_TISSUE_SITE_PATIENT	PATIENT	STRING	Text term that describes the anatomic site of the tumor or disease.	Tumor Disease Anatomic Site	1				
3764	3764	3764	3764	3764	3764	3764	3764	3764	3764	3764	3764	3764	3775	PLATINUM_RESISTANT	PATIENT	STRING	Platinum Resistant	Platinum Treatment Resistant	1				
3765	3765	3765	3765	3765	3765	3765	3765	3765	3765	3765	3765	3765	3776	PLATINUM_SENSITIVE	PATIENT	STRING	Platinum Sensitivity	Platinum Treatment Sensitivity	1				
3766	3766	3766	3766	3766	3766	3766	3766	3766	3766	3766	3766	3766	3777	GRADE_1	PATIENT	STRING	Grade 1	Grade 1	1				
3767	3767	3767	3767	3767	3767	3767	3767	3767	3767	3767	3767	3767	3778	GRADE_2	PATIENT	STRING	Grade 2	Grade 2	1				
3768	3768	3768	3768	3768	3768	3768	3768	3768	3768	3768	3768	3768	3779	GRADE_3	PATIENT	STRING	Grade 3	Grade 3	1				
3769	3769	3769	3769	3769	3769	3769	3769	3769	3769	3769	3769	3769	3780	RETINOBLASTOMA	PATIENT	STRING	Retinoblastoma	Retinoblastoma	1				
3770	3770	3770	3770	3770	3770	3770	3770	3770	3770	3770	3770	3770	3781	ALK_POSITIVE	SAMPLE	STRING	ALK Positive	ALK Positive	1				
3771	3771	3771	3771	3771	3771	3771	3771	3771	3771	3771	3771	3771	3782	AR_NEGATIVE	SAMPLE	STRING	AR Negative	AR Negative	1				
3772	3772	3772	3772	3772	3772	3772	3772	3772	3772	3772	3772	3772	3783	AR_POSITIVE	SAMPLE	STRING	AR Positive	AR Positive	1				
3773	3773	3773	3773	3773	3773	3773	3773	3773	3773	3773	3773	3773	3784	BRCA1_NEGATIVE	SAMPLE	STRING	Is the BRCA1 status negative	BRCA1 Negative	1				
3774	3774	3774	3774	3774	3774	3774	3774	3774	3774	3774	3774	3774	3785	BRCA1_POSITIVE	SAMPLE	STRING	Is BRCA1 status positive	BRCA1 Positive	1				
3775	3775	3775	3775	3775	3775	3775	3775	3775	3775	3775	3775	3775	3786	BRCA2_NEGATIVE	SAMPLE	STRING	Is BRCA2 status negative	BRCA2 Negative	1				
3776	3776	3776	3776	3776	3776	3776	3776	3776	3776	3776	3776	3776	3787	BRCA2_POSITIVE	SAMPLE	STRING	Is BRCA2 Status positive	BRCA2 Positive	1				
3777	3777	3777	3777	3777	3777	3777	3777	3777	3777	3777	3777	3777	3788	BREAST_IMPLANTS	PATIENT	STRING	Breast Implants	Breast Implants	1				
3778	3778	3778	3778	3778	3778	3778	3778	3778	3778	3778	3778	3778	3789	C_MYC_NEGATIVE	SAMPLE	STRING	c-MYC Negative	c-MYC Negative	1				
3779	3779	3779	3779	3779	3779	3779	3779	3779	3779	3779	3779	3779	3790	C_MYC_POSITIVE	SAMPLE	STRING	c-MYC Positive	c-MYC Positive	1				
3780	3780	3780	3780	3780	3780	3780	3780	3780	3780	3780	3780	3780	3791	CROHN_DISEASE	PATIENT	STRING	Crohn's Disease	Crohn's Disease	1				
3781	3781	3781	3781	3781	3781	3781	3781	3781	3781	3781	3781	3781	3792	EGFR_NEGATIVE	SAMPLE	STRING	Is the EGFR status negative	EGFR Negative	1				
3782	3782	3782	3782	3782	3782	3782	3782	3782	3782	3782	3782	3782	3793	ER_NEGATIVE	SAMPLE	STRING	Is the ER status negative	ER Negative	1				
3783	3783	3783	3783	3783	3783	3783	3783	3783	3783	3783	3783	3783	3794	ER_POSITIVE	SAMPLE	STRING	Is the ER status positive	ER Positive	1				
3784	3784	3784	3784	3784	3784	3784	3784	3784	3784	3784	3784	3784	3795	HER2_NEGATIVE	SAMPLE	STRING	Is the HER2 status negative	HER2 Negative	1				
3785	3785	3785	3785	3785	3785	3785	3785	3785	3785	3785	3785	3785	3796	HER2_POSITIVE	SAMPLE	STRING	Is the HER2 status positive	HER2 Positive	1				
3786	3786	3786	3786	3786	3786	3786	3786	3786	3786	3786	3786	3786	3797	HPV_NEGATIVE	SAMPLE	String	Is the HPV status negative	HPV Negative	1				
3787	3787	3787	3787	3787	3787	3787	3787	3787	3787	3787	3787	3787	3798	HPV_POSITIVE	SAMPLE	STRING	Is the HPV status positive	HPV Positive	1				
3788	3788	3788	3788	3788	3788	3788	3788	3788	3788	3788	3788	3788	3799	IDH1_POSITIVE	SAMPLE	STRING	Is the IDH1 status positive	IDH1 Positive	1				
3789	3789	3789	3789	3789	3789	3789	3789	3789	3789	3789	3789	3789	3800	IDH2_NEGATIVE	SAMPLE	STRING	Is the IDH2 status negative	IDH2 Negative	1				
3790	3790	3790	3790	3790	3790	3790	3790	3790	3790	3790	3790	3790	3801	IDH2_POSITIVE	SAMPLE	STRING	Is the IDH2 status positive	IDH2 Positive	1				
3791	3791	3791	3791	3791	3791	3791	3791	3791	3791	3791	3791	3791	3802	KRAS_POSITIVE	SAMPLE	STRING	Is the KRAS status positive	KRAS Positive	1				
3792	3792	3792	3792	3792	3792	3792	3792	3792	3792	3792	3792	3792	3803	P16_NEGATIVE	SAMPLE	STRING	Is the P16 status negative	P16 Negative	1				
3793	3793	3793	3793	3793	3793	3793	3793	3793	3793	3793	3793	3793	3804	P16_POSITIVE	SAMPLE	STRING	Is the P16 Status positive	P16 Positive	1				
3794	3794	3794	3794	3794	3794	3794	3794	3794	3794	3794	3794	3794	3805	PDX_ID	SAMPLE	STRING	Identifier for the PDX case	PDX ID	1				
3795	3795	3795	3795	3795	3795	3795	3795	3795	3795	3795	3795	3795	3806	PR_NEGATIVE	SAMPLE	STRING	Is the PR Status Negative	PR Negative	1				
3796	3796	3796	3796	3796	3796	3796	3796	3796	3796	3796	3796	3796	3807	PR_POSITIVE	SAMPLE	STRING	Is the PR Status positive	PR Positive	1				
3797	3797	3797	3797	3797	3797	3797	3797	3797	3797	3797	3797	3797	3809	TIME_TO_RECURRENCE	PATIENT	NUMBER	Time to Recurrence	Time to Recurrence	1				
3798	3798	3798	3798	3798	3798	3798	3798	3798	3798	3798	3798	3798	3810	ULCERATIVE_COLITIS	PATIENT	STRING	Does the patient have Ulcerative Colitis	Ulcerative Colitis	1				
3799	3799	3799	3799	3799	3799	3799	3799	3799	3799	3799	3799	3799	3811	UV_EXPOSURE	PATIENT	STRING	UV Exposure	UV Exposure	1				
3800	3800	3800	3800	3800	3800	3800	3800	3800	3800	3800	3800	3800	3812	IDH1_NEGATIVE	SAMPLE	STRING	Is the IDH1 status negative	IDH1 Negative	1				
3801	3801	3801	3801	3801	3801	3801	3801	3801	3801	3801	3801	3801	3813	GBC_ABC_STATUS	SAMPLE	STRING	GBC and ABC Status	GBC/ABC Status	1				
3802	3802	3802	3802	3802	3802	3802	3802	3802	3802	3802	3802	3802	3814	IHC_DOUBLE_EXPRESSOR	SAMPLE	STRING	IHC Double Expressor	IHC Double Expressor	1				
3803	3803	3803	3803	3803	3803	3803	3803	3803	3803	3803	3803	3803	3815	BCL2_STATUS	SAMPLE	STRING	BCL2 Status	BCL2 Status	1				
3804	3804	3804	3804	3804	3804	3804	3804	3804	3804	3804	3804	3804	3816	BCL2_FISH_STATUS	SAMPLE	STRING	BCL2 Fish Status	BCL2 Fish Status	1				
3805	3805	3805	3805	3805	3805	3805	3805	3805	3805	3805	3805	3805	3817	BCL6_FISH_STATUS	SAMPLE	STRING	BCL6 Fish Status	BCL6 Fish Status	1				
3806	3806	3806	3806	3806	3806	3806	3806	3806	3806	3806	3806	3806	3818	MYC_FISH	SAMPLE	STRING	MYC Fish Status	MYC Fish Status	1				
3807	3807	3807	3807	3807	3807	3807	3807	3807	3807	3807	3807	3807	3819	FISH_DOUBLE_HIT	SAMPLE	STRING	FISH Double Hit	FISH Double Hit	1				
3808	3808	3808	3808	3808	3808	3808	3808	3808	3808	3808	3808	3808	3820	TIMING_OF_SEQUENCING	SAMPLE	STRING	Timing of Sequencing	Timing of Sequencing	1				
3809	3809	3809	3809	3809	3809	3809	3809	3809	3809	3809	3809	3809	3821	BIOPSY_FROM_RELAPSE	PATIENT	STRING	Biopsy from Relapse	Biopsy from Relapse	1				
3810	3810	3810	3810	3810	3810	3810	3810	3810	3810	3810	3810	3810	3822	DISEASE_RELAPSED	PATIENT	STRING	Did the disease relapse?	Disease Relapsed	1				
3811	3811	3811	3811	3811	3811	3811	3811	3811	3811	3811	3811	3811	3823	TRANSFORMED_DZ_ORIGINAL_TO_TX	SAMPLE	STRING	Transformed Dz (Original to Tx)	Transformed Dz (Original to Tx)	1				
3812	3812	3812	3812	3812	3812	3812	3812	3812	3812	3812	3812	3812	3824	TRANSFORMATION_DATE	SAMPLE	STRING	Transformation Date	Transformation Date	1				
3813	3813	3813	3813	3813	3813	3813	3813	3813	3813	3813	3813	3813	3825	CNS_PPX	SAMPLE	STRING	CNS PPx	CNS PPx	1				
3814	3814	3814	3814	3814	3814	3814	3814	3814	3814	3814	3814	3814	3826	MAINTENANCE	SAMPLE	STRING	Maintenance	Maintenance	1				
3815	3815	3815	3815	3815	3815	3815	3815	3815	3815	3815	3815	3815	3827	SCT	SAMPLE	STRING	SCT	SCT	1				
3816	3816	3816	3816	3816	3816	3816	3816	3816	3816	3816	3816	3816	3828	RADIO_IMMUNO_TREATMENT	SAMPLE	STRING	Radio-Immuno Treatment	Radio-Immuno Treatment	1				
3817	3817	3817	3817	3817	3817	3817	3817	3817	3817	3817	3817	3817	3829	MDS_RISK_FACTOR	PATIENT	STRING	MDS risk factor for leukemia	MDS Risk Factor	1				
3818	3818	3818	3818	3818	3818	3818	3818	3818	3818	3818	3818	3818	3830	BRCA	PATIENT	STRING	BRCA Germline Status	BRCA Germline Status	1				
3819	3819	3819	3819	3819	3819	3819	3819	3819	3819	3819	3819	3819	3831	DENOVO_MBC	SAMPLE	STRING	Denovo MBC	Denovo MBC	1				
3820	3820	3820	3820	3820	3820	3820	3820	3820	3820	3820	3820	3820	3832	HER2_FISH_RATIO	SAMPLE	STRING	HER2 Fish Ratio	HER2 Fish Ratio	1				
3821	3821	3821	3821	3821	3821	3821	3821	3821	3821	3821	3821	3821	3833	HR_STATUS_SAMPLE	SAMPLE	STRING	HR Sample Status	HR Sample Status	1				
3822	3822	3822	3822	3822	3822	3822	3822	3822	3822	3822	3822	3822	3834	PR_PCT_PRIMARY	SAMPLE	NUMBER	PR PCT Primary Sample	PR PCT Primary Sample	1				
3823	3823	3823	3823	3823	3823	3823	3823	3823	3823	3823	3823	3823	3835	ER_PCT_PRIMARY	SAMPLE	STRING	ER PCT Primary	ER PCT Primary	1				
3824	3824	3824	3824	3824	3824	3824	3824	3824	3824	3824	3824	3824	3836	RECEPTOR_STATUS_PRIMARY	SAMPLE	STRING	Receptor Status Primary	Receptor Status Primary	1				
3825	3825	3825	3825	3825	3825	3825	3825	3825	3825	3825	3825	3825	3837	RECEPTOR_STATUS_PATIENT	SAMPLE	STRING	Receptor Status Patient	Receptor Status Patient	1				
3826	3826	3826	3826	3826	3826	3826	3826	3826	3826	3826	3826	3826	3838	N_STAGE_SAMPLE	SAMPLE	STRING	N Stage (Sample)	N Stage (Sample)	1				
3827	3827	3827	3827	3827	3827	3827	3827	3827	3827	3827	3827	3827	3839	M_STAGE_SAMPLE	SAMPLE	STRING	M Stage (Sample)	M Stage (Sample)	1				
3828	3828	3828	3828	3828	3828	3828	3828	3828	3828	3828	3828	3828	3840	PRIOR_BREAST_PRIMARY	SAMPLE	STRING	Prior Breast Primary	Prior Breast Primary	1				
3829	3829	3829	3829	3829	3829	3829	3829	3829	3829	3829	3829	3829	3841	INVASIVE_CARCINOMA_DX_TIME	SAMPLE	NUMBER	Time to Diagnosis Invasive Carcinoma 	Time to Diagnosis Invasive Carcinoma 	1				
3830	3830	3830	3830	3830	3830	3830	3830	3830	3830	3830	3830	3830	3842	NGS_SAMPLE_COLLECTION_TIME	SAMPLE	NUMBER	NGS Sample Collection Time Period	NGS Sample Collection Time Period	1				
3831	3831	3831	3831	3831	3831	3831	3831	3831	3831	3831	3831	3831	3843	PRIOR_LOCAL_RECURRENCE	PATIENT	STRING	Prior Local Recurrence	Prior Local Recurrence	1				
3832	3832	3832	3832	3832	3832	3832	3832	3832	3832	3832	3832	3832	3844	INVASIVE_CARCINOMA_DX_AGE	SAMPLE	NUMBER	Invasive Carcinoma Diagnosis Age	Invasive Carcinoma Diagnosis Age	1				
3833	3833	3833	3833	3833	3833	3833	3833	3833	3833	3833	3833	3833	3845	PDX_RELATED	SAMPLE	STRING	Yes use for PDX or a PDX sample; No not use in PDX	Related to PDX	1				
3834	3834	3834	3834	3834	3834	3834	3834	3834	3834	3834	3834	3834	3846	TREATMENT_DETAIL_BEFORE_PDX	PATIENT	STRING	Treatment summary prior to passing in PDX (only show in summary table)	Treatment Details before PDX	1				
3835	3835	3835	3835	3835	3835	3835	3835	3835	3835	3835	3835	3835	3847	SPECIMEN_DEFINITION	SAMPLE	STRING	For tumor, define the # of treatments and whether run IMPACT (e.g. I2 means after 2 rounds treatments, and sample run IMPACT; T2 means after 2 rounds treatements, sample didn't run IMPACT); For PDX tumor, define the sample passage in PDX (P0 means tumor grow in mouse and collect)	Specimen Definition	1				
3836	3836	3836	3836	3836	3836	3836	3836	3836	3836	3836	3836	3836	3848	PDX_MUTATION_FEATURE	SAMPLE	STRING	Selected mutations according to driving mutations	PDX Mutation Feature	1				
3837	3837	3837	3837	3837	3837	3837	3837	3837	3837	3837	3837	3837	3849	PDX_DEL_FEATURE	SAMPLE	STRING	Selected deep deletions according to driving mutations	PDX Del. Feature	1				
3838	3838	3838	3838	3838	3838	3838	3838	3838	3838	3838	3838	3838	3850	PDX_AMP_FEATURE	SAMPLE	STRING	Selected amplifications according to driving mutations	PDX Amp. Feature	1				
3839	3839	3839	3839	3839	3839	3839	3839	3839	3839	3839	3839	3839	3851	PDX_IMPACT_PASSAGE	SAMPLE	STRING	Which passage has been run IMPACT	PDX IMPACT Passage	1				
3840	3840	3840	3840	3840	3840	3840	3840	3840	3840	3840	3840	3840	3852	PDX_IMPACT_NUMBER	SAMPLE	NUMBER	PDX sample # of those have run IMPACT	PDX IMPACT Number	1				
3841	3841	3841	3841	3841	3841	3841	3841	3841	3841	3841	3841	3841	3853	PDX_RNA_SEQUENCED	SAMPLE	STRING	Whether receive the RNAseq	PDX RNAseq	1				
3842	3842	3842	3842	3842	3842	3842	3842	3842	3842	3842	3842	3842	3854	PDX_RNASEQ_PASSAGE	SAMPLE	STRING	Which passage has been run RNAseq	PDX RNAseq Passage	1				
3843	3843	3843	3843	3843	3843	3843	3843	3843	3843	3843	3843	3843	3855	PDX_RNASEQ_NUMBER	SAMPLE	NUMBER	PDX sample # of those have run RNAseq	PDX RNAseq Number	1				
3844	3844	3844	3844	3844	3844	3844	3844	3844	3844	3844	3844	3844	3856	PDX_MRI	SAMPLE	STRING	Whether receive mouse brain MRI	PDX MRI	1				
3845	3845	3845	3845	3845	3845	3845	3845	3845	3845	3845	3845	3845	3857	HETEROGENEITY	PATIENT	STRING	Is there a heterogeneous architectural pattern?	Heterogeneity	1				
3846	3846	3846	3846	3846	3846	3846	3846	3846	3846	3846	3846	3846	3858	ARCHITECTURAL_PATTERN_GREATER_THAN_50_PERCENT	PATIENT	STRING	Is there a predominant architectural pattern >50%?	Architectural Pattern Greater Than 50 Percent	1				
3847	3847	3847	3847	3847	3847	3847	3847	3847	3847	3847	3847	3847	3859	ARCHITECTURAL_PATTERN_GREATER_THAN_70_PERCENT	PATIENT	STRING	Is there a predominant architectural pattern >70%?	Architectural Pattern Greater Than 70 Percent	1				
3848	3848	3848	3848	3848	3848	3848	3848	3848	3848	3848	3848	3848	3860	NUCLEUS_SCORE	PATIENT	NUMBER	What is the Nucleus Score?	Nucleus Score	1				
3849	3849	3849	3849	3849	3849	3849	3849	3849	3849	3849	3849	3849	3861	CYTOPLASM_VARIABILITY	PATIENT	NUMBER	Is there cytoplasm variability?	Cytoplasm Variability	1				
3850	3850	3850	3850	3850	3850	3850	3850	3850	3850	3850	3850	3850	3862	CLEAR_CELL_COMPONENT	PATIENT	STRING	Is there a clear cell component?	Clear Cell Component	1				
3851	3851	3851	3851	3851	3851	3851	3851	3851	3851	3851	3851	3851	3863	PERIDUCTAL_INFILTRATION	PATIENT	STRING	Is there periductal infiltration?	Periductal Infiltration	1				
3852	3852	3852	3852	3852	3852	3852	3852	3852	3852	3852	3852	3852	3864	AJCC_SUMMARY_STAGE	PATIENT	STRING	What is the Summary stage (8th ed. AJCC)?	AJCC Summary Stage	1				
3853	3853	3853	3853	3853	3853	3853	3853	3853	3853	3853	3853	3853	3865	UNCOMMON_MUTATION_PROFILE	PATIENT	STRING	Did the tumor have an uncommon mutation profile?	Uncommon Mutation Profile	1				
3854	3854	3854	3854	3854	3854	3854	3854	3854	3854	3854	3854	3854	3866	PATIENT_SURGERY_NUMBER	SAMPLE	NUMBER	Patient Surgery Number	Patient Surgery Number	1				
3855	3855	3855	3855	3855	3855	3855	3855	3855	3855	3855	3855	3855	3867	ENHANCING	SAMPLE	STRING	Enhancing	Enhancing	1				
3856	3856	3856	3856	3856	3856	3856	3856	3856	3856	3856	3856	3856	3868	ACQUIRED_AFTER_RADIOTHERAPY	SAMPLE	STRING	Acquired after radiotherapy	Acquired after radiotherapy	1				
3857	3857	3857	3857	3857	3857	3857	3857	3857	3857	3857	3857	3857	3869	ACQUIRED_AFTER_ALKYLATOR_TREATMENT	SAMPLE	STRING	Acquired after alkylator treatment	Acquired after alkylator treatment	1				
3858	3858	3858	3858	3858	3858	3858	3858	3858	3858	3858	3858	3858	3870	ACQUIRED_AFTER_ANY_SYSTEMIC_TREATMENT	SAMPLE	STRING	Acquired after any systemic treatment	Acquired after any systemic treatment	1				
3859	3859	3859	3859	3859	3859	3859	3859	3859	3859	3859	3859	3859	3871	TMZ_HYPERMUTATED	SAMPLE	STRING	TMZ Hypermutated	TMZ Hypermutated	1				
3860	3860	3860	3860	3860	3860	3860	3860	3860	3860	3860	3860	3860	3872	OVERALL_SURVIVAL_STATUS_FROM_SURGERY	SAMPLE	STRING	Overall Survival Status From Surgery	Overall Survival Status From Surgery	1				
3861	3861	3861	3861	3861	3861	3861	3861	3861	3861	3861	3861	3861	3873	OVERALL_SURVIVAL_MONTHS_FROM_SURGERY	SAMPLE	NUMBER	Overall Survival (Months from Surgery)	Overall Survival (Months from Surgery)	1				
3862	3862	3862	3862	3862	3862	3862	3862	3862	3862	3862	3862	3862	3874	PROGRESSION_FREE_SURVIVAL_STATUS	SAMPLE	STRING	Progression-Free Survival Status	Progression-Free Survival Status	1				
3863	3863	3863	3863	3863	3863	3863	3863	3863	3863	3863	3863	3863	3875	PROGRESSION_FREE_SURVIVAL_MONTHS_FROM_SURGERY	SAMPLE	NUMBER	Progression-Free Survival (Months from Surgery)	Progression-Free Survival (Months from Surgery)	1				
3864	3864	3864	3864	3864	3864	3864	3864	3864	3864	3864	3864	3864	3876	PATH_GRADE_DX_TUMOR	PATIENT	STRING	Pathological Grade of Diagnostic Tumor	Pathological Grade of Diagnostic Tumor	1				
3865	3865	3865	3865	3865	3865	3865	3865	3865	3865	3865	3865	3865	3877	PFS_MONTHS_FIRST_LINE_TX	NUMBER	PATIENT	First Line Therapy PFS (months)	First Line Therapy PFS (months)	1				
3866	3866	3866	3866	3866	3866	3866	3866	3866	3866	3866	3866	3866	3878	PROGRESSION_STATUS	PATIENT	STRING	Progression Status	Progression Status	1				
3867	3867	3867	3867	3867	3867	3867	3867	3867	3867	3867	3867	3867	3879	MMRD_IHC	SAMPLE	STRING	MMR-D by IHC	MMR-D by IHC	1				
3868	3868	3868	3868	3868	3868	3868	3868	3868	3868	3868	3868	3868	3880	IHC_DETAIL	PATIENT	STRING	IHC Detail	IHC Detail	1				
3869	3869	3869	3869	3869	3869	3869	3869	3869	3869	3869	3869	3869	3881	POLE_IMPACT	PATIENT	STRING	POLE ultra-mutated by IMPACT	POLE ultra-mutated	1				
3870	3870	3870	3870	3870	3870	3870	3870	3870	3870	3870	3870	3870	3882	CANCER_TYPE_DETAILED_msk_solid_heme									
3871	3871	3871	3871	3871	3871	3871	3871	3871	3871	3871	3871	3871	3883	CANCER_TYPE_DETAILED_msk_solid_heme_priority									
3872	3872	3872	3872	3872	3872	3872	3872	3872	3872	3872	3872	3872	3884	CANCER_TYPE_DETAILED_mskarcher									
3873	3873	3873	3873	3873	3873	3873	3873	3873	3873	3873	3873	3873	3885	CANCER_TYPE_DETAILED_mskarcher_priority									
3874	3874	3874	3874	3874	3874	3874	3874	3874	3874	3874	3874	3874	3886	CANCER_TYPE_DETAILED_mskimpact									
3875	3875	3875	3875	3875	3875	3875	3875	3875	3875	3875	3875	3875	3887	CANCER_TYPE_DETAILED_mskimpact_heme									
3876	3876	3876	3876	3876	3876	3876	3876	3876	3876	3876	3876	3876	3888	CANCER_TYPE_DETAILED_mskimpact_heme_priority									
3877	3877	3877	3877	3877	3877	3877	3877	3877	3877	3877	3877	3877	3889	CANCER_TYPE_DETAILED_mskimpact_priority									
3878	3878	3878	3878	3878	3878	3878	3878	3878	3878	3878	3878	3878	3890	CANCER_TYPE_DETAILED_mskraindance									
3879	3879	3879	3879	3879	3879	3879	3879	3879	3879	3879	3879	3879	3891	CANCER_TYPE_DETAILED_mskraindance_priority									
3880	3880	3880	3880	3880	3880	3880	3880	3880	3880	3880	3880	3880	3892	CANCER_TYPE_msk_solid_heme									
3881	3881	3881	3881	3881	3881	3881	3881	3881	3881	3881	3881	3881	3893	CANCER_TYPE_msk_solid_heme_priority									
3882	3882	3882	3882	3882	3882	3882	3882	3882	3882	3882	3882	3882	3894	CANCER_TYPE_mskarcher									
3883	3883	3883	3883	3883	3883	3883	3883	3883	3883	3883	3883	3883	3895	CANCER_TYPE_mskarcher_priority									
3884	3884	3884	3884	3884	3884	3884	3884	3884	3884	3884	3884	3884	3896	CANCER_TYPE_mskimpact									
3885	3885	3885	3885	3885	3885	3885	3885	3885	3885	3885	3885	3885	3897	CANCER_TYPE_mskimpact_heme									
3886	3886	3886	3886	3886	3886	3886	3886	3886	3886	3886	3886	3886	3898	CANCER_TYPE_mskimpact_heme_priority									
3887	3887	3887	3887	3887	3887	3887	3887	3887	3887	3887	3887	3887	3899	CANCER_TYPE_mskimpact_priority									
3888	3888	3888	3888	3888	3888	3888	3888	3888	3888	3888	3888	3888	3900	CANCER_TYPE_mskraindance									
3889	3889	3889	3889	3889	3889	3889	3889	3889	3889	3889	3889	3889	3901	CANCER_TYPE_mskraindance_priority									
3890	3890	3890	3890	3890	3890	3890	3890	3890	3890	3890	3890	3890	3902	CANCER_TYPE_sclc_mskimpact_2017									
3891	3891	3891	3891	3891	3891	3891	3891	3891	3891	3891	3891	3891	3903	CANCER_TYPE_sclc_mskimpact_2017_priority									
3892	3892	3892	3892	3892	3892	3892	3892	3892	3892	3892	3892	3892	3904	CBEST_B_MEM_mel_cell_2016									
3893	3893	3893	3893	3893	3893	3893	3893	3893	3893	3893	3893	3893	3905	CBEST_B_MEM_mel_cell_2016_priority									
3894	3894	3894	3894	3894	3894	3894	3894	3894	3894	3894	3894	3894	3906	CBEST_B_NAIVE_mel_cell_2016									
3895	3895	3895	3895	3895	3895	3895	3895	3895	3895	3895	3895	3895	3907	CBEST_B_NAIVE_mel_cell_2016_priority									
3896	3896	3896	3896	3896	3896	3896	3896	3896	3896	3896	3896	3896	3908	CBEST_DENDRITIC_ACT_mel_cell_2016									
3897	3897	3897	3897	3897	3897	3897	3897	3897	3897	3897	3897	3897	3909	CBEST_DENDRITIC_ACT_mel_cell_2016_priority									
3898	3898	3898	3898	3898	3898	3898	3898	3898	3898	3898	3898	3898	3910	CBEST_DENDRITIC_REST_mel_cell_2016									
3899	3899	3899	3899	3899	3899	3899	3899	3899	3899	3899	3899	3899	3911	CBEST_DENDRITIC_REST_mel_cell_2016_priority									
3900	3900	3900	3900	3900	3900	3900	3900	3900	3900	3900	3900	3900	3912	CBEST_EOSINOPHILS_mel_cell_2016									
3901	3901	3901	3901	3901	3901	3901	3901	3901	3901	3901	3901	3901	3913	CBEST_EOSINOPHILS_mel_cell_2016_priority									
3902	3902	3902	3902	3902	3902	3902	3902	3902	3902	3902	3902	3902	3914	CBEST_MACRO_M0_mel_cell_2016									
3903	3903	3903	3903	3903	3903	3903	3903	3903	3903	3903	3903	3903	3915	CBEST_MACRO_M0_mel_cell_2016_priority									
3904	3904	3904	3904	3904	3904	3904	3904	3904	3904	3904	3904	3904	3916	CBEST_MACRO_M1_mel_cell_2016									
3905	3905	3905	3905	3905	3905	3905	3905	3905	3905	3905	3905	3905	3917	CBEST_MACRO_M1_mel_cell_2016_priority									
3906	3906	3906	3906	3906	3906	3906	3906	3906	3906	3906	3906	3906	3918	CBEST_MACRO_M2_mel_cell_2016									
3907	3907	3907	3907	3907	3907	3907	3907	3907	3907	3907	3907	3907	3919	CBEST_MACRO_M2_mel_cell_2016_priority									
3908	3908	3908	3908	3908	3908	3908	3908	3908	3908	3908	3908	3908	3920	CBEST_MAST_ACT_mel_cell_2016									
3909	3909	3909	3909	3909	3909	3909	3909	3909	3909	3909	3909	3909	3921	CBEST_MAST_ACT_mel_cell_2016_priority									
3910	3910	3910	3910	3910	3910	3910	3910	3910	3910	3910	3910	3910	3922	CBEST_MAST_REST_mel_cell_2016									
3911	3911	3911	3911	3911	3911	3911	3911	3911	3911	3911	3911	3911	3923	CBEST_MAST_REST_mel_cell_2016_priority									
3912	3912	3912	3912	3912	3912	3912	3912	3912	3912	3912	3912	3912	3924	CBEST_MONO_mel_cell_2016									
3913	3913	3913	3913	3913	3913	3913	3913	3913	3913	3913	3913	3913	3925	CBEST_MONO_mel_cell_2016_priority									
3914	3914	3914	3914	3914	3914	3914	3914	3914	3914	3914	3914	3914	3926	CBEST_NEUTROPHILS_mel_cell_2016									
3915	3915	3915	3915	3915	3915	3915	3915	3915	3915	3915	3915	3915	3927	CBEST_NEUTROPHILS_mel_cell_2016_priority									
3916	3916	3916	3916	3916	3916	3916	3916	3916	3916	3916	3916	3916	3928	CBEST_NK_ACT_mel_cell_2016									
3917	3917	3917	3917	3917	3917	3917	3917	3917	3917	3917	3917	3917	3929	CBEST_NK_ACT_mel_cell_2016_priority									
3918	3918	3918	3918	3918	3918	3918	3918	3918	3918	3918	3918	3918	3930	CBEST_NK_REST_mel_cell_2016									
3919	3919	3919	3919	3919	3919	3919	3919	3919	3919	3919	3919	3919	3931	CBEST_NK_REST_mel_cell_2016_priority									
3920	3920	3920	3920	3920	3920	3920	3920	3920	3920	3920	3920	3920	3932	CBEST_PLASMA_mel_cell_2016									
3921	3921	3921	3921	3921	3921	3921	3921	3921	3921	3921	3921	3921	3933	CBEST_PLASMA_mel_cell_2016_priority									
3922	3922	3922	3922	3922	3922	3922	3922	3922	3922	3922	3922	3922	3934	CBEST_T_CD4_MEM_ACT_mel_cell_2016									
3923	3923	3923	3923	3923	3923	3923	3923	3923	3923	3923	3923	3923	3935	CBEST_T_CD4_MEM_ACT_mel_cell_2016_priority									
3924	3924	3924	3924	3924	3924	3924	3924	3924	3924	3924	3924	3924	3936	CBEST_T_CD4_MEM_REST_mel_cell_2016									
3925	3925	3925	3925	3925	3925	3925	3925	3925	3925	3925	3925	3925	3937	CBEST_T_CD4_MEM_REST_mel_cell_2016_priority									
3926	3926	3926	3926	3926	3926	3926	3926	3926	3926	3926	3926	3926	3938	CBEST_T_CD4_NAIVE_mel_cell_2016									
3927	3927	3927	3927	3927	3927	3927	3927	3927	3927	3927	3927	3927	3939	CBEST_T_CD4_NAIVE_mel_cell_2016_priority									
3928	3928	3928	3928	3928	3928	3928	3928	3928	3928	3928	3928	3928	3940	CBEST_T_CD8_mel_cell_2016									
3929	3929	3929	3929	3929	3929	3929	3929	3929	3929	3929	3929	3929	3941	CBEST_T_CD8_mel_cell_2016_priority									
3930	3930	3930	3930	3930	3930	3930	3930	3930	3930	3930	3930	3930	3942	CBEST_T_FOLLI_HEL_mel_cell_2016									
3931	3931	3931	3931	3931	3931	3931	3931	3931	3931	3931	3931	3931	3943	CBEST_T_FOLLI_HEL_mel_cell_2016_priority									
3932	3932	3932	3932	3932	3932	3932	3932	3932	3932	3932	3932	3932	3944	CBEST_T_G_D_mel_cell_2016									
3933	3933	3933	3933	3933	3933	3933	3933	3933	3933	3933	3933	3933	3945	CBEST_T_G_D_mel_cell_2016_priority									
3934	3934	3934	3934	3934	3934	3934	3934	3934	3934	3934	3934	3934	3946	CBEST_T_REG_mel_cell_2016									
3935	3935	3935	3935	3935	3935	3935	3935	3935	3935	3935	3935	3935	3947	CBEST_T_REG_mel_cell_2016_priority									
3936	3936	3936	3936	3936	3936	3936	3936	3936	3936	3936	3936	3936	3948	CIBERSORT_ABSOLUTE_mel_cell_2016									
3937	3937	3937	3937	3937	3937	3937	3937	3937	3937	3937	3937	3937	3949	CIBERSORT_ABSOLUTE_mel_cell_2016_priority									
3938	3938	3938	3938	3938	3938	3938	3938	3938	3938	3938	3938	3938	3950	CIBERSORT_CORRELATION_mel_cell_2016									
3939	3939	3939	3939	3939	3939	3939	3939	3939	3939	3939	3939	3939	3951	CIBERSORT_CORRELATION_mel_cell_2016_priority									
3940	3940	3940	3940	3940	3940	3940	3940	3940	3940	3940	3940	3940	3952	CIBERSORT_P_mel_cell_2016									
3941	3941	3941	3941	3941	3941	3941	3941	3941	3941	3941	3941	3941	3953	CIBERSORT_P_mel_cell_2016_priority									
3942	3942	3942	3942	3942	3942	3942	3942	3942	3942	3942	3942	3942	3954	CIBERSORT_RMSE_mel_cell_2016									
3943	3943	3943	3943	3943	3943	3943	3943	3943	3943	3943	3943	3943	3955	CIBERSORT_RMSE_mel_cell_2016_priority									
3944	3944	3944	3944	3944	3944	3944	3944	3944	3944	3944	3944	3944	3956	CNA_NUMBER_brain_pdx_msk_2018									
3945	3945	3945	3945	3945	3945	3945	3945	3945	3945	3945	3945	3945	3957	CNA_NUMBER_brain_pdx_msk_2018_priority									
3946	3946	3946	3946	3946	3946	3946	3946	3946	3946	3946	3946	3946	3958	COMMENTS_brain_pdx_msk_2018									
3947	3947	3947	3947	3947	3947	3947	3947	3947	3947	3947	3947	3947	3959	COMMENTS_brain_pdx_msk_2018_priority									
3948	3948	3948	3948	3948	3948	3948	3948	3948	3948	3948	3948	3948	3960	COVERED_BASES_uccc_nih_2017									
3949	3949	3949	3949	3949	3949	3949	3949	3949	3949	3949	3949	3949	3961	COVERED_BASES_uccc_nih_2017_datatype									
3950	3950	3950	3950	3950	3950	3950	3950	3950	3950	3950	3950	3950	3962	CURRENT_PDX_PASSAGE_brain_pdx_msk_2018									
3951	3951	3951	3951	3951	3951	3951	3951	3951	3951	3951	3951	3951	3963	CURRENT_PDX_PASSAGE_brain_pdx_msk_2018_priority									
3952	3952	3952	3952	3952	3952	3952	3952	3952	3952	3952	3952	3952	3964	CYTOLOGY_ihch_impact_cmo_2018									
3953	3953	3953	3953	3953	3953	3953	3953	3953	3953	3953	3953	3953	3965	CYTOLOGY_ihch_impact_cmo_2018_attributetype									
3954	3954	3954	3954	3954	3954	3954	3954	3954	3954	3954	3954	3954	3966	CYTOLYTIC_SCORE_mel_cell_2016									
3955	3955	3955	3955	3955	3955	3955	3955	3955	3955	3955	3955	3955	3967	CYTOLYTIC_SCORE_mel_cell_2016_priority									
3956	3956	3956	3956	3956	3956	3956	3956	3956	3956	3956	3956	3956	3968	CYTOLYTIC_SCORE_skcm_mskcc_2014									
3957	3957	3957	3957	3957	3957	3957	3957	3957	3957	3957	3957	3957	3969	CYTOLYTIC_SCORE_skcm_mskcc_2014_priority									
3958	3958	3958	3958	3958	3958	3958	3958	3958	3958	3958	3958	3958	3970	CYTOLYTIC_SCORE_skcm_mskcc_2015									
3959	3959	3959	3959	3959	3959	3959	3959	3959	3959	3959	3959	3959	3971	CYTOLYTIC_SCORE_skcm_mskcc_2015_priority									
3960	3960	3960	3960	3960	3960	3960	3960	3960	3960	3960	3960	3960	3972	DARWIN_PATIENT_AGE_mixedpact									
3961	3961	3961	3961	3961	3961	3961	3961	3961	3961	3961	3961	3961	3973	DARWIN_PATIENT_AGE_mixedpact_priority									
3962	3962	3962	3962	3962	3962	3962	3962	3962	3962	3962	3962	3962	3974	DARWIN_VITAL_STATUS_mixedpact									
3963	3963	3963	3963	3963	3963	3963	3963	3963	3963	3963	3963	3963	3975	DARWIN_VITAL_STATUS_mixedpact_priority									
3964	3964	3964	3964	3964	3964	3964	3964	3964	3964	3964	3964	3964	3976	DFS_MONTHS_mixedpact									
3965	3965	3965	3965	3965	3965	3965	3965	3965	3965	3965	3965	3965	3977	DFS_MONTHS_mixedpact_priority									
3966	3966	3966	3966	3966	3966	3966	3966	3966	3966	3966	3966	3966	3978	DFS_STATUS_mixedpact									
3967	3967	3967	3967	3967	3967	3967	3967	3967	3967	3967	3967	3967	3979	DFS_STATUS_mixedpact_priority									
3968	3968	3968	3968	3968	3968	3968	3968	3968	3968	3968	3968	3968	3980	DNA_INPUT_msk_impact_2017									
3969	3969	3969	3969	3969	3969	3969	3969	3969	3969	3969	3969	3969	3981	DNA_INPUT_msk_impact_2017_datatype									
3970	3970	3970	3970	3970	3970	3970	3970	3970	3970	3970	3970	3970	3982	ESTIMATE_SCORE_skcm_mskcc_2014									
3971	3971	3971	3971	3971	3971	3971	3971	3971	3971	3971	3971	3971	3983	ESTIMATE_SCORE_skcm_mskcc_2014_priority									
3972	3972	3972	3972	3972	3972	3972	3972	3972	3972	3972	3972	3972	3984	ESTIMATE_SCORE_skcm_mskcc_2015									
3973	3973	3973	3973	3973	3973	3973	3973	3973	3973	3973	3973	3973	3985	ESTIMATE_SCORE_skcm_mskcc_2015_priority									
3974	3974	3974	3974	3974	3974	3974	3974	3974	3974	3974	3974	3974	3986	ETHNICITY_msk_solid_heme									
3975	3975	3975	3975	3975	3975	3975	3975	3975	3975	3975	3975	3975	3987	ETHNICITY_msk_solid_heme_priority									
3976	3976	3976	3976	3976	3976	3976	3976	3976	3976	3976	3976	3976	3988	ETHNICITY_mskarcher									
3977	3977	3977	3977	3977	3977	3977	3977	3977	3977	3977	3977	3977	3989	ETHNICITY_mskarcher_priority									
3978	3978	3978	3978	3978	3978	3978	3978	3978	3978	3978	3978	3978	3990	ETHNICITY_mskimpact									
3979	3979	3979	3979	3979	3979	3979	3979	3979	3979	3979	3979	3979	3991	ETHNICITY_mskimpact_heme									
3980	3980	3980	3980	3980	3980	3980	3980	3980	3980	3980	3980	3980	3992	ETHNICITY_mskimpact_heme_priority									
3981	3981	3981	3981	3981	3981	3981	3981	3981	3981	3981	3981	3981	3993	ETHNICITY_mskimpact_priority									
3982	3982	3982	3982	3982	3982	3982	3982	3982	3982	3982	3982	3982	3994	ETHNICITY_mskraindance									
3983	3983	3983	3983	3983	3983	3983	3983	3983	3983	3983	3983	3983	3995	ETHNICITY_mskraindance_priority									
3984	3984	3984	3984	3984	3984	3984	3984	3984	3984	3984	3984	3984	3996	GENE_PANEL_msk_solid_heme									
3985	3985	3985	3985	3985	3985	3985	3985	3985	3985	3985	3985	3985	3997	GENE_PANEL_msk_solid_heme_priority									
3986	3986	3986	3986	3986	3986	3986	3986	3986	3986	3986	3986	3986	3998	GENE_PANEL_mskarcher									
3987	3987	3987	3987	3987	3987	3987	3987	3987	3987	3987	3987	3987	3999	GENE_PANEL_mskarcher_priority									
3988	3988	3988	3988	3988	3988	3988	3988	3988	3988	3988	3988	3988	4000	GENE_PANEL_mskimpact									
3989	3989	3989	3989	3989	3989	3989	3989	3989	3989	3989	3989	3989	4001	GENE_PANEL_mskimpact_heme									
3990	3990	3990	3990	3990	3990	3990	3990	3990	3990	3990	3990	3990	4002	GENE_PANEL_mskimpact_heme_priority									
3991	3991	3991	3991	3991	3991	3991	3991	3991	3991	3991	3991	3991	4003	GENE_PANEL_mskimpact_priority									
3992	3992	3992	3992	3992	3992	3992	3992	3992	3992	3992	3992	3992	4004	GENE_PANEL_mskraindance									
3993	3993	3993	3993	3993	3993	3993	3993	3993	3993	3993	3993	3993	4005	GENE_PANEL_mskraindance_priority									
3994	3994	3994	3994	3994	3994	3994	3994	3994	3994	3994	3994	3994	4006	HISTO_MUCIN_EC_ihch_impact_cmo_2018									
3995	3995	3995	3995	3995	3995	3995	3995	3995	3995	3995	3995	3995	4007	HISTO_MUCIN_EC_ihch_impact_cmo_2018_attributetype									
3996	3996	3996	3996	3996	3996	3996	3996	3996	3996	3996	3996	3996	4008	HISTO_MUCIN_IC_ihch_impact_cmo_2018									
3997	3997	3997	3997	3997	3997	3997	3997	3997	3997	3997	3997	3997	4009	HISTO_MUCIN_IC_ihch_impact_cmo_2018_attributetype									
3998	3998	3998	3998	3998	3998	3998	3998	3998	3998	3998	3998	3998	4010	HISTO_SCAR_ihch_impact_cmo_2018									
3999	3999	3999	3999	3999	3999	3999	3999	3999	3999	3999	3999	3999	4011	HISTO_SCAR_ihch_impact_cmo_2018_attributetype									
4000	4000	4000	4000	4000	4000	4000	4000	4000	4000	4000	4000	4000	4012	HLA_A_mel_cell_2016									
4001	4001	4001	4001	4001	4001	4001	4001	4001	4001	4001	4001	4001	4013	HLA_A_mel_cell_2016_priority									
4002	4002	4002	4002	4002	4002	4002	4002	4002	4002	4002	4002	4002	4014	HLA_A_skcm_mskcc_2014									
4003	4003	4003	4003	4003	4003	4003	4003	4003	4003	4003	4003	4003	4015	HLA_A_skcm_mskcc_2014_priority									
4004	4004	4004	4004	4004	4004	4004	4004	4004	4004	4004	4004	4004	4016	HLA_A_skcm_mskcc_2015									
4005	4005	4005	4005	4005	4005	4005	4005	4005	4005	4005	4005	4005	4017	HLA_A_skcm_mskcc_2015_priority									
4006	4006	4006	4006	4006	4006	4006	4006	4006	4006	4006	4006	4006	4018	HLA_B_mel_cell_2016									
4007	4007	4007	4007	4007	4007	4007	4007	4007	4007	4007	4007	4007	4019	HLA_B_mel_cell_2016_priority									
4008	4008	4008	4008	4008	4008	4008	4008	4008	4008	4008	4008	4008	4020	HLA_B_skcm_mskcc_2014									
4009	4009	4009	4009	4009	4009	4009	4009	4009	4009	4009	4009	4009	4021	HLA_B_skcm_mskcc_2014_priority									
4010	4010	4010	4010	4010	4010	4010	4010	4010	4010	4010	4010	4010	4022	HLA_B_skcm_mskcc_2015									
4011	4011	4011	4011	4011	4011	4011	4011	4011	4011	4011	4011	4011	4023	HLA_B_skcm_mskcc_2015_priority									
4012	4012	4012	4012	4012	4012	4012	4012	4012	4012	4012	4012	4012	4024	HLA_C_mel_cell_2016									
4013	4013	4013	4013	4013	4013	4013	4013	4013	4013	4013	4013	4013	4025	HLA_C_mel_cell_2016_priority									
4014	4014	4014	4014	4014	4014	4014	4014	4014	4014	4014	4014	4014	4026	HLA_C_skcm_mskcc_2014									
4015	4015	4015	4015	4015	4015	4015	4015	4015	4015	4015	4015	4015	4027	HLA_C_skcm_mskcc_2014_priority									
4016	4016	4016	4016	4016	4016	4016	4016	4016	4016	4016	4016	4016	4028	HLA_C_skcm_mskcc_2015									
4017	4017	4017	4017	4017	4017	4017	4017	4017	4017	4017	4017	4017	4029	HLA_C_skcm_mskcc_2015_priority									
4018	4018	4018	4018	4018	4018	4018	4018	4018	4018	4018	4018	4018	4030	IMMUNE_SCORE_mel_cell_2016									
4019	4019	4019	4019	4019	4019	4019	4019	4019	4019	4019	4019	4019	4031	IMMUNE_SCORE_mel_cell_2016_priority									
4020	4020	4020	4020	4020	4020	4020	4020	4020	4020	4020	4020	4020	4032	IMMUNE_SCORE_skcm_mskcc_2014									
4021	4021	4021	4021	4021	4021	4021	4021	4021	4021	4021	4021	4021	4033	IMMUNE_SCORE_skcm_mskcc_2014_priority									
4022	4022	4022	4022	4022	4022	4022	4022	4022	4022	4022	4022	4022	4034	IMMUNE_SCORE_skcm_mskcc_2015									
4023	4023	4023	4023	4023	4023	4023	4023	4023	4023	4023	4023	4023	4035	IMMUNE_SCORE_skcm_mskcc_2015_priority									
4024	4024	4024	4024	4024	4024	4024	4024	4024	4024	4024	4024	4024	4036	INSTITUTE_msk_solid_heme									
4025	4025	4025	4025	4025	4025	4025	4025	4025	4025	4025	4025	4025	4037	INSTITUTE_msk_solid_heme_priority									
4026	4026	4026	4026	4026	4026	4026	4026	4026	4026	4026	4026	4026	4038	INSTITUTE_mskarcher									
4027	4027	4027	4027	4027	4027	4027	4027	4027	4027	4027	4027	4027	4039	INSTITUTE_mskarcher_priority									
4028	4028	4028	4028	4028	4028	4028	4028	4028	4028	4028	4028	4028	4040	INSTITUTE_mskimpact									
4029	4029	4029	4029	4029	4029	4029	4029	4029	4029	4029	4029	4029	4041	INSTITUTE_mskimpact_heme									
4030	4030	4030	4030	4030	4030	4030	4030	4030	4030	4030	4030	4030	4042	INSTITUTE_mskimpact_heme_priority									
4031	4031	4031	4031	4031	4031	4031	4031	4031	4031	4031	4031	4031	4043	INSTITUTE_mskimpact_priority									
4032	4032	4032	4032	4032	4032	4032	4032	4032	4032	4032	4032	4032	4044	INSTITUTE_mskraindance									
4033	4033	4033	4033	4033	4033	4033	4033	4033	4033	4033	4033	4033	4045	INSTITUTE_mskraindance_priority									
4034	4034	4034	4034	4034	4034	4034	4034	4034	4034	4034	4034	4034	4046	LYMPH_NODE_METASTASIS_ihch_impact_cmo_2018									
4035	4035	4035	4035	4035	4035	4035	4035	4035	4035	4035	4035	4035	4047	LYMPH_NODE_METASTASIS_ihch_impact_cmo_2018_attributetype									
4036	4036	4036	4036	4036	4036	4036	4036	4036	4036	4036	4036	4036	4048	MITOTIC_SCORE_ihch_impact_cmo_2018									
4037	4037	4037	4037	4037	4037	4037	4037	4037	4037	4037	4037	4037	4049	MITOTIC_SCORE_ihch_impact_cmo_2018_attributetype									
4038	4038	4038	4038	4038	4038	4038	4038	4038	4038	4038	4038	4038	4050	MUTATION_LOAD_mel_cell_2016									
4039	4039	4039	4039	4039	4039	4039	4039	4039	4039	4039	4039	4039	4051	MUTATION_LOAD_mel_cell_2016_priority									
4040	4040	4040	4040	4040	4040	4040	4040	4040	4040	4040	4040	4040	4052	MUTATION_NUMBER_brain_pdx_msk_2018									
4041	4041	4041	4041	4041	4041	4041	4041	4041	4041	4041	4041	4041	4053	MUTATION_NUMBER_brain_pdx_msk_2018_priority									
4042	4042	4042	4042	4042	4042	4042	4042	4042	4042	4042	4042	4042	4054	M_STAGE_mel_cell_2016									
4043	4043	4043	4043	4043	4043	4043	4043	4043	4043	4043	4043	4043	4055	M_STAGE_mel_cell_2016_priority									
4044	4044	4044	4044	4044	4044	4044	4044	4044	4044	4044	4044	4044	4056	NEOAGCNT_mel_cell_2016									
4045	4045	4045	4045	4045	4045	4045	4045	4045	4045	4045	4045	4045	4057	NEOAGCNT_mel_cell_2016_priority									
4046	4046	4046	4046	4046	4046	4046	4046	4046	4046	4046	4046	4046	4058	NEOAGCNT_skcm_mskcc_2014									
4047	4047	4047	4047	4047	4047	4047	4047	4047	4047	4047	4047	4047	4059	NEOAGCNT_skcm_mskcc_2014_priority									
4048	4048	4048	4048	4048	4048	4048	4048	4048	4048	4048	4048	4048	4060	NEOAGCNT_skcm_mskcc_2015									
4049	4049	4049	4049	4049	4049	4049	4049	4049	4049	4049	4049	4049	4061	NEOAGCNT_skcm_mskcc_2015_priority									
4050	4050	4050	4050	4050	4050	4050	4050	4050	4050	4050	4050	4050	4062	ONCOTREE_CODE_mel_cell_2016									
4051	4051	4051	4051	4051	4051	4051	4051	4051	4051	4051	4051	4051	4063	ONCOTREE_CODE_mel_cell_2016_priority									
4052	4052	4052	4052	4052	4052	4052	4052	4052	4052	4052	4052	4052	4064	OS_MONTHS_mel_cell_2016									
4053	4053	4053	4053	4053	4053	4053	4053	4053	4053	4053	4053	4053	4065	OS_MONTHS_mel_cell_2016_priority									
4054	4054	4054	4054	4054	4054	4054	4054	4054	4054	4054	4054	4054	4066	OS_MONTHS_mixedpact									
4055	4055	4055	4055	4055	4055	4055	4055	4055	4055	4055	4055	4055	4067	OS_MONTHS_mixedpact_priority									
4056	4056	4056	4056	4056	4056	4056	4056	4056	4056	4056	4056	4056	4068	OS_MONTHS_sclc_mskimpact_2017									
4057	4057	4057	4057	4057	4057	4057	4057	4057	4057	4057	4057	4057	4069	OS_MONTHS_sclc_mskimpact_2017_priority									
4058	4058	4058	4058	4058	4058	4058	4058	4058	4058	4058	4058	4058	4070	OS_STATUS_mel_cell_2016									
4059	4059	4059	4059	4059	4059	4059	4059	4059	4059	4059	4059	4059	4071	OS_STATUS_mel_cell_2016_priority									
4060	4060	4060	4060	4060	4060	4060	4060	4060	4060	4060	4060	4060	4072	OS_STATUS_mixedpact									
4061	4061	4061	4061	4061	4061	4061	4061	4061	4061	4061	4061	4061	4073	OS_STATUS_mixedpact_priority									
4062	4062	4062	4062	4062	4062	4062	4062	4062	4062	4062	4062	4062	4074	OS_STATUS_msk_solid_heme									
4063	4063	4063	4063	4063	4063	4063	4063	4063	4063	4063	4063	4063	4075	OS_STATUS_msk_solid_heme_priority									
4064	4064	4064	4064	4064	4064	4064	4064	4064	4064	4064	4064	4064	4076	OS_STATUS_mskarcher									
4065	4065	4065	4065	4065	4065	4065	4065	4065	4065	4065	4065	4065	4077	OS_STATUS_mskarcher_priority									
4066	4066	4066	4066	4066	4066	4066	4066	4066	4066	4066	4066	4066	4078	OS_STATUS_mskimpact									
4067	4067	4067	4067	4067	4067	4067	4067	4067	4067	4067	4067	4067	4079	OS_STATUS_mskimpact_heme									
4068	4068	4068	4068	4068	4068	4068	4068	4068	4068	4068	4068	4068	4080	OS_STATUS_mskimpact_heme_priority									
4069	4069	4069	4069	4069	4069	4069	4069	4069	4069	4069	4069	4069	4081	OS_STATUS_mskimpact_priority									
4070	4070	4070	4070	4070	4070	4070	4070	4070	4070	4070	4070	4070	4082	OS_STATUS_mskraindance									
4071	4071	4071	4071	4071	4071	4071	4071	4071	4071	4071	4071	4071	4083	OS_STATUS_mskraindance_priority									
4072	4072	4072	4072	4072	4072	4072	4072	4072	4072	4072	4072	4072	4084	OS_STATUS_sclc_mskimpact_2017									
4073	4073	4073	4073	4073	4073	4073	4073	4073	4073	4073	4073	4073	4085	OS_STATUS_sclc_mskimpact_2017_priority									
4074	4074	4074	4074	4074	4074	4074	4074	4074	4074	4074	4074	4074	4086	PARTC_CONSENTED_12_245_msk_solid_heme									
4075	4075	4075	4075	4075	4075	4075	4075	4075	4075	4075	4075	4075	4087	PARTC_CONSENTED_12_245_msk_solid_heme_priority									
4076	4076	4076	4076	4076	4076	4076	4076	4076	4076	4076	4076	4076	4088	PARTC_CONSENTED_12_245_mskarcher									
4077	4077	4077	4077	4077	4077	4077	4077	4077	4077	4077	4077	4077	4089	PARTC_CONSENTED_12_245_mskarcher_priority									
4078	4078	4078	4078	4078	4078	4078	4078	4078	4078	4078	4078	4078	4090	PARTC_CONSENTED_12_245_mskimpact									
4079	4079	4079	4079	4079	4079	4079	4079	4079	4079	4079	4079	4079	4091	PARTC_CONSENTED_12_245_mskimpact_heme									
4080	4080	4080	4080	4080	4080	4080	4080	4080	4080	4080	4080	4080	4092	PARTC_CONSENTED_12_245_mskimpact_heme_priority									
4081	4081	4081	4081	4081	4081	4081	4081	4081	4081	4081	4081	4081	4093	PARTC_CONSENTED_12_245_mskimpact_priority									
4082	4082	4082	4082	4082	4082	4082	4082	4082	4082	4082	4082	4082	4094	PARTC_CONSENTED_12_245_mskraindance									
4083	4083	4083	4083	4083	4083	4083	4083	4083	4083	4083	4083	4083	4095	PARTC_CONSENTED_12_245_mskraindance_priority									
4084	4084	4084	4084	4084	4084	4084	4084	4084	4084	4084	4084	4084	4096	PATH_SATELLITE_NODULES_ihch_impact_cmo_2018									
4085	4085	4085	4085	4085	4085	4085	4085	4085	4085	4085	4085	4085	4097	PATH_SATELLITE_NODULES_ihch_impact_cmo_2018_attributetype									
4086	4086	4086	4086	4086	4086	4086	4086	4086	4086	4086	4086	4086	4098	PATIENT_ID_mel_cell_2016									
4087	4087	4087	4087	4087	4087	4087	4087	4087	4087	4087	4087	4087	4099	PATIENT_ID_mel_cell_2016_priority									
4088	4088	4088	4088	4088	4088	4088	4088	4088	4088	4088	4088	4088	4100	PDX_AMP_FEATURE_brain_pdx_msk_2018									
4089	4089	4089	4089	4089	4089	4089	4089	4089	4089	4089	4089	4089	4101	PDX_AMP_FEATURE_brain_pdx_msk_2018_priority									
4090	4090	4090	4090	4090	4090	4090	4090	4090	4090	4090	4090	4090	4102	PDX_DEL_FEATURE_brain_pdx_msk_2018									
4091	4091	4091	4091	4091	4091	4091	4091	4091	4091	4091	4091	4091	4103	PDX_DEL_FEATURE_brain_pdx_msk_2018_priority									
4092	4092	4092	4092	4092	4092	4092	4092	4092	4092	4092	4092	4092	4104	PDX_MUTATION_FEATURE_brain_pdx_msk_2018									
4093	4093	4093	4093	4093	4093	4093	4093	4093	4093	4093	4093	4093	4105	PDX_MUTATION_FEATURE_brain_pdx_msk_2018_priority									
4094	4094	4094	4094	4094	4094	4094	4094	4094	4094	4094	4094	4094	4106	PDX_RNASEQ_NUMBER_brain_pdx_msk_2018									
4095	4095	4095	4095	4095	4095	4095	4095	4095	4095	4095	4095	4095	4107	PDX_RNASEQ_NUMBER_brain_pdx_msk_2018_priority									
4096	4096	4096	4096	4096	4096	4096	4096	4096	4096	4096	4096	4096	4108	PDX_RNASEQ_PASSAGE_brain_pdx_msk_2018									
4097	4097	4097	4097	4097	4097	4097	4097	4097	4097	4097	4097	4097	4109	PDX_RNASEQ_PASSAGE_brain_pdx_msk_2018_priority									
4098	4098	4098	4098	4098	4098	4098	4098	4098	4098	4098	4098	4098	4110	PDX_SURVIVAL_RANGE_brain_pdx_msk_2018									
4099	4099	4099	4099	4099	4099	4099	4099	4099	4099	4099	4099	4099	4111	PDX_SURVIVAL_RANGE_brain_pdx_msk_2018_priority									
4100	4100	4100	4100	4100	4100	4100	4100	4100	4100	4100	4100	4100	4112	PREVIOUS_MAPKI_mel_cell_2016									
4101	4101	4101	4101	4101	4101	4101	4101	4101	4101	4101	4101	4101	4113	PREVIOUS_MAPKI_mel_cell_2016_priority									
4102	4102	4102	4102	4102	4102	4102	4102	4102	4102	4102	4102	4102	4114	PRIMARY_SITE_mel_cell_2016									
4103	4103	4103	4103	4103	4103	4103	4103	4103	4103	4103	4103	4103	4115	PRIMARY_SITE_mel_cell_2016_priority									
4104	4104	4104	4104	4104	4104	4104	4104	4104	4104	4104	4104	4104	4116	RACE_msk_solid_heme									
4105	4105	4105	4105	4105	4105	4105	4105	4105	4105	4105	4105	4105	4117	RACE_msk_solid_heme_priority									
4106	4106	4106	4106	4106	4106	4106	4106	4106	4106	4106	4106	4106	4118	RACE_mskarcher									
4107	4107	4107	4107	4107	4107	4107	4107	4107	4107	4107	4107	4107	4119	RACE_mskarcher_priority									
4108	4108	4108	4108	4108	4108	4108	4108	4108	4108	4108	4108	4108	4120	RACE_mskimpact									
4109	4109	4109	4109	4109	4109	4109	4109	4109	4109	4109	4109	4109	4121	RACE_mskimpact_heme									
4110	4110	4110	4110	4110	4110	4110	4110	4110	4110	4110	4110	4110	4122	RACE_mskimpact_heme_priority									
4111	4111	4111	4111	4111	4111	4111	4111	4111	4111	4111	4111	4111	4123	RACE_mskimpact_priority									
4112	4112	4112	4112	4112	4112	4112	4112	4112	4112	4112	4112	4112	4124	RACE_mskraindance									
4113	4113	4113	4113	4113	4113	4113	4113	4113	4113	4113	4113	4113	4125	RACE_mskraindance_priority									
4114	4114	4114	4114	4114	4114	4114	4114	4114	4114	4114	4114	4114	4126	RECEPTOR_STATUS_PATIENT_breast_msk_2018									
4115	4115	4115	4115	4115	4115	4115	4115	4115	4115	4115	4115	4115	4127	RECEPTOR_STATUS_PATIENT_breast_msk_2018_attributetype									
4116	4116	4116	4116	4116	4116	4116	4116	4116	4116	4116	4116	4116	4128	RECEPTOR_STATUS_PATIENT_breast_msk_2018_displayname									
4117	4117	4117	4117	4117	4117	4117	4117	4117	4117	4117	4117	4117	4129	SAMPLE_COVERAGE_msk_impact_2017									
4118	4118	4118	4118	4118	4118	4118	4118	4118	4118	4118	4118	4118	4130	SAMPLE_COVERAGE_msk_impact_2017_datatype									
4119	4119	4119	4119	4119	4119	4119	4119	4119	4119	4119	4119	4119	4131	SAMPLE_COVERAGE_msk_solid_heme									
4120	4120	4120	4120	4120	4120	4120	4120	4120	4120	4120	4120	4120	4132	SAMPLE_COVERAGE_msk_solid_heme_datatype									
4121	4121	4121	4121	4121	4121	4121	4121	4121	4121	4121	4121	4121	4133	SAMPLE_COVERAGE_msk_solid_heme_priority									
4122	4122	4122	4122	4122	4122	4122	4122	4122	4122	4122	4122	4122	4134	SAMPLE_COVERAGE_mskarcher									
4123	4123	4123	4123	4123	4123	4123	4123	4123	4123	4123	4123	4123	4135	SAMPLE_COVERAGE_mskarcher_datatype									
4124	4124	4124	4124	4124	4124	4124	4124	4124	4124	4124	4124	4124	4136	SAMPLE_COVERAGE_mskarcher_priority									
4125	4125	4125	4125	4125	4125	4125	4125	4125	4125	4125	4125	4125	4137	SAMPLE_COVERAGE_mskimpact									
4126	4126	4126	4126	4126	4126	4126	4126	4126	4126	4126	4126	4126	4138	SAMPLE_COVERAGE_mskimpact_datatype									
4127	4127	4127	4127	4127	4127	4127	4127	4127	4127	4127	4127	4127	4139	SAMPLE_COVERAGE_mskimpact_heme									
4128	4128	4128	4128	4128	4128	4128	4128	4128	4128	4128	4128	4128	4140	SAMPLE_COVERAGE_mskimpact_heme_datatype									
4129	4129	4129	4129	4129	4129	4129	4129	4129	4129	4129	4129	4129	4141	SAMPLE_COVERAGE_mskimpact_heme_priority									
4130	4130	4130	4130	4130	4130	4130	4130	4130	4130	4130	4130	4130	4142	SAMPLE_COVERAGE_mskimpact_priority									
4131	4131	4131	4131	4131	4131	4131	4131	4131	4131	4131	4131	4131	4143	SAMPLE_COVERAGE_mskraindance									
4132	4132	4132	4132	4132	4132	4132	4132	4132	4132	4132	4132	4132	4144	SAMPLE_COVERAGE_mskraindance_datatype									
4133	4133	4133	4133	4133	4133	4133	4133	4133	4133	4133	4133	4133	4145	SAMPLE_COVERAGE_mskraindance_priority									
4134	4134	4134	4134	4134	4134	4134	4134	4134	4134	4134	4134	4134	4146	SAMPLE_COVERAGE_sclc_mskimpact_2017									
4135	4135	4135	4135	4135	4135	4135	4135	4135	4135	4135	4135	4135	4147	SAMPLE_COVERAGE_sclc_mskimpact_2017_datatype									
4136	4136	4136	4136	4136	4136	4136	4136	4136	4136	4136	4136	4136	4148	SAMPLE_COVERAGE_sclc_mskimpact_2017_priority									
4137	4137	4137	4137	4137	4137	4137	4137	4137	4137	4137	4137	4137	4149	SAMPLE_ID_mel_cell_2016									
4138	4138	4138	4138	4138	4138	4138	4138	4138	4138	4138	4138	4138	4150	SAMPLE_ID_mel_cell_2016_priority									
4139	4139	4139	4139	4139	4139	4139	4139	4139	4139	4139	4139	4139	4151	SAMPLE_TYPE_mixedpact									
4140	4140	4140	4140	4140	4140	4140	4140	4140	4140	4140	4140	4140	4152	SAMPLE_TYPE_mixedpact_priority									
4141	4141	4141	4141	4141	4141	4141	4141	4141	4141	4141	4141	4141	4153	SAMPLE_TYPE_msk_solid_heme									
4142	4142	4142	4142	4142	4142	4142	4142	4142	4142	4142	4142	4142	4154	SAMPLE_TYPE_msk_solid_heme_priority									
4143	4143	4143	4143	4143	4143	4143	4143	4143	4143	4143	4143	4143	4155	SAMPLE_TYPE_mskarcher									
4144	4144	4144	4144	4144	4144	4144	4144	4144	4144	4144	4144	4144	4156	SAMPLE_TYPE_mskarcher_priority									
4145	4145	4145	4145	4145	4145	4145	4145	4145	4145	4145	4145	4145	4157	SAMPLE_TYPE_mskimpact									
4146	4146	4146	4146	4146	4146	4146	4146	4146	4146	4146	4146	4146	4158	SAMPLE_TYPE_mskimpact_heme									
4147	4147	4147	4147	4147	4147	4147	4147	4147	4147	4147	4147	4147	4159	SAMPLE_TYPE_mskimpact_heme_priority									
4148	4148	4148	4148	4148	4148	4148	4148	4148	4148	4148	4148	4148	4160	SAMPLE_TYPE_mskimpact_priority									
4149	4149	4149	4149	4149	4149	4149	4149	4149	4149	4149	4149	4149	4161	SAMPLE_TYPE_mskraindance									
4150	4150	4150	4150	4150	4150	4150	4150	4150	4150	4150	4150	4150	4162	SAMPLE_TYPE_mskraindance_priority									
4151	4151	4151	4151	4151	4151	4151	4151	4151	4151	4151	4151	4151	4163	SAMPLE_TYPE_sclc_mskimpact_2017									
4152	4152	4152	4152	4152	4152	4152	4152	4152	4152	4152	4152	4152	4164	SAMPLE_TYPE_sclc_mskimpact_2017_priority									
4153	4153	4153	4153	4153	4153	4153	4153	4153	4153	4153	4153	4153	4165	SEX_mel_cell_2016									
4154	4154	4154	4154	4154	4154	4154	4154	4154	4154	4154	4154	4154	4166	SEX_mel_cell_2016_priority									
4155	4155	4155	4155	4155	4155	4155	4155	4155	4155	4155	4155	4155	4167	SEX_msk_solid_heme									
4156	4156	4156	4156	4156	4156	4156	4156	4156	4156	4156	4156	4156	4168	SEX_msk_solid_heme_priority									
4157	4157	4157	4157	4157	4157	4157	4157	4157	4157	4157	4157	4157	4169	SEX_mskarcher									
4158	4158	4158	4158	4158	4158	4158	4158	4158	4158	4158	4158	4158	4170	SEX_mskarcher_priority									
4159	4159	4159	4159	4159	4159	4159	4159	4159	4159	4159	4159	4159	4171	SEX_mskimpact									
4160	4160	4160	4160	4160	4160	4160	4160	4160	4160	4160	4160	4160	4172	SEX_mskimpact_heme									
4161	4161	4161	4161	4161	4161	4161	4161	4161	4161	4161	4161	4161	4173	SEX_mskimpact_heme_priority									
4162	4162	4162	4162	4162	4162	4162	4162	4162	4162	4162	4162	4162	4174	SEX_mskimpact_priority									
4163	4163	4163	4163	4163	4163	4163	4163	4163	4163	4163	4163	4163	4175	SEX_mskraindance									
4164	4164	4164	4164	4164	4164	4164	4164	4164	4164	4164	4164	4164	4176	SEX_mskraindance_priority									
4165	4165	4165	4165	4165	4165	4165	4165	4165	4165	4165	4165	4165	4177	SEX_sclc_mskimpact_2017									
4166	4166	4166	4166	4166	4166	4166	4166	4166	4166	4166	4166	4166	4178	SEX_sclc_mskimpact_2017_priority									
4167	4167	4167	4167	4167	4167	4167	4167	4167	4167	4167	4167	4167	4179	SOMATIC_STATUS_msk_solid_heme									
4168	4168	4168	4168	4168	4168	4168	4168	4168	4168	4168	4168	4168	4180	SOMATIC_STATUS_msk_solid_heme_priority									
4169	4169	4169	4169	4169	4169	4169	4169	4169	4169	4169	4169	4169	4181	SOMATIC_STATUS_mskarcher									
4170	4170	4170	4170	4170	4170	4170	4170	4170	4170	4170	4170	4170	4182	SOMATIC_STATUS_mskarcher_priority									
4171	4171	4171	4171	4171	4171	4171	4171	4171	4171	4171	4171	4171	4183	SOMATIC_STATUS_mskimpact									
4172	4172	4172	4172	4172	4172	4172	4172	4172	4172	4172	4172	4172	4184	SOMATIC_STATUS_mskimpact_heme									
4173	4173	4173	4173	4173	4173	4173	4173	4173	4173	4173	4173	4173	4185	SOMATIC_STATUS_mskimpact_heme_priority									
4174	4174	4174	4174	4174	4174	4174	4174	4174	4174	4174	4174	4174	4186	SOMATIC_STATUS_mskimpact_priority									
4175	4175	4175	4175	4175	4175	4175	4175	4175	4175	4175	4175	4175	4187	SOMATIC_STATUS_mskraindance									
4176	4176	4176	4176	4176	4176	4176	4176	4176	4176	4176	4176	4176	4188	SOMATIC_STATUS_mskraindance_priority									
4177	4177	4177	4177	4177	4177	4177	4177	4177	4177	4177	4177	4177	4189	STROMAL_SCORE_mel_cell_2016									
4178	4178	4178	4178	4178	4178	4178	4178	4178	4178	4178	4178	4178	4190	STROMAL_SCORE_mel_cell_2016_priority									
4179	4179	4179	4179	4179	4179	4179	4179	4179	4179	4179	4179	4179	4191	TREATMENT_DETAIL_BEFORE_PDX_brain_pdx_msk_2018									
4180	4180	4180	4180	4180	4180	4180	4180	4180	4180	4180	4180	4180	4192	TREATMENT_DETAIL_BEFORE_PDX_brain_pdx_msk_2018_priority									
4181	4181	4181	4181	4181	4181	4181	4181	4181	4181	4181	4181	4181	4193	TREATMENT_mel_cell_2016									
4182	4182	4182	4182	4182	4182	4182	4182	4182	4182	4182	4182	4182	4194	TREATMENT_mel_cell_2016_priority									
4183	4183	4183	4183	4183	4183	4183	4183	4183	4183	4183	4183	4183	4195	TUBULE_SCORE_ihch_impact_cmo_2018									
4184	4184	4184	4184	4184	4184	4184	4184	4184	4184	4184	4184	4184	4196	TUBULE_SCORE_ihch_impact_cmo_2018_attributetype									
4185	4185	4185	4185	4185	4185	4185	4185	4185	4185	4185	4185	4185	4197	TUMOR_CONTENT_mrt_bcgsc_2016									
4186	4186	4186	4186	4186	4186	4186	4186	4186	4186	4186	4186	4186	4198	TUMOR_CONTENT_mrt_bcgsc_2016_displayname									
4187	4187	4187	4187	4187	4187	4187	4187	4187	4187	4187	4187	4187	4199	TUMOR_PURITY_msk_impact_2017									
4188	4188	4188	4188	4188	4188	4188	4188	4188	4188	4188	4188	4188	4200	TUMOR_PURITY_msk_impact_2017_datatype									
4189	4189	4189	4189	4189	4189	4189	4189	4189	4189	4189	4189	4189	4201	TUMOR_PURITY_msk_solid_heme									
4190	4190	4190	4190	4190	4190	4190	4190	4190	4190	4190	4190	4190	4202	TUMOR_PURITY_msk_solid_heme_datatype									
4191	4191	4191	4191	4191	4191	4191	4191	4191	4191	4191	4191	4191	4203	TUMOR_PURITY_msk_solid_heme_priority									
4192	4192	4192	4192	4192	4192	4192	4192	4192	4192	4192	4192	4192	4204	TUMOR_PURITY_mskarcher									
4193	4193	4193	4193	4193	4193	4193	4193	4193	4193	4193	4193	4193	4205	TUMOR_PURITY_mskarcher_datatype									
4194	4194	4194	4194	4194	4194	4194	4194	4194	4194	4194	4194	4194	4206	TUMOR_PURITY_mskarcher_priority									
4195	4195	4195	4195	4195	4195	4195	4195	4195	4195	4195	4195	4195	4207	TUMOR_PURITY_mskimpact									
4196	4196	4196	4196	4196	4196	4196	4196	4196	4196	4196	4196	4196	4208	TUMOR_PURITY_mskimpact_datatype									
4197	4197	4197	4197	4197	4197	4197	4197	4197	4197	4197	4197	4197	4209	TUMOR_PURITY_mskimpact_heme									
4198	4198	4198	4198	4198	4198	4198	4198	4198	4198	4198	4198	4198	4210	TUMOR_PURITY_mskimpact_heme_datatype									
4199	4199	4199	4199	4199	4199	4199	4199	4199	4199	4199	4199	4199	4211	TUMOR_PURITY_mskimpact_heme_priority									
4200	4200	4200	4200	4200	4200	4200	4200	4200	4200	4200	4200	4200	4212	TUMOR_PURITY_mskimpact_priority									
4201	4201	4201	4201	4201	4201	4201	4201	4201	4201	4201	4201	4201	4213	TUMOR_PURITY_mskraindance									
4202	4202	4202	4202	4202	4202	4202	4202	4202	4202	4202	4202	4202	4214	TUMOR_PURITY_mskraindance_datatype									
4203	4203	4203	4203	4203	4203	4203	4203	4203	4203	4203	4203	4203	4215	TUMOR_PURITY_mskraindance_priority									
4204	4204	4204	4204	4204	4204	4204	4204	4204	4204	4204	4204	4204	4216	TUMOR_PURITY_sclc_mskimpact_2017									
4205	4205	4205	4205	4205	4205	4205	4205	4205	4205	4205	4205	4205	4217	TUMOR_PURITY_sclc_mskimpact_2017_datatype									
4206	4206	4206	4206	4206	4206	4206	4206	4206	4206	4206	4206	4206	4218	TUMOR_PURITY_sclc_mskimpact_2017_priority									
4207	4207	4207	4207	4207	4207	4207	4207	4207	4207	4207	4207	4207	4219	TUMOR_SIZE_bfn_duke_nus_2015									
4208	4208	4208	4208	4208	4208	4208	4208	4208	4208	4208	4208	4208	4220	TUMOR_SIZE_bfn_duke_nus_2015_datatype									
0														BIOPSY_SITE	SAMPLE	STRING	Site where sample was collected from.	Biopsy Site	1				
1														CLINICAL_BENEFIT	PATIENT	STRING	Patients have clinical benefit when mRECIST response is different than Progressive Disease.	Clinical Benefit	1				
2														CLINICAL_STAGE	PATIENT	STRING	Clinical stage of cancer.	Clinical Stage	1				
3														SPECIMEN_PRESERVATION_TYPE	SAMPLE	STRING	Indicates whether the sample is FFPE or not.	Specimen Preservation Type	1				
4														ICI_PATHWAY	PATIENT	STRING	Pathway that is being targeted by the ICI treatment.	ICI Pathway	1				
5														ICI_RX	PATIENT	STRING	Drug used for the treatment. Combination therapies, where more than one drug is administered, are represented by the name of both drugs.	ICI Drug	1				
6														ICI_TARGET	PATIENT	STRING	What is the target of the ICI drug.	ICI Drug Target	1				
7														METASTASIZED	SAMPLE	STRING	Indicates whether the cancer is metastatic or not.	Metastasized	1				
8														NEOICI_RX	SAMPLE	STRING	ICI drug given prior to surgery as a neoadjuvant	Neoici Rx	1				
9														NON_ICI_RX	SAMPLE	STRING	Which non ICI drugs did a patient get during the study. Combination therapies, where more than one procedure occurs, are represented by the name of both treatments.	Non Ici Rx	1				
10														POLYP_HISTOLOGY	SAMPLE	STRING	Polyp Histology	Polyp Histology	1				
11														PRIOR_ICI_RX	SAMPLE	STRING	ICI treatment(s) administered before the ICI treatment in the study. Combination therapies, where more than one procedure occurs, are represented by the name of both treatments.	Prior Ici Rx	1				
12														PRIOR_RX	SAMPLE	STRING	Treatment(s) a patient had before the ICI treatment in the study. Combination therapies, where more than one procedure occurs, are represented by the name of both treatments.	Prior Rx	1				
13														PROGRESSION	PATIENT	STRING	Progressors are defined as patients with mRECIST of Progressive Disease.	Progression	1				
14														RESPONDER	PATIENT	STRING	Responders are defined as patients with mRECIST of Partial Response or Complete Response, whereas Non-Responders are those with Progressive Disease or Stable Disease.	Responder	1				
15														RESPONSE	SAMPLE	STRING	Response to treatment following modified Response Evaluation Criteria in Solid Tumors (mRECIST) guidelines.	Response	1				
16														SAMPLE_TREATMENT	SAMPLE	STRING	The time of sample collection in relation to the ICI treatment time. Most of the datasets collected samples Pre treatment.	Sample Treatment	1				
17														SUBSQ_ICI_RX	SAMPLE	STRING	ICI treatment(s) administered after the ICI treatment in the study. Combination therapies, where more than one procedure occurs, are represented by the name of both treatments.	Subsq Ici Rx	1				
18														SUBSQ_RX	SAMPLE	STRING	Treatment(s) a patient had after the ICI treatment in the study. Combination therapies, where more than one procedure occurs, are represented by the name of both treatments.	Subsq Rx	1				
19														TIDE_NO_BENEFITS	SAMPLE	STRING	TIDE prediction of benefit to ICI treatment.	Tide No Benefits	1				
20														TIDE_RESPONDER	SAMPLE	STRING	TIDE prediction of response to ICI treatment.	Tide Responder	1				
21														TISSUE_SUBTYPE	PATIENT	STRING	Original tumor tissue subtype.	Tissue Subtype	1				
22														TUMOR_TISSUE_TYPE	SAMPLE	STRING	Type of tumor tissue collected	Tumor Tissue Type	1				
23														ETHNICITY	PATIENT	STRING	Ethnicity of the patient	Ethnicity	1				
24														GENDER	PATIENT	STRING	Patient gender	Gender	1				
25														RACE	PATIENT	STRING	Race of the patient	Race	1				
26														AGE_AT_DIAGNOSIS	PATIENT	NUMBER	Age At Diagnosis	Age at Diagnosis	1				
27														OS_STATUS	PATIENT	STRING	Overall Survival Status from Start of treatment	Overall Survival Status	1				
28														OS_MONTHS	PATIENT	NUMBER	Overall Survival (Months) from start of treatment	Overall Survival (Months)	1				
29														PFS_STATUS	PATIENT	STRING	Progression-Free Status from Start of treatment	Progression-Free Status	1				
30														PFS_MONTHS	PATIENT	NUMBER	Progression-Free (Months) from start of treatment	Progression-Free (Months)	1				
31														CANCER_TISSUE	SAMPLE	STRING	Original tumor tissue.	Cancer Tissue	1				
32														AMADEUS_STUDY	PATIENT	STRING	Tumor type described in the publication for the AMADEUS trial (Tsimberidou et al, 2024)	AMADEUS Cancer Type	1				
33														IMMUNE_SUBTYPE	SAMPLE	STRING	Immune Subtype described in Thorsson et al, 2018 e computed using the Immune Subtype Classifier tool (https://github.com/CRI-iAtlas/ImmuneSubtypeClassifier)	Immune Subtype	1				
34														TCGA_STUDY	PATIENT	STRING	TCGA Tumor type	TCGA Tumor type	1				
35														TCGA_SUBTYPE	SAMPLE	STRING	TCGA Tumor subtype	TCGA Tumor subtype	1				
